<DOC>
<DOCNO> FR940202-2-00001 </DOCNO>
<PARENT> FR940202-2-00001 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4703 -->

<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 22&blank;/&blank;Wednesday, February 2, 1994&blank;/&blank;Notices
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Vol. 59, No. 22
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
Wednesday, February 2, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00002 </DOCNO>
<PARENT> FR940202-2-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF AGRICULTURE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Forest Service</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=91 g=1 f=1 -->

<RINDOCK>RIN 0596&hyph;AA33</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Financial Security of National Forest System Timber Sale Contracts
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Forest Service, USDA.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice; adoption of final policy.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Forest Service is adopting final policy and procedure related to timber sale contract financial security. The
final policy will increase the amount of the bid guarantee, revise the method for determining damages for failure
to consummate a contract, eliminate the performance bond ceiling, and limit the applicability of the sale discounting
procedures. The intent of the final policy is to better protect the public's interest in the sale of National Forest
System timber by reducing the opportunity for speculative bidding and defaulting contract obligations. This policy
is being issued to guide Forest Service personnel as Amendment No. 2400&hyph;93&hyph;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=7 f=2 -->
XX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 to the Forest Service Manual (FSM) chapter 2430, Amendment No. 2400&hyph;93&hyph;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=7 f=2 -->
XX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 to FSM chapter 2450 and Amendment No. 2409.18&hyph;93&hyph;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=7 f=2 -->
XX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 to chapter 50 of FSH 2409.18, the Timber Sale Preparation Handbook.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
These amendments are effective February 2, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Questions about this policy should be addressed to Fred Walk, Timber Management Staff, Forest Service, USDA, P.O.
96090, Washington, DC 20090&hyph;6090, (202) 205&hyph;0858.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Background
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
After the timber market collapse of 1981, an unprecedent number of National Forest System timber sale contracts became
unprofitable. Some contracts were defaulted and others were ``bought out'' by the Government under the Federal Timber
Contract Payment Modification Act. The market decline during the 1980 period exposed a number of potential long-term
difficulties with National Forest System timber sale procedures which, if not remedied, could result in speculative
bidding and increase the potential for contract defaults in the future.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In 1982, the Forest Service began implementing a number of contract reforms to reduce speculative and unsound bidding,
to provide for an even flow of timber receipts into the Treasury, and to prevent sale defaults. The following changes
or additions to financial requirements on National Forest System sales were made:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The timber sale bid guarantee was raised to 5 percent of the advertised value of contract;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) A cash deposit was required. The initial deposit requirement was for 5 percent of the bid value of a sale; this was
later increased to 10 percent;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) The maximum amount of the performance bond was changed from $200,000 to $500,000; and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00003 </DOCNO>
<PARENT> FR940202-2-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=2 -->
(4) A midpoint payment to the Government was required to provide additional incentive for timely timber removal.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
These changes in timber sale financial requirements have been somewhat successful in stabilizing timber sale contracting
by encouraging performance; discouraging speculation; and more adequately securing contract performance. However,
additional changes are needed to further enhance financial security of timber sale contracts and to protect the taxpayer
from repudiation of bids and default of contracts.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Past experience indicates that prices being bid for Forest Service timber frequently rise substantially over the
advertised rates established by the agency's appraisal of the fair market value of the timber. The agency determines
the appraised value by using the selling value of lumber and other forest products or by using transaction evidence
of other comparable timber sales. When bid values far exceed advertised values and lumber selling values remain constant
or rise minimally, the potential for purchase financial loss increases. Thus, based on bidding experience, the Forest
Service believes that the public and the Government could be facing additional repudiations of bids and defaults
of contracts if lumber selling values do not keep pace with bid values and if additional financial security requirements
are not instituted. Accordingly, the agency believes it is essential to take additional steps to protect the public's
financial interests in timber sale contracts, assure timely execution and completion of contracts, and minimize
the financial risk to the Government. These additional financial security measure were published as a proposed policy
in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of December 7, 1990 (55 FR 50651).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Analysis and Response to Public Comments
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The comment period on the proposed policy closed January 7, 1991. Nineteen respondents submitted comments. The comments
came from 2 private citizens, 10 timber purchasers, 5 timber purchase associations, a preservation association,
and timber advocacy group. Of the 19 public comments received, 15 came from the West and 4 from the East. Fifty-eight
percent of the respondents expressed support for the policy proposals either in their entirety or with suggested
modification. The remaining 42 percent did not support the proposal primarily because of perceived increases in
the cost of doing business.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The following summarizes the comments and suggestions received on the proposed policy changes and the Department's
response to these in the final policy.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
1. Performance Guarantee Ceiling
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed policy would have eliminated the present $500,000 ceiling on the amount of performance guarantee required
by the timber sale contract and set the minimum performance guarantee at 10 percent of the bid value.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
One respondent suggested that, at the time of first entry into a sale area, the performance bond be equal to the present
value of the ``worse case'' outcome of the logging operation. The agency disagrees. The objective of a performance
guarantee or performance bond is to assure that the terms of the contract are met. Performance guarantees must protect
the interests of the Government. The respondent's suggestion would be impossible to administer. The Agency believes
that determining the ``worst case'' outcome would be highly subjective and subject to dispute between the contract
parties. The ``worst case'' outcome might be the default of a high priced sale which was later resold to determine damages.
Making a projection of some future resale value of a sale that may or may not be defaulted is speculative and could result
in very high performance bonds which would place an unfair economic burden on the majority of the timber purchasers
who fully perform their timber sale contracts.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Four respondents objected to eliminating the performance bond ceiling. They thought the change would result in increases
in their bonding requirements, put them at a competitive disadvantage, and discriminate against small business.
The agency recognizes that small business could be disadvantaged in obtaining bonding in excess of $500,000. Nevertheless,
the agency believes that only a few large and high value timber sales will require bonds of more than $500,000. The agency
is of the opinion that 10 percent of the bid value is a reasonable amount for providing the minimum amount of performance
bond to provide assurance of contract performance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Most of the timber sale contracts sold within the last 15 years have required a performance guarantee that was equivalent
to 10 percent of the bid value subject to certain maximum amounts. The maximum performance guarantee for sales sold
since the spring of 1982 has been $500,000. Removal of the $500,000 ceiling would ensure that the performance guarantee
amount would be applied equally to all sales. In the face of existing bids, the current ceiling could result in less
secure guarantees that purchasers of high-priced sales will perform their contracts. Removal of the ceiling on performance
guarantees should not affect many of those purchasers that ordinarily bid on National Forest timber sales. The removal
of the cap would only affect sales with more than $5 million bid value. Very few sales are this size, and few small businesses
buy timber sales that are this expensive. Therefore, the change would not stifle or constrain competition. What the
removal of the ceiling will do is help to deter speculation by increasing capital requirements and, thus, in these
large sales increase bidder financial liability in the event of default.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Having considered the comments received, the agency is retaining the elimination of the $500,000 upper limit on performance
bonds in the final policy.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
2. Increased Bid Guarantee
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under the proposed policy, the amount of bid guarantee required for bidding on National Forest System timber sales
would increase to 10 percent of the advertised value.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
One respondent suggested that the purchaser be required to pay the full amount of the winning bid at the time of the sale.
The agency believes this would place a severe economic hardship on timber purchasers that would result in a significant
decrease in competition and a reduction in receipts to Federal, State, and county treasuries. In some cases, requiring
full payment of bid value at time of sale could prevent companies from purchasing National Forest System timber resulting
in loss of employment and economic hardship to dependent communities.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00004 </DOCNO>
<PARENT> FR940202-2-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Five respondents were opposed to increasing the amount of bid guarantee to 10 percent of the advertised value. The
basis for their objection was that the additional bid guarantee would place an additional economic stress on the small
timber purchaser and would eliminate many from bidding. The agency disagrees. The bid guarantee (deposit with bid)
is a good faith showing that a timber sale high bidder will complete the requirements for contract award and will execute
the contract within the specified time period. The bid guarantee also serves as a measure of the ability of the bidder
to meet the financial requirements for a downpayment, periodic payment, and bonding capacity. Many bidders use bid
bonds as a bid guarantee rather than obligating their cash. If bid bonds are used, only the high bidder would be required
to convert the bid bond to cash, and it is not necessarily an increase in cash requirements for all bidders. The high
bidder's cash would then be used to offset the amount required for downpayment. The increase in bid guarantee from
5 percent to 10 percent of advertised value will result in the high bidder making a larger cash deposit for the approximately
30 days between the bid date and the due date for the downpayment. This short-term increased cash requirement could
create a financial hardship for some high bidders. The agency believes that this hardship is more than offset by the
increased protection from speculative bidding and from contract repudiation. The increase in bid guarantee will
also provide the government with increased financial security by providing a source of funds to satisfy the Government's
losses if the contract is repudiated. Therefore, an increase in bid guarantee to 10 percent of the advertised value
is adopted in the final policy.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
3. Procedures for Determining Contract Repudiation Damages
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed policy based the determination of damages resulting from repudiation of a bid on the terms contained
in timber sale contract provision C(T)9.4. Provision C(T)9.4 generally establishes damages as the difference between
current contract value at the time of breach and the bid value established upon resale. The proposed policy provided
the option of retaining the timber and establishing damages for breach based on appraised rather than resale value,
if resale could not be accomplished in the immediate future or if no bid was received at resale.
<!-- PJG 0012 frnewline -->
One respondent supported the concept that repudiation constitutes a breach of contract. The respondent suggested
that the penalty for this breach should not only exclude the bidder from participating in the resale, but also treat
damages as a default with the bidder being required to furnish double the normal downpayment until any default amount
is satisfied. The agency agrees with this comment. Repudiation of contracts will be handled under 36 CFR 223.49(e)
which requires that a purchaser or affiliate awarded a future Forest Service contract must meet additional downpayment
requirements under specific circumstances, including failure to perform in accordance with the terms of a timber
sale contract. The additional downpayment requirements are that such a purchaser must make a minimum downpayment
equal to 20 percent of the total advertised value, plus 40 percent of the total bid premium.
<!-- PJG 0012 frnewline -->
Three respondents suggested that repudiated contracts be offered and sold to the second high bidder at the price submitted
by that bidder. They further suggested that damages be determined as the difference between the original high bid
and the second high bid. This approach would be satisfactory in many instances. The agency believes, however, that
there will be instances where second high bidders would decline to accept the sale at the price they bid because of the
lapse of time from the bid date. When this occurs there would be no resale of the timber and, consequently, no basis for
determining damages. This approach would also present the risk of selling the sale at the lower second high bid when,
during an ascending market, open competitive bidding would result in a higher bid. Consequently, the final policy
retains the features of the proposed policy, and damage calculation will be based on offering the sale to the lower
bidders in descending order of their bids at the high bid price. If no bidder accepts the sale at the high bid price, it
would normally be reoffered at advertised rates for open bidding.
<!-- PJG 0012 frnewline -->
One respondent stated that the proposed policy was an over reaction to the problem and suggested that the government
make an estimate of repudiation damages before advertising and then set the bid guarantee accordingly. This approach
is similar to the concept of liquidated damages that is currently the method for determining damages resulting from
repudiation of service contracts. however, the agency believes that to adequately protect the public interest,
damages must be based on an actual loss or cost to the government and that estimating the damages of a potential repudiation
well in advance of the fact would be fraught with inaccuracies and very subjective. It would be very difficult to accurately
estimate bid rates 60 or more days in advance. In summary, this approach would not provide the government with an adequate
determination of damages resulting from repudiation of a bid.
<!-- PJG 0012 frnewline -->
Four respondents objected to the language of the proposed policy that would provide the Forest Service the option
of retaining the timber and establishing damages for this breach based on appraisal rather than resale, if resale
cannot be accomplished in the immediate future or if no bids are received on the resale. These respondents think that
the Forest Service must resell the repudiated sale in order to establish damages. They contend that if the repudiated
sale is withdrawn for some reason, the government has not suffered damages. They would establish damages based on
the resale value plus certain additional costs, such as interest and the cost of resale. The agency disagrees with
this comment. The effort and resources expended to prepare and offer a timber sale are made in good faith. Repudiations
add delay and costs regardless of subsequent events. Delay may cause loss of the opportunity to sell the timber at all
if timber is damaged or deteriorates due to fire, insects, or storm damage. Also legal or other government actions
such as new legislation, new court interpretations of existing law, or an agency listing of a wildlife species as threatened
or endangered may develop during or as a result of delay which make prompt resale not possible. Even though most sales
are reoffered for sale within six months, the agency strongly believes that damages based on the appraised value of
the sale plus administrative costs associated with the repudiation are appropriate if the sale cannot be reoffered.
<!-- PJG 0012 frnewline -->
Therefore, the final policy differs from the proposed policy only in that a bidder that repudiates a timber sale contract
will be subject to double down payment for future contracts. Under the final policy, when a sale is reoffered and the
resale bid price does not exceed the original purchaser's price plus certain additional costs (e.g. interest and
the cost of resale), damages are assessed at the amount of the deficiency. Further, the policy provides the Forest
Service the option of retaining the timber and establishing damages for this breach based on appraisal rather than
resale, when resale is not accomplished in the immediate future or if no bids are received at resale.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
4. Timber Sale Discounting
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed policy would have discontinued the discount procedure implemented on a forest-wide test basis on some
National Forests in western Oregon, western Washington, and northern California and would have applied the current
discounting procedures on an individual sale basis when timber characteristics support a need for immediate harvesting.
Instances might include fire-damaged, insect-damaged, and wind-thrown timber when prompt removal would support
the accomplishment of land management objectives and provide for optimal utilization of salvage timber.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00005 </DOCNO>
<PARENT> FR940202-2-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Four respondents objected to discontinuing the discounting test. They stated that discounting provides an incentive
to counter the hoarding tendency of some purchasers and enhances the continued harvest of timber sales in a timely
manner. These respondents think that an incentive-based approach encouraging early harvest is much better than
the proposed policy which they considered a disincentive. Two respondents objected to use of discounting procedures
on an individual sale basis. Stating that the proposal was inadequately defined, was an administrative over-reaction,
and was costly and complicated, these respondents concluded that the Forest Service will be reluctant to apply discounting
to individual sales.
<!-- PJG 0012 frnewline -->
The agency recognizes that incentives such as discounting are effective in encouraging early harvest of timber.
However, the agency believes that continued area-wide use of discounting as an inducement for early harvest of timber
is not warranted based on current market conditions, low volume of timber under contract, current rapid rates of harvest,
and anticipated lower sale levels. The agency believes that blanket use of discounting unnecessarily devalues the
timber when there is no need for prompt harvest of timber. Further, the agency believes the continued use of discounting
could contribute to speculative bidding by persons who expect to harvest timber early in the contract period. Such
speculation may result in an unfair competitive advantage for some purchasers. Also, if a purchaser's expectations
of early harvest cannot be realized, payment of undiscounted prices higher than expected could cause default.
<!-- PJG 0012 frnewline -->
Despite agency concerns about the blanket application of area-wide discounting, the agency believes that there
are some situations (e.g., early removal of fire-damaged, insect-damaged, and wind-thrown timber), where the use
of discounting can be warranted. In such situations, the expectation is that lower payment rates and the other disadvantages
of discounting will be more than offset by the benefits of prompt harvest of timber subject to rapid deterioration
and by protection of other resource values. Further, discounting procedures on an area-wide basis may become warranted
if the present market or other conditions is an area change to the degree that encouragement of prompt harvest is in
the government's interest. For example, high levels of uncut volume under contract could cause the agency to consider
area-wide use of discounting.
<!-- PJG 0012 frnewline -->
Recognizing that the discount procedures are complicated and that there could be some reluctance among Forest Service
officials to include discounting provisions in an individual timber sale contract or to seek approval for area-wide
use, the agency believes that justification and approval processes will ensure that discounting is applied only
where and when there is good rationale for its use.
<!-- PJG 0012 frnewline -->
Therefore, having considered all of the comments, the final policy on discounting is the same as that proposed. The
final policy provides for use of discounting upon an individual sale basis when specific situations justify the need
for immediate harvesting and on an area-wide basis only when warranted by market conditions and upon request of the
Regional Forester and approved by the Chief. Under the final policy, situations requiring the use of discounting
must be documented by the line officer with the authority to approve the sale on which it is to be used. When market conditions
warrant discounting on a National Forest or area-wide basis, the Regional Forester may request approval to use discounting
from the Chief of the Forest Service. The request for approval must document the existing and anticipated market conditions
(e.g., volume under contract, rate of removal, when volume is removed during the contract, expected sell levels)
for the Region or area affected.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Conclusion
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The objectives of the financial security measures contained in this final policy are to assure timely execution and
completion of timber sale contracts, to maintain competition by qualified bidders, to discourage speculation,
and to minimize the financial risk to the Government in instances where purchasers do not complete contracts.
<!-- PJG 0012 frnewline -->
The final policy eliminates the present $500,000 ceiling on the amount of performance guarantee required by the timber
Sale contract, and establishes the minimum performance guarantee at 10 percent of the total bid value.
<!-- PJG 0012 frnewline -->
The final policy increases the amount of bid guarantee required to bid on National Forest System timber sales to 10
percent of the total advertised value.
<!-- PJG 0012 frnewline -->
Under the final policy, repudiation of a bid will be considered a breach of contract and damages will be based on the
bid price of the reoffered timber plus administrative costs, such as the costs incurred by the government in making
the reoffer plus interest. Further, if no bids are received on the reoffered sale or if the timber cannot be immediately
reoffered due to delay or other factors, damages will be the difference between the repudiated bid value and the appraised
value of the reoffering. Administrative costs will then be added to the difference in values.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00006 </DOCNO>
<PARENT> FR940202-2-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The final policy discontinues the discounting procedure implemented on a forest-wide, test basis on some National
Forests in western Washington, Oregon and Northern California initiated in 1982 (47 FR 16181). The final policy provides
for Service-wide use of discounting upon an individual sale basis when specific situations justify the need for immediate
harvesting and on an area-wide basis only when warranted by market conditions and upon request of the Regional Forester
and approval by the Chief.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Regulatory Impact
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This action has been reviewed under USDA procedures and Executive Order 12291 on Federal Regulations. It has been
determined that this policy is not a major rule. The procedures implemented by this policy will not have an effect of
$100 million or more on the economy, substantially increase prices or costs for consumers, industry, State, or local
governments, nor adversely affect competition, employment, investment, productivity, innovation, or the ability
of United States-based enterprises to compete in foreign markets. In short, little or no effect on the National economy
will result from this notice of policy change. This action consists of administrative changes to policy for timber
sale contract financial security. With regard to the removal of the bond maximum, very few sales are over $5 million
in value; therefore, few sales or purchasers are involved. The largest of sales are more likely to affect large businesses
than small. The change in liability for repudiation of contract (by failing to provide the necessary bond; execute
the contract; or make the required cash deposit) will only have an effect on purchasers who do not consummate their
contracts. These purchasers are expected to be few in number. All prospective purchasers must submit a bid guarantee
with their bids. The guarantee is returned to the unsuccessful bidders after completion of the bid opening procedures.
Only the high bidder is required to maintain the bid guarantee until the contract is consummated. Under existing procedures,
the successful purchaser would have to provide a performance bond equal to 10 percent of the bid value and, in addition,
make a minimum cash deposit equal to 10 percent of the bid value within 30 days after notification of award. In view of
existing requirements, increasing the bid guarantee to 10 percent of the advertised value should have minimal effects
on purchasers.
<!-- PJG 0012 frnewline -->
This final policy has been analyzed in accordance with the principles and criteria contained in Executive Order 12630,
and it has been determined that the final policy does not pose the risk of a taking of constitutionally protected private
property.
<!-- PJG 0012 frnewline -->
Moreover, this policy has been considered in light of the Regulatory Flexibility Act (5 U.S.C. 601 et. seq.), and it
has been determined that this policy will not have a significant effect on a substantial number of small entities as
defined by the Act. Additional financial security measures do have some economic impact on all classes of businesses,
and the majority of the agency's timber sales are purchased by small businesses. However, the adopted measures have
the intended effect of preventing speculative bids, defaults, and repudiation of timber sales. Therefore, they
will benefit the majority of small businesses dependent on the agency's timber sales as a source of raw material, by
helping ensure that small businesses are not competing for the limited timber resource that is offered for sale against
businesses that speculatively bid or make a high bid and then lack the financial means to operate the sales. Moreover,
these measures will preserve the long-range revenues to affected counties and will reduce the adverse economic impacts
these entities would experience in the event of sale defaults.
<!-- PJG 0012 frnewline -->
Further, this policy has been reviewed under Executive Order 12778, Civil Justice Reform. Adoption of this policy
will have the following effect: (1) All state and local laws and regulations that are in conflict with this policy or
which would impede its full implementation are preempted; (2) the policy expressly repeals or modifies previous
policies; (3) the policy is not to be applied retroactively; (4) and no administrative procedures are necessary before
a party may file suit in court challenging this policy.
<!-- PJG 0012 frnewline -->
This policy will not result in additional paperwork not already required by law or not already approved for use. Therefore,
the review provisions of the Paperwork Reduction Act of 1980 (44 U.S.C. 3507) and implementing regulations at 5 CFR
part 1320 do not apply.
<!-- PJG 0012 frnewline -->
This policy deals with business practices related to timber sale contracts and, as such, has no direct effect on the
amount, location, or manner of timber offered for purchase. Section 31.1b, paragraph 2, of Forest Service Handbook
1909.15 (57 FR 43180; September 18, 1992) excludes from documentation in an environmental assessment or impact statement
``rules, regulations, or policies to establish Service-wide administrative procedures, program processes, or
instructions.'' Based on consideration of the comments received and the nature and scope of this policy, the Forest
Service has determined that this rule falls within this category of actions and that no extraordinary circumstances
exist which would require preparation of an environmental assessment or environmental impact statement (40 CFR
1508.4).
<!-- PJG 0012 frnewline -->
The text of the final policy as it will be issued in the Forest Service Manual and Timber Sale Preparation Handbook is
set out at the end of this notice.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 28, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
David M. Unger,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Chief.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00007 </DOCNO>
<PARENT> FR940202-2-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Financial Security Measures
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Forest Service Manual Chapter 2430, Commercial Timber Sales
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2431.33_Discounting. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The line officer with the authority to make the timber sale may approve the use of discounting procedures set forth
in FSH 2409.18, section 54.4 for an individual timber sale to:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Support a need for immediate harvesting, such as an economic incentive for early removal of fire-damaged, insect-damaged,
or wind-thrown timber; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Support the accomplishment of land management objectives; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Provide for optimal utilization of salvage timber. Document the need and rationale for discounting in the environmental
assessment or other environmental documentation prepared for the sale.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The use of discounting on an area-wide basis is permissible upon the Regional Forester's request and the Chief's approval
when remaining volume under contract in an area exceeds 3 times the Allowable Sale Quantity (ASQ) or exceeds 3 or more
years of sold volume whichever is greater. In making this determination, consider total unprocessed volume inventories
held by area purchasers. Base the request to provide a discounting incentive on the need for increasing or providing
an even flow of timber receipts to the Government.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2431.43_Bid Guarantee. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Require a bid guarantee of 10 percent of the advertised value for National Forest System timber sales.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2432.54_Bid Repudiation. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Consider a timber sale contract to be repudiated when a timber sale is not consummated because the high bidder fails
to make the downpayment, provide a performance bond, and/or execute the contract. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2432.54a_Notice to Purchaser. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Contracting Officer shall notify the bidder of the repudiation and breach of contract by certified mail. The date
of the receipt of notice shall be the date of the repudiation. Also, include notice that the bidder has breached the
contract and:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Is subject to exclusion from bidding on the resale pursuant to 36 CFR 223.86(a)(1).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. May be required to make downpayment equal to 20 percent of the total advertised value, plus 40 percent of the total
bid premium on future Forest Service contracts pursuant to 36 CFR 223.49(e).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2432.54b_Assessment of Damages. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Assess damages for a repudiated sale in the following manner and sequence:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Offer the sale to the second high bidder at the rates bid by the high bidder. If the second high bidder declines the
contract, offer it in turn to remaining bidders in the order of their bids. If any bidder accepts the contract offer
at the high bid rate, assess no damages.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. If there is no second high bidder, more than one second high bidder (tied), or all bidders decline the contract offer,
attempt to readvertise the repudiated sale within six months of repudiation at appropriate appraised rates.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. Determine damages based on the difference between the total resale bid value and the total value of the repudiated
contract. Add certain additional costs (such as interest and the cost of resale) as indicated in the applicable provision
of the sample contract prepared for the sale. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. If there are no bids on the readvertised sale, base damages on the difference between the readvertised appraised
value and the total bid value of the repudiated contract. Add certain additional costs (such as interest and the cost
of resale) as indicated by the applicable provision of the sample contract prepared for the sale.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. If the sale is not excepted to be readvertised within 6 months, base damages on the difference between the appraised
value of the repudiated contract as of date of repudiation and the total bid value of the repudiated contract. Add certain
additional costs (such as interest and the cost of resale) as indicated by the applicable provision of the sample contract
prepared for the repudiated sale.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Forest Service Manual Chapter 2450, Timber Sale Contract Administration
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
FSM 2456.14_Penal Sum of the Performance Bond. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The penal sum of the performance bond shall be at least 10 percent of the total bid value rounded up to the next $100 when
the bid value is $10,000 or less and the next $1,000 when the bid value exceeds $10,000. The bond may be higher than the
minimum amount of bond if needed to cover work required of the purchaser after the logging season is completed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Forest Service Handbook
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
FSH 2409.18, Timber Sale Preparation Handbook_Chapter 50, Final Package Preparation, Review, Appraisal and Offering

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
54.4_Discount of Payment Rates for Early Harvest. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Use the procedures of this section for individual sales or on an area-wide basis where discounting has been approved
(FSM 2431.33). Use the following guidelines in establishing discounted rates:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00008 </DOCNO>
<PARENT> FR940202-2-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Discounting of payment rates for early harvest may only be authorized for scaled sales. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Discount rates are a percentage factor based upon a combination of the interest rate being paid on money being borrowed
by the Treasury at the time of advertisement and the length of time before the sale termination date that material is
cut and scaled, up to a maximum discount of 25%. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. Make no discount for material scaled during the 12 months before termination of the sale. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. For material scaled 12 to 24 months before termination date, apply a discount factor of 50 percent of the Treasury
rate stated in the advertisement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
c. For material scaled 24 to 36 months before the termination date, apply a discount factor of 100 percent of the Treasury
rate stated in the advertisement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
d. For material scaled 36 to 48 months before the termination date, apply a discount factor of 150 percent of the Treasury
rate stated in the advertisement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
e. For material scaled 48 to 60 months before the termination date, apply a discount factor of 200 percent of the Treasury
rate stated in the advertisement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
f. For material scaled 60 to 72 months before the termination date, apply a discount factor of 250 percent of the Treasury
rate stated in the advertisement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
g. Make no discount factor exceeding 25 percent of the bid rates at any time. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 h. Apply no discount factor that reduces the miminum charge below that needed to ensure cost recovery of small business
opted road construction to be done by the Forest Service or that reduces the minimum charge below base rates. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
i. Apply no discount rate that reduces the minimum charge for a combination of species, product, and unit of measure
listed in the timer sale contract below the advertised rate for that combination. That is, limit the maximum discount
to the bid premium shown for each appraisal group listed. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR doc. 94&hyph;2302 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3410&hyph;11&hyph;M 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00009 </DOCNO>
<PARENT> FR940202-2-00002 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF COMMERCE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Economic Development Administration</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 930942&hyph;3331]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Federal Levee Repair Policy Under Economic Development Assistance for Disaster Relief Activities Under Public
Law 103&hyph;75, Chapter I; Correction
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Economic Development Administration (EDA), Department of Commerce.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Correction.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 In notice document 93&hyph;31632 beginning on page 69102 in the issue of Wednesday, December 29, 1993, make the following
correction:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On page 69102 in the first column, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 ``Preapplications in accordance with criteria set forth herein for levee repairs which are needed to protect critical
public infrastructure will be received until January 28, 1994.'' This should be changed to read ``Preapplications
or Letters of Intent (which describe the project location, scope of work, total estimated cost, and other pertinent
information necessary for the proposal evaluation) in accordance with criteria set forth herein for levee repairs
which are needed to protect critical public infrastructure will be received until February 18, 1994.''
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 27, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Wilbur F. Hawkins,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=3 -->
Acting Assistant Secretary for Economic Development.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2354 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;24&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00010 </DOCNO>
<PARENT> FR940202-2-00003 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Minority Business Development Agency</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Business Development Center Applications: Honolulu, HI</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Minority Business Development Agency, Commerce.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In accordance with Executive Order 11625 and 15 U.S.C. 1512, the Minority Business Development Agency (MBDA) is soliciting
competitive applications under its Minority Business Development Center (MBDC) Program. The total cost of performance
for the first budget period (12 months) from July 1, 1994 to June 30, 1995, is estimated at $333,125. The application
must include a minimum cost-share of 15% of the total project cost through non-Federal contributions. Cost-sharing
contributions may be in the form of cash contributions, clients fees, in-kind contributions or combinations thereof.
The MBDC will operate in the Honolulu, Hawaii Geographic Service Area.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The funding instrument for this project will be a cooperative agreement. Competition is open to individuals, non-profit
and for-profit organizations, state and local governments, American Indian tribes and educational institutions
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The MBDC program provides business development services to the minority business community to help establish and
maintain viable minority businesses. To this end, MBDA funds organizations to identify and coordinate public and
private sector resources on behalf of minority individuals and firms; to offer a full range of management and technical
assistance to minority entrepreneurs; and to serve as a conduit of information and assistance regarding minority
business.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Applications will be evaluated on the following criteria; The experience and capabilities of the firm and its staff
in addressing the needs of the business community in general and, specifically, the special needs of minority businesses,
individuals and organizations (50 points); the resources available to the firm in providing business development
services (10 points); the firm's approach (techniques and methodologies) to performing the work requirements included
in the application (20 points); and the firm's estimated cost for providing such assistance (20 points). An application
must receive at least 70% of the points assigned to each evaluation criteria category to be considered programmatically
acceptable and responsive. Those applications determined to be acceptable and responsive will then be evaluated
by the Director or MBDA. Final award selections shall be based on the number of points received, the demonstrated responsibility
of the applicant, and the determination of those most likely to further the purpose of the MBDA program. Negative audit
findings and recommendations and unsatisfactory performance under prior Federal awards may result in an application
not being considered for award. The applicant with the highest point score will not necessarily receive the award.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MBDC's shall be required to contribute at least 15% of the total project cost through non-Federal contributions.
To assist in this effort, the MBDCs may charge client fees for management and technical assistance (M&amp;TA) rendered.
Based on a standard rate of $50 per hour, the MBDC will charge client fees at 20% of the total cost for firms with gross
sales of $500,000 or less, and 35% of the total cost for firms with gross sales of over $500,000.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Quarterly reviews culminating in year-to-date evaluations will be conducted to determine if funding for the project
should continue. Continued funding will be at the total discretion of MBDA based on such factors as an MBDC's performance,
the availability of funds and Agency priorities.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The closing date for applications is March 21, 1994. Applications must be postmarked on or before March 21, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The mailing address for submission is: San Francisco Regional Office, Minority Business Development Agency, U.S.
Department of Commerce, 221 Main Street, Room 1280, San Francisco, California 94105, 415/744&hyph;3001.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A pre-application conference to assist all interested applicants will be held at the following address and time:
San Francisco Regional Office, Minority Business Development Agency, U.S. Department of Commerce, 221 Main Street,
Room 1280, San Francisco, California 94105, March 1, 1994 at 10 a.m.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Melda Cabrera, Regional Director, San Francisco Regional Office at 415/744&hyph;3001.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Anticipated processing time of this award is 120 days. Executive Office 12372, ``Intergovernmental Review of Federal
Programs,'' is not applicable to this program. The collection of information requirements for this project have
been approved by the Office of Management and Budget (OMB) and assigned OMB control number 0640&hyph;0006. Questions
concerning the preceding information can be answered by the contact person indicated above, and copies of application
kits and applicable regulations can be obtained at the above address.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Pre-Award Cost
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Applicants are hereby notified that if they incur any costs prior to an award being made, they do so solely at their
own risk of not being reimbursed by the Government. Notwithstanding any verbal assurance that an applicant may have
received, there is no obligation on the part of the Department of Commerce to cover pre-award costs.
<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00011 </DOCNO>
<PARENT> FR940202-2-00003 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Awards under this program shall be subject to all Federal laws, and Federal and Departmental regulations, policies,
and procedures applicable to Federal financial assistance awards.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Outstanding Account Receivable
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_No award of Federal funds shall be made to an applicant who has an outstanding delinquent Federal debt until either
the delinquent account is paid in full, a repayment schedule is established and at least one payment is received, or
other arrangements satisfactory to the Department of Commerce are made.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Name Check Policy
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_All non-profit and for-profit applications are subject to a name check review process. Name checks are intended
to reveal if any key individuals associated with the applicant have been convicted of or are presently facing criminal
charges such as fraud, theft, perjury, or other matters which significantly reflect on the applicant's management,
honesty or financial integrity.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Award Termination
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_The Departmental Grants Officers may terminate any grant/cooperative agreement in whole or in part at any time before
the date of completion whenever it is determined that the award recipient has failed to comply with the conditions
of the grant/cooperative agreement. Examples of some of the conditions which can cause termination are unsatisfactory
performance of MBDC work requirements, and reporting inaccurate or inflated claims of client assistance. Such inaccurate
or inflated claims may be deemed illegal and punishable by law.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
False Statements
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_A false statement on an application for Federal financial assistance is grounds for denial or termination of funds,
and grounds for possible punishment by a fine or imprisonment as provided in 18 U.S.C. 1001. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Primary Applicant Certifications
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_All primary applicants must submit a completed Form CD&hyph;511, ``Certifications Regarding Debarment, Suspension
and Other Responsibility Matters; Drug-Free Workplace Requirements and Lobbying.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Nonprocurement Debarment and Suspension
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Prospective participants (as defined at 15 CFR Part 26, Section 105) are subject to 15 CFR Part 26, ``Nonprocurement
Debarment and Suspension'' and the related section of the certification form prescribed above applies.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Drug Free Workplace
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Grantees (as defined at 15 CFR part 26, Section 605) are subject to 15 CFR part 26, Subpart F, ``Governmentwide Requirements
for Drug-Free Workplace (Grants)'' and the related section of the certification form prescribed above applies.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Anti-Lobbying
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Persons (as defined at 15 CFR part 28, Section 105) are subject to the lobbying provisions of 31 U.S.C. 1352, ``Limitation
on use of appropriated funds to influence certain Federal contracting and financial transactions,'' and the lobbying
section of the certification form prescribed above applies to applications/bids for grants, cooperative agreements,
and contracts for more than $100,000.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Anti-Lobbying Disclosures
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Any applicant that has paid or will pay for lobbying using any funds must subject an SF&hyph;LLL, ``Disclosure of
Lobbying Activities,'' as required under 15 CFR part 28, appendix B.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Lower Tier Certifications
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Recipients shall require applications/bidders for subgrants, contracts, subcontracts, or other lower tier covered
transactions at any tier under the award to submit, if applicable, a complete Form CD&hyph;512, ``Certifications
Regarding Debarment, Suspension, Ineligibility and Voluntary Exclusion-Lower Tier Covered Transactions and
Lobbying'' and disclosure form, SF&hyph;LLL, ``Disclosure of Lobbying Activities.'' Form CD&hyph;512 is intended
for the use of recipients and should not be transmitted to DOC. SF&hyph;LLL submitted by any tier recipient or subrecipient
should be submitted to DOC in accordance with the instructions contained in the award document.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
(Catalog of Federal Domestic Assistance 11.800 Minority Business Development)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Melda Cabrera,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Regional Director, San Francisco Regional Office.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2259 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;21&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00012 </DOCNO>
<PARENT> FR940202-2-00004 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Business Development Center Applications: Oxnard, California</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Minority Business Development Agency, Commerce.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In accordance with Executive Order 11625 and 15 U.S.C. 1512, the Minority Business Development Agency (MBDA) is soliciting
competitive applications under its Minority Business Development Center (MBDC) Program. The total cost of performance
for the first budget period (12 months) from July 1, 1994 to June 30, 1995, is estimated at $222,196. The application
must include a minimum cost-share of 15% of the total project cost through non-Federal contributions. Cost-sharing
contributions may be in the form of cash contributions, clients fees, in-kind contributions or combinations thereof.
The MBDC will operate in the Oxnard, California Geographic Service Area.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The funding instrument for this project will be a cooperative agreement. Competition is open to individuals, non-profit
and for-profit organizations, state and local governments, American Indian tribes and educational institutions.
<!-- PJG 0012 frnewline -->
The MBDC program provides business development services to the minority business community to help establish and
maintain viable minority businesses. To this end, MBDA funds organizations to identify and coordinate public and
private sector resources on behalf of minority individuals and firms; to offer a full range of management and technical
assistance to minority entrepreneurs; and to serve as a conduit of information and assistance regarding minority
business.
<!-- PJG 0012 frnewline -->
Applications will be evaluated on the following criteria: the experience and capabilities of the firm and its staff
in addressing the needs of the business community in general and, specifically, the special needs of minority businesses,
individuals and organizations (50 points); the resources available to the firm in providing business development
services (10 points); the firm's approach (techniques and methodologies) to performing the work requirements included
in the application (20 points); and the firm's estimated cost for providing such assistance (20 points). An application
must receive at least 70% of the points assigned to each evaluation criteria category to be considered programmatically
acceptable and responsive. Those applications determined to be acceptable and responsive will then be evaluated
by the Director of MBDA. Final award selections shall be based on the number of points received, the demonstrated responsibility
of the applicant, and the determination of those most likely to further the purpose of the MBDA program. Negative audit
findings and recommendations and unsatisfactory performance under prior Federal awards may result in an application
not being considered for award. The applicant with the highest point score will not necessarily receive the award.
<!-- PJG 0012 frnewline -->
MBDCs shall be required to contribute at least 15% of the total project cost through non-Federal contributions. To
assist in this effort, the MBDCs may charge client fees for management and technical assistance (M&amp;TA) rendered.
Based on a standard rate of $50 per hour, the MBDC will charge client fees at 20% of the total cost for firms with gross
sales of $500,000 or less, and 35% of the total cost for firms with gross sales of over $500,000.
<!-- PJG 0012 frnewline -->
Quarterly reviews culminating in year-to-date evaluations will be conducted to determine if funding for the project
should continue. Continued funding will be at the total discretion of MBDA based on such factors as an MBDC's performance,
the availability of funds and Agency priorities.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The closing date for applications is March 21, 1994. Applications must be postmarked on or before March 21, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The mailing address for submission is: San Francisco Regional Office, Minority Business Development Agency, U.S.
Department of Commerce, 221 Main Street, room 1280, San Francisco, California 94105, 415/744&hyph;3001.
<!-- PJG 0012 frnewline -->
A pre-application conference to assist all interested applicants will be held at the following address and time:
San Francisco Regional Office, Minority Business Development Agency, U.S. Department of Commerce, 221 Main Street,
room 1280, San Francisco, California 94105, March 1, 1994 at 10 a.m.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Melda Cabrera, Regional Director, San Francisco Regional Office at 415/744&hyph;3001.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Anticipated processing time of this award is 120 days. Executive Order 12372, ``Intergovernmental Review of Federal
Programs,'' is not applicable to this program. The collection of information requirements for this project have
been approved by the Office of Management and Budget (OMB) and assigned OMB control number 0640&hyph;0006. Questions
concerning the preceding information can be answered by the contact person indicated above, and copies of application
kits and applicable regulations can be obtained at the above address.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Pre-Award Costs_
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicants are hereby notified that if they incur any costs prior to an award being made, they do so solely at their own
risk of not being reimbursed by the Government. Notwithstanding any verbal assurance that an applicant may have received,
there is no obligation on the part of the Department of Commerce to cover pre-award costs.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00013 </DOCNO>
<PARENT> FR940202-2-00004 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Awards under this program shall be subject to all Federal laws, and Federal and Departmental regulations, policies,
and procedures applicable to Federal financial assistance awards. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Outstanding Account Receivable
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_No award of Federal funds shall be made to an applicant who has an outstanding delinquent Federal debt until either
the delinquent account is paid in full, a repayment schedule is established and at least one payment is received, or
other arrangements satisfactory to the Department of Commerce are made. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Name Check Policy
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_All non-profit and for-profit applicants are subject to a name check review process. Name checks are intended to
reveal if any key individuals associated with the applicant have been convicted of or are presently facing criminal
charges such as fraud, theft, perjury, or other matters which significantly reflect on the applicant's management,
honesty or financial integrity.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Award Termination
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_The Departmental Grants Officer may terminate any grant/cooperative agreement in whole or in part at any time before
the date of completion whenever it is determined that the award recipient has failed to comply with the conditions
of the grant/cooperative agreement. Examples of some of the conditions which can cause termination are unsatisfactory
performance of MBDC work requirements, and reporting inaccurate or inflated claims of client assistance. Such inaccurate
or inflated claims may be deemed illegal and punishable by law.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
False Statements
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_A false statement on an application for Federal financial assistance is grounds for denial or termination of funds,
and grounds for possible punishment by a fine or imprisonment as provided in 18 U.S.C. 1001.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Primary Applicant Certifications
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_All primary applicants must submit a completed Form CD&hyph;511, ``Certifications Regarding Debarment, Suspension
and Other Responsibility Matters; Drug-Free Workplace Requirements and Lobbying.''
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Nonprocurement Debarment and Suspension
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Prospective participants (as defined at 15 CFR part 26, section 105) are subject to 15 CFR Part 26, ``Nonprocurement
Debarment and Suspension'' and the related section of the certification form prescribed above applies.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Drug Free Workplace
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Grantees (as defined at 15 CFR part 26, section 605) are subject to 15 CFR Part 26, Subpart F, ``Governmentwide Requirements
for Drug-Free Workplace (Grants)'' and the related section of the certification form prescribed above applies.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Anti-Lobbying
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Persons (as defined at 15 CFR part 28, section 105) are subject to the lobbying provisions of 31 U.S.C. 1352, ``Limitation
on use of appropriated funds to influence certain Federal contracting and financial transactions,'' and the lobbying
section of the certification form prescribed above applies to applications/bids for grants, cooperative agreements,
and contracts for more than $100,000.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Anti-Lobbying Disclosures
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Any applicant that has paid or will pay for lobbying using any funds must submit an SF&hyph;LLL, ``Disclosure of Lobbying
Activities,'' as required under 15 CFR part 28, appendix B.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Lower Tier Certifications
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Recipients shall require applications/bidders for subgrants, contracts, subcontracts, or other lower tier covered
transactions at any tier under the award to submit, if applicable, a completed Form CD&hyph;512, ``Certifications
Regarding Debarment, Suspension, Ineligibility and Voluntary Exclusion-Lower Tier Covered Transactions and
Lobbying'' and disclosure form, SF&hyph;LLL, ``Disclosure of Lobbying Activities.'' Form CD&hyph;512 is intended
for the use of recipients and should not be transmitted to DOC. SF&hyph;LLL submitted by any tier recipient or subrecipient
should be submitted to DOC in accordance with the instructions contained in the award document.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
11.800 Minority Business Development (Catalog of Federal Domestic Assistance)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Melda Cabrera,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Regional Director San Francisco Regional Office.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2260 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;21&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00014 </DOCNO>
<PARENT> FR940202-2-00005 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Business Development Center Applications: State of Alaska</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Minority Business Development Agency, Commerce.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In accordance with Executive Order 11625 and 15 U.S.C. 1512, the Minority Business Development Agency (MBDA) is soliciting
competitive applications under its Minority Business Development Center (MBDC) Program. The total cost of performance
for the first budget period (12 months) from July 1, 1994 to June 30, 1995, is estimated at $198,971. The application
must include a minimum cost-share of 15% of the total project cost through non-Federal contributions, clients fees,
in-kind contributions or combinations thereof. The MBDC will operate in the State of Alaska Geographic Service Area.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The funding instrument for this project will be a cooperative agreement. Competition is open to individuals, non-profit
and for-profit organizations, state and local governments, American Indian tribes and educational institutions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The MBDC program provides business development services to the minority business community to help establish and
maintain viable minority businesses. To this end, MBDA funds organizations to identify and coordinate public and
private sector resources on behalf of minority individuals and firms; to offer a full range of management and technical
assistance to minority entrepreneurs; and to serve as a conduit of information and assistance regarding minority
business.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Applications will be evaluated on the following criteria: the experience and capabilities of the firm and its staff
in addressing the needs of the business community in general and, specifically, the special needs of minority businesses,
individuals and organizations (50 points); the resources available to the firm in providing business development
services (10 points); the firm's approach (techniques and methodologies) to performing the work requirements included
in the applications (20 points); and the firm's estimated cost for providing such assistance (20 points). An application
must receive at least 70% of the points assigned to each evaluation criteria category to be considered programmatically
acceptable and responsive. Those applications determined to be acceptable and responsive will then be evaluated
by the Director of MBDA. Final award selections shall be based on the number of points received, the demonstrated responsibility
of the applicant, and the determination of those most likely to further the purpose of the MBDA program. Negative audit
findings and recommendations and unsatisfactory performance under prior Federal awards may result in an application
not being considered for award. The applicant with the highest point score will not necessarily receive the award.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MBDCs shall be required to contribute at least 15% of the total project cost through non-Federal contributions. To
assist in this effort, the MBDCs may charge client fees for management and technical assistance (M&amp;TA) rendered.
Based on a standard rate of $50 per hour, the MBDC will charge client fees at 20% of the total cost for firms with gross
sales of $500,000 or less, and 35% of the total cost for firms with gross sales of over $500,000.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Quarterly reviews culminating in year-to-date evaluations will be conducted to determine in funding for the project
should continue. Continued funding will be at the total discretion of MBDA based on such factors as an MBDC's performance,
the availability of funds and Agency priorities.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The closing date for applications in March 21, 1994. Applications must be postmarked on or before March 21, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The mailing address for submission is: San Francisco Regional Office, Minority Business Development Agency, U.S.
Department of Commerce, 221 Main Street, room 1280, San Francisco, California 94105, 415/744&hyph;3001.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A pre-application conference to assist all interested applicants will be held at the following address and time:
San Francisco Regional Office, Minority Business Development Agency, U.S. Department of Commerce, 221 Main Street,
room 1280, San Francisco, California 94105, 415/744&hyph;3001, March 1, 1994 at 10 a.m.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Melda Cabrera, Regional Director San Francisco Regional Office at 415/744&hyph;3001.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Anticipated processing time of this award is 120 days. Executive Order 12372, ``Intergovernmental Review of Federal
Programs,'' is not applicable to this program. The collection of information requirements for this project have
been approved by the Office of Management and Budget (OMB) and assigned OMB control number 0640&hyph;0006. Questions
concerning the preceding information can be answered by the contract person indicated above, and copies of application
kits and applicable regulations can be obtained at the above address.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Pre-Award Cost
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Applicants are hereby notified that if they incur any costs prior to an award being made, they do so solely at their
own risk of not being reimbursed by the Government. Notwithstanding any verbal assurance that an applicant may have
received, there is no obligation on the part of the Department of Commerce to cover pre-award costs.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00015 </DOCNO>
<PARENT> FR940202-2-00005 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Awards under this program shall be subject to all Federal laws, and Federal and Departmental regulations, policies,
and procedures applicable to Federal financial assistance awards. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Outstanding Account Receivable
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_No award of Federal funds shall be made to an applicant who has an outstanding delinquent Federal debt until either
the delinquent account is paid in full, a repayment schedule is established and at least one payment is received, or
other arrangements satisfactory to the Department of Commerce are made. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Name Check Policy
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_All non-profit and for-profit applicants are subject to a name check review process. Name checks are intended to
reveal if any key individuals associated with the applicant have been convicted of or are presently facing criminal
charges such as fraud, theft, perjury, or other matters which significantly reflect on the applicant's management,
honesty or financial integrity. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Award Termination
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_The Department Grants Officer may terminate any grant/cooperative agreement in whole or in part at any time before
the date of completion whenever it is determined that the award recipient has failed to comply with the conditions
of the grant/cooperative agreement. Examples of some of the conditions which can cause termination are unsatisfactory
performance of MBDC work requirements, and reporting inaccurate or inflated claims of client assistance. Such inaccurate
or inflated claims may be deemed illegal and punishable by law. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
False Statements
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_A false statement on an application for Federal financial assistance is grounds for denial or termination of funds,
and grounds for possible punishment by a fine or imprisonment as provided in 18 U.S.C. 1001. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Primary Applicant Certifications
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_All primary applicants must submit a completed Form CD&hyph;511, ``Certifications Regarding Debarment, Suspension
and Other Responsibility Matters; Drug-Free Workplace Requirements and Lobbying.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Nonprocurement Debarment and Suspension
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Prospective participants (as defined at 15 CFR part 26, section 105) are subject to 15 CFR part 26, ``Nonprocurement
Debarment and Suspension'' and the related section of the certification form prescribed above applies. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Drug Free Workplace
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Grantees (as defined at 15 CFR part 26, section 605) are subject to 15 CFR Part 26, Subpart F, ``Governmentwide Requirements
for Drug-Free Workplace (Grants)'' and the related section of the certification form prescribed above applies.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Anti-Lobbying
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Persons (as defined at 15 CFR part 28, section 105) are subject to the lobbying provisions of 31 U.S.C. 1352, ``Limitation
on use of appropriated funds to influence certain Federal contracting and financial transactions,'' and the lobbying
section of the certification form prescribed above applies to applications/bids for grants, cooperative agreements,
and contracts for more than $100,000. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Anti-Lobbying Disclosures
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Any applicant that has paid or will pay for lobbying using any funds must submit an SF&hyph;LLL, ``Disclosure of Lobbying
Activities,'' as required under 15 CFR part 28, appendix B. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Lower Tier Certifications
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Recipients shall require applications/bidders for subgrants, contracts, subcontracts, or other lower tier covered
transactions at any tier under the award to submit, if applicable, a complete Form CD&hyph;512, ``Certifications
Regarding Debarment, Suspension, Ineligibility and Voluntary Exclusion-Lower Tier Covered Transactions and
Lobbying'' and disclosure form, SF&hyph;LLL, ``Disclosure of Lobbying Activities.'' Form CD&hyph;512 is intended
for the use of recipients and should not be transmitted to DOC. SF&hyph;LLL submitted by any tier recipient or subrecipient
should be submitted to DOC in accordance with the instructions contained in the award document.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
(Catalog of Federal Domestic Assistance 11.800 Minority Business Development)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Melda Cabrera, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Regional Director, San Francisco Regional Office. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2258 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;21&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00016 </DOCNO>
<PARENT> FR940202-2-00006 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>National Oceanic and Atmospheric Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[I.D. 012593C] </RINDOCK>
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Shrimp Fishery of the Gulf of Mexico; Public Hearings </DOCTITLE>
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
National Marine Fisheries Service (NMFS), National Oceanic and Atmospheric Administration (NOAA), Commerce.

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of public hearings and request for comments. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Gulf of Mexico Fishery Management Council (Council) will convene two public hearings on draft Amendment 7 to the
Fishery Management Plan for the Shrimp Fishery of the Gulf of Mexico. Amendment 7 proposes to: (1) Define overfishing
for white shrimp; (2) provide for a framework adjustment for the overfishing definitions for brown, white, and pink
shrimp; (3) revise the overfishing definition for royal red shrimp; and (4) eliminate the total allowable level of
foreign fishing to allow the domestic fleet to harvest the optimum yield. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Written comments on the proposed action must be received by April 22, 1994. The hearings are scheduled as follows:
Wednesday, February 23, 1994, in Galveston, Texas, from 6 p.m. to 8 p.m. and Thursday, March 3, 1994, in Corpus Christi,
Texas from 2 p.m. to 4 p.m. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments should be addressed to Wayne E. Swingle, Executive Director, Gulf of Mexico Fishery Management Council,
5401 West Kennedy Boulevard, suite 331, Tampa, FL 33609. The hearings will be held at the following locations: 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
1. Galveston, Texas_Ballroom North, Holiday Inn on the Beach, 5002 Seawall Boulevard, Galveston, Texas 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
2. Corpus Christi, Texas_Marriott Bayfront Hotel, 900 Shoreline Boulevard, Corpus Christi, Texas. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0065 forcenewline -->
0
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Terrance R. Leary, 813&hyph;228&hyph;2815. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The hearings are physically accessible to people with disabilities. Requests for sing language interpretation
or other auxiliary aids should be directed to Laura Mataluni at the above Council address by February 15, 1994. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 27, 1994. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
David S. Crestin, 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Office of Fisheries Conservation and Management National Marine Fisheries Service. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2347 Filed 2&hyph;1&hyph;94; 8:45 am] 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;22&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00017 </DOCNO>
<PARENT> FR940202-2-00007 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>National Telecommunications and Information Administration (NTIA)</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Public Hearing on Universal Service and the National Information Infrastructure </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NTIA will hold a public hearing, titled ``Telecommunications to Serve the Cities_Universal Service in Urban America''
in Los Angeles, California at the California Museum of Science and Industry (Exposition Park), Mark Taper Hall of
Economics and Finance, Seminar Room, second floor, on February 16, 1994, from 8 a.m. to 4 p.m. Demonstrations of advanced
telecommunications technologies will be held from 11:30 a.m. to 4 p.m. at the California Afro-American Museum at
600 Exposition Park. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
To register for the hearing, fax or mail to Yvette Barrett, NTIA, Room 4888, Herbert C. Hoover Building, 14th and Constitution
Ave. NW., Washington, DC 20230, fax (202) 482&hyph;6173, on or before February 14, 1994, the following information:
name, title, company/affiliation, address, telephone number, fax number, areas of interest, and whether written
testimony is intended to be provided for the record. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Joann Anderson, (202) 482&hyph;1880, Office of Policy Analysis and Development. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Larry Irving, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Secretary for Communications and Information. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2405 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;60&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00018 </DOCNO>
<PARENT> FR940202-2-00008 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Patent and Trademark Office</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Meeting of the Public Advisory Committee for Trademark Affairs</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Patent and Trademark Office, Commerce.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Change in notice of public meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The location of the meeting of the Public Advisory Committee for Trademark Affairs, published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 of January 18, 1994, (59 FR 2597) has been changed.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PLACE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
U.S. Patent and Trademark Office, 2900 Crystal Drive, South Tower Building, Arlington, Virginia, in the Lobby level
Conference Room.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 28, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Fred E. McKelvey,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Assistant Secretary of Commerce and Acting Commissioner of Patents and Trademarks.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2350 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;16&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00019 </DOCNO>
<PARENT> FR940202-2-00009 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>COMMITTEE FOR THE IMPLEMENTATION OF TEXTILE AGREEMENTS</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Adjustment of an Import Limit for Certain Cotton and Man-Made Fiber Textile Products Produced or Manufactured in
Guatemala</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Committee for the Implementation of Textile Agreements (CITA).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Issuing a directive to the Commissioner of Customs increasing a limit.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Januay 31, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Nicole Bivens Collinson, International Trade Specialist, Office of Textiles and Apparel, U.S. Department of Commerce,
(202) 482&hyph;4212. For information on the quota status of this limit, refer to the Quota Status Reports posted on
the bulletin boards of each Customs port or call (202) 927&hyph;5850. For information on embargoes and quota re-openings,
call (202) 482&hyph;3715.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Executive Order 11651 of March 3, 1972, as amended; section 204 of the Agricultural Act of 1956, as amended (7 U.S.C.
1854).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The current limit for Categories 351/651 is being increased by recrediting unused carryforward.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A description of the textile and apparel categories in terms of HTS numbers is available in the CORRELATION: Textile
and Apparel Categories with the Harmonized Tariff Schedule of the United States (see 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice 58 FR 62645, published on November 29, 1993). Also see 58 FR 61679, published on November 22, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The letter to the Commissioner of Customs and the actions taken pursuant to it are not designed to implement all of the
provisions of the bilateral agreement, but are designed to assist only in the implementation of certain of its provisions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Rita D. Hayes,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chairman, Committee for the Implementation of Textile Agreements.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Committee for the Implementation of Textile Agreements
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=34 g=1 f=1 -->
January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Commissioner of Customs,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Department of the Treasury, Washington, DC 20229.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Dear Commissioner: This directive amends, but does not cancel, the directive issued to you on November 12, 1993, by
the Chairman, Committee for the Implementation of Textile Agreements. That directive concerns imports of certain
cotton, wool and man-made fiber textile products, produced or manufactured in Guatemala and exported during the
twelve-month period beginning on January 1, 1994 and extending through December 31, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Effective on January 31, 1994, you are directed to increase the limit for Categories 351/651 to 212,000 dozen
<FOOTCITE></FOOTCITE>

<FOOTCITE>1</FOOTCITE>
, as provided under the terms of the current bilateral agreement between the Governments of the United States and Guatemala.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=3 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=3 -->
The limit has not been adjusted to account for any imports exported after December 31, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
The guaranteed access level for Categories 351/651 remains unchanged.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Committee for the Implementation of Textile Agreements has determined that this action falls within the foreign
affairs exception to the rulemaking provisions of 5 U.S.C. 553(a)(1).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sincerely,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=3 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=06 g=1 f=1 -->
Rita D. Hayes,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chairman, Committee for the Implementation of Textile Agreements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2353 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;DR&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00020 </DOCNO>
<PARENT> FR940202-2-00010 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF DEFENSE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Department of the Navy</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Notice of Intent to Prepare an Environmental Impact Statement for Proposed Realignment of Naval Air Warfare Center,
Patuxent River, MD
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to section 102(2)(C) of the National Environmental Policy Act of 1969, as implemented by the Council on Environmental
Quality regulations (40 CFR parts 1500&hyph;1508), the Department of the Navy announces its intent to prepare an
Environmental Impact Statement (EIS) to evaluate the environmental effects of the realignment of Naval Air Warfare
Center, Aircraft Division (NAWCAD) Patuxent River, Lexington Park, Maryland. This action is being conducted in
accordance with the Defense Base Closure and Realignment Act of 1990 (Pub. L. 101&hyph;510) and the specific 1993
base closure and realignment decisions which became effective in September 1993.
<!-- PJG 0012 frnewline -->
The proposed action involves the relocation of personnel and activities from the Naval Air Systems Command, Arlington,
Virginia, and from NAWCAD Trenton, New Jersey, to NAWCAD Patuxent River and, possibly, to the Naval Electronic Systems
Engineering Activity (NESEA) site, St. Inigoes, Maryland. The Navy was directed to close NESEA St. Inigoes by the
same 1993 base closure and realignment decisions; however, it was decided that the property would not be disposed
of, but would be transferred to the Naval Air Systems Command to support its relocation to southeastern Maryland.
<!-- PJG 0012 frnewline -->
In order to meet the facility and operational requirements of the realigning activities at the two receiving sites,
the realignment will require 500,000 to 700,000 square feet of facilities. These facility and operational requirements
will be met through the utilization of existing space (renovation of buildings) and/or new construction of facilities,
such as administrative buildings, parking structures, test labs and other support facilities. Approximately 3,000
additional personnel, with their dependents, will relocate to support the various activities.
<!-- PJG 0012 frnewline -->
Alternatives addressed in the EIS will focus on means of meeting realignment requirements at NAWCAD Patuxent River,
including alternative construction site locations. The EIS will discuss environmental impacts resulting from
the construction and operation of facilities as well as expected associated impacts to the local communities resulting
from the relocation of military and civilian personnel and their dependents. Major environmental issues that will
be addressed in the EIS will include, but not be limited to, impacts on cultural resources, terrestrial and aquatic
habitats, stormwater runoff, noise, and air quality. Other impacts to be considered will include impacts to community
services, such as school capacity, infrastructure, and traffic. Cumulative impacts associated with the realignment
of all personnel and activities to the region around NAWCAD Patuxent River will be considered.
<!-- PJG 0012 frnewline -->
The Navy will initiate a scoping process for the purpose of determining the scope of issues to be addressed and for identifying
the significant issues related to this action. The Navy will hold a public scoping meeting on Thursday, February 17,
1994, beginning at 7 p.m. at the Carter Office Building, Leonardtown, Maryland. The meeting will be advertised in
Southern Maryland tri-county area newspapers.
<!-- PJG 0012 frnewline -->
A brief presentation will precede requests for public comment. Navy representatives will be available at this meeting
to receive comments from the public regarding issues of concern. It is important that federal, state, and local agencies
and interested individuals take this opportunity to identify environmental concerns that should be addressed during
the preparation of the EIS. In the interest of available time, each speaker will be asked to limit his/her oral comments
to five minutes.
<!-- PJG 0012 frnewline -->
Agencies and the public are also invited and encouraged to provide written comments in addition to, or in lieu of, oral
comments at the public meeting. To be most helpful, scoping comments should clearly describe specific issues or topics
which the commentor believes the EIS should address. Written statements and or questions regarding the scoping process
should be mailed to: Commanding Officer, Naval Air Station Patuxent River, Building 407, Patuxent River, Maryland
20670&hyph;5409, (Attn: Joan Hinson), telephone (301) 826&hyph;7512. All comments must be received no later than
March 28, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 28, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Michael P. Rummel,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
LCDR, JAGC, USN, Federal Register Liaison Officer.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2348 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3810&hyph;AE&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00021 </DOCNO>
<PARENT> FR940202-2-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Intent To Prepare an Environmental Impact Statement for Proposed Disposal And Reuse of Naval Air Station Glenview,
Glenview, IL</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to the National Environmental Policy Act as implemented by the Council on Environmental Quality regulations
(40 CFR parts 1500&hyph;1508), the Department of the Navy announces its intent to prepare an Environmental Impact
Statement (EIS) to evaluate the environmental effects of the disposal and reuse of Naval Air Station (NAS) Glenview,
Glenview, Illinois.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In accordance with recommendations of the 1993 Base Closure and Realignment Commission, the Navy plans to close NAS
Glenview in 1995. Operations conducted at NAS Glenview will be disestablished or relocated to other Department of
Defense locations. The proposed action involves the disposal of land, buildings, and infrastructure of NAS Glenview
for subsequent reuse.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Navy intends to analyze the environmental effects of the disposal of NAS Glenview based on the reasonably foreseeable
reuse of the property, taking into account uses to be identified by the Glenview Naval Air Station Community Reuse
Planning Group. It is anticipated that reuse alternatives for NAS Glenview may include, but not be limited to: Aviation,
housing, education or institutional, light industry, office space, wildlife preserve, recreational, or a combination
of those uses. The ``no action'' alternative of Navy retention of NAS Glenview land, buildings, and infrastructure
in caretaker status will also be addressed in the EIS. However, because of the process mandated by the Base Closure
and Realignment Act, selection of the ``no action'' alternative would be considered impracticable for the Navy to
implement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Major environmental issues that will be addressed in the EIS include, but are not limited to: Air quality, water quality,
wetlands, endangered species, cultural resources, and socioeconomic impacts.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Navy will initiate a scoping process for the purpose of determining the scope of issues to be addressed and for identifying
the significant issues related to the proposed reuse alternatives. The Navy will hold a public scoping meeting on
Thursday, February 17, 1994, beginning at 7 p.m., at the Lyceum Conference Room, Glenbrook South High School Auditorium,
4000 West Lake Avenue, Glenview, Illinois. This meeting will be advertised in area newspapers.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A brief presentation will precede request for public comment.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Navy representatives will be available at this meeting to receive comments from the public regarding issues of concern
to the public. It is important that federal, state, and local agencies and interested individuals take this opportunity
to identify environmental concerns that should be addressed during the preparation of the EIS. In the interest of
available time, each speaker will be asked to limit oral comments to five minutes.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Agencies and the public are also invited and encouraged to provide written comment in addition to, or in lieu of, oral
comments at the public meeting. To be most helpful, scoping comments should clearly describe specific issues or topics
which the commenter believes the EIS should address. Written statements and/or questions regarding the scoping
process should be mailed no later than 3 March 1994 to: Commanding Officer, Southern Division, Naval Facilities Engineering
Command, P.O. Box 190010, Charleston, SC 29419&hyph;9010 (Attn: Mr. Thomas Burst, Code 203), telephone (803) 743&hyph;0590.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 28, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Michael P. Rummel,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
LCDR, JAGC, USN, Federal Register Liaison Officer.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2349 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3810&hyph;AE&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00022 </DOCNO>
<PARENT> FR940202-2-00012 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF ENERGY</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Federal Energy Regulatory Commission</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. ER93&hyph;932&hyph;000, et al.] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Central Vermont Public Service Corp. et al.; Electric Rate and Corporate Regulation Filings 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 25, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that the following filings have been made with the Commission: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
1. Central Vermont Public Service Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER93&hyph;932&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 27, 1993, Central Vermont Public Service Corporation (``Central Vermont'' or the ``Company'')
tendered for filing an amendment to its filing in the above-referenced docket. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 7, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
2. 2322120 Nova Scotia Limited
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. EG94&hyph;16&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On January 18, 1994 ``2322120 Nova Scotia Limited'' (``O&amp;M Sub''), c/o Kelly A. Tomblin, Energy Initiatives,
Inc., One Upper Pond Road, Parsippany, New Jersey 07054, filed with the Federal Energy Regulatory Commission an application
for determination of exempt wholesale generator status pursuant to part 365 of the Commission's Regulations. 
<!-- PJG 0012 frnewline -->
O&amp;M Sub states that it is a Nova Scotia corporation formed to provide certain operation and maintenance services
to an electric and steam generating facility to be located in Brooklyn, the Province of Nova Scotia, Canada, which
facility will be owned by Brooklyn Energy Limited Partnership, a Nova Scotia limited partnership. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 14, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
3. Southern California Edison Co.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER93&hyph;576&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, Southern California Edison Company (Edison) tendered for filing an amendment
in the above-referenced docket. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 3, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
4. Florida Power Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. EL94&hyph;17&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 29, 1993, Florida Power Corporation (Florida Power) tendered for filing a Petition for
Declaratory Order. Florida Power requests that the Commission, pursuant to Section 207 of the Rules of Practice and
Procedure, issue a declaratory order resolving a dispute between Florida Power, Tampa Electric and the City of St.
Cloud, Florida over the pricing of firm transmission service. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 4, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
5. 2322177 Nova Scotia Limited
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. EG94&hyph;15&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On January 18, 1994, 2322177 Nova Scotia Limited (``Equity Sub''), located care of Kelly A. Tomblin, Energy Initiatives,
Inc., One Upper Pond, Parsippany, New Jersey, 07054, filed an application with the Federal Energy Regulatory Commission
for determination of exempt wholesale generator status pursuant to part 365 of the Commission's regulations. 
<!-- PJG 0012 frnewline -->
Equity Sub intends to operate a wood-fired cogeneration facility with a net power production capacity of 26.5 MW.
Equity Sub is a Nova Scotia corporation formed to acquire a limited partnership interest in Brooklyn Energy Limited
Partnership, a Nova Scotia limited partnership formed to own an electric and steam generating facility to be located
in Brooklyn, the Province of Nova Scotia, Canada. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 14, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00023 </DOCNO>
<PARENT> FR940202-2-00012 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
6. Entergy Services, Inc. and 
<!-- PJG 0012 frnewline -->
Gulf States Utilities Co. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket Nos. EC92&hyph;21&hyph;000 and ER92&hyph;806&hyph;004]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 30, 1993, Entergy Services, Inc. tendered for filing copies of its compliance filing
in the above-referenced dockets. On January 3, 1994 and January 11, 1994, Entergy Services, Inc. tendered for filing
revised copies of its December 30, 1993, compliance filing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 4, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
7. New York State Electric &amp; Gas Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;191&hyph;000 Corp.]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 28, 1993, New York State Electric &amp; Gas Corporation (NYSEG) tendered for filing an
amendment to its November 29, 1993 filing in the above-referenced docket. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 4, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Standard Paragraphs
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
E. Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with Rules 211
and 214 of the Commission's Rules of Practice and Procedure (18 CFR 385.211 and 18 CFR 385.214). All such motions or
protests should be filed on or before the comment date. Protests will be considered by the Commission in determining
the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing
to become a party must file a motion to intervene. Copies of this filing are on file with the Commission and are available
for public inspection. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2292 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00024 </DOCNO>
<PARENT> FR940202-2-00013 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. EF94&hyph;5031&hyph;000, et al.] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Electric Rate and Corporate Regulation Filings </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 24, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that the following filings have been made with the Commission: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
1. United States Department of Energy_Western Area Power Administration (Pick-Sloan Missouri Basin Program-Eastern
Division) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. EF94&hyph;5031&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 10, 1994, the Deputy Secretary of Energy tendered for filing, on behalf of the Western Area
Power Administration, revised rates for firm power from the Pick-Sloan Missouri Basin Program-Eastern Division.
The Deputy Secretary states that he has confirmed and approved the revised rates on an interim basis. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 7, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
2. United States Department of Energy_Western Area Power Administration (Parker-Davis Project) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. EF94&hyph;5041&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 10, 1994, the Deputy Secretary of Energy tendered for filing, on behalf of the Western Area
Power Administration, revised rates for firm power from the Parker-Davis Project and for firm and nonfirm transmission
service from the Parker-Davis Project. The Deputy Secretary states that he has confirmed and approved the revised
rates on an interim basis. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 7, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
3. United States Department of Energy_Western Area Power Administration (Loveland Area Projects) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. EF94&hyph;5181&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 10, 1994, the Deputy Secretary of Energy tendered for filing, on behalf of the Western Area
Power Administration, revised rates for firm power from the Loveland Area Projects and firm and nonfirm transmission
service from the Loveland Area Projects transmission system. The Deputy Secretary states that he has confirmed and
approved the revised rates on an interim basis. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 7, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Standard Paragraphs 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
E. Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street NE., Washington, DC 20426, in accordance with Rules 211 and
214 of the Commission's Rules of Practice and Procedure (18 CFR 385.211 and 18 CFR 385.214). All such motions or protests
should be filed on or before the comment date. Protests will be considered by the Commission in determining the appropriate
action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a
party must file a motion to intervene. Copies of this filing are on file with the Commission and are available for public
inspection. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2291 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00025 </DOCNO>
<PARENT> FR940202-2-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Project No. 2402&hyph;003 Michigan]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Upper Peninsula Power Co; Availability of Draft Environmental Assessment</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with the National Environmental Policy Act of 1969 and the Federal Energy Regulatory Commission's
(Commission's) regulations, 18 CFR part 380 (Order No. 486, 52 FR 47897), the Office of Hydropower Licensing has reviewed
the application for major new license for the Prickett Project, located on the Sturgeon River, in Baraga and Houghton
counties, Michigan and has prepared a Draft Environmental Assessment (draft EA) for the project. In the draft EA,
the Commission's staff has analyzed the environmental impacts of the existing project and has concluded that approval
of the project, with appropriate enhancement measures, would not constitute a major federal action significantly
affecting the quality of the human environment.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of the draft EA are available for review in the Public Reference Branch, room 3104 of the Commission's offices
at 941 North Capitol Street NE., Washington, DC 20426.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Please submit any comments within 45 days from the date of this notice. Comments should be addressed to Lois D. Cashell,
Secretary, Federal Energy Regulatory Commission, 925 North Capitol Street NE., Washington, DC 20426. Please affix
Project No. 2402 to all comments. For further information, please contact CarLisa Linton, Environmental Coordinator,
at (202) 219&hyph;2802.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2310 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00026 </DOCNO>
<PARENT> FR940202-2-00015 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;113&hyph;000, et al.] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Columbia Gas Transmission Corporation, et al.; Natural Gas Certificate Filings </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that the following filings have been made with the Commission: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
1. Columbia Gas Transmission Corp. and Tennessee Gas Pipeline Co. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. RP94&hyph;113&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 13, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 10, 1994, Columbia Gas Transmission Corporation (Columbia) and Tennessee Gas Pipeline
Company (Tennessee) filed a joint petition pursuant to section 207 of the Commission's Rules of Practice and Procedure,
18 CFR 385.207, requesting an order approving a stipulation entered into on October 1, 1993. Petitioners state the
stipulation provides for termination of all firm transportation and storage contracts between them, through permanent
assignment of Tennessee capacity to Columbia's customers and through payment of an exit fee to Tennessee by Columbia
for abandonment of unassigned capacity on Tennessee. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Petitioners state that under the terms of the stipulation Columbia will assign all of its capacity rights under Contract
No. T&hyph;2030 (15,637 Dth per day of storage withdrawal under Tennessee's SS&hyph;E rate schedule), and under
Contract Nos. T&hyph;4613/T&hyph;4872 (10,425 Dth per day of firm transportation under Tennessee's FT&hyph;B
rate schedule). Columbia would also assign a portion of its rights under Contract No. T&hyph;3871 (263,998 Dth per
day of firm transportation under Tennessee's FT&hyph;A rate schedule). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The petitioners further state Columbia will pay Tennessee a negotiated exit fee for termination of the unassigned
portion of Columbia's capacity rights under Contract No. T&hyph;3871 and for termination of Contact Nos. T&hyph;3869/T&hyph;4870
(6,928 Dth per day of firm transportation under Tennessee's FT&hyph;B rate schedule). They state the exit fee will
be computed at the time the stipulation becomes effective, based on a formula that takes into account, among other
things, the amount of unassigned capacity, estimates of Tennessee's rates over the term of the contracts, and the
net present value of the nominal claim. Based on assumptions with a January 1, 1995 effective date, petitioners estimate
an exit fee of $36.7 million. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Petitioners request an order approving recovery of the exit fee in Columbia's rates through its TCRA (transportation
costs rate adjustment) mechanism. They request authorization for Tennessee to retain a portion of the exit fee equal
to the amount it would have collected from Columbia in demand charges for the unassigned capacity through July 1, 1995.
Tennessee proposes to credit the remaining portion of the exit fee to its firm customers through its GSR cost recovery
mechanism. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Petitioners further request abandonment authorization under section 7(b) of the Natural Gas Act for the following
transportation and exchange services: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Tennessee 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Rate Schedule T&hyph;133 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Rate Schedule T&hyph;140 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Rate Schedule T&hyph;147 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Tennessee and Columbia 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Tennessee Rate Schedule X&hyph;58_Columbia Rate Schedule X&hyph;78 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tennessee Rate Schedule X&hyph;60_Columbia Rate Schedule X&hyph;90 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tennessee Rate Schedule X&hyph;66_Columbia Rate Schedule X&hyph;119 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 1, 1994, in accordance with the first paragraph of Standard Paragraph F at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
2. Texas Eastern Transmission Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. CP94&hyph;178&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 14, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 12, 1994, Texas Eastern Transmission Corporation (Texas Eastern), P. O. Box 1642, Houston,
Texas 77251&hyph;1642, filed in Docket No. CP94&hyph;178&hyph;000, an application pursuant to Section 7(b) of
the Natural Gas Act for permission and approval to abandon by sale certain facilities in the Caillou Island area, Terrebonne
Parish, Louisiana, all as more fully set forth in the application which is on file with the Commission and open to public
inspection. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Specifically, Texas Eastern proposes to abandon, by sale to The Offshore Group, a barge and appurtenant equipment
located in the Caillou Island Field, Terrebonne Parish, Louisiana. Texas Eastern states that it was authorized to
construct certain facilities, including the barge, to connect natural gas supplies dedicated to it by Louisiana
Land and Exploration Company (LL&amp;E). LL&amp;E owns compression facilities on the barge which are used to deliver
natural gas to Texas Eastern. LL&amp;E has made arrangements with Texaco, Inc. to provide compression service to
deliver the natural gas to Texas Eastern. LL&amp;E therefore no longer requires Texas Eastern's barge or the facilities
on it. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 4, 1994, in accordance with Standard Paragraph F at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00027 </DOCNO>
<PARENT> FR940202-2-00015 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
3. Transcontinental Gas Pipe Line Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. CP94&hyph;182&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 14, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 13, 1994, Transcontinental Gas Pipe Line Corporation (TGPL), Post Office Box 1396, Houston,
Texas 77251, filed in Docket No. CP94&hyph;182&hyph;000 a request pursuant to &sect;157.205 of the Commission's
Regulations under the Natural Gas Act (18 CFR 157.205) for authorization to construct and operate a sales tap to Exxon
Company, U.S.A. (Exxon) under TGPL's blanket certificate issued in Docket No. CP83&hyph;426&hyph;000 pursuant
to Section 7 of the Natural Gas Act, all as more fully set forth in the request which is on file with the Commission and
open to public inspection. 
<!-- PJG 0012 frnewline -->
Specifically, TGPL proposes to construct and operate a new sales tap to Exxon on TGPL's existing 20-inch South McMullen
Lateral in McMullen County, Texas. TGPL states that it would use the facilities to deliver, on an interruptible basis,
up to 400 Mcf of natural gas per day to Exxon. TGPL would transport the natural gas for Exxon under part 284 of the Commission's
Regulations, it is stated. TGPL states that Exxon would reimburse it for the cost of the facilities. 
<!-- PJG 0012 frnewline -->
TGPL asserts that the new sales tap would not have any significant impact on TGPL's peak day or annual deliveries and
is not prohibited by TGPL's gas tariff. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 28, 1994, in accordance with Standard Paragraph G at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Standard Paragraphs
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
F. Any person desiring to be heard or to make any protest with reference to said application should on or before the comment
date, file with the Federal Energy Regulatory Commission, Washington, DC 20426, a motion to intervene or a protest
in accordance with the requirements of the Commission's Rules of Practice and Procedure (18 CFR 385.214 or 385.211)
and the Regulations under the Natural Gas Act (18 CFR 157.10). All protests filed with the Commission will be considered
by it in determining the appropriate action to be taken but will not serve to make the protestants parties to the proceeding.
Any person wishing to become a party to a proceeding or to participate as a party in any hearing therein must file a motion
to intervene in accordance with the Commission's Rules. 
<!-- PJG 0012 frnewline -->
Take further notice that, pursuant to the authority contained in and subject to the jurisdiction conferred upon the
Federal Energy Regulatory Commission by Sections 7 and 15 of the Natural Gas Act and the Commission's Rules of Practice
and Procedure, a hearing will be held without further notice before the Commission or its designee on this application
if no motion to intervene is filed within the time required herein, if the Commission on its own review of the matter
finds that a grant of the certificate and/or permission and approval for the proposed abandonment are required by
the public convenience and necessity. If a motion for leave to intervene is timely filed, or if the Commission on its
own motion believes that a formal hearing is required, further notice of such hearing will be duly given. 
<!-- PJG 0012 frnewline -->
Under the procedure herein provided for, unless otherwise advised, it will be unnecessary for applicant to appear
or be represented at the hearing. 
<!-- PJG 0012 frnewline -->
G. Any person or the Commission's staff may, within 45 days after issuance of the instant notice by the Commission,
file pursuant to Rule 214 of the Commission's Procedural Rules (18 CFR 385.214) a motion to intervene or notice of intervention
and pursuant to &sect;157.205 of the Regulations under the Natural Gas Act (18 CFR 157.205) a protest to the request.
If no protest is filed within the time allowed therefor, the proposed activity shall be deemed to be authorized effective
the day after the time allowed for filing a protest. If a protest is filed and not withdrawn within 30 days after the time
allowed for filing a protest, the instant request shall be treated as an application for authorization pursuant to
Section 7 of the Natural Gas Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2294 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00028 </DOCNO>
<PARENT> FR940202-2-00016 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. JD94&hyph;02389T Oklahoma&hyph;69]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>State of Oklahoma; NGPA Notice of Determination by Jurisdictional Agency Designating Tight Formation </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 27, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 24, 1994, the Corporation Commission of the State of Oklahoma (Oklahoma) submitted the
above-referenced notice of determination pursuant to &sect;271.703(c)(3) of the Commission's regulations, that
the Hoxbar Formation, underlying portions of Caddo and Grady Counties, Oklahoma, qualifies as a tight formation
under section 107(b) of the Natural Gas Policy Act of 1978. The recommended area is described as all of Section 13, in
Township 10 North, Range 9 West, and Section 19, in Township 10 North, Range 8 West.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The notice of determination also contains Oklahoma's findings that the referenced formation meets the requirements
of the Commission's regulations set forth in 18 CFR part 271. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The application for determination is available for inspection, except for material which is confidential under
18 CFR 275.206, at the Federal Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426.
Persons objecting to the determation may file a protest, in accordance with 18 CFR 275.203 and 275.204, within 20 days
after the date this notice is issued by the Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2313 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00029 </DOCNO>
<PARENT> FR940202-2-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. CP94&hyph;181&hyph;000, et al.] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Williams Natural Gas Company, et al.; Natural Gas Certificate Filings </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 25, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that the following filings have been made with the Commission: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
1. Williams Natural Gas Co.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. CP94&hyph;181&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 13, 1994, Williams Natural Gas Company (Williams) P.O. Box 3288, Tulsa, Oklahoma 74101,
filed in Docket No. CP94&hyph;181&hyph;000, an application pursuant to Section 7(b) of the Natural Gas Act for permission
and approval to abandon approximately 73.3 miles of 12-inch and 20-inch transmission pipeline located in Alfalfa
County, Oklahoma and Barber, Harper, Sumner and Sedgwick Counties, Kansas, all as more fully set forth in the application
which is on file with the Commission and open to public inspection. 
<!-- PJG 0012 frnewline -->
Williams proposes to abandon by reclaim approximately 8.8 miles of 12-inch pipeline and 61.2 miles of 20-inch pipeline
and to abandon in place approximately 3.3 miles of 20-inch pipeline. 
<!-- PJG 0012 frnewline -->
Williams states that all deliveries made from the pipeline to be abandoned have been relocated to an adjacent 6-inch
pipeline, therefore there would be no abandonment of service. Williams states further that the estimated cost of
abandonment would be approximately $227,130 with an estimated salvage value of $525,000. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 15, 1994, in accordance with Standard Paragraph F at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
2. Panhandle Eastern Pipe Line Co.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. CP94&hyph;188&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 18, 1994, Panhandle Eastern Pipeline Company (Panhandle), P.O. Box 1642, Houston, Texas
77251&hyph;1642, filed in Docket No. CP94&hyph;188&hyph;000 an application pursuant to Sections 7 (b) and (c) of
the Natural Gas Act for a certificate of public convenience and necessity authorizing the construction and operation
of certain new facilities and the abandonment of certain other facilities in its Howell Storage Field, all as more
fully set forth in the application which is on file with the Commission and open to public inspection. 
<!-- PJG 0012 frnewline -->
Specifically, Panhandle proposes to construct and operate a new injection/withdrawal well and approximately 225
feet of 8-inch storage well flow line in its Howell Storage Field in Livingston County, Michigan. Panhandle states
that part of the storage field lies directly under the City of Howell where there are no existing injection/withdrawal
wells, which results in this portion of the storage field not being drained efficiently. The proposed well would enable
Panhandle to more efficiently cycle the portion of the storage field under the City of Howell, it is stated. Panhandle
further states that the proposed well would increase the working gas inventory by about 900,000 Mcf, with a corresponding
decrease in the base gas inventory. Panhandle asserts that the new facilities would not increase the certificated
maximum capacity of the field or the maximum peak day withdrawal rate. Panhandle further proposes to connect an existing
well to the new storage well flow line and to abandon in place the 4-inch storage well flow line presently connecting
the existing well to the storage field gathering system. 
<!-- PJG 0012 frnewline -->
Panhandle states that the proposed well would be drilled utilizing new horizontal drilling technology at a location
90 feet from the wellhead of an existing well. Panhandle asserts that because of the experimental nature of the new
well, its drilling and completion are being done in cooperation with the Gas Research Institute (GRI). GRI has agreed
to co-fund this project and will share the technical results with other GRI members. 
<!-- PJG 0012 frnewline -->
Panhandle estimates the cost of the project to be $1,104,200, which will be financed with general funds available
to Panhandle. GRI would contribute $300,000 toward the cost of the project it is stated. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 15, 1994, in accordance with Standard Paragraph F at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00030 </DOCNO>
<PARENT> FR940202-2-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
3. National Fuel Gas Supply Corporation 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. CP94&hyph;195&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 24, 1994, National Fuel Gas Supply Corporation (National Fuel), 10 Lafayette Square,
Buffalo, New York 14203, filed in Docket No. CP94&hyph;195&hyph;000 a request pursuant to &sect;&sect;157.205
and 157.212 of the Commission's Regulations under the Natural Gas Act (18 CFR 157.205 and 157.212) for authorization
to continue to operate facilities constructed on an emergency basis to implement an interruptible transportation
service for a new shipper, Songer Gas Company (Songer), under the blanket certificate issued in Docket No. CP83&hyph;4&hyph;000,
pursuant to Section 7(c) of the Natural Gas Act, all as more fully set forth in the request which is on file with the Commission
and open to public inspection. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
National Fuel states that on January 16, 1994, a customer of Songer's notified National Fuel that he and sixteen other
customers were out of gas. It was indicated that a phone call to Mr. Ken Songer revealed that he was planning to thaw out
his wells but that he could not get his tractor started. It is then indicated that on that same day National Fuel installed
a temporary connection to provide service for Songer's customers and subsequently filed a report of emergency transaction
with the Commission. National Fuel states that it proposes to continue the operation of the emergency facility beyond
the sixty-day period permitted under the emergency regulations. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
National Fuel estimates total annual deliveries of 500 Mcf. National Fuel indicates that the facility cost approximately
$850. National Fuel also states that the proposed delivery point is not prohibited by its existing tariff. National
Fuel further states that the addition of the delivery facilities would have a minimal impact on its peak day and annual
deliveries. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: March 11, 1994, in accordance with Standard Paragraph G at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Standard Paragraphs
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
F. Any person desiring to be heard or to make any protest with reference to said application should on or before the comment
date, file with the Federal Energy Regulatory Commission, Washington, DC 20426, a motion to intervene or a protest
in accordance with the requirements of the Commission's rules of Practice and Procedure (18 CFR 385.214 or 385.211)
and the Regulations under the Natural Gas Act (18 CFR 157.10). All protests filed with the Commission will be considered
by it in determining the appropriate action to be taken but will not serve to make the protestants parties to the proceeding.
Any person wishing to become a party to a proceeding or to participate as a party in any hearing therein must file a motion
to intervene in accordance with the Commission's Rules. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Take further notice that, pursuant to the authority contained in and subject to the jurisdiction conferred upon the
Federal Energy Regulatory Commission by Sections 7 and 15 of the Natural Gas Act and the Commission's Rules of Practice
and Procedure, a hearing will be held without further notice before the Commission or its designee on this application
if no motion to intervene is filed within the time required herein, if the Commission on its own review of the matter
finds that a grant of the certificate and/or permission and approval for the proposed abandonment are required by
the public convenience and necessity. If a motion for leave to intervene is timely filed, or if the Commission on its
own motion believes that a formal hearing is required, further notice of such hearing will be duly given. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Under the procedure herein provided for, unless otherwise advised, it will be unnecessary for applicant to appear
or be represented at the hearing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
G. Any person or the Commission's staff may, within 45 days after issuance of the instant notice by the Commission,
file pursuant to Rule 214 of the Commission's Procedural Rules (18 CFR 385.214) a motion to intervene or notice of intervention
and pursuant to &sect;157.205 of the Regulations under the Natural Gas Act (18 CFR 157.205) a protest to the request.
If no protest is filed within the time allowed therefor, the proposed activity shall be deemed to be authorized effective
the day after the time allowed for filing a protest. If a protest is filed and not withdrawn within 30 days after the time
allowed for filing a protest, the instant request shall be treated as an application for authorization pursuant to
Section 7 of the Natural Gas Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2293 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00031 </DOCNO>
<PARENT> FR940202-2-00018 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;115&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Algonquin Gas Transmission Co.; Proposed Changes in FERC Gas Tariff </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 27, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 21, 1994, Algonquin Gas Transmission Company (Algonquin) tendered for filing as part
of its FERC Gas Tariff, Fourth Revised Volume No. 1, the following tariff sheet: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Sub First Revised Sheet No. 98 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed effective date of the tariff sheet is November 1, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Algonquin states that the purpose of this filing is to recover stranded costs allocated to Algonquin in Texas Eastern
Transmission Corporation's (Texas Eastern) filing in Docket No. RP93&hyph;204&hyph;000 dated December 30, 1993.
In compliance with the October 29 Order in Docket No. RP93&hyph;204&hyph;000, Texas Eastern submitted a filing to
recover stranded costs using the allocation method accepted by the Commission in the December 17 Order in Docket Nos.
RS92&hyph;11&hyph;000, et al. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Algonquin states that copies of this filing were served upon each affected party and interested state commissions.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with &sect;&sect;385.214
and 385.211 of the Commission's Rules and Regulations. All such motions or protests should be filed on or before February
3, 1994. Protests will be considered by the Commission in determining the appropriate action to be taken, but will
not serve to make protestants parties to the proceeding. Any person wishing to become a party must file a motion to intervene.
Copies of this filing are on file with the Commission and are available for public inspection in the public reference
room. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2308 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00032 </DOCNO>
<PARENT> FR940202-2-00019 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. TM94&hyph;1&hyph;112&hyph;003]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Blue Lake Gas Storage Co.; Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 21, 1994, Blue Lake Gas Storage Company (Blue Lake) tendered for filing as part of its FERC
Gas Tariff, First Revised Volume No. 1, Substitute First Revised Sheet No. 5.
<!-- PJG 0012 frnewline -->
Blue Lake states that Substitute First Revised Sheet No. 5 inserts the portion of the definition under footnote No.
3 which was inadvertently omitted when Blue Lake filed its First Revised Sheet No. 5. In all other respects Substitute
First Revised Sheet No. 5 is the same as First Revised Sheet No. 5 which was accepted in the above captioned Dockets by
the Commission in a January 12, 1994 Order. Blue Lake requests that October 1, 1993, the same date that First Revised
Sheet No. 5 became effective, also be the effective date for Substitute First Revised Sheet No. 5.
<!-- PJG 0012 frnewline -->
Blue Lake states that copies of the filing were served upon Blue Lake's jurisdictional customer.
<!-- PJG 0012 frnewline -->
Any person desiring to protest said filing should file a protest with the Federal Energy Regulatory Commission, 825
North Capitol Street, NE., Washington, DC 20426, in accordance with 18 CFR 385.211 of the Commission's Rules and Regulations.
All such protests should be filed on or before February 3, 1994. Protests will be considered by the Commission in determining
the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Copies of this
filing are on file with the Commission and are available for public information in the public reference room.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2315 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00033 </DOCNO>
<PARENT> FR940202-2-00020 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP93&hyph;4&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Mississippi River Transmission Corp.; Informal Settlement Conference</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that an informal settlement conference will be convened in this proceeding on Monday, February 7, 1994,
at 10 a.m., and continuing on Tuesday, February 8, 1994, at 10 a.m., at the offices of the Federal Energy Regulatory
Commission, 810 First Street, NE., Washington, DC, for the purpose of exploring the possible settlement of the above-referenced
docket.
<!-- PJG 0012 frnewline -->
Any party, as defined by 18 CFR 385.102(c), or any participant, as defined by 18 CFR 385.102(b), is invited to attend.
Persons wishing to become a party must move to intervene and receive intervenor status pursuant to the Commission's
regulations (18 CFR 385.214).
<!-- PJG 0012 frnewline -->
For additional information, contact Warren C. Wood at (202) 208&hyph;2091.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2311 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00034 </DOCNO>
<PARENT> FR940202-2-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Project No. 2420&hyph;001 Utah]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>PacifiCorp Electric Operations; Availability of Draft Environmental Assessment</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with the National Environmental Policy Act of 1969 and the Federal Energy Regulatory Commission's
(Commission's) regulations, 18 CFR Part 380 (Order No. 486, 52 FR 47897), the Office of Hydropower Licensing has reviewed
the application for a new license for the existing Cutler Project, located on the Bear River in Cache and Box Elder Counties,
Utah, near Logan, and has prepared a Draft Environmental Assessment (DEA) for the project. In the DEA, the Commission's
staff has analyzed the existing and potential future environmental impacts of the project and has concluded that
issuance of a new license for the project, with appropriate environmental protection and enhancement measures,
would not constitute a major federal action significantly affecting the quality of the human environment.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of the DEA are available for review in the Public Reference Branch, room 3104, of the Commission's offices at
941 North Capitol Street, NE., Washington, DC 20426.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any comments should be filed within 30 days from the date of this notice and should be addressed to Lois D. Cashell, Secretary,
Federal Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426. For further information,
contact Vince Yearick, Environmental Coordinator, at (202) 219&hyph;3073.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2312 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00035 </DOCNO>
<PARENT> FR940202-2-00022 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;117&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Panhandle Eastern Pipe Line Co., Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 24, 1994 Panhandle Eastern Pipe Line Company (Panhandle) tendered for filing as part of
its FERC Gas Tariff, Original Volume No. 2 revised sheets listed on Appendix A to the filing.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Panhandle states that such changes are made to amend Rate Schedule T&hyph;39 for the transportation of natural gas
on behalf of United Cities Gas Company (United Cities) to reflect Trunkline Gas Company's and Panhandle's transportation
rates as approved in Docket Nos. RP89&hyph;160&hyph;000, RP89&hyph;114&hyph;000, RP92&hyph;165&hyph;000,
RS92&hyph;25&hyph;000, and RS92&hyph;22&hyph;000, et al.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Panhandle respectfully requests that the Commission grant such waivers as may be necessary for the acceptance of
the tariff sheets submitted herewith, to become effective on the dates shown thereon.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Panhandle states that a copy of this letter and enclosures was served on United Cities and the respective state commission.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with &sect;&sect;385.211
and 385.214 of the Commission's Rules and Regulations. All such motions or protests should be filed on or before February
3, 1994. Protests will be considered by the Commission in determining the appropriate action to be taken, but will
not serve to make protestants parties to the proceedings. Any person wishing to become a party must file a motion to
intervene. Copies of this filing are on file with the Commission and are available for public inspection in the public
reference room.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2316 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00036 </DOCNO>
<PARENT> FR940202-2-00023 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;116&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Texas Eastern Transmission Corp.; Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 24, 1994, Texas Eastern Transmission Corporation (Texas Eastern) submitted for filing
as part of its FERC Gas Tariff, Sixth Revised Volume No. 1, the following tariff sheets:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Proposed to be Effective October 1, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=3 -->
Revised 2nd Sub Original Sheet No. 628
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Proposed to be Effective October 3, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=3 -->
2nd Revised 2nd Sub Original Sheet No. 628
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Proposed to be Effective November 1, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=3 -->
2nd Sub First Revised Sheet No. 628
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Texas Eastern states that the proposed tariff sheets reflect the inclusion of references to Rate Schedule LLFT, effective
October 1, 1993, and Rate Schedule VKFT, effective October 3, 1993, in the definition of GSR Demand Account and in Section
15.2(D) of the General Terms and Conditions. In addition, Texas eastern states that the tariff sheets reflect the
inclusion of the mitigation measure for Rate Schedule SCT Customers filed on November 15, 1993 in Docket No. RS92&hyph;11&hyph;020
and approved by the Commission's ``Fourth Order on Compliance Filing and Third Order on Rehearing'' issued December
17, 1993 in Docket No. RS92&hyph;11, et al
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
., to be effective June 1, 1993.
<!-- PJG 0012 frnewline -->
The proposed effective date of the tariff sheets are October 1, 1993, October 3, 1993 and November 1, 1993, as shown
above.
<!-- PJG 0012 frnewline -->
Texas Eastern states that copies of the filing were served on firm customers of Texas Eastern and interested state
commissions.
<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with Rules 211
and 214 of the Commission's Rules of Practice and Procedure. All such motions or protests should be filed on or before
February 3, 1994. Protests will be considered by the Commission in determining the appropriate action to be taken,
but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file a motion
to intervene. Copies of this filing are on file with the Commission and are available for public inspection.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2307 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00037 </DOCNO>
<PARENT> FR940202-2-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket Nos. RP93&hyph;106&hyph;000, et al.]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Texas Gas Transmission Corp.; Informal Settlement Conference</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that an informal settlement conference will be convened in the above-captioned proceeding at 10 a.m.
on February 4, 1994, at the offices of the Federal Energy Regulatory Commission, 810 First Street, NE., Washington,
DC, for the purpose of exploring the possible settlement of the above-referenced dockets.
<!-- PJG 0012 frnewline -->
Any party, as defined by 18 CFR 385.102(c), or any participant as defined in 18 CFR 385.102(b), is invited to attend.
Persons wishing to become a party must move to intervene and receive intervenor status pursuant to the Commission's
regulations (18 CFR 385.214).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For additional information please contact Michael D. Cotleur, (202) 208&hyph;1076, or Arnold H. Meltz (202) 208&hyph;2161.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2309 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00038 </DOCNO>
<PARENT> FR940202-2-00025 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK></RINDOCK>
<!-- PJG 0012 frnewline -->
[Docket No. TM94&hyph;8&hyph;29&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE></DOCTITLE>
<!-- PJG 0012 frnewline -->
Transcontinental Gas Pipe Line Corp.; Proposed Changes in FERC Gas Tariff
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Take notice that on January 24, 1994 Transcontinental Gas Pipe Line Corporation (TGPL) tendered for filing as part
of its FERC Gas Tariff, Third Revised Volume No. 1, certain revised tariff sheets included in Appendix A attached to
the filing.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
TGPL states that the purpose of the instant filing is to track rate changes attributable to (1) transportation service
purchased from Texas Gas Transmission Corporation (Texas Gas) under its Rate Schedule FT the costs of which are included
in the rates and charges payable under TGPL's Rate Schedule FT&hyph;NT, (2) transportation service purchased from
National Fuel Gas Supply Corporation (National Fuel) under its Rate Schedule X&hyph;42 the costs of which are included
in the rates and charges payable under TGPL's Rate Schedule LSS, (3) transportation service purchased from National
Fuel under its Rate Schedule X&hyph;54 the costs of which are included in the rates and charges payable under TGPL's
Rate Schedule SS&hyph;2 and (4) transportation service purchased from National Fuel under its Rate Schedule X&hyph;58
the costs of which are included in the rates and charges payable under TGPL's Niagara Import Point Project_System
Expansion (NIPPs&hyph;SE) firm transportation service. The tracking filing is being made pursuant to Section 4
of TGPL's Rate Schedule FT&hyph;NT, Section 4 of TGPL's Rate Schedule LSS, Section 4 of TGPL's Rate Schedule SS&hyph;2
and Section 8.01(i) of TGPL's NIPPs&hyph;SE Rate Schedules X&hyph;315, X&hyph;316, X&hyph;318 and X&hyph;324.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
TGPL states that included in Appendices B through E attached to the filing are the explanations of the rate changes
and details regarding the computation of the revised FT&hyph;NT, LSS, SS&hyph;2 and NIPPs&hyph;SE rates, respectively.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
TGPL states that copies of the filing are being mailed to each of its FT&hyph;NT, LSS, SS&hyph;2 and NIPPs&hyph;SE
customers and interested State Commissions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE. Washington, DC 20426, in accordance with Sections 385.214
and 385.211 of the Commission's Rules and Regulations. All such motions or protests should be filed on or before February
3, 1994. Protests will be considered by the Commission in determining the appropriate action to be taken, but will
not serve to make protestants parties to the proceeding. Any person wishing to become a party must file a motion to intervene.
Copies of this filing are on file with the Commission and are available for public inspection in the public reference
room.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2317 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00039 </DOCNO>
<PARENT> FR940202-2-00026 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. TM94&hyph;2&hyph;43&hyph;001]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Williams Natural Gas Co.; Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 21, 1994, Williams Natural Gas Company (WNG) tendered for filing as part of its FERC Gas
Tariff, Second Revised Volume No. 1, Second Substitute Second Revised Sheet No. 6A. The proposed effective date of
this tariff sheet is January 1, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
WNG states that this filing is being made in compliance with Commission order issued December 30, 1993 in Docket Nos.
TM94&hyph;3&hyph;20&hyph;000, et al. The order required all interstate pipelines that are members of GRI that have
tariff provisions applicable to new customers that differ from the method of determining new customers' load factors
set forth in the order, to revise their tariffs. In accordance with the order, WNG is refiling Sheet No. 6A to include
the high load factor rate.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
WNG states that a copy of its filing was served on all jurisdictional customers and interested state commissions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to protest said filing should file a protest with the Federal Energy Regulatory Commission, 825
North Capitol Street, NE., Washington, DC 20426, in accordance with &sect;385.211 of the Commission's Rules and
Regulations. All such protests should be filed on or before February 3, 1994. Protests will be considered by the Commission
in determining the appropriate action to be taken, but will not serve to make protestants parties to the proceedings.
Copies of this filing are on file with the Commission and are available for public inspection in the public reference
room.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2314 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00040 </DOCNO>
<PARENT> FR940202-2-00027 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>ENVIRONMENTAL PROTECTION AGENCY</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[FRL&hyph;4832&hyph;7] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Clean Air Act; Acid Rain Provisions 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of the 1994 EPA SO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Allowance Auctions. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Pursuant to Title IV of the Clean Air Act and 40 CFR Part 73, the EPA is responsible for implementing a program to reduce
emissions of sulfur dioxide (SO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
), a precursor of acid rain. The centerpiece of the SO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 control program is the allocation of transferable allowances, or authorizations to emit SO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
, which are distributed in limited quantities for existing utility units and which eventually must be held by virtually
all utility units to cover their SO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 emissions. These allowances may be transferred among polluting sources and others, so that market forces may govern
their ultimate use and distribution, resulting in the most cost-effective sharing of the emissions control burden.
In addition, EPA is directed under Section 416 of the Act to conduct annual sales and auctions of a small portion of allowances
(2.8%) withheld from the total allowances allocated to utilities each year. Sales and auctions are expected to stimulate
and support such a market in allowances and to provide a public source of allowances, particularly to new units for
which no allowances are allocated. Today, the Acid Rain Division is giving notice of the second annual SO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 allowance auctions. The regulations governing the auctions and sales were promulgated on December 17, 1991 (40 CFR
part 73, subpart E). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
EPA has delegated the administration of the EPA allowance auctions to the Chicago Board of Trade (CBOT). The auctions
will be conducted under the regulations cited above. Anyone can participate in the EPA auctions and bidders are not
restricted as to the quantity or price of their bid. Allowances sold at the auctions will be sold to the highest bidder
until no allowances remain. The 1994 auctions will consist of one ``spot'' auction and two ``advance'' auctions.
Allowances sold in the spot auction are useable for compliance beginning in 1995. Allowances sold in the 6-year advance
auction are useable for compliance beginning in 2000; allowances sold in the 7-year advance auction are useable for
compliance beginning in 2001. 25,000 allowances will be sold in the 6-year advance auction, which are the unsold allowances
from the 1993 direct sale. 50,000 spot allowances will be sold in the spot auction and 100,000 allowances will be sold
in the 7-year advance auction. Bid Forms for the 1994 auctions must be received by the CBOT by the close of business on
March 22, 1994. The auctions themselves will be conducted on March 28, 1994, with the results announced the next day.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CBOT will also sell in the 1994 auctions any spot, 6-year advance, or 7-year advance allowances that are offered by
others holding allowances in EPA's Allowance Tracking System. However, offered allowances will be sold after the
allowances that were withheld from the utilities, so offered allowances will consequently be sold at a lower price
than the withheld allowances. Owners of offered allowances may set a minimum price for their allowances. To offer
allowances in the EPA auctions, owners of allowances must submit an SO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Allowance Offer Form to EPA by the close of business on March 11, 1994. The auction and sale regulations require that
offer forms be received by EPA no later than 15 business days prior to the date of the auctions, which would be March 4,
1994. However, this year, the date that offer forms must be received by EPA is being extended to March 11, 1994 due to
the delay in the opening of the Allowance Tracking System. This extension will not be implemented permanently and
only applies to the 1994 auctions. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
 U.S. EPA Acid Rain Division (6204J), Attn: Auctions and Sales, 401 M St., SW., Washington, DC 20460. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Chicago Board of Trade, Attn: EPA Auctions, 141 W. Jackson Blvd., suite 2240, Chicago, IL 60604. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Forms needed to participate in the EPA auctions will be available from the Acid Rain Division by February 14, 1994.
To obtain forms, call the Acid Rain Hotline at (202) 233&hyph;9620. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Information on bidding in the 1994 EPA auctions can be found in the brochure ``How to Bid in the EPA SO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Allowance Auctions, Second Annual Auctions_March 28, 1994;'' general information on the EPA auctions can be found
in the ``Acid Rain Program Allowance Auctions and Direct Sales'' fact sheet. These publications can be obtained by
calling the Acid Rain Hotline or by writing to EPA at the address listed above. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 25, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Brian J. McLean, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Acid Rain Division. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2355 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00041 </DOCNO>
<PARENT> FR940202-2-00028 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[FRL&hyph;4832&hyph;5]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Public Water System Supervision Program Revision for Puerto Rico</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 United States Environmental Protection Agency (USEPA).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice is hereby given that Puerto Rico is revising its approved Public Water System Supervision Primacy Program.
Puerto Rico has adopted drinking water regulations that satisfy the national Primary Drinking Water Regulations
(NPDWR) for the Surface Water Treatment Rule (SWTR) and the Total Coliforms Rule (TCR) promulgated by USEPA on June
29, 1989 (54 FR 27486 and 54 FR 27544) respectively.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The USEPA has determined that Puerto Rico's SWTR and TCR regulations are no less stringent than the corresponding
Federal regulations and that Puerto Rico continues to meet all requirements for primary enforcement responsibility
as specified in 40 CFR 142.10.
<!-- PJG 0012 frnewline -->
All interested parties, other than Federal Agencies, may request a public hearing. A request for a public hearing
must be submitted to the USEPA Regional Administrator at the address shown below within thirty (30) days after the
date of this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Notice. If a substantial request for a public hearing is made within the required thirty-day period, a public hearing
will be held and a notice will be given in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and a newspaper of general circulation. Frivolous or insubstantial requests for a hearing may be denied by the Regional
Administrator. If no timely and appropriate request for a hearing is received and the Regional Administrator does
not choose to hold a hearing on his or her own motion, this determination shall become final and effective thirty (30)
days after publication of this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Notice.
<!-- PJG 0012 frnewline -->
Any request for a public hearing shall include the following information:
<!-- PJG 0012 frnewline -->
(1) The name, address and telephone number of the individual organization or other entity requesting a hearing;
<!-- PJG 0012 frnewline -->
(2) A brief statement of the requesting person's interest in the Regional Administrator's determination and a brief
statement on information that the requesting person intends to submit at such hearing; and
<!-- PJG 0012 frnewline -->
(3) The signature of the individual making the requests or, if the request is made on behalf of an organization or other
entity, the signature of a responsible official of the organization or other entity.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Requests for Public Hearing shall be addressed to: Regional Administrator, U.S. Environmental Protection Agency_Region
II, Jacob K. Javits Federal Building, 26 Federal Plaza, New York, New York 10278.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
All documents relating to this determination are available for inspection between the hours of 9 a.m. and 4:30 p.m.,
Monday through Friday, at the following offices:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Puerto Rico Department of Health, Public Water System Supervision Program, Edificio A. Centro Medico, Call Box 70184,
San Juan, Puerto Rico 00909.
<!-- PJG 0012 frnewline -->
USEPA-Caribbean Field Office, Office 2A, Podiatry Center Building, 1413 Fernandez Juncos Avenue, Santurce, Puerto
Rico 00909.
<!-- PJG 0012 frnewline -->
U.S. Environmental Protection Agency_Region II, Public Water System Supervision Section Room 853, Jacob K. Javits
Federal Building, 26 Federal Plaza, New York, New York 10278.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Walter E. Andrews, Chief, Drinking and Groundwater Protection Branch, U.S. Environmental Protection Agency_Region
II, (212) 264&hyph;1800.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Section 1413 of the Safe Drinking Water Act, as amended, and 40 CFR 142.10 of the NPDWR.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
William J. Muszynski,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=3 -->
Acting Regional Adminstrator, EPA, Region 2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->
.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2283 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00042 </DOCNO>
<PARENT> FR940202-2-00029 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[FRL&hyph;4831&hyph;4]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Radiation Cleanup Regulation Subcommittee of the National Advisory Council for Environmental Policy and Technology;
Public Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Environmental Protection Agency (EPA).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of public meeting.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Under the Federal Advisory Committee Act, PL92563, EPA gives notice that the Radiation Cleanup Regulation Subcommittee
of the National Advisory Council for Environmental Policy and Technology's (NACEPT) Environmental Information
and Assessments (EIA) Committee will meet by conference call on Thursday, February 24, 1994, from 1 p.m. to 4 p.m.,
EST. The Subcommittee provides advice to EPA regarding the development of regulations to be applied to sites contaminated
with radioactive material.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Agency received the benefit of Subcommittee members' views on appropriate risk/cleanup levels, future land
use, and site specific public involvement at the open subcommittee meeting of October 18&hyph;19, 1993. This conference
call will provide an update on how those views have helped inform the Agency's decision-making process to date as regulatory
development progresses. There will also be a limited discussion of regulations governing the disposal of wastes
generated during cleanup operations, which are in the preliminary stages of development. This conference call is
primarily intended to provide an intermediate update for subcommittee members. It is anticipated that a full-scale
subcommittee meeting will be held in the Spring for in-depth discussion of all pertinent issues.
<!-- PJG 0012 frnewline -->
For additional information, contact Miles Kahn, Designated Federal Official, Office of Radiation and Indoor Air,
Radiation Studies Division, Mailcode 6603J, 401 M Street, SW., Washington, DC 20460. Phone: 202&hyph;233&hyph;9384
or FAX: 202&hyph;233&hyph;9650. Individuals wishing to participate in the conference call as audience or commenters
should call the Designated Federal Official as soon as possible, since there is a limited number of conference lines
available.
<!-- PJG 0012 frnewline -->
Members of the public wishing to submit comments on the issues discussed by the subcommittee should submit them in
writing to: USEPA_Mail Stop 6102; Air Docket No. A&hyph;93&hyph;27; Room M&hyph;1500; First Floor, Waterside Mall;
401 M St., SW., Washington, DC 20460.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 24, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Morris Altschuler,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Office of Cooperative Environmental Management.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2276 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00043 </DOCNO>
<PARENT> FR940202-2-00030 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[OPP&hyph;30360; FRL&hyph;4757&hyph;3] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Micro Flo Co.; Application to Register a Pesticide Product </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This notice announces receipt of an application submitted by Micro Flo Company, to register the pesticide product
Corn Rootworm Granular Bait, a biological insecticide containing an active ingredient not included in any previously
registered product pursuant to the provisions of section 3(c)(4) of the Federal Insecticide, Fungicide, and Rodenticide
Act (FIFRA), as amended. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Written comments must be submitted by March 3, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By mail submit comments identified by the document control number [OPP&hyph;30360] and the file symbol (51036&hyph;ENU)
to: Public Response and Program Resources Branch, Field Operations Division (7506C), Attention PM 18, Office of
Pesticide Programs, Environmental Protection Agency, 401 M St., SW., Washington, DC 20460, In person, bring comments
to: Environmental Protection Agency, Rm. 1132, CM #2, 1921 Jefferson Davis Highway, Arlington, VA. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Information submitted in any comment concerning this notice may be claimed confidential by marking any part or all
of that information as ``Confidential Business Information'' (CBI). Information so marked will not be disclosed
except in accordance with procedures set forth in 40 CFR part 2. A copy of the comment that does not contain CBI must be
submitted for inclusion in the public record. Information not marked confidential may be disclosed publicly by EPA
without prior notice to the submitter. All written comments will be available for public inspection in Rm. 1132 at
the address given above, from 8 a.m. to 4 p.m., Monday through Friday, except legal holidays. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 PM 18, Phil Hutton, Registration Division (7505C), Rm. 213, CM #2, (703&hyph;305&hyph;7690). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 EPA received an application from Micro Flo Company, P.O. Box 5948, Lakeland, FL 33807, to register the pesticide product
Corn Rootworm Granular Bait (File Symbol 51036&hyph;ENU), a biological insecticide. This product contains the
following plant floral volatile attractants as active ingredients: cinnamaldehyde, cinnamyl alcohol, 4-methoxy
cinnamaldehyde, 3-phenyl propanol, 4-methoxy phenethyl alcohol, indole, and 1,2,4 trimethoxybenzene, ingredients
not included in any previously registered product pursuant to the provisions of section 3(c)(4) of FIFRA. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The product was classified for general outdoor use against adult Diabroticine corn rootworms and cucumber beetles

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Diabrotica
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Acalymma
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 species on specific raw agricultural commodities and ornamentals. Notice of receipt of the application does not
imply a decision by the Agency on the application. 
<!-- PJG 0012 frnewline -->
Notice of approval or denial of an application to register a pesticide product will be announced in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. The procedure for requesting data will be given in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 if an application is approved. 
<!-- PJG 0012 frnewline -->
Comments received within the specified time period will be considered before a final decision is made; comments received
after the time specified will be considered only to the extent possible without delaying processing of the application.

<!-- PJG 0012 frnewline -->
Written comments filed pursuant to this notice, will available in the Public Response and Program Resources Branch,
Field Operation Division office at the address provided from 8 a.m. to 4 p.m., Monday through Friday, except legal
holidays. It is suggested that persons interested in reviewing the application file, telephone the FOD office (703&hyph;305&hyph;5805),
to ensure that the file is available on the date of intended visit.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
7 U.S.C. 136. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Environmental protection, Pesticides and pests, Product registration. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 24, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Stephen L. Johnson, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Registration Division, Office of Pesticide Programs. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2279 Filed 2&hyph;1-94; 8:45 am] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00044 </DOCNO>
<PARENT> FR940202-2-00031 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[FRL&hyph;48324]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>AERR Co. Site, Unincorporated Jefferson County, Colorado; Notice of Proposed Administrative Settlement Pursuant
to the Comprehensive Environmental Response, Compensation, and Liability Act, as Amended by the Superfund Amendments
and Reauthorization Act</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
U.S. Environmental Protection Agency.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of proposed administrative settlement; request for public comment.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In accordance with section 122(i) of the Comprehensive Environmental Response, Compensation, and Liability Act,
42 U.S.C. 9622(i), as amended by the Superfund Amendments and reauthorization Act (``CERCLA''), notice is hereby
given of a proposed administrative settlement concerning the AERR Co. site in unincorporated Jefferson County,
Colorado. The proposed administrative settlement resolves an EPA claim under section 107 of CERCLA, 42 U.S.C. 9607
against Adolph Coors Company, Ball Corporation, Continental Can Company, The Denver Post Corporation, Eastman
Kodak Company, Eaton Corporation, Entrada Industries, Inc., Hewlett-Packard Company, Pease Industries, Sterling
Stainless Tube Corporation, and Syntex Chemicals, Inc. The settlement requires the settling parties to pay $488,867.41
to the Hazardous Substances Superfund.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For thirty (30) days following the date of publication of this notice, the Agency will receive written comments relating
to the settlement. The Agency's response to any comments received will be available for public inspection at EPA Region
VIII's Superfund Records Center, which is located on the 8th floor of the North Tower, at 999 18th Street, Denver, Colorado.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments must be submitted by March 4, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The proposed administrative settlement and additional background information relating to the settlement are available
for public inspection at EPA Region VIII's Superfund Records Center, at the address listed above. A copy of the proposed
settlement may be obtained from Carol Pokorny (8HWM&hyph;ER), Enforcement Specialist, USEPA, 999 18th Street,
suite 500, Denver, CO 80202&hyph;2466. Comments should reference the AERR CO. Site, Jefferson County, CO, EPA Docket
No. CERCLA&hyph;VIII&hyph;94&hyph;04, and should be addressed to Ms. Pokorny at the address given above.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Wendy Silver, Office of Regional Counsel, (303) 294&hyph;7570.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: November 23, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Kerrigan G. Clough,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Regional Administrator.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2277 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00045 </DOCNO>
<PARENT> FR940202-2-00032 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>FEDERAL MARITIME COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>U.S./Central America Liner Association, et al.; Notice of Agreement(s) Filed</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Federal Maritime Commission hereby gives notice of the filing of the following agreement(s) pursuant to section
5 of the Shipping Act of 1984.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Interested parties may inspect and obtain a copy of each agreement at the Washington, DC, Office of the Federal Maritime
Commission, 800 North Capitol Street, NW., 9th Floor. Interested parties may submit comments on each agreement to
the Secretary, Federal Maritime Commission, Washington, DC 20573, within 10 days after the date of the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in which this notice appears. The requirements for comments are found in &sect;572.603 of title 46 of the Code of Federal
Regulations. Interested persons should consult this section before communicating with the Commission regarding
a pending agreement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Agreement No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
202&hyph;010987&hyph;019.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Title: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
U.S./Central America Liner Association.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Parties: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=14 g=1 f=3 -->
Crowley American Transport, Inc.
<!-- PJG 0012 frnewline -->
Seaboard Marine, Ltd.
<!-- PJG 0012 frnewline -->
Sea-Land Service, Inc. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Synopsis: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment (1) changes the name of the Agreement to the Latin American Shipping Service Association;
(2) adds King Ocean Central America, S.A., and Tropical Shipping and Construction Co., Ltd., as parties to the Agreement;
(3) clarifies the intermodal portion of the geographic scope; (4) modifies the alternate port service authority
to ports within a trade area section; (5) authorizes the parties to interchange equipment; (6) revises the trade area
sections of the Agreement and authorizes parties to limit their participation in such sections; (7) modifies Article
11, Prohibited Acts, to conform to Commission regulations and to clearly delineate the parties' obligations; (8)
revises independent action provisions; and (9) revises service contract provisions. The amendment also restates
the Agreement.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Agreement No.:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 224&hyph;200563&hyph;002.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Title: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Port of Oakland/Trans Pacific Container Service Corporation Terminal Agreement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Parties:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=14 g=1 f=1 -->
Port of Oakland (``Port'') 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Trans Pacific Container Service Corporation (``TPCC'').
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Synopsis:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The proposed amendment would permit the Port to assign certain marine terminal facilities to TPCC for the 25 year term
of the Agreement.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00046 </DOCNO>
<PARENT> FR940202-2-00032 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Agreement No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
224&hyph;200842.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Title: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Port Authority of New York &amp; New Jersey/Sea-Land Service, Inc. Container Incentive Agreement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Parties:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=14 g=1 f=3 -->
The Port Authority of New York &amp; New Jersey (``Port'')
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sea-Land Service, Inc. (``Sea-Land'')
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Synopsis: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Agreement provides for the Port to pay Sea-Land a container incentive of $20.00 for each import container and $30.00
for each export container loaded or unloaded from a vessel at the Port's marine terminals during calendar year 1994,
provided each container is shipped by rail to or from points more than 260 miles from the Port.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Agreement No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
224&hyph;200843.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Title: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Port Authority of New York &amp; New Jersey/D.B. Turkish Cargo Lines Container Incentive Agreement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Parties:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=14 g=1 f=3 -->
The Port Authority of New York &amp; New Jersey (``Port'')
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D. B. Turkish Cargo Lines (``Turkish'').
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Synopsis: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Agreement provides for the Port to pay Turkish a container incentive of $20.00 for each import container and $30.00
for each export container loaded or unloaded from a vessel at the Port's marine terminals during calendar year 1994,
provided each container is shipped by rail to or from points more than 260 miles from the Port.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Agreement No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
224&hyph;200845.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Title: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Port of Galveston/Sun Line Cruises Terminal Agreement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Parties:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=14 g=1 f=3 -->
Port of Galveston (``Port'')
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sun Line Cruises (``Sun Cruises'')
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Synopsis: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed Agreement would permit Sun Line to pay the Port dockage charges that were in effect on February 1, 1993,
for the term of the Agreement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By Order of the Federal Maritime Commission
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Joseph C. Polking,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2284 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6730&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00047 </DOCNO>
<PARENT> FR940202-2-00033 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>FEDERAL RESERVE SYSTEM</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Bank of Waunakee Employee Stock Ownership Plan, et al.; Formations of; Acquisitions by; and Mergers of Bank Holding
Companies</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The companies listed in this notice have applied for the Board's approval under section 3 of the Bank Holding Company
Act (12 U.S.C. 1842) and &sect;225.14 of the Board's Regulation Y (12 CFR 225.14) to become a bank holding company or
to acquire a bank or bank holding company. The factors that are considered in acting on the applications are set forth
in section 3(c) of the Act (12 U.S.C. 1842(c)).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Each application is available for immediate inspection at the Federal Reserve Bank indicated. Once the application
has been accepted for processing, it will also be available for inspection at the offices of the Board of Governors.
Interested persons may express their views in writing to the Reserve Bank or to the offices of the Board of Governors.
Any comment on an application that requests a hearing must include a statement of why a written presentation would
not suffice in lieu of a hearing, identifying specifically any questions of fact that are in dispute and summarizing
the evidence that would be presented at a hearing.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Unless otherwise noted, comments regarding each of these applications must be received not later than February 25,
1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
A. Federal Reserve Bank of Chicago
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (James A. Bluemle, Vice President) 230 South LaSalle Street, Chicago, Illinois 60690:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Bank of Waunakee Employee Stock Ownership Plan,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Waunakee, Wisconsin; to become a bank holding company by acquiring 95 percent of the voting shares of Waunakee Bank
Shares, Inc., Waunakee, Wisconsin, and thereby indirectly acquire Bank of Waunakee, Waunakee, Wisconsin.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2. Capitol Bancorp, Ltd., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Lansing, Michigan; to acquire 100 percent of the voting shares of Financial Center Corporation, Holland, Michigan,
and thereby indirectly acquire Paragon Bank &amp; Trust, Holland, Michigan.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
3. Mutual Bancshares Corporation, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Milwaukee, Wisconsin; to become a bank holding company by acquiring 100 percent of Mutual Savings Bank, Milwaukee,
Wisconsin, a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
de novo
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 bank, which will merge with Mutual Savings Bank, Brown Deer, Wisconsin.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
4. Old Kent Financial Corporation, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Grand Rapids, Michigan, and Old Kent-Illinois, Inc., Chicago, Illinois; to acquire 100 percent of the voting shares
of Edgemark Financial Corporation, Chicago, Illinois, and thereby indirectly acquire Merchandise National Bank,
Chicago, Illinois; Edgewood Bank, Countryside, Illinois; EdgeMark Bank-Lombard, Lombard, Illinois; First National
Bank of Lockport, Lockport, Illinois; and EdgeMark Bank-Rosemont, Rosemont, Illinois.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Board of Governors of the Federal Reserve System, January 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jennifer J. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Secretary of the Board.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2305 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6210&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00048 </DOCNO>
<PARENT> FR940202-2-00034 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Robert W. Hanson; Change in Bank Control Notice</DOCTITLE>
<!-- PJG 0012 frnewline -->

<DOCTITLE>Acquisition of Shares of Banks or Bank Holding Companies</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The notificant listed below has applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and  225.41 of the Board's
Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. The factors that are considered in acting on
notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).
<!-- PJG 0012 frnewline -->
The notice is available for immediate inspection at the Federal Reserve Bank indicated. Once the notice has been accepted
for processing, it will also be available for inspection at the offices of the Board of Governors. Interested persons
may express their views in writing to the Reserve Bank indicated for the notice or to the offices of the Board of Governors.
Comments must be received not later than February 22, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
A. Federal Reserve Bank of Minneapolis
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (James M. Lyon, Vice President) 250 Marquette Avenue, Minneapolis, Minnesota 55480:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Robert W. Hanson
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Eden Prairie, Minnesota; to acquire an additional 13.3 percent of the voting shares of St. Joseph Bancshares, Inc.,
St. Joseph, Minnesota, for a total of 33.4 percent, and thereby indirectly acquire First State Bank, St. Joseph, Minnesota.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Board of Governors of the Federal Reserve System, January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jennifer J. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Secretary of the Board.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94-2322 Filed 2-1-94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6210-01-F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00049 </DOCNO>
<PARENT> FR940202-2-00035 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE></DOCTITLE>
<!-- PJG 0012 frnewline -->
Dann Gerald Snow, et al.; Change in Bank Control Notices; Acquisitions of Shares of Banks or Bank Holding Companies

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and &sect;225.41
of the Board's Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. The factors that are considered
in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The notices are available for immediate inspection at the Federal Reserve Bank indicated. Once the notices have been
accepted for processing, they will also be available for inspection at the offices of the Board of Governors. Interested
persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board
of Governors. Comments must be received not later than February 22, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
A. Federal Reserve Bank of Richmond 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(Lloyd W. Bostian, Jr., Senior Vice President) 701 East Byrd Street, Richmond, Virginia 23261: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->

<!-- PJG 0012 frnewline -->
1. Danny Gerald Snow, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Manassas, Virginia; to acquire an additional 3.27 percent of the voting shares of Security Bank Corporation, Manassas,
Virginia, for a total of 10.67 percent. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->

<!-- PJG 0012 frnewline -->
B. Federal Reserve Bank of Atlanta 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(Zane R. Kelley, Vice President) 104 Marietta Street, N.W., Atlanta, Georgia 30303: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->

<!-- PJG 0012 frnewline -->
1. Preston Turner Bostwick, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Arlington, Georgia; to retain 60.3 percent of the voting shares of B.H.C., Inc., Arlington, Georgia, and thereby
indirectly acquire Bostwick Banking Co., Arlington, Georgia. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->

<!-- PJG 0012 frnewline -->
C. Federal Reserve Bank of Chicago 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(James A. Bluemle, Vice President) 230 South LaSalle Street, Chicago, Illinois 60690: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->

<!-- PJG 0012 frnewline -->
1. James L. Blin, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Osprcy, Florida; Bywater Properties, Iowa City, Iowa; Willis Crees, Waterloo, Iowa; Collin Fritz, Peoria, Arizona;
Vernon Hoffman, Independence, Iowa; William Kuehn, Sumner, Iowa; Gary Short and Harriet Short, both of Independence,
Iowa; to acquire an additional 68.35 percent of the voting shares of Independence Bancshares, Inc., Independence,
Iowa, for a total of 81.91 percent, and thereby indirectly acquire Security State Bank, Independence, Iowa, and First
State Bancorporation, Independence, Iowa, and thereby indirectly acquire Northeast Security Bank, Sumner, Iowa.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->

<!-- PJG 0012 frnewline -->
2. Van A. Dukeman, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
David J. Downey George T. Shapland and Gregory B. Lykins, all of Champaign, Illinois; to acquire, as a group, 33.19
percent of the voting shares of BankIllinois Financial Co., Champaign, Illinois, and thereby indirectly acquire
Bank of Illinois in Champaign, Illinois. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->

<!-- PJG 0012 frnewline -->
D. Federal Reserve Bank of Dallas 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(Genie D. Short, Vice President) 2200 North Pearl Street, Dallas, Texas 75201&hyph;2272: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->

<!-- PJG 0012 frnewline -->
1. Albert Furman, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Glenview, Illinois; to acquire 45.4 percent; Robert Cook, Union Grove, Wisconsin, to acquire 7.6 percent; Robert
Durham, Austin, Texas, to acquire 7.6 percent; Howard Marvin, Palm Desert, California, to acquire 7.6 percent; and
Robert Wunsch, Austin, Texas, to acquire 7.6 percent of the voting shares of Hutto State Bank, Hutto, Texas. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->

<!-- PJG 0012 frnewline -->
E. Federal Reserve Bank of San Francisco 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(Kenneth R. Binning, Director, Bank Holding Company) 101 Market Street, San Francisco, California 94105: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->

<!-- PJG 0012 frnewline -->
1. Kaharudin Latief, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Jakarta, Indonesia; to acquire 33.3 percent of the voting shares of Bank of San Francisco Company Holding Company,
San Francisco, California, and thereby indirectly acquire Bank of San Francisco, San Francisco, California. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Board of Governors of the Federal Reserve System, January 26, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Jennifer J. Johnson. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Secretary of the Board. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2306 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6210&hyph;F&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00050 </DOCNO>
<PARENT> FR940202-2-00036 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Southwest Bancshares, Inc., et al.; Formations of; Acquisitions by; and Mergers of Bank Holding Companies</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The companies listed in this notice have applied for the Board's approval under section 3 of the Bank Holding Company
Act (12 U.S.C. 1842) and  225.14 of the Board's Regulation Y (12 CFR 225.14) to become a bank holding company or to acquire
a bank or bank holding company. The factors that are considered in acting on the applications are set forth in section
3(c) of the Act (12 U.S.C. 1842(c)).
<!-- PJG 0012 frnewline -->
Each application is available for immediate inspection at the Federal Reserve Bank indicated. Once the application
has been accepted for processing, it will also be available for inspection at the offices of the Board of Governors.
Interested persons may express their views in writing to the Reserve Bank or to the offices of the Board of Governors.
Any comment on an application that requests a hearing must include a statement of why a written presentation would
not suffice in lieu of a hearing, identifying specifically any questions of fact that are in dispute and summarizing
the evidence that would be presented at a hearing.
<!-- PJG 0012 frnewline -->
Unless otherwise noted, comments regarding each of these applications must be received not later than February 25,
1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
A. Federal Reserve Bank of St. Louis
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Randall C. Sumner, Vice President) 411 Locust Street, St. Louis, Missouri 63166:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Southwest Bancshares, Inc.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Jonesboro, Arkansas; to acquire 100 percent of the voting shares of FirstBank of Arkansas, Kensett, Arkansas.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
B. Federal Reserve Bank of Kansas City
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (John E. Yorke, Senior Vice President) 925 Grand Avenue, Kansas City, Missouri 64198:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Peoples Bancshares, Inc.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Clay Center, Kansas; to become a bank holding company by acquiring 100 percent of the voting shares of The Peoples
National Bank, Clay Center, Kansas.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Board of Governors of the Federal Reserve System, January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jennifer J. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Secretary of the Board.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94-2323 Filed 2-1-94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6210-01-F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00051 </DOCNO>
<PARENT> FR940202-2-00037 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Agency for Toxic Substances and Disease Registry</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Low Level Exposure to Chemicals and Neurologic Sensitivity; Meeting
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Name: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Conference on Low Level Exposure to Chemicals and Neurologic Sensitivity.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Times and Dates: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
8 a.m.&hyph;5:15 p.m., April 6, 1994. 8 a.m.&hyph;4 p.m., April 7, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Place: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The Stouffer Harbor Place Hotel, 202 East Pratt Street, Baltimore, Maryland, 21202, telephone 410/547&hyph;1200.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Status: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The entire meeting will be open to the public, limited only by space available.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Purpose: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
To explore clinical observations and basic research information potentially relevant to neurobiologic mechanisms
of sensitivity to low level chemical exposures, and to discuss possible tools for advancing the understanding of
the neurological effects of low level environmental chemical exposures. The information gained from this meeting
will be used by the Agency for Toxic Substance and Disease registry (ATSDR) to develop testable hypotheses.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Contact Persons for More Information: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Patricia Price, M.D., ATSDR, Mailstop E&hyph;33, 1600 Clifton Road, NE., Atlanta, Georgia, telephone 404/639&hyph;6204;
Frank Mitchell, M.D., ATSDR, Mailstop E&hyph;28, 1600 Clifton Road, NE., Atlanta, Georgia, telephone 404/639&hyph;0700.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Elvin Hilyer,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Director for Policy Coordination.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2329 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;70&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00052 </DOCNO>
<PARENT> FR940202-2-00038 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Centers for Disease Control and Prevention</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Hospital Infection Control Practices Advisory Committee: Subcommittee on Prevention and Control of Antimicrobial
Resistant Microorganisms in Hospitals; Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92&hyph;463), the Centers for
Disease Control and Prevention (CDC) announces the following subcommittee meeting.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Name: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Subcommittee on Prevention and Control of Antimicrobial Resistant Microorganisms in Hospitals.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Time and Date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
9 a.m.&hyph;3:30 p.m., February 18, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Place: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
CDC, Auditorium A, 1600 Clifton Road, NE., Atlanta, Georgia 30333.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Status: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Open to the public, limited only by the space available.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Purpose: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
This subcommittee will review current knowledge about the epidemiology and laboratory aspects of antimicrobial
resistance among nosocomial pathogens and develop an agenda for a workshop later this year to revise and/or develop
recommendations to control these pathogens in acute care settings.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Matters to be Discussed: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The subcommittee will hold its second meeting to review current knowledge about the epidemiology and laboratory
aspects of vancomycin resistance in enterococci and develop a comprehensive strategic plan to detect, prevent,
and control resistant enterococci in U.S. hospitals. Agenda items are subject to change as priorities dictate.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Contact Person for More Information: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Julia S. Garner, R.N., M.N., Nurse Consultant, Hospital Infections Program, NCID, CDC, 1600 Clifton Road, NE., Mailstop
A&hyph;07, Atlanta, Georgia 30333, telephone 404/639&hyph;1552.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Elvin Hilyer,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Director for Policy Coordination, Centers for Disease Control and Prevention (CDC).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2330 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;18&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00053 </DOCNO>
<PARENT> FR940202-2-00039 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->
Food and Drug Administration
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 93F&hyph;0483]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Rio Linda Chemical Co., Inc.; Filing of Food Additive Petition</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Food and Drug Administration, HHS.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Food and Drug Administration (FDA) is announcing that Rio Linda Chemical Co., Inc., has filed a petition proposing
that the food additive regulations be amended to provide for the safe use of chlorine dioxide to disinfect waters contacting
fresh meat, fresh poultry, processed meat, and processed poultry.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Written comments on the petitioner's environmental assessment by March 4, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Submit written comments to the Dockets Management Branch (HFA&hyph;305), Food and Drug Administration, rm. 1&hyph;23,
12420 Parklawn Dr., Rockville, MD 20857.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Robert L. Martin, Center for Food Safety and Applied Nutrition (HFS&hyph;217), Food and Drug Administration, 200
C St. SW., Washington, DC 20204&hyph;0001, 202&hyph;254&hyph;9519.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Under the Federal Food, Drug, and Cosmetic Act (sec. 409(b)(5) (21 U.S.C. 348(b)(5))), notice is given that a food
additive petition (FAP 4A4408) has been filed by Rio Linda Chemical Co., Inc., 410 North 10th St., Sacramento, CA 95814.
The petition proposes that the food additive regulations be amended to provide for the safe use of chlorine dioxide
to disinfect waters contacting fresh meat, fresh poultry, processed meat, and processed poultry. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The potential environmental impact of this action is being reviewed. To encourage public participation consistent
with regulations promulgated under the National Environmental Policy Act (40 CFR 1501.4(b)), the agency is placing
the environmental assessment submitted with the petition that is the subject of this notice on public display at the
Dockets Management Branch (address above) for public review and comment. Interested persons may, on or before March
4, 1994, submit to the Dockets Management Branch (address above) written comments. Two copies of any comments are
to be submitted, except that individuals may submit one copy. Comments are to be identified with the docket number
found in brackets in the heading of this document. Received comments may be seen in the office above between 9 a.m. and
4 p.m. Monday through Friday. FDA will also place on public display any amendments to, or comments on, the petitioner's
environmental assessment without further announcement in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. If, based on its review, the agency finds that an environmental impact statement is not required and this petition
results in a regulation, the notice of availability of the agency's finding of no significant impact and the evidence
supporting that finding will be published with the regulation in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in accordance with 21 CFR 25.40(c). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 24, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Fred R. Shank,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Center for Food Safety and Applied Nutrition.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2268 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;01&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00054 </DOCNO>
<PARENT> FR940202-2-00040 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Advisory Committee; Notice of Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Food and Drug Administration, HHS.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA).
This notice also summarizes the procedures for the meeting and methods by which interested persons may participate
in open public hearings before FDA's advisory committees.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
MEETING:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The following advisory committee meeting is announced:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Subcommittee Meeting of the Anesthetic and Life Support Drugs Advisory Committee
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date, time, and place
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. March 1 and 2, 1994, 8 a.m., Potomac Inn, Ballrooms A, B, and C, Three Research Ct., Rockville, MD.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Type of meeting and contact person
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Open committee discussion, March 1, 1994, 8 a.m. to 1 p.m.; open public hearing, 1 p.m. to 3 p.m., unless public participation
does not last that long; open committee discussion, 3 p.m. to 5 p.m.; open committee discussion, March 2, 1994, 8 a.m.
to 1 p.m.; Igor Cerny, Center for Drug Evaluation and Research (HFD&hyph;9), Food and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301&hyph;443&hyph;5455.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
General function of the committee
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. The committee reviews and evaluates data on the safety and effectiveness of marketed and investigational human
drugs for use in the field of anesthesiology and surgery.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Agenda_Open public hearing
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee.
Those desiring to make formal presentations should notify the contact person before February 15, 1994, and submit
a brief statement of the general nature of the evidence or arguments they wish to present, the 
<!-- PJG 0012 frnewline -->
names and addresses of proposed participants, and an indication of the approximate time required to make their comments.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Open committee discussion
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. The committee will discuss how to ensure the safe use of products intended for premedication (including preoperative
sedation, conscious sedation, and monitored anesthesia care) in pediatric practice. Recommendations from the
meeting will serve as the basis for labeling information that can promote the safe administration of products intended
for pediatric premedication.
<!-- PJG 0012 frnewline -->
FDA public advisory committee meetings may have as many as four separable portions: (1) An open public hearing, (2)
an open committee discussion, (3) a closed presentation of data, and (4) a closed committee deliberation. Every advisory
committee meeting shall have an open public hearing portion. Whether or not it also includes any of the other three
portions will depend upon the specific meeting involved. There are no closed portions for the meetings announced
in this notice. The dates and times reserved for the open portions of each committee meeting are listed above.
<!-- PJG 0012 frnewline -->
The open public hearing portion of each meeting shall be at least 1 hour long unless public participation does not last
that long. It is emphasized, however, that the 1 hour time limit for an open public hearing represents a minimum rather
than a maximum time for public participation, and an open public hearing may last for whatever longer period the committee
chairperson determines will facilitate the committee's work.
<!-- PJG 0012 frnewline -->
Public hearings are subject to FDA's guideline (subpart C of 21 CFR part 10) concerning the policy and procedures for
electronic media coverage of FDA's public administrative proceedings, including hearings before public advisory
committees under 21 CFR part 14. Under 21 CFR 10.205, representatives of the electronic media may be permitted, subject
to certain limitations, to videotape, film, or otherwise record FDA's public administrative proceedings, including
presentations by participants.
<!-- PJG 0012 frnewline -->
Meetings of advisory committees shall be conducted, insofar as is practical, in accordance with the agenda published
in this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice. Changes in the agenda will be announced at the beginning of the open portion of a meeting.
<!-- PJG 0012 frnewline -->
Any interested person who wishes to be assured of the right to make an oral presentation at the open public hearing portion
of a meeting shall inform the contact person listed above, either orally or in writing, prior to the meeting. Any person
attending the hearing who does not in advance of the meeting request an opportunity to speak will be allowed to make
an oral presentation at the hearing's conclusion, if time permits, at the chairperson's discretion.
<!-- PJG 0012 frnewline -->
The agenda, the questions to be addressed by the committee, and a current list of committee members will be available
at the meeting location on the day of the meeting.
<!-- PJG 0012 frnewline -->
Transcripts of the open portion of the meeting may be requested in writing from the Freedom of Information Office (HFI&hyph;35),
Food and Drug Administration, rm. 12A&hyph;16, 5600 Fishers Lane, Rockville, MD 20857, approximately 15 working
days after the meeting, at a cost of 10 cents per page. The transcript may be viewed at the Dockets Management Branch
(HFA&hyph;305), Food and Drug Administration, rm. 1&hyph;23, 12420 Parklawn Dr., Rockville, MD 20857, approximately
15 working days after the meeting, between the hours of 9 a.m. and 4 p.m., Monday through Friday. Summary minutes of
the open portion of the meeting may be requested in writing from the Freedom of Information Office (address above)
beginning approximately 90 days after the meeting. 
<!-- PJG 0012 frnewline -->
This notice is issued under section 10(a)(1) and (2) of the Federal Advisory Committee Act (5 U.S.C. app. 2), and FDA's
regulations (21 CFR part 14) on advisory committees.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jane E. Henney,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Commissioner for Operation.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2269 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;01&hyph;F 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00055 </DOCNO>
<PARENT> FR940202-2-00041 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Health Resources and Services Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Announcement of Application Deadlines for Fiscal Year 1994 for Selected Programs of the Maternal and Child Health
Bureau </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Health Resources and Services Administration (HRSA), PHS.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Advance notice of application deadline dates.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Health Resources and Services Administration's 
<!-- PJG 0012 frnewline -->
Maternal and Child Health Bureau (MCHB) expects to provide funding 
<!-- PJG 0012 frnewline -->
for new and competing renewal grant projects and cooperative 
<!-- PJG 0012 frnewline -->
agreements for the following programs during fiscal year 1994. 
<!-- PJG 0012 frnewline -->
The HRSA is announcing anticipated application deadline, award, 
<!-- PJG 0012 frnewline -->
funding and project period information for the following 
<!-- PJG 0012 frnewline -->
categories of: (1) Special Projects of Regional and National 
<!-- PJG 0012 frnewline -->
Significance (SPRANS) under the MCH Federal Set-Aside Program, 
<!-- PJG 0012 frnewline -->
funded under section 502(a) of the Social Security Act; (2) HIV 
<!-- PJG 0012 frnewline -->
Demonstration Program for Children, Adolescents and Families 
<!-- PJG 0012 frnewline -->
funded under Title IV of the Ryan White C.A.R.E. Act; and (3) 
<!-- PJG 0012 frnewline -->
Emergency Medical Services for Children Project Grants, funded 
<!-- PJG 0012 frnewline -->
under section 1910 of the Public Health Service Act.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Potential applicants may contact 
<!-- PJG 0012 frnewline -->
Chief, Grants Management Branch, Office of Program Support, 
<!-- PJG 0012 frnewline -->
Maternal and Child Health Bureau, Health Resources and Services 
<!-- PJG 0012 frnewline -->
Administration, Room 18&hyph;12, Parklawn Building, 5600 Fishers Lane, 
<!-- PJG 0012 frnewline -->
Rockville, Maryland 20857, (301) 443&hyph;1440 for application 
<!-- PJG 0012 frnewline -->
information and other programmatic information concerning these 
<!-- PJG 0012 frnewline -->
programs. Requests should specify the category or categories of 
<!-- PJG 0012 frnewline -->
activities for which an application is requested.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 A Notice of Availability of Funds will 
<!-- PJG 0012 frnewline -->
be published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 for each of these programs, 
<!-- PJG 0012 frnewline -->
announcing program provisions, priorities, and review criteria. 
<!-- PJG 0012 frnewline -->
The actual amounts available for awards and their allocation may 
<!-- PJG 0012 frnewline -->
vary from those in this notice, based on the volume and quality of 
<!-- PJG 0012 frnewline -->
applications received. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Set forth below is the application information, in table form: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 5,L2,i1,s75,r50,r50,r50,xs65 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
MCH Federal Set-aside Grant and Cooperative Agreements Anticipated Deadline, Award, Funding, and Project Period
Information, by Category 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=96 g=1 f=4 -->
[FY 1994] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Funding source category
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Application deadline 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Estimated number of awards 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Estimated amounts available 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Project period
<!-- PJG 007 0152 intable -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Grants in the following areas: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=4 -->
(1) Research 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
March 1, 1994&hyph;August 1, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 20 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
$2.5 million 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 5 years.
<!-- PJG 007 0162 intable -->
s
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=12 g=1 f=4 -->
(2) Training: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=4 -->
(2.1) Long term 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
April 15, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 28 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
13.4 million 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 5 years. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2.2) Continuing Education 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
July 1, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 14 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
750,000 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 3 years.
<!-- PJG 007 0162 intable -->
s
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=03 g=1 f=4 -->
(3) Genetic Disease 
<!-- PJG 0012 frnewline -->
Testing, Counseling 
<!-- PJG 0012 frnewline -->
and Information
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
April 25, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3 million
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3 years. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=4 -->
(4) Special MCH 
<!-- PJG 0012 frnewline -->
Improvement 
<!-- PJG 0012 frnewline -->
Projects (MCHIP) of 
<!-- PJG 0012 frnewline -->
Regional and 
<!-- PJG 0012 frnewline -->
National Signifi-cance in the 
<!-- PJG 0012 frnewline -->
following areas: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=4 -->
(4.1) Maternal, 
<!-- PJG 0012 frnewline -->
Infant, Child, 
<!-- PJG 0012 frnewline -->
and Adolescent 
<!-- PJG 0012 frnewline -->
Health 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
April 29, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 10
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1.0 million
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 3 years.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4.1.1) School 
<!-- PJG 0012 frnewline -->
Health Program 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
(Date to be announced)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 10
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2.5 million
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 2 years.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4.2) Health Care 
<!-- PJG 0012 frnewline -->
Reform for CSHCN 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 10, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
20 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3.5 million
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4 years.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4.3) Data 
<!-- PJG 0012 frnewline -->
Utilization 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
June 15, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
500,000
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 3 years.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4.4) Healthy 
<!-- PJG 0012 frnewline -->
Tomorrows 
<!-- PJG 0012 frnewline -->
Partnership for 
<!-- PJG 0012 frnewline -->
Children 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 10
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
500,000
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
5 years.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4.5) Field_Initiated Projects 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
April 1, 1994&hyph;August 15, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 10
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 500,000
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 5 years.
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
Cooperative 
<!-- PJG 0012 frnewline -->
Agreements (MCHIPs) 
<!-- PJG 0012 frnewline -->
in the following 
<!-- PJG 0012 frnewline -->
area: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=4 -->
(1) CSHCN Child and 
<!-- PJG 0012 frnewline -->
Adolescent Service 
<!-- PJG 0012 frnewline -->
System Program 
<!-- PJG 0012 frnewline -->
(CASSP) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 10, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1.5 million 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Up to 5 years.
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00056 </DOCNO>
<PARENT> FR940202-2-00041 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 5,L2,i1,s75,r50,r50,r50,xs65 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=4 -->
HIV Demonstration Grants for Children, Adolescents and Families Under Title IV of the Ryan White C.A.R.E. Act Anticipated
Deadline, Award, Funding, and Project Period Information, by Category
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=96 g=1 f=4 -->
[FY 1994]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Funding source category 
<!-- PJG 007 0150 intable -->
1Application deadline 
<!-- PJG 007 0150 intable -->
1Estimated number of awards 
<!-- PJG 007 0150 intable -->
1Estimated amounts available 
<!-- PJG 007 0150 intable -->
1Project period
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Grants in the following categories:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=4 -->
(1) HIV Demonstration Projects for Children, Adolescents, and Families 
<!-- PJG 007 0104 intable -->
April 8, 1994 
<!-- PJG 007 0104 intable -->
Up to 20 
<!-- PJG 007 0104 intable -->
 $10 million 
<!-- PJG 007 0104 intable -->
3 years.
<!-- PJG 007 0162 intable -->
s
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=02 g=1 f=4 -->
(2) Comprehensive Care Planning 
<!-- PJG 007 0104 intable -->
April 8, 1994 
<!-- PJG 007 0104 intable -->
Up to 4 
<!-- PJG 007 0104 intable -->
0.3 million 
<!-- PJG 007 0104 intable -->
1 to 2 years.
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00057 </DOCNO>
<PARENT> FR940202-2-00041 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 5,L2,i1,s75,r50,r50,r50,xs65 -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Emergency Medical Services for Children Project Grants and Cooperative Agreements Anticipated Deadline, Award,
Funding, and Project Period Information by Category
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=96 g=1 f=4 -->
[FY 1994]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Funding source category
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Application deadline
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Estimated number of awards
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Estimated amounts available
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Project period
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Grants in the following areas:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=4 -->
(1) State Planning
<!-- PJG 007 0104 intable -->
March 4, 1994
<!-- PJG 007 0104 intable -->
4
<!-- PJG 007 0104 intable -->
$200,000
<!-- PJG 007 0104 intable -->
1 year.
<!-- PJG 007 0162 intable -->
s
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=12 g=1 f=4 -->
(2) State Systems:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=4 -->
(2.A) Implementation 
<!-- PJG 007 0104 intable -->
April 22, 1994
<!-- PJG 007 0104 intable -->
4
<!-- PJG 007 0104 intable -->
1.25 million
<!-- PJG 007 0104 intable -->
2 years.
<!-- PJG 0012 frnewline -->
(2.B) System Enhancement
<!-- PJG 007 0104 intable -->
April 22, 1994
<!-- PJG 007 0104 intable -->
5
<!-- PJG 007 0104 intable -->
600,000
<!-- PJG 007 0104 intable -->
2 years.
<!-- PJG 007 0162 intable -->
s
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=02 g=1 f=4 -->
(3) Targeted Issues
<!-- PJG 007 0104 intable -->
April 22, 1994
<!-- PJG 007 0104 intable -->
5
<!-- PJG 007 0104 intable -->
$750,000
<!-- PJG 007 0104 intable -->
2 years.
<!-- PJG 007 0162 intable -->
s
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=22 g=1 f=4 -->
Cooperative Agreements in the following area:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=4 -->
(1) Resource Capacity
<!-- PJG 007 0104 intable -->
April 22, 1994
<!-- PJG 007 0104 intable -->
2
<!-- PJG 007 0104 intable -->
800,000
<!-- PJG 007 0104 intable -->
2 years.
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Dated: January 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=4 -->
William A. Robinson, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=4 -->
Acting Administrator.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=4 -->
[FR Doc. 94&hyph;2271 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=4 -->
BILLING CODE 4160-&hyph;15&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00058 </DOCNO>
<PARENT> FR940202-2-00042 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=4 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=4 -->

<DOCTITLE>Extension of Deadline Date for Grants for Interdisciplinary Training for Health Care for Rural Areas for FY 1994 </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
The Health Resources and Services Administration (HRSA) announced in the Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on January 6, 1994 (59 FR 771) that applications are being accepted for fiscal year (FY) 1994, Grants for Interdisciplinary
Training for Health Care for Rural Areas under the authority of section 778, title VII of the Public Health Service
(PHS) Act, as amended by the Health Professions Education Extension Amendments of 1992, Public Law 102&hyph;408,
dated October 13, 1992. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 Section 778 of the Public Health Service Act, as amended, authorizes the Secretary to award grants for interdisciplinary
training projects designed to provide or improve access to health care in rural areas. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 To provide additional time for applicants to complete applications, the deadline date for this program is extended
to February 15, 1994. Applications will be considered to be ``on time'' if they are either: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 (1) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Received on or before
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 the established deadline date, or 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 (2) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sent on or before
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 the established deadline date and received in time for orderly processing. (Applicants should request a legibly
dated U.S. Postal Service postmark or obtain a legibly dated receipt from a commercial carrier or U.S. Postal Service.
Private metered postmarks shall not be acceptable as proof of timely mailing.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 Late applications not accepted for processing will be returned to the applicant. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 If additional programmatic information is needed, please contact: 
<!-- PJG 0012 frnewline -->
Dr. Marcia Brand, Program Officer, 
<!-- PJG 0012 frnewline -->
Division of Associated, Dental and Public 
<!-- PJG 0012 frnewline -->
Health Professions, 
<!-- PJG 0012 frnewline -->
Bureau of Health Professions, HRSA, 
<!-- PJG 0012 frnewline -->
Parklawn Building, room 8C&hyph;02, 
<!-- PJG 0012 frnewline -->
5600 Fishers Lane, 
<!-- PJG 0012 frnewline -->
Rockville, MD 20857, 
<!-- PJG 0012 frnewline -->
Telephone: 301&hyph;443&hyph;6763, 
<!-- PJG 0012 frnewline -->
FAX: 301&hyph;443&hyph;1164.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
William A. Robinson, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Administrator. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2270 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;15&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00059 </DOCNO>
<PARENT> FR940202-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>National Institutes of Health</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Consensus Development Conference on Helicobacter Pylori and Peptic Ulcer Disease</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notice is hereby given to the NIH Consensus Development Conference on ``Helicobacter Pylori and Peptic Ulcer Disease,''
which will be held February 7&hyph;9, 1994, in the Masur Auditorium of the National Institutes of Health, 9000 Rockville
Pike, Bethesda, Maryland 20892. This conference is sponsored by the National Institute of Diabetes and Digestive
and Kidney Diseases and the NIH Office of Medical Applications of Research. The conference is cosponsored by the National
Institute of Allergy and Infectious Diseases. The conference begins at 8:30 a.m. on February 7 and 8 and at 9 a.m. on
February 9.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
One in a series of NIH Consensus Development Conferences, this conference will evaluate all the data that are available
on H. pylori and its role in causing peptic ulcer disease and gastric malignancy and on the best and most appropriate
means of diagnosing and treating H. pylori infection. The conference will bring together specialists in gastroenterology,
infectious disease, epidemiology, and pathology, as well as representatives from the public.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Following 11/2 days of presentations and discussion by the audience, an independent non-Federal consensus panel
will weigh the scientific evidence and write a draft statement in response to the following key questions:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;What is the role of H. pylori infection in causing peptic ulcer disease and gastric malignancy?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;Does eradication of H. pylori infection alter the natural history of peptic ulcer disease?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;Which patients with H. pylori infection should be treated?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;What are the best and most appropriate means of diagnosis and monitoring of H. pylori infection?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;What are the best means of eradication of H. pylori infection?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;What are the most important issues to be addressed by future research in H. pylori infection?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
On the final day of the meeting, the consensus panel chairman will read the draft statement to the conference audience
and invite comments and questions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Advance information on the conference program and conference registration materials may be obtained from: Laura
Hazan, Technical Resources, Inc., 3202 Tower Oaks Blvd., suite 200, Rockville, Maryland 20852, (301) 770&hyph;3153.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The final consensus statement will be submitted for publication in professional journals and other publications.
The final consensus statement will be available approximately April 1, 1994. Requests for the final consensus statement
should be addressed to the NIH Consensus Program Information Service, P.O. Box 2577, Kensington, Maryland 20891,
phone 1&hyph;800&hyph;NIH&hyph;OMAR (1&hyph;800&hyph;644&hyph;6627).
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 24, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Harold Varmus,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, NIH.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2448 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4140&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00060 </DOCNO>
<PARENT> FR940202-2-00044 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF THE INTERIOR</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of the Secretary</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
National Wild &amp; Scenic Rivers System; Approval of Application
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Office of the Secretary, DOI.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of approval.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Secretary of the Interior hereby announces approval of an application by the Governor of Arkansas to include segments
of the Cossatot River, Arkansas and its tributary Brushy Creek as state-administered components of the National
Wild and Scenic Rivers System.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Alan Ragins, Rivers, Trails and Conservation Program, National Park Service, Southwest Region, P.O. Box 728, 1220
St. Francis Drive, Santa Fe, New Mexico 87504&hyph;0728 (Telephone: 505&hyph;988&hyph;1876).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Pursuant to the authority granted the Secretary of the Interior by section 2 of the Wild and Scenic Rivers Act (Pub.
L. 90&hyph;542, as amended; 16 U.S.C. 1273, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
) and upon proper application of the Governor of the State of Arkansas, a 10.4-mile segment of the Cossatot River and
a 0.3-mile segment of Brushy Creek in Arkansas are hereby designated as state-administered components of the National
Wild and Scenic Rivers System.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Secretarial designation covers that part of the Cossatot and Brushy Creek within the boundaries of the Cossatot
River Sate Park-Natural Area in Polk and Howard Counties. This action is based on the designation of the river by the
State of Arkansas and the protection offered this river and its immediate environment by and pursuant to applicable
State laws and regulations.
<!-- PJG 0012 frnewline -->
On July 3, 1990, President Clinton, then the Governor of Arkansas, petitioned the Secretary of the Interior to add
the above described segments of the Cossatot River to the National System. On April 22, 1992, Congress added the Cossatot
to the National Wild and Scenic Rivers System (Pub. L. 102&hyph;275). However, the State is pursuing its original
request for Secretarial designation for the following reasons:
<!-- PJG 0012 frnewline -->
1. To officially classify the State-managed river segments as ``Scenic.''
<!-- PJG 0012 frnewline -->
2. To recognize the State Management Plan for the Cossatot River State Park and Natural Area.
<!-- PJG 0012 frnewline -->
3. To refine the current definition of the State's portion of the scenic river corridor.
<!-- PJG 0012 frnewline -->
In response to the Governor's request, the Secretary, through the National Park Service conducted a complete review
of the State application and documents associated with the designation decision. As a result of that review, the Secretary
has determined that the 10.4-mile segment of the Cossatot River and a 0.3-mile segment of Brushy Creek in the State's
application should be designated as a State-administered component of the National Wild and Scenic Rivers System,
as provided for in section 2(a)(ii) of the Wild and Scenic Rivers Act.
<!-- PJG 0012 frnewline -->
The State of Arkansas has fulfilled the requirements of the Act by designating these segments as components of the
Arkansas System of Natural and Scenic Rivers and by adopting a program of action that will adequately protect the river
from adverse State actions. The National Park Service evaluation of the river concluded that these segments of the
Cossatot River and Brushy Creek meet the criteria for the scenic classification under the Act. Accordingly, the following
river segments are classified as scenic pursuant to section 2(b) of the Act to be administered by State government:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cossatot River: Scenic_
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The 10.4-mile segment of the Cossatot River within the boundaries of the Cossatot River State Park-Natural Area just
above the State Highway 246 crossing, at the Ouachita National Forest boundary in Polk County to the crossing at State
Highway 4 in Howard County.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brushy Creek: Scenic_
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The 0.3-mile segment of Brushy Creek within the boundaries of the Cossatot River State Park-Natural Area in Polk County.
<!-- PJG 0012 frnewline -->
This action is taken following public involvement and consultation with the Departments of Agriculture, Army, Energy,
Transportation, the Federal Energy Regulation Commission, and the U.S. Environmental Protection Agency as required
by section 4(c) of the Wild and Scenic Rivers Act. A 45-day period for public comment on the State's application and
river management plan and on the environmental assessment of the proposed national designation was provided from
April 15, 1991, to May 31, 1991. All comments received have been carefully considered.
<!-- PJG 0012 frnewline -->
Notice is hereby given that effective upon this date, the above-described river segments are approved for inclusion
in the National Wild and Scenic Rivers System to be administered by the State of Arkansas.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 14, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Bruce Babbitt,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary of the Interior.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2287 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;70&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00061 </DOCNO>
<PARENT> FR940202-2-00045 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Fish and Wildlife Service</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Aquatic Nuisance Species Task Force Intentional Introductions Policy Review Committee; Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Department of the Interior, Fish and Wildlife Service.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice announces a meeting of the Intentional Introductions Policy Review Committee (Committee), a committee
of the Aquatic Nuisance Species Task Force. The Committee will meet to review the final version of the proposed report
to Congress.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Intentional Introductions Policy Review Committee will meet from 9 a.m. to 3 p.m. on Thursday, February 17, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Intentional Introductions Policy Review Committee meeting will be held in room 13836, National Oceanic and Atmospheric
Administration Building, 3, 1315 East-West Highway, Silver Spring, MD 20910.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Dean Wilkinson, Intentional Introductions Policy Review Committee Chair, National Marine Fisheries Service,
Office of Protected Resources, 1335 East-West Highway, Silver Spring, MD 20910 at (301) 713&hyph;2322.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Pursuant to section 10(a)(2) of the Federal Advisory Committee Act (5 U.S.C. App. I), this notice announces a meeting
of the Intentional Introductions Policy Review Committee, a committee of the Aquatic Nuisance Species Task Force
established under the authority of the Nonindigenous Aquatic Nuisance Prevention and Control Act of 1990 (Pub. L.
101&hyph;646, 104 Stat. 4761, 16 U.S.C. 4701 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
et seq., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 November 29, 1990). Minutes of the meetings will be maintained by the Coordinator, Aquatic Nuisance Species Task
Force, room 840, 4401 North Fairfax Drive, Arlington, Virginia 22203 and will be available for public inspection
during regular business hours, Monday through Friday within 30 days following the meeting.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Noreen Clough,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Assistant Director_Fisheries, Acting Co-Chair, Aquatic Nuisance Species Task Force.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2344 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;55&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00062 </DOCNO>
<PARENT> FR940202-2-00046 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Minerals Management Service</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Outer Continental Shelf, Alaska, Gas and Oil Lease Sale 148 </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Minerals Management Service, Interior. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Call for information and nominations and notice of intent to prepare an environmental impact statement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Authority.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 This Call/NOI is published pursuant to the Outer Continental Shelf (OCS) Lands Act (43 U.S.C. 1331&hyph;1356, (1988)),
and the regulations issued thereunder (30 CFR part 256). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Purpose of Call.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The purpose of the Call is to gather information for proposed OCS Gas and Oil Lease Sale 148. This proposed sale, located
in the Chukchi Sea Planning Area, is tentatively scheduled for June 1997. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Information and nominations on gas and oil leasing, exploration, and development and production within the Chukchi
Sea Planning Area are sought from all interested parties. This early planning and consultation step is part of the
Area Evaluation and Decision Process and is important for ensuring that all interests and concerns are communicated
to the Department of the Interior for future decisions in the leasing process pursuant to the OCS Lands Act, as amended
(43 U.S.C. 1331&hyph;1356) (1988), and regulations at 30 CFR part 256. This Call does not indicate a preliminary decision
to lease in the area described below. Final delineation of the area for possible leasing will be made at a later date
and in compliance with all applicable laws including requirements of the National Environmental Policy Act (42 U.S.C.
4321 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
), as amended, and with established departmental procedures. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of Area. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The area of this Call, located offshore the State of Alaska in the Chukchi Sea Planning Area as identified on the attached
map, extends offshore from approximately 3 miles to 200 miles, in water depths from around 10 to 100 meters. The area
available for nominations and comments consists of approximately 4,700 whole and partial blocks (about 10 million
hectares or 26 million acres). Respondents may nominate and are asked to comment on any acreage within the entire Call
area. A large-scale map of the Chukchi Sea Planning Area (hereinafter referred to as the Call map), showing boundaries
of the area on a block-by-block basis, and a complete list of Official Protraction Diagrams (OPD's), are available
from the Records Manager, Alaska OCS Region, Minerals Management Service, 949 East 36th Avenue, room 502, Anchorage,
Alaska 99508&hyph;4302, telephone (907) 271&hyph;6621. The OPD's may be purchased from the Records Manager for
$2 each. Current editions of the listed OPD's are based on the North American Datum of 1983. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00063 </DOCNO>
<PARENT> FR940202-2-00046 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Instructions on Call. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Respondents are requested to nominate blocks within the Call area that they would like to be considered for inclusion
in proposed OCS Lease Sale 148. Nominations must be depicted on the Call map by outlining the area(s) of interest along
block lines. Respondents are asked to submit a list of whole and partial blocks nominated (by OPD designations) to
facilitate correct interpretation of their nominations on the Call map. Although the identities of those submitting
nominations become a matter of public record, the individual nominations are deemed to be proprietary information.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Respondents are also requested to rank areas nominated according to priority of interest (e.g., Priority 1 (high),
Priority 2 (medium), or Priority 3 (low)). Areas nominated that do not indicate priorities will be considered Priority
3. Respondents are encouraged to be specific in indicating areas or blocks by priority. Blanket priorities on large
areas are not useful in the analysis of industry interest. The telephone number and name of a person to contact in the
respondent's organization for additional information should be included in the response.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comments are sought from all interested parties about particular geologic, environmental, biological, archaeological,
or social and economic conditions, conflicts, or other information that might bear upon potential leasing and development
in the Call area. Comments are also sought on potential conflicts with approved local coastal management plans (CMP's)
that may result from the proposed sale and future OCS gas and oil activities. If possible, these comments should identify
specific CMP policies of concern, the nature of the conflicts foreseen, and steps that MMS could take to avoid or mitigate
the potential conflicts. Comments may be in terms of broad areas or restricted to particular blocks of concern. Those
submitting comments are requested to list block numbers or outline the subject area on the large-scale Call map.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Nominations and comments must be received no later than 45 days following publication of this document in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in envelopes labeled ``Nominations for Proposed Chukchi Sea Lease Sale 148,'' or ``Comments on the Call for Information
and Nominations for Proposed Chukchi Sea Lease Sale 148,'' as appropriate. The original Call map with indications
of interest and/or comments must be submitted to the Regional Supervisor, Leasing and Environment, Alaska OCS Region,
Minerals Management Service, 949 East 36th Avenue, room 603, Anchorage, Alaska 99508-4302.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Use of Information from Call. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Information submitted in response to this Call will be used for several purposes. First, responses will be used to
help identify the areas for potential gas and oil development. Second, comments on possible environmental effects
and potential-use conflicts will be used in the analysis of environmental conditions in and near the Call area. The
third program for this Call is to assist in the scoping of the EIS and the development of alternatives to the proposed
action for analysis. The NOI to prepare an EIS is included later in this document. Fourth, comments may be used in developing
lease terms and conditions to ensure safe offshore gas and oil activities. Fifth, comments may be used to point out
potential conflicts between offshore gas and oil activities and the State's CMP.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Existing Information. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Information Base Review (IBR) step was completed in March 1993. The purpose of the IBR is to evaluate the availability
and quality of information relevant to decisions on this proposed Sale.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The IBR for Chukchi Sea Sale 148 included publication of a Request for Interest and Information in December 1992, with
comments due by the end of January 1993, and Information Transfer Meetings in Anchorage, Alaska, in January 1993.
On the basis of the information analyzed during the review process, a determination was made that there is sufficient
information and interest to proceed with the Call.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The National Research Council of the National Academy of Sciences is conducting a study on environmental information
for gas and oil leasing decisions in the Beaufort and Chukchi Seas, and Navarin Basin OCS Planning Areas. This study,
expected to be completed in the first quarter of 1994, will examine information needs, costs of obtaining information,
potential improvements in the management and prediction of environmental effects that may result from acquiring
additional information, and alternatives to conducting additional studies. The conclusions of this report can
be considered, along with information received in response to the Call and scoping efforts, in subsequent decisions
in the prelease process.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
An extensive environmental, social and economic studies program has been under way in this area since 1975. The emphasis
has been on: geologic mapping; environmental characterization of biologically sensitive habitats; endangered
whales and marine mammals; physical oceanography; ocean-circulation modeling; and ecological effects of gas and
oil activities. A complete listing of available study reports and information for ordering copies may be obtained
from the Records Manager, Alaska OCS Region, at the address stated under Description of Area. The reports may also
be ordered directly from the U.S. Department of Commerce, National Technical Information Service, 5285 Port Royal
Road, Springfield, Virginia 22161 or by telephone at (730) 487-4650. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addition, a program status report for continuing studies in this area may be obtained from the Chief, Environmental
Studies Section, Alaska OCS Region, at the address stated under Instructions on Call or by telephone at (907) 271-6620.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00064 </DOCNO>
<PARENT> FR940202-2-00046 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Summary Reports and Indices and technical and geologic reports are available for review at the MMS Alaska OCS Region
(see address under Description of Area). Copies of the Alaska OCS Regional Summary Reports may also be obtained from
the OCS Information Program, Office of Offshore Information and Publications, Minerals Management Service, 381
Elden Street, Herndon, Virginia 22070. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Tentative Schedule.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Approximate dates for actions and decision and consultation points in the planning process are: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 2,L2,tp0,i1,s150,xs60  -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Milestones 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Dates 
<!-- PJG 007 0152 intable -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Comments Due on the Call 
<!-- PJG 007 0104 intable -->
March 1994. 
<!-- PJG 0012 frnewline -->
Scoping Comments Due 
<!-- PJG 007 0104 intable -->
April 1994. 
<!-- PJG 0012 frnewline -->
Area Identification 
<!-- PJG 007 0104 intable -->
October 1994. 
<!-- PJG 0012 frnewline -->
Draft EIS/Proposed Notice of Sale Published 
<!-- PJG 007 0104 intable -->
December 1995. 
<!-- PJG 0012 frnewline -->
Hearings on Draft EIS Held 
<!-- PJG 007 0104 intable -->
January 1996. 
<!-- PJG 0012 frnewline -->
Governor's Comments Due on Proposed Notice of Sale 
<!-- PJG 007 0104 intable -->
March 1996. 
<!-- PJG 0012 frnewline -->
Final EIS Filed with EPA 
<!-- PJG 007 0104 intable -->
January 1997. 
<!-- PJG 0012 frnewline -->
Constistency Determination Signed 
<!-- PJG 007 0104 intable -->
January 1997. 
<!-- PJG 0012 frnewline -->
Final Notice of Sale Published 
<!-- PJG 007 0104 intable -->
May 1997. 
<!-- PJG 0012 frnewline -->
Sale 
<!-- PJG 007 0104 intable -->
June 1997. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
8. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Purpose of Notice of Intent to Prepare an Environmental Impact Statement. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Purusant to the regulations (40 CFR 1501.7) implementing the provisions of the National Environmental Policy Act
of 1969 (42 U.S.C. 4321 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
), as amended, MMS is announcing its intent to prepare an EIS regarding the gas and oil leasing proposal known as OCS
Gas and Oil Lease Sale 148 Chukchi Sea. Throughout the scoping process, Federal, State, and local governments and
other interested parties have the opportunity to aid MMS in determing the significant issues and alternatives to
be analyzed in the EIS and the possible need for additional information. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The EIS analysis will focus on the potential environmental effects of leasing, exploration, and development of the
blocks included in the area defined in the Area Identification procedure as the proposed area of the Federal action.
Alternatives to the proposal that may be considered are to delay the sale, cancel the sale, or modify the sale. The Proposed
Final Comprehensive Program 1992&hyph;1997 indicated that during the prelease process for this sale, consideration
will be given to establishing a coastal buffer. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Instructions on Notice of Intent. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Federal, State, and local governments and other interested parties are requested to send their written comments
on the scope of the EIS, significant issues that should be addressed, and alternatives that should be considered to
the Regional Supervisor, Leasing and Environment, Alaska OCS Region, at the address stated under Instructions on
Call above. Comments should be enclosed in an envelope labeled ``Comments on the Notice of Intent to Prepare an EIS
on the proposed Chukchi Sea Lease Sale 148.'' Comments are due not later than 45 days from publication of this Notice.

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Tom Fry,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Minerals Management Service. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Approved: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Bob Armstrong, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Secretary Land and Minerals Management. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;MR&hyph;M 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d629 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
E:GRAPHICSEN02FE94.016
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

</IMPORT>

<!-- PJG /STAG -->

<!-- PJG STAG 4703 -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2290 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;MR&hyph;C 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00065 </DOCNO>
<PARENT> FR940202-2-00047 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF THE INTERIOR,</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>National Park Service</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Mississippi River Corridor Study Commission 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 National Park Service, Interior 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of meeting.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This notice sets the schedule for the forthcoming meeting of the Mississippi River Corridor Study Commission. Notice
of this meeting is required under the Federal Advisory Committee Act (Public Law 92&hyph;463). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Meeting Date and Time
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: March 14, 1994; 8 a.m. until 4:30 p.m. March 16, 1994; 8 a.m. until noon.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
Addresses:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Embassy Square Suites Conference Room, 2000 N. St. NW. Washington, DC. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The business meeting will be open to the public. Space and facilities to accommodate members of the public are limited
and persons will be accommodated on a first-come, first-served basis. The Chairman will permit attendees to address
the Commission, but may restrict the length of presentations. An agenda will be available from the National Park Service,
Midwest Region, 1 week prior to the meeting.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 David N. Given, Associate Regional Director, Planning and Resource Preservation, National Park Service, Midwest
Region, 1709 Jackson Street, Omaha, Nebraska 68102 (402) 221&hyph;3082.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Mississippi River Corridor Study Commission was established by Public Law 101&hyph;398, September 28, 1990.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 24, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
William W. Schenk,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Regional Director, Midwest Region.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2288 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;70&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00066 </DOCNO>
<PARENT> FR940202-2-00048 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>INTERNATIONAL TRADE COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Investigation No. 337&hyph;TA&hyph;315 (Enforcement Proceeding)]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
In the Matter of Certain Plastic Encapsulated Integrated Circuits: Designation of Commission Investigative Attorney

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notice is hereby given that, as of this date, Thomas L. Jarvis, Esq. of the Office of Unfair Import Investigations is
designated as the Commission investigative attorney in the above-cited investigation. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Secretary is requested to publish this Notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lynn I. Levine, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Office of Unfair Import Investigations, 500 E Street, S.W., Washington, DC 20436 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2340 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7020&hyph;02&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00067 </DOCNO>
<PARENT> FR940202-2-00049 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Investigations Nos. 731&hyph;TA&hyph;636 and 637 (Final)] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Stainless Steel Wire Rod From Brazil and France </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Determinations 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On the basis of the record&sect;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 developed in the subject investigations, the Commission determines,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 pursuant to section 735(b) of the Tariff Act of 1930 (19 U.S.C. 1673d(b)) (the Act), that an industry in the United States
is materially injured by reason of imports from Brazil and France of stainless steel wire rod, provided for in subheading
7221.00.00 of the Harmonized Tariff Schedule of the United States, that have been found by the Department of Commerce
to be sold in the United States at less than fair value (LTFV). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The record is defined in &sect;207.2(f) of the Commission's Rules of Practice and Procedure (19 CFR 207.2(f)). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Commissioner Brunsdale dissenting. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Background 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission instituted these investigations effective August 2, 1993, following preliminary determinations
by the Department of Commerce that imports of stainless steel wire rod from Brazil and France were being sold at LTFV
within the meaning of section 733(b) of the Act (19 U.S.C. 1673b(b)). Notice of the institution of the Commission's
investigations and of a public hearing to be held in connection therewith was given by posting copies of the notice
in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice
in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of August 18, 1993 (58 FR 43908). The hearing was held in Washington, DC, on October 14, 1993, and all persons who requested
the opportunity were permitted to appear in person or by counsel. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Commission transmitted its determinations in these investigations to the Secretary of Commerce on January 21,
1994. The views of the Commission are contained in USITC Publication 2721 (January 1994), entitled ``Stainless Steel
Wire Rod from Brazil and France: Investigations Nos. 636 and 637 (Final).'' 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued: January 24, 1994. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By order of the Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donna R. Koehnke, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2338 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7020&hyph;02&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00068 </DOCNO>
<PARENT> FR940202-2-00050 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Investigation No. 337&hyph;TA&hyph;355]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Certain Vehicle Security Systems and Components Thereof </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notice is hereby given that the prehearing conference in this matter will commence at 10 a.m. on February 9, 1994, in
Courtroom A (room 100), U.S. International Trade Commission Building, 500 E St. SW., Washington, DC, and the hearing
will commence immediately thereafter. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Secretary shall publish this notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued: January 25, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Sidney Harris, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Administrative Law Judge. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2339 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7020&hyph;02&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00069 </DOCNO>
<PARENT> FR940202-2-00051 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>INTERSTATE COMMERCE COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Finance Docket No. 32410]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
The Alabama Great Southern Railway Co._Acquisition Exemption_Illinois Central Railroad Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Interstate Commerce Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of Exemption.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Under 49 U.S.C. 10505, the Commission exempts from the prior approval requirements of 49 U.S.C. 11343-44 Alabama
Great Southern Railroad Company's (AGS) acquisition from the Illinois Central Railroad (IC) and operation of two
rail line segments in Louisiana totaling about 3.60 route miles. The segments are between milepost NA 38.25 near Colt
and milepost 36.0 in Slidell, on IC's Shoreline District, and between milepost NN 36.66 in North Slidell and milepost
35.31 in Slidell, at IC's connection with AGS's trackage on IC's Bogalusa District, together with all the appurtenances
thereto and fixed improvements thereon. The exemption is subject to standard employee protective conditions.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This exemption will be effective on March 4, 1994. Petitions to stay must be filed by February 17, 1994, and petitions
to reopen must be filed by February 28, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Send pleadings referring to Finance Docket No. 32410 to (1) Office of the Secretary, Case Control Branch, Interstate
Commerce Commission, Washington, DC 20423, (2) James R. Paschall, Norfolk Southern Corporation, 3 Commercial Place,
Norfolk, VA 23510-2191.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Richard B. Felder (202) 927-5610. (TDD for hearing impaired (202) 927-5721.)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Additional information is contained in the Commission's decision. To purchase a copy of the full decision, write
to, call, or pick up in person from: Dynamic Concepts, Inc., room 2229, Interstate Commerce Commission Building,
Washington, DC 20423. Telephone: (202) 289-4357/4359. (Assistance for the hearing impaired is available through
TDD service (202) 927-5721).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 Decided:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 By the Commission, Chairman McDonald, Vice Chairman Phillips, Commissioners Simmons, and Philbin.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Sidney L. Strickland, Jr.,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2357 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7035&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00070 </DOCNO>
<PARENT> FR940202-2-00052 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF JUSTICE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>National Institute of Corrections</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Advisory Board Meeting
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Time and Date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
8 a.m., Tuesday, March 8, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Place: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Los Angeles Airport Marriott Hotel; 5855 West Century Boulevard; Los Angeles, California.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Status: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Open.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Matters to be Considered: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
An update on the selection of the NIC Director, a progress report on NIC's strategic management and performance review
process, an update of mental health issues in jails, an update of the NIC/NIJ/CMHS Agreement, an update of the NIC staffing
analysis, a funding status report of the NASA/NIC program, a NIC budget update, the FY 1995 Program Plan recommendation,
a briefing on the California Corrections Executive Council, and a report on the Memorandum of Understanding with
the National Institute on Drug Abuse.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Contact Person for More Information: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Larry Solomon, Deputy Director (202) 307&hyph;3106, ext. 155.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Verna M. Muckle, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Deputy Director.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2203 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4410&hyph;36&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00071 </DOCNO>
<PARENT> FR940202-2-00053 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>National Science Foundation</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Academic Research Infrastructure Program; Notice of Competition</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The National Science Foundation announces the FY&hyph;1994 competition for the Academic Research Infrastructure
Program. This program is designed to improve the condition of research equipment and facilities in our Nation's academic
institutions in all areas of science traditionally supported by the National Science Foundation. One of the goals
of the program is to assist graduate and undergraduate academic institutions, including those that historically
have received limited Federal research and development funds, to improve their academic science and engineering
infrastructure. The Program consists of two components: instrumentation and facilities modernization. The former
provides support for the acquisition or development of major state-of-the-art research instrumentation. The latter
provides support for the renovation and/or repair of existing science and engineering research and research training
facilities. In FY&hyph;1994, separate competitions will be held for instrumentation and facilities modernization.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Program expects to allocate approximately $50 million in FY&hyph;1994 for instrumentation and $50 million for
facilities modernization. Previous proposal success rates for the program have been 26% for instrumentation and
30% for facilities modernization respectively. Awards for instrumentation will range from $100,000 to $2 million
with a required matching/cost sharing at the level between 30&hyph;50% for all institutions. Awards for facility
renovation/repair projects will range from $100,000 to $2 million with a required 50% matching/cost sharing on the
part of the submitting institution from Ph.D.-granting institutions or at a level between 20% and 50% from non-Ph.D.-granting
institutions. It is not the intent of the program to fund new construction or expansion of existing facilities. Proposals
may be submitted by institutions of higher education, independent nonprofit research institutions, research museums,
and legally incorporated consortia thereof. Proposals for Instrumentation must be received by March 15, 1994, and
proposals for Facilities Modernization must be received by April 5, 1994. For additional information and proposal
guidelines, call the Office of Science and Technology Infrastructure at (703) 306&hyph;1040, or write to: the National
Science Foundation, OSTI, 4201 Wilson Boulevard, Arlington, VA 22230, or send email requests to: ari@nsf (BITNET)
or ari@nsf. gov (INTERNET).
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Sherrie Blevins Green,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Program Manager for Academic Research Infrastructure.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2286 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7555&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00072 </DOCNO>
<PARENT> FR940202-2-00054 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>NUCLEAR REGULATORY COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Biweekly Notice</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Applications and Amendments to Facility Operating Licenses Involving No Significant Hazards Considerations
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
I. Background
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to Public Law 97-415, the U.S. Nuclear Regulatory Commission (the Commission or NRC staff) is publishing
this regular biweekly notice. Public Law 97-415 revised section 189 of the Atomic Energy Act of 1954, as amended (the
Act), to require the Commission to publish notice of any amendments issued, or proposed to be issued, under a new provision
of section 189 of the Act. This provision grants the Commission the authority to issue and make immediately effective
any amendment to an operating license upon a determination by the Commission that such amendment involves no significant
hazards consideration, notwithstanding the pendency before the Commission of a request for a hearing from any person.

<!-- PJG 0012 frnewline -->
This biweekly notice includes all notices of amendments issued, or proposed to be issued from January 7, 1994, through
January 21, 1994. The last biweekly notice was published on January 19, 1994 (59 FR 2859).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice Of Consideration Of Issuance Of Amendments To Facility Operating Licenses, Proposed No Significant Hazards
Consideration Determination, And Opportunity For A Hearing
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission has made a proposed determination that the following amendment requests involve no significant hazards
consideration. Under the Commission's regulations in 10 CFR 50.92, this means that operation of the facility in accordance
with the proposed amendment would not (1) involve a significant increase in the probability or consequences of an
accident previously evaluated; or (2) create the possibility of a new or different kind of accident from any accident
previously evaluated; or (3) involve a significant reduction in a margin of safety. The basis for this proposed determination
for each amendment request is shown below. 
<!-- PJG 0012 frnewline -->
The Commission is seeking public comments on this proposed determination. Any comments received within 30 days after
the date of publication of this notice will be considered in making any final determination. 
<!-- PJG 0012 frnewline -->
Normally, the Commission will not issue the amendment until the expiration of the 30-day notice period. However,
should circumstances change during the notice period such that failure to act in a timely way would result, for example,
in derating or shutdown of the facility, the Commission may issue the license amendment before the expiration of the
30-day notice period, provided that its final determination is that the amendment involves no significant hazards
consideration. The final determination will consider all public and State comments received before action is taken.
Should the Commission take this action, it will publish in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a notice of issuance and provide for opportunity for a hearing after issuance. The Commission expects that the need
to take this action will occur very infrequently. 
<!-- PJG 0012 frnewline -->
Written comments may be submitted by mail to the Rules Review and Directives Branch, Division of Freedom of Information
and Publications Services, Office of Administration, U.S. Nuclear Regulatory Commission, Washington, DC 20555,
and should cite the publication date and page number of this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
notice. Written comments may also be delivered to Room P-223, Phillips Building, 7920 Norfolk Avenue, Bethesda,
Maryland from 7:30 a.m. to 4:15 p.m. Federal workdays. Copies of written comments received may be examined at the NRC
Public Document Room, the Gelman Building, 2120 L Street, NW., Washington, DC 20555. The filing of requests for a hearing
and petitions for leave to intervene is discussed below.
<!-- PJG 0012 frnewline -->
By March 4, 1994, the licensee may file a request for a hearing with respect to issuance of the amendment to the subject
facility operating license and any person whose interest may be affected by this proceeding and who wishes to participate
as a party in the proceeding must file a written request for a hearing and a petition for leave to intervene. Requests
for a hearing and a petition for leave to intervene shall be filed in accordance with the Commission's ``Rules of Practice
for Domestic Licensing Proceedings'' in 10 CFR Part 2. Interested persons should consult a current copy of 10 CFR 2.714
which is available at the Commission's Public Document Room, the Gelman Building, 2120 L Street, NW., Washington,
DC 20555 and at the local public document room for the particular facility involved. If a request for a hearing or petition
for leave to intervene is filed by the above date, the Commission or an Atomic Safety and Licensing Board, designated
by the Commission or by the Chairman of the Atomic Safety and Licensing Board Panel, will rule on the request and/or
petition; and the Secretary or the designated Atomic Safety and Licensing Board will issue a notice of a hearing or
an appropriate order. 
<!-- PJG 0012 frnewline -->
As required by 10 CFR 2.714, a petition for leave to intervene shall set forth with particularity the interest of the
petitioner in the proceeding, and how that interest may be affected by the results of the proceeding. The petition
should specifically explain the reasons why intervention should be permitted with particular reference to the following
factors: (1) the nature of the petitioner's right under the Act to be made a party to the proceeding; (2) the nature and
extent of the petitioner's property, financial, or other interest in the proceeding; and (3) the possible effect
of any order which may be entered in the proceeding on the petitioner's interest. The petition should also identify
the specific aspect(s) of the subject matter of the proceeding as to which petitioner wishes to intervene. Any person
who has filed a petition for leave to intervene or who has been admitted as a party may amend the petition without requesting
leave of the Board up to 15 days prior to the first prehearing conference scheduled in the proceeding, but such an amended
petition must satisfy the specificity requirements described above.
<!-- PJG 0012 frnewline -->
Not later than 15 days prior to the first prehearing conference scheduled in the proceeding, a petitioner shall file
a supplement to the petition to intervene which must include a list of the contentions which are sought to be litigated
in the matter. Each contention must consist of a specific statement of the issue of law or fact to be raised or controverted.
In addition, the petitioner shall provide a brief explanation of the bases of the contention and a concise statement
of the alleged facts or expert opinion which support the contention and on which the petitioner intends to rely in proving
the contention at the hearing. The petitioner must also provide references to those specific sources and documents
of which the petitioner is aware and on which the petitioner intends to rely to establish those facts or expert opinion.
Petitioner must provide sufficient information to show that a genuine dispute exists with the applicant on a material
issue of law or fact. Contentions shall be limited to matters within the scope of the amendment under consideration.
The contention must be one which, if proven, would entitle the petitioner to relief. A petitioner who fails to file
such a supplement which satisfies these requirements with respect to at least one contention will not be permitted
to participate as a party. 
<!-- PJG 0012 frnewline -->
Those permitted to intervene become parties to the proceeding, subject to any limitations in the order granting leave
to intervene, and have the opportunity to participate fully in the conduct of the hearing, including the opportunity
to present evidence and cross-examine witnesses. 
<!-- PJG 0012 frnewline -->
If a hearing is requested, the Commission will make a final determination on the issue of no significant hazards consideration.
The final determination will serve to decide when the hearing is held. 
<!-- PJG 0012 frnewline -->
If the final determination is that the amendment request involves no significant hazards consideration, the Commission
may issue the amendment and make it immediately effective, notwithstanding the request for a hearing. Any hearing
held would take place after issuance of the amendment. 
<!-- PJG 0012 frnewline -->
If the final determination is that the amendment request involves a significant hazards consideration, any hearing
held would take place before the issuance of any amendment. 
<!-- PJG 0012 frnewline -->
A request for a hearing or a petition for leave to intervene must be filed with the Secretary of the Commission, U.S.
Nuclear Regulatory Commission, Washington, DC 20555, Attention: Docketing and Services Branch, or may be delivered
to the Commission's Public Document Room, the Gelman Building, 2120 L Street, NW., Washington DC 20555, by the above
date. Where petitions are filed during the last 10 days of the notice period, it is requested that the petitioner promptly
so inform the Commission by a toll-free telephone call to Western Union at 1-(800) 248-5100 (in Missouri 1-(800) 342-6700).
The Western Union operator should be given Datagram Identification Number N1023 and the following message addressed
to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
(Project Director)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: petitioner's name and telephone number, date petition was mailed, plant name, and publication date and page number
of this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
notice. A copy of the petition should also be sent to the Office of the General Counsel, U.S. Nuclear Regulatory Commission,
Washington, DC 20555, and to the attorney for the licensee. 
<!-- PJG 0012 frnewline -->
Nontimely filings of petitions for leave to intervene, amended petitions, supplemental petitions and/or requests
for a hearing will not be entertained absent a determination by the Commission, the presiding officer or the Atomic
Safety and Licensing Board that the petition and/or request should be granted based upon a balancing of factors specified
in 10 CFR 2.714(a)(1)(i)-(v) and 2.714(d). 
<!-- PJG 0012 frnewline -->
For further details with respect to this action, see the application for amendment which is available for public inspection
at the Commission's Public Document Room, the Gelman Building, 2120 L Street, NW., Washington, DC 20555, and at the
local public document room for the particular facility involved. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Carolina Power &amp; Light Company, Docket No. 50-261, H. B. Robinson Steam Electric Plant, Unit No. 2, Darlington
County, South Carolina
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
November 4, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment revises Technical Specification 6.13.1 to provide use of alarming dosimeters in high radiation
areas. This change includes newly revised 10 CFR Part 20 requirement references and is consistent with NUREG-1413,
Standard Technical Specifications - Westinghouse Plants, Specification 5.11.1.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. The proposed amendment does not involve a significant increase in the probability or consequences of an accident
previously evaluated. This change could involve a reduction in personnel radiation exposure by utilizing alarming
dosimeters. This change does not involve any plant systems or components which could increase the probability of
an accident. Therefore, there would be no increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The proposed amendment does not create the possibility of a new or different kind of accident from any accident previously
evaluated. This change could reduce the possibility of an accidental overexposure by alerting personnel when their
maximum allowable exposure has been received. This change does not involve any plant systems or components. Therefore,
the proposed changes do not create the possibility of a new or different kind of accident from any accident previously
evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The proposed amendment does not involve a significant reduction in the margin of safety. Due to the nature of this
proposed change, it is not related to any plant system. Therefore, the proposed changes do not involve a significant
reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Hartsville Memorial Library, Home and Fifth Avenues, Hartsville, South Carolina 29550 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
R. E. Jones, General Counsel, Carolina Power &amp; Light Company, Post Office Box 1551, Raleigh, North Carolina 27602

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
S. Singh Bajwa
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Commonwealth Edison Company, Docket Nos. STN 50-454 and STN 50-455, Byron Station, Unit Nos. 1 and 2, Ogle County,
Illinois Docket Nos. STN 50-456 and STN 50-457, Braidwood Station, Unit Nos. 1 and 2, Will County, Illinois
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 27, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendments would revise the Braidwood Station, Units 1 and 2, and Byron Station, Units 1 and 2, Technical
Specifications (TS) regarding inspection requirements for pipe snubbers. The proposed changes implement Generic
Letter (GL) 90-09, and would affect the surveillance requirements of TS section 4.7.8 and the bases for these requirements,
section 3/4.7.8. Specifically, the amendment would change the existing inspection periods, visual inspection
acceptance criteria, and functional test requirements. Additionally, there would be changes to the bases to include
reference to GL 90-09, and other editorial changes would be made. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. The proposed changes do not involve a significant increase in the probability or consequences of an accident previously
evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The amended surveillance requirement adds a table that addresses the maximum number of snubber failures that can
be tolerated prior to reducing the inspection interval. This number is a function of the population size of a particular
type of snubber. The revised requirement will allow the inspection intervals to be compatible with the 24 month fuel
cycles, and provisions are included to extend the inspection interval up to 48 months. A provision is included to allow
an evaluation to determine operability to justify continued operation with a snubber that is unacceptable.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The purpose of the amendment request is to provide for alternative inspection intervals that take the size of the population
of a snubber type into account. The proposed change provides the same confidence level and allows snubber inspection
and corrective action to be performed during refueling outages. This allows the plant to avoid a mid-cycle outage
due to a small number of snubber failures.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change allows for a small percentage of snubbers in each category to fail the required visual examination
without adjusting the inspection frequency. If a statistically significant percentage of snubbers fail, the visual
examination inspection interval is reduced based on the percentage of failed snubbers.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change has no direct or indirect impact on reactivity management activities.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The change is not expected to have an impact on equipment failures. Any snubbers that fail to meet the visual examination
acceptance criteria are either functionally tested in the as-found condition to verify continued acceptability,
or an evaluation is performed to demonstrate the acceptability of continued operation with an unacceptable snubber.
No new equipment is being introduced and no systems are operated in a configuration that has not been evaluated, so
no new failure modes are introduced.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
The affected transients are the design basis earthquake and the spectrum of event initiating transients, with the
capability of imposing significant dynamic loads or otherwise which impact the structural integrity of the Reactor
Coolant System (RCS).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The snubbers are installed to ensure the structural integrity of the RCS and required support systems. Their failure
is passive in nature. The probability of a transient initiating event occurring is unrelated to the existence or condition
of equipment that is designed to perform a mitigating function. The snubbers are installed to ensure an acceptable
system response to a dynamic load, and their availability does not impact the frequency of occurrence of earthquakes
or other transients resulting in significant dynamic loading.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The revised testing provisions are designed to allow some flexibility while still maintaining a high probability
that the installed snubbers will be capable of performing their intended function when required. The revised surveillances
appropriately consider the size of the population of a particular type of snubber, and are sufficient to ensure the
consequences of an accident will be unchanged when the revised requirements are implemented. By maintaining a statistically
high level of confidence in the function of the plant's snubbers, the system response to transient initiating events
will be as designed and thus, the off-site dose projected to occur of any affected transient will remain acceptably
low.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
As previously stated, the revised surveillance provides a high confidence that the affected systems will remain
intact and functional. Evaluation of the effects of operating with a degraded snubber is required to ensure that adequate
margin exists to support continued plant operation. If this evaluation cannot adequately justify continued operation,
the appropriate action statement will be applied. These provisions are sufficient to assure that the probability
of an equipment malfunction will not increase.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The consequences of equipment malfunction will not increase. Sufficient redundancy exists to accommodate the complete
failure of one train of required equipment. The requisite electrical and physical separation are sufficient to ensure
that the redundant train remains unaffected. This redundancy is adequate to ensure that the undetected failure of
a snubber will not have a severe impact on overall system response to a transient.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The proposed changes do not create the possibility of a new or different kind of accident from any accident previously
evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The possibility of a new or different type of accident is not created by this change. No new or different equipment is
being introduced, and no system will be operated in a different configuration without first having the effects of
the new configuration evaluated. The new configuration would be system and/or plant operation with a snubber installed
that has failed its visual examination. The required evaluation must be sufficient to provide confidence that continued
operation is acceptable; otherwise, the provisions of the action statement will be observed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The proposed changes do not involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
No reduction in the margin of safety will occur as a result of this proposed change. As previously described, the controls
in place will provide a high confidence the affected systems will continue to be functional. No significant increase
in the rate of occurrence of undetected inoperable snubbers is expected to occur, and the allowable failures prior
to applying an increased test frequency is still a small percentage of the total snubber population.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For Byron, the Byron Public Library, 109 N. Franklin, P.O. Box 434, Byron, Illinois 61010; for Braidwood, the Wilmington
Township Public Library, 201 S. Kankakee Street, Wilmington, Illinois 60481
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Michael I. Miller, Esquire; Sidley and Austin, One First National Plaza, Chicago, Illinois 60690
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
James E. Dyer
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Commonwealth Edison Company, Docket Nos. STN 50-454 and STN 50-455, Byron Station, Unit Nos. 1 and 2, Ogle County,
Illinois Docket Nos. STN 50-456 and STN 50-457, Braidwood Station, Unit Nos. 1 and 2, Will County, Illinois
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
September 2, 1993, supplemented by letter dated January 7, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would revise the Braidwood Station, Units 1 and 2, and Byron Station, Units 1 and 2, Technical
Specifications (TS) to allow replacement of the 125 Volt DC Gould batteries with the new 125 Volt DC AT&amp;T batteries
and rephrase their design duty cycle. In addition, the proposed amendment would revise the batteries crosstie loading
limitations and the crosstie breaker limitations. The associated Bases would also be revised to discuss the purpose
for the crosstie limitations and to discuss design duty cycle requirements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
A. The proposed change does not involve a significant increase in the probability or consequences of an accident previously
evaluated. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The replacement AT&amp;T battery has been selected to meet or exceed the design, functional, and operational requirements
of those of the present Gould battery, including crosstie load limitations. The crosstie breaker limitation change
to allow crosstie between two shutdown units is consistent with the Safety Evaluations issued with Technical Specification
Amendment 5 for both Braidwood and Byron Stations. The remaining changes are administrative in nature or provide
clarification to maintain consistency with other Technical Specifications and the Standard Technical Specifications.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The overall design, function, and operation of the DC system and equipment has not been altered by these changes. The
proposed changes do not affect any accident initiators or precursors and do not alter the design assumptions for the
systems or components used to mitigate the consequences of an accident as analyzed in UFSAR Chapter 15. Therefore,
there is no increase in the probability or consequences of an accident previously evaluated. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. The proposed change does not create the possibility of a new or different kind of accident from any accident previously
evaluated.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
The replacement AT&amp;T battery will provide the same functions as those of the present Gould battery and will be
operated with the same types of operational controls. These limits will include battery float terminal voltage,
individual cell voltage and electrolyte specific gravity, and crosstie loading. Crosstie conditions are allowed
under the present Technical Specifications. The remaining changes are administrative in nature or provide clarification
to maintain consistency with other Technical Specifications and the Standard Technical Specifications. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The DC system and its equipment will continue to perform the same functions and be operated in the same fashion. The
proposed change does not create any new or common failure modes. The proposed changes do not introduce any new accident
initiators or precursors, or any new design assumptions for the systems or components used to mitigate the consequences
of an accident. Therefore, the possibility of a new or different kind of accident from any accident previously evaluated
has not been created. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. The proposed change does not involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The replacement AT&amp;T battery will meet or exceed the design, functional, and qualification requirements of
those of the present Gould batteries. The proposed Technical Specification limitations for the AT&amp;T battery
are derived from the same methodology and margins as those for the Gould battery. Increasing the crosstie loading
limit takes advantage of the larger AT&amp;T battery capacity with its increased design margin. The proposed change
to the crosstie loading limit will continue to conservatively envelop the postulated design requirements. The remaining
changes are administrative in nature or provide clarification to maintain consistency with other Technical Specifications
and the Standard Technical Specifications. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The inherent design conservatism of the DC system and its equipment has not been altered. The DC system and its equipment
will continue to be operated with the same degree of conservatism. Therefore, there is no reduction in the margin of
safety. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For Byron, the Byron Public Library, 109 N. Franklin, P.O. Box 434, Byron, Illinois 61010; for Braidwood, the Wilmington
Township Public Library, 201 S. Kankakee Street, Wilmington, Illinois 60481
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Michael I. Miller, Esquire; Sidley and Austin, One First National Plaza, Chicago, Illinois 60690
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
James E. Dyer
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Commonwealth Edison Company, Docket Nos. 50-373 and 50-374, LaSalle County Station, Units 1 and 2, LaSalle County,
Illinois
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
October 28, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would revise the Emergency Core Cooling System (ECCS) injection valve stroke times and ECCS
response times for Motor-Operated Valve (MOV) modifications that increase injection valve stroke times. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1) The proposed changes do not involve a significant increase in the probability or consequences of an accident previously
evaluated because:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The probability of an accident previously evaluated will not increase as a result of this change, because the only
modification being performed is to the stroke times for the LPCS [Low Pressure Core Spray System], LPCI [Low Pressure
Coolant Injection System], and HPCS [High Pressure Core Spray System] injection valves. Changing the opening or
closing time of the injection valves for these ECCS systems does not cause any accident previously evaluated to occur.
Therefore, modifying their stroke times will not increase the probability of occurrence for any accident previously
evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The consequences of a LOCA [Loss of Coolant Accident] are not significantly increased and do not exceed the previously
accepted licensing criteria for this accident. GE [General Electric Company] has calculated the revised licensing
basis PCT [Peak Centerline Temperature] for LaSalle Station to be 1260
<!-- PJG 0017 degreeslatlong -->
&cir;F, which is well below the 2200
<!-- PJG 0017 degreeslatlong -->
&cir;F criterion of 10 CFR 50.46 and Section 15.6.5 of NUREG-0800 (Standard Review Plan). The acceptance criteria
for cladding oxidation, metal-water reaction (hydrogen generation), coolable geometry and long-term cooling
also continue to be met with the increased valve stroke times.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
GE has performed sensitivity analysis justifying the continued applicability of previous analyses for Anticipated
Transients Without Scram (ATWS), containment analyses, off-site dose (Main Steamline Break Outside Containment),
and HPCS-related transients (Loss of Feedwater Flow). Other events are not affected because these systems are not
assumed to function.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2) The proposed changes do not create the possibility of a new or different kind of accident from any accident previously
evaluated because:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The only modification is to increase the stroke time of the injection valves for LPCS, LPCI, and HPCS. This does not
result in any changed component interactions, other than to increase the affected ECCS response times. The injection
valves will still provide the function for which they were designed. Since the systems will continue to function as
intended, the proposed changes do not create the possibility of a new or different kind of accident from any previously
evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3) The proposed changes do not involve a significant reduction in a margin of safety because:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
While the calculated licensing basis PCT is larger than that previously calculated with the current valve stroke
times, the new PCT remains far below the 2200
<!-- PJG 0017 degreeslatlong -->
&cir;F licensing acceptance limit associated with a LOCA. This limit has been previously evaluated as providing
a sufficient margin of safety. All other LOCA licensing limits also continue to be met with the increased stroke times.
For other accidents and transients, the increased stroke times have a negligible effect on the results, so the margin
of safety is preserved.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Public Library of Illinois Valley Community College, Rural Route No. 1, Oglesby, Illinois 61348
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Michael I. Miller, Esquire; Sidley and Austin, One First National Plaza, Chicago, Illinois 60690
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
James E. Dyer
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Consumers Power Company, Docket No. 50-255, Palisades Plant, Van Buren County, Michigan 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
April 15, 1992, as modified by letters dated December 8, 1992, and June 25, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would revise the provisions in the Technical Specifications to incorporate Generic Letter
90-06, ``Resolution of Generic Issue 70, `Power-Operated Relief Valve and Block Valve Reliability,' and Generic
Issue 94, `Additional Low-Temperature Overpressure Protection for Light-Water Reactors,''' power-operated
relief valve (PORV) requirements for power operation, and to modify the primary coolant system (PCS) overpressure
protection specification venting requirements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. Involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed Technical Specification requiring Operability of the PORVs and their block valves does not alter plant
operation or configuration in any way. It is current practice to maintain these valves in an Operable condition to
meet the requirements of existing Specification 3.1.8, which is applicable when below 430
<!-- PJG 0017 degreeslatlong -->
&cir;F. The effect of the proposed changes is to extend the applicability of the Operability requirement for these
valves. The addition of PORV Operability requirements when at Hot Standby and above would not involve a significant
increase in the probability or consequence of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Replacing the requirements to vent the PCS through a 1.3 square inch vent with a vent capable of relieving 167 gpm at
a pressure less than the Appendix G limits will not significantly increase the probability or consequences of an overpressurization
event occurring. The 1.3 square inch vent area in Technical Specification 3.1.8 was intended to be a means of protecting
the Primary Coolant System (PCS) from exceeding the limit of the 10 CFR [Part] 50, Appendix G, curve following an overpressure
transient. Analysis has shown that manual vent valves PC-514 and PC-515 will provide a relief capacity of 167 gpm at
a PCS pressure of approximately 115 psig, well below the minimum 331 psig limit (Appendix G curve limit for a 40
<!-- PJG 0017 degreeslatlong -->
&cir;F/hr heat-up). This relief capacity will protect the PCS against a pressure transient caused by a maximum charging/letdown
imbalance coincident with a 40
<!-- PJG 0017 degreeslatlong -->
&cir;F/hr PCS heat-up rate and a 60
<!-- PJG 0017 degreeslatlong -->
&cir;F/hr pressurizer heat-up rate.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Two other pressure transients, a High Pressure Safety Injection (HPSI) pump start and a Primary Coolant Pump (PCP)
start, are also precluded. With the PCS in a vented and depressurized state, the PCS would be below 212
<!-- PJG 0017 degreeslatlong -->
&cir;F Existing technical specifications require both HPSI pumps to be rendered inoperable below 260
<!-- PJG 0017 degreeslatlong -->
&cir;F and, with the system depressurized, normal operating procedures prohibit a PCP start due to insufficient
pump net positive suction head (NPSH).
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Therefore, the 1.3 square inch requirement can be replaced with a requirement to have a vent capable of relieving 167
gpm at a PCS pressure less than or equal to the Appendix G limit with no significant increase in the probability or consequences
of an overpressurization event occurring.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
2. Create the possibility of a new or different kind of accident from any previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The addition of PORV Operability requirements when at Hot Standby and above will not alter plant operation or configuration.
It will not alter any equipment or analyses. Therefore the addition of these PORV Operability requirements will not
create the possibility of a new or different kind of accident from any previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The new technical specifications requirements for PCS vent capacity will provide an equivalent or better, overpressure
protection as compared to the existing requirement. No analysis has been found that shows that the existing 1.3 square
inch vent area will protect the PCS from exceeding the Appendix G curve limit. However, analysis has been developed
which shows that manual vent valves PC-514 and PC-515 will provide adequate relief capacity, maintaining PCS pressure
within the 10 CFR [Part] 50, Appendix G, limits. Furthermore, two other pressure transients, a HPSI pump start and
a PCP start, are also precluded by either existing technical specifications or normal plant operating procedures.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Another related analysis has shown that relief valve RV-3164, the Low Pressure Safety Injection (LPSI) pumps, the
LPSI pump seals, and the system piping of the shutdown cooling system have the capability of providing adequate overpressure
protection to the shutdown cooling system.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The addition of the manual vent valves do not introduce a vent path where a vent path had not previously existed. Therefore,
the possibility of an accident of a new or different type, than previously evaluated in the FSAR, will not be created.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The margin of safety will not be reduced by the proposed Technical Specifications changes. The extension of PORV Operability
requirements has no effect on any margin of safety. The previous requirement assumed that a vent with an equivalent
flow area as the original PORV would provide the same relief as the PORV itself and gave no consideration to how that
flow area should factor in system losses or vent location. The new technical specification requirement offers a means
to ensure the PCS will be protected against all achievable overpressure transients for the system configuration,
with analyses to support it.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Van Wylen Library, Hope College, Holland, Michigan 49423. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Judd L. Bacon, Esquire, Consumers Power Company, 212 West Michigan Avenue, Jackson, Michigan 49201
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. Randolph Blough, Acting
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
GPU Nuclear Corporation, et al., Docket No. 50-219, Oyster Creek Nuclear Generating Station, Ocean County, New Jersey

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 16, 1993 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment clarifies the requirements for maintaining secondary containment integrity when one or
more Reactor Building Ventilation supply and exhaust valves are declared inoperable. The technical specification
(TS) change adds a new Limiting Condition for Operation, Basis Statement, and Surveillance Requirements for these
isolation valves. The change revises TS definition 1.14c, adds new Specifications 3.5.B.2, 3.5.B.3, 4.5.R, and
a Basis statement to TS 3.5, edits T.S. 3.5.B.1.1. It also renumbers TS 3.5.B.2 through 3.5.B.4, to 3.5.B.4 through
3.5.B.7. It also revises specification references within to reflect new specification numbers.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
GPU Nuclear has determined that operation of the Oyster Creek Nuclear Generating Station in accordance with the proposed
Technical Specifications does not involve a significant hazard. The changes do not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Involve a significant increase in the probability or the consequence of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The failure of any component in the [Reactor Building Ventilation System] RBVS was not considered as a credible initiating
event for a design basis accident. However, the RBVS is designed to mitigate the consequences of a potential radiological
release by the isolation of all supply and exhaust ducts to the environs. Since the failure of the RBVS was never considered
as one of the initiators of an accident, this proposed change cannot increase the probability of occurrence of an accident.
During the proposed Limiting Condition for Operation (LCO), the supply or exhaust duct will be isolated within 8 hours
by one isolation valve secured in its post accident design position. Since the duct can perform its post accident design
function (isolation), there is no increase in the consequences of an accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Create the possibility of a new or different kind of accident from any previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The design function of the RBVS automatic isolation valves is to isolate the ducts which penetrate the Reactor Building
or Secondary Containment during a radiological release. During the LCO, the duct will be isolated within 8 hours by
one isolation valve secured in the closed position. Since the duct will be isolated, this change will not create a possibility
for an accident or malfunction of a different type than previously identified.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
If a RBVS automatic isolation valve (supply) is declared inoperable, the proposed LCO would allow continued plant
operation with that supply duct isolated. Since the RBVS can still perform its design function (redundant ductwork)
under normal plant and design accident conditions, there is no reduction in the margin of safety. For an inoperable
isolation valve in the exhaust duct, the exhaust duct will be isolated within 8 hours by one isolation valve secured
in the closed position. Further, the RBVS and the [Standby Gas Treatment System] SGTS will be aligned for an accident
condition with no reduction in the margin of safety.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Ocean County Library, Reference Department, 101 Washington Street, Toms River, New Jersey 08753
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Ernest L. Blake, Jr., Esquire. Shaw, Pittman, Potts &amp; Trowbridge, 2300 N Street, NW., Washington, DC 20037. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
John F. Stolz
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Indiana Michigan Power Company, Docket Nos. 50-315 and 50-316, Donald C. Cook Nuclear Plant, Unit Nos. 1 and 2, Berrien
County, Michigan
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment requests: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
November 17, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment requests: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendments would modify the Technical Specifications to allow a portion of the Waste Gas Holdup System
(WGHS) Explosive Monitoring System to be inoperable for 160 days on a one-time basis. This is to allow replacement
of the Waste Gas Oxygen Analyzer.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
We have evaluated the proposed T/S changes and have determined that the changes should involve no significant hazards
consideration. Operation of the Cook Nuclear Plant in accordance with the proposed amendment will not: 
<!-- PJG 0012 frnewline -->
(1) Involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed amendment does not involve a significant increase in the probability or consequences of an accident
previously evaluated. The purpose of the hydrogen and oxygen monitors is to measure the concentrations of these gases
in the WGHS to ensure that the gas mixture is non-flammable. We can accomplish this purpose and ensure safe operation
of the WGHS by operating the system in the proposed manner. During the equipment replacement interval, we will be assuming
that the hydrogen concentration is above the flammable limit (4%). The limiting factor then is the oxygen concentration
at which hydrogen and oxygen become flammable. The existing hydrogen monitor will be in continuous operation to verify
the hydrogen level. The information provided by the oxygen monitor being replaced is not essential to the safe operation
of the WGHS since it is redundant to information provided by the remaining oxygen monitor. The only difference between
the two (2) oxygen monitors is that the one being replaced provides an automatic isolation of the waste gas decay tank
when the oxygen concentration reaches 3%. The isolation of the waste gas decay tanks will be performed manually during
the replacement. In the event the remaining oxygen monitor becomes inoperable, we will follow the currently approved
T/Ss. Since operation of the WGHS in the manner we have proposed will ensure that the purpose of the oxygen and hydrogen
monitors is fulfilled and safe operation of the WGHS is maintained, the proposed change will not involve a significant
increase in the probability or consequences of a previously analyzed incident.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
The proposed change to the Automatic Gas Analyzer (QC-31) tag number to QC-1400 will not reduce in any way requirements
or commitments in the existing T/Ss. The proposed change will eliminate confusion of spare parts of the new analyzer
panel installed in 1990.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Create the possibility of a new or different kind of accident from any previously analyzed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed amendment does not create the possibility of a new or different kind of accident from any previously evaluated.
During the replacement of the monitors the waste gas holdup system will continue to operate normally. The proposed
method of operation will ensure that the oxygen and hydrogen gas mixture is non-flammable. For this reason, operating
the explosive gas monitoring system in the proposed manner will not place the plant in a new or unanalyzed condition.
Therefore, we believe that this change will not introduce a new or different kind of accident than previously analyzed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed editorial change will not create the possibility of a new or different kind of accident from any previously
evaluated, because these changes will not place the plant in a new or unanalyzed condition.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed amendment does not involve a significant reduction in the margin of safety. The remaining oxygen monitor
will be available to maintain the oxygen concentration below the limit required for hydrogen flammability in oxygen.
In addition, the oxygen grab samples will provide redundant information and will serve as a check of the monitor's
readings. If the remaining monitor becomes inoperable, we will follow the actions of our current T/Ss. During the
equipment replacement period, we will be assuming that the hydrogen concentration is above the flammable limit (4%).
This will then make the oxygen level the controlling parameter in a possible flammable combination of oxygen and hydrogen.
The existing hydrogen monitor will be in continuous operation to verify the hydrogen level. These proposed interim
measures will not significantly affect our ability to maintain the hydrogen and oxygen concentration within the
limits to prevent flammability. Therefore, we believe that operation of the system in this manner does not involve
a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed editorial change will not involve a significant reduction in margin of safety, because all accident
analyses and nuclear design bases remain unchanged.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment requests involve
no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Maud Preston Palenske Memorial Library, 500 Market Street, St. Joseph, Michigan 49085
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Gerald Charnoff, Esq., Shaw, Pittman, Potts and Trowbridge, 2300 N Street, NW, Washington, DC 20037
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. Randolph Blough, Acting
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Indiana Michigan Power Company, Docket Nos. 50-315 and 50-316, Donald C. Cook Nuclear Plant, Unit Nos. 1 and 2, Berrien
County, Michigan
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment requests: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 20, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment requests: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendments would revise the Technical Specifications to change Train A and B Emergency Loads from 8 hour
to composite 4 hour, delete a load on the Train B batteries load list, and revise the operational loads on the Train N
batteries.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Per 10 CFR 50.92, a proposed amendment does not involve a significant hazards consideration if the change does not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) create the possibility of a new or different kind of accident from any previously analyzed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Criterion 1
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The change is proposed to comply with the LOCA/LOOP [loss-of-coolant accident/loss-of-offsite power] and SBO [Station
Blackout] requirement for Cook Nuclear Plant for battery testing. The composite test as addressed above meets these
requirements for four hour test profiles. This change is consistent with the UFSAR three hour LOCA/LOOP and NUMARC
87-00 Station Blackout Rule four hour. Based on these considerations, the proposed change does not involve a significant
increase in the probability or consequences of an accident previously evaluated. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Criterion 2
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The change only addresses the battery profile test which meets both LOCA/LOOP and SBO for Cook Nuclear Plant. No specific
physical or operational changes to the plant will occur due to this change. Thus, the change will not create the possibility
of a new or different kind of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Criterion 3
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change revises the battery profile test table from an eight hour to a four composite test which complies
with both LOCA/LOOP and SBO as defined for Cook Nuclear Plant. Therefore, the proposed change does not involve a significant
reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment requests involve
no significant hazards consideration.
<!-- PJG 0012 frnewline -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Maud Preston Palenske Memorial Library, 500 Market Street, St. Joseph, Michigan 49085 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Gerald Charnoff, Esq., Shaw, Pittman, Potts and Trowbridge, 2300 N Street, NW, Washington, DC 20037
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. Randolph Blough, Acting
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Indiana Michigan Power Company, Docket Nos. 50-315 and 50-316, Donald C. Cook Nuclear Plant, Unit Nos. 1 and 2, Berrien
County, Michigan
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment requests: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 22, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment requests: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendments would revise the Technical Specifications section addressing steam generator stop valves
making it more consistent with the revised Standard Technical Specifications and clarifying certain surveillance
requirements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Per 10 CFR 50.92, a proposed change does not involve a significant hazards consideration if the change does not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. involve a significant increase in the probability or consequences of an accident previously evaluated,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. create the possibility of a new or different kind of accident from any accident previously evaluated, or
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Criterion 1
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The limiting conditions for operation involving the steam generator stop valves are not altered by this proposed
change. The surveillance requirements are lessened for Unit 2 in that valve stroke timing does not have to be performed
on valves that are closed. This is consistent with the wording of the Unit 1 T/S, and reflects the fact that, when closed,
the valves are already in the position required by the assumptions in the safety analysis and therefore stroke timing
is not necessary. The remaining changes are consistent with NUREG 1431, and as such, have already been found acceptable
by the NRC. Therefore, it is concluded that the proposed amendment does not involve a significant increase in the probability
or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Criterion 2
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
No changes to the limiting conditions for operation of the steam generator stop valves are proposed as part of this
amendment request. The proposed changes do not involve any physical changes to the plant. The changes will allow operation
in Modes 2 and 3 with more than one steam generator stop valve inoperable. However, inoperable valves must be closed
and their closure periodically reverified. When closed, the valves are already in the position required by the assumptions
in the safety analysis. Thus, the proposed changes do not create the possibility of a new or different kind of accident
from any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Criterion 3
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
The limiting conditions for operation involving the steam generator stop valves are not altered by this proposed
change. The surveillance requirements are lessened for Unit 2 in that valve stroke timing does not have to be performed
on valves that are closed. This is consistent with the wording of the Unit 1 T/S, and reflects the fact that, when closed,
the valves are already in the position required by the assumptions in the safety analysis and therefore stroke timing
is not necessary. The remaining changes are consistent with NUREG 1431, and, as such, have already been found acceptable
by the NRC. Therefore, it is concluded that the proposed changes do not involve a significant reduction in a margin
of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment requests involve
no significant hazards consideration.
<!-- PJG 0012 frnewline -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Maud Preston Palenske Memorial Library, 500 Market Street, St. Joseph, Michigan 49085
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Gerald Charnoff, Esq., Shaw, Pittman, Potts and Trowbridge, 2300 N Street, NW, Washington, DC 20037
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. Randolph Blough, Acting
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Niagara Mohawk Power Corporation, Docket No. 50-220, Nine Mile Point Nuclear Station Unit No. 1, Oswego County, New
York 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 22, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would revise Technical Specification (TS) 3.4.4.e (Emergency Ventilation System). TS 3.4.4.e
currently permits fuel handling operations to continue during refueling for up to 7 days with one circuit of the emergency
ventilation system inoperable provided all active components of the other emergency ventilation system circuit
are operable. The proposed revision would permit fuel handling operations to continue during refueling beyond 7
days with one circuit of the emergency ventilation system inoperable provided the remaining emergency ventilation
system circuit is operable and in operation. The licensee stated that the proposed revision is consistent with recently
issued Amendment No. 47 to the Nine Mile Point Unit 2 TSs and with the NRC's Improved Standard Technical Specifications,
NUREG-1433.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The operation of Nine Mile Point Unit 1 [NMP1], in accordance with the proposed amendment, will not involve a significant
increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Emergency Ventilation System responds to a release of radioactivity to the secondary containment by maintaining
a negative pressure in secondary containment and by providing a filtered elevated release. The proposed change to
LCO [Limiting Condition for Operation] 3.4.4.e would allow continuation of refueling beyond seven days with one
emergency ventilation circuit inoperable provided the operable emergency ventilation circuit is in operation.
A plant specific PRA [Probabilistic Risk Assessment] was performed to evaluate the probability of a fuel bundle drop
event resulting in a need to start the Emergency Ventilation System with a concurrent failure of the Emergency Ventilation
System that would result in an unfiltered ground level release under the current Technical Specifications and the
proposed change. The results of this assessment indicate that the probability is not significantly increased. In
addition, the order of magnitude of the probability of such a release, under the current or proposed Technical Specifications,
is very small, i.e., 10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=5 f=1 -->
-6
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
. This amendment requires no physical changes to NMP1. Therefore, the proposed changes to the Technical Specifications
do not significantly increase the probability of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Section XV.C.3 of the UFSAR [Updated Final Safety Analysis Report] evaluates a fuel bundle drop accident. The radiological
consequences of this accident are within the guidelines of 10 CFR Part 100. The UFSAR radiological evaluation takes
credit for the operation of an emergency ventilation circuit in mitigating the consequences of this accident. During
refueling with one emergency ventilation circuit inoperable for more than seven days, the proposed Technical Specification
change would require that an operable emergency ventilation circuit be placed in operation. With an operable emergency
ventilation circuit operating prior to a fuel bundle drop accident, the radiological consequences of this accident
remains bounded by the current UFSAR evaluation. Therefore, from a radiological perspective, the proposed Technical
Specification change is bounded by the current radiological evaluation in the UFSAR. Therefore, the Technical Specification
change does not significantly increase the consequences of a previously evaluated accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The operation of Nine Mile Point Unit 1, in accordance with the proposed amendment, will not create the possibility
of a new or different kind of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This amendment does not involve any accident precursors or initiators. During an accident involving the release
of radioactivity to the secondary containment atmosphere an operable emergency ventilation circuit would already
be running and performing its safety function. The operating status of a running emergency ventilation circuit,
which was manually started, would be unaffected by the receipt of an automatic start signal due to the detection of
high radiation in secondary containment. Accordingly, the proposed Technical Specification change will not create
the possibility of a new or different kind of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The operation of Nine Mile Point Unit 1, in accordance with proposed amendment, will not involve a significant reduction
in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The current Technical Specifications, LCO 3.4.4, provide a margin of safety by requiring both emergency ventilation
circuits to be operable during a refueling condition. With one emergency ventilation circuit inoperable, the current
Technical Specifications allow continuation of refueling for up to seven days, at which time refueling must be stopped.
This Technical Specification requirement ensures that an emergency ventilation circuit will be available to provide
a filtered release to the environment during an accident which could result in the release of radioactivity to the
secondary containment atmosphere.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change to LCO 3.4.4.e would allow continuation of refueling beyond seven days with one emergency ventilation
circuit inoperable provided the operable emergency ventilation circuit is in operation. By placing the remaining
operable emergency ventilation circuit in operation, active single failures associated with its startup have been
eliminated. These eliminated failures include automatic initiation instrumentation, relaying logic, breaker
operation, fan startup and valve operation. With an operable emergency ventilation circuit in operation, its safety
function is being performed. In addition, the status of the operating emergency ventilation circuit is indicated
in the control room. Therefore, the running, operable emergency ventilation circuit provides a level of safety comparable
to two non-running, operable emergency ventilation circuits.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Based upon the above analysis, the margin of safety is not significantly reduced by allowing refueling to continue
beyond seven days with one emergency ventilation circuit inoperable since the operable emergency ventilation circuit
is in operation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
These changes are consistent with Amendment No. 47 for Nine Mile Point Unit 2 and with the Improved Standard Technical
Specifications, NUREG-1433.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Accordingly, as determined by the analysis above, this proposed amendment involves no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant
hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Reference and Documents Department, Penfield Library, State University of New York, Oswego, New York 13126.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mark J. Wetterhahn, Esquire, Winston &amp; Strawn, 1400 L Street, NW., Washington, DC 20005-3502.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Robert A. Capra
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Niagara Mohawk Power Corporation, Docket No. 50-220, Nine Mile Point Nuclear Station Unit No. 1, Oswego County, New
York 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 27, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would relocate Technical Specification (TS) Tables 3.2.7, ``Reactor Coolant Isolation
Valves,'' and 3.3.4, ``Primary Containment Isolation Valves,'' from TS 3.2.7/4.2.7 and 3.3.4/4.3.4, respectively,
to a plant procedure overning lists removed from TSs per Generic Letter (GL) 91-08, ``Removal of Component Lists from
Technical Specifications.'' The plant procedure would be subject to the requirements specified in the Administrative
Controls section of the Nine Mile Point Nuclear Station Unit No. 1 (NMP-1) TS. The proposed amendment would also make
conforming changes to the TS Bases. These lists of valves will continue to be included in the NMP-1 Updated Final Safety
Analysis Report (FSAR). The licensee stated that the proposed changes would be consistent with NRC staff guidance
issued in GL 91-08. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The operation of Nine Mile Point Unit 1, in accordance with the proposed amendment, will not involve a significant
increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1.The proposed amendment does not involve a physical change to any system, structure, or component that affects the
probability or consequences of any accident or malfunction of equipment important to safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Relocation of the component lists to plant procedures and the Updated FSAR is in accordance with Generic Letter 91-08.
This change does not alter the existing operability or surveillance requirements for the components to which they
apply. The proposed changes are under the change control provisions in Section 6.0, ``Administrative Controls,''
of the Technical Specifications. The changes associated with the Bases for Specification[s] 3.2.7/4.2.7 and 3.3.4/4.3.4
are consistent with the issuance of prior license amendments. Since the proposed amendment does not affect the operation
or testing of any plant systems or components, it will have no impact on the probability or consequences of accidents
or malfunctions previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2.The operation of Nine Mile Point Unit 1, in accordance with the proposed amendment, will not create the possibility
of a new or different kind of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed changes to Technical Specification 3.2.7/4.2.7, 3.3.4/4.3.4 and Bases do not introduce any new modes
of plant operation or new accident precursors, involve any physical alterations to plant configurations, or make
changes to system setpoints which could initiate a new or different kind of accident. The proposed changes relocate
Reactor Coolant Primary Containment Isolation Valve Tables 3.2.7 and 3.3.4 into a procedure governing controlled
lists removed from TS per Generic Letter 91-08 under the change control provisions in Section 6.0, ``Administrative
Controls,'' of the Technical Specifications. The testing associated with these valves remains unchanged, therefore,
it will not affect system or component operability. In addition, the removal of generic reference to the 60 second
closure time is consistent with previously issued license amendments and has no impact on either the Limiting Condition
for Operation or Surveillance Requirement. Therefore, the proposed changes do not create the possibility of a new
or different kind of accident from any previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The operation of Nine Mile Point Unit 1, in accordance with the proposed amendment, will not involve a significant
reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Technical Specification Limiting Conditions for Operation and Surveillance Requirements for the valves listed
in Tables 3.2.7 and 3.3.4 are not being altered. The valve lists will be incorporated into a procedure governing controlled
lists removed from TS per Generic Letter 91-08. This is controlled by Section 6.0, ``Administrative Procedures.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addition, removal of generic reference to the 60 second closure time is consistent with previously issued license
amendments and has no impact on either the Limiting Conditions for Operation or Surveillance Requirements. Therefore,
the proposed changes will not involve a significant reduction in a margin of safety. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant
hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Reference and Documents Department, Penfield Library, State University of New York, Oswego, New York 13126.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mark J. Wetterhahn, Esquire, Winston &amp; Strawn, 1400 L Street, NW., Washington, DC 20005-3502.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Robert A. Capra
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
North Atlantic Energy Service Corporation, Docket No. 50-443, Seabrook Station, Unit No. 1, Rockingham County,
New Hampshire
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
October 4, 1993 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would delete the emergency diesel-generator engine speed specification from Surveillance
Requirement (SR) 4.8.1.1.2a.5 and would replace the diesel engine speed requirement with an electrical frequency
requirement in SR 4.8.1.1.2g. Currently, SR 4.8.1.1.2a.5 specifies both a minimum engine speed and a nominal electrical
frequency and acceptable deviation from the nominal value. SR 4.8.1.1.2g currently specifies only a minimum engine
speed. The specified minimum engine speed is not consistent with the acceptable frequency deviation below the nominal
value.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration.
The NRC staff has reviewed the licensee's analysis against the standards of 10 CFR 50.92(c). The NRC staff's review
is presented below.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
A. The changes do not involve a significant increase in the probability or consequences of an accident previously
evaluated (10 CFR 50.92(c)(1)) because the proposed changes merely delete the specification of emergency diesel-generator
minimum engine speed while retaining or substituting the specification of electrical frequency to be attained by
the emergency diesel-generator. The diesel engine and generator are directly coupled and must rotate at the same
speed, therefore, speed and frequency are directly related and specification of acceptance values for both parameters
is redundant. Furthermore, electrical frequency, not engine speed, is the parameter of interest with regard the
ability of the system to power emergency loads. The proposed changes do not affect the adequacy of the surveillance
test or the reliability of the system to power emergency loads, and do not involve any physical changes to facility
structures, systems, or components. Therefore, since the reliability of the emergency diesel-generators will
not be reduced, the probability or consequences of any accident previously evaluated is not increased.
<!-- PJG 0012 frnewline -->
B. The changes do not create the possibility of a new or different kind
<!-- PJG 0012 frnewline -->
of accident from any accident previously evaluated (10 CFR 50.92(c)(2)) because no physical changes to facility
structures, systems, or components are involved and they do not affect the manner by which the facility is operated.

<!-- PJG 0012 frnewline -->
C. The changes do not involve a significant reduction in a margin of safety (10 CFR 50.92(c)(3)) because the proposed
changes do not affect the manner by which the facility is operated or involve changes to equipment or features which
affect the operational characteristics of the facility. 
<!-- PJG 0012 frnewline -->
 Based on this review, it appears that the three standards of 10 CFR 50.92(c) are satisfied. Therefore, the NRC staff
proposes to determine that the amendment request involves no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Exeter Public Library, 47 Front Street, Exeter, New Hampshire 03833.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Thomas Dignan, Esquire, Ropes &amp; Gray, One International Place, Boston Massachusetts 02110-2624.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
John F. Stolz
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
North Atlantic Energy Service Corporation, Docket No. 50-443, Seabrook Station, Unit No. 1, Rockingham County,
New Hampshire
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
October 28, 1993 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would implement 13 of the 47 line item Technical Specification (TS) improvements recommended
by Generic Letter 93-05. Most of the proposed changes would revise the allowable time intervals for performing certain
Surveillance Requirements (SR) on various plant components during power operation or would delete the requirement
entirely or under certain conditions. One proposed change would modify testing requirements identified in an ACTION
statement. The specific changes are as follows:
<!-- PJG 0012 frnewline -->
1. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
SR 4.1.3.1.2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - The allowable interval between tests to demonstrate the operability of any partially or fully withdrawn control
rod would be increased to 92 days from 31 days.
<!-- PJG 0012 frnewline -->
2. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
SR 4.6.4.1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - The allowable interval between tests to demonstrate the operability of the hydrogen monitors by performing an Analog
Channel Operational Test (ACOT) would be increased to 92 days from 31 days, and by performing a Channel Calibration
to every refueling outage from 92 days on a staggered basis.
<!-- PJG 0012 frnewline -->
3. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
SR 4.3.2.1, Table 4.3-2, Functional Unit 3.c.4 and SR 4.3.3.1, Table 4.3-3, Functional Units 1 through 6
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - The allowable interval between tests to demonstrate the operability of the radiation monitors by performing an
ACOT and Digital Channel Operational Test (DCOT) would be increased to quarterly from monthly.
<!-- PJG 0012 frnewline -->
4. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
SR 4.4.6.2.2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
- The time the plant may be in Cold Shutdown before Pressure Isolation Valve testing is required prior to entering Mode
2 would be increased to 7 days from 72 hours.
<!-- PJG 0012 frnewline -->
5. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
SR 4.4.11.1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - The allowable interval between tests to demonstrate the operability of the Reactor Coolant System vent block valves
would be increased to cold shutdown from every 92 days.
<!-- PJG 0012 frnewline -->
6. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
SR 4.4.3.2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - The allowable interval between tests to verify pressurizer heater capacity would be increased to each refueling
outage from 92 days.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
7. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
SR 4.5.1.1.1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 - The requirement to verify the boron concentration of the accumulator contents after a volume increase of 1-percent
or more would be removed under certain conditions.
<!-- PJG 0012 frnewline -->
8. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
SR 4.5.1.1.2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 - The requirement to perform an ACOT and Channel Calibration on accumulator water level and pressure instrumentation
would be deleted.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
9. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
SR 4.5.2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - The requirement to visually inspect the containment sump upon completion of each containment entry would be modified
to avoid unnecessary containment sump inspections when multiple containment entries are made on the same day. 
<!-- PJG 0012 frnewline -->
10. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
SR 4.6.2.1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - The allowable interval between tests to verify that each containment spray nozzle is unobstructed would be increased
to every 10 years from 5 years.
<!-- PJG 0012 frnewline -->
11. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
SR 4.6.4.2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - The allowable interval between tests to demonstrate operability of each hydrogen recombiner system would be increased
to each refueling interval from 6 months.
<!-- PJG 0012 frnewline -->
12. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
SR 4.7.1.2.1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - The allowable interval between tests of the auxiliary and startup feedwater pumps would be increased to 92 days on
a staggered test basis from 31 days.
<!-- PJG 0012 frnewline -->
13. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
TS 3.8.1.1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - The ACTION statements would be changed so that when the Limiting Conditions for Operation are not met due to:
<!-- PJG 0012 frnewline -->
a. Inoperability of one or two offsite power circuits the starting of a diesel-generator would no longer be required;
<!-- PJG 0012 frnewline -->
b. Inoperability of one diesel-generator, starting of the remaining diesel-generator would be required within
8 hours only under certain conditions instead of within 24 hours under all conditions;
<!-- PJG 0012 frnewline -->
c. Inoperability of a diesel-generator and an offsite power circuit, starting of the remaining diesel-generator
would be required within 8 hours only under certain conditions instead of within 24 hours under all conditions.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration.
The NRC staff has reviewed the licensee's analysis against the standards of 10 CFR 50.92(c). The NRC staff's review
is presented below. 
<!-- PJG 0012 frnewline -->
A. The changes do not involve a significant increase in the probability or consequences of an accident previously
evaluated (10 CFR 50.92(c)(1)) because the proposed changes either merely modify the allowable intervals between
certain surveillance tests, delete the SR, or alter an ACTION statement with regard to required testing. The safety
functions of the related structures, systems, or components are not changed in any manner nor are the reliabilities
of any structure, system, or component reduced by the revised surveillance or testing requirements. The changes
do not affect the manner by which the facility is operated and do not change any facility design feature, structure,
system, or component. Since there is no change to the facility or operating procedures, and the safety functions and
reliabilities of structures, systems, or components are not affected, there is no affect upon the probability or
consequences of any accident previously analyzed.
<!-- PJG 0012 frnewline -->
B. The changes do not create the possibility of a new or different kind
<!-- PJG 0012 frnewline -->
of accident from any accident previously evaluated (10 CFR 50.92(c)(2)) because they do not change the facility or
affect the manner by which the facility is operated. The proposed changes merely change certain surveillance or testing
requirements.
<!-- PJG 0012 frnewline -->
C. The changes do not involve a significant reduction in a margin of safety (10 CFR 50.92(c)(3)) because they do not
affect the manner by which the facility is operated or change equipment or features which affect the operational characteristics
of the facility.
<!-- PJG 0012 frnewline -->
Based on this review, it appears that the three standards of 10 CFR 50.92(c) are satisfied. Therefore, the NRC staff
proposes to determine that the amendment request involves no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Exeter Public Library, 47 Front Street, Exeter, New Hampshire 03833.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Thomas Dignan, Esquire, Ropes &amp; Gray, One International Place, Boston Massachusetts 02110-2624.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
John F. Stolz 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Northeast Nuclear Energy Company, et al., Docket No. 50-336, Millstone Nuclear Power Station, Unit No. 2, New London
County, Connecticut
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 17, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment changes the action statements for the limiting conditions associated with the electrical
power sources (Technical Specification 3.8.1.1).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
In accordance with 10 CFR 50.92, NNECO has reviewed the attached proposed changes and has concluded that they do not
involve a significant hazards consideration. The basis for this conclusion is that the three criteria of 10CFR50.92(c)
are not compromised. The proposed changes do not involve a significant hazards consideration because the changes
would not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed changes to rewrite the action statements for Technical Specification 3.8.1.1 will decrease the wear
on the EDGs [emergency diesel generators] by reducing the number of required starts. These changes will also allow
adequate time for the completion of manufacturer recommended EDG engine prelube and warmup procedures. They ensure
that the operability of the AC sources is demonstrated with reasonable assurance. Also, the reliability of the EDGs
will be enhanced by reducing the potential for numerous unloaded EDG starts during an LCO [limiting condition for
operation] period. The proposed changes could reduce the number of required unloaded EDG starts from nine to one.
Therefore, these proposed changes do not involve a significant increase in the probability or consequences of an
accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Create the possibility of a new or different kind of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed changes to rewrite the action statements for Technical Specification 3.8.1.1 do not alter the method
of operating the plant, nor do they introduce any new failure modes. The proposed changes affect EDG testing frequency
only, they have no impact on any accident analysis. The proposed changes provide assurance that the EDGs will be able
to power their respective safety systems if required. Also, they do not involve any physical alterations to plant
equipment or procedures which would introduce any new or unique operational modes or accident precursors.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3.Involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed changes to rewrite the action statements for Technical Specification 3.8.1.1 do not affect the capability
of the EDGs to perform their function. The intent of the changes is to increase the overall EDG reliability, by reducing
the wear resulting from excessive and unwarranted testing. The proposed changes do not involve a significant reduction
in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Learning Resource Center, Three Rivers Community-Technical College, Thames Valley Campus, 574 New London Turnpike,
Norwich, Connecticut 06360. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Gerald Garfield, Esquire, Day, Berry &amp; Howard, City Place, Hartford, Connecticut 06103-3499.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
John F. Stolz
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Power Authority of the State of New York, Docket No. 50-333, James A. FitzPatrick Nuclear Power Plant, Oswego County,
New York
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 12, 1992, as supplemented September 17, 1992, March 17, 1993, August 17, 1993, August 18, 1993, and December 29,
1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The purpose of the proposed changes is to revise the Technical Specifications (TS) to permit operation of the James
A. FitzPatrick Nuclear Power Plant at an uprated power of 2536 MWt. The licensee's engineering analyses and evaluations
confirm that the plant can be operated at an uprated power. The increase in the rated power from 2436 MWt to 2536 MWt corresponds
to a 4.8 percent increase in rated steam flow. The increase in rated power remains below the plant design power level
of 2550 MWt which was the basis for the original plant safety evaluation.
<!-- PJG 0012 frnewline -->
The changes affect the operating parameters of the reactor, operational restrictions, setpoints for safety systems,
analytical results, and test requirements. There are also administrative changes. The changes in each of these categories
are summarized as follows:
<!-- PJG 0012 frnewline -->
Reactor Parameters: The effect on reactor parameters is limited. Higher power is achieved by control rod pattern
adjustments to increase reactor thermal power in a more uniform (flattened) power
<!-- PJG 0012 frnewline -->
distribution to increase steam flow without increasing core recirculation flow. This requires an increased reactor
dome pressure for adequate turbine inlet pressure.
<!-- PJG 0012 frnewline -->
Operational Limits: The increased thermal power requires a change to the limitation on operation in the high power
low flow portion of the power/flow map to limit thermal hydraulic instabilities and power oscillations.
<!-- PJG 0012 frnewline -->
Setpoints: The increased reactor pressure has a direct impact on the high pressure scram setpoint and the safety relief
valve setpoint. Additionally, the bypass for the turbine stop valve closure and control valve fast closure scram
will be changed in proportion to the increase in thermal power.
<!-- PJG 0012 frnewline -->
Analysis Results: Analyses of uprated power transients and accidents requires changes to various TS and their Bases.
Operational parameters and assumptions used in analyses were revised to reflect their use as initial conditions.
Revised radiological analyses changed dose results. The results of the accident analyses requires revisions to
properly reflect plant capabilities.
<!-- PJG 0012 frnewline -->
Testing: A number of changes to testing requirements result from power uprate. The increase to reactor pressure has
a direct effect on hydrostatic leakage testing pressure. The test pressure for High Pressure Coolant Injection (HPCI)
and Reactor Core Isolation Cooling (RCIC) pumps will be revised to reflect safety relief valve setpoints assumed
in analyses.
<!-- PJG 0012 frnewline -->
Administrative: Administrative changes (i.e., adding references, revising references and correcting associated
errors) will also be made.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
No changes to the Radiological Effluent Technical Specifications were identified.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Operation of the FitzPatrick plant at a thermal power of 2536 MWt will not involve a significant hazards consideration
as defined in 10 CFR 50.92, since it would not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The James A. FitzPatrick nuclear power plant was reviewed for operation at a rated power of 2550 MWt at the time of its
operating license, [***]. This review was based on the original design of the plant. Since that time, a number of safety
issues of a generic and plant specific nature as well as plant modifications have changed the originally reviewed
design.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Generic criteria, methodologies and evaluation scope required to uprate BWRs up to 5% were prepared by General Electric
and submitted to the NRC in LTR-1 [NEDC-31897P-A, ``Generic Guidelines for General Electric Boiling Water Reactor
Power Uprate"]. This was supplemented by the submittal of generic evaluations in LTR-2 [NEDC-31984P, ``Generic
Evaluations of General Electric Boiling Water Reactor Power Uprate'' and Supplement 1] to determine: which NRC and
industry generic communications were applicable to power uprate and how they should be treated; analytical evaluations
that could be generically approved; bounding evaluations of components and equipment, and; the effect of power uprate
on safety margin. These generic evaluations are supplemented by plant specific evaluations. The Power Uprate Safety
Analysis Report (PUSAR) describes the dependence placed on References 1 and 2, the additional analyses that were
performed, the results of these additional analyses and overall conclusions on the safety impacts of power uprate.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The plant systems and components will be within design limits at power uprate conditions with minor modifications.
At uprated power, the power plant will not be operated in a manner that is different from current operations except
for limited changes to operating parameters such as primary system pressure, steam flow and feedwater temperature.
Setpoints are revised as necessary to reflect new operational conditions and analyses. The ECCS-LOCA [emergency
core cooling system-loss-of-coolant accident] analysis using current practices demonstrates compliance with
design and regulatory acceptance criteria at uprated power.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The radiological consequences of accidents have been evaluated using more current methodologies with consistent
assumptions and continue to meet acceptance criteria. Compliance with NRC dose criteria using current methodologies
is discussed in Section 9.2 of the PUSAR. The effect of power uprate on dose analyses now discussed in the FSAR [Final
Safety Analysis Report] were qualitatively assessed recognizing that power uprate increases doses in direct proportion
to the 4.1% increase in thermal power. An increase of 4.1% to the calculated doses currently identified in FSAR Chapter
14 indicates that a reevaluation using the original methodology would have demonstrated compliance with current
NRC dose criteria. A review of Table 14.4-2 indicates that, with the 4.1% increase, offsite doses would be substantially
less than NRC allowable values. A review of Table 14.8-1 indicates that, with the 4.1% increase, control room doses
would be substantially less than NRC allowables except for the main steam line break (MSLB). However, the MSLB dose
would drop well below allowables once the proposed change on allowable coolant activity (reduces the limit by more
than a factor of ten) is accounted for.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
[Thus, based on the above analysis and supplemental analyses performed by the NRC staff, the increase in power level
discussed herein and associated Technical Specification changes do not significantly increase the probability
or consequences of an accident previously evaluated.]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. create the possibility of a new or different kind of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Operation at uprated power involves no changes to the manner in which the plant is operated. There are changes to operational
parameters and setpoints but analyses of these identified no new failure modes or accident scenarios. The effects
of transients and accidents fall within design capabilities. Systems and components are capable of operating and
performing their safety functions at uprated power. No mechanisms for creating a new or different accident were identified.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The power uprate will not result in significant increases to primary system temperature and pressure due to postulated
operating transients or accidents. These and other margins of safety have been discussed in the PUSAR, where it is
demonstrated that there will be no reductions in the margin of safety because the plant will still meet its design and
regulatory acceptance criteria. For example, the core will continue to be operated with the same margin to the safety
limit minimum critical power ratio. Fuel thermal limits will continue to meet NRC acceptance criteria. Plant systems
and equipment are designed for uprated power conditions and have been evaluated for their capability to perform at
uprated conditions. They will continue to perform within design limits.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant
hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Reference and Documents Department, Penfield Library, State University of New York, Oswego, New York 13126.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. Charles M. Pratt, 1633 Broadway, New York, New York 10019. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Robert A. Capra
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Power Authority of the State of New York, Docket No. 50-333, James A. FitzPatrick Nuclear Power Plant, Oswego County,
New York
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 22, 1993 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment to the James A. FitzPatrick Technical Specifications proposes to remove the reference to
American Society for Testing and Materials (ASTM) Standard D 270-65 from Surveillance Requirement 4.12.A.1.i.
ASTM D 270-65, which specifies procedures to draw a representative fuel oil sample, has been superseded and is no longer
in effect. The FitzPatrick Surveillance Procedure currently requires sampling in accordance with ASTM D 270-65
but notes that it has been superseded by ASTM D 4057-88. The proposed change makes Surveillance Requirement 4.12.A.1.i
consistent with fuel oil Surveillance Requirement 4.9.C.1, for the emergency diesel generators (EDGs), by adopting
the current industry fuel oil sampling standard. There are no changes to the acceptance criteria for fuel oil quality
which are based on ASTM D 975-81.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Operation of the FitzPatrick plant in accordance with the proposed Amendment would not involve a significant hazards
consideration as defined in 10 CFR 50.92, since it would not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Plant accident analyses are not affected by the Technical Specification change. The change removes reference to
ASTM D 270-65 as the method for obtaining samples of diesel fuel oil from Surveillance Requirement 4.12.A.1.i. The
American Society for Testing and Materials has superseded ASTM D 270-65 with ASTM D 4057. The proposed change provides
improved flexibility to adopt standards as they are issued without requiring a license amendment and makes Surveillance
Requirement 4.12.A.1.i consistent with both Surveillance Requirement 4.9.C.1 for the EDG and the STS [Standard
Technical Specification]. The nature of this change will not cause any increase in the probability or consequences
of previously evaluated accidents.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. create the possibility of a new or different kind of accident from those previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change involves no hardware modifications to any plant structures, systems or components. The change
removes reference to ASTM D 270-65 as the method for obtaining samples of diesel fuel oil from Surveillance Requirement
4.12.A.1.i. The American Society for Testing and Materials has superseded ASTM D 270-65 with ASTM D 4057. The nature
of this change is such that no new or different kind of accident can be created.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change will not cause a reduction in the margin of safety. The results of the plant accident analyses continue
to bound operation under the proposed changes so there is no reduction in the margin of safety. The change removes reference
to ASTM D 270-65 to allow the use of ASTM D 4057-88 as the method for obtaining samples of diesel fire pump fuel oil. The
change will make Surveillance Requirement 4.12.A.1.i consistent with existing Surveillance Requirement 4.9.C.1
for the EDG and allow current standards to be used for fuel oil sampling. Revisions of this nature will not cause a reduction
in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
50.92(c) are satisfied. 
<!-- PJG 0012 frnewline -->
Therefore, the NRC staff proposes to determine that the amendment request involves no significant hazards consideration.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Reference and Documents Department, Penfield Library, State University of New York, Oswego, New York 13126.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. Charles M. Pratt, 1633 Broadway, New York, New York 10019. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Robert A. Capra
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Power Authority of the State of New York, Docket No. 50-333, James A. FitzPatrick Nuclear Power Plant, Oswego County,
New York
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 28, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment to the James A. FitzPatrick Technical Specifications (TSs) revises the scope of startup and
power escalation reports to reflect the guidance provided by the Standard Technical Specifications (STS). Current
TS requirements state, ``The report shall address each of the tests identified in the FSAR [Final Safety Analysis
Report] ....'' 
<!-- PJG 0012 frnewline -->
The list of tests provided in the FSAR includes many tests which were required for the initial plant startup but are
not performed for subsequent startups. Currently, the licensee satisfies TS requirements in the startup reports
by identifying tests which are not performed, their purpose, and the reason for not performing them.
<!-- PJG 0012 frnewline -->
The inclusion of such a section in the startup reports is unnecessary. This amendment would revise the TSs to permit
subsequent startup reports to address only those tests that are actually performed.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Operation of the FitzPatrick plant in accordance with the proposed Amendment would not involve a significant hazards
consideration as defined in 10 CFR 50.92, since it would not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
The proposed changes involve no hardware modifications, no changes to the operation of any system or component, no
changes to structures, and alters future startup reports by addressing only tests that are performed. A change in
reporting format will not eliminate the performance of startup tests that are necessary or required. These changes
can not alter the probability or consequences of existing accident analyses as documented in the FSAR or the NRC staff
SER [Safety Evaluation Report].
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. create the possibility of a new or different kind of accident from those previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The changes do not alter the testing procedures or methodologies. The changes provide a basis, in accordance with
NRC guidance, for allowing future startup test reports to mention and discuss only those tests that are actually performed.
These changes can not result in a new or different type of accident than those previously evaluated.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
3. involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
There are no changes to tests that are performed in support of plant startup [***]. Removing a requirement for reporting
on tests that are not performed will not cause a reduction in any margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant
hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Reference and Documents Department, Penfield Library, State University of New York, Oswego, New York 13126.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. Charles M. Pratt, 1633 Broadway, New York, New York 10019. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Robert A. Capra
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Power Authority of the State of New York, Docket No. 50-333, James A. FitzPatrick Nuclear Power Plant, Oswego County,
New York
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 29, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment to the James A. FitzPatrick Technical Specifications would eliminate an inconsistency between
the Reactor Coolant System (RSC) leakage detection and operability requirements in Limiting Conditions for Operation
(LCO) 3.6.D.1 and 3.6.D.4.
<!-- PJG 0012 frnewline -->
LCO 3.6.D.1 currently requires that RCS leakage be below specified limits when there is irradiated fuel in the reactor
vessel and reactor coolant temperature is greater than 212
<!-- PJG 0017 degreeslatlong -->
&cir;F. LCO 3.6.D.4 requires the leakage monitoring systems to be operable during power operation (i.e., when the
mode switch is in the Startup/Hot Standby position or the Run position with the reactor critical above 1 percent rated
power, as defined per Specification 1.0.O). These two LCOs are not consistent. The proposed revision of LCO 3.6.D.4
will take the more conservative approach of requiring the leakage monitoring systems to be operable when the leakage
limits of LCO 3.6.D.1 are in effect.
<!-- PJG 0012 frnewline -->
The proposed changes also make editorial corrections which are considered administrative in nature.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Operation of the FitzPatrick plant in accordance with the proposed Amendment would not involve a significant hazards
consideration as defined in 10 CFR 50.92, since it would not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed amendment involves no hardware changes, no changes to the operation of any systems or components and
no changes to structures. It alters an LCO to require plant leakage detection systems to be operable during the same
plant conditions that RCS leakage limits apply. The revised LCO requires leakage detection systems in operational
modes consistent with other portions of the Technical Specifications. Additional changes include editorial corrections
such as correct specification numbering, proper system identification, and clarification of a surveillance requirement
cross reference. Since the change to the LCO for leakage detection will require operability under a greater range
of plant conditions to be consistent with detection requirements, there is no change to previously determined accident
probabilities or consequences. The editorial changes have no adverse safety implications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. create the possibility of a new or different kind of accident from those previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed amendment involves no hardware changes, no changes to the operation of any systems or components and
no changes to structures. It alters the Technical Specifications only to the extent of making two LCOs consistent
by requiring the leakage detection system to be operable when leakage limits apply and making editorial changes.
Editorial changes and increasing the plant conditions for leakage system operability can not create the possibility
of a new or different kind of accident from those previously evaluated since the editorial changes have no safety significance
and the operability changes are being made for consistency with the modes when leakage detection is required to function.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed amendment revisions involve no hardware changes, no changes to the operation of any systems and no changes
to structures. The revised LCO criteria for RCS leakage detection system operability has increased the plant conditions
when operability is required to match the plant conditions when leakage limits apply. Editorial changes and expanded
operability requirements in the LCOs will not result in any change to existing safety margins.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant
hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Reference and Documents Department, Penfield Library, State University of New York, Oswego, New York 13126.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. Charles M. Pratt, 1633 Broadway, New York, New York 10019. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Robert A. Capra
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Power Authority of the State of New York, Docket No. 50-333, James A. FitzPatrick Nuclear Power Plant, Oswego County,
New York
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 29, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This proposed amendment to the James A. FitzPatrick Technical Specifications, Appendix B, revises Surveillance
Requirement 3.1.a and Table 3.10-2. The existing Surveillance Requirement in Specification 3.1.a, which references
Table 3.10-2, requires the performance of instrument checks, tests, and calibrations to assure the operability
of specific gaseous effluent radiation monitors. It does not require any surveillances for the associated data recorders.
However, Limiting Condition for Operation (LCO) 3.1.a specifically states that ''...pathways shall be monitored
and recorded ....'' which requires the recorders to be operable for the gaseous effluent monitoring system to be considered
operable. The proposed changes to the Radiological Effluent Technical Specifications (RETS) add the radiation
monitor recorders to the Surveillance Requirement and Table 3.10-2 for the gaseous effluent monitoring system.
This will provide the surveillance requirements for the data recorders.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Operation of the FitzPatrick plant in accordance with the proposed Amendment would not involve a significant hazards
consideration as defined in 10 CFR 50.92, since it would not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
The proposed amendment involves no hardware changes, no changes to the operation of any systems or components and
no changes to structures. It alters procedures by including the recorders in the Surveillance Requirements for determining
the operability of the radiological monitoring/recording instrumentation. The inclusion of the data recorders
in the Surveillance Requirements for checking, testing, and calibration does not reduce gaseous effluent monitoring
capability while providing greater assurance that data is recorded. Adding the existing system surveillance to
the Technical Specifications will not have any affect on previously evaluated accident probabilities or consequences.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. create the possibility of a new or different kind of accident from those previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed amendment involves no hardware changes, no changes to the operation of any systems or components and
no changes to structures. It alters procedures by including the data recorders in the Surveillance Requirements
for the radiation monitors. These changes do not affect the manner in which the gaseous effluent radiation monitoring
system is operated or tested. The resulting changes do not pose a safety issue concern different from those analyzed
previously in the FSAR [Final Safety Analysis Report] or the NRC staff SER [Safety Evaluation Report].
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed amendment involves no hardware changes, no changes to the operation of any systems and no changes to structures.
It alters procedures by including the data recorders in the Surveillance Requirements for the radiation monitors.
The revised surveillance requirement increases the scope of surveillance for the gaseous effluent radiation monitoring
system, for consistency with the LCO. It does not cause any reduction in any safety margins.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant
hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Reference and Documents Department, Penfield Library, State University of New York, Oswego, New York 13126.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. Charles M. Pratt, 1633 Broadway, New York, New York 10019. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Robert A. Capra
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Power Authority of the State of New York, Docket No. 50-333, James A. FitzPatrick Nuclear Power Plant, Oswego County,
New York
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 11, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This proposed amendment to the James A. FitzPatrick Technical Specifications (TS) would temporarily waive the 2-year
maximum surveillance interval for the Type C test (local leak rate test) of the shutdown cooling isolation valves
(10MOV-17 and 10MOV-18). The waiver would permit deferring this test until the next refueling outage, currently
scheduled for the end of November 1994.
<!-- PJG 0012 frnewline -->
TS 4.7.A.2.e(5) and 10 CFR Part 50 Appendix J require the containment isolation valves to be leak-rate tested during
each refueling outage, but at intervals of not greater than 2 years. As a result of the extended 1991-1993 refueling
outage, and the length of the current operating cycle, tests of all containment isolation valves are due prior to the
start of the next refueling outage. Two mid-cycle outages were scheduled, in part, to accommodate the testing of these
valves, except for the shutdown cooling isolation valves. The shutdown cooling isolation valves cannot be removed
from service during a non-refueling outage to accommodate a leak-rate test since its associated system is needed
to remove reactor decay heat. The reliability of the isolation valve design, and the very low probability that the
shutdown cooling system penetration would result in a pathway for leakage to the reactor building, as discussed in
the application, is provided as justification for this one-time schedular extension.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Operation of the FitzPatrick plant in accordance with the proposed amendment would not involve a significant hazards
consideration as defined in 10 CFR 50.92, since it would not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change is limited to a one-time schedular extension in the shutdown cooling isolation valve Type C test.
The change does not introduce any new modes of plant operation, make any physical changes, or alter any operational
setpoints. Therefore, the change does not degrade the performance of any safety system assumed to function in the
accident analysis. The extension will not result in a significant increase in valve leakage considering that: (1)
the valves are infrequently stroked, and then only when the reactor vessel is at low pressure, (2) monitoring the normal
operating status of the RHR [residual heat removal] system assures the absence of gross valve leakage, and (3) the
valves were replaced with valves of an improved design which has been confirmed by past Type C tests to exhibit satisfactory
leak rate performance. For these reasons, the change does not involve a significant increase in the probability of
an accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The change does not involve a significant increase in the consequences of an accident evaluated since any leakage
through the shutdown cooling penetration will not significantly increase for reasons discussed in the previous
paragraph, and such leakage is negligible compared to the main steam line break accident analyzed in the FSAR [final
safety analysis report].
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. create the possibility of a new or different kind of accident from those previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change does not introduce new accident initiators or failure mechanisms since the change does not alter
the physical characteristics of any plant system or component. The change is limited to a one-time schedule extension
for the shutdown cooling isolation valve Type C tests.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
There is a very low probability of a significant increase in valve leakage considering the demonstrated reliability
of the current valve design, the infrequent use of the valves, and the monitoring of the normal operating status of
the RHR system. Moreover, any potential incremental benefit of performing the tests within the two year requirement
would not be sufficient to offset the increased occupational radiation exposure associated with testing, and the
risk to plant safety associated with the removal from service of the primary method of decay heat removal. Consequently,
the proposed change does not involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant
hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Reference and Documents Department, Penfield Library, State University of New York, Oswego, New York 13126.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. Charles M. Pratt, 1633 Broadway, New York, New York 10019. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Robert A. Capra
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Tennessee Valley Authority, Docket Nos. 50-327 and 50-328, Sequoyah Nuclear Plant, Units 1 and 2, Hamilton County,
Tennessee
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
October 1, 1993 TS 93-09
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed changes would revise the setpoints and time delays for the auxiliary feedwater (AFW) and 6.9 kv shutdown
board loss of voltage and degraded voltage instrumentation. The proposed changes would affect Technical Specification
(TS) Tables 3.3-3, 3.3-4, 3.3-5, 4.3-2, and the Bases for Specification 3/4.7.1.2. Table 3.3-3 would be revised:
(1) to reflect the use of a two-out-of-three voltage sensor logic for loss of power detection (and one-out-of-two
logic scheme for the timing relays) by adding requirements for the respective AFW, 6.9 kv shutdown board, and emergency
diesel generator (EDG) voltage sensors and load shed timers; (2) by changing the description of the functional unit
from ``Station Blackout'' to ``Loss of Power Start;'' (3) by adding a footnote to indicate that the new requirements
apply only to the shutdown boards on the same unit; (4) by increasing the modes for which the EDG sensors and timers must
be operable to include Modes 5 and 6 when the associated EDG must be operable; (5) by changing the associated Action
statements to reflect the design changes and consistency; (6) to reflect consistent terminology in the Table and
action statements; (7) by changing the minimum number of channels that would be required to be operable; (8) by changing
the footnote to reflect the conditions when the loss-of-power instrumentation is required to be operable in Modes
5 and 6; and (9) by adding an exclusion to Specification 3.0.4. Similar changes were proposed for Tables 3.3-4, 3.3-5
and 4.3-2. The proposed change to Bases 3/4.7.1.2 would clarify AFW operability on loss of power. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
TVA has evaluated the proposed technical specification (TS) change and has determined that it does not represent
a significant hazards consideration based on criteria established in 10 CFR 50.92(c). Operation of Sequoyah Nuclear
Plant (SQN) in accordance with the proposed amendment will not: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed revision supports the implementation of design logic and setpoint changes to the loss-of-power relaying.
This relaying is designed to ensure adequate voltage is available to safety-related loads in order to enhance their
operability and support accident mitigation functions and to provide for auxiliary feedwater (AFW) pump starts.
The design changes alter relay logic and delete unnecessary relaying, but do not change the diesel generator (D/G)
start and load-shedding actuations that result from loss-of-power conditions. Therefore, no new actuations or
functions have been created; and because the existing and proposed functions provide for accident mitigation considerations
that are not the source of an accident, the probability of an accident is not increased. The deletion of the 6.9-kilovolt
shutdown board normal-feeder undervoltage relays actually reduces the potential for inadvertent shutdown board
blackouts as a result of short-duration voltage transients or instrument failures.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The setpoints and time delays for loss-of-power functions have been modified based on the guidelines developed by
the Electrical Distribution System Clearinghouse as evaluated and determined through detailed analysis by TVA.
This design is documented in TVA Calculations SQN-EEB-MS-TI06-0008, 27DAT, and DS-1-2 and is available for NRC review
at the SQN site. The assigned values are conservative settings that will ensure adequate voltage is supplied to safety-related
loads for accident mitigation and safety functions under normal, degraded, and loss-of-offsite-power voltage
conditions with appropriate time delays to prevent damage to electrical loads and minimize premature or unnecessary
actuations. The identification of loss-of-voltage conditions is enhanced by the design changes to ensure the timely
sequencing of loads onto the D/G and the initiation of AFW pump starts for accident mitigation. Because there are no
reductions in safety functions resulting from the design logic, setpoint, and time-delay changes to the loss-of-power
instrumentation and offsite dose levels for postulated accidents will not be increased, the consequences of an accident
are not increased. 
<!-- PJG 0012 frnewline -->
The applicable mode addition, TS 3.0.4 exclusion deletion, and response time measurement clarification incorporated
in the proposed change do not affect plant functions. These changes reflect the requirements that SQN has been maintaining
and serve to clarify the requirements to provide consistency of application and easier understanding. The AFW footnote
addition and bases revision only clarify operability conditions that are consistent with the plant design for the
AFW pump and loss-of-power instrumentation. Because there are no changes to plant functions or operations, these
revisions have no impact on accident probabilities or consequences.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Create the possibility of a new or different kind of accident from any previously analyzed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
As described above, the loss-of-power instrumentation ensures adequate voltage to safety-related loads by initiating
D/G starts and load shedding and provides for AFW pump starting, but is not considered to be the source of an accident.
Although the design logic, setpoint, and time-delay actuation criteria have changed, the output functions to various
plant systems that actuate for load shedding and D/G starts remain the same. Therefore, actuation criteria have been
affected, but not safety functions, and the TVA evaluation has confirmed that the new design enhances the ability
to maintain adequate voltage to support safety functions. Since safety functions have not changed and the new loss-of-power
instrumentation design continues to support operability of safety-related equipment, no new or different accident
is created.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The applicable mode addition, TS 3.0.4 exclusion deletion, and response time measurement clarification, as well
as the AFW operability clarifications, do not affect plant functions and will not create a new accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed loss-of-power TS changes support design logic, setpoint, and time-delay requirements that have been
verified by TVA analysis to provide acceptable voltage levels for safety-related components. In determining the
acceptability of these voltage levels, the minimum voltage for operation as well as detrimental component heating
resulting from sustained degraded-voltage conditions were considered. This design ensures that safety-related
loads will be available and operable for normal and accident plant conditions. The applicable mode addition, TS 3.0.4
exclusion deletion, response time measurement clarification, and AFW operability clarifications provide enhancements
to TS requirements and do not affect plant functions. Therefore, no safety functions are reduced by these changes
and there is no reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC has reviewed the licensee's analysis and, based on this
<!-- PJG 0012 frnewline -->
review, it appears that the three standards of 10 CFR 50.92(c) are 
<!-- PJG 0012 frnewline -->
satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant hazards
consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Chattanooga-Hamilton County Library, 1101 Broad Street, Chattanooga, Tennessee 37402
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
General Counsel, Tennessee Valley Authority, 400 West Summit Hill Drive, ET 11H, Knoxville, Tennessee 37902 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Frederick J. Hebdon 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Tennessee Valley Authority, Docket Nos. 50-327 and 50-328, Sequoyah Nuclear Plant, Units 1 and 2, Hamilton County,
Tennessee
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
November 18, 1993 (TS 93-17) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed change would delete the requirement of License Condition 2.H of the Operating License. This license
condition requires reporting the violation of certain license conditions to the NRC Regional Administrator within
24 hours by phone and facsimile, and a followup report within 14 days.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
TVA has evaluated the proposed technical specification (TS) change and has determined that it does not represent
a significant hazards consideration based on criteria established in 10 CFR 50.92(c). Operation of Sequoyah Nuclear
Plant (SQN) in accordance with the proposed amendment will not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change is a deletion of an administrative reporting requirement that does not in any way affect a previously
analyzed accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Create the possibility of a new or different kind of accident from any previously analyzed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Since there are no changes in the way the plant is operated, the potential for an unanalyzed accident is not created.
The proposed change is administrative in nature and does not affect any accident initiators for SQN. No new failure
modes are introduced.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3.Involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Plant safety margins are established through limiting conditions of operation, limiting safety system settings,
and safety limits specified in the TSs. As a result of the proposed amendment, there will be no changes to either the
physical design of the plant or to any of these settings and limits. The proposed changes are administrative and do
not affect the safe operation of SQN. Therefore, there will be no changes to any of the margins of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC has reviewed the licensee's analysis and, based on this
<!-- PJG 0012 frnewline -->
review, it appears that the three standards of 10 CFR 50.92(c) are 
<!-- PJG 0012 frnewline -->
satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant hazards
consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Chattanooga-Hamilton County Library, 1101 Broad Street, Chattanooga, Tennessee 37402
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
General Counsel, Tennessee Valley Authority, 400 West Summit Hill Drive, ET 11H, Knoxville, Tennessee 37902
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Frederick J. Hebdon
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Tennessee Valley Authority, Docket Nos. 50-327 and 50-328, Sequoyah Nuclear Plant, Units 1 and 2, Hamilton County,
Tennessee
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 7, 1993 (TS 93-16) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed change would incorporate the following changes to Section 6.0, ``Administrative Controls,'' of the
Technical Specifications (TS): (1) delete Section 6.1.2 that indicates that the Corporate Manager of Radiological
Control has the responsibility for the radiological environmental program, dose calculations, and projections;
(2) added a requirement in Section 6.5.1.6 for review of the Offsite Dose Calculations Manual (ODCM) by the Plant Operations
Review Committee (PORC); (3) added implementation of the ODCM to Section 6.8.1 as an activity requiring written procedures
and deleted the requirement that they be maintained by the Radiological Control Group; (4) delete the requirement
in Section 6.8.4.a for Radiological Control to implement and control the ODCM; (5) changed the review authority for
changes to the ODCM from the Radiological Assessment Review Committee (RARC) to the PORC and added a reference to Specification
6.5.1A in Section 6.14.1.2; (6) approval authority for deviations from the overtime guidelines in Section 6.2.2.g
would be changed to show that Plant Manager designee also has the authority; (7) PORC member titles would be changed
in accordance with the current organizational structure; (8) the requirements for the RARC would be deleted from
Sections 6.5.2.7.i, 6.5.3, 6.10.2.k and the index; (9) move the condenser inleakage monitoring requirement from
Section 6.8.5.c.(vii) to 6.8.5.c.(iii) and delete the requirement to repair, plug, or isolate leaks; (10) change
the title ``Shift Supervisor'' (SS) to ``Shift Operations Supervisor'' (SOS) in various locations in Section 6 and
in Operating License Items 2.C.(23).A and 2.C.(16).a for Units 1 and 2 respectively; (11) change the title of the Senior
Vice President, Nuclear Group, in Section 6.2.1 to Senior Vice President, Nuclear Power; (12) change the title of
the Operational Quality Assurance Program in Section 6.5.2.8.d to Nuclear Quality Assurance Program; and (13) move
the requirement for implementation of the Quality Assurance Program for environmental monitoring from Section
6.8.4.b to Section 6.8.1.h. Other administrative changes related to these changes were also submitted that affect
Section 6.0, the operating license, index, and definitions. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
TVA has evaluated the proposed technical specification (TS) change and has determined that it does not represent
a significant hazards consideration based on criteria established in 10 CFR 50.92(c). The operation of Sequoyah
Nuclear Plant (SQN) in accordance with the proposed amendment will not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed changes only affect the administrative controls found in Section 6.0 of the SQN TSs and the operating
license. No plant equipment or operating practices are affected by these changes. The revised administrative controls
will continue to adequately implement administrative activities to support plant nuclear safety. Since there are
no physical changes to the plant, there is no increase in the probability of an accident because these administrative
controls are not the source of previously evaluated accidents. Similarly, with no change to plant equipment or operating
requirements, the plant response to accident conditions and therefore the consequences of an accident remain unchanged.
These proposed changes will not increase the consequences of an accident and offsite dose rates will not be impacted.

<!-- PJG 0012 frnewline -->
2. Create the possibility of a new or different kind of accident from any previously analyzed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The administrative controls affected by the proposed changes are not considered to be the source of any accident and
these changes will not alter any plant features or processes. Therefore, the proposed changes will not create the
possibility of a new or different kind of accident and the administrative controls will continue to implement the
actions necessary to support plant activities and nuclear safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Plant features and setpoints remain unchanged by the proposed changes to the administrative controls. The margins
of safety established by the SQN design are not affected by these changes. The proposed administrative controls will
continue to maintain the actions and programs that ensure appropriate plant design, operation, and procedures to
support the required margin of safety. Therefore, the proposed changes will not reduce the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC has reviewed the licensee's analysis and, based on this
<!-- PJG 0012 frnewline -->
review, it appears that the three standards of 10 CFR 50.92(c) are 
<!-- PJG 0012 frnewline -->
satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant hazards
consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Chattanooga-Hamilton County Library,1101 Broad Street, Chattanooga, Tennessee 37402 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
General Counsel, Tennessee Valley Authority, 400 West Summit Hill Drive, ET 11H, Knoxville, Tennessee 37902
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Frederick J. Hebdon
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Wisconsin Electric Power Company, Docket Nos. 50-266 and 50-301, Point Beach Nuclear Plant, Unit Nos. 1 and 2, Town
of Two Creeks, Manitowoc County, Wisconsin
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
September 29, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendments would change the test intervals from monthly to quarterly, consistent with the Inservice
Test Program, for several pumps and related systems, including safety injection, residual heat removal and containment
spray pumps.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. The proposed amendments will not involve a significant increase in the probability or consequences of an accident
previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The addition of specific general considerations related to equipment surveillance requirements and their relationship
to equipment operability are administrative in nature. They do not change the interpretation or intent of the Technical
Specifications. These conditions are consistent with the Westinghouse Standard Technical Specifications (STS).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The addition of the specific requirement for the Inservice Test Program to Section 15.4.2 of the Technical Specifications
only reiterates the requirements of 10 CFR 50.55a(g). This requirement does not implement any new requirements on
the operation or testing of equipment. 
<!-- PJG 0012 frnewline -->
The decrease in the number of equipment operational transients due to the increase in the surveillance interval for
the Safety Injection System (SI), Residual Heat Removal (RHR) System, and Containment Spray (CS) System pumps and
valves will result in an increase in system availability. Reduced testing is also expected to have a positive affect
on overall equipment reliability since frequent testing results in increased wear and potential for equipment failure.
Other actions including a monthly verification of system lineups for the SI, CS and RHR systems provides increased
assurance of system operability between surveillance tests. The potential for equipment problems to go undetected
for a longer period of time is small as indicated by equipment surveillance history.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Therefore, these changes will not effect the probability or consequences of previously analyzed accidents.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The proposed amendments will not create the possibility of a new or different kind of accident from any accident
previously analyzed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
These changes only affect the equipment testing frequency. Equipment design, operation and the methods of testing
will not be changed. Therefore, the proposed changes cannot create the possibility of a new or different kind of accident
than any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The proposed amendments will not involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed changes which implement the requirements of 10 CFR 50.55a(g) and clarify the general considerations
related to equipment surveillances are administrative in nature. They do not change the intent of any existing license
or other requirement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The increase in equipment surveillance intervals will result in an improvement in equipment and system availability
and reliability. Surveillance of equipment will be performed as required by the regulations and Section XI of the
ASME Boiler and Pressure Vessel Code. These proposed changes will reduce the potential for equipment failures due
to unnecessary testing.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Adequate assurance is provided by testing in accordance with the ASME Code requirements and periodic verification
of system lineups to ensure that the affected systems remain operable and capable of performing their design function.
Therefore, a reduction in a margin of safety will not occur.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Joseph P. Mann Library, 1516 Sixteenth Street, Two Rivers, Wisconsin 54241.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Gerald Charnoff, Esq., Shaw, Pittman, Potts and Trowbridge, 2300 N Street, NW., Washington, DC 20037.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
John N. Hannon
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Wisconsin Public Service Corporation, Docket No. 50-305, Kewaunee Nuclear Power Plant, Kewaunee County, Wisconsin

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 1, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would revise the Kewaunee Nuclear Power Plant (KNPP) Technical Specifications (TS) by incorporating
technical and administrative changes to TS 3.10, Control Rod and Power Distribution Limits. The proposed changes
eliminate specifications for fuel designs no longer used at Kewaunee, specify required actions to be taken upon exceeding
control bank insertion limits, and revise the limits for Departure from Nucleate Boiling (DNB) related parameters
to assure operation within the assumptions of the Updated Safety Analysis Report (USAR) analyses.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
(a) TS 3.10.b.1, 3.10.b.4 and Table TS 3.10-2
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed changes were reviewed in accordance with the provisions of 10 CFR 50.92 to show no significant hazards
exist. The proposed changes will not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1) Involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed changes eliminate the specifications for fuel that is no longer used at the Kewaunee Nuclear Power Plant.
Eliminating these specifications does not affect the probability of any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The specifications for the current fuel vendor are being retained and ensure the consequences of previously evaluated
Departure from Nucleate Boiling (DNB) related accidents are enveloped by the Updated Safety Analysis Report (USAR)
analyses. Therefore, these changes will not increase the consequences of an accident previously evaluated in the
USAR.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2) Create the possibility of a new or different kind of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change does not alter the plant configuration, operating setpoints, or overall plant performance.
Therefore, it does not create the possibility of a new or different kind of accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3) Involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change deletes specifications for fuel that is no longer used at the Kewaunee Nuclear Power Plant. The
limits for the current fuel vendor are retained and are not affected by this proposed change. This does not alter the
input or assumptions of the safety analysis, and therefore it will not involve a reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) TS 3.10.d
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
The proposed change was reviewed in accordance with the provisions of 10 CFR 50.92 to show no significant hazards exist.
The proposed change will not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1) Involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change specifies the required actions to be taken when the control bank insertion limits are exceeded.
The current TS requires compliance with the control bank insertion limits, but gives no corrective action for when
these limits are exceeded. The new specification requires operators to initiate boration to restore shutdown margin
within one hour of exceeding the control bank insertion limits and to restore the control banks to within the limits
within 2 hours. If either of these requirements cannot be achieved, within 1 hour the operators must initiate actions
to achieve Hot Standby within the next 6 hours and Hot Shutdown within the following 6 hours. Adding these requirements
clarifies and enhances the Technical Specifications and will have no impact on the probability of an accident previously
evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed addition is conservative and ensures that proper and adequate measures are taken when the control bank
exceeds the control bank insertion limits. Therefore, this addition will not increase the consequences of an accident
previously evaluated in the USAR.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2) Create the possibility of a new or different kind of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change does not alter the plant configuration, operating setpoints, or overall plant performance.
Therefore, it does not create the possibility of a new or different kind of accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3) Involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change is conservative and clarifies the necessary actions to be taken when control bank insertion limits
are exceeded. This proposed change is an enhancement to the specification and does not reduce the margin of safety.

<!-- PJG 0012 frnewline -->
(c) TS 3.10.k
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change was reviewed in accordance with the provisions of 10 CFR 50.92 to show no significant hazards exist.
The proposed change will not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1) Involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change decreases the maximum RCS inlet temperature limit for steady state 100% operation from 536.5
degrees Fahrenheit to 535.5 degrees Fahrenheit. The value of 539.5 degrees Fahrenheit is the assumed RCS inlet temperature
for the DNB related accidents analyzed in the USAR. These accidents are the Uncontrolled Rod Cluster Control Assembly
Withdrawal at Power Accident, the Uncontrolled Rod Cluster Control Assembly Withdrawal from a Subcritical Condition
Accident, the Rod Cluster Control Assembly Misalignment, the Start-Up of an Inactive Reactor Coolant Loop Accident,
the Excessive Heat Removal due to Feedwater System Malfunction Accident, the Excessive Load Increase Incident,
the Loss of Reactor Coolant Flow Accident, the Loss of External Electrical Load, the Steam Line Break, and the Rod Cluster
Control Assembly Ejection. A four degree assumed instrument error reduces the maximum allowed RCS inlet temperature
to 535.5 degrees Fahrenheit. Decreasing this value to ensure consistency with the USAR analysis assumptions will
have no impact on the probability of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change is conservative to ensure that the consequences of a previously evaluated DNB-related accident
are enveloped by the USAR analysis. Therefore, this change will not increase the consequences of an accident previously
evaluated in the USAR.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2) Create the possibility of a new or different kind of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->
The proposed change does not alter the plant configuration, operating setpoints, or overall plant performance.
Therefore, it does not create the possibility of a new or different kind of accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3) Involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change is conservative and is consistent with the assumptions in the USAR. This proposed change is an
enhancement to the specification and does not reduce the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) TS 3.10.l
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change was reviewed in accordance with the provisions of 10 CFR 50.92 to show no significant hazards exist.
The proposed change will not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1) Involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change increased the minimum RCS pressure limit for steady-state 100% power operation from the currently
specified 2200 psig to 2205 psig. The value of 2205 psig (30 psig below the nominal design value of 2235 psig) was the
assumed initial condition for the DNB related accidents analyzed in the USAR. These accidents are the Uncontrolled
Rod Cluster Control Assembly Withdrawal at Power Accident, the Uncontrolled Rod Cluster Control Assembly Withdrawal
from a Subcritical Condition Accident, the Rod Cluster Control Assembly Misalignment, the Start-Up of an Inactive
Reactor Coolant Loop Accident, the Excessive Heat Removal due to Feedwater System Malfunction Accident, the Excessive
Load Increase Incident, the Loss of Reactor Coolant Flow Accident, the Loss of External Electrical Load, the Steam
Line Break, and the Rod Cluster Control Assembly Ejection. Increasing this value to ensure consistency with the USAR
analysis assumptions will have no impact on the probability of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change is conservative to ensure that the consequences of a previously evaluated DNB-related accident
is enveloped by the USAR analysis. Therefore, this change will not increase the consequences of an accident previously
evaluated in the USAR.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2) Create the possibility of a new or different kind of accident from any accident previously evaluated. 
<!-- PJG 0012 frnewline -->
The proposed change does not alter the plant configuration, operating setpoints, or overall plant performance.
Therefore, it does not create the possibility of a new or different kind of accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3) Involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change is conservative and is consistent with the assumptions in the USAR. This proposed change is an
enhancement to the specification and does not reduce the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) TS 3.10.m
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change was reviewed in accordance with the provisions of 10 CFR 50.92 to show no significant hazards exist.
The proposed change will not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1)Involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
TS 3.10.m.1 provides the limits and required actions to be taken when the RCS flow rate per loop is less than the USAR
analysis assumptions. Decreasing the flow limit to be consistent with the USAR assumptions will have no impact on
the probability of an accident previously evaluated. Compliance with the flow limit assumed in the USAR analyses
ensures the consequences of previously evaluated DNB-related accidents are enveloped by the USAR analyses. Therefore,
this change will not increase the consequences of an accident previously evaluated in the USAR.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed revision places an additional restriction on RCS flow when less than the design flow rate of 89,000 gallons
per minute per loop. The intent of specifying action in accordance with 3.10.n is to ensure that reactor power is reduced
to a point at which the DNB ratio margin is restored. Compliance with this specification will not increase the probability
of an accident previously evaluated, nor increase the consequences of an accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The intent of TS 3.10.m.2 is to clarify the conditions under which the reactor coolant flow rate is verified. The conditions,
methodology, and uncertainties associated with this verification are not changed by this specification. Clarifying
the TS by inclusion of the conditions for verifying the flow rate will not increase the probability or consequences
of any accident previously evaluated.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
2) Create the possibility of a new or different kind of accident from any accidents previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A new or different kind of accident from those previously evaluated will not be created by this TS change. The proposed
amendment does not alter the plant configuration, operating setpoints or overall plant performance. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3) Involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A specification on steady-state RCS flow rate is necessary to ensure DNB ratio criteria will be met during the DNBR
limiting events analyzed in the USAR. Reducing the reactor coolant flow limit to the value assumed in the USAR analyses
does not result in a reduction in the margin of safety. 
<!-- PJG 0012 frnewline -->
The additional restrictions being imposed if the specified limit is not met provide additional assurance the DNBR
margin will be restored. These additional restrictions do not exist in the current TS. The imposition of these restrictions
results in an enhancement to the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Clarifying the TS by inclusion of conditions under which the flow verification is to be performed will not reduce the
margin of safety. Existing approved constraints, methodology, and uncertainties are not being changed by this clarification.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(f) TS 3.10.n 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change was reviewed in accordance with the provisions of 10 CFR 50.92 to show no significant hazards exist.
The proposed change will not:
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
1) Involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The intent of this new TS is to outline the actions required when the limits of TS 3.10.k (RCS temperature), TS 3.10.l
(RCS pressure) and TS 3.10.m.1 (RCS flow) are exceeded. Collectively, these three specifications place limits on
the DNB-related parameters to assure each is maintained within the normal steady-state envelope assumed in the USAR
safety analysis. This specification is an enhancement to our existing specification to add clear guidance which
does not presently exist. Providing this information for the plant staff and operators will not increase the probability
of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The addition of this action statement will ensure that the consequences of an analyzed accident are not increased.
The proposed specification allows 2 hours to evaluate and restore parameters to within limits. If this time frame
is not satisfied, then within the next 6 hours, power is reduced in order to restore a margin of safety. Following analysis,
thermal power may be raised not to exceed a level analyzed to maintain a minimum DNBR of 1.30.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2) Create the possibility of a new or different kind of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed amendment does not alter the plant configuration, operating setpoints or overall plant performance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3) Involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Addition of the specification is an enhancement to the current specification which does not alter input to the safety
analysis. Therefore, it will not involve a reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(g) Administrative changes to Section TS 3.10 including Figure TS 3.10-2.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change was reviewed in accordance with the provisions of 10 CFR 50.92 to show no significant hazards exist.
The proposed changes will not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1) Involve a significant increase in the probability or consequences of an accident previously evaluated, or 
<!-- PJG 0012 frnewline -->
2) Create the possibility of a new or different kind of accident from any accident previously evaluated, or
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3) Involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed changes are administrative in nature and do not alter the intent or interpretation of the TS. Therefore,
no significant hazards exist.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
University of Wisconsin Library Learning Center, 2420 Nicolet Drive, Green Bay, Wisconsin 54301. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Bradley D. Jackson, Esq., Foley and Lardner, P. O. Box 1497, Madison, Wisconsin 53701-1497.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
John N. Hannon 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Wisconsin Public Service Corporation, Docket No. 50-305, Kewaunee Nuclear Power Plant, Kewaunee County, Wisconsin
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 7, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would revise Kewaunee Nuclear Power Plant (KNPP) Technical Specification (TS) 5.3.a.1 to
provide flexibility in the repair of fuel assemblies containing damaged and leaking fuel rods by reconstituting
the assemblies, provided that an NRC-approved methodology is used. This proposed change is consistent with guidance
provided in Supplement 1 to Generic Letter (GL) 90-02, ``Alternative Requirements for Fuel Assemblies in the Design
Features Section of Technical Specifications,'' dated July 21, 1992. In addition, administrative changes to KNPP
TS Section 5 have been proposed. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The proposed changes were revised in accordance with the provision of 10 CFR 50.92 to show no significant hazards exist.
The proposed changes will not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1) involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This proposed change to the requirements for ``Fuel Assemblies'' in the ``Design Features'' section of the KNPP TS
will not involve a significant increase in the probability or consequences of an accident previously evaluated.
This proposed change will not result in modifications to fuel assemblies that would have a significant effect on safety
because of the requirement to implement these changes using an NRC-approved methodology. This requirement will
confirm conformance to existing design limits and confirm that safety analyses criteria are met before operation
during the next fuel cycle. This license amendment request is consistent with guidance provided by the NRC and will
result in flexibility for improved fuel performance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2) create the possibility of a new or different kind of accident from any accident previously evaluated. 
<!-- PJG 0012 frnewline -->
The creation of new or different kind of accident from any previously evaluated accident is not considered a possibility
because the changes are administrative in nature and do not represent an actual modification to the plant or change
its safety analyses.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3) involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The margin of safety is maintained by adherence to other fuel related TS limits and the USAR design bases. The changes
do not directly affect any safety system or the safety limits, and thus does not affect the plant margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Accordingly, these proposed changes do not involve a significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
University of Wisconsin Library Learning Center, 2420 Nicolet Drive, Green Bay, Wisconsin 54301. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Bradley D. Jackson, Esq., Foley and Lardner, P. O. Box 1497, Madison, Wisconsin 53701-1497.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
John N. Hannon
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice Of Issuance Of Amendments To Facility Operating Licenses
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
During the period since publication of the last biweekly notice, the Commission has issued the following amendments.
The Commission has determined for each of these amendments that the application complies with the standards and requirements
of the Atomic Energy Act of 1954, as amended (the Act), and the Commission's rules and regulations. The Commission
has made appropriate findings as required by the Act and the Commission's rules and regulations in 10 CFR Chapter I,
which are set forth in the license amendment. 
<!-- PJG 0012 frnewline -->
Notice of Consideration of Issuance of Amendment to Facility Operating License, Proposed No Significant Hazards
Consideration Determination, and Opportunity for A Hearing in connection with these actions was published in the

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
as indicated.
<!-- PJG 0012 frnewline -->
Unless otherwise indicated, the Commission has determined that these amendments satisfy the criteria for categorical
exclusion in accordance with 10 CFR 51.22. Therefore, pursuant to 10 CFR 51.22(b), no environmental impact statement
or environmental assessment need be prepared for these amendments. If the Commission has prepared an environmental
assessment under the special circumstances provision in 10 CFR 51.12(b) and has made a determination based on that
assessment, it is so indicated. 
<!-- PJG 0012 frnewline -->
For further details with respect to the action see (1) the applications for amendment, (2) the amendment, and (3) the
Commission's related letter, Safety Evaluation and/or Environmental Assessment as indicated. All of these items
are available for public inspection at the Commission's Public Document Room, the Gelman Building, 2120 L Street,
NW., Washington, DC 20555, and at the local public document rooms for the particular facilities involved. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Carolina Power &amp; Light Company, et al., Docket Nos. 50-325 and 50-324, Brunswick Steam Electric Plant, Units
1 and 2, Brunswick County, 
<!-- PJG 0012 frnewline -->
North Carolina
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
October 19, 1993 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendments change the Technical Specifications (TS) add a footnote to TS 4.6.1.2.b that allows a one-time exemption
from the accelerated containment integrated leak rate test (CILRT) requirements to return the CILRT frequency for
both units to a normal Type A test interval.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 11, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 11, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment Nos.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
167 and 198
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-71 and DPR-62. Amendments revise the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
November 10, 1993 (58 FR 59745) The Commission's related evaluation of the amendments is contained in a Safety Evaluation
dated January 11, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
University of North Carolina at Wilmington, William Madison Randall Library, 601 S. College Road, Wilmington, North
Carolina 28403-3297.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Duke Power Company, Docket Nos. 50-269, 50-270, and 50-287, Oconee Nuclear Station, Units 1, 2, and 3, Oconee County,
South Carolina
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 3, 1993, as supplemented August 11, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendments revise the limiting conditions for operation and surveillance requirements related to the Low Pressure
Service Water System.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 13, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To be implemented within 30 days from the date of issuance.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment Nos.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 203, 203, and 200
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-38, DPR-47, and DPR-55: The amendments revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
October 13, 1993 (58 FR 52983) The Commission's related evaluation of the amendments is contained in a Safety Evaluation
dated January 13, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Oconee County Library, 501 West South Broad Street, Walhalla, South Carolina 29691
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Entergy Operations, Inc., Docket No. 50-368, Arkansas Nuclear One,
<!-- PJG 0012 frnewline -->
Unit No. 2, Pope County, Arkansas
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
October 27, 1993 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment relocated the requirement of Technical Specification 4.5.2.g.1 to verify the correct position of
each electrical and/or mechanical position stop for the Emergency Core Cooling System throttle valves within 4 hours
of each valve stroking operation or maintenance on the valve, to procedures that control the maintenance and operation
of these valves.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 14, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To be implemented within 30 days from the date of issuance.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 155 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-6. Amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 8, 1993 (58 FR 64606) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated January 14, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Tomlinson Library, Arkansas Tech University, Russellville, Arkansas 72801
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Entergy Operations, Inc., System Energy Resources, Inc., South Mississippi Electric Power Association, and Mississippi
Power &amp; Light Company, Docket No. 50-416, Grand Gulf Nuclear Station, Unit 1, Claiborne County, Mississippi
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 11, 1993 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment changed the Grand Gulf Nuclear Station Technical Specifications to support compliance with the new
requirements of Title 10 Code of Federal Regulations Part 20 and Part 50.36a. The request to change the wording of TS
1.46 which relates to the definition of an UNRESTRICTED AREA remains under consideration and will be the subject of
a future licensing action.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 10, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 10, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No: 111 
<!-- PJG 0012 frnewline -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-29. Amendment revises the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
September 1, 1993 (58 FR 46233) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated January 10, 1994. 
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Judge George W. Armstrong Library, Post Office Box 1406, S. Commerce at Washington, Natchez, Mississippi 39120.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
North Atlantic Energy Service Corporation, Docket No. 50-443, Seabrook Station, Unit No. 1, Rockingham County,
New Hampshire
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 27, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment changes the footnote on page 1 of License NPF-86 by deleting Vermont Electric Generation and Transmission
Cooperative, Inc., (Vermont), as one of the entities for which North Atlantic Energy Service Corporation (North
Atlantic) is authorized to act. The change reflects the purchase of Vermont's share of the Seabrook Station, Unit
1 by North Atlantic Energy Corporation (NAEC) pursuant to a prior settlement of a claim by Vermont against Public Service
Company of New Hampshire (PSNH). NAEC acquired PSNH's interest in the Seabrook Station, Unit 1 in accordance with
the Plan for Reorganization for PSNH.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 7, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To be implemented by May 30, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 28
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-86. Amendment revised the License.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
October 13, 1993 
<!-- PJG 0012 frnewline -->
(58 FR 52990). The Commission's related evaluation of the amendment is contained in a Safety Evaluation dated January
7, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Exeter Public Library, 47 Front Street, Exeter, New Hampshire 03833.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Omaha Public Power District, Docket No. 50-285, Fort Calhoun Station, Unit No. 1, Washington County, Nebraska
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
October 7, 1992 as supplemented July 12, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment changed the setpoint limit for the degraded-voltage protection system referred to as the offsite-power
low signal.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 14, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 14, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 159
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-40. Amendment revised the TechnicalSpecifications.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
November 25, 1992 (57 FR 55584) The additional information contained in the supplemental letter dated July 12, 1993,
was clarifying in nature and, thus, within the scope of the initial notice and did not affect the staff's proposed no
significant hazards consideration determination. The Commission's related evaluation of the amendment is contained
in a Safety Evaluation dated January 14, 1994. 
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
W. Dale Clark Library, 215 South 15th Street, Omaha, Nebraska 68102
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Omaha Public Power District, Docket No. 50-285, Fort Calhoun Station, Unit No. 1, Washington County, Nebraska
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
September 15, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revised the Technical Specifications (TSs) by implementing Generic Letters (GLs) 86-10 and 88-12.
This removed the fire protection TSs and placed these parts in the Updated Safety Analysis Report (USAR). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 14, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 14, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 160
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-40. Amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
November 10, 1993 (58 FR 59753) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated January 14, 1994. 
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
W. Dale Clark Library, 215 South 15th Street, Omaha, Nebraska 68102
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Philadelphia Electric Company, Docket No. 50-352, Limerick Generating Station, Unit 1, Montgomery County, Pennsylvania.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 3, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This amendment removes shutdown system control valves and primary containment isolation valves from TS Tables 3.3.7.4-1,
``Remote Shutdown Instrumentation and Controls,'' and 3.6.3-1, ``Primary Containment Isolation Valves,'' as
a result of eliminating the steam condensing mode of the Residual Heat Removal system. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 12, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 12, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
65
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-39. This amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
September 29, 1993 (58 FR 50969) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated January 12, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pottstown Public Library, 500 High Street, Pottstown, Pennsylvania 19464.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Power Authority of The State of New York, Docket No. 50-286, Indian Point Nuclear Generating Unit No. 3, Westchester
County, New York 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 21, 1993, as supplemented October 7, 1993, and December 3, 1993 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revised the Technical Specifications (TSs) to incorporate the following changes:
<!-- PJG 0012 frnewline -->
(1) The safety injection system test frequency (specified in TS Section 4.5.A.1.a) was changed to accommodate operation
on a 24-month cycle.
<!-- PJG 0012 frnewline -->
(2) The loss of normal AC in conjunction with a safety injection signal test frequency (specified in TS Section 4.6.A.3)
was changed to accommodate operation on a 24-month cycle. This TS section was also reformatted to improve clarity.
<!-- PJG 0012 frnewline -->
(3) The auxiliary feedwater system undervoltage automatic start test frequency (specified in TS Table 4.1-1) was
changed to accommodate operation on a 24-month cycle.
<!-- PJG 0012 frnewline -->
(4) The auxiliary feedwater system main feedwater pump trip automatic start test frequency (specified in TS Table
4.1-1) was changed to accommodate operation on a 24-month cycle.
<!-- PJG 0012 frnewline -->
In addition, quarterly testing and 24-month calibration requirements were added to TS Table 4.1-1 for the main steam
line flow instrumentation. These surveillances were added to ensure operability of the main steam line flow circuits
and to be consistent with the TSs surveillance requirements for other engineered safety features instruments.
<!-- PJG 0012 frnewline -->
These changes followed the guidance provided in Generic Letter 91-04, ``Changes in Technical Specification Surveillance
Intervals to Accommodate a 24-Month Fuel Cycle.''
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 11, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As of the date of issuance to be implemented within 30 days.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 142
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-64: Amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 4, 1993 (58 FR 41510)
<!-- PJG 0012 frnewline -->
The Commission's related evaluation of the amendment is contained in a Safety Evaluation dated January 11, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
White Plains Public Library, 100 Martine Avenue, White Plains, New York 10610.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Power Authority of The State of New York, Docket No. 50-286, Indian Point Nuclear Generating Unit No. 3, Westchester
County, New York 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
October 29, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revises Technical Specifications (TSs) Sections 3.10 (Control Rods and Power Distribution Limits)
and 4.2 (Inservice Inspections) to correct administrative errors that resulted from the issuance of TS Amendment
Nos. 57 and 103. The amendment corrects the errors and further clarifies the TS.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 12, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As of the date of issuance to be implemented within 30 days.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
143
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-64: Amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 8, 1993 (58 FR 64615) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated January 12, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
White Plains Public Library, 100 Martine Avenue, White Plains, New York 10610.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
The Cleveland Electric Illuminating Company, Centerior Service Company, Duquesne Light Company, Ohio Edison Company,
Pennsylvania Power Company, Toledo Edison Company, Docket No. 50-440, Perry Nuclear Power Plant, Unit No. 1, Lake
County, Ohio
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
October 30, 1991
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revised Technical Specification 3.1.3.2, ``Control Rod Maximum Scram Insertion Times,'' to clarify
the conditions under which the plant must be shut down in the event that individual control rod scram insertion times
exceed the allowable values.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 19, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 19, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
54
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-58. This amendment revised the Technical Specifications. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 11, 1991 (56 FR 64651) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated January 19, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Perry Public Library, 3753 Main Street, Perry, Ohio 44081
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice Of Issuance Of Amendments To Facility Operating Licenses And Final Determination Of No significant Hazards
Consideration And Opportunity For A Hearing (Exigent Public Announcement Or Emergency Circumstances)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
During the period since publication of the last biweekly notice, the Commission has issued the following amendments.
The Commission has determined for each of these amendments that the application for the amendment complies with the
standards and requirements of the Atomic Energy Act of 1954, as amended (the Act), and the Commission's rules and regulations.
The Commission has made appropriate findings as required by the Act and the Commission's rules and regulations in
10 CFR Chapter I, which are set forth in the license amendment. 
<!-- PJG 0012 frnewline -->
Because of exigent or emergency circumstances associated with the date the amendment was needed, there was not time
for the Commission to publish, for public comment before issuance, its usual 30-day Notice of Consideration of Issuance
of Amendment, Proposed No Significant Hazards Consideration Determination, and Opportunity for a Hearing. 
<!-- PJG 0012 frnewline -->
For exigent circumstances, the Commission has either issued a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
notice providing opportunity for public comment or has used local media to provide notice to the public in the area
surrounding a licensee's facility of the licensee's application and of the Commission's proposed determination
of no significant hazards consideration. The Commission has provided a reasonable opportunity for the public to
comment, using its best efforts to make available to the public means of communication for the public to respond quickly,
and in the case of telephone comments, the comments have been recorded or transcribed as appropriate and the licensee
has been informed of the public comments.
<!-- PJG 0012 frnewline -->
In circumstances where failure to act in a timely way would have resulted, for example, in derating or shutdown of a
nuclear power plant or in prevention of either resumption of operation or of increase in power output up to the plant's
licensed power level, the Commission may not have had an opportunity to provide for public comment on its no significant
hazards consideration determination. In such case, the license amendment has been issued without opportunity for
comment. If there has been some time for public comment but less than 30 days, the Commission may provide an opportunity
for public comment. If comments have been requested, it is so stated. In either event, the State has been consulted
by telephone whenever possible.
<!-- PJG 0012 frnewline -->
Under its regulations, the Commission may issue and make an amendment immediately effective, notwithstanding the
pendency before it of a request for a hearing from any person, in advance of the holding and completion of any required
hearing, where it has determined that no significant hazards consideration is involved. 
<!-- PJG 0012 frnewline -->
The Commission has applied the standards of 10 CFR 50.92 and has made a final determination that the amendment involves
no significant hazards consideration. The basis for this determination is contained in the documents related to
this action. Accordingly, the amendments have been issued and made effective as indicated. 
<!-- PJG 0012 frnewline -->
Unless otherwise indicated, the Commission has determined that these amendments satisfy the criteria for categorical
exclusion in accordance with 10 CFR 51.22. Therefore, pursuant to 10 CFR 51.22(b), no environmental impact statement
or environmental assessment need be prepared for these amendments. If the Commission has prepared an environmental
assessment under the special circumstances provision in 10 CFR 51.12(b) and has made a determination based on that
assessment, it is so indicated.
<!-- PJG 0012 frnewline -->
For further details with respect to the action see (1) the application for amendment, (2) the amendment to Facility
Operating License, and (3) the Commission's related letter, Safety Evaluation and/or Environmental Assessment,
as indicated. All of these items are available for public inspection at the Commission's Public Document Room, the
Gelman Building, 2120 L Street, NW., Washington, DC 20555, and at the local public document room for the particular
facility involved. 
<!-- PJG 0012 frnewline -->
The Commission is also offering an opportunity for a hearing with respect to the issuance of the amendment. By March
4, 1994, the licensee may file a request for a hearing with respect to issuance of the amendment to the subject facility
operating license and any person whose interest may be affected by this proceeding and who wishes to participate as
a party in the proceeding must file a written request for a hearing and a petition for leave to intervene. Requests for
a hearing and a petition for leave to intervene shall be filed in accordance with the Commission's ``Rules of Practice
for Domestic Licensing Proceedings'' in 10 CFR Part 2. Interested persons should consult a current copy of 10 CFR 2.714
which is available at the Commission's Public Document Room, the Gelman Building, 2120 L Street, NW., Washington,
DC 20555 and at the local public document room for the particular facility involved. If a request for a hearing or petition
for leave to intervene is filed by the above date, the Commission or an Atomic Safety and Licensing Board, designated
by the Commission or by the Chairman of the Atomic Safety and Licensing Board Panel, will rule on the request and/or
petition; and the Secretary or the designated Atomic Safety and Licensing Board will issue a notice of a hearing or
an appropriate order. 
<!-- PJG 0012 frnewline -->
As required by 10 CFR 2.714, a petition for leave to intervene shall set forth with particularity the interest of the
petitioner in the proceeding, and how that interest may be affected by the results of the proceeding. The petition
should specifically explain the reasons why intervention should be permitted with particular reference to the following
factors: (1) the nature of the petitioner's right under the Act to be made a party to the proceeding; (2) the nature and
extent of the petitioner's property, financial, or other interest in the proceeding; and (3) the possible effect
of any order which may be entered in the proceeding on the petitioner's interest. The petition should also identify
the specific aspect(s) of the subject matter of the proceeding as to which petitioner wishes to intervene. Any person
who has filed a petition for leave to intervene or who has been admitted as a party may amend the petition without requesting
leave of the Board up to 15 days prior to the first prehearing conference scheduled in the proceeding, but such an amended
petition must satisfy the specificity requirements described above. 
<!-- PJG 0012 frnewline -->
Not later than 15 days prior to the first prehearing conference scheduled in the proceeding, a petitioner shall file
a supplement to the petition to intervene which must include a list of the contentions which are sought to be litigated
in the matter. Each contention must consist of a specific statement of the issue of law or fact to be raised or controverted.
In addition, the petitioner shall provide a brief explanation of the bases of the contention and a concise statement
of the alleged facts or expert opinion which support the contention and on which the petitioner intends to rely in proving
the contention at the hearing. The petitioner must also provide references to those specific sources and documents
of which the petitioner is aware and on which the petitioner intends to rely to establish those facts or expert opinion.
Petitioner must provide sufficient information to show that a genuine dispute exists with the applicant on a material
issue of law or fact. Contentions shall be limited to matters within the scope of the amendment under consideration.
The contention must be one which, if proven, would entitle the petitioner to relief. A petitioner who fails to file
such a supplement which satisfies these requirements with respect to at least one contention will not be permitted
to participate as a party. 
<!-- PJG 0012 frnewline -->
Those permitted to intervene become parties to the proceeding, subject to any limitations in the order granting leave
to intervene, and have the opportunity to participate fully in the conduct of the hearing, including the opportunity
to present evidence and cross-examine witnesses. Since the Commission has made a final determination that the amendment
involves no significant hazards consideration, if a hearing is requested, it will not stay the effectiveness of the
amendment. Any hearing held would take place while the amendment is in effect. 
<!-- PJG 0012 frnewline -->
A request for a hearing or a petition for leave to intervene must be filed with the Secretary of the Commission, U.S.
Nuclear Regulatory Commission, Washington, DC 20555, Attention: Docketing and Services Branch, or may be delivered
to the Commission's Public Document Room, the Gelman Building, 2120 L Street, NW., Washington, DC 20555, by the above
date. Where petitions are filed during the last 10 days of the notice period, it is requested that the petitioner promptly
so inform the Commission by a toll-free telephone call to Western Union at 1-(800) 248-5100 (in Missouri 1-(800) 342-6700).
The Western Union operator should be given Datagram Identification Number N1023 and the following message addressed
to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
(Project Director)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: petitioner's name and telephone number, date petition was mailed, plant name, and publication date and page number
of this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
notice. A copy of the petition should also be sent to the Office of the General Counsel, U.S. Nuclear Regulatory Commission,
Washington, DC 20555, and to the attorney for the licensee. 
<!-- PJG 0012 frnewline -->
Nontimely filings of petitions for leave to intervene, amended petitions, supplemental petitions and/or requests
for a hearing will not be entertained absent a determination by the Commission, the presiding officer or the Atomic
Safety and Licensing Board that the petition and/or request should be granted based upon a balancing of the factors
specified in 10 CFR 2.714(a)(1)(i)-(v) and 2.714(d).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Commonwealth Edison Company, Docket No. 50-265, Quad Cities Nuclear Power Station, Unit 2, Rock Island County, Illinois
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
October 29, 1993, as supplemented by letters dated December 22, 1993 and January 14, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The license amendment dispositions Unreviewed Safety Questions (USQ) related to proposed plant modifications
associated with reactor vessel water level instrumentation. These modifications have been initiated to mitigate
the circumstances outlined in NRC Bulletin 93-03, ``Resolutions of Issues Related to Reactor Vessel Water Level
Instrumentation in BWRs.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 19, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 19, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
139
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-30. 
<!-- PJG 0012 frnewline -->
Public comments requested as to proposed no significant hazards consideration: No.
<!-- PJG 0012 frnewline -->
The Commission's related evaluation of the amendment, finding of emergency circumstances, and final determination
of no significant hazards consideration are contained in a Safety Evaluation dated January 19, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Michael I. Miller, Esquire; Sidley and Austin, One First National Plaza, Chicago, Illinois 60690
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Dixon Public Library, 221 Hennepin Avenue, Dixon, Illinois 61021. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
James E. Dyer
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated at Rockville, Maryland, this 26th day of January 1994.
<!-- PJG 0012 frnewline -->
For the Nuclear Regulatory Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John N. Hannon, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Division of Reactor Projects - III/IV/V, Office of Nuclear Reactor Regulation
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[Doc. 94-2174 Filed 2-1-94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7590-01-F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00073 </DOCNO>
<PARENT> FR940202-2-00055 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>OFFICE OF MANAGEMENT AND BUDGET</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of Federal Procurement Policy</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Management Oversight of Service Contracting
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Executive Office of the President, Office of Management and Budget, Office of Federal Procurement Policy (OFPP).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
OFPP is requesting comments on proposed changes to OFPP Policy Letter 93&hyph;1, ``Management Oversight of Service
Contracting'' which are set forth in Supplement No. 1 to the Policy Letter.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
OFPP Policy Letter 93&hyph;1, ``Management Oversight of Service Contracting,'' was signed by the former OFPP Administrator
on November 19, 1993 and published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 on December 2, 1993 (58 FR 63593).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Policy Letter is now being revised with a goal of establishing a more ``results-oriented'' approach to providing
agencies with best practices to use in managing and administering service contracts. The initial guidance neither
prescribes specific improvements that agencies can make in this area nor ways that results can be measured. During
this Administration, OFPP's activities will focus on two major objectives: streamlining the procurement process
and achieving excellence in contractor performance. We believe that one way to improve contractor performance is
to improve contract management and administration. In this regard, we plan to work with the agencies and industry
to develop practices that represent best value in contract management and administration. This approach is in keeping
with the National Performance Review principle of providing guiding principles rather than rigid rules. Hence,
we are revising the Policy Letter, in particular sections 8a and 8b, to reflect this new approach. Agencies are encouraged
to begin developing implementation strategies and initiating staff training to ensure effective implementation
of the provisions of this revised Policy Letter until the Federal Acquisition Regulation (FAR) is changed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Since the December 2, 1993 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice which also included the rescission of OMB Circular No. A&hyph;120, some agencies have raised concerns that
the rescission of the Circular was effective immediately but the Policy Letter was not effective until 30 days after
publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. (OFPP has a statutory requirement to allow 30 days before any procurement policy can become effective.) We understand
the concern, but it was our intent to make the rescission of Circular A&hyph;120 effective immediately, although
we realize that it takes time to have the FAR guidance changed. In the interim, agencies are encouraged to review their
internal procedures for managing and controlling the use of advisory and assistance services and determine what
changes may be needed to ensure compliance with this revised Policy Letter. Some agencies may elect to use their existing
management control procedures for all services covered by the Policy Letter until the FAR guidance is in place.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We are issuing the following changes to the Policy Letter which are included in the attached Supplement No. 1:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. The second sentence under section 4 (Definition) is being revised to clarify that only nonpersonal services obtained
under contract from the private sector (i.e., business firms, educational institutions, non-profits, and state
and local governments) are covered. Services obtained through the use of interagency agreements are not covered
by this Policy Letter.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The second paragraph under section 5 (Exclusions) is revised to delete reference to the management oversight responsibilities
which will be consistent with the revised paragraphs 8a. and 8b.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The second introductory paragraph under section 7 (Good Management Practices) is being revised to delete reference
to the requirement for individual and class reviews, and the reference to the responsible management official. Agencies
must ensure that they are in compliance with appropriate OFPP Policy Letters applicable to service contracting and
use good management practices and contract administration techniques when contracting for services.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00074 </DOCNO>
<PARENT> FR940202-2-00055 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. Paragraphs a. and b. under Section 8 (Responsibilities) are being revised in their entirety to incorporate the
new ``best practices'' approach to managing and administering service contracts. 
<!-- PJG 0012 frnewline -->
5. Paragraph d. under section 8, which pertains to the Inspectors General, is being revised to ensure that any reviews
are simply to ensure that agencies are in compliance with the revised Policy Letter.
<!-- PJG 0012 frnewline -->
The guidance in section 7 which refers to the questions in the appendix A, and any resulting ``best practices'' models
developed by OFPP in contract administration should not be viewed as mandatory regulatory guidance for audit purposes.
We believe that agencies should use the questions as warning signals to prevent problems from occurring and the ``best
practices'' models to help resolve those problems.
<!-- PJG 0012 frnewline -->
All other provisions of the policy Letter remain unchanged.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
COMMENT DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments must be received on or before March 4, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments should be sent to Dr. Steven Kelman, Administrator, Office of Federal Procurement Policy, Office of Management
and Budget, Old Executive Office Building, room 352, Washington, DC 20503.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Linda G. Williams, Deputy Associate Administrator, 202&hyph;395&hyph;3302.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Government Procurement.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Steven Kelman,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Administrator.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00075 </DOCNO>
<PARENT> FR940202-2-00055 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Policy Letter 93&hyph;1, Supplement No. 1
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
To the Heads of Executive Departments and Agencies
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Subject: Management Oversight of Service Contracting.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The purpose of this supplement to Policy Letter 93&hyph;1 is to provide agencies with a more ``results-oriented''
approach to managing and administering service contracts by introducing the ``best practices'' concept. The Policy
Letter was issued on November 19, 1993 and published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 on December 2, 1993 (58 FR 63593).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The following changes are being made to the Policy Letter:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Section 4. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Definition.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 The second sentence is revised to read: For purposes of this Policy Letter, only nonpersonal services obtained under
contract are covered.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Section 5. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Exclusions.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 The second paragraph is revised to read:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Services obtained under contracts below the small purchase threshold, through the use of interagency agreements,
and that are incidental to supply contracts also are excluded from coverage of this Policy Letter. However, agencies
should ensure that they are in compliance with appropriate OFPP Policy Letters applicable to service contracting
and use good management practices and contract administration techniques when using these contracting methods
to obtain services.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Section 7. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Good Management Practices.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 The second introductory paragraph is revised to read:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The following sections offer guidance to ensure that good management practices are being followed. Agencies should
involve procurement and program officials when developing requirements for service contracts. Appendix A contains
a series of questions to help analyze and perfect service contract requirements within these guidelines. If the guidelines
apply, and if the response to any of the questions listed in the Appendix is affirmative, agencies should ensure that
they are in compliance with appropriate OFPP Policy Letters applicable to service contracting and use good management
practices and contract administration techniques.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Section 8. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Responsibilities.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Paragraphs a., b., and d. are revised to read:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. Heads of Agencies. Agency heads (or their designees) should ensure that:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) Requirements for services are clearly defined and appropriate performance standards are developed so that contractor
performance meets contract terms and conditions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Service contracts are awarded and administered in such a manner that will provide the customer its goods and services
on time, and within budget.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Specific procedures are in place when contracting for services to assure compliance with OFPP Policy Letter 92&hyph;1,
Inherently Governmental Functions (57 FR 45096 (1992), 91&hyph;2, Service Contracting (56 FR 15110 (1991), and
89&hyph;1, Conflicts of Interest Policies Applicable to Consultants, 54 FR 51805 (1989).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) Implementation strategies are developed and necessary staff training is initiated to assure effective implementation
of these policies.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. Contracting Officials. Contracting officials should ensure that ``best practice'' techniques, such as those
set forth below, are used when contracting for services:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The corporate experience section of a contractor's bid proposal should be reviewed to detect conflicts of interest.
Usually, the corporate experience section contains the contractor's prior business clients.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Monthly progress reports should be reviewed to detect whether the contractor may be performing inherently governmental
functions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Contracting officials should also seek other best practices techniques in contract management and administration
that may be used within their own contracting activities or other agencies that will help to achieve excellence in
contractor performance. OFPP will also be working to develop governmentwide ``best practices'' models in contract
administration which will be issued as separate guidance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
d. Inspectors General. The Inspectors General are encouraged to conduct vulnerability assessments of service contracting
and, where warranted, include in their annual plans a review of service contracts to ensure compliance with the Policy
Letter.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The guidance in section 7 which refers to the questions in appendix A, and any resulting ``best practices'' models
developed by OFPP should not be viewed as mandatory regulatory guidance for audit purposes.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
All other provisions of the Policy Letter remain unchanged.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Information Contact.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 For information regarding this Supplement, contact Linda G. Williams, Deputy Associate Administrator, Office
of Federal Procurement Policy, 725 17th Street, NW., room 9001, Washington, DC 20503. Telephone (202) 395&hyph;3302.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Effective Date.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 This supplement is effective 30 days after the date of publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Steven Kelman,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Administrator.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2356 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3110&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00076 </DOCNO>
<PARENT> FR940202-2-00056 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>PENSION BENEFIT GUARANTY CORPORATION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Disaster Relief</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Pension Benefit Guaranty Corporation.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of disaster relief in response to Los Angeles earthquake.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Pension Benefit Guaranty Corporation is waiving penalties for certain late payments of premiums, is forgoing
assessment of penalties for failure to comply with certain information submission requirements, and is extending
the deadlines for complying with certain requirements of its administrative review and standard termination regulations.
This relief is generally available to persons residing in, or whose principal place of business is within, an area
designated by the Federal Emergency Management Agency as affected by the major disaster declared by the President
of the United States on account of the severe earthquake in the Los Angeles area.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Harold J. Ashner, Assistant General Counsel, or Renae R. Hubbard, Special Counsel, Office of the General Counsel,
suite 340, Pension Benefit Guaranty Corporation, 1200 K Street NW., Washington, DC 20005, 202&hyph;326&hyph;4024
(202&hyph;326&hyph;4179 for TTY and TDD). (These are not toll-free numbers.)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Pension Benefit Guaranty Corporation (``PBGC'') administers the pension plan termination insurance program
under title IV of the Employee Retirement Income Security Act of 1974, as amended (``ERISA''), 29 U.S.C. 1001 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
et seq
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
. Under ERISA and the PBGC's regulations, a number of deadlines must be met in order to avoid the imposition of penalties
or other consequences. Four areas in which the PBGC is providing relief are (1) penalties for late payment of premiums
due the PBGC, (2) ERISA section 4071 penalties for failure to provide required notices or other material information
by the applicable time limit, (3) deadlines for filing a standard termination notice and distributing plan assets
in a standard termination, and (4) deadlines for filing requests for reconsideration or appeals of certain agency
determinations.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The President of the United States has declared, under the Disaster Relief Act of 1974, as amended (42 U.S.C. 5121,
5122(2), 5141(b)), that a major disaster exists because of the severe earthquake that struck the Los Angeles area
on January 17, 1994. At this time, three California counties (Los Angeles, Ventura, and Orange) are designated areas
(within the meaning of Federal Emergency Management Agency (FEMA'') regulations; 44 CFR 205.2(a)(5)).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00077 </DOCNO>
<PARENT> FR940202-2-00056 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Given the severity of this major disaster, as the Executive Director of the PBGC, I have decided to provide relief from
certain PBGC deadlines and penalties. For purposes of premium penalties, section 4071 penalties, and standard termination
deadlines, this notice is applicable with respect to plans whose administrators' or sponsors' principal place of
business, or for which the office of a service provider, bank, insurance company, or other person maintaining information
necessary to meet the applicable deadlines, is located in a designated disaster area. For purposes of filing requests
for reconsideration or appeals, this notice is applicable to any aggrieved person who is residing in, or whose principal
place of business is within, a designated disaster area, or with respect to whom the office of the service provider,
bank, insurance company, or other person maintaining the information necessary to file the request for reconsideration
or appeal is within such an area. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Premiums
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The PBGC will waive the late payment penalty charge with respect to any premium payment required to be made on or after
January 15, 1994, and before March 15, 1994, if the payment is made by March 15, 1994. The PBGC is not permitted by law
to waive late payment interest charges. (ERISA section 4007(b); 29 CFR 2610.7 and 2610.8(b)(3).)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Section 4071 Penalties
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The PBGC will not assess a section 4071 penalty for a failure to file any of the following notices that were, or will be,
required to be filed with the PBGC on or after January 15, 1994, and before March 15, 1994, if the notice is filed by March
15, 1994:
<!-- PJG 0012 frnewline -->
Standard termination post-distribution certification (PBGC Form 501; ERISA section 4041(b)(3)(B); 29 CFR 2617.28(h)
(57 FR 59206, 59233&hyph;34, December 14, 1992);
<!-- PJG 0012 frnewline -->
(2) Notice of termination for multiemployer plans (ERISA section 4041A; 29 CFR 2673.2);
<!-- PJG 0012 frnewline -->
(3) Notice of plan amendments increasing benefits by more than $10 million (ERISA section 307(e)); and
<!-- PJG 0012 frnewline -->
(4) Reportable event notice, except for reportable events related to bankruptcy or insolvency (or similar proceeding
or settlement), liquidation or dissolution, and transactions involving a change in contributing sponsor or controlled
group (ERISA section 4043; 29 CFR 2615.21, 2615.22, and 2615.23).
<!-- PJG 0012 frnewline -->
The PBGC will not assess a section 4071 penalty for a failure to provide certain supporting information and documentation
when any of the following notices is timely filed:
<!-- PJG 0012 frnewline -->
(1) Notice of failure to make required contributions totaling more than $1 million (including interest) (PBGC Form
200; ERISA section 302(f)(4); 29 CFR 2615.30), and
<!-- PJG 0012 frnewline -->
(2) Notice of a reportable event related to bankruptcy or insolvency (or similar proceeding or settlement), liquidation
or dissolution, or a transaction involving a change in contributing sponsor or controlled group. For a notice of failure
to make required contributions, the timely filed notice must include at least items 1 through 7 and items 11 and 12 of
Form 200; the responses to items 8 through 10, with the certifications in items 11 and 12, may be filed late. For a reportable
event notice, the timely filed notice must include at least the information specified in 29 CFR 2615.3(b) (1) through
(5); the information that may be filed late is that specified in 29 CFR 2615.3(b) (6) through (9) and 2615.3(c) (5) and
(6), as applicable. This relief applies to notices that were, or will be, required to be filed with the PBGC on or after
January 15, 1994, and before March 15, 1994, provided that all supporting information and documentation are filed
by March 15, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Standard Termination Notice and Distribution of Assets
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
With respect to a standard termination for which the standard termination notice is required to be filed, or the distribution
of plan assets is required to be completed, on or after January 15, 1994, the PBGC is extending to March 15, 1994, the
time within which the standard termination notice must be filed (and, thus, the time within which notices of plan benefits
must be provided) and the time within which the distribution of plan assets must be completed. In addition, as noted
above, the PBGC is providing relief from penalties for late filing of the post-distribution certification. (On August
24, 1993, the PBGC published an interim rule amending 29 CFR 2617.3, 2617.25, and 2617.28 to provide for extensions
of time under the circumstances addressed in this notice (58 FR 44738; as corrected, 58 FR 48600, September 17, 1993).)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Requests for Reconsideration or Appeals
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For persons who are aggrieved by certain agency determinations and for whom a request for reconsideration or an appeal
is required to be filed on or after January 15, 1994, and before March 15, 1994, the PBGC will extend the time for filing
to March 15, 1994. (On August 24, 1993, the PBGC published an interim rule amending 29 CFR 2606.4, 2606.33, and 2606.53
to provide for extensions of time under the circumstances addressed in this notice (58 FR 44738; as corrected, 58 FR
48600, September 17, 1993).)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Applying for Waivers/Extensions
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A submission to the PBGC to which a waiver or an extension is applicable under this notice should be marked in bold print
``EARTHQUAKE RELIEF, County of (fill in appropriate county name and state)'' at the top center.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC this 28th day of January, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Martin Slate,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Executive Director, Pension Benefit Guaranty Corporation.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2345 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7708&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00078 </DOCNO>
<PARENT> FR940202-2-00057 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT> POSTAL RATE COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Commission Visits</DOCTITLE>
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 25, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notice is hereby given that on February 8, 9, and 10, 1994, members of the Commission and certain advisory staff personnel
will visit the mailing operations of: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;ADVO, Inc., Windsor, Connecticut; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;Dow Jones &amp; Company, Inc., Chicopee, Massachusetts; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;I.T.T. Hartford Insurance Group, Hartford, Connecticut; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;J.C. Penney Company, Manchester, Connecticut. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A report of the visits will be on file in the Commission's Docket Room. For further information, contact Charles L.
Clapp, Secretary of the Commission at 202&hyph;789&hyph;6840. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Charles L. Clapp,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2257 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7710&hyph;FW&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00079 </DOCNO>
<PARENT> FR940202-2-00058 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>SECURITIES AND EXCHANGE COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Release No. 34&hyph;33524; File Nos. SR&hyph;MCC&hyph;93&hyph;4 and SCCP&hyph;93&hyph;03]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Self-Regulatory Organizations; Midwest Clearing Corporation and Stock Clearing Corporation of Philadelphia,
Notice of Filing and Order Granting Accelerated Approval of Proposed Rule Changes Relating to the Establishment
of Interfaces With the National Securities Clearing Corporation's Fixed Income Transaction System 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (``Act''),
<FOOTCITE>1</FOOTCITE>
 notice is hereby given that on August 23, 1993, and October 15, 1993, respectively, the Midwest Clearing Corporation
(``MCC'') and the Stock Clearing Corporation of Philadelphia (``SCCP'') filed with the Securities and Exchange
Commission (``Commission'') the proposed rule changes as described in Items I and II below, which Items have been
prepared primarily by MCC and SCCP. The Commission is publishing this notice and order to solicit comments from interested
persons and to grant accelerated approval of the proposed rule changes.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b)(1) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
I. Self-Regulatory Organizations' Statement of the Terms of Substance of the Proposed Rule Changes 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
MCC and SCCP each propose to establish an interface with National Securities Clearing Corporation's (``NSCC'')
recently approved Fixed Income Transaction System (``FITS'') which is designed to achieve higher rates of trade
comparison at earlier times in the municipal securities comparison process.
<FOOTCITE>2</FOOTCITE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For a detailed discussion of the various legal, regulatory, and operational issues of FITS, refer to Securities Exchange
Act Release No. 32747 (August 13, 1993), 58 FR 44530 [File No. SR&hyph;NSCC&hyph;93&hyph;02] (order approving proposed
rule change). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
II. Self-Regulatory Organizations' Statement on the Purpose of, and Statutory Basis for, the Proposed Rule Changes
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In its filing with the Commission, MCC and SCCP included statements concerning the purpose of and basis for the proposed
rule changes and discussed any comments they received on the proposed rule changes. The text of these statements may
be examined at the places specified in Item IV below. MCC and SCCP have prepared summaries, set forth in section (A),
(B), and (C) below, of the most significant aspects of such statements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Self-Regulatory Organizations' Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Changes
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under the proposed rule filings, MCC and SCCP each will implement procedures to establish an interface with NSCC's
FITS to enable MCC and SCCP participants to take advantage of the improved input and comparison features of FITS. It
should be noted that all trade comparison will be conducted at NSCC and not at either MCC or SCCP. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MCC and SCCP are required by NSCC to submit two-side original trade input information on behalf of their respective
participants to NSCC by 2 a.m. on the business day after trade date (``T+1'').
<FOOTCITE>3</FOOTCITE>
 NSCC will transmit a comparison report to MCC and SCCP reflecting the compared trades of their respective participants
early on the morning of T+1 so that MCC and SCCP can produce contract reports for their own participants.
<FOOTCITE>4</FOOTCITE>
 MCC's and SCCP's interfaces with NSCC will enable their participants to take full advantage of the features and benefits
offered by FITS.
<FOOTCITE>5</FOOTCITE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
MCC has set a deadline of midnight central standard time (``c.s.t.'') on T for its participants to submit trade information
to MCC. SCCP has set a deadline of 1 a.m. eastern standard time (``e.s.t.'') on T for its participants to submit trade
information to SCCP.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
MCC will provide contract reports to MCC participants by 6 a.m. c.s.t., and SCCP will provide contract reports to SCCP
participants by 8 a.m. e.s.t. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For a detailed discussion of the benefits of FITS, refer to Securities Exchange Act Release No. 32747, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
supra
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 note 2.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Self-Regulatory Organizations' Statement on Burden on Competition 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
MCC and SCCP do not believe a burden will be placed on competition as a result of the proposed rule changes. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Self-Regulatory Organizations' Statement on Comments on the Proposed Rule Changes Received From Members, Participants
or Others
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
No comments were received.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
III. Date of Effectiveness of the Proposed Rule Changes and Timing for Commission Action
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 17A(a)(2)(A) of the Act directs the Commission to facilitate a national system for the prompt and accurate
clearance and settlement of securities transactions.
<FOOTCITE>6</FOOTCITE>
 Because the interfaces enable MCC and SCCP participants to utilize FITS with all its benefits, the Commission believes,
for all the reasons set forth in the FITS approval order,
<FOOTCITE>7</FOOTCITE>
 that the proposed rule changes filed by MCC and SCCP further this goal.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78q&hyph;1(a)(2)(A) (i) and (ii).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Supra
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 note 2.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
MCC and SCCP have requested that the Commission find good cause for approving the proposed rule changes prior to the
thirtieth day after the date of publication of notice of the filing. The Commission finds good cause for so approving
the proposed rule change because the Commission has previously published notice of and has approved NSCC's implementation
of the system.
<FOOTCITE>8</FOOTCITE>
 NSCC's proposed rule change did not generate any comment letters, and none are expected on MCC's and SCCP's proposals.
Furthermore, MCC and SCCP filed the proposed rule changes implementing the interfaces with FITS subsequent to the
interfaces becoming operational.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Supra
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 note 2. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Solicitation of Comments
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Interested persons are invited to submit written data, views, and arguments concerning the foregoing. Persons making
written submissions should file six copies thereof with the Secretary, Securities and Exchange Commission, 450
Fifth Street NW., Washington, DC 20549. Copies of the submissions, all subsequent amendments, all written statements
with respect to the proposed rule change that are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person, other than those that may be withheld from the public
in accordance with the provisions of 5 U.S.C. 552, will be available for inspection and copying in the Commission's
Public Reference Section, 450 Fifth Street NW., Washington, DC 20549, and at the principal offices of MCC and SCCP.
All submissions should refer to File Nos. SR&hyph;MCC&hyph;93&hyph;04 and SR&hyph;SCCP&hyph;93&hyph;03 and
should be submitted by February 23, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
It is therefore ordered, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
pursuant to Section 19(b)(2) of the Act,
<FOOTCITE>9</FOOTCITE>
 that the proposed rule changes (File Nos. SR&hyph;MCC&hyph;93&hyph;04 and SR&hyph;SCCP&hyph;93&hyph;03) be,
and hereby are, approved.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
9
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b)(2). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission by the Division of Market Regulation, pursuant to delegated authority.
<FOOTCITE>10</FOOTCITE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
10
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
17 CFR 200.30&hyph;3(a)(12) (1992).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2319 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00080 </DOCNO>
<PARENT> FR940202-2-00059 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Release No. 34&hyph;33525; File No. SR&hyph;NSCC&hyph;93&hyph;11]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; National Securities Clearing Corporation; Order Approving a Proposed Rule Change
Relating to Capital and Clearing Fund Requirements for Users of Mutual Fund Services</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On August 20, 1993, the National Securities Clearing Corporation (``NSCC'') filed a proposed rule change (File No.
SR&hyph;NSCC&hyph;93&hyph;11) with the Securities and Exchange Commission (``Commission'') pursuant to Section
19(b) of the Securities Exchange Act of 1934 (``Act'').
<FOOTCITE>1</FOOTCITE>
 On August 23, 1993, NSCC filed an amendment to the proposed rule change. Notice of the proposal was published in the

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on November 12, 1993, to solicit comments from interested persons.
<FOOTCITE>2</FOOTCITE>
 Two comment letters were received; both of which were in support of the proposed rule change.
<FOOTCITE>3</FOOTCITE>
 As discussed below, this order approves the proposal.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Securities Exchange Act Release No. 33157 (November 4, 1993), 58 FR 60077.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Letters from Donald J. Boteler, Vice President_Operations, Investment Company Institute, to Jonathan G. Katz,
Secretary, Commission (November 16, 1993) and Steven J. Paggioli, Robert H. Wadsworth &amp; Associates, Inc., to
Jonathan G. Katz, Secretary, Commission (December 1, 1993).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Description
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NSCC has revised its capital standards for broker-dealers and banks that desire to join NSCC to use only NSCC'S mutual
fund services
<FOOTCITE>4</FOOTCITE>
 and for entities that desire to join NSCC to become Funds Members.
<FOOTCITE>5</FOOTCITE>
 NSCC also has revised its clearing fund requirements for members that limit their use of NSCC services to only NSCC's
mutual fund services. The revisions are to better reflect the risks and nature of NSCC's mutual fund services, which
are not guaranteed by NSCC.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
NSCC's mutual fund services are described in detail in NSCC Rule 52, ``Mutual Fund Services.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Entities qualifying as Fund Members are governed primarily by NSCC Rule 51, ``Fund Member,'' and Addendum I, ``Standards
of Financial Responsibility and Operational Capacity for Fund Members'' of NSCC Rules and Procedures. Fund Members
are broker-dealer distributors of mutual fund shares that are not full clearing members of NSCC but utilize NSCC's
mutual fund services.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Broker-dealer applicants for NSCC membership that wish to restrict their NSCC activities to the mutual fund services
will be required to have $25,000 in excess net capital over the minimum net capital requirement imposed by the Commission
or their designated examining authority, whichever is greater. Bank or trust company applicants will be required
to have $100,000 in excess capital over the capital requirement imposed by their state or federal regulatory authority.
<FOOTCITE>6</FOOTCITE>
 Members who are accepted under these proposed alternative standards will be required, depending on their level of
settlement debits with NSCC, to make deposits to the clearing funds for their mutual fund services activities of $10,000,
$20,000, or $40,000 instead of the current $5,000, $10,000, or $20,000, respectively.
<FOOTCITE>7</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The proposed rule change also will change the definition of the term ``Mutual Fund Services Broker-Dealer'' to ``Mutual
Fund Services Member'' in order to include broker-dealers, banks, trust companies, and other entities as members
whose activities are limited to the mutual fund services at NSCC.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
NSCC's clearing fund formula is set forth in Part XV of NSCC's Procedures. Pursuant to proposed Section A.I.(b)(ii)
of Part (XV, a member accepted for membership under the proposed mutual fund services only standards will have a clearing
fund requirement of $10,000 if its daily settlement debits are no more than $100,000, $20,000 if its daily settlement
debits are no more than $500,000, and $40,000 if its daily settlement debits are more than $500,000.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Broker-dealer applicants for Fund Member status that distribute shares for investment companies with aggregate
assets under management of $500,000 or more will be required to have $25,000 in excess net capital over the minimum
net capital requirement imposed by the Commission or their designated examining authority, whichever is greater.
Applicants that distribute shares for investment companies with aggregate assets under management of less than
$500,000 will be required to have excess net capital of $50,000 over the minimum net capital requirements imposed
by the Commission or their designated examining authority, whichever is greater. Investment company applicants
will be permitted to become Fund Members provided that they have a minimum of $100,000 in assets under management.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Discussion
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission believes the proposal is consistent with Section 17A of the Act.
<FOOTCITE>8</FOOTCITE>
 Specifically, Section 17A(b)(3)(B) requires a clearing agency's rules to provide for the participation of registered
broker-dealers, registered clearing agencies, registered investment companies, and banks deemed appropriate
to the development of a national system for the clearance and settlement of securities transactions.
<FOOTCITE>9</FOOTCITE>
 NSCC's rule change expands the number of members eligible to clear and settle their mutual fund transactions through
NSCC's facilities. Access to NSCC's mutual fund services is increasingly important to all entities in the mutual
fund industry. Lower net capital requirements will enable smaller mutual funds, broker-dealers, banks, and trust
companies to participate in NSCC's mutual fund services. Smaller entities thus achieve a parity with their larger
competitors in terms of access to orderly, automated transaction processing systems, which are now the industry
standard. A common automated means of communication among those entities involved in mutual fund transactions serves
the public interest by eliminating the existence of inefficient, error-prone manual data interchanges.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78q&hyph;1 (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
9
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78q&hyph;1(b)(3)(B) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission also believes that NSCC's rule change satisfies the requirements of Sections 17A(b)(3)(A) and (F)
that a clearing agency be organized and that its rules be designed to safeguard securities and funds in its custody
or control or for which it is responsible.
<FOOTCITE>10</FOOTCITE>
 Because NSCC does not guarantee the completion of mutual fund transactions under its mutual fund services program,
the Commission does not believe that any additional risk to NSCC will result from the lower net capital requirements
for those members that use only the mutual fund services of NSCC and does not believe that NSCC's ability to safeguard
securities or funds will be impaired. Along with lower net capital requirements, NSCC is imposing increased clearing
fund requirements for members who participate in NSCC's mutual fund services program under the alternative net capital
requirements approved in this order. The Commission believes that the increased clearing funds requirements will
help protect NSCC and its participants from the risk of default by members using NSCC's mutual fund services.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
10
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78q&hyph;1(b)(3)(A) and (F) (1988). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Conclusion
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For the reasons stated above, the Commission finds that NSCC's proposal is consistent with section 17A of the Act.
<FOOTCITE>11</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
11
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C 78q&hyph;1 (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
It is therefore ordered, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
pursuant section 19(b)(2) of the Act,
<FOOTCITE>12</FOOTCITE>
 that the proposed rule change (File No. SR&hyph;NSCC&hyph;93&hyph;11) be, and hereby is, approved.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
12
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b)(2) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission by the Division of Market Regulation, pursuant to delegated authority.
<FOOTCITE>13</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
13
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
17 CFR 200.30&hyph;3(a)(12) (1992).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2321 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00081 </DOCNO>
<PARENT> FR940202-2-00060 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Release No. 34&hyph;33531; File No. SR&hyph;NYSE&hyph;93&hyph;49]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; Notice of Filing of Proposed Rule Change by New York Stock Exchange, Inc. Relating
to Bond Listing Standards</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (``Act''), 15 U.S.C. 78s(b)(1), notice is hereby
given that on December 22, 1993, the New York Stock Exchange, Inc. (``NYSE'' or ``Exchange'') filed with the Securities
and Exchange Commission (``Commission'' or ``SEC'') the proposed rule change as described in Items I, II and III below,
which Items have been prepared by the self-regulatory organization. The Commission is publishing this notice to
solicit comments on the proposed rule change from interested persons.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
I. Self-Regulatory Organization's Statement of the Terms of Substance of the Proposed Rule Change
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed rule change would enable the Exchange to simplify and relax its standards for the listing and delisting
of debt securities.
<!-- PJG 0012 frnewline -->
The complete text of the proposed rule change is available at the Office of the Secretary, NYSE, and at the Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
II. Self-Regulatory Organization's Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In its filing with the Commission, the self-regulatory organization included statements concerning the purpose
of and basis for the proposed rule change and discussed any comments it received on the proposed rule change. The text
of these statements may be examined at the places specified in Item IV below. The self-regulatory organization has
prepared summaries, set forth in Sections A, B, and C below, of the most significant aspects of such statements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Self-Regulatory Organization's Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
1. Purpose
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Exchange is proposing to revise its standards for the listing and delisting of debt securities. In particular,
the Exchange seeks to clarify and simplify its debt security listing standards.
<!-- PJG 0012 frnewline -->
The Exchange hopes to make an Exchange listing more accessible for issuers of debt securities and to facilitate the
listing of debt securities. The Exchange's goal in both cases is to augment the number of listed debt securities. The
Exchange believes that this will serve the public interest because it will subject a greater number of debt securities
to the Exchange's trading and disclosure systems.
<!-- PJG 0012 frnewline -->
In order to accomplish these goals, the Exchange proposes to rely upon the Exchange's equity listing and maintenance
standards in determining whether issues can adequately demonstrate that they can meet interest obligations on debt
securities. That is, where an issuer has common stock listed on the Exchange and is in good standing, the Exchange would
normally list the issuer's debt security issues of $5 million or more. Because the debt security enjoys seniority
over the equity issue, the ``good standing'' test warrants listing the debt security.
<!-- PJG 0012 frnewline -->
Where the issuer of a debt security does not list its common stock on the Exchange, the Exchange proposes to rely upon
the analyses of nationality recognized securities rating organizations (``NRSRO'') for the interest-coverage
determination.
<!-- PJG 0012 frnewline -->
For those purposes, the Exchange proposes to make the following changes to Paragraphs 102.03, 103.05, 703.06, 801.00
and 802.00 of the Exchange's Listed Company Manual:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Under Paragraph 102.03:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;As at present, the Exchange would require the issue to have a market value or principal amount of $5 million.

<!-- PJG 0012 frnewline -->
&bull;The Exchange would no longer require the issuer to demonstrate on a pro forma basis interest coverage on all
debt securities.
<FOOTCITE>1</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Currently, Paragraph 802.00 deems coverage to be ``inadequate'' if interest charges on all debt issued by the company,
its parent or a subsidiary exceed pro forma earnings (before or after taxes) as reported in a filing to the Commission.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
&bull;The Exchange would no longer evaluate the anticipated distribution of a debt security. (The proposed rule
change proposes a conforming change to Paragraph 703.06 to remove a mention of the distribution requirement.)
<!-- PJG 0012 frnewline -->
&bull;The Exchange would not longer require convertible debt securities to be convertible only into common stock
listed on the Exchange, although the Exchange would require that equity securities underlying convertible securities
be subject to a real-time last sale reporting obligation.
<!-- PJG 0012 frnewline -->
&bull;I the case of debt securities proposed to be listed by ``unaffiliated'' issuers:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00082 </DOCNO>
<PARENT> FR940202-2-00060 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
An NRSRO must have assigned a current rating to the issue that is no lower than the ratings in the S&amp;P Corporation
``B'' category (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
i.e.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, ``B-'' or better) or another NRSRO's counterpart to the S&amp;P Corporation rating.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Alternatively, if no NRSRO has assigned a rating to the issue, an NRSRO must have currently assigned either an investment
grade rating (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
i.e.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, an S&amp;P Corporation rating no lower that 
<!-- PJG 0320 forcenewline -->
``BBB-'' or another NRSRO's counterpart to the S&amp;P Corporation rating) to a senior issue or, in the case of a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pari passu
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<FOOTCITE>2</FOOTCITE>
 or junior issue (including a preferred stock or debt security issue), a rating no lower than the ratings in the S&amp;P
Corporation ``B'' category (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
i.e.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
,
<!-- PJG 0034 unknown -->
 ``B-'' or better) or another NRSRO's counterpart to the S&amp;P Corporation rating.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
A 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
pari passu
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 issue would have equal standing with the debt issue to be listed.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the case of a listing for an unrated issue that is junior to an issue with an investment grade rating, the Exchange
notes that a junior issue would generally be rated no more than one rating category below an immediate senior issue.
Thus, the Exchange feels that such an unrated debt issue seeking to list would, if it were rated, receive a rating that
satisfies the minimum ``B-'' rating standard. All other unrated debt issues of unaffiliated issuers must either
be senior to or 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pari passu
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 with an issue rated at least ``B-'' in order to qualify for listing on the Exchange.
<!-- PJG 0012 frnewline -->
An ``unaffiliated'' issuer is one that has no equity securities listed on the Exchange; is not, directly or indirectly,
majority-owned by, nor under common control with, an issuer of Exchange-listed equity securities; and is not issuing
a debt security that an issuer of Exchange-listed equity securities is guaranteeing.
<!-- PJG 0012 frnewline -->
Paragraph 103.05 makes the same changes to the listing standards for the debt securities of non-U.S. companies as
Paragraph 102.03 makes in respect of the standards for domestic debt securities.
<!-- PJG 0012 frnewline -->
Under Paragraph 810.00, the Exchange proposes to review the continued listing of a debt security convertible into
an equity security when the equity security is delisted. In addition, the Exchange proposes to delist a debt security
when the underlying equity security ceases to be subject to real-time trade reporting.
<!-- PJG 0012 frnewline -->
Under Paragraph 802.00, the Exchange would no longer view inadequate interest coverage of an issuer or its parent
or a subsidiary as reason for delisting a security.
<FOOTCITE>3</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
See supra, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
note 1.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the case of a sovereign issue, the Exchange will evaluate whether to list the issue for trading on a case-by-case
basis. The Exchange's current policy in respect of municipal securities is to list initially only term/dollar bonds.
<FOOTCITE>4</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
A term/dollar municipal bond is issued with a single maturity date (as opposed to a serial bond), and is quoted in dollars
or as a percentage of its par value (rather than by yield). As such, it resembles a corporate bond. Telephone conversation
between Fred Siesel, Director, Fixed Income Markets, NYSE, and Beth Stekler, Attorney, SEC, on January 7, 1994.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Exchange believes that it should extend to a broader universe of debt securities the benefits that derive from
the Exchange's unique bond market and price disclosure mechanism, especially for individual bond holders and small
to mid-sized institutions. The debt security listing standard modifications that the proposed rule change proposes
would effect such an extension to the betterment of the community of investors and debt securities.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2. Statutory Basis
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The basis under the Act for the proposed rule change is the requirement under Section 6(b)(5) that an exchange have
rules that are designed to prevent fraudulent and manipulative acts and practices, to promote just and equitable
principles of trade, to remove impediments to and perfect the mechanism of a free and open market and a national market
system, and, in general, to protect investors and the public interest.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00083 </DOCNO>
<PARENT> FR940202-2-00060 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Self-Regulatory Organization's Statement on Burden on Competition
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed rule change does not impose any burden on competition that is not necessary or appropriate in furtherance
of the purposes of the Act.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Self-Regulatory Organization's Statement on Comments on the Proposed Rule Change Received From Members, Participants
or Others
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Exchange has not solicited, and does not intend to solicit, comments on the proposed rule change. The Exchange
has not received any unsolicited written comments from members or other interested parties.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
III. Date of Effectiveness of the Proposed Rule Change and Timing for Commission Action
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Within 35 days of the publication of this notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or within such other period (i) as the Commission may designate up to 90 days of such date if it finds such longer period
to be appropriate and publishes its reasons for so finding or (ii) as to which the self-regulatory organization consents,
the Commission will:
<!-- PJG 0012 frnewline -->
(A) By order approve the proposed rule change, or
<!-- PJG 0012 frnewline -->
(B) Institute proceedings to determine whether the proposed rule change should be disapproved.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Solicitation of Comments
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Interested persons are invited to submit written data, views and arguments concerning the foregoing. Persons making
written submissions should file six copies thereof with the Secretary, Securities and Exchange Commission, 450
Fifth Street, NW., Washington, DC 20549. Copies of the submission, all subsequent amendments, all written statements
with respect to the proposed rule change that are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person, other than those that may be withheld from the public
in accordance with the provisions of 5 U.S.C. &sect;552, will be available for inspection and copying at the Commission's
Public Reference Station, 450 Fifth Street, NW., Washington, DC 20549. Copies of such filing will also be available
for inspection and copying at the principal office of the NYSE. All submissions should refer to File No. SR&hyph;NYSE&hyph;93&hyph;49
and should be submitted by February 23, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission, by the Division of Market Regulation, pursuant to delegated authority.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2320 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00084 </DOCNO>
<PARENT> FR940202-2-00061 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF TRANSPORTATION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Federal Highway Administration</USBUREAU>
<!-- PJG 0012 frnewline -->

<USBUREAU>Research and Special Programs Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. PDA&hyph;3(RF)] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Chester, West Virginia Ordinance No. 305 
<!-- PJG 0012 frnewline -->
Regarding Transportation of Hazardous Wastes 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Federal Highway Administration (FHWA) and Research and Special Programs Administration (RSPA), DOT. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice Dismissing Application and Closing the Docket. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
APPLICANT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
National Solid Wastes Management Association, on behalf of its Chemical Waste Transportation Institute. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
LOCAL LAW AFFECTED:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Ordinance No. 305 of the City of Chester, West Virginia, Regarding Transportation of Hazardous Wastes. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
APPLICABLE FEDERAL REQUIREMENTS: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Hazardous Materials Transportation Act (HMTA), 49 App. U.S.C. &sect;1801 et seq., and the Hazardous Materials Regulations,
49 CFR Parts 171&hyph;180. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
MODE AFFECTED:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Highway 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The application for a determination of preemption is dismissed, and this docket is closed, because Ordinance No.
305 of Chester, West Virginia never went into effect. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Frazer C. Hilder, Office of the Chief Counsel, Research and Special Programs Administration, U.S. Department of
Transportation, Washington, DC 20590&hyph;0001 (Tel. No. 202&hyph;366&hyph;4400). 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
In December 1991, the National Solid Wastes Management Association, on behalf of its Chemical Waste Transportation
Institute (CWTI), petitioned for an administrative determination that the HMTA preempts Chester, West Virginia
Ordinance No. 305, regarding the transportation of hazardous wastes. In its application, CWTI stated that the Chester
City Council had ``enacted Ordinance No. 305,'' and the copy of Ordinance No. 305 attached to CWTI's application indicated
that the Ordinance had been ``Passed and Adopted'' on December 2, 1991. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On April 6, 1992, FHWA and RSPA published a Public Notice and Invitation to Comment on CWTI's application. 57 FR 11654.
That Notice was issued jointly by both agencies because the requirements in Ordinance No. 305 purported to affect
both the highway routing of hazardous materials and other aspects of hazardous materials transportation. See 57
FR at 11655. In response to that Notice, four industry associations and more than 20 individual companies submitted
comments opposing Ordinance No. 305 and supporting a finding of preemption. One party submitting comments, the Tri-State
Area Transporters Association, stated that Ordinance No. 305 was originally scheduled to become effective February
1, 1992, but that in January 1992, ``Chester apparently revised the ordinance, with no effective date given.'' 
<!-- PJG 0012 frnewline -->
No party, including the City of Chester, submitted comments opposing CWTI's application. CWTI submitted further
comments, which it called ``rebuttal.'' 
<!-- PJG 0012 frnewline -->
In a recent telephone conversation, Chester Mayor Ken Morris advised RSPA that Ordinance No. 305 was never adopted
and never went into effect. Copies of a December 6, 1993 letter to Mayor Morris, confirming the substance of this telephone
conversation, were sent to CWTI and each party submitting comments on CWTI's application. In a December 17, 1993 letter,
CWTI advised that, based on information from its members, Ordinance No. 305 has never been enforced and that CWTI had
``no objection to DOT dismissing the Institute's petition at this time *&blank;*&blank;* without prejudice *&blank;*&blank;*
'' 
<!-- PJG 0012 frnewline -->
CWTI's application is hereby dismissed, and the docket is closed. If the requirements contained in Chester, West
Virginia Ordinance No. 305 are ever adopted and enforced, CWTI may again submit an application for a preemption determination.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC on January 25, 1994 . 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Rodney E. Slater,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Administrator, Federal Highway Administration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Alan I. Roberts, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Administrator for Hazardous Materials Safety, Research and Special Programs Administration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2285 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;60&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00085 </DOCNO>
<PARENT> FR940202-2-00062 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Federal Railroad Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Application for Approval of Discontinuance or </DOCTITLE>
<!-- PJG 0012 frnewline -->
Modification of a Railroad Signal System or Relief From the 
<!-- PJG 0012 frnewline -->
Requirements of 49 CFR Part 236
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to 49 CFR part 235 and 49 U.S.C. App. 26, the following railroads have petitioned the Federal Railroad Administration
(FRA) seeking approval for the discontinuance or modification of the signal system or relief from the requirements
of 49 CFR part 236 as detailed below. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Block Signal Application (BS&hyph;AP)&hyph;No. 3274 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicant: Kansas City Southern Railway Company, 
<!-- PJG 0012 frnewline -->
Mr. M. W. Hahn, 
<!-- PJG 0012 frnewline -->
Vice President_Transportation, 
<!-- PJG 0012 frnewline -->
4601 Blanchard Road, 
<!-- PJG 0012 frnewline -->
Shreveport, Louisiana 71107. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Kansas City Southern Railway Company seeks approval of the proposed modification of the traffic control system,
on the single main track, near Gentry, Arkansas, milepost 225.19, on the Second Subdivision; consisting of the discontinuance
and removal of automatic block signal No. 2252. 
<!-- PJG 0012 frnewline -->
The reason given for the proposed changes is to improve train operation and avoid unnecessary blocking of highway
traffic at Flint Creek Road. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
BS&hyph;AP&hyph;No. 3275 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicant: CSX Transportation, 
<!-- PJG 0012 frnewline -->
Mr. W. J. Scheerer, 
<!-- PJG 0012 frnewline -->
Chief Engineer_Train Control, 
<!-- PJG 0012 frnewline -->
500 Water Street, 
<!-- PJG 0012 frnewline -->
Jacksonville, Florida 32202. 
<!-- PJG 0012 frnewline -->
CSX Transportation seeks approval of the proposed modification of the signal system, on all main tracks and No. 1 and
No. 2 tracks, between CP 43, milepost PLE43.4, near 
<!-- PJG 0012 frnewline -->
New Castle, Pennsylvania, and CP 17Y, milepost PLY16.8, near Pittsburgh, Pennsylvania, on the Cumberland Division,
Pittsburgh Subdivision, consisting of the following: 
<!-- PJG 0012 frnewline -->
1. The discontinuance and removal of 52 controlled signals, 20 automatic signals, and 2 power-operated derails;

<!-- PJG 0012 frnewline -->
2. The relocation of 45 controlled signals and 12 automatic signals; and 
<!-- PJG 0012 frnewline -->
3. The conversion of 10 power-operated switches to hand operation. 
<!-- PJG 0012 frnewline -->
The reason given for the proposed changes is the installation of new signal equipment to replace inadequate and deteriorated
signal facilities. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
BS&hyph;AP&hyph;No. 3276 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicant: Union Pacific Railroad Company, 
<!-- PJG 0012 frnewline -->
Mr. P. M. Abaray, 
<!-- PJG 0012 frnewline -->
Chief Engineer_Signals &amp; Construction, 
<!-- PJG 0012 frnewline -->
1416 Dodge Street, room 1000, 
<!-- PJG 0012 frnewline -->
Omaha, Nebraska 68179. 
<!-- PJG 0012 frnewline -->
The Union Pacific Railroad Company seeks approval of the proposed modification of the traffic control system, on
the two main tracks and siding, near Browder, Texas, milepost 216.6, 
<!-- PJG 0012 frnewline -->
Ft. Worth Division, Dallas Subdivision, consisting of the following: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00086 </DOCNO>
<PARENT> FR940202-2-00062 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The discontinuance and removal of CPT217, including six controlled signals, 45L, 47L, 49L, 45R, 47R, and 49R; and

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The installation of four automatic signals, 2179&hyph;1, 2179&hyph;2, 2178&hyph;1, and 2178&hyph;2 near milepost
218.96. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The reason given for the proposed changes is that the signals at CPT217 are no longer necessary because the power-operated
crossovers have been removed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
BS&hyph;AP&hyph;No. 3277 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicant: Union Pacific Railroad Company, Mr. P.M. Abaray, Chief Engineer_Signals &amp; Construction, 1416 Dodge
Street, room 1000, Omaha, Nebraska 68179. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Union Pacific Railroad Company seeks approval of the proposed discontinuance and removal of signal 2889&hyph;3
and 2889&hyph;4 at milepost 288.8, and the discontinuance and removal of the associated coded cab signal track circuits,
on yard tracks 289 and 290, from milepost 288.8 to CP B288 at milepost 287.2, in the North Platte Terminal, North Platte,
Nebraska. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The reason given for the proposed changes is that due to operational changes, tracks 289 and 290 are no longer used to
bypass the classification yard. Tracks 289 and 290 have been incorporated into a nine track westbound coal yard used
for the staging and inspection of empty coal trains, making the signals and coded cab track circuits unnecessary.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
BS&hyph;AP&hyph;No. 3278 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
Applicants: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=14 g=1 f=1 -->
Mid-Michigan Railroad, Inc., Mr. Dale W. Carlstrom, General Manager, 432 East Grove Street, Greenville, Michigan
48838. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Grand Rapids and Eastern Railroad Company, Mr. Dennis Kling, General Manager, 430 East Grove Street, Greenville,
Michigan 48838. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mid-Michigan Railroad, Inc. (MMRR) and the Grand Rapids and Eastern Railroad Company (GRE) jointly seek approval
of the proposed discontinuance and removal of the automatic interlocking, near Lowell, Michigan, MMRR milepost
104.9, where a single main track of the MMRR crosses at grade a single main track of the GRE; consisting of the discontinuance
and removal of all interlocking and associated approach signals, and the installation of a swing gate. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The reason given for the proposed changes is to eliminate facilities no longer required for present day operations.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
BS&hyph;AP&hyph;No. 3279 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicant: Red River Valley and Western Railroad Company, Mr. Kent P. Shoemaker, Chairman and CEO, P.O. Box 608, Wahpeton,
North Dakota 58074. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Red River Valley and Western Railroad Company (RRVW) seeks approval of the proposed discontinuance and removal
of the automatic block signal system, on the single main track, between Wahpeton Junction, milepost 1.4 and Casselton,
milepost 55.0, North Dakota, on the Cass Line, Second Subdivision. RRVW proposes to operate the trackage under track
warrant control rules. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00087 </DOCNO>
<PARENT> FR940202-2-00062 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The reason given for the proposed changes is that the character and use of the trackage has changed substantially since
the automatic block signal system (ABS) was originally installed and the ABS is no longer required for safe operations.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
BS&hyph;AP&hyph;No. 3280 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicant: Burlington Northern Railroad Company, Mr. W. G. Peterson, Director, Signal Engineering, 373 Inverness
Drive South, Englewood, Colorado 80112&hyph;5831. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Burlington Northern Railroad Company seeks approval of the proposed modification of the traffic control system,
on the single main track, between Jonesboro, Arkansas, milepost 424.0 and Harvard, Arkansas, milepost 471.0, on
the Springfield Division, Thayer Subdivision; consisting of the discontinuance and removal of 14 automatic block
signals and 2 controlled signals, and the installation of 26 automatic block signals and 2 controlled signals. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The reason given for the proposed changes is to respace and relocate signals associated with a pole line elimination
project and installation of solid-state coded track circuits. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
BS&hyph;AP&hyph;No. 3281 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicant: Chicago and North Western Transportation Company, Mr. D. E. Waller, Vice President, Engineering and
Materials, One North Western Center, Chicago, Illinois 60606. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Chicago and North Western Transportation Company (CNW) seeks approval of the proposed modification of the automatic
block signal system, on the single main track, between Merriam, milepost 35.6 and Belle Plaine, milepost 46.4; and
between Kasota, milepost 76.8 and Mankato, milepost 85.6, Minnesota, on the Merriam Subdivision, consisting of
the relocation of 12 signals and the discontinuance and removal of two signals. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The reason given for the proposed changes is to maximize efficiency and safety of train operations by replacing aging
pole line with modern solid state coded track circuitry. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
BS&hyph;AP&hyph;No. 3282 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicant: CSX Transportation, Mr. W. J. Scheerer, Chief Engineer, Train Control, 500 Water Street, Jacksonville,
Florida 32202. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CSX Transportation seeks approval of the proposed modification of the signal system, on the single main track between
Dalton, milepost WA98 and Tilton, milepost WA90, Georgia on the Corbin Division, W&amp;A Subdivision, consisting
of the discontinuance and removal of four automatic signals, 93.6, 93.5, 96.9, and 97.0; and the relocation of four
automatic signals, 91.9, 92.0, 95.0, and 95.1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The reason given for the proposed changes is to improve operations and increase efficiency. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Rules Standards &amp; Instructions Application (RS&amp;I-AP)-No. 1091 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
Applicants: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=14 g=1 f=1 -->
National Railroad Passenger Corporation, Mr. C. P. Wahmann, Assistant Vice President, Transportation, 30th and
Market Streets, Philadelphia, Pennsylvania 19104. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CSX Transportation, Mr. R. H. Young, Jr., Assistant Vice President, Passenger Services, 500 Water Street, Jacksonville,
Florida 32202. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The National Railroad Passenger Corporation (Amtrak) and CSX Transportation (CSX) jointly seek temporary relief
from &sect;236.566 of the Rules, Standards and Instructions (49 CFR part 236) to the extent that Amtrak be permitted
to operate Passenger Train No. 50 with cab signals cut out between ``SY'' (Seminary), milepost 103.9 and ``RO'', milepost
110.0, a distance of 6.1 miles, on the RF&amp;P Subdivision of CSX. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The justification for relief is that it will be several months before a sufficient number of F&hyph;40 locomotives
are retrofitted with ``tuned-75 decoders'' to assure proper cab signal operation through the application area.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any interested party desiring to protest the granting of an application shall set forth specifically the grounds
upon which the protest is made, and contain a concise statement of the interest of the protestant in the proceeding.
The original and two copies of the protest shall be filed with the Associate Administrator for Safety, FRA, 400 Seventh
Street, SW., Washington, DC 20590 within 45 calendar days of the date of issuance of this notice. Additionally, one
copy of the protest shall be furnished to the applicant at the address listed above. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
FRA expects to be able to determine these matters without oral hearing. However, if a specific request for an oral hearing
is accompanied by a showing that the party is unable to adequately present his or her position by written statements,
an application may be set for public hearing. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC on January 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Phil Olekszyk, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Associate Administrator for Safety. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2272 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;06&hyph;P 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00088 </DOCNO>
<PARENT> FR940202-2-00063 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>National Highway Traffic Safety Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 94&hyph;10; Notice 1]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
AC Cars Ltd; Receipt of Petition for Temporary Exemption From Standard No. 208
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
AC Cars Ltd. of Weybridge, Surrey, England, has petitioned for a temporary exemption until November 1, 1996, for its
Ace model, from the automatic protection requirements of Federal Motor Vehicle Safety Standard No. 208, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Occupant Crash Protection. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The basis of the petition is that compliance would cause substantial economic hardship.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Notice of receipt of the petition is published in accordance with agency regulations on the subject (49 CFR part 555)
and does not represent any judgment of the agency on the merits of the petition.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Petitioner's Hardship Arguments
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under 15 U.S.C. 1410(a)(1)(A), the Administrator may provide a temporary exemption upon a finding that ``compliance
would cause substantial economic hardship and that the manufacturer has, in good faith, attempted to comply&blank;*&blank;*&blank;*.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The following is a summary of AC's petition. The company is privately owned and produced no motor vehicles during the
12 months preceding the filing of its petition. The first prototype of the Ace was shown in 1986. Since then, the company
has spent much time redesigning it ``to meet the increasingly higher standards of emissions and safety *&blank;*&blank;*
with the original intentions of achieving first sales into North America.'' To date, the petitioner has spent approximately
5,000,000 Pounds Sterling on the project, 100,000 of which (and 1,250 man hours) have been spent in the past two years
in research and development relating to meeting the automatic restraint requirements of Standard No. 208. Because
the Ace is a full convertible, the company found that it could not adopt an automatic seat belt system. Additional design
changes, development and actual testing are necessary in order to install in the Ace an airbag system that meets Standard
No. 208. Being a small manufacturer of motor vehicles, the petitioner has had to rely on the expertise of outside parties
in the design and development of necessary components.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
AC has concluded that modifications of the following will be required to accommodate driver and passenger side airbag
systems: Interior dash and cockpit components, seats, steering wheel and chassis. The estimted cost of these modifications
is 750,000 Pounds Sterling, exclusive of testing costs. The company's balance sheet shows that its cumulative losses,
which were approximately 1,500,000 Pounds Sterling as of December 31, 1989, has increased to approximately 4,275,000
Pounds Sterling as of September 30, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The company anticipates that it will be able to conform by November 1, 1996. It projects total sales of 200 units in 1994
and 350 in 1995, half of which are proposed for North American sales.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Arguments Why an Exemption Would be in the Public Interest and Consistent With Traffic Safety Objectives
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In order to grant an exemption, the Administrator must also find that the exemption is in the public interest and consistent
with the objectives of the National Traffic and Motor Vehicle Safety Act. In support of its petition, AC has informed
NHTSA that the Ace will be equipped with a three-point restraint system that conforms to Standard No. 208, ``the mountings
of which have been tested in accordance with and achieved FMV210 (sic) US standard approval.'' Further, except for
the automatic restraint requirements, the Ace has been designed to meet all other Federal motor vehicle safety standards,
and the bumper standard. It will be manufactured ``using the following US sourced components: Ford engine, transmission,
exhaust, wiring and associated components.'' According to the petitioner, ``US parts sourcing and dealer network
labor involvement is also in the best interest of the US economy.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Interested persons are invited to submit comments on the petition described above. Comments should refer to the Docket
number and be submitted to: Docket Section, National Highway Traffic Safety Administration, room 5109, 400 Seventh
St. SW., Washington, DC 20590. It is requested but not required that 10 copies be submitted.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
All comments received before the close of business on the comment closing date indicated below will be considered,
and will be available for examination in the docket at the above address both before and after that date. To the extent
possible, comments filed after the closing date will also be considered. Notice of final action on the petition will
be published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 pursuant to the authority indicated below.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Comment closing date: March 4, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
15 U.S.C. 1410; delegations of authority at 49 CFR 1.50 and 501.8.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued on: January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Barry Felrice,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Administrator for Rulemaking.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2351 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;59&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00089 </DOCNO>
<PARENT> FR940202-2-00064 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 93&hyph;71; Notice 2]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Determination That Nonconforming 1986 Bentley Turbo Passenger Cars Are Eligible for Importation</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
National Highway Traffic Safety Administration (NHTSA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of determination by NHTSA that nonconforming 1986 Bentley Turbo passenger cars are eligible for importation.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice announces the determination by NHTSA that 1986 Bentley Turbo passenger cars not originally manufactured
to comply with all applicable Federal motor vehicle safety standards are eligible for importation to the United States
because they are substantially similar to a vehicle originally manufactured for importation into and sale in the
United States and certified by its manufacturer as complying with the safety standards (the U.S.-certified version
of the 1986 Bentley Turbo), and they are capable of being readily modified to conform to the standards.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The determination is effective February 2, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Ted Bayler, Office of Vehicle Safety Compliance, NHTSA (202&hyph;366&hyph;5306).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->
Background
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Under section 108(c)(3)(A)(i) of the National Traffic and Motor Vehicle Safety Act (the Act), 15 U.S.C. 1397(c)(3)(A)(i),
a motor vehicle that was not originally manufactured to conform to all applicable Federal motor vehicle safety standards
must be refused admission into the United States on and after January 31, 1990, unless NHTSA has determined that the
motor vehicle is substantially similar to a motor vehicle originally manufactured for importation into and sale
in the United States, certified under section 114 of the Act, and of the same model year as the model of the motor vehicle
to be compared, and is capable of being readily modified to conform to all applicable Federal motor vehicle safety
standards.
<!-- PJG 0012 frnewline -->
Petitions for eligibility determinations may be submitted by either manufacturers or importers who have registered
with NHTSA pursuant to 49 CFR part 592. As specified in 49 CFR 593.7, NHTSA publishes notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of each petition that it receives, and affords interested persons an opportunity to comment on the petition. At the
close of the comment period, NHTSA determines, on the basis of the petition and any comments that it has received, whether
the vehicle is eligible for importation. The agency then publishes this determined in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.
<!-- PJG 0012 frnewline -->
G&amp;K Automotive Conversion, Inc. of Santa Ana, California (Registered Importer R&hyph;90&hyph;007) petitioned
NHTSA to determine whether 1986 Bentley Turbo passenger cars are eligible for importation into the United States.
NHTSA published notice of the petition on October 26, 1993 (58 FR 57670) to afford an opportunity for public comment.
The reader is referred to that notice for a thorough description of the petition. No comments were received in response
to the notice. Based on its review of the information submitted by the petitioner, NHTSA has determined to grant the
petition.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Vehicle Eligibility Number for Subject Vehicles
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The importer of a vehicle admissible under any final determination must indicate on the form HS&hyph;7 accompanying
entry the appropriate vehicle eligibility number indicating that the vehicle is eligible for entry. VSP 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
53 is the vehicle eligibility number assigned to vehicles admissible under this determination.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Final Determination
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Accordingly, on the basis of the foregoing, NHTSA hereby determines that a 1986 Bentley Turbo not originally manufactured
to comply with all applicable Federal motor vehicle safety standards is substantially similar to a 1986 Bentley Turbo
originally manufactured for importation into and sale in the United States and certified under section 114 of the
National Traffic and Motor Vehicle Safety Act, and is capable of being readily modified to conform to all applicable
Federal motor vehicle safety standards.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 15 U.S.C. 1397(c)(3)(A)(i) (I) and (C)(ii); 49 CFR 593.8; delegations of authority at 49 CFR 1.50 and 501.8.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued on: January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
William A. Boehly,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Administrator for Enforcement.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2352 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;59&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00090 </DOCNO>
<PARENT> FR940202-2-00065 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Generalized System of Preferences; Information on Imports During First 10 Months of 1993; Opportunity for Public
Comment; Disposition of the Review of Worker Rights Practices in Costa Rica and Paraguay in the 1993 Annual GSP Review</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Office of the United States Trade Representative.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice informs the public of certain import statistics for the period from January through October 1993 and affords
the public an opportunity to comment on certain discretionary decisions the President may make with respect to the
Generalized System of Preferences (GSP) program. These decisions concern: (1) The GSP ``competitive need'' limits
set forth in section 504(c) of the Trade Act of 1974, as amended (the ``1974 Act'') (19 U.S.C. 2464(c)); (2) the ``de
minimis waiver'' authority set forth in section 504(d)(2) of the 1974 Act; and (3) the redesignation authority set
forth in section 504(c)(5) of the 1974 Act. Presidential decisions concerning the application of competitive need
limits and other product-related decisions stemming from the 1993 Annual Review are expected to be announced in April,
and implemented on July 1, 1994. This notice also announces the successful disposition of the review of worker rights
practices in Costa Rica and Paraguay in the 1993 Annual GSP Review.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
GSP Subcommittee, Office of the United States Trade Representative, 600 17th Street NW., room 517, Washington, DC
20506. The telephone number is (202) 395&hyph;6971.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->
I. Competitive Need Limits
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Pursuant to section 504(c), any GSP-eligible beneficiary country that exported to the United States during the most
recent calendar year a quantity of any one GSP eligible article in excess of (1) $25 million indexed to the nominal growth
of U.S. Gross National Product (GNP) since 1974, or (2) 50 percent of the value of total U.S. imports of the article,
is to be removed from GSP eligibility with respect to that article not later than July 1 of the next calendar year. The
preliminary estimate of this dollar limit, subject to revision, is $107,320,423 for calendar year 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
II. Reduced Competitive Need Limits
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Pursuant to section 504(c)(2) of the 1974 Act, a general review of the GSP was initiated in 1985 and the results of the
review were announced on January 2, 1987 (52 FR 389). The purpose of the general review was to determine whether beneficiary
countries had become sufficiently competitive in GSP-eligible products, on a product and country specific basis.
For beneficiaries found to be sufficiently competitive with respect to a product, the percentage competitive need
limit was reduced to 25 percent and the dollar limit was reduced to $25 million, indexed to the nominal growth of U.S.
GNP since 1984. The preliminary estimate of this dollar limit, subject to revision, is $41,621,070 for calendar year
1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
III. Discretionary Decisions
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=2 -->
A. De Minimis Waivers
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Section 504(d)(2) of the 1974 Act permits the President to disregard the 50 percent ``competitive need'' limit with
respect to any eligible article if the value of total imports of the article during the most recent calendar year did
not exceed $5 million, indexed to the nominal growth of U.S. GNP since 1979. The preliminary estimate of the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
de minimis
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 level, subject to revision, is $12,553,356 for calendar year 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Redesignation of Eligible Articles
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If a country is no longer a beneficiary developing country with respect to an eligible article because imports exceeded
the competitive need limits in a prior year, then, pursuant to section 504(c)(5) of the 1974 Act, the President may
redesignate the beneficiary developing country with respect to the eligible article if imports do not exceed the
competitive need limits in a subsequent year.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Implementation of Competitive Need Limits, Waivers, and Redesignations
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00091 </DOCNO>
<PARENT> FR940202-2-00065 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A proclamation will be issued to be effective July 1, 1994, making the adjustments to the list of eligible articles
that are required by section 504(c) of the 1974 Act and announcing the discretionary decisions referred to in this
notice, on the basis of official data covering all of calendar year 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It should be emphasized that the information set forth below covers only the first 10 months of 1993. Partial year data
is being published now to provide the maximum possible advance indication of adjustments that may be made to meet the
requirements of section 504(c) of the 1974 Act and to afford the earliest opportunity for comment on the possible discretionary
decisions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
List I below shows specific GSP-eligible articles for beneficiaries which have already exceeded estimated competitive
need limitations (i.e., a beneficiary supplied over $107,320,423 or $41,621,070 in the case where a beneficiary
has been found sufficiently competitive in the product, during January&hyph;October 1993) or have been graduated
from the GSP in early years pursuant to the President's discretionary authority.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
List II below shows beneficiaries which are approaching the competitive need limitations (i.e., a beneficiary accounted
for over 42 percent of the value of total U.S. imports and/or over $85,856,338 million or in the case where a beneficiary
has been found sufficiently competitive, over 21 percent and/or $33,296,856 million during January&hyph;October
1993).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
List III below shows beneficiaries which, despite accounting for more than 50 percent (or 25 percent in the case of
a beneficiary found sufficiently competitive in a product) of the value of total U.S. imports of an article, may be
eligible to receive GSP benefits through the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
de minimis
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 waiver (i.e., where a beneficiary accounted for more than the applicable percentage limit but the value of total U.S.
imports of the item was less that $12,553,356 during January&hyph;October 1993).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
List IV below shows articles from beneficiaries which are currently ineligible for GSP duty-free treatment but which
may be eligible for redesignation to GSP status pursuant to the President's discretionary authority (i.e., a beneficiary
accounted for less than 50 percent, or 25 percent in the case of products for which it was found sufficiently competitive,
of the value of U.S. imports and the value of U.S. imports of the article from the beneficiary developing country was
less than the applicable dollar limit during January&hyph;October 1993). This list does not include articles from
India which do not receive GSP treatment as a result of Presidential Proclamation 6425 of April 29, 1992 (57 FR 19067),
6446 of June 15, 1992 (57 FR 26969) or 6447 of June 15, 1992 (57 FR 26981).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
V. Public Comments
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
All written comments with regard to the decisions summarized above should be addressed to: GSP Subcommittee, Office
of the U.S. Trade Representative, 600 17th Street NW., room 517, Washington, DC 20506. All submissions must be in English
and should conform to the information requirements of 15 CFR 2007. Furthermore, each party providing comments should
indicate on the first page of the submission its name, the relevant Harmonized Tariff Schedule subheading(s), the
beneficiary country or territory of interest, and the type of action (i.e., the use of the President's 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
de minimis
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 waiver authority, etc.) in which the party is interested.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A party must provide fourteen copies of its statement which must be received by the Chairman of the GSP Subcommittee
no later than 5 p.m., Wednesday, March 2. Comments received after the deadline will not be accepted. If the comments
contain business confidential information, fourteen copies of a non-confidential version must also be submitted.
A justification as to why the information contained in the submission should be treated confidentially must be included
in the submission. In addition, the submissions containing confidential information should be clearly marked ``confidential''
at the top and bottom of each page of the submission. The version that does not contain confidential information should
also be clearly marked, at the top and bottom of each page, ``public version'' or ``non-confidential''.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Written comments submitted in connection with these decisions, except for information granted ``business confidential''
status pursuant to 15 CFR 2007.7, will be available for public inspection shortly after the filing deadline by appointment
only with the staff of the USTR Public Reading Room. Other requests and questions should be directed to the GSP Information
Center at USTR by calling (202) 395&hyph;6971.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
VI. Disposition of the Review of Worker Rights Practices in Costa Rica and Paraguay in the 1993 Annual GSP Review
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In June 1993, petitions were filed with the Office of the United States Trade Representative that requested a review
of worker rights practices in Costa Rica and in Paraguay in the 1993 Annual GSP Review. In October 1993, the petitions
were accepted and a review was initiated to determine whether Costa Rica and Paraguay were complying with the worker
rights provision of section 502 of the Trade Act of 1974 (19 U.S.C. 2462), which requires beneficiary countries to
have taken and be taking steps to afford internationally recognized worker rights (58 FR 53959). At the time that the
petitions were accepted for review, United States Trade Representative Kantor noted that, because actions to improve
worker rights in Costa Rica and Paraguay were in process, the GSP reviews could be terminated at any time during the
review period. In December 1993, Costa Rica and Paraguay were found to be taking steps to afford internationally recognized
worker rights, as provided in section 502 of the Trade Act of 1974, because substantial positive actions had been taken
by the Government of Costa Rica and the Government of Paraguay to resolve the allegations and shortcomings listed
in the petitions. Accordingly, the GSP reviews were terminated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Frederick L. Montgomery,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chairman, Trade Policy Staff Committee.
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3190&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d320 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
E:GRAPHICSEN02FE94.017
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</IMPORT>

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d320 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
E:GRAPHICSEN02FE94.018
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</IMPORT>

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d320 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
E:GRAPHICSEN02FE94.019
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</IMPORT>

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d320 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
E:GRAPHICSEN02FE94.020
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</IMPORT>

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d320 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
E:GRAPHICSEN02FE94.021
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</IMPORT>

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d320 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
E:GRAPHICSEN02FE94.022
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</IMPORT>

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d320 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
E:GRAPHICSEN02FE94.023
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</IMPORT>

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d320 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
E:GRAPHICSEN02FE94.024
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</IMPORT>

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d320 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
E:GRAPHICSEN02FE94.025
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</IMPORT>

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d320 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
E:GRAPHICSEN02FE94.026
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</IMPORT>

<!-- PJG /STAG -->

<!-- PJG STAG 4703 -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2300 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3190&hyph;-01&hyph;C
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00092 </DOCNO>
<PARENT> FR940202-2-00066 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4718 -->

<!-- PJG STAG 4718 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 22&blank;/&blank;Wednesday, February 2, 1994&blank;/&blank;Sunshine Act Meetings
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Vol. 59, No. 22
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
Wednesday, February 2, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=94 g=1 f=1 -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=10 g=1 f=2 -->
AFRICAN DEVELOPMENT FOUNDATION
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
Board of Directors Meeting
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
TIME:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 10:00 a.m.&hyph;12:00 noon.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PLACE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 ADF Headquarters.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Friday, February 4, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
STATUS:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Open.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Agenda
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
11:00&blank;President's Report
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12:00&blank;Audit Committee Report
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12:30&blank;Executive Session
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If you have any questions or comments, please direct them to Ms. Janis McCollim, Executive Assistant to the President,
who can be reached at (202) 673&hyph;3916.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Gregory Robeson Smith,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
President.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2426 Filed 1&hyph;31&hyph;94; 12:49 pm]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6116&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00093 </DOCNO>
<PARENT> FR940202-2-00067 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
department of energy
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
federal energy regulatory commission
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
``federal register'' citation of previous announcement: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
January 25, 1994, 59 FR 3647.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
previously announced time and date of meeting: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
January 26, 1994, 10:00 a.m.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
change in the meeting: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The following Docket Numbers have been added to Item CAG&hyph;5 on the Agenda scheduled for January 26, 1994:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Item No., Docket No., and Company
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
CAG&hyph;5_RP93&hyph;184&hyph;000, RP93&hyph;185&hyph;000 and RP94&hyph;76&hyph;000, Carnegie Natural
Gas Company
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2465 Filed 1&hyph;31&hyph;94; 2:18 pm]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6712&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->
 
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00094 </DOCNO>
<PARENT> FR940202-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
National Science Foundation 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG ITAG l=10 g=1 f=2 -->
National Science Board Office 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATE AND TIME: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=25 g=1 f=2 -->
February 10, 1994, 8:00 a.m., Closed Session 
<!-- PJG 0012 frnewline -->
February 11, 1994, 9:00 a.m., Closed Session 
<!-- PJG 0012 frnewline -->
February 12, 1994, 9:50 a.m., Open Session 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PLACE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
National Science Foundation, 4201 Wilson Boulevard, Arlington, VA 22230. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
STATUS: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=2 -->
Part of this meeting will be open to the public.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Part of this meeting will be closed to the public. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
MATTERS TO BE CONSIDERED: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=2 -->
Thursday, February 10, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=2 -->
Closed Session (8:00 a.m._5:00 p.m.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=2 -->
_Committee and Task Force Meetings 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=2 -->
Friday, February 11, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=2 -->
Closed Session (9:00 a.m._9:50 a.m.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=2 -->
_Minutes of November 1993 Meeting 
<!-- PJG 0012 frnewline -->
_Budget 
<!-- PJG 0012 frnewline -->
_Grants and Contracts 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=2 -->
Friday, February 11, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=2 -->
Open Session (9:50 a.m._11:35 a.m.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=2 -->
_Minutes 
<!-- PJG 0012 frnewline -->
_Chairman's Report 
<!-- PJG 0012 frnewline -->
_Director's Report
<!-- PJG 0012 frnewline -->
_Reports from Committees 
<!-- PJG 0012 frnewline -->
_Presentation 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=2 -->
Marta Cehelsky, 
<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=2 -->
Executive Officer. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=2 -->
[FR Doc. 94&hyph;2385; Filed 1&hyph;31&hyph;94; 9:14 am] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=2 -->
BILLING CODE 7555&hyph;01&hyph;M 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00095 </DOCNO>
<PARENT> FR940202-2-00069 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=2 -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
U.S. RAILROAD RETIREMENT BOARD 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
Notice of Public Meeting 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Notice is hereby given that the Railroad Retirement Board will hold a meeting on February 9, 1994, 9:00 a.m., at the
Board's meeting room on the 8th floor of its headquarters building, 844 North Rush Street, Chicago, Illinois, 60611.
The agenda for this meeting follows: 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=2 -->
Portion Open to the Public 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
(1) Plan to Improve the Quality and Timeliness of RUIA Claims Processing. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(2) Generic National performance Review Letter. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(3) Field Migration Schedule. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(4) Pocatello Base Point_Change-of-Station Moving Expenses (Pocatello). 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(5) ADP Steering Committee. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(6) Bureau of the Actuary.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(7) Regulations_Parts 202 and 301, Employers Under the Railroad Retirement Act and Railroad Unemployment Insurance
Act. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(8) Regulations_Part 203, Employees Under the Railroad Retirement Act. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(9) Regulations_Part 230, Reduction and Non-Payment of Annuities by Reason of Work. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(10) Regulations_Part 328, Voluntary Leaving of Work. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(11) Regulations_Part 345, Contribution and Contribution Reports. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=2 -->
Portion Closed to the Public 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
(A) 1994 Performance Appraisal Plans (Individuals Who Report Directly to the Board). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=2 -->
The person to contact for more information is Beatrice Ezerski, Secretary to the Board, COM No. 312&hyph;751&hyph;4920,
FTS No. 386&hyph;4920. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->
Dated: January 28, 1994. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=2 -->
Beatrice Ezerski, 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=2 -->
Secretary to the Board. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=2 -->
[FR Doc. 94&hyph;2416 Filed 1&hyph;31&hyph;94; 11:58 am] 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=2 -->
BILLING CODE 7905&hyph;01&hyph;M 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00096 </DOCNO>
<PARENT> FR940202-2-00070 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=2 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
TIME AND DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
9:00 a.m., February 7, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PLACE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Uniformed Services University of the Health Sciences, Room D3001, 4301 Jones Bridge Road, Bethesda, Maryland 20814&hyph;4799.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
STATUS: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Open_under ``Government in the Sunshine Act'' (5 U.S.C. 552b(e)(3)).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
MATTERS TO BE CONSIDERED: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=1 -->
9:00 a.m. Meeting_Board of Regents
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
(1) Approval of Minutes_1 November 1993; (2) Awards; (3) Graduate Degrees; (4) Faculty Matters; (5) Departmental
Reports; (6) Financial Report; (7) Report_President, USUHS; (8) Comments_Chairman, Board of Regents.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
New Business
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
CONTACT PERSON FOR MORE INFORMATION: Charles R. Mannix, Executive Secretary of the Board of Regents, 301/295&hyph;3028.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 31, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Linda Bynum,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Alternate OSD Federal Register Liaison Officer, Department of Defense.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2486 Filed 1&hyph;31&hyph;94; 3:46 pm]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 5000&hyph;04&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00097 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4717 -->

<!-- PJG STAG 4717 -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Wednesday
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
February 2, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=1 -->
Part II
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->
Department of Health and Human Services
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Centers for Disease Control and Prevention
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Draft Guideline for Prevention of Nosocomial Pneumonia; Notice of Comment Period
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG FTAG 4701 -->

<!-- PJG STAG 4701 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 22&blank;/&blank;Wednesday, February 2, 1994&blank;/&blank;Notices
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Centers for Disease Control and Prevention</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Draft Guideline for Prevention of Nosocomial Pneumonia: Part 1. ``Issues on Prevention of Nosocomial Pneumonia_1994''
and Part 2. ``Recommendations for Prevention of Nosocomial Pneumonia''; Notice of Comment Period
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Centers for Disease Control and Prevention (CDC), Public Health Service (PHS), Department of Health and Human Services
(DHHS).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This notice is a request for review and comment of the draft Guideline for Prevention of Nosocomial Pneumonia. The
Guideline consists of two parts entitled ``Issues on Prevention of Nosocomial Pneumonia_1994,'' and ``Recommendations
for Prevention of Nosocomial Pneumonia,'' prepared by the Hospital Infection Control Practices Advisory Committee
(HICPAC) and the National Center for Infectious Diseases (NCID), CDC.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Written comments on the draft document must be received on or before April 4, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments on this document should be submitted in writing to the CDC, Attention: Pneumonia Guideline Information
Center, Mailstop A07, 1600 Clifton Road, NE., Atlanta, Georgia 30333. To order copies of the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 containing the document, contact the U.S. Government Printing Office, Order and Information Desk, Washington,
DC 20402&hyph;9329, at (202) 783&hyph;3238. Specify the date of the issue requested and stock number 069&hyph;001&hyph;000&hyph;70&hyph;0.
See page II of the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 for additional ordering and cost information. In addition, the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 may be viewed and photocopied at most libraries designated as U.S. Government Depository Libraries and at many other
public and academic libraries that receive the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 throughout the country. The order-desk operator can tell you the location of the U.S. Government Depository Library
nearest you.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Pneumonia Guideline Information Center, (404) 332&hyph;2569.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This document updates and replaces the previously published CDC Guideline for the Prevention of Nosocomial Pneumonia.
Emphasis is placed on bacterial pneumonias, including gram-negative bacillary pneumonias and Legionnaires' disease;
pneumonia due to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 spp.; and lower respiratory tract infections caused by respiratory syncytial and influenza viruses. Part I, ``Issues
on Prevention of Nosocomial Pneumonia_1994,'' was prepared by staff of NCID, CDC, and provides the background for
the HICPAC-consensus recommendations contained in Part II, ``Recommendations for Prevention of Nosocomial Pneumonia.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
HICPAC was established in 1991 to provide advice and guidance to the Secretary, DHHS; the Assistant Secretary for
Health; the Director, CDC; and the Director, NCID, regarding the practice of hospital infection control and strategies
for surveillance, prevention, and control of nosocomial infections in U.S. hospitals. The committee also advises
the CDC on periodic updating of guidelines and other policy statements regarding prevention of nosocomial infections.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Guideline for Prevention of Nosocomial Pneumonia is the first of a series of CDC guidelines being revised by HICPAC
and NCID, CDC.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 25, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Walter R. Dowdle,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Director, Centers for Disease Control and Prevention (CDC).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00098 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=74 g=1 f=1 -->
GUIDELINE FOR PREVENTION OF NOSOCOMIAL PNEUMONIA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Second Edition
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Table of Contents
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Executive Summary
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Introduction
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Part I. Issues on Prevention of Nosocomial Pneumonia_1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Bacterial Pneumonia
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
I. Etiologic Agents
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
II. Diagnosis
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
III. Epidemiology
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
IV. Pathogenesis
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
V. Risk Factors and Control Measures
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Oropharyngeal, Tracheal, and Gastric Colonization
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Aspiration of Oropharyngeal and Gastric Flora
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. Mechanically Assisted Ventilation
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D. Cross-Colonization Via Hands of Personnel
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
E. Contamination of Devices Used on the Respiratory Tract
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Mechanical Ventilators and Anesthesia Machines
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Humidifiers, Breathing Circuits, and Heat-Moisture Exchangers
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Large-Volume Nebulizers
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Small-Volume Medication Nebulizers
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. Suction Catheters, Resuscitation Bags, Oxygen Analyzers, and Ventilator Spirometers
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
F. Thoraco-Abdominal Surgical Procedures
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
G. Other Prophylactic Measures
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Vaccination of Patients
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Prophylaxis With Systemic Antimicrobial Agents
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Kinetic Therapy for the Immobilized State
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Legionnaires' Disease
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
I. Epidemiology
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
II. Diagnosis
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
III. Modes of Transmission
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
IV. Definition of Nosocomial Legionnaires' Disease
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
V. Prevention and Control Measures
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Prevention of Legionnaires' Disease in Hospitals With No Identified Cases (Primary Prevention)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Prevention of Legionnaires' Disease in Hospitals With Identified Cases (Secondary Prevention)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Aspergillosis
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
I. Epidemiology
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
II. Pathogenesis
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
III. Diagnosis
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
IV. Risk Factors and Control Measures
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Viral Pneumonias
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
RSV Infection
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
I. Epidemiology
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
II. Diagnosis
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
III. Modes of Transmission
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
IV. Control Measures
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Influenza
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
I. Epidemiology
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
II. Diagnosis
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
III. Prevention and Control Measures
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Part II. Recommendations for Prevention of Nosocomial Pneumonia
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Introduction
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Prevention and Control of Bacterial Pneumonia
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
I. Staff Education and Infection Surveillance
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Staff Education
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Surveillance
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
II. Interruption of Transmission of Microorganisms
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Sterilization or Disinfection, and Maintenance of Equipment and Devices
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. General Measures
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Mechanical Ventilators, Anesthesia Machines and Circle Systems, and Pulmonary-Function Testing Equipment
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Ventilator Circuits With Humidifiers
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Ventilator Circuits With Hygroscopic Condenser-Humidifiers or Heat-Moisture Exchangers
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. Wall Humidifiers
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. Small-Volume Medication Nebulizers: ``In-Line'' and Hand-Held Nebulizers
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00099 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=24 g=1 f=1 -->
7. Large-volume nebulizers and mist tents 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8. Other Devices 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Interruption of Person-to-Person Transmission of Bacteria 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Handwashing 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Barrier Precautions 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Care of Patients with Tracheostomy 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Suctioning of Respiratory Tract Secretions 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
III. Modifying Host Risk for Infection 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Precautions for Prevention of Endogenous Pneumonia 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Prevention of Aspiration 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Prevention of Gastric Colonization 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Prevention of Postoperative Pneumonia 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. Other Prophylactic Procedures for Pneumonia 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Vaccination of Patients 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Systemic Antimicrobial Prophylaxis 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Use of Rotating ``Kinetic'' Beds 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Prevention and Control of Legionnaires' Disease 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
I. Staff Education and Infection Surveillance 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Staff Education 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Surveillance 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
II. Interruption of Transmission of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
 spp. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Primary Prevention (Preventing Nosocomial Legionnaires' Disease when No Cases have been Documented) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Nebulization and Other Devices 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Cooling Towers 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Water-Distribution System 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Secondary Prevention (Response to Identification of Laboratory-Confirmed Nosocomial Legionellosis) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Prevention and Control of Nosocomial Pulmonary Aspergillosis 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
I. Staff Education and Infection Surveillance 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Staff Education 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Surveillance 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
II. Interruption of Transmission of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
 spp. Spores 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Planning New Specialized-Care Units for High-Risk Patients 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. In Existing Facilities with no Cases of Nosocomial Aspergillosis 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. When a Case of Nosocomial Aspergillosis Occurs 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
III. Modifying Host Risk for Infection 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Prevention and Control of Respiratory Syncytial Virus (RSV) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
I. Staff Education and Infection Surveillance 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Staff Education 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Surveillance 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
II. Interruption of Transmission of RSV 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Prevention of Person-to-Person Transmission 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Primary Measures for Contact Isolation 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. Handwashing 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. Gloving
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
c. Gowning 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
d. Staffing 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
e. Limiting Visitors 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Control of RSV Outbreaks 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. Use of Private Room, Cohorting, and Patient-Screening 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. Personnel Cohorting 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
c. Postponing Patient Admission 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
d. Wearing Eye-Nose Goggles 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Prevention and Control of Influenza 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
I. Staff Education and Infection Surveillance 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Staff Education 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Surveillance 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
II. Modifying Host Risk for Infection 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Vaccination 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Patients 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Personnel 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Use of Antiviral Agents 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
III. Interruption of (Person-to-Person) Transmission 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
IV. Control of Influenza Outbreaks 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Determining the Outbreak Strain 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Vaccination of Patients and Personnel 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. Amantadine or Rimantadine Administration 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D. Interruption of (Person-to-Person) Transmission 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00100 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Table 1. Microorganisms Isolated from Respiratory Tract Specimens Obtained by Various Representative Methods
from Adult Patients with a Diagnosis of Nosocomial Pneumonia 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Table 2. Controlled Studies on Nosocomial Lower Respiratory Tract Infections and Other Associated Outcomes of Selective
Decontamination of the Digestive Tract in Adult Patients with Mechanically Assisted Ventilation 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Table 3. Risk Factors and Suggested Infection Control Measures for Prevention of Nosocomial Pneumonia 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Figure 1. Pathogenesis of Nosocomial Bacterial Pneumonia 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Appendix A. Semicritical Items Used on the Respiratory Tract 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Appendix B. Maintenance Procedures to Decrease Survival and Multiplication of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
 spp. in Potable-Water Distribution Systems 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Appendix C. Culturing Environmental Specimens for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
 spp. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Appendix D. Procedure for Cleaning Cooling Towers and Related Equipment to Prevent Legionellosis 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
References 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Executive Summary 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This document updates and replaces the previously published CDC Guideline for Prevention of Nosocomial Pneumonia
(Infection Control 1982;3:327&hyph;33, Resp Care 1983;28:221&hyph;32, and Am J Infect Control 1983;11230&hyph;9).
The revised guideline is designed to reduce the incidence of nosocomial pneumonia and provides the rationale (in
Part I) for the recommendations (in Part II) considered prudent by consensus of the members of HICPAC. A working draft
of the guideline has been reviewed by experts in infection control, pulmonology, respiratory therapy, anesthesiology,
internal medicine, and pediatrics. However, all recommendations in the guideline may not reflect the opinions of
all reviewers. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pneumonia is the second most common nosocomial infection in the United States and is associated with substantial
morbidity and mortality. Most patients with nosocomial pneumonia are those with extremes of age, severe underlying
disease, immunosuppression, depressed sensorium, cardiopulmonary disease, and thoraco-abdominal surgery.
Although patients with mechanically assisted ventilation do not comprise a major proportion of patients with nosocomial
pneumonia, they have the highest risk of developing the infection. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Most bacterial nosocomial pneumonias occur by aspiration of bacteria colonizing the oropharynx or upper gastrointestinal
tract of the patient. Intubation and mechanical ventilation greatly increase the risk of nosocomial bacterial pneumonia
because they alter first-line patient defenses. Pneumonias due to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp., and influenza virus are often caused by inhalation of contaminated aerosols. Respiratory syncytial virus
(RSV) infection usually follows viral inoculation of the conjunctivae or nasal mucosa by contaminated hands. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Traditional preventive measures for nosocomial pneumonia include decreasing aspiration by the patient, preventing
cross-contamination or colonization via hands of personnel, appropriate disinfection or sterilization of respiratory-therapy
devices, use of available vaccines to protect against particular infections, and education of hospital staff and
patients. New measures under investigation involve reducing oropharyngeal and gastric colonization by pathogenic
microorganisms. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Introduction
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Guideline for Prevention of Nosocomial Pneumonia is intended for use by personnel who are responsible for surveillance
and control of infections in acute-care hospitals. The guideline may not be applicable in long-term care facilities
because of the unique characteristics of these settings. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00101 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The revised guideline addresses common problems encountered by infection-control practitioners regarding the
prevention and control of nosocomial pneumonia in U.S. hospitals. Sections on the prevention of bacterial pneumonia
in mechanically ventilated and/or critically ill patients, care of respiratory-therapy devices, prevention of
cross-contamination, and prevention of viral lower respiratory-tract infections, such as respiratory syncytial
virus (RSV) and influenza infections, have been expanded and updated. New sections on Legionnaires' disease and
pneumonia due to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. have been added. Lower respiratory tract infection due to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Mycobacterium tuberculosis
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 is not addressed in this document; it is covered in separate guidelines.
<FOOTCITE>1</FOOTCITE>

<FOOTCITE>*</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<!-- PJG ITAG l=28 g=1 f=1 -->
*Footnotes to appear at end of docket.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Part I, Issues for Prevention of Nosocomial Pneumonia_1994, can be an important resource for educating healthcare
workers regarding prevention and control of nosocomial respiratory tract infections. Because education of healthcare
workers is the cornerstone of an effective infection control program, hospitals should give high priority to continuing
infection control educational programs for these staff members. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
PART I. ISSUES ON PREVENTION OF NOSOCOMIAL PNEUMONIA_1994 
<!-- PJG 0012 frnewline -->
BACTERIAL PNEUMONIA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Etiologic Agents 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The reported distribution of etiologic agents causing nosocomial pneumonia varies between hospitals because of
differences in patient populations and diagnostic methods employed.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2&hyph;11
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In general, however, bacteria have been the most frequently isolated pathogens.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2&hyph;7,10,12&hyph;14
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Schaberg et al. reported that in 1986&hyph;1989, aerobic bacteria comprised at least 73%, and fungi 4%, of isolates
from sputum and tracheal aspirates of cases at the University of Michigan Hospitals and hospitals participating
in the National Nosocomial Infection Surveillance (NNIS); very few anaerobic bacteria and no viruses were reported,
probably because anaerobic and viral cultures were not performed routinely in the reporting hospitals (Table 1).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Similarly, cultures of bronchoscopic specimens from mechanically ventilated patients with pneumonia have rarely
yielded anaerobes.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
6&hyph;8,10,12,15,16
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Only the report by Bartlett, which was based mainly on cultures of transtracheal aspirates in patients not receiving
mechanically assisted ventilation, showed a predominance of anaerobes.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Nosocomial bacterial pneumonias are frequently polymicrobial,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
5,8,10,12,13,16&hyph;20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and gram-negative bacilli are the usual predominant organisms (Table 1);
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2&hyph;7,10,12&hyph;14
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 however, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Staphylococcus aureus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (especially methicillin-resistant 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
S. aureus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
6,8,11,16,21
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and other gram-positive cocci, including 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Streptococcus pneumoniae,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
6,8
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 have recently emerged as significant isolates;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
15
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Haemophilus influenza
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 has been isolated from mechanically ventilated patients with pneumonia that occurs within 48&hyph;96 hours after
intubation.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
4&hyph;6,13,16,22
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In NNIS hospitals, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Pseudomonas aeruginosa, Enterobacter 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
sp.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 Klebsiella pneumoniae, Escherichia coli, Serratia marcescens, and Proteus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. comprised 50% of the isolates from cultures of respiratory tract specimens of patients for whom nosocomial pneumonia
was diagnosed by using clinical criteria; 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
S. aureus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 accounted for 16%, and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
H. influenzae,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for 6% (Table 1).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Fagon and co-workers reported that gram-negative bacilli were present in 75% of quantitative cultures of protected-specimen
brushings (PSB) from patients who had received mechanically assisted ventilation and acquired nosocomial pneumonia;
40% were polymicrobial.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
6
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In the report by Torres et al., 20% of pathogens recovered from cultures of PSB, blood, pleural fluid, or percutaneous
lung aspirate were gram-negative bacilli in pure culture, and 17% were polymicrobial; however, 54% of specimens
did not yield any microorganism, probably because of receipt of antibiotics by patients.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
7
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Diagnosis 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The diagnosis of nosocomial bacterial pneumonia has been difficult.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
8,9,17,23&hyph;32
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Frequently, the criteria for diagnosis have been fever, cough, and development of purulent sputum, in combination
with radiologic evidence of a new or progressive pulmonary infiltrate, a suggestive Gram's stain, and cultures of
sputum, tracheal aspirate, pleural fluid, or blood.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
4,5,23,25,33&hyph;36
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Although clinical criteria together with cultures of sputum or tracheal specimens may be sensitive for bacterial
pathogens, they are highly nonspecific, especially in patients with mechanically assisted ventilation;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
9,10,13&hyph;16,19,24&hyph;26,29,31,37&hyph;42
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on the other hand, cultures of blood or pleural fluid have very low sensitivity.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
9,19,20,43
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Because of these problems, a group of investigators recently formulated consensus recommendations for standardization
of methods to diagnose pneumonia in clinical research studies of ventilator-associated pneumonia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
44&hyph;46
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 These methods involve bronchoscopic techniques, e.g., quantitative culture of PSB,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
6,8&hyph;10,14,16,27,31,38,41,47,48
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 BAL,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
8,13,41,47,49&hyph;54
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and pBAL.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
15
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The reported sensitivities and specificities of these methods have ranged between 70% to 100% and 60% to 100%, respectively,
depending on the tests or diagnostic criteria they were compared with. Because these techniques are invasive, they
may cause complications such as hypoxemia, bleeding, or arrhythmia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
9,14,42,44,52,55,56
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In addition, the sensitivity of the PSB procedure may decrease in patients receiving antibiotic therapy.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
10,14,27
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Nonbronchoscopic (NB) procedures, e.g., NB-pBAL
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
13,27,57,58
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or NB&hyph;PSB,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
14
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 which utilize blind catheterization of the distal airways, have been developed recently; however, they have not
been extensively evaluated. Although the use of bronchoscopic and nonbronchoscopic diagnostic tests can be a major
step in better defining the epidemiology of nosocomial pneumonia especially in mechanically ventilated patients,
further studies are needed to determine their applicability in daily clinical practice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Epidemiology 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00102 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NNIS reports that pneumonias (diagnosed on the basis of the CDC surveillance definition of nosocomial pneumonia)
and surgical-wound infections account for approximately 15% each of all hospital-associated infections and are
the second most common nosocomial infections after that of the urinary tract.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In 1984, the overall incidence of lower respiratory tract infection was 6 per 1,000 discharged patients.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The incidence ranged from 4.2 to 7.7 per 1,000 discharged patients for nonteaching and university-affiliated hospitals,
respectively, probably reflecting institutional differences in the level of patients' risk for acquiring nosocomial
pneumonia. 
<!-- PJG 0012 frnewline -->
Nosocomial bacterial pneumonia often has been identified as a postoperative infection.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
59,60
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In the Study of the Efficacy of Nosocomial Infection Control in the 1970s, 75% of reported cases of nosocomial bacterial
pneumonia occurred in patients who had had a surgical operation; the risk was 38 times greater for thoracoabdominal
procedures than for those involving other body sites.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
60
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 More recent epidemiologic studies, including NNIS studies, have identified other subsets of patients at high risk
of developing nosocomial bacterial pneumonia: Patients with endotracheal intubation and/or mechanically assisted
ventilation, depressed level of consciousness (particularly those with closed-head injury), prior episode of
a large-volume aspiration, or underlying chronic lung disease, and patients >70 years of age. Other risk factors include
24-hour ventilator-circuit changes, fall-winter season, stress-bleeding prophylaxis with cimetidine with or
without antacid, presence of a nasogastric tube, severe trauma, and recent bronchoscopy.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
7,34,35,61&hyph;69
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Recently, NNIS stratified the incidence density of nosocomial pneumonia by patients' use of mechanical ventilator
and type of intensive care unit (ICU). From 1986 to 1990, the median rate of ventilator-associated pneumonia per 1,000
ventilator-days ranged from 4.7 in pediatric ICUs to 34.4 in burn ICUs.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
63
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In contrast, the median rate of nonventilator-associated pneumonia per 1000 ICU-days ranged from 0 in pediatric
and respiratory ICUs to 3.2 in trauma ICUs. 
<!-- PJG 0012 frnewline -->
Nosocomial pneumonia has been associated with high fatality rates. Crude mortality rates of 20%&hyph;50% and attributable
mortality rates of 30%&hyph;33% have been reported; in one study, pneumonia comprised 60% of all deaths due to nosocomial
infections.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
18,35,70&hyph;75
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Patients receiving mechanically assisted ventilation have higher mortality rates than patients not receiving
ventilation support; however, other factors, such as a patient's underlying disease(s) and organ failure, are stronger
predictors of death in patients with pneumonia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
34
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Pneumonia-associated morbidity has not been evaluated in recent years. Past studies, however, have shown that pneumonia
could prolong hospitalization by 4&hyph;9 days.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
74&hyph;77
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 A conservative estimate of the direct cost of excess hospital stay due to pneumonia is $1.1 billion a year for the nation.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
78
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Because of its reported frequency, associated high fatality rate, and attendant costs, nosocomial pneumonia is
a major infection control problem. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Pathogenesis 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Bacteria may invade the lower respiratory tract by aspiration of oropharyngeal organisms, inhalation of aerosols
containing bacteria, or less frequently, by hematogenous spread from a distant body site (Figure 1). In addition,
bacterial translocation from the gastrointestinal tract has been recently hypothesized as a mechanism for infection.
Of these routes, aspiration is believed to be the most important for both nosocomial and community-acquired pneumonia.

<!-- PJG 0012 frnewline -->
In radioisotope-tracer studies of healthy adults, 45% were found to aspirate during sleep.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
79
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Persons with abnormal swallowing, such as those who have depressed consciousness, respiratory tract instrumentation
and/or mechanically assisted ventilation, gastrointestinal tract instrumentation or diseases, or have just undergone
surgery, are particularly likely to aspirate.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
7,34,35,60,80
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
The high incidence of gram-negative bacillary pneumonia in hospitalized patients appears to be the result of factors
that promote colonization of the pharynx by gram-negative bacilli and the subsequent entry of these organisms into
the lower respiratory tract.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
33,81&hyph;84
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Whereas aerobic gram-negative bacilli are recovered infrequently or are found in small numbers in pharyngeal cultures
of healthy persons,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
81,85
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 colonization dramatically increases in patients with coma, hypotension, acidosis, azotemia, alcoholism, diabetes
mellitus, leukocytosis, leukopenia, pulmonary disease, nasogastric or endotracheal tubes in place, and in patients
given antimicrobial agents.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
33,84,86,87
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Oropharyngeal or tracheobronchial colonization by gram-negative bacilli begins with the adherence of the microorganisms
to the host's epithelial cells.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
83,88&hyph;90
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Adherence may be affected by multiple factors related to the bacteria (presence of pili, cilia, capsule, or production
of elastase or mucinase), host cell (surface proteins and polysaccharides), and environment (pH and presence of
mucin in respiratory secretions).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
82,83,88,91&hyph;100
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The exact interactions among these factors have not been fully elucidated, but studies indicate that certain substances,
such as fibronectin, can inhibit the adherence of gram-negative bacilli to host cells.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
91,93,101
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Conversely, certain conditions, such as malnutrition, severe illness, or post-operative state, can increase adherence
of gram-negative bacteria.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
82,91,95,100,102
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Besides the oropharynx, the stomach has been postulated to be an important reservoir of organisms that cause nosocomial
pneumonia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
34,103&hyph;107
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The stomach's role may vary depending on the patient's underlying conditions and on prophylactic or therapeutic
interventions.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
22,104,108&hyph;111
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In healthy persons, few bacteria entering the stomach survive in the presence of hydrochloric acid at pH&lt;2.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
112,113
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 However, when gastric pH increases from the normal levels to >4, microorganisms are able to multiply to high concentrations
in the stomach.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
110,112,114&hyph;116
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 This can occur in patients with advanced age,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
114
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 achlorhydria,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
112
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 ileus, or upper gastrointestinal disease, and in patients receiving enteral feeding, antacids, or histamine-2
[H&hyph;2] antagonists.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
104,110,111,116&hyph;118
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The contribution of other factors, such as duodeno-gastric reflux and the presence of bile, to gastric colonization
in patients with impaired intestinal motility has been suggested and needs further investigation.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
109
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Bacteria can also gain entry into the lower respiratory tract of hospitalized patients through inhalation of aerosols
generated primarily by contaminated respiratory-therapy or anesthesia-breathing equipment.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
119&hyph;122
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Outbreaks related to the use of respiratory-therapy equipment have been associated with contaminated nebulizers,
which are humidification devices that produce large amounts of aerosol droplets &lt;4&mu;m via ultrasound, spinning
disk, or the Venturi mechanism.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
119,122,123
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 When the fluid in the reservoir of a nebulizer becomes contaminated with bacteria, the aerosol produced may contain
high concentrations of bacteria that can be deposited deep in the patient's lower respiratory tract.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
119,123,124
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Because endotracheal and tracheal tubes provide direct access to the lower respiratory tract, contaminated aerosol
inhalation is particularly hazardous for intubated patients. In contrast to nebulizers, bubble-through or wick
humidifiers mainly increase the water-vapor (or molecular-water) content of inspired gases. Although heated bubble-through
humidifiers generate aerosol droplets, they do so in quantities that may not be clinically significant;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
120,125
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 wick humidifiers do not generate aerosols. 
<!-- PJG 0012 frnewline -->
Rarely, bacterial pneumonia can result from hematogenous spread of infection to the lung from another infection
site, e.g., pneumonia resulting from purulent phlebitis or right-sided endocarditis. Another mechanism, translocation
of bacteria via the passage of viable bacteria from the lumen of the gastrointestinal tract through epithelial mucosa
to the mesenteric lymph nodes and to the lung has been shown in animal models.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
126
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Translocation is postulated to occur in patients with immunosuppression, cancer or burns;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
126
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 however data are lacking regarding this mechanism in humans.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
127
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00103 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
V. Risk Factors and Control Measures
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Several large studies have examined potential risk factors for nosocomial bacterial pneumonia (Table 3).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
7,34,35,128,129
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Although specific risk factors may differ between study populations, they can be grouped into the following general
categories: (1) Host factors such as extremes of age and severe underlying conditions, including immunosuppression;
(2) factors, such as admission to the ICU, underlying chronic lung disease, or coma, that enhance colonization of
the oropharynx and/or stomach by microorganisms; (3) conditions favoring aspiration or reflux, including endotracheal
intubation or insertion of nasogastric tube; (4) conditions requiring prolonged use of mechanical ventilatory
support with exposure to contaminated respiratory equipment and/or contact with colonized hands of healthcare
workers; and (5) factors that impede adequate pulmonary toilet, such as surgical procedures involving the head,
neck, thorax, or upper abdomen, and immobilization due to trauma or illness.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
7,33&hyph;35,59,128
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Oropharyngeal, Tracheal, and Gastric Colonization
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The association between colonization of the oropharynx,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
81,130
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 trachea,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
131
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or stomach
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
103,104,110,116
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and predisposition to gram-negative bacillary pneumonia prompted attempts to prevent infection either by prophylactic
local application of antimicrobial agent(s)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
132,133
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or utilizing the phenomenon of local bacterial interference.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
134,135
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Although early work suggested that the former method, aerosolized antimicrobials, could eradicate common gram-negative
pathogens from the upper respiratory tract,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
131
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 superinfection occurred in some patients receiving this therapy.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
132&hyph;134,136,137
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The latter method, bacterial interference (with alpha-hemolytic streptococci), has been successfully used by
some investigators to prevent oropharyngeal colonization by aerobic gram-negative bacilli.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
134
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 However, the efficacy of this method for use in general has not been evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The administration of antacids and H2-blockers for prevention of stress bleeding in critically ill, postoperative,
and/or mechanically ventilated patients has been associated with gastric bacterial overgrowth in many studies.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
34,105,106,111,115,116,138&hyph;140
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Sucralfate, a cytoprotective agent that has little effect on gastric pH and may have bactericidal properties of its
own, has been suggested as a potential substitute for antacids and H2-blockers.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
141&hyph;143
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The results of clinical trials comparing the risk of pneumonia in patients receiving sucralfate to that in patients
given antacids and/or H2-blockers have been variable.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
105,111,140,141,144,145
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In most randomized trials, ICU patients receiving mechanically assisted ventilation and antacids with or without
H2&hyph;b lockers had increased gastric pH, high bacterial counts in the gastric fluid, and increased risk of pneumonia
compared with patients given sucralfate.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
105,111,140,141,144
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In one report with a large number of study patients, the incidence of early-onset pneumonia (occurring &gt;4 days
after intubation) did not differ between patient groups, but late-onset pneumonia occurred in 5% of 76 patients who
received sucralfate, 16% of 69 given antacids, and 21% of 68 who received an H2-blocker.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
140
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 On the other hand, a meta-analysis of data from eight earlier studies did not show a strong association between nosocomial
pneumonia and drugs that raise gastric pH.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
146
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Further comparative studies are underway in which bronchoscopy with PSB or BAL is utilized for the diagnosis of pneumonia.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Selective decontamination of the digestive tract (SDD) is another strategy designed to prevent bacterial colonization
and lower respiratory tract infection in mechanically ventilated patients.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
147&hyph;170
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 SDD is aimed at preventing oropharyngeal and gastric colonization with aerobic gram-negative bacilli and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Candida 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp., without altering the anaerobic flora (Table 2).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
147&hyph;170
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 A variety of SDD regimens use a combination of locally administered nonabsorbable antibiotic agents such as polymyxin,
an aminoglycoside (tobramycin, gentamicin, or, rarely, neomycin), or a quinolone (norfloxacin or ciprofloxacin),
coupled with either amphotericin B or nystatin. The local antimicrobial preparation is applied as a paste to the oropharynx
and given orally or via the nasogastric tube four times a day. In addition, in many studies, a systemic (intravenous)
antimicrobial such as cefotaxime or trimethoprim is administered to the patient.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
While most clinical trials,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
147&hyph;151,153&hyph;160,162,164,169
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 including two meta-analyses,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
163,170
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of SDD have demonstrated a decrease in the rates of nosocomial respiratory infections, these trials have been difficult
to assess because they have differed in study design and population, and many have had short follow-up periods (Table
2). In most of these studies, the diagnosis of pneumonia was based on clinical criteria; bronchoscopy with BAL or PSB
was used in only a few studies.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
152,153,164,167,169
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Two recently published large double-blind, placebo-controlled trials demonstrated no benefit from SDD.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
166,167
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In one, a large French multicenter study by Gastinne et al, a significant decrease in incidence of gram-negative bacillary
pneumonia was not accompanied by a decrease in pneumonia from all causes.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
167
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In the other study, by Hammond et al, no differences were noted between patients randomized to SDD or to placebo; however,
both patient groups received intravenous cefotaxime.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
166
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Although an earlier meta-analysis suggested a trend toward decreased mortality in patients given SDD,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
163
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 a more recent and more extensive analysis highlights the equivocal effect of SDD on patient mortality, as well as the
high cost of using SDD to prevent pneumonia or death (i.e., in order to prevent one case of nosocomial pneumonia, or
one death due to nosocomial pneumonia, 6 [range: 5&hyph;9] or 23 [range: 13&hyph;39] patients, respectively, would
have to be given SDD.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
170
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Furthermore, there are concerns over the development of antimicrobial resistance and superinfection with gram-positive
bacteria and other antibiotic-resistant nosocomial pathogens.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
148,149,152,155
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Thus, currently available data do not justify the routine use of SDD for prevention of nosocomial pneumonia in ICU
patients. SDD may be ultimately useful for specific subsets of ICU patients, such as those with trauma or severe immunosuppression,
e.g., bone-marrow transplant recipients.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A new approach advocated to prevent oropharyngeal colonization in patients receiving enteral nutrition is to reduce
bacterial colonization of the stomach by acidifying the enteral feed.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
171
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Although the absence of bacteria from the stomach has been confirmed in patients given acidified enteral feeding,
the effect on the incidence of nosocomial pneumonia has not been evaluated.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
171
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00104 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Aspiration of Oropharyngeal and Gastric Flora
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Clinically significant aspiration usually occurs in patients who have one or more of the following conditions: a
depressed level of consciousness, dysphagia due to neurologic or esophageal disorders, an endotracheal (naso-
or oro-tracheal) and nasogastric tube in place, and receipt of enteral feeding.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
35,79,80,172&hyph;176
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Placement of nasogastric tube may increase nasopharyngeal colonization, cause reflux of gastric contents, or allow
bacterial migration via the tube from the stomach to the upper airway.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
173,176&hyph;178
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 When enteral feedings are administered, gross contamination of the enteral solution during preparation
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
179&hyph;181
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and elevated gastric pH
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
67,182,183
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 may lead to gastric colonization with gram-negative bacilli. In addition, gastric reflux and aspiration may occur
because of increased intragastric volume and pressure.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
67,110,173
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Prevention of pneumonia in such patients may be difficult, but methods that make regurgitation less likely, for example,
placing the patient in a semirecumbent position by elevating the head of the bed,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
175,184,185
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 administering enteral nutrition intermittently in small boluses rather than continuously,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
67,183
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 using flexible, small-bore enteral tubes,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
176,186
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and witholding enteral feeding when the residual volume in the stomach is large or if bowel sounds are not heard upon
auscultation of the abdomen, may be beneficial.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
175,187,188
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 On the other hand, placing the enteral tube below the stomach (e.g. in the jejunum) has yielded equivocal results.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
189,190
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Mechanically Assisted Ventilation and Endotracheal Intubation
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Patients receiving continuous, mechanically assisted ventilation have 6&hyph;21 times the risk of developing
nosocomial pneumonia compared with patients not receiving ventilatory support.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
34,60,62,70
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Data from the study by Fagon and co-workers indicate that the risk of developing ventilator-associated pneumonia
increases by 1% per day.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
6
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 This increased risk is partly due to carriage of oropharyngeal organisms upon passage of the endotracheal tube into
the trachea during intubation, as well as to depressed host defenses secondary to the patient's severe underlying
illness.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
7,34,35,191
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In addition, bacteria can aggregate on the surface of the tube over time and form a glycocalyx (biofilm) that protects
the bacteria from action of antimicrobial agents or host defenses.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
192
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Some investigators believe that these bacterial aggregates may become dislodged by ventilation flow, tube manipulation,
or suctioning, and subsequently embolize into the lower respiratory tract and cause focal pneumonia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
193,194
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Removing tracheal secretions by gentle suctioning and using aseptic technique to reduce cross-contamination from
respiratory therapy equipment or hands of personnel have been utilized traditionally to help prevent pneumonia
in patients receiving mechanically assisted ventilation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The risk of pneumonia is also increased by the direct access of bacteria to the lower respiratory tract, often because
of leakage around the endotracheal cuff,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
195,196
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 which allows pooled secretions above the cuff to enter the trachea.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
197
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In one recent study, the occurrence of nosocomial pneumonia was delayed and decreased in intubated patients whose
endotracheal tubes had a separate dorsal lumen that allowed drainage (by suctioning) of secretions in the space above
endotracheal cuff and below the glottis.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
197
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 However, further studies are needed to determine the cost-benefit ratio of using this device.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
D. Cross-Colonization Via Hands of Personnel
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pathogens causing nosocomial pneumonia, such as gram-negative bacilli and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Staphylococcus aureus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, are ubiquitous in the hospital, especially in intensive or critical care areas.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
198,199
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Transmission of these microorganisms to patients frequently occurs via healthcare workers' hands that become contaminated
or transiently colonized with the microorganisms.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
200&hyph;205
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Procedures such as tracheal suctioning and manipulation of ventilator circuit or endotracheal tubes increase the
opportunity for cross-contamination. The risk of cross-contamination can be reduced by using aseptic technique
and sterile or disinfected equipment when appropriate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
62
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and eliminating pathogens from the hands of personnel.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
62,206&hyph;208
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In theory, adequate handwashing is an effective way of removing transient bacteria from the hands,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
207,208
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 but personnel compliance with handwashing has been generally poor, despite the best efforts at educating healthcare
workers.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
209&hyph;212
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 For this reason, the routine use of gloves has been advocated to help prevent cross-contamination.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
213,214
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Routine gloving (in addition to gowning) was associated with a decrease in the incidence of nosocomial respiratory-syncytial
virus (RSV)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
215
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and other ICU infections.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
216
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 It should be emphasized, however, that nosocomial pathogens can colonize gloves,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
217
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and that outbreaks have been traced to healthcare workers who did not change gloves after patient contact.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
218
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
E. Contamination of Devices Used on the Respiratory Tract
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Devices used on the respiratory tract for respiratory therapy (e.g., nebulizer), diagnostic examination (e.g.,
bronchoscope or spirometer), and administration of anesthesia are potential reservoirs or vehicles for infectious
microorganisms.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
62,219&hyph;221
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Routes of transmission may be from device to patient,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
120,122,221&hyph;230
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 from one patient to another, or from one body site to the lower respiratory tract of the same patient via hand or device.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
220,231,232
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Contaminated nebulizer reservoirs can allow the growth of hydrophilic bacteria that may be subsequently aerosolized
during device use.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
119,122,123,228
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Gram-negative bacilli such as 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Pseudomonas 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Xanthomonas 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Flavobacterium 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp., and nontuberculous mycobacteria can multiply to substantial concentrations in nebulizer fluid
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
227,233&hyph;235
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and increase the patient's risk of acquiring pneumonia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
120&hyph;123,227,228,236,237
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00105 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Proper cleaning and sterilization or disinfection of reusable equipment are important components of a program to
reduce infections associated with respiratory therapy and anesthesia equipment.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
221&hyph;226,238,239
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Respiratory therapy devices have been classified as semi-critical because they come into contact with mucous membranes
but do not ordinarily penetrate body surfaces, and the associated infection risk following their use in patients
is less than that associated with devices that penetrate normally sterile tissues (See Appendix A).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
240
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 There is no evidence that low-level contamination of respiratory therapy device prior to use by a patient, as may occur
following high-level disinfection of the device, presents a greater risk of respiratory infection than does sterile
equipment. Thus, if after they are thoroughly cleaned, these devices cannot be sterilized by steam autoclave or ethylene
oxide,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
241
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 they can be subjected to high-level disinfection by pasteurization at 75
<!-- PJG 0017 degreeslatlong -->
&cir;C for 30 min,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
242&hyph;244
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or by using liquid chemical disinfectants approved by the Environmental Protection Agency (EPA) as sterilants/disinfectants.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
214,245&hyph;247
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 When rinsing is needed after a respiratory device has been sterilized or disinfected, only sterile water is used because
tap or locally-prepared distilled water may harbor microorganisms that can cause pneumonia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
233,234,248&hyph;250
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
1. Mechanical Ventilators and Anesthesia Machines 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
The internal machinery of mechanical ventilators and anesthesia machines is not considered an important source
of bacterial contamination of inhaled air.251
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Thus, routine sterilization or high-level disinfection of the internal machinery is considered unnecessary. Using
high-efficiency bacterial filters at various positions in the breathing circuit had been advocated previously.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
252,253
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Filters interposed between the machinery and the main breathing circuit can eliminate contaminants from the driving
gas and prevent retrograde contamination of the machine by the patient but may also alter the functional specifications
of the breathing device by impeding high gas flows.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
252,253
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In addition, when used with anesthesia equipment, filters placed between the inspiratory-phase circuit and the
patient have not been shown to prevent infections.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
254,255
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Placement of a filter or condensate trap at the expiratory-phase tubing of the mechanical-ventilator circuit may
help prevent cross-contamination of the ventilated patient's immediate environment,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
231,256
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 but the importance of such filters in preventing nosocomial pneumonia needs further evaluation. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2. Humidifiers, Breathing Circuits, and Heat-Moisture Exchangers
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Most U.S. hospitals currently use ventilators with either bubble-through or wick humidifiers that produce either
insignificant
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
125,257
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or no aerosols, respectively, for humidification. Thus, they do not seem to pose an important risk for pneumonia in
patients. In addition, bubble-through humidifiers are usually heated to temperatures that reduce or eliminate
bacterial pathogens.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
257,258
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Sterile water, however, is still generally used to fill these humidifiers
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
259
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 because tap or distilled water may harbor 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. that are more heat-resistant than other bacteria.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
236,250
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
The potential risk for pneumonia in patients using mechanical ventilators with heated bubble-through humidifiers
stems primarily from the condensate that forms in the inspiratory-phase tubing of the ventilator circuit as a result
of the difference in the temperatures of the inspiratory-phase gas and ambient air; condensate formation increases
if the tubing is unheated.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
260
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The tubing and condensate can rapidly become contaminated, usually with bacteria that originate from the patient's
oropharynx.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
260
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In the study by Craven et al, 33% of inspiratory circuits were colonized with bacteria from patients' oropharynx within
2 hours and 80% within 24 hours of use.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
260
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Spillage of the contaminated condensate into the patient's tracheobronchial tree, as can occur during procedures
in which the tubing may be moved (e.g., suctioning, adjusting the ventilator setting, or feeding or caring for the
patient), may increase the risk of pneumonia in the patient.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
260
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Thus, in many hospitals, healthcare workers are trained to prevent such spillage and to drain the fluid periodically.
Microorganisms contaminating ventilator-circuit condensate can be transmitted to other patients via hands of
the healthcare worker handling the fluid, especially if the healthcare worker fails to wash his or her hands after
handling the condensate. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The role of ventilator-tubing changes in preventing pneumonia in patients using mechanical ventilators with bubble-through
humidifiers has been investigated. Initial studies of in-use contamination of mechanical ventilator circuits
with humidifiers have shown that neither the rate of bacterial contamination of inspiratory-phase gas nor the incidence
of pneumonia was significantly increased when tubings were changed every 24 hours rather than every 8 or 16 hours.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
261
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Craven et al later showed that changing the ventilator circuit every 48 hours rather than 24 hours did not result in
an increase in contamination of the inspiratory-phase gas or tubing of the ventilator circuits.262 In addition,
the incidence of nosocomial pneumonia was not significantly higher when circuits were changed every 48 hours than
when changes were done every 24 hours.262 More recent reports suggest that the risk of pneumonia may not increase when
the interval for circuit change is prolonged beyond 48 hours. Dreyfuss and others showed that the risk of pneumonia
(8 [29%] of 28) was not significantly higher when the circuits were never changed for the duration of use by the patient,
than (11 [31%] of 35) when the circuits were changed every 48 hours.263
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
These findings indicate that the recommended daily change in ventilator circuits may be extended to "48 hours. This
change in recommendation is expected to result in large savings in device use and personnel time for U.S. hospitals.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
259,262
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The maximum time, however, that a circuit can be safely left unchanged on a patient has yet to be determined. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Condensate formation in the inspiratory-phase tubing of a ventilator breathing circuit can be decreased by elevating
the temperature of the inspiratory-phase gas with a heated wire in the inspiratory-phase tubing. However, in one
report, three cases of endotracheal- or tracheostomy-tube blockage by dried-up patient secretions were attributed
to the decrease in the relative humidity of inspired gas that results from the elevation of the gas temperature.264
Until further data are available about the frequency of the occurrence of such cases, users of heated ventilator tubing
should be aware of the advantages and potential complications of using heated tubing. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00106 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Condensate formation can be eliminated by using a heat-moisture exchanger (HME) or a hygroscopic condenser humidifier
(``artificial nose'').
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
265,270
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 An HME recycles heat and moisture exhaled by the patient, and eliminates the need for a humidifier. In the absence of
a humidifier, no condensate forms in the inspiratory-phase tubing of the ventilator circuit. Thus, bacterial colonization
of the tubing is prevented, and the need to routinely change tubings periodically is obviated. Some models of HMEs
are equipped with bacterial filters, but the advantage of these filters remains unknown. HMEs can increase the dead
space and resistance to breathing, may leak around the endotracheal tube, and may result in drying of sputum and blockage
of the tracheo-bronchial tree.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
271
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Although recently developed HMEs with humidifiers increase airway humidity without increasing colonization with
bacteria,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
267,272
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 more studies are needed to determine whether the incidence of pneumonia is decreased.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
273&hyph;276
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
3. Large-Volume Nebulizers
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
Nebulizers with large-volume (>500 cc) reservoirs, including those used in intermittent positive-pressure breathing
(IPPB) machines and ultrasonic or spinning-disk room-air ``humidifiers,'' pose the greatest risk of pneumonia
to patients, probably because of the total amount of aerosol they generate.222,225,227,236,277
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 These reservoirs can become contaminated by hands of personnel, unsterile humidification fluid, or inadequate
sterilization or disinfection between uses.119 Once introduced into the reservoir, various bacteria, including

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp., can multiply to sufficiently large numbers within 24 hours to pose a risk of infection in patients who receive
inhalation therapy.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
121,122,227,237,277
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Sterilization or high-level disinfection of these nebulizers can eliminate vegetative bacteria from their reservoirs
and make them safe for patient use.240 Unlike nebulizers attached to IPPB machines, however, room-air ``humidifiers''
have a high cost-benefit ratio: evidence of clinical benefits from their use in hospitals is lacking, and the potential
cost of daily sterilization or disinfection of, and use of sterile water to fill, such devices is substantial. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
4. Small-Volume Medication Nebulizers
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Small-volume medication nebulizers for administration of bronchodilators, including those that are hand-held
and those that are in the inspiratory circuit of mechanical ventilators, can produce bacterial aerosols.228 Hand-held
nebulizers have rarely been associated with nosocomial pneumonia, and only when contaminated by medications from
multidose vials.278 Medication nebulizers inserted in the ventilator circuit (``in-line'') may become contaminated
by condensate in the inspiratory tubing and increase the patient's risk of pneumonia because the nebulizer aerosol
is directed through the endotracheal tube and bypasses many of the normal host defenses against infection.260 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
5. Suction Catheters, Resuscitation Bags, Oxygen Analyzers, and Ventilator Spirometers
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Tracheal suction catheters can introduce microorganisms into a patient's lower respiratory tract. Preliminary
studies suggest that the risk of pneumonia is not different between patients on whom the single-use suction method
is used and those on whom the newly developed closed multi-use catheter system is used.279 In addition, the advantages
of using one system over the other, in terms of oxygen desaturation in patients and less environmental contamination,
have not been clearly shown.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
280&hyph;282
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Resuscitation bags are particularly difficult to clean and dry between uses; microorganisms in secretions or fluid
left in the bag may be aerosolized and/or sprayed into the lower respiratory tract of the patient on whom the bag is used;
in addition, contaminating microorganisms may be transmitted from one patient to another via hands of staff members.283&hyph;285
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Oxygen analyzers and ventilator spirometers have been associated with outbreaks of gram-negative respiratory
tract colonization and pneumonia resulting from patient-to-patient transmission of organisms via hands of personnel.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
220,286
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 These devices require sterilization or high-level disinfection between uses on different patients. Education
of physicians, respiratory therapists, and nursing staff regarding the associated risks and appropriate care of
these devices is essential. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
F. Thoraco-Abdominal Surgical Procedures 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Certain patients are at high risk of developing postoperative pulmonary complications, including pneumonia. These
persons include those who are more than 70 years of age, are obese, or have chronic obstructive pulmonary disease.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
287&hyph;290
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Abnormal pulmonary function tests (especially decreased maximum expiration flow rate), a history of smoking, the
presence of tracheostomy or prolonged intubation, or protein depletion that can cause respiratory-muscle weakness
are also risk factors.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
59,65,129
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Patients who undergo surgery of the head, neck, thorax, or abdomen may suffer from impairment of normal swallowing
and respiratory clearance mechanisms as a result of instrumentation of the respiratory tract, anesthesia, or increased
use of narcotics and sedatives;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
288,291,292
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 patients who undergo upper abdominal surgery usually suffer from diaphragmatic dysfunction that results in decreased
functional residual capacity of the lungs, closure of airways, and atelectasis.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
293,294
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Interventions aimed at reducing the postoperative patient's risk of pneumonia have been developed.295 These include
deep breathing exercises, chest physiotherapy, use of incentive spirometry, IPPB, and continuous positive airway
pressure (CPAP) by face mask.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
295&hyph;305
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Studies evaluating the relative efficacy of these modalities have shown variable results, and have been difficult
to compare because of differences in outcome variables assessed, patient populations studied, and study design.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
295,297,298,304&hyph;307
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Nevertheless, many studies have found deep breathing exercises, chest physiotherapy, use of incentive spirometry,
and IPPB as advantageous maneuvers, especially in patients with preoperative pulmonary dysfunction.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
298,299,301,302,304&hyph;306
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In addition, control of pain that interferes with cough and deep breathing during the immediate postoperative period
has been shown to decrease the incidence of pulmonary complications after surgery; several methods of controlling
pain have been used; these include intramuscular or intravenous (including patient-controlled) administration,
or regional (e.g., epidural) analgesia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
308&hyph;315 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00107 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=5 f=1 -->
G. Other Prophylactic Measures 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
1. Vaccination of Patients
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
Although pneumococci are not a major cause of nosocomial pneumonia, they have been identified as etiologic agents
of serious nosocomial pulmonary infection and bacteremia.316&hyph;318
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The following factors render patients at high risk of complications from pneumococcal infections: "65 years of age,
chronic cardiovascular or pulmonary disease, diabetes mellitus, alcoholism, cirrhosis, cerebrospinal fluid
leaks, immunosuppression, functional or anatomic asplenia, or HIV infection. Pneumococcal vaccine is effective
in preventing pneumococcal disease.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
319,320
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Because two-thirds or more of patients with serious pneumococcal disease have been hospitalized at least once within
5 years before their pneumococcal illness, offering pneumococcal vaccine in hospitals, e.g., at the time of patient
discharge, should contribute substantially to preventing the disease.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
319,321 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2. Prophylaxis With Systemic Antimicrobial Agents 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Systemic antimicrobial administration has been a prevalent practice in the prevention of nosocomial infections,
including pneumonia, especially in patients who are weaned off mechanical ventilators, postoperative, and/or
critically ill.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
322
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 However, the efficacy of such practice is questionable; and the potential for superinfection, which may result from
any antimicrobial therapy, is a problem.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
84,322&hyph;326
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
3. Kinetic Therapy for the Immobilized State 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
Continuous lateral rotational therapy (CLRT) or ``kinetic'' therapy is a recently introduced maneuver for prevention
of pulmonary and other complications from prolonged immobilization or bed rest, such as in patients with acute stroke,
critical illness, head injury or traction, blunt chest trauma, and/or mechanically assisted ventilation.327&hyph;332
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 CLRT involves the use of a bed that turns continuously and slowly (about eight full rotations per hour) along its longitudinal
axis. Among the hypothesized benefits of CLRT are improved drainage of secretions within the lungs and lower airways,
increased tidal volume, and reduction of venous thrombosis with resultant pulmonary embolization.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
174,333&hyph;335
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 However, the efficacy of CLRT in preventing pneumonia needs further evaluation because available studies yielded
variable results.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
327&hyph;330
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In addition, the studies either involved small numbers of patients,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
328
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 lacked adequate randomization,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
327
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 had no clear definition of pneumonia,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
327
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 did not distinguish between community-acquired and nosocomial pneumonia,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
328,332
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or did not adjust for possible confounding factors such as mechanical ventilation, endotracheal intubation, nasogastric
intubation, and enteral feeding.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
327 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
LEGIONNAIRES' DISEASE 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Legionnaires' disease is a multisystem illness, with pneumonia, caused by 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella spp. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In contrast, Pontiac fever is a self-limited influenza-like illness, without pneumonia, that is associated with

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
336
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Epidemiology 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Since identification of the etiologic agent, numerous outbreaks of nosocomial Legionnaires' disease have been
reported and have provided the opportunity to study the epidemiology of epidemic legionellosis. In contrast, the
epidemiology of endemic Legionnaires' disease has not been well elucidated. The overall proportion of nosocomial
pneumonias due to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. in North America has not been determined, although individual hospitals have reported a ranges of 0%&hyph;14%.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
337&hyph;339
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Because diagnostic tests for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella spp. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
infection are not routinely performed on all patients with hospital-acquired pneumonia in most hospitals, this
range probably underestimates the incidence of Legionnaires' disease.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp. are commonly found in a variety of natural and man-made aquatic environments
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
340,341
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and may enter hospital water systems in low or undetectable numbers.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
342,343
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Cooling towers, evaporative condensers, heated potable-water-distribution systems within hospitals, and locally
produced distilled water can provide a suitable environment for legionellae to multiply. Factors known to enhance
colonization and amplification of legionellae in man-made water environments include temperatures of 25&hyph;42
<!-- PJG 0017 degreeslatlong -->
&cir;C,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
344&hyph;349
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 stagnation,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
350
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 scale and sediment,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
346
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and the presence of certain free-living aquatic amoebae that are capable of supporting intracellular growth of legionellae.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
351,352 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A person's risk of acquiring legionellosis following exposure to contaminated water depends on a number of factors,
including the type and intensity of exposure and the exposed person's health status.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
353&hyph;355
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Persons with severe immunosuppression or chronic underlying illnesses, such as hematologic malignancy or end-stage
renal disease, are at markedly increased risk for legionellosis.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
355&hyph;358
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Persons in the later stages of acquired immunodeficiency syndrome are also probably at increased risk of legionellosis,
but data are limited because of infrequent testing of patients. Persons with diabetes mellitus, chronic lung disease,
or non-hematologic malignancy, those who smoke cigarettes, and the elderly are at moderately increased risk.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
336
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Nosocomial Legionnaires' disease has also been reported among patients at children's hospitals.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
359,360
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Underlying disease and advanced age are not only risk factors for acquiring Legionnaires' disease but also for dying
from the illness. In a multivariate analysis of 3,524 cases reported to CDC from 1980 through 1989, immunosuppression,
advanced age, end-stage renal disease, cancer, and nosocomial acquisition of disease were each independently associated
with a fatal outcome.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
355
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The mortality rate among 803 persons with nosocomially acquired cases was 40% compared with 20% among 2,721 persons
with community-acquired cases,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
355
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 probably reflecting increased severity of underlying disease in hospitalized patients. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00108 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Diagnosis 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The clinical spectrum of disease due to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp. is broad and ranges from asymptomatic infection to rapidly progressive pneumonia. Legionnaires' disease cannot
be distinguished clinically or radiographically from pneumonia caused by other agents,361,362 and evidence of
infection with other respiratory pathogens does not rule out the possibility of concomitant 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp. infection.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
363&hyph;365
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The diagnosis of legionellosis may be confirmed by any one of the following: Culture isolation of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 from respiratory secretions or tissues, or microscopic visualization of the bacterium in respiratory secretions
or tissue by immunofluorescent microscopy; and, for legionellosis due to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
L. pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 serogroup 1, detection of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
L. pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 serogroup-1 antigens in urine by radioimmunoassay, or observation of a four-fold rise in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
L. pneumophila 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
serogroup-1 antibody titer to "1:128 in paired acute and convalescent serum specimens by use of an indirect immunofluorescent
antibody test (IFA).366 A single elevated antibody titer does not confirm a case of Legionnaires' disease because
IFA titers "1:256 are found in 1&hyph;16% of healthy adults.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
364,367&hyph;370
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Because the above tests complement each other, performing each test when Legionnaires' disease is suspected increases
the probability of confirming the diagnosis.371 However, because none of the laboratory tests is 100% sensitive,
the diagnosis of legionellosis is not ruled out even if one or more of the tests are negative.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
371,372
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Of the available tests, the most specific is culture isolation of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
sp. from any respiratory tract specimen.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
373,374
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Modes of Transmission 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Inhalation of aerosols of water contaminated with 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
sp. is believed to be the primary mechanism of entry of these organisms into a patient's respiratory tract.336 In several
hospital outbreaks, patients were considered to be infected through exposure to contaminated aerosols generated
by cooling towers, showers, faucets, respiratory therapy equipment, and room-air humidifiers.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
227,375&hyph;382 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In several studies, aspiration of contaminated potable water has been proposed as the mode of transmission to certain
patients.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
383&hyph;385
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Person-to-person transmission, however, has not been observed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00109 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Definition of Nosocomial Legionnaires' Disease 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The incubation period for Legionnaires' disease is generally 2&hyph;10 days; thus, for epidemiologic purposes,
in this document and in the accompanying recommendations by the HICPAC, laboratory-confirmed legionellosis that
occurs in a patient who has spent "10 days continuously in the hospital prior to onset of illness is considered definite
nosocomial Legionnaires' disease, and laboratory-confirmed infection that occurs 2&hyph;10 days after hospitalization
is possible nosocomial infection. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
V. Prevention and Control Measures 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Prevention of Legionnaires' Disease in Hospitals With No Identified Cases (Primary Prevention) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Prevention strategies in healthcare facilities with no cases of nosocomial legionellosis have varied by institution,
depending on the immunologic status of the patients, the design and construction of the facility, resources available
for implementation of prevention strategies, and state and local regulations. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
There are at least two schools of thought regarding the most appropriate and cost-effective approach to prevent nosocomial
legionellosis, especially in hospitals where no cases or only sporadic cases of the illness are detected. However,
a study comparing the cost-benefit ratios of these strategies has not been done. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The first approach is based on periodic, routine culturing of water samples from the hospital's potable water system,
for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
387
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 When a positive culture is obtained, the hospital's potable water system is decontaminated and diagnostic laboratory
tests for legionellosis are made available to clinicians in the hospital's microbiology department, so that active
surveillance for cases can be instituted.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
388
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 This approach is based on the premise that no cases of nosocomial legionellosis can occur in the absence of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp. from the potable water system, and, conversely, once 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp. are cultured from the water, cases of nosocomial legionellosis may occur.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
383,389 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Proponents of this strategy indicate that when physicians are informed that the potable water system of the hospital
is culture-positive for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp., they are more inclined to conduct the necessary tests for legionellosis.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
388
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 A potential advantage of this approach is the lower cost of culturing a limited number of water samples, if the testing
is done infrequently, compared with the cost of routine laboratory diagnostic testing for legionellosis in all patients
with nosocomial pneumonia in hospitals that have had no cases of nosocomial legionellosis. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The main argument against this approach is that in the absence of cases, the relationship between the results of water
cultures and the risk of legionellosis remains undefined. The bacterium has been frequently present in hospital
water systems,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
390
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 often without being associated with known cases of disease.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
250,338,391,392
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In a study of 84 hospitals in Quebec, 68% were found to be colonized with 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp., and 26% were colonized at >30% of sites sampled; however, cases of Legionnaires' disease were rarely reported
from these hospitals.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
250
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Similarly, at one hospital where active surveillance for legionellosis and environmental culturing for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp. were done, no cases of legionellosis occurred in a urology ward during a 3.5-month period when 70% of water samples
from the ward were culture-positive for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
L. pneumophila 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
serogroup 1.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
338
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Interpretation of the results of routine culturing of water may be confounded by variable culture results among sites
sampled within a single water system and by fluctuations in the concentration of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp. in the same site.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
393,394
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In addition, the risk of illness following exposure to a given source may be influenced by a number of factors other
than the presence or concentration of organisms; these include the degree to which contaminated water is aerosolized
into respirable droplets, the proximity of the infectious aerosol to potential host, the susceptibility of the host,
and the virulence properties of the contaminating strain.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
395&hyph;397
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Thus, data are insufficient to assign a level of risk of disease even on the basis of the number of colony-forming units
detected in samples from the hospital environment. By routinely culturing water samples, many hospitals will have
to be committed to water-decontamination programs to eradicate 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp. Because of this problem, routine monitoring of water from the hospital's potable water system and from aerosol-producing
devices is not widely recommended.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
398
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The second approach to prevent and control nosocomial legionellosis is by: (a) Maintaining a high index of suspicion
for legionellosis and appropriately using diagnostic tests for legionellosis in patients with nosocomial pneumonia
who are at high risk of developing the disease and dying from the infection,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
338,399
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (b) initiating an investigation for a hospital source of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. upon identification of one laboratory-confirmed case of definite or two laboratory-confirmed cases of possible
nosocomial Legionnaires' disease, and (c) routinely maintaining cooling towers and using only sterile water for
filling and terminal rinsing of nebulization devices. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In hospitals with no identified cases of legionellosis, further study is needed of the cost-benefit ratio of control
measures aimed at creating an environment that is not conducive to survival or multiplication of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp., e.g., routine maintenance of potable water at "50
<!-- PJG 0017 degreeslatlong -->
&cir;C or &lt;20
<!-- PJG 0017 degreeslatlong -->
&cir;C at the tap or chlorination of heated water to achieve 1&hyph;2 mg/L free residual chlorine at the tap.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
338,383,393,400&hyph;403
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Prevention of Legionnaires' Disease in Hospitals With Identified Cases (Secondary Prevention) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The indications for a full-scale environmental investigation to search for and subsequently decontaminate identified
sources of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp. in hospital environments remain to be elucidated, and probably vary from hospital to hospital. In institutions
where as few as 1&hyph;3 nosocomial cases are identified over a period of up to several months, intensified surveillance
for Legionnaires' disease has frequently detected numerous additional cases.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
357,376,380,401 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This suggests the need for a low threshold for initiating an investigation following the identification of nosocomial,
laboratory-confirmed cases of legionellosis. However, when developing a strategy to respond to such an identification,
infection-control personnel should consider the level of risk of nosocomial acquisition of, and mortality from,

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp. infection at their particular hospital. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
An epidemiologic investigation of the source of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp. involves several important steps, including retrospective review of microbiologic and medical records, active
surveillance to identify all recent or ongoing cases of legionellosis, identification of risk factors (including
environmental exposures for infection, such as showering or use of respiratory-therapy equipment), collection
of water samples from environmental sources implicated by the epidemiologic investigation and from other potential
sources of aerosolized water, and subtype-matching between legionellae isolated from patients and environmental
samples.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
382,404&hyph;406 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The latter step can be crucial in supporting epidemiologic evidence of a link between human illness and a specific
source.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
407
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00110 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In hospitals where the heated-water system has been identified as the source of the organism, the system has been decontaminated
by pulse (one-time) thermal disinfection or superheating (i.e., flushing for at least 5 minutes each distal outlet
of the hot-water system with water at "65
<!-- PJG 0017 degreeslatlong -->
&cir;C) and hyperchlorination (flushing all outlets of the hot-water system with water containing "10 mg/L free
residual chlorine).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
403,408&hyph;410
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Following either of these procedures, most hospitals maintain heated-water at "50
<!-- PJG 0017 degreeslatlong -->
&cir;C or &lt;20
<!-- PJG 0017 degreeslatlong -->
&cir;C at the tap or chlorinate heated water to achieve 1&hyph;2 mg/L free residual chlorine at the tap.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
338,383,393,400&hyph;403
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Additional measures, such as physical cleaning or replacement of hot-water storage tanks, water-heaters, faucets,
and showerheads, may be required because scale and sediment that provide organisms protection from the biocidal
effects of heat and chlorine, may accumulate in them.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
346,403
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Alternative methods for control and eradication of legionellae in water systems, such as treatment of water with
ozone, ultraviolet light, or heavy metal ions, have limited the growth of legionellae under laboratory,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
344,411,412
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or, in the case of ultraviolet light, operating conditions.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
413
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 However, further data are needed regarding the efficacy of these methods when used in hospital water systems
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
414
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 before they can be considered standard. In hospitals where the cooling towers are contaminated, measures for decontamination
have been previously published.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
415
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For highly immunocompromised patients, other preventive measures have been used. At one hospital, immunosuppressed
patients were restricted from taking showers, and, for these patients, only sterile water was used for drinking or
flushing nasogastric tubes;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
384
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In another hospital, a combined approach, consisting of continuous heating, particulate filtration, ultraviolet
treatment, and monthly pulse hyperchlorination of the water supply of the bone-marrow transplant unit, was used
to decrease the incidence of Legionnaires' disease.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
413
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In view of the high cost of an environmental investigation and of instituting control measures to eradicate 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. from sources in the hospital
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
416,417
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and the differential risk, based on host factors, for acquiring nosocomial legionellosis and of having severe and
fatal infection with the microorganism, the decision to search for and the choice of procedures to eradicate hospital
environmental sources of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. should take into account the type of patient population served by the hospital. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ASPERGILLOSIS 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Epidemiology 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. are ubiquitous fungi, commonly occurring in soil, water, and decaying vegetation. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. have been cultured from unfiltered air, ventilation systems, contaminated dust dislodged during hospital
renovation and construction, horizontal surfaces, food, and ornamental plants.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
418
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A. fumigatus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A. flavus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 are the most frequently isolated 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. in patients with proven aspergillosis.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
419
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Nosocomial aspergillosis has been recognized increasingly as a cause of severe illness and mortality in highly immunocompromised
patients, e.g., patients undergoing chemotherapy and/or organ transplantation, including bone-marrow transplantation
for hematologic and other malignant neoplasms.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
420&hyph;423
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The most important nosocomial infection due to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. is pneumonia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
424
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Hospital outbreaks of pulmonary aspergillosis have occurred mainly in granulocytopenic patients, especially
in bone-marrow transplant units.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
424&hyph;430
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Although invasive aspergillosis has been reported in recipients of solid-organ transplants (e.g., heart or kidney),
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
431&hyph;435
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 the incidence of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. infections in these patients has been lower than in recipients of bone-marrow transplants, probably because
of the recent decrease in the use of corticosteroids and the introduction of cyclosporine.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
433,436
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In solid-organ transplant recipients, the efficacy of infection control measures, such as provision of protected
environments and prophylaxis with antifungal agents, in preventing aspergillosis has not been well evaluated.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
433,434,437&hyph;439
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In one study of heart-transplant recipients, protective isolation of patients alone failed to prevent fungal infections.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
440
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The reported attributable mortality from invasive pulmonary aspergillosis has varied, depending on the patient
population studied. Rates have been as high as 95% in recipients of allogeneic bone-marrow transplants and patients
with aplastic anemia, compared with rates of 13&hyph;80% in leukemic patients.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
441&hyph;443
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Pathogenesis 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In contrast to most bacterial pneumonias, the primary route of acquiring 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 sp. infection is by inhalation of the fungal spores. In severely immunocompromised patients, primary 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. pneumonia results from local lung tissue invasion.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
419,444,445
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Subsequently, the fungus may disseminate via the bloodstream to involve multiple other deep organs.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
419,445,446
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 A role for nasopharyngeal colonization with 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp., as an intermediate step before invasive pulmonary disease, has been proposed, but remains to be elucidated.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
438,447,448
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 On the other hand, colonization of the lower respiratory tract by 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp., especially in patients with preexisting lung disease such as chronic obstructive lung disease, cystic fibrosis,
or inactive tuberculosis, has predisposed patients to invasive pulmonary and/or disseminated infection.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
419,445,449
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00111 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Diagnosis 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Diagnosing pneumonia due to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. is often difficult without performing invasive procedures. Bronchoalveolar lavage has been a useful screening
test,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
450&hyph;452
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 but lung biopsy is still considered the most reliable technique.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
453
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Histopathologic demonstration of tissue invasion by fungal hyphae has been required in addition to isolation of

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. from respiratory tract secretions because the latter, by itself, may indicate colonization.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
454
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 However, when 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. is grown from the sputum of a febrile, granulocytopenic patient with a new pulmonary infiltrate, it is highly
likely that the patient has pulmonary aspergillosis.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
447,455
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Routine blood cultures are remarkably insensitive for detecting 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
456
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and systemic antibody responses in immunocompromised patients are likely to be unreliable indicators of infection.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
457&hyph;459
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Antigen-based serologic assays are now being developed in an attempt to allow for the rapid and specific diagnosis
of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. infections; however, their clinical usefulness is presently undefined.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
460,461
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Risk Factors and Control Measures 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The major risk factor for invasive aspergillosis is severe and prolonged granulocytopenia, both disease- and therapy-induced.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
462
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Since bone-marrow transplant recipients experience the most severe degree of granulocytopenia, they probably
constitute the population at highest risk of developing invasive aspergillosis.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
442,463
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The tendency of bone-marrow transplant recipients to develop severe granulocytopenia (&lt;1,000 polymorphonuclears/&mu;l)
is associated with the type of graft they receive. While both autologous and allogeneic bone-marrow transplant recipients
are severely granulocytopenic for up to 4 weeks after the transplant procedure, allogeneic-transplant recipients
may, in addition, develop acute or chronic graft-versus-host disease. The latter may occur up to several months after
the procedure, and the disease and/or its therapy (often with high doses of corticosteroids, cyclosporine, and other
immunosuppressive agents) may result in severe granulocytopenia. Consequently, in developing strategies to prevent
invasive 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. infection in bone-marrow-transplant patients, infection control personnel should consider exposures of
the patient to the fungus not only during the patient's immediate posttransplantation period, but also other exposures
(e.g., at home or in an ambulatory-care setting) subsequent to the immediate posttransplant period, when the patient
(especially allogeneic-transplant recipients) may again manifest severe granulocytopenia. To help address this
problem, various studies are now in progress to evaluate newer methods of enhancing host resistance to invasive fungal
(and other) infections, and of eliminating or suppressing respiratory fungal colonization of the upper respiratory
tract. These methods include, respectively, the use of granulocyte-colony-stimulating factors and intranasal
application of amphotericin B, or oral or systemic antifungal drug prophylaxis.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
418,464&hyph;467
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 For solid-organ transplant recipients, risk factors for invasive aspergillosis have not been as extensively studied.
In one study of liver-transplant recipients, risk factors for invasive infection with 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 sp. identified by univariate analysis included preoperative and postoperative receipt of steroids and antimicrobial
agents, and prolonged duration of transplant surgery.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
468
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The presence of aspergilli in the hospital environment is the major extrinsic risk factor for the occurrence of opportunistic
invasive 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 sp. infection.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
437,469
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Environmental disturbances due to construction and/or renovation activities in and around hospitals markedly
raise the airborne 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. spore counts in such hospitals and have been associated with nosocomial aspergillosis.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
426,428,429,470&hyph;473
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In addition, aspergillosis in high-risk immunosuppressed patients has been associated with other hospital environmental
reservoirs, including bird droppings in air ducts supplying high-risk patient areas,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
474
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and contaminated fireproofing material or damp wood.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
428,475
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
A single case of nosocomial 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. pneumonia is often difficult to link to a specific environmental exposure. However, additional cases may remain
undetected without an active search that includes an intensive retrospective review of microbiologic, histopathologic,
and postmortem records; notification of clinicians caring for high-risk patients; and establishment of a system
for prospective surveillance for additional cases. When additional cases are detected, the likelihood is increased
that a hospital environmental source of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. can be identified.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
426,428,470&hyph;475
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Previous investigations have shown the importance of construction activities and/or fungal ``contamination''
of hospital air-handling systems as major sources for outbreaks.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
424,426,428,470&hyph;474
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 New molecular typing techniques, namely karyotyping
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
476
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and DNA endonuclease profiling (now available for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A. fumigatus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
),
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
477
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 may significantly aid in identifying the source of an outbreak. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Outbreaks of invasive aspergillosis reinforce the importance of maintaining an environment as free of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. spores as possible for patients with severe granulocytopenia. To achieve this goal, specialized services in
many large hospitals, in particular bone-marrow transplant services, have installed ``protected environments''
for the care of their high-risk, severely granulocytopenic patients, and increased their vigilance during hospital
construction and routine maintenance of hospital air-filtration and ventilation systems, to prevent exposing
high-risk patients to bursts of fungal spores.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
426,428,470&hyph;474,478&hyph;483
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
While the exact configuration and specifications of the protected environments may vary between hospitals, these
patient-care areas are built to minimize fungal spore counts in air by maintaining (a) high-efficiency filtration
of incoming air as it enters the room (i.e., at point of use) with HEPA filters that are 99.97% efficient in filtering
0.3&mu;-sized particles, (b) directed room airflow_from intake on one side of the room, across the patient, and out
through the exhaust on the opposite side of the room, (c) positive room-air pressure relative to the corridor, (d)
well-sealed rooms, and (e) high rates of room-air changes (range: 15 to >400 per hour).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
424,479&hyph;481,483&hyph;485
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The oldest and most studied protected environment is a room with laminar airflow, consisting of a bank of HEPA filters
along an entire wall through which air is pumped by blowers into the room at a uniform velocity (30&hyph;90 feet/minute),
forcing the air to move in a laminar, or at least unidirectional, pattern.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
486
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The air usually exits at the opposite end of the room, and ultra-high (100&hyph;400 per hour) air-change rates are
achieved.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
424
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The net effects are: essentially sterile air in the room, minimal air turbulence, minimal opportunity for microorganism
build-up, and a consistently clean environment.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
424
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
The efficacy of a laminar-airflow system in decreasing or eliminating the risk of nosocomial aspergillosis in high-risk
patients has been demonstrated.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
424,479,484,485
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 However, such a system is costly to install and maintain.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
469
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Less expensive alternative systems with lower air-change rates (10&hyph;15 per hour) have been utilized in some
centers.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
480,481,487
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 However, studies comparing the efficacy of these alternative systems with laminar-airflow rooms in eliminating

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. spores and preventing nosocomial aspergillosis are limited. One institution employing cross-flow ventilation,
point-of-use high-efficiency filters, and 15 air changes per hour reported that cases of nosocomial aspergillosis
in patients housed in these rooms have occurred, albeit at a low rate (3.4%).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
481,487
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The infections, however, were due to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A. flavus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_a species that was never cultured from the room air, suggesting that the patients were probably exposed to fungal
spores when they were allowed outside their rooms.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
481
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copper-8-quinolinolate has been used on environmental surfaces contaminated with 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. to control a reported outbreak,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
488
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and incorporated in fireproofing material of a newly constructed hospital
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
481
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 to help decrease the environmental spore burden, but its general applicability is yet to be established. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00112 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=74 g=1 f=1 -->
VIRAL PNEUMONIAS 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Viruses can be an important and often unappreciated cause of nosocomial pneumonia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
489,490
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In one prospective study of endemic nosocomial infections, approximately 20% of patients with pneumonia had viral
infections.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
490
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
}
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Although early diagnosis and treatment of viral infections have become possible in recent years,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
491&hyph;494
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 many hospitalized patients remain at high risk for developing severe and sometimes fatal viral infections.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
489,495&hyph;502 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Based on these data and on well-documented outbreaks with nosocomial viral transmission,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
503&hyph;506 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 measures to prevent viral transmission should be instituted. 
<!-- PJG 0012 frnewline -->
Nosocomial respiratory viral infections (1) usually follow community outbreaks that occur during a particular
period every year,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
505,507&hyph;510
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (2) confer only short-term immunity,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
511
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (3) affect healthy and ill persons,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
497,498,504,512&hyph;514
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and (4) have exogenous sources. A number of viruses, including adenoviruses, influenza virus, measles virus, parainfluenza
viruses, respiratory syncytial virus (RSV), rhinoviruses, and varicella-zoster virus can cause nosocomial pneumonia;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
498,505,506,515&hyph;521
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 however, adenoviruses, influenza or parainfluenza viruses, and RSV have been reported to account for most (70%)
of nosocomial pneumonias due to viruses.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
522,523
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Because influenza and RSV infections account for a substantial portion of morbidity and mortality due to viral pneumonia
and have been well studied epidemiologically, this section focuses on the principles and approaches to control these
infections. However, because the modes of transmission of RSV (i.e., by large droplets or by contact with contaminated
hands or other fomites) are the same as those of parainfluenza viruses and similar to those of adenoviruses and rhinoviruses
(i.e., mainly by large droplets or contact with contaminated hands or other fomites, but also possibly by aerosol
inhalation), infection-control measures recommended for RSV infection are applicable to infections caused by
the other three viruses.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
524&hyph;529
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Prevention of nosocomial infections due to measles and varicella-zoster is addressed in another document.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
213
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
RSV INFECTION 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Epidemiology 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
RSV infection is most common during infancy and early childhood, but may also occur in adults.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
134,512,515,530,531
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Infection usually causes mild or moderately severe upper respiratory illness. However, life-threatening pneumonia
or bronchiolitis has been reported in children with chronic cardiac and pulmonary disease, immunocompromised patients,
and the elderly.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
497,499,514,515,532,533
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Recent surveillance of 10 U.S. hospital laboratories performing cultures for RSV suggests that community outbreaks
occur yearly between December and March, last from 3&hyph;5 months, and are associated with increased hospitalization
and deaths among infants and young children.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
534
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 During community outbreaks of RSV, children admitted to the hospital with respiratory symptoms often serve as reservoirs
for RSV.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
503,505
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Diagnosis 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The clinical characteristics of RSV infection, especially in neonates, are often indistinguishable from those
of other viral respiratory tract infections.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
515,516
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Culture of RSV from respiratory secretions remains the ``gold standard'' for diagnosis. Although rapid antigen-detection
kits utilizing direct immunofluorescence or enzyme-linked immunosorbent assay are available and can provide results
within hours, the benefit of using these tests to identify infected and susceptible patients depends on the sensitivity
and specificity of the test. The reported sensitivity and specificity of RSV enzyme immunoassays vary between 80%
and 95%, and may even be lower in actual practice.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
535&hyph;538
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In general, once laboratory-confirmed cases of RSV infection are identified in a hospital, a presumptive diagnosis
of RSV infection in subsequent cases with manifestations suggestive of RSV infection may be acceptable for infection
control purposes. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00113 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Modes of Transmission 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
RSV is present in large numbers in the respiratory secretions of symptomatic persons infected with the virus and can
be transmitted directly via large droplets during close contact with such persons, or indirectly via RSV-contaminated
hands or fomites.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
503,524,525
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The portal of entry is usually the conjunctiva or the nasal mucosa.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
526
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Inoculation by RSV-contaminated hands is the usual way of depositing the virus onto the eyes or nose.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
503,524&hyph;526
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Hands can become contaminated through handling of infected persons' respiratory secretions or contaminated fomites.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
524,525
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
In nosocomial RSV outbreaks in which the viral isolates were typed, more than one strain of RSV has often been identified,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
504,513,539
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 suggesting multiple sources of the virus. Potential sources include patients, hospital staff, and visitors. Because
infected infants shed large amounts of virus in their respiratory secretions and easily contaminate their immediate
surroundings, they are a major reservoir for RSV.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
540
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Hospital staff may become infected after exposure in the community
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
541
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or in the hospital, and in turn, infect patients, other health-care workers, or hospital visitors.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
516,542
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Control Measures 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Various combinations of control measures ranging from the simple to the complex have been effective, to some degree
or other, in preventing and controlling nosocomial RSV infection.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
215,542&hyph;549
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Successful programs have had two elements in common: implementation of contact-isolation precautions, and compliance
with these precautions by healthcare personnel. In theory, strict handwashing should prevent most nosocomial RSV
infections. However, health-care workers' handwashing practices have always been poor, even in institutions with
good educational programs.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
210,211
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Thus, other preventive measures are usually relied upon to prevent RSV infection. 
<!-- PJG 0012 frnewline -->
The basic precautions that have been associated with decreased incidence of nosocomial RSV infections are gloving
and gowning.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
215
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Gloving has helped decrease transmission probably because gloves remind patient-care personnel to comply with
handwashing and other precautions, and deter persons from touching their eyes or noses. The benefits from gloving,
however, are offset if gloves are not changed between patients or after contact with contaminated fomites, and if
hands are not adequately washed after glove removal.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
218
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Gowning, in combination with gloving, during contact with RSV-infected infants or their immediate environment
has been used successfully to prevent infection.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
215
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In addition, the use of eye-nose goggles rather than masks has protected healthcare workers from infection; however,
eye-nose goggles are not widely available and are inconvenient to wear.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
546,550
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Additional measures may be indicated to control ongoing nosocomial transmission of RSV or to prevent transmission
to patients at high risk for serious complications of infections, such as those with compromised cardiac, pulmonary,
or immune systems. The following additional control measures have been used in various combinations: (1) Use of private
rooms for infected patients OR cohorting of infected patients, with or without pre-admission screening by rapid
laboratory diagnostic tests, (2) cohorting of personnel, (3) exclusion of healthcare workers who have symptoms
of upper respiratory tract infection from the care of uninfected patients at high risk of severe or fatal RSV infection,
e.g., infants, (4) limiting visitors, and (5) postponing admission of patients at high risk of complications from
RSV infection.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
213,543,545,547,549
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Although the exact role of each of these measures has not been fully elucidated, their use for control of outbreaks
seems prudent. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
INFLUENZA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Epidemiology 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pneumonia in patients with influenza may be due to the influenza virus itself, secondary bacterial infection, or
a combination of both.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
551&hyph;553
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Influenza-associated pneumonia can occur in any person, but is more common in the very young or old and in persons in
any age group with immunosuppression or certain chronic medical conditions such as severe underlying heart or lung
disease.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
531,554&hyph;556
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Influenza typically occurs annually in the winter between December and April; peak activity in a community usually
lasts from 6 to 8 weeks during this period.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
557,558
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 During influenza epidemics in the community, nosocomial outbreaks may occur and are characterized by abrupt onset
and rapid transmission.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
559&hyph;561
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Most reported institutional outbreaks of influenza have occurred in nursing homes; however, hospital outbreaks
have been reported on pediatric and chronic-care wards, as well as on medical and neonatal intensive care units.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
506,562&hyph;565
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Influenza is believed to be spread from person to person by direct deposition of virus-laden large droplets onto the
mucosal surfaces of the upper respiratory tract of an individual during close contact with an infected person, as
well as by droplet nuclei or small-particle aerosols.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
566&hyph;569
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The extent to which transmission may occur by virus-contaminated hands or fomites is unknown; however, it is not the
primary mode of spread.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
570
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
The most important reservoirs of influenza virus are infected persons, and the period of greatest communicability
is during the first 3 days of illness; however, the virus can be shed before onset of symptoms, and up to 7 or more days
after illness onset.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
506,557,571
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Diagnosis 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Influenza is clinically indistinguishable from other febrile respiratory illnesses, but during outbreaks with
laboratory-confirmed cases, a presumptive diagnosis of the infection can be made in cases with similar manifestations.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
572
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In the past, diagnosis of influenza was made by virus isolation from nasopharyngeal secretions or by serologic conversion,
but recently developed rapid diagnostic tests that are similar to culture in sensitivity and specificity allow early
diagnosis and treatment of cases and provide a basis for prompt initiation of antiviral prophylaxis as part of outbreak
control.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
573&hyph;578
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00114 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Prevention and Control Measures 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Vaccination of persons at high risk for complications of influenza is currently the most effective measure for reducing
the impact of influenza, and should be done before the influenza season each year. Such persons include those "65 years
of age; those in long-term-care units; those with chronic disorders of the pulmonary or cardiovascular systems,
those with diabetes mellitus, renal dysfunction, hemoglobinopathies, musculo-skeletal disorders, or immunosuppression;
and children 6 months&hyph;18 years of age who are receiving long-term aspirin therapy.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
564,579&hyph;581
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 When high vaccination rates are achieved in closed or semi-closed settings, the risk of outbreaks is reduced because
of induction of herd immunity.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
582,583
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
When an institutional outbreak is due to influenza A, antiviral agents may be used both for treatment of ill persons
and as prophylaxis for others.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
584
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Two related antiviral agents, amantadine hydrochloride and rimantadine hydrochloride, are effective against
influenza-A, but not influenza-B, virus.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
493,585&hyph;587
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 These agents can be used (1) for short-term prophylaxis after late vaccination of high-risk persons; (2) as prophylaxis
for persons for whom vaccination is contraindicated; (3) as prophylaxis for immunocompromised persons who may not
produce protective levels of antibody in response to vaccination; (4) for prophylaxis for unvaccinated healthcare
workers who provide care to high-risk patients, either for the duration of influenza activity in the community or
until immunity develops after vaccination; and (5) when vaccine strains do not closely match the epidemic viral strain.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
584
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Amantadine has been available in the United States for many years; rimantadine has just recently been approved for
use. Both drugs protect against all naturally-occurring strains of type A influenza virus; thus, antigenic changes
in the virus that may reduce vaccine efficacy do not alter the effectiveness of amantadine or rimantadine. Both are
70&hyph;90% effective in preventing illness if taken before exposure to influenza A virus.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
585,588
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In addition, they lessen the severity and duration of illness due to influenza A when administered within 24&hyph;48
hours after onset of symptoms.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
589,590
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Amantadine can limit nosocomial spread of influenza A if it is administered to all or most patients at the time influenza
is recognized in a facility.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
562,591,592
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Side effects from amantadine are more common than those from rimantadine; they include mild and transitory nervousness,
insomnia, impaired concentration, mood changes, light-headedness, anorexia, and nausea. These symptoms have
been reported in 5&hyph;10% of healthy young adults receiving 200 mg of the drug per day.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
493,585
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In the elderly, the symptoms may be more severe; in addition, dizziness and ataxia are more common in this age group.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
593,594
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Thus, it is recommended that for persons "65 years of age and/or those who have renal insufficiency, amantadine dosage
should be reduced to &gt;100 mg per day. Further reductions are recommended on the basis of the patient's creatinine
clearance.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
595,596
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 However, because recommended dosages based on creatinine clearance may provide only a rough estimate of the optimal
dose for a given patient,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
597
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 such persons should be carefully observed so that adverse reactions can be recognized promptly and the dose further
reduced or the drug discontinued, if necessary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Emergence of amantadine- and rimantadine-resistant strains of influenza A virus has been observed in persons who
receive these drugs for treatment of the infection.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
598,599
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Because of the potential risk of transmission of resistant viral strains to close contacts of persons receiving amantadine
or rimantadine for treatment,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
599,600
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 to the extent possible, infected persons taking either drug should avoid contact with others during treatment and
for 2 days after discontinuing treatment.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
600,601
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 This is particularly important if the contacts are uninfected persons taking amantadine or rimantadine for prophylaxis.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
600,602
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Vaccination of high-risk patients and of hospital personnel before the influenza season is the primary focus of efforts
to prevent and control nosocomial influenza.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
581,584,603
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The decision to use amantadine or rimantadine as an adjunct to vaccination in the prevention and control of nosocomial
influenza is based in part on results of virologic and epidemiologic surveillance in the hospital and the community.
When outbreaks of influenza A occur in a hospital, and antiviral prophylaxis of high-risk persons and treatment of
cases is undertaken, administration of amantadine or rimantadine is begun as early in the outbreak as possible to
reduce transmission.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
562,584,591,602
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Measures other than vaccination and chemoprophylaxis with amantadine or rimantadine have been recommended for
control of nosocomial influenza outbreaks. Because influenza can be transmitted during contact with an infected
person, contact-isolation precautions, such as placing a patient symptomatic with influenza in a private room,
cohorting of patients with influenza, and masking upon entering a room with persons with influenza have been recommended.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
213
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Handwashing, gloving, and gowning by healthcare workers during the period of viral shedding by patients have also
been recommended, but the exact role of these measures in preventing influenza transmission remains to be elucidated.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
213,561,604
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Although influenza can be transmitted via the airborne route, the efficacy of placing infected persons in rooms with
negative pressure in relation to their immediate environment has not been assessed. In addition, this measure may
be impractical during institutional outbreaks that occur in the midst of a community epidemic of influenza because
many newly admitted patients and healthcare workers may be infected with the virus; thus, the hospital would face
the logistical problem of accommodating all ill persons in rooms with special ventilation. Although controlled
studies are not available to measure their effectiveness, the following additional measures have been recommended
for consideration, particularly during severe outbreaks: (1) Curtailment or elimination of elective admissions,
both medical and surgical; (2) restriction of cardiovascular and pulmonary surgery; (3) restriction of hospital
visitors, especially those with acute respiratory illnesses; and (4) work restriction for healthcare workers with
acute respiratory illness.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
604
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00115 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=74 g=1 f=1 -->
PART II. RECOMMENDATIONS FOR PREVENTION OF NOSOCOMIAL PNEUMONIA 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Introduction 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The recommendations are presented according to the etiology of the infection, in the following order: bacterial
pneumonia, including Legionnaires' disease; fungal pneumonia (aspergillosis); and virus-associated pneumonia
(RSV and influenza infections). Each topic is subdivided according to the following general approaches for nosocomial
infection control, as applicable to the infection: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Staff education and infection surveillance; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Interruption of transmission of microorganisms by eradicating infecting; microorganisms from their epidemiologically
important reservoirs, and/or preventing person-to-person transmission; and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Modifying host risk for infection. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
As in previous CDC guidelines, each recommendation is categorized on the basis of existing scientific evidence,
theoretical rationale, applicability, and economic impact.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
213,214,605&hyph;609
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 However, the previous CDC system of categorizing recommendations has been modified as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
CATEGORY IA
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Strongly recommended for all hospitals and strongly supported by well-designed experimental or epidemiologic
studies. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
CATEGORY IB
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_ Strongly recommended for all hospitals and viewed as effective by experts in the field and a consensus of HICPAC based
on strong rationale and suggestive evidence, even though definitive scientific studies may not have been done. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
CATEGORY II
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Suggested for implementation in many hospitals. Recommendations may be supported by suggestive clinical or epidemiologic
studies, a strong theoretical rationale, or definitive studies applicable to some but not all hospitals. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NO RECOMMENDATION; UNRESOLVED ISSUE
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Practices for which insufficient evidence or consensus regarding efficacy exists. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Prevention and Control of Bacterial Pneumonia 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
I. Staff Education and Infection Surveillance 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Staff Education 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Educate healthcare workers regarding nosocomial bacterial pneumonias and infection control procedures to prevent
their occurrence.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
610&hyph;613
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Surveillance 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Conduct surveillance for bacterial pneumonia in ICU patients at high-risk for nosocomial bacterial pneumonia
(e.g., patients with mechanically assisted ventilation, selected postoperative patients) to determine trends
and identify potential problems.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
7,34,35,59,60,614&hyph;616
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Include data regarding the causative microorganisms and their antimicrobial susceptibility patterns.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2&hyph;4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Express data as rates (e.g., number of infected patients or infections per 100 ICU days or per 1,000 ventilator-days)
to facilitate intra- and inter-hospital comparisons.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
63,617&hyph;619
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Do not routinely perform surveillance cultures of patients or of equipment or devices used for respiratory therapy,
pulmonary-function testing, or delivery of inhalation anesthesia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
62,620,621
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. INTERRUPTION OF TRANSMISSION OF MICROORGANISMS 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Sterilization or Disinfection, and Maintenance of Equipment and Devices 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
1. General Measures 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. Thoroughly clean all equipment and devices to be sterilized or disinfected. Decontaminate equipment or device
before or during cleaning if it is contaminated with blood and/or marked ``contaminated'' and received from patients
who are on certain types of isolation.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
245,246,622
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. Sterilize semicritical equipment or devices, i.e., items that touch mucous membranes (See device list, Appendix
A). If sterilization is not feasible, use high-level disinfection either by wet heat pasteurization (76
<!-- PJG 0017 degreeslatlong -->
&cir;C for 30 minutes), or by using liquid disinfectants approved as sterilants or disinfectants by the Environmental
Protection Agency.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
240,242,244,246,623
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Follow disinfection with appropriate rinsing, drying, and packaging, taking care not to contaminate the items in
the process. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
c. Use sterile (not distilled, nonsterile), pyrogen-free water for rinsing reusable equipment and devices after
they have been chemically disinfected.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
227,233,234,248
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
d. Do not reprocess an equipment or device that is manufactured for single use only, unless data show that reprocessing
the equipment or device poses no threat to the patient, is cost-effective, and does not change the structural integrity
or function of the equipment or device.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
624,625
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Mechanical Ventilators, Anesthesia Machines and Circle Systems, and Pulmonary-Function Testing Equipment

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. Do not routinely sterilize or disinfect the internal machinery of mechanical ventilators or anesthesia-breathing
machines and their circle systems.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
626,627
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. Do not routinely sterilize or disinfect the internal machinery of pulmonary-function testing machines between
uses on different patients.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
628,629
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Ventilator Circuits with Humidifiers 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. Do not routinely change more frequently than every 48 hours the breathing circuit, including tubing and exhalation
valve, and the attached bubbling or wick humidifier of a ventilator that is in use on an individual patient.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
34,257,262
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00116 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. NO RECOMMENDATION for the maximum length of time after which the breathing circuit and the attached bubbling or
wick humidifier of a ventilator in use on a patient should be changed.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
263
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
c. Sterilize reusable breathing circuits and bubbling or wick humidifiers, or subject them to high-level disinfection
between their uses on different patients.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
240,242,244,246
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
d. Periodically drain and discard any condensate that collects in the tubing of a mechanical ventilator or anesthesia
machine, taking precautions not to allow condensate to drain toward the patient. Wash hands after performing the
procedure or handling the fluid.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
256,260
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
e. NO RECOMMENDATION for placing a filter or trap at the distal end of the expiratory-phase tubing of the breathing
circuit to collect condensate.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
231,256
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
f. Do not place bacterial filters between the humidifier reservoir and the inspiratory-phase tubing of the breathing
circuit of a mechanical ventilator, or in the circuit of an anesthesia machine.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
254,627,630
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g. Humidifier fluids.
<!-- PJG 0012 frnewline -->
(1) Use sterile water to fill bubbling humidifiers.125,233,234,260 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) Use sterile, distilled, or tap water to fill wick humidifiers.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
233,234,260
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(3) NO RECOMMENDATION for preferential use of a closed, continuous-feed humidification system. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE 
<!-- PJG 0012 frnewline -->
4. Ventilator Circuits With Hygroscopic Condenser-Humidifiers or Heat-Moisture Exchangers 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. NO RECOMMENDATION for preferential use of hygroscopic condenser-humidifier or heat-moisture exchanger rather
than a heated humidifier to prevent nosocomial pneumonia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
272&hyph;276
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. Change the hygroscopic condenser-humidifier or heat-moisture exchanger when evidence of gross contamination
or mechanical dysfunction of the device is present.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
272
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
c. Do not routinely change the breathing circuit attached to a hygroscopic condenser-humidifier or heat-moisture
exchanger while it is in use on a patient.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
272,275
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->
5. Wall Humidifiers 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. Follow manufacturers' instructions for use and maintenance of disposable wall oxygen humidifiers unless data
show that the modification in their use or maintenance poses no threat to the patient and is cost effective.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
631&hyph;635
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. Between patients, change the reservoir, tubing (including any nasal prongs), and any mask used to deliver oxygen
from a wall outlet. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->
6. Small-Volume Medication Nebulizers: ``In-Line'' and Hand-Held Nebulizers 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. Between treatments on the same patient, disinfect or rinse with sterile water and air-dry small-volume medication
nebulizers.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
228,378
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. Replace nebulizers between patients with those that have undergone sterilization or high-level disinfection.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
119,121,122,248
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
c. Use only sterile fluids for nebulization, and dispense these fluids aseptically.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
223,227,233,234,248,278,378
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
d. If multi-dose medication vials are used, handle, dispense, and store them according to directions on the vial label
or package insert.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
278,636,637
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->
7. Large-Volume Nebulizers and Mist Tents 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. Do not use large-volume room-air humidifiers that create aerosols (e.g., by venturi principle, ultrasound, or
spinning disk) and thus are really nebulizers, unless they can be sterilized or subjected to high level disinfection
at least daily and filled only with sterile water.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
224,225,227,236,277,638
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. Sterilize large-volume nebulizers that are used for inhalation therapy, e.g., for tracheostomized patients,
or subject them to high-level disinfection between patients and after every 24 hours of use on the same patient.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
119,121,122
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
c. Use mist-tent nebulizers and reservoirs that have undergone sterilization or high-level disinfection, and replace
them between patients and after every 24 hours of use on the same patient.639 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->
8. Other Devices 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. Between patients, sterilize or use high-level disinfection on respirometers, oxygen sensors, and other respiratory
devices used on multiple patients.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
220,286
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. Sterilize or use high-level disinfection on hand-powered resuscitation bags (for example, Ambu bags) between
patients.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
239,283&hyph;285
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
c. Remove faucet aerators.640 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Interruption of Person-to-Person Transmission of Bacteria 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
1. Handwashing 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00117 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Wash hands after contact with mucous membranes, respiratory secretions, or objects contaminated with respiratory
secretions, whether or not gloves are worn. Wash hands before and after contact with a patient who has an endotracheal
or tracheostomy tube in place, and before and after contact with any respiratory device that is used on the patient,
whether or not gloves are worn.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
201,203,207,208,641,642
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->
2. Barrier Precautions 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. Wear gloves for handling respiratory secretions or objects contaminated with respiratory secretions of any patient.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
215,216
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. Change gloves and wash hands between patients; after handling respiratory secretions or objects contaminated
with secretions from one patient and before contact with another patient, object, or environmental surface; and
between contacts with a contaminated body site and respiratory tract of, or respiratory device on, the same patient.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
215,217,218
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
c. Wear a gown when soiling with respiratory secretions from a patient is anticipated, and change the gown after such
contact and before providing care to another patient.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
215
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->
3. Care of Patients with Tracheostomy 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. Perform tracheostomy under sterile conditions. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. When changing a tracheostomy tube, use aseptic technique and replace the tube with one that has undergone sterilization
or high-level disinfection. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->
4. Suctioning of Respiratory Tract Secretions 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 NO RECOMMENDATION
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for wearing sterile rather than clean gloves when suctioning a patient's respiratory secretions. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=3 -->
UNRESOLVED ISSUE 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. If the open suction system is employed, use a sterile single-use catheter. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=3 -->
CATEGORY II
<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
c. Use only sterile fluid to remove secretions from the suction catheter. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=3 -->
CATEGORY IB 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
d. Change suction-collection tubing and canisters between patients. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=3 -->
Category IB 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
e.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 NO RECOMMENDATION
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for using a multi-use closed-system suction catheter in preference to a single-use open-system catheter.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
279&hyph;282
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=3 -->
UNRESOLVED ISSUE 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
f.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 NO RECOMMENDATION
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for routinely using an endotracheal tube with a dorsal lumen above the endotracheal cuff, to allow drainage (by suctioning)
of tracheal secretions that accumulate in the patient's subglottic area.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
197
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=3 -->
UNRESOLVED ISSUE
<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Modifying Host Risk for Infection 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Precautions for Prevention of Endogenous Pneumonia 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
1. Prevention of Aspiration 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. Discontinue enteral-tube feeding and remove devices such as endotracheal and/or nasogastric or other enteral
tubes from patients as soon as the clinical indications for these are resolved.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
7,34,35,80,110,173,175,176,192,643
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. If there is no contraindication to the maneuver, elevate at an angle of 30&hyph;45
<!-- PJG 0017 degreeslatlong -->
&cir; the head of the bed of a patient who is receiving mechanically assisted ventilation and has a nasogastric or other
enteral tube in place.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
175,184
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 01 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 01 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
c. Routinely verify appropriate placement of the feeding tube.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
175644&hyph;646
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 01 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
d. Routinely assess the patient's intestinal motility, (e.g., by auscultating for bowel sounds and measuring residual
gastric volume or abdominal girth) and adjust the rate and volume of enteral feeding to avoid regurgitation.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
175,188,643
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 01 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 01 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
e. Use small-bore tubes for enteral feeding;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
175,176,186,644,647
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 01 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 01 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
f. Administer enteral feeding intermittently in small quantities, rather than continuously.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
2T167,183,647,648
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00118 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG QTAG 01 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 01 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g. NO RECOMMENDATION for preferentially placing the feeding tubes, e.g., jejunal tubes, distal to the pylorus;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
189,190,649
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 01 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 01 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
h. NO RECOMMENDATION for using oro-tracheal rather than naso-tracheal tube.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
650
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 01 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 01 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2. Prevention of Gastric Colonization
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. If stress-bleeding prophylaxis is needed for a patient with mechanically assisted ventilation, use an agent that
does not raise the patient's gastric pH.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
22,34,105,111,115,140&hyph;142,144&hyph;146
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Category II
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. NO RECOMMENDATION for selective decontamination of an ICU patient's digestive tract with oral and/or intravenous
antimicrobials to prevent gram-negative bacillary (or 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Candida
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp.) pneumonia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
147&hyph;170
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
c. NO RECOMMENDATION for routine acidification of gastric feedings.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
171
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Prevention of Postoperative Pneumonia
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Instruct preoperative patients, especially those at high risk of developing pneumonia, regarding frequent coughing,
taking deep breaths, and ambulating as soon as medically indicated in the postoperative period.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
302,304
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 High-risk patients include those who will receive anesthesia, especially those who will have an abdominal, thoracic,
head, or neck operation, or who have substantial pulmonary dysfunction, such as patients with chronic obstructive
lung disease, a musculoskeletal abnormality of the chest, or abnormal pulmonary function tests.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
287&hyph;290,293,294
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Encourage postoperative patients to cough frequently, take deep breaths, move about the bed, and ambulate unless
it is medically contraindicated.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
301,302,304
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. Control pain that interferes with coughing and deep breathing during the immediate postoperative period by using
systemic analgesia,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
309,652
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 including patient-controlled analgesia,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
310&hyph;312
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 with as little cough-suppressant effect as possible; appropriate support for abdominal wounds, such as tightly
placing a pillow across the abdomen; or regional (e.g., epidural) analgesia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
313&hyph;315
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. Use an incentive spirometer or intermittent positive pressure breathing, perform chest physiotherapy on patients
at high risk of developing postoperative pneumonia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
295,298,299,302,304,305,307
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (See III&hyph;B&hyph;1 above for definition of high-risk patients.)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Other Prophylactic Procedures for Pneumonia
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
1. Vaccination of Patients
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Vaccinate patients at high risk for complications of pneumococcal infections with pneumococcal polysaccharide
vaccine. High-risk patients include persons "65 years old; adults with chronic cardiovascular or pulmonary disease,
diabetes mellitus, alcoholism, cirrhosis, or cerebrospinal fluid leaks; and children and adults with immunosuppression,
functional or anatomic asplenia, or HIV infection.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
319&hyph;321
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Systemic Antimicrobial Prophylaxis
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Do not routinely administer systemic antimicrobial agents to prevent nosocomial pneumonia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
84,191,322&hyph;325,653
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Use of Rotating ``Kinetic'' Beds
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NO RECOMMENDATION for the use of continuous lateral rotational therapy (i.e., placing patients on ``kinetic'' beds
that turn on their longitudinal axes continuously and slowly) for prevention of nosocomial pneumonia in patients
in the ICU, critically ill patients, or patients immobilized by illness and/or trauma.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
327&hyph;332
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Prevention and Control of Legionnaires' Disease
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
I. Staff Education and Infection Surveillance
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Staff Education
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Educate (1) physicians and nurses to heighten their suspicion for cases of nosocomial Legionnaires' disease and
to use appropriate methods for its diagnosis, and (2) patient-care, infection-control, and engineering personnel
about measures to control nosocomial legionellosis.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
611&hyph;613
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00119 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Surveillance
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Establish mechanism(s) to provide clinicians with appropriate laboratory tests for the diagnosis of Legionnaires'
disease.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
339,367,368,372,654
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Conduct active search for cases of nosocomial Legionnaires' disease, especially in patients who are at high-risk
of acquiring the disease (patients who are immunosuppressed, including organ-transplant patients, patients with
AIDS, and patients receiving systemic steroids; are "65 years of age; or have chronic underlying disease such as diabetes
mellitus, congestive heart failure, and chronic obstructive lung disease).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
338,339,353,355&hyph;359,365
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Refer to the accompanying background document for definition of nosocomial legionellosis.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NO RECOMMENDATION
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for routinely culturing water systems for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
250,338,383,387&hyph;389,391&hyph;393,408,655
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Interruption of Transmission of Legionella SPP.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Primary Prevention (Preventing Nosocomial Legionnaires' Disease When No Cases Have Been Documented)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
1. Nebulization and Other Devices
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. Use only sterile (not distilled, nonsterile) water for rinsing nebulization devices and other respiratory-care
equipment after they have been cleaned and/or disinfected.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
250,656
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. Use only sterile (not distilled, nonsterile) water to fill reservoirs of devices used for nebulization.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
227,236,250,378,656
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
c. Do not use large-volume room-air humidifiers that create aerosols (e.g., by venturi principle, ultrasound, or
spinning disk) and thus are really nebulizers, unless they can be sterilized or subjected to high-level disinfection
daily and filled only with sterile water.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
236,656
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Cooling Towers
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. When a new hospital building is constructed, place cooling tower(s) in such a way that the tower drift is directed
away from the hospital's air-intake system, and design the cooling towers such that the volume of aerosol drift is
minimized.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
375,657
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. For operational cooling towers, install drift eliminators, regularly use an effective biocide, maintain the
tower according to manufacturers' recommendations, and keep adequate maintenance records.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
375,415,658
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Water-Distribution System
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NO RECOMMENDATION
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for routinely maintaining potable water at the outlet at "50
<!-- PJG 0017 degreeslatlong -->
&cir;C or &lt;20
<!-- PJG 0017 degreeslatlong -->
&cir;C, or chlorinating heated water to achieve 1&hyph;2 mg/L free residual chlorine at the tap.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
338,383,393,400&hyph;403
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NO RECOMMENDATION
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for treatment of water with ozone, ultraviolet light, or heavy-metal ions.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
344,411,412,414
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Secondary Prevention (Response to Identification of Laboratory-Confirmed Nosocomial Legionellosis)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
When a single case of laboratory-confirmed, definite nosocomial Legionnaires' disease is identified, OR if two
or more cases of laboratory-confirmed, possible nosocomial Legionnaires' disease occur within 6 months of each
other (Refer to background document for definition of definite and possible nosocomial Legionnaires' disease.):
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Contact the local or state health department or the CDC for consultation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. If a case is identified in a severely immunocompromised patient such as an organ-transplant recipient, OR if the
hospital houses severely immunocompromised patients, conduct a combined epidemiologic and environmental investigation
(as outlined from II&hyph;B&hyph;3&hyph;b&hyph;1 through II&hyph;B&hyph;5, below) to determine the source(s)
of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 sp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. If the hospital does not house severely immunocompromised patients, conduct an epidemiologic investigation
via a retrospective review of microbiologic, serologic, and postmortem data, and an intensive prospective surveillance
for additional cases of nosocomial Legionnaires' disease.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00120 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. If there is no evidence of continued nosocomial transmission, continue the intensive prospective surveillance
(as in II&hyph;B&hyph;3, above) for at least 2 months after surveillance was begun. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. If there is evidence of continued transmission: 
<!-- PJG 0012 frnewline -->
(1) Conduct an environmental investigation to determine the source(s) of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
sp. by collecting water samples from potential sources of aerosolized water, following the methods described in
Appendix C and saving and subtyping isolates of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp. obtained from patients and environment.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
227,375&hyph;382,404,406
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) If a source is not identified, continue surveillance for new cases for at least 2 months, and, depending on the scope
of the outbreak, decide on either deferring decontamination pending identification of the source(s) of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp., or proceeding with decontamination of the hospital's water distribution system, with special attention to
the specific hospital areas involved in the outbreak. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(3) If a source of infection is identified by epidemiologic and environmental investigation, promptly decontaminate
it.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
417
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) If the heated-water system is implicated: 
<!-- PJG 0012 frnewline -->
i. Decontaminate the heated-water system either by superheating (flushing for at least 5 minutes each distal outlet
of the system with water at "65
<!-- PJG 0017 degreeslatlong -->
&cir;C), OR by hyperchlorination (flushing for at least 5 minutes all outlets of the system with water containing
"10 mg/L free residual chlorine).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
403,408&hyph;410
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Post warning signs at each outlet being flushed to prevent scald injury to patients, staff, or visitors. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
ii. Depending on local and state regulations regarding potable-water temperature in public buildings, maintain
potable water at the outlet at "50
<!-- PJG 0017 degreeslatlong -->
&cir;C or &lt;20
<!-- PJG 0017 degreeslatlong -->
&cir;C, or chlorinate heated water to achieve 1&hyph;2 mg/L free residual chlorine at the tap in hospitals housing
patients who are at high risk of acquiring nosocomial legionellosis (e.g., immunocompromised patients).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
338,383,393,400&hyph;403
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (See appendix B.) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
iii. NO RECOMMENDATION for treatment of water with ozone, ultraviolet light, or heavy-metal ions.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
344,411,412,414
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
iv. Clean hot-water storage tanks and water-heaters to remove accumulated scale and sediment.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
346
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. Restrict immunocompromised patients from taking showers, and use only sterile water for their oral consumption
until 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. becomes undetectable by culture in the hospital water.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
384
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) If cooling towers or evaporative condensers are implicated, decontaminate the cooling-tower system using the
protocol outlined in Appendix D.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
415
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(4) Assess the efficacy of implemented measures in reducing or eliminating 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. by collecting specimens for culture at 2-week intervals for 3 months. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) If 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 sp. is not detected in cultures during 3 months of monitoring, collect cultures monthly for another 3 months. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00121 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) If 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 sp. is detected in one or more cultures, reassess the implemented control measures, modify them accordingly, and
repeat decontamination procedures. Options for repeat decontamination include the intensive use of the same technique
utilized for initial decontamination, or a combination of superheating and hyperchlorination. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(5) Keep adequate records of all infection control measures, including maintenance procedures, and of environmental
test results for cooling towers and potable-water systems. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Prevention and Control of Nosocomial Pulmonary Aspergillosis 
<!-- PJG 0012 frnewline -->
I. Staff Education and Infection Surveillance 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Staff Education 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Educate healthcare workers regarding nosocomial pulmonary aspergillosis especially in immunocompromised patients,
and about infection control procedures to decrease its 
<!-- PJG 0034 unknown -->
occurrence.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
611&hyph;613
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Surveillance 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Maintain a high index of suspicion for diagnosis of nosocomial pulmonary aspergillosis in high-risk patients
(i.e., patients with prolonged, severe granulocytopenia [&lt;1,000 polymorphonuclear cells/mm
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for 2 weeks or &lt;100 polymorphonuclear cells/mm
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for 1 week]), such as organ-transplant recipients or patients with hematologic malignancies who are receiving chemotherapy.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
435,462,463,659
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Maintain surveillance for cases of nosocomial pulmonary aspergillosis by periodically reviewing the hospital's
microbiologic, histopathologic, and postmortem data. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. NO RECOMMENDATION for routine, periodic culturing of the nasopharynx of high-risk patients,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
437,438
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or devices, air samples, dust, ventilation ducts, and filters in rooms occupied by high-risk patients.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
418,428,437,471&hyph;473
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Interruption of Transmission of Aspergillus SPP. Spores 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Planning New Specialized-Care Units for High-Risk Patients 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. When constructing new specialized-care units for high-risk patients, ensure that patient rooms have adequate
capacity to minimize fungal spore counts via maintenance of (a) high-efficiency air filtration, (b) directed room
airflow, (c) positive air pressure in patient's room in relation to the corridor, (d) properly sealed room, and (e)
high rates of room-air changes.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
424,479&hyph;481,484,488,660,661
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->
a. Air Filtration 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Install high efficiency particulate air (HEPA) filters that are 99.97% efficient in filtering 0.3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
u
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
-sized particles, at the point of use, i.e. at the room-air intake site.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
424,479&hyph;481,484,488,660,661
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->
b. Directed Room Airflow 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Place air-intake and exhaust ports such that room air comes in from one side of the room, flows across the patient's
bed, and exits on the opposite side of the room. In addition, place intake and exhaust ports such that healthcare personnel
entering the room to care for the patient would stand between the patient and the exhaust port.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
480,481
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->
c. Well-Sealed Room 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Construct windows, doors, and intake and exhaust ports to achieve complete sealing of the room against air leaks.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=1 -->
480,481
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->
d. Room-Air Pressure 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Ensure that room-air pressure can be maintained continuously above that of corridor, e.g., as can be demonstrated
by performance of the smoke-tube test, unless there are clinical-care or infection-control contraindications
to do so.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
480,481
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(1) To maintain positive room-air pressure in relation to the corridor, supply room air at a rate that is 10&hyph;20%
more than the rate of exhausting air from the room.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
480,481
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) Construct rooms that have an anteroom with an independent exhaust for placement of patients at high risk of aspergillosis
who also have an infection (e.g., varicella or infectious tuberculosis) requiring negative room-air pressure in
relation to the corridor.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
480
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->
e. Room-Air Changes 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Maintain room-air changes at "15 per hour.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
480,486,487
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. NO RECOMMENDATION for the preferential installation of a particular system, such as one with ultra-high (100&hyph;400
per hour) air change rates, e.g., laminar airflow, over other systems that meet the conditions in II&hyph;A&hyph;1&hyph;a
through II&hyph;A&hyph;1&hyph;e above.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
424,479&hyph;481,484,488,660,661
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. Formulate hospital policies to minimize exposures of high-risk patients to potential sources of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
spp., such as hospital construction and renovation, cleaning activities, carpets, food, potted plants, and flower
arrangements.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
418,437,662&hyph;664
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. NO RECOMMENDATION for prophylactic use of copper-8-quinolinolate biocide in fireproofing material.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
418,427,481,488
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00122 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. In Existing Facilities With No Cases of Nosocomial Aspergillosis 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Place high-risk patients in protected environment that meets the conditions outlined in Section II&hyph;A&hyph;1&hyph;a
through II&hyph;A&hyph;1&hyph;e above.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
424,437,479,488,660,661,665
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Routinely inspect air-handling systems in high-risk patient-care areas, maintain adequate air exchanges and
pressure differentials, and eliminate air leakages. Coordinate repairs of the system with relocation of high-risk
patients to other areas with optimal air-handling capabilities.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
418,428,437 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3. Minimize the time high-risk patients spend outside their rooms for diagnostic procedures and other activities;
and when high-risk patients leave their rooms, require them to wear well-fitting masks capable of filtering 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
 spp. spores. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
4. Regularly clean ceiling tiles, air-duct grates, and other surfaces in patient rooms to prevent dust accumulation,
and maintain adequate seals on windows to prevent room infiltration by outside air, especially in areas occupied
by patients at high-risk for developing aspergillosis. Conduct such cleaning when the rooms are not occupied by patients.437

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5. Systematically review and coordinate infection-control strategies with personnel in charge of hospital engineering,
maintenance, central supply and distribution, and catering.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
418,473 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
6. When planning hospital construction and renovation activities, assess whether patients at high-risk for aspergillosis
are likely to be exposed to high ambient-air spore counts of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
 spp. from construction and renovation sites, and develop a plan to prevent such exposures.418,473 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
7. During construction or renovation activities: 
<!-- PJG 0012 frnewline -->
(a) Construct barriers between patient-care and construction areas to prevent dust from entering patient-care
areas; these barriers (e.g., plastic or drywall) should be impermeable to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
 spp.418,428,472,473 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
(b) In construction/renovation areas inside the hospital, create and maintain negative pressure relative to that
in adjacent patient-care areas if there are no contraindications for such pressure differential, e.g., there are
patients with infectious tuberculosis in the adjacent patient-care areas.418,428,472,473,488 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
(c) Direct pedestrian traffic from construction areas away from patient-care areas to limit opening and closing
of doors (or other barriers) that may cause dust dispersion, entry of contaminated air, or tracking of dust into patient
areas.418,428,472,473 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
(d) Clean newly constructed areas before allowing patients to enter the areas.418,473 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
8. Eliminate exposures of patients at high-risk for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=3 -->
aspergillosis
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
 to activities, such as floor or carpet vacuuming, that may cause spores of Aspergillus spp. and other fungi to be aerosolized.418,437,473

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
9. Eliminate exposures of patients at high-risk for aspergillosis to potential environmental sources of Aspergillus
spp., such as 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
-contaminated food, potted plants, or flower arrangements.418,437,473,662&hyph;664 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
10. Prevent birds from gaining access to hospital air-intake ducts.474 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. When a Case of Nosocomial Aspergillosis Occurs 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Begin a prospective search for additional cases in hospitalized patients and an intensified retrospective review
of the hospital's microbiologic, histopathologic, and postmortem records. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. If there is no evidence of continuing transmission, continue routine maintenance procedures to prevent nosocomial
aspergillosis, as in Section II&hyph;B&hyph;1 through II&hyph;B&hyph;10 above. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. If evidence of continuing 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. infection exists, conduct an environmental investigation to determine and eliminate the source.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
424,427,428,472,484,488 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00123 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
a. Collect environmental samples from potential sources of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
 spp., especially those sources implicated in the epidemiologic investigation, by using appropriate methods,424,427,428,472,484,488,666
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 e.g., use of a high-volume air sampler rather than settle plates.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
424 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. Perform molecular subtyping of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. obtained from patients and the environment to establish strain identity.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
476,477 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
c. If air-handling systems supplying high-risk patient-care areas are not optimal, consider temporary deployment
of portable HEPA filters until rooms with optimal air-handling systems are available for all patients at high risk
of invasive aspergillosis.469 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
d. If an environmental source is identified, perform corrective measures as needed to eliminate the source from the
high-risk patients' environment. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
e. If an environmental source is not identified, review existing infection-control measures, including engineering
aspects, to identify potential areas that can be corrected or improved. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Modifying Host Risk for Infection 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. Administer cytokines, including granulocyte colony-stimulating factor and granulocyte-macrophage stimulating
factor, to increase host resistance to aspergillosis by decreasing the duration and severity of chemotherapy-induced
granulocytopenia.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
464,465 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
B. NO RECOMMENDATION for administration of intranasal amphotericin B or oral antifungal agents (including amphotericin
B and triazole compounds) in high-risk patients for prophylaxis against aspergillosis.466,467,667 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
UNRESOLVED ISSUE 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=5 f=1 -->
Prevention and Control of Respiratory Syncytial Virus Infection
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
(The principles and recommendations below are applicable for prevention and control of nosocomial 
<!-- PJG 0012 frnewline -->
lower respiratory tract infections due to adenovirus, parainfluenza virus and rhinovirus.) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=5 f=1 -->
I. Staff Education and Infection Surveillance
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=5 f=1 -->
A. Staff Education 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
Educate personnel about the epidemiology, modes of transmission and means of preventing spread of respiratory syncytial
virus (RSV).215,611&hyph;613 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=5 f=1 -->
B. Surveillance 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
1. Establish mechanism(s) by which the appropriate hospital personnel are promptly alerted to any increase in RSV
activity in the local community. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2. During periods of increased prevalence of RSV in the community (and during December&hyph;March), attempt prompt
diagnosis of RSV infection by using rapid diagnostic techniques as clinically indicated in pediatric patients,
especially infants, and in immunocompromised adults admitted to the hospital with respiratory illness.545,549

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=5 f=1 -->
II. Interruption of Transmission of RSV
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=5 f=1 -->
A. Prevention of Person-to-Person Transmission
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
1. Primary Measures for Contact Isolation 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
a. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=3 -->
Handwashing.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
 Wash hands after contact with a patient, or after touching respiratory secretions or fomites potentially contaminated
with respiratory secretions, whether or not gloves are worn.207,503,524&hyph;526,547 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
b. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=3 -->
Gloving.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
 (1) Wear gloves for handling patients or respiratory secretions of patients with proven or suspected RSV infection,
or fomites potentially contaminated with patient secretions.215,503,524,525,543,549 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
(2) Change gloves between patients, or after handling respiratory secretions or fomites contaminated with secretions
from one patient before contact with another patient.215,217
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Wash hands after removing gloves. (See II&hyph;A&hyph;1&hyph;a, above.) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
c. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Gowning.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Wear a gown when soiling with respiratory secretions from a patient is anticipated, e.g., when handling infants with
RSV infection or other viral respiratory illness, and change the gown after such contact and before caring for another
patient.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
215,542,544,549 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
d. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=3 -->
Staffing. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
Restrict healthcare workers in the acute stages of an upper respiratory illness, i.e., those who are sneezing and/or
coughing, from taking care of RSV-uninfected infants and other patients at high risk for complications from RSV infection,
e.g., children with severe underlying cardio-pulmonary conditions, children receiving chemotherapy for malignancy,
and patients who are otherwise immunocompromised.547,549 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=5 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
e. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=3 -->
Limiting Visitors. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
Do not allow persons with symptoms of respiratory infection to visit uninfected pediatric, immunosuppressed, and
cardiac patients.543 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00124 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2. Control of RSV Outbreaks 
<!-- PJG 0012 frnewline -->
a. Use of Private Room, Cohorting, and Patient-Screening 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To control ongoing RSV transmission in the hospital, admit young children with symptoms of viral respiratory illness
to single rooms when possible, OR perform RSV-screening diagnostic tests on young children upon admission and cohort
them according to their RSV-infection status.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
543,545,547,549
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->
b. Personnel Cohorting 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
During an outbreak of nosocomial RSV, cohort personnel as much as practical, i.e., restrict personnel who give care
to infected patients from giving care to uninfected patients, and vice-versa.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
543,547,549
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->
c. Postponing Patient Admission 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
During outbreaks of nosocomial RSV, postpone elective admission of uninfected patients at high risk of complications
from RSV infection. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->
d. Wearing Eye-Nose Goggles 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NO RECOMMENDATION for wearing eye-nose goggles for close contact with an RSV-infected patient.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
546,550
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
UNRESOLVED ISSUE 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Prevention and Control of Influenza 
<!-- PJG 0012 frnewline -->
I. Staff Education and Infection Surveillance 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Staff Education 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Educate personnel about the epidemiology, modes of transmission and means of preventing the spread of influenza.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
611&hyph;613,668,669
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Surveillance 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Establish mechanism(s) by which the appropriate hospital personnel are promptly alerted of any increase in influenza
activity in the local community. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Arrange for laboratory tests to be available to clinicians, for use when clinically indicated, to promptly confirm
the diagnosis of influenza and other acute viral respiratory illnesses, especially during November-April.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
573&hyph;578
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Modifying Host Risk to Infection 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Vaccination 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
1. Patients 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Offer vaccine to outpatients and inpatients at high risk of complications from influenza, beginning in September
and continuing until influenza activity has begun to decline.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
581,584,603,670&hyph;672
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Patients at high risk of complications from influenza include those "65 years of age; in long-term-care units; with
chronic disorders of the pulmonary or cardiovascular systems, diabetes mellitus, renal dysfunction, hemoglobinopathies,
musculo-skeletal disorders that impede adequate respiration, or immunosuppression; and children 6 months-18
years of age who are receiving long-term aspirin therapy.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
581
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->
2. Personnel 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Vaccinate healthcare workers before the influenza season each year, preferably between mid-October and mid-November.
Until influenza activity declines, continue to make vaccine available to newly hired personnel and to those who initially
refuse vaccination. If vaccine supply is limited, give highest priority to staff caring for patients at greatest
risk of severe complications from influenza infection, as listed in Section II-A&hyph;1 above.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
581
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Use of Antiviral Agents (See Section IV Below, Control of Influenza Outbreaks) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Interruption of (Person-to-Person) Transmission 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. Keep a patient for whom influenza is suspected or diagnosed in a private room, or in a room with other patients with
proven influenza, unless there are medical contraindications to do so. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
B. As much as feasible, maintain negative air pressure in rooms of patients for whom influenza is suspected or diagnosed,
or place together persons with influenza-like illness in a hospital area with an independent air-supply-and-exhaust
system.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
566,567,569,673
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00125 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
C. Institute masking of individuals who enter the room of a patient with influenza.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
566,567,673
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
D. As much as possible during periods of influenza activity in the community, remove patient-care staff who have symptoms
of febrile upper respiratory tract infection suggestive of influenza from duties that involve direct patient contact.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
604,674
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
E. When community and/or nosocomial outbreaks are characterized by high attack rates and severe illness: 
<!-- PJG 0012 frnewline -->
1. Restrict hospital visitors who have a febrile respiratory illness. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Curtail or eliminate elective medical and surgical admissions as necessary. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. Restrict cardiovascular and pulmonary surgery to only emergency cases. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Control of Influenza Outbreaks 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Determining the Outbreak Strain 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Early in the outbreak, obtain nasopharyngeal-swab or nasal-wash specimens from patients with symptoms suggestive
of influenza for influenza virus culture or antigen detection. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Vaccination of Patients and Personnel 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Administer current influenza vaccine to unvaccinated patients and staff, especially if the outbreak occurs early
in the influenza season.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
562,581
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Amantadine or Rimantadine Administration 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. When a nosocomial outbreak of influenza A is suspected or recognized: 
<!-- PJG 0012 frnewline -->
a. Administer amantadine or rimantadine for prophylaxis to all uninfected patients in the involved unit for whom
it is not contraindicated. Do not delay administration of amantadine or rimantadine unless the results of diagnostic
tests to identify the infecting strain(s) can be obtained within 12 to 24 hours after specimen collection.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
584,587
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. Administer amantadine or rimantadine for prophylaxis to unvaccinated staff members for whom it is not medically
contraindicated, and who are in the involved unit or taking care of high-risk patients.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
584
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Discontinue amantadine or rimantadine if laboratory tests confirm or strongly suggest that influenza type A is
not the cause of the outbreak.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
585,602
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. If the cause of the outbreak is confirmed or believed to be influenza type A AND vaccine has been administered only
recently to susceptible patients and personnel, continue amantadine or rimantadine prophylaxis until 2 weeks after
the vaccination.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
675
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. To the extent possible, do not allow contact between those at high risk of complications from influenza and patients
or staff who are taking amantadine or rimantadine for treatment of acute respiratory illness; prevent contact during
and for two days after the latter discontinue treatment.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
586,598&hyph;602
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
CATEGORY IB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
D. Interruption of (Person-to-Person) Transmission (See Section III, A&hyph;E Above.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00126 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 5,L2,i1,s100,r50,r75,r50,r100  -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
1._
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Microorganisms Isolated From Respiratory Tract Specimens Obtained by Various Representative Methods From Adult
Patients With a Diagnosis of Nosocomial Pneumonia 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&blank; 
<!-- PJG 007 0150 intable -->
1Schaber4 
<!-- PJG 007 0150 intable -->
1Bartlett5 
<!-- PJG 007 0150 intable -->
1Fagon6 
<!-- PJG 007 0150 intable -->
1Torres7 
<!-- PJG 007 0152 intable -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
Hospital Type 
<!-- PJG 007 0104 intable -->
NNIS &amp; UMH
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
A
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
Veterans 
<!-- PJG 007 0104 intable -->
General 
<!-- PJG 007 0104 intable -->
General. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Patients Studied: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
Ventilated or Non-ventilated 
<!-- PJG 007 0104 intable -->
Mixed 
<!-- PJG 007 0104 intable -->
Mixed 
<!-- PJG 007 0104 intable -->
Ventilated 
<!-- PJG 007 0104 intable -->
Ventilated. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Number 
<!-- PJG 007 0104 intable -->
N/A
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
B
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
159 
<!-- PJG 007 0104 intable -->
49 
<!-- PJG 007 0104 intable -->
78. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Number of episodes of pneumonia 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
159 
<!-- PJG 007 0104 intable -->
52 
<!-- PJG 007 0104 intable -->
78. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Specimen(s) Cultured 
<!-- PJG 007 0104 intable -->
Sputum, Tracheal Aspirate 
<!-- PJG 007 0104 intable -->
Transtracheal Aspirate, Pleural Fluid, Blood 
<!-- PJG 007 0104 intable -->
Protected Specimen Brushing 
<!-- PJG 007 0104 intable -->
Protected Specimen Brushing, Lung Aspirate, Pleural Fluid, Blood. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
Culture Results:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
No organism isolated 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
0 
<!-- PJG 007 0104 intable -->
0 
<!-- PJG 007 0104 intable -->
54%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Polymicrobial 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
54%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
40%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
13%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Number of isolates 
<!-- PJG 007 0104 intable -->
15,499 
<!-- PJG 007 0104 intable -->
314 
<!-- PJG 007 0104 intable -->
111 
<!-- PJG 007 0104 intable -->
N/A. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
Aerobic Bacteria 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=02 g=1 f=2 -->
Gram-Negative Bacilli 
<!-- PJG 007 0104 intable -->
50%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
46%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
75%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
16%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pseudomonas aeruginosa 
<!-- PJG 007 0104 intable -->
17%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
9%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
31%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
5%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Enterobacter sp. 
<!-- PJG 007 0104 intable -->
11 
<!-- PJG 007 0104 intable -->
4 
<!-- PJG 007 0104 intable -->
2 
<!-- PJG 007 0104 intable -->
0. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Klebsiella sp. 
<!-- PJG 007 0104 intable -->
7 
<!-- PJG 007 0104 intable -->
23 
<!-- PJG 007 0104 intable -->
4 
<!-- PJG 007 0104 intable -->
0.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
E. coli 
<!-- PJG 007 0104 intable -->
6 
<!-- PJG 007 0104 intable -->
14 
<!-- PJG 007 0104 intable -->
8 
<!-- PJG 007 0104 intable -->
0. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Serratia sp. 
<!-- PJG 007 0104 intable -->
5 
<!-- PJG 007 0104 intable -->
0 
<!-- PJG 007 0104 intable -->
0 
<!-- PJG 007 0104 intable -->
1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Proteus sp. 
<!-- PJG 007 0104 intable -->
3 
<!-- PJG 007 0104 intable -->
11 
<!-- PJG 007 0104 intable -->
15 
<!-- PJG 007 0104 intable -->
1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Citrobacter sp. 
<!-- PJG 007 0104 intable -->
1 
<!-- PJG 007 0104 intable -->
0 
<!-- PJG 007 0104 intable -->
2 
<!-- PJG 007 0104 intable -->
0. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Acinetobacter calcoaceticus 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
0 
<!-- PJG 007 0104 intable -->
15 
<!-- PJG 007 0104 intable -->
9. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Others 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
0 
<!-- PJG 007 0104 intable -->
10 
<!-- PJG 007 0104 intable -->
0. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Haemophilus influenza 
<!-- PJG 007 0104 intable -->
6%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
17%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
10%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
0%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
Legionella sp. 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
2%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
2%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Gram-Positive Cocci 
<!-- PJG 007 0104 intable -->
17%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
56%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
52%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
4%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
Staphylococcus aureus 
<!-- PJG 007 0104 intable -->
16%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
25%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
33%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
2%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Streptococcus sp. 
<!-- PJG 007 0104 intable -->
1 
<!-- PJG 007 0104 intable -->
31 
<!-- PJG 007 0104 intable -->
21 
<!-- PJG 007 0104 intable -->
2. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Others 
<!-- PJG 007 0104 intable -->
0 
<!-- PJG 007 0104 intable -->
0 
<!-- PJG 007 0104 intable -->
8 
<!-- PJG 007 0104 intable -->
0. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Anaerobes 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
35%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
2%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
0. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
Peptostreptococcus 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
14%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
0. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Fusobacterium sp. 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
10 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
0. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Peptococcus sp. 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
11 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
0. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bacteroides melaninogenicus 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
9 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
0. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bacteroides fragilis 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
8 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
0. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Fungi 
<!-- PJG 007 0104 intable -->
4%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
0 
<!-- PJG 007 0104 intable -->
1%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
Aspergillus sp. 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
0 
<!-- PJG 007 0104 intable -->
1%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Candida sp. 
<!-- PJG 007 0104 intable -->
4%
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
0 
<!-- PJG 007 0104 intable -->
0. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Viruses 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
N/A 
<!-- PJG 007 0104 intable -->
N/A. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->
Legend: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG ITAG l=01 g=5 f=1 -->
A
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
NNIS &amp; UMH=National Nosocomial infection Surveillance System and University of Michigan Hospital. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
B
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
N/A=Not Applicable: Not tested or Not reported. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Percent episodes. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Percent isolates. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Percent episodes (Percentages not additive due to polymicrobial etiology in some episodes). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Percent patients with pure culture. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG ITAG l=01 g=1 f=4 -->
Note:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 Footnotes appear at the end of the document. 
<!-- PJG /ITAG -->

</TABLE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00127 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 11,L2,i1,s30,r30,r30,xs50,xs50,xs50,xs50,xs50,xs50,xs50,xs50 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
2_
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Controlled Studies on Nosocomial Lower Respiratory Tract Infections and Other Associated Outcomes of Selective
Decontamination of the Digestive Tract in Adult Patients With Mechanically Assisted Ventilation
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Author
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Study patients
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Lower respiratory tract infection
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2Diagnostic method
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2Infection rate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
3SDD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=5 f=1 -->
C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
 (%)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
3Controls (%)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Colonization or infection with resistant
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=5 f=1 -->
A
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
 microorganisms
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2SDD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=5 f=1 -->
C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
 (%)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2Controls (%)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Overall mortality in hospital
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2SDD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=5 f=1 -->
C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
 (%)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2Controls (%)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Mean total number of days in ICU
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=5 f=1 -->
B
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2SDD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=5 f=1 -->
C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2Controls
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Stoutenbeek
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
147
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1984)
<!-- PJG 007 0104 intable -->
Trauma SDD=63; Controls=59
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 TS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 culture
<!-- PJG 007 0104 intable -->
8
<!-- PJG 007 0104 intable -->
59
<!-- PJG 007 0104 intable -->
``No increase''
<!-- PJG 007 0104 intable -->
``No increase''
<!-- PJG 007 0104 intable -->
3
<!-- PJG 007 0104 intable -->
8
<!-- PJG 007 0104 intable -->
Not reported
<!-- PJG 007 0104 intable -->
Not reported.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Unertl
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
148
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1987)
<!-- PJG 007 0104 intable -->
General ICU SDD=19; Controls=20
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
21
<!-- PJG 007 0104 intable -->
70
<!-- PJG 007 0104 intable -->
21
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
26
<!-- PJG 007 0104 intable -->
30
<!-- PJG 007 0104 intable -->
18
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
G
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
23
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
G
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Leding
<!-- PJG 0034 unknown -->
ham
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
149
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1988)
<!-- PJG 007 0104 intable -->
General ICU SDD=163; Controls=161
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
2
<!-- PJG 007 0104 intable -->
11
<!-- PJG 007 0104 intable -->
``No increase''
<!-- PJG 007 0104 intable -->
``No increase''
<!-- PJG 007 0104 intable -->
24
<!-- PJG 007 0104 intable -->
24
<!-- PJG 007 0104 intable -->
Not reported
<!-- PJG 007 0104 intable -->
Not reported.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kerver
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
150
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1988)
<!-- PJG 007 0104 intable -->
Surgical ICU SDD=49; Controls=47
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
12
<!-- PJG 007 0104 intable -->
85
<!-- PJG 007 0104 intable -->
``Not recorded''
<!-- PJG 007 0104 intable -->
``Not recorded''
<!-- PJG 007 0104 intable -->
29
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=4
<!-- PJG 007 0104 intable -->
32 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=17
<!-- PJG 007 0104 intable -->
17
<!-- PJG 007 0104 intable -->
20
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Ulrich
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
151
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1989)
<!-- PJG 007 0104 intable -->
General ICU SDD=48; Controls=52
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 TS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 culture
<!-- PJG 007 0104 intable -->
15
<!-- PJG 007 0104 intable -->
50
<!-- PJG 007 0104 intable -->
GP=78
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
I
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0120 intable -->
GN=3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
J
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
GP=44
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
I
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0120 intable -->
GN=2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
J
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
31 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=0
<!-- PJG 007 0104 intable -->
54 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=15
<!-- PJG 007 0104 intable -->
17
<!-- PJG 007 0104 intable -->
13.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Brun-Buis
<!-- PJG 0034 unknown -->
son
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
152
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1989)
<!-- PJG 007 0104 intable -->
Medical ICU SDD=36; Controls=50
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 TS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 PSB
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
K
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 culture
<!-- PJG 007 0104 intable -->
20
<!-- PJG 007 0104 intable -->
22
<!-- PJG 007 0104 intable -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
16
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
22 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=9
<!-- PJG 007 0104 intable -->
24 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=10
<!-- PJG 007 0104 intable -->
14
<!-- PJG 007 0104 intable -->
15.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Godard
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
153
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1990)
<!-- PJG 007 0104 intable -->
General ICU SDD=97; Controls=84
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 TS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 &amp; PSB
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
K
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 culture
<!-- PJG 007 0104 intable -->
2
<!-- PJG 007 0104 intable -->
15
<!-- PJG 007 0104 intable -->
GN=15
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
I
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
GN=15
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
I
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
12
<!-- PJG 007 0104 intable -->
18
<!-- PJG 007 0104 intable -->
11
<!-- PJG 007 0104 intable -->
16.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Rodriquez-Rol
<!-- PJG 0034 unknown -->
dan
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
154
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1990)
<!-- PJG 007 0104 intable -->
General ICU SDD=13; Controls=15
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 TS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 culture
<!-- PJG 007 0104 intable -->
Pn-0
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
L
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0120 intable -->
TB=23
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
M
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
Pn=73
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
L
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0120 intable -->
TB=20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
M
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
``None noticed''
<!-- PJG 007 0104 intable -->
``None noticed''
<!-- PJG 007 0104 intable -->
30 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=0
<!-- PJG 007 0104 intable -->
33 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=13
<!-- PJG 007 0104 intable -->
Not reported
<!-- PJG 007 0104 intable -->
Not reported.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Flaherty
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
155
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1990)
<!-- PJG 007 0104 intable -->
Cardiac Surgery ICU SDD=51; Controls=56
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
2
<!-- PJG 007 0104 intable -->
9
<!-- PJG 007 0104 intable -->
GN=22
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
GN=21
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
0
<!-- PJG 007 0104 intable -->
2
<!-- PJG 007 0104 intable -->
Not reported
<!-- PJG 007 0104 intable -->
Not reported.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
McClel
<!-- PJG 0034 unknown -->
land
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
156
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1990)
<!-- PJG 007 0104 intable -->
Renal &amp; Respiratory Failure SDD=15; Controls=12
<!-- PJG 007 0104 intable -->
TS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 culture
<!-- PJG 007 0104 intable -->
7
<!-- PJG 007 0104 intable -->
50
<!-- PJG 007 0104 intable -->
Not reported
<!-- PJG 007 0104 intable -->
``Not reported''
<!-- PJG 007 0104 intable -->
60 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=27
<!-- PJG 007 0104 intable -->
58 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=8
<!-- PJG 007 0104 intable -->
Not reported
<!-- PJG 007 0104 intable -->
Not reported.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tetteroo
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
157
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1990)
<!-- PJG 007 0104 intable -->

<!-- PJG 0012 frnewline -->
Esophageal Resection SDD=56; Controls=56
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 Culture of Bronchial Aspirate
<!-- PJG 007 0104 intable -->
2
<!-- PJG 007 0104 intable -->
14
<!-- PJG 007 0104 intable -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
5 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=4
<!-- PJG 007 0104 intable -->
4 
<!-- PJG 007 0120 intable -->
ir
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=0
<!-- PJG 007 0104 intable -->
6
<!-- PJG 007 0104 intable -->
5.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pugin
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
158
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1991)
<!-- PJG 007 0104 intable -->
Surgical ICU SDD=25; Controls=27
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 TS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 culture
<!-- PJG 007 0104 intable -->
16
<!-- PJG 007 0104 intable -->
78
<!-- PJG 007 0104 intable -->
``No New antibiotic resistance''
<!-- PJG 007 0104 intable -->
``No New antibiotic resistance''
<!-- PJG 007 0104 intable -->
28
<!-- PJG 007 0104 intable -->
26
<!-- PJG 007 0104 intable -->
13
<!-- PJG 007 0104 intable -->
15.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Aerdts
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
159
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1991)
<!-- PJG 007 0104 intable -->
General ICU SDD=17; Controls&hyph;A=18
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 Controls&hyph;B=21
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 TS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 culture
<!-- PJG 007 0104 intable -->
6
<!-- PJG 007 0104 intable -->
A=78 
<!-- PJG 007 0120 intable -->
B=62
<!-- PJG 007 0104 intable -->
``Not observed''
<!-- PJG 007 0104 intable -->
``Not observed''
<!-- PJG 007 0104 intable -->
12 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=6
<!-- PJG 007 0104 intable -->
A=22 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=11 
<!-- PJG 007 0120 intable -->
B=10 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=0
<!-- PJG 007 0104 intable -->
23
<!-- PJG 007 0104 intable -->
A=30 
<!-- PJG 007 0120 intable -->
B=25.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Harte
<!-- PJG 0034 unknown -->
nauer
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
160
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1991)
<!-- PJG 007 0104 intable -->
Surgical ICU ICU&hyph;1: SDD=50; Controls=61 ICU&hyph;2: SDD=49 Controls=40
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 TS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 culture
<!-- PJG 007 0104 intable -->
ICU&hyph;1; 10 
<!-- PJG 007 0120 intable -->
ICU&hyph;2: 10
<!-- PJG 007 0104 intable -->
46 
<!-- PJG 007 0120 intable -->
45
<!-- PJG 007 0104 intable -->
S=34
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
Q
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0120 intable -->
GN=0
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0120 intable -->
S=37
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
Q 
<!-- PJG 007 0120 intable -->
GN=0N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
S=33
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
Q
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0120 intable -->
GN=0
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0120 intable -->
S=37
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
Q
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0120 intable -->
GN=0
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
38 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=8 
<!-- PJG 007 0120 intable -->
31 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=6
<!-- PJG 007 0104 intable -->
48 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=21 
<!-- PJG 007 0120 intable -->
43 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=25
<!-- PJG 007 0104 intable -->
12 
<!-- PJG 007 0120 intable -->
13
<!-- PJG 007 0104 intable -->
13.
<!-- PJG 007 0120 intable -->
17.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Fox
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
161
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1991)
<!-- PJG 007 0104 intable -->
Cardiac Bypass SDD=12; Controls=12
<!-- PJG 007 0104 intable -->
TS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 culture
<!-- PJG 007 0104 intable -->
66
<!-- PJG 007 0104 intable -->
50
<!-- PJG 007 0104 intable -->
Not reported
<!-- PJG 007 0104 intable -->
Not reported
<!-- PJG 007 0104 intable -->
17
<!-- PJG 007 0104 intable -->
66
<!-- PJG 007 0104 intable -->
12
<!-- PJG 007 0104 intable -->
12.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Blair
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
162
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1991)
<!-- PJG 007 0104 intable -->
General ICU SDD=126; Controls=130
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
10
<!-- PJG 007 0104 intable -->
35
<!-- PJG 007 0104 intable -->
``No evidence of increased resistance''
<!-- PJG 007 0104 intable -->
``No evidence of increased resistance''
<!-- PJG 007 0104 intable -->
14
<!-- PJG 007 0104 intable -->
19
<!-- PJG 007 0104 intable -->
8
<!-- PJG 007 0104 intable -->
8.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Vanden
<!-- PJG 0034 unknown -->
broucke-Grauls
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
163
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1991)
<!-- PJG 007 0104 intable -->
ICUs (Pooled data)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
R
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 SDD&hyph;A=488; Controls&hyph;A (Historical)=540 SDD&hyph;B=225; Control&hyph;B (Random)=266
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 TS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 culture
<!-- PJG 007 0104 intable -->
A=7
<!-- PJG 007 0120 intable -->
B=8
<!-- PJG 007 0104 intable -->
A=28 
<!-- PJG 007 0120 intable -->
B=45
<!-- PJG 007 0104 intable -->
``No increase in resistant microorganisms in 10 of 11 studies''
<!-- PJG 007 0104 intable -->
``No increase in resistant microorganisms in 10 of 11 studies''
<!-- PJG 007 0104 intable -->
A=25 
<!-- PJG 007 0120 intable -->
B=21
<!-- PJG 007 0104 intable -->
A=26 
<!-- PJG 007 0120 intable -->
B=26
<!-- PJG 007 0104 intable -->
Not reported
<!-- PJG 007 0104 intable -->
Not reported.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Winter
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
164
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1992)
<!-- PJG 007 0104 intable -->
General ICU SDD=91; Control&hyph;A=84; Controls&hyph;B=92
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 BAL
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
S
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 culture
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3
<!-- PJG 007 0104 intable -->
A=11
<!-- PJG 007 0120 intable -->
B=23
<!-- PJG 007 0104 intable -->
1&hyph;8
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
T
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
A=1&hyph;7
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
T
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0120 intable -->
B=1&hyph;17
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
T
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
36
<!-- PJG 007 0104 intable -->
A=43
<!-- PJG 007 0120 intable -->
B=43
<!-- PJG 007 0104 intable -->
6
<!-- PJG 007 0104 intable -->
A=7.
<!-- PJG 007 0120 intable -->
B=8.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Ferrer
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
165
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1992)
<!-- PJG 007 0104 intable -->
General ICU SDD+22; Controls=22
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 TS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Culture
<!-- PJG 007 0104 intable -->
27
<!-- PJG 007 0104 intable -->
32
<!-- PJG 007 0104 intable -->
Not reported
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
U
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
Not reported
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
U
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
32
<!-- PJG 007 0104 intable -->
23
<!-- PJG 007 0104 intable -->
18
<!-- PJG 007 0104 intable -->
15.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hammond
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
166
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1992)
<!-- PJG 007 0104 intable -->
General ICU SDD=114; Controls=125
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 TS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E culture
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Pn=15
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
L
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0120 intable -->
Br=6
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
W
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
Pn=15
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
L
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0120 intable -->
Br=6
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
W
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
Not reported
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
V
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
Not reported
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
V
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
18 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=6
<!-- PJG 007 0104 intable -->
17 
<!-- PJG 007 0120 intable -->
IR
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
=6
<!-- PJG 007 0104 intable -->
16
<!-- PJG 007 0104 intable -->
17.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gastinne
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
167
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1992)
<!-- PJG 007 0104 intable -->
Medical ICU SDD=220; Controls=225
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 TS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=8 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 PSB
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
K
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 culture
<!-- PJG 007 0104 intable -->
12
<!-- PJG 007 0104 intable -->
15
<!-- PJG 007 0104 intable -->
Not reported
<!-- PJG 007 0104 intable -->
Not reported
<!-- PJG 007 0104 intable -->
40 
<!-- PJG 007 0120 intable -->
34
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
36
<!-- PJG 007 0120 intable -->
34
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
18
<!-- PJG 007 0104 intable -->
19.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cockerill
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
168
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1992)
<!-- PJG 007 0104 intable -->
Surgical and Medical ICUs SDD=75; Controls=75
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 TS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=8 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 culture
<!-- PJG 007 0104 intable -->
Pn=5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
L
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0120 intable -->
TB=4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
M
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
Pn=16
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
L
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 007 0120 intable -->
TB=5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
M
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
16
<!-- PJG 007 0104 intable -->
11
<!-- PJG 007 0104 intable -->
15
<!-- PJG 007 0104 intable -->
21
<!-- PJG 007 0104 intable -->
10
<!-- PJG 007 0104 intable -->
12.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Korinek
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
169
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1993)
<!-- PJG 007 0104 intable -->
Neurosurgical ICU SDD=63; Controls=60
<!-- PJG 007 0104 intable -->
Clinical &amp; Radiologic;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 TS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 &amp; PSB
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
K
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 culture
<!-- PJG 007 0104 intable -->
24
<!-- PJG 007 0104 intable -->
42
<!-- PJG 007 0104 intable -->
``No evidence of increased resistance''
<!-- PJG 007 0104 intable -->
``No evidence of increased resistance''
<!-- PJG 007 0104 intable -->
8
<!-- PJG 007 0104 intable -->
7
<!-- PJG 007 0104 intable -->
24
<!-- PJG 007 0104 intable -->
29.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
SDD Trialists
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
170
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (1993)
<!-- PJG 007 0104 intable -->
ICUs (Pooled Data)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
R
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 SDD=2047; Controls=2095
<!-- PJG 007 0104 intable -->
Variable
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdds Ratio=
<!-- PJG 007 0120 intable -->
&blank;0.37;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
Y
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 95% CI
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
Z
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
.0.31-0.43
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdds Ratio=
<!-- PJG 007 0120 intable -->
&blank;0.37;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
Y
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 95% CI
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
Z
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
.0.31-0.43
<!-- PJG 007 0104 intable -->
Not analyzed
<!-- PJG 007 0104 intable -->
Not analyzed
<!-- PJG 007 0104 intable -->
27 
<!-- PJG 007 0120 intable -->

<!-- PJG 007 0170 intable -->
lOdds Ratio=0.90; 
<!-- PJG 007 0120 intable -->
&blank;95% CI
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
Z
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
:0.79&hyph;104
<!-- PJG 007 0104 intable -->
27 
<!-- PJG 007 0120 intable -->

<!-- PJG 007 0170 intable -->
lOdds Ratio=0.90; 
<!-- PJG 007 0120 intable -->
&blank;95% CI
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
Z
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
:0.79&hyph;104
<!-- PJG 007 0104 intable -->
Not analyzed
<!-- PJG 007 0104 intable -->
Not analyzed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->
Legend:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG ITAG l=01 g=5 f=1 -->
A
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Resistant to at least one antimicrobial in the SDD regimen, during the study period.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
B
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
ICU: Intensive care unit.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
SDD: Selective digestive tract decontamination.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
D
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Clinical criteria included temperature >38
<!-- PJG 0017 degreeslatlong -->
&cir;C, purulent bronchorrhea, WBC >(12,000&hyph;15,000/mm
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
) Radiologic criterion was evidence of new and progressive infiltrate(s).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
E
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
TS: Tracheal secretions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Percentage of patients infected or colonized with gram-positive (GP) and/or gram-negative bacillary (GN) organisms
at any body site.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
G
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Median.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
IR: Infection-related.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
I
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Percentage of gram-positive (GP) isolates.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
J
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Percentage of gram-negative bacillary (GN) isolates.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
K
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
PSB: Protected-specimen brushing.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
L
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Pn: Pneumonia.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
M
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
TB: Tracheo-bronchial infection.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Percentage of patients with GN infection or colonization.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Patients given penicillin (ampicillin, piperacillin or flucloxacillin) for clinical infection(s).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
P
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Patients given cephalosporin (cephadrine, cefuroxime, or cefotaxime) for clinical infection(s).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
Q
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Percentage of patients with coagulase-negative staphylococcal infection or colonization.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
R
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Meta-analysis.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
S
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
BAL: Broncho-alveolar lavage.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
T
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Percentage of isolates.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
U
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
However, MRSA bronchial colonization occurred in 45% of SDD patients and 21% of controls.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
V
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
However, at 4 weeks, 13% and 5%, respectively, of oropharyngeal cultures of SDD and control patients had MRSA, and
41% of SDD and control patients were colonized with enterococci.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
W
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Br: Bronchial infraction.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
In ICU.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
Y
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Computed using data from 3,836 patients and 526 events, 260 in SDD- and 366 in control-patients.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
Z
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
CI: Confidence interval.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG ITAG l=01 g=1 f=4 -->
Note: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Footnotes appear at the end of the document.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00128 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 2,L2,i1,xs130,r200 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
3._
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Risk Factors and Suggested Infection Control Measures for Prevention of Nosocomial Pneumonia 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Risk factors
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Infection control measures suggested to prevent nosocomial pneumonia
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Bacterial Pneumonia: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=3 -->
Host-Related 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=3 -->
Age (>65 years) 
<!-- PJG 0012 frnewline -->
Underlying illness: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=3 -->
Chronic Obstructive Pulmonary 
<!-- PJG 0012 frnewline -->
Disease (COPD)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Good chest physiotherapy: incentive spirometry; positive end expiratory pressure or continuous positive airway
pressure by face mask. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Immunosuppression 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Avoid exposure to potential nosocomial pathogens; decrease duration of immunosuppression, such as by administration
of granulocyte macrophage colony stimulating factor (GMCSF). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Depressed consciousness
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Caution on prescribing central nervous system depressants. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Surgery (thoracic/abdominal)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Chest physiotherapy if with COPD; proper positioning; early ambulation. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=3 -->
Device-Related 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Proper cleaning, sterilization or disinfection, and handling of devices; remove devices as soon as indication for
their use ceases. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=3 -->
Endotracheal intubation and Mechanical ventilation 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Gentle suctioning of secretions; place patient in semirecumbent position, i.e., 30
<!-- PJG 0017 degreeslatlong -->
&cir; head-elevation; use nonalkalinizing gastric cytoprotective agent on patients at risk for stress bleeding;
changing ventilator circuits not more often than every 48 hours; draining and discarding inspiratory-tubing condensate,
or using heat-moisture exchanger if indicated. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Nasogastric-tube (NGT) placement and Enteral feeding
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Use small-bore NGT; routinely verify appropriate tube placement; promptly remove NGT. Avoid large-bolus feeding;
drain residual. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=3 -->
Personnel- or Procedure-Related: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=3 -->
Cross-contamination by hands
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Educate and train personnel; adequate handwashing and appropriate gloving; surveillance for cases of pneumonia,
and feedback to personnel.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Antibiotic administration
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Prudent antibiotic use, especially on high-risk intensive-care unit (ICU) patients.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Legionnaires' Disease:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=3 -->
Host-Related
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=3 -->
Immunosuppression
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Decrease duration of immunosuppression, such as by administration of GMCSF.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=3 -->
Device-Related
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=3 -->
Contaminated aerosol from devices
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Sterilize/disinfect aerosol-producing devices before use; use only sterile water for respiratory humidifying
devices; not using cool-mist room-air ``humidifiers''.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=3 -->
Environment-Related 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=3 -->
Aerosols from contaminated water supply 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Hyperchlorinate or superheat hospital water system; routine maintenance of water-supply system; consider use
of sterile water for drinking by immunosuppressed patients. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cooling-tower draft
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Proper design, placement, and maintenance of cooling towers. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Aspergillosis: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=3 -->
Host-Related 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=3 -->
Severe granulocytopenia
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Decrease duration of immunosuppression, such as by administration of GMCSF; consider placing severely granulocytopenic
patients in protected environment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=3 -->
Environment-Related 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=3 -->
Construction activity 
<!-- PJG 007 0104 intable -->
Remove granulocytopenic patients from vicinity of construction; if not already done, placing severely granulocytopenic
patients in protected environment; mask severely granulocytopenic patients when they leave protected environment.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Other environmental sources of aspergilli 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Routine maintenance of hospital air-handling system and rooms of immunosuppressed patients. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Respiratory Syncytial Virus Infection: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=3 -->
Host-Related 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=3 -->
Age (&lt;2 years) Congenital pulmonary/cardiac disease, Immunosuppression 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Consider routine pre-admission screening of high-risk patients for severe RSV infection, followed by cohorting
of patients and nursing personnel during hospital outbreaks of RSV infection. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=3 -->
Personnel- or Procedure-Related 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=3 -->
Cross-contamination by hands 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Personnel education; handwashing; gloving; gowning; during outbreaks, use private rooms or cohort patients and
nursing personnel, and limit visitors.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Influenza: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=2 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Use private room or cohort infected patients. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=3 -->
Host-Related
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=3 -->
Age (>65 years) Immunosuppression
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Vaccinate high-risk patients before the influenza season each year; use amantadine or rimantadine for chemoprophylaxis
during an outbreak. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=3 -->
Personnel-Related 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=3 -->
Infected personnel
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Vaccinate personnel caring for high-risk patients, before the influenza season each year; use amantadine or rimantadine
for prophylaxis during an outbreak. 
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<BILLING>
<!-- PJG ITAG l=68 g=1 f=3 -->
BILLING CODE 4160&hyph;18&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d640 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=3 -->
E:graphicsEN02FE94.004
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</IMPORT>

<!-- PJG /STAG -->

<!-- PJG STAG 4703 -->

<BILLING>
<!-- PJG ITAG l=68 g=1 f=3 -->
BILLING CODE 4160&hyph;18&hyph;C
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=3 -->
Appendix A_Semicritical Items Used on the Respiratory Tract 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Air-pressure monitors 
<!-- PJG 0012 frnewline -->
Anesthesia breathing circuits including: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=3 -->
inspiratory and expiratory tubings 
<!-- PJG 0012 frnewline -->
y connectors 
<!-- PJG 0012 frnewline -->
right-angle connectors 
<!-- PJG 0012 frnewline -->
face mask 
<!-- PJG 0012 frnewline -->
reservoir bags 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Breathing circuits of mechanical ventilators 
<!-- PJG 0012 frnewline -->
Bronchoscopes and their accessories 
<!-- PJG 0012 frnewline -->
CO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
 analyzers 
<!-- PJG 0012 frnewline -->
Endotracheal and endobronchial tubes 
<!-- PJG 0012 frnewline -->
Laryngoscope blades 
<!-- PJG 0012 frnewline -->
Mouthpieces and tubings of pulmonary-function testing equipment 
<!-- PJG 0012 frnewline -->
Oral and nasal airways 
<!-- PJG 0012 frnewline -->
Resuscitation bags 
<!-- PJG 0012 frnewline -->
Spirometers 
<!-- PJG 0012 frnewline -->
Suction catheters 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00129 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Appendix B_Maintenance Procedures to Decrease Survival and Multiplication 
<!-- PJG 0012 frnewline -->
of Legionella SPP. In Potable-Water Distribution Systems 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
I. Providing water at "50
<!-- PJG 0017 degreeslatlong -->
&cir;C at all points in the heated water system, 
<!-- PJG 0012 frnewline -->
including the taps
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This requires that water in calorifiers (water heaters) be maintained at "60
<!-- PJG 0017 degreeslatlong -->
&cir;C. In the United Kingdom, where maintenance of water temperatures at "50
<!-- PJG 0017 degreeslatlong -->
&cir;C in hospitals has been mandated, installation of blending or mixing valves at or near taps to reduce the water
temperature to &gt;43
<!-- PJG 0017 degreeslatlong -->
&cir;C has been recommended in certain settings to reduce the risk of scald injury to patients, visitors, and health
care workers.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
400
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 However, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. can multiply even in short segments of pipe containing water at this temperature. Increasing the flow rate from
the hot-water-circulation system may help lessen the likelihood of water stagnation and cooling.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
403,676
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Insulation of plumbing to ensure delivery of cold (&lt;20
<!-- PJG 0017 degreeslatlong -->
&cir;C) water to water heaters (and to cold-water outlets) may diminish the opportunity for bacterial multiplication.345
``Dead legs'' or capped spurs within the plumbing system provide areas of stagnation and cooling to &lt;50
<!-- PJG 0017 degreeslatlong -->
&cir;C regardless of the circulating-water temperature; these segments may need to be removed to prevent colonization.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
677
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Rubber fittings within plumbing systems have been associated with persistent colonization, and replacement of
these fittings may be required for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 spp. eradication.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
678
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=16 g=1 f=1 -->
II. Continuous chlorination that maintains concentrations of free residual chlorine at 1&hyph;2 mg/L at the tap
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This requires flow-adjusted, continuous injectors of chlorine throughout the water distribution system. Adverse
effects of continuous chlorination include accelerated corrosion of plumbing resulting in system leaks and production
of potentially carcinogenic trihalomethanes. However, when levels of free residual chlorine are below 3 mg/L, trihalomethane
levels are kept below the maximum ``safety level'' recommended by the Environmental Protection Agency.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
401,679,680
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Appendix C_Culturing Environmental Specimens for Legionella SPP 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
I. Recommended procedure for collecting and processing environmental specimens for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
 spp.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=14 g=1 f=1 -->
A. Collect water (if possible, one-liter samples) in sterile, screw-top bottles, preferably containing sodium
thiosulfate at a concentration of 0.5 cc of 0.1N solution/liter of sample water. (Sodium thiosulfate inactivates
any residual halogen biocide). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Collect culture-swabs of the internal surfaces of faucets, aerators, and showerheads; in a sterile, screw-top
container such as a 50 cc plastic centrifuge tube, submerge each swab in 5&hyph;10 cc of sample water taken from the
same device from which the sample was obtained. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. As soon as possible after collection, water samples and swabs should be transported to and processed in a laboratory
proficient at culturing water specimens for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
 spp. Samples may be transported at room temperature but must be protected from temperature extremes. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D. Test samples for the presence of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
 spp. by culture onto semi-selective media. Use standard laboratory procedures. (Detection of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
 spp. antigen by the direct fluorescent antibody technique is not suitable for environmental samples.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=5 f=1 -->
681&hyph;683
<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
 In addition, the use of polymerase chain reaction (PCR) for identification of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
 spp. is not recommended until more data on the sensitivity and specificity of this procedure are available.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=5 f=1 -->
684
<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=16 g=1 f=1 -->
II. Possible samples and sampling sites for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
 spp. in the hospital 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Water Samples 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
Potable Water System 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
Incoming water main 
<!-- PJG 0012 frnewline -->
Water softener 
<!-- PJG 0012 frnewline -->
Holding tanks/cisterns 
<!-- PJG 0012 frnewline -->
Water heater tanks (inflow and outflow sites) 
<!-- PJG 0012 frnewline -->
Potable water outlets (faucets or taps, showers) especially outlets located in or near case-patients' rooms 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
Cooling Tower/Evaporative Condenser 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
Make-up water (water added to system to replace water lost by evaporation, drift, and leakage) 
<!-- PJG 0012 frnewline -->
Basin (area under tower for collection of cooled water) 
<!-- PJG 0012 frnewline -->
Sump (section of basin from which cooled water returns to heat 
<!-- PJG 0012 frnewline -->
source) 
<!-- PJG 0012 frnewline -->
Heat source (e.g., chillers) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
Other Sources 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
Humidifiers 
<!-- PJG 0012 frnewline -->
Bubblers for oxygen 
<!-- PJG 0012 frnewline -->
Water used for respiratory therapy equipment 
<!-- PJG 0012 frnewline -->
Decorative fountains 
<!-- PJG 0012 frnewline -->
Irrigation equipment 
<!-- PJG 0012 frnewline -->
Fire sprinkler system (if recently used) 
<!-- PJG 0012 frnewline -->
Whirlpools/spas 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Swabs 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
Potable Water System 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
Faucets (proximal to aerators) 
<!-- PJG 0012 frnewline -->
Faucet aerators 
<!-- PJG 0012 frnewline -->
Shower heads 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
Cooling Towers 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
Internal components (e.g., splash bars and other fill surfaces) 
<!-- PJG 0012 frnewline -->
Areas with visible biofilm accumulation 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00130 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Appendix D_Procedure for Cleaning Cooling Towers and Related Equipment
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
(Adapted from the Emergency Protocol in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
Control of Legionella spp. in Cooling Towers: Summary Guidelines.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=5 f=1 -->
415
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
I. Preparatory to Chemical Disinfection and Mechanical Cleaning 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
A. Provide protective equipment to workers who would perform the disinfection, to prevent their exposure to a) chemicals
used for disinfection, and b) aerosolized water containing 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
 spp. Protective equipment may include full-length protective clothing, boots, gloves, goggles, and a full- or half-face
mask that combines high efficiency particulate air filter and chemical cartridges to protect against airborne chlorine
levels of up to 10 mg/L. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Shut off cooling-tower. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
1. If possible, shut off heat source. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Shut off fans, if present, on the cooling tower/evaporative condenser (CT/EC). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Shut off the system blowdown (purge) valve. Shut off automated blowdown controller, if present, and set system
controller to manual. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Keep make-up water valves open. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. Close building air-intake vents within at least 30 meters of the CT/EC until after the cleaning procedure is complete.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. Continue operating pumps for water circulation through the CT/EC. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
II. Chemical Disinfection 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
A. Add fast-release, chlorine-containing disinfectant in pellet, granular, or liquid form, and follow instructions
on the product label. Examples of disinfectants are sodium hypochlorite (NaOCl) or calcium hypochlorite (Ca(OCl)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
, calculated to achieve initial FRC of 50 mg/L, i.e., 3.0 lbs (1.4 kg) industrial grade NaOCl (12&hyph;15% available
Cl) per 1,000 gallons of CT/EC water; 10.5 lbs (4.8 kg) domestic grade NaOCl (3&hyph;5% available Cl) per 1,000 gallons
of CT/EC water; or 0.6 lb (0.3 kg) Ca(OCl)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
 per 1,000 gallons of CT/EC water. (Other appropriate compounds may be suggested by a water-treatment specialist.)
If significant biodeposits are present, add more chlorine. If the water volume in CT/EC is unknown, estimate it (in
gallons) to be 10x the recirculation rate in gallons/minute or 30x the refrigeration capacity in tons. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Record type and quality of all chemicals used for disinfection, exact time when chemicals are added to the system,
and time and results of measurements of free residual chlorine (FRC) and pH. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. Within 15 minutes of adding disinfectant, add the dispersant by first dissolving it in water and adding the resulting
solution to a turbulent zone in the water system. Examples of low or non-foaming, silicate-based dispersants are:
automatic-dishwasher compounds, such as Cascade* or Calgonite* or an equivalent product. (Dispersants are added
at 10&hyph;25 lbs. (4.5&hyph;11.25 kg) per 1,000 gallons of CT/EC water.)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*Use of product names is for identification only and does not imply endorsement by the Public Health Service or the
U.S. Department of Health and Human Services.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=16 g=1 f=1 -->
D. After adding disinfectant and dispersant, continue circulating the water through the system. Monitor FRC with
an FRC-measuring device, e.g., a swimming pool test kit, and measure pH with a pH meter every 15 minutes for 2 hours.
Add chlorine as needed to maintain FRC at "10 mg/L. Adjust pH to 7.5&hyph;8.0. The pH may be lowered by using any acid
(e.g., muriatic acid or sulfuric acid used for maintenance of swimming pools) that is compatible with treatment chemicals.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
E. Two hours after adding disinfectant and dispersant or after FRC level is stable at "10 mg/L, monitor at 2-hour intervals
and maintain FRC at "10 mg/L for 24 hours. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
F. After FRC level is maintained at "10 mg/L for 24 hours, drain the system. CT/EC water may be drained to the sanitary
sewer. Municipal water and sewerage authorities should be contacted regarding local regulations. If a sanitary
sewer is not available, consult local or state authorities (e.g. Department of Natural Resources) regarding disposal
of water. If necessary, drain-off may be dechlorinated by dissipation or chemical neutralization (i.e. with sodium
bisulfite). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
G. Refill system with water and repeat procedure outlined in steps 2&hyph;6. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
III. Mechanical Cleaning 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
A. After water from the second chemical disinfection has been drained, shut down the CT/EC. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Inspect all water contact areas for sediment, sludge, and scale. Using brushes and/or a low-pressure water hose,
thoroughly clean all CT/EC water contact areas including basin, sump, fill, spray nozzles, and fittings. Replace
components as needed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. If possible, clean CT/EC water contact areas within the chillers. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
IV. After Mechanical Cleaning 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
A. Fill system with water, and add chlorine to achieve FRC level of 10 mg/L. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Circulate water for one hour, then open blowdown valve and flush the entire system until it is free of turbidity.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. Drain system. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D. Open any air intake vents that were closed prior to cleaning. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
E. Fill system with water. CT/EC may be put back into service using an effective water-treatment program. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
REFERENCES 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health-care settings,
with special focus on HIV-related issues. MMWR 1990; 39(RR&hyph;17):1&hyph;29. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Horan T, Culver D, Jarvis W, et al. Pathogens causing nosocomial infections. Preliminary data from the National
Nosocomial Infections Surveillance System. Antimicrob Newsletter 1988; 5:65&hyph;67. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Horan TC, White JW, Jarvis WR, et al. Nosocomial infection surveillance, 1984. MMWR 1986; 35:17SS&hyph;29SS.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991;
91 (suppl 3B):72S&hyph;75S. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. Bartlett JG, O'Keefe P, Tally FP, et al. Bacteriology of hospital-acquired pneumonia. Arch Intern Med 1986; 146:868&hyph;871.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. Fagon JY, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation:
Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques.
Am Rev Respir Dis 1989; 139:877&hyph;884. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. Torres A, Aznar R, Gatell JM, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically
ventilated patients. Am Rev Respir Dis 1990; 142:523&hyph;528. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8. Chastre J, Fagon JY, Soler P, et al. Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing
ventilation: Comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush. Am J Med 1988;
85:499&hyph;506. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9. Fagon J, Chastre J, Hance AJ, et al. Detection of nosocomial lung infection in ventilated patients: Use of a protected
specimen brush and quantitative culture technique in 147 patients. Am Rev Respir Dis 1988; 138:110&hyph;116. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10. Chastre J, Viau F, Brun P, et al. Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary
infections in ventilated patients. Am Rev Respir Dis 1984; 130:924&hyph;929. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11. Rello J, Quintana E, Ausina V, et al. Incidence, etiology, and outcome of nosocomial pneumonia in mechanically
ventilated patients. Chest 1991; 100:439&hyph;444. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12. Jimenez P, Torres A, Rodriguez-Riosin R, et al. Incidence and etiology of pneumonia acquired during mechanical
ventilation. Crit Care Med 1989; 17:882&hyph;885. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
13. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia
by bacteriologic analysis of bronchoscopic and nonbronchoscopic blind bronchoalveolar lavage fluid. Am Rev Respir
Dis 1991; 143:1121&hyph;1129. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
14. Torres A, De La Bellacasa JP, Rodriguez-Riosin R, De Anta MT, Agusti-Vidal A. Diagnostic value of telescoping
plugged catheters in mechanically ventilated patients with bacterial pneumonia using the metras catheter. Am Rev
Respir Dis 1988; 138:117&hyph;120. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00131 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
15. Meduri GU, Beals DH, Meijub AG, Baselski V. Protected bronchoalveolar lavage: A new bronchoscopic technique
to retrieve uncontaminated distal airway secretions. Am Rev Respir Dis 1991; 143:855&hyph;864. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
16. De Castro FR, Violan JS, Capuz BL, Luna JC, Rodriguez BG, Alonso JLM. Reliability of bronchoscopic protected catheter
brush in the diagnosis of pneumonia in mechanically ventilated patients. Crit Care Med 1991; 19:171&hyph;175. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
17. Davidson M, Tempest B, Palmer DL. Bacteriologic diagnosis of acute pneumonia. JAMA 1976; 235:158&hyph;163.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
18. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gilbert C. Nosocomial pneumonia in ventilated patients:
a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94:281&hyph;288. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
19. Higuchi JH, Coalson JJ, Johanson WG, Jr. Bacteriologic diagnosis of nosocomial pneumonia in primates: Usefulness
of the protected specimen brush. Am Rev Respir Dis 1982; 125:53&hyph;57. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
20. Bryan CS, Reynolds KL. Bacteremic nosocomial pneumonia: Analysis of 172 episodes from a single metropolitan
area. Am Rev Respir Dis 1984; 129:668&hyph;671. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
21. Espersen F, Gabrielsen J. Pneumonia due to Staphylococcus aureus during mechanical ventilation. J Infect Dis
1981; 144:19&hyph;23. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
22. Reusser P, Zimmerli W, Scheidegger D, Marbet GA, Buser M, Gyr K. Role of gastric colonization in nosocomial infections
and endotoxemia: a prospective study in neurosurgical patients on mechanical ventilation. J Infect Dis 1989; 160:414&hyph;421.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
23. Johanson WG, Jr., Pierce AK, Sanford JP, et al. Nosocomial respiratory infections with gram-negative bacilli:
The significance of colonization of the respiratory tract. Ann Intern Med 1972; 77:701&hyph;706. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
24. Berger R, Arango L. Etiologic diagnosis of bacterial nosocomial pneumonia in seriously ill patients. Crit Care
Med 1985; 13:833&hyph;836. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
25. Andrews CP, Coalson JJ, Smith JD, et al. Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury.
Chest 1981; 80:254&hyph;258. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
26. Salata RA, Lederman MM, Shlaes DM, et al. Diagnosis of nosocomial pneumonia in intubated, intensive care unit
patients. Am Rev Respir Dis 1987; 136:426&hyph;432. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
27. Pham LH, Brun-Buisson C, Legrand P, et al. Diagnosis of nosocomial pneumonia in mechanically ventilated patients:
Comparison of a plugged telescoping catheter with the protected specimen brush. Am Rev Respir Dis 1991; 143:1055&hyph;1061.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
28. Meduri GU. Ventilator-associated pneumonia in patients with respiratory failure. Chest 1990; 97:1208&hyph;1219.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
29. Bell RC, Coalson JJ, Smith JD, Johanson WG, Jr. Multiple organ system failure and infection in adult respiratory
distress syndrome. Ann Intern Med 1983; 99:293&hyph;298. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
30. Tobin MJ, Grenvik A. Nosocomial lung infection and its diagnosis. Crit Care Med 1984; 12:191&hyph;200. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
31. Villers D, Deriennic M, Raffi R, et al. Reliability of the bronchoscopic protected catheter brush in intubated
and ventilated patients. Chest 1985; 88:527&hyph;530. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
32. Guckian JC, Christensen WD. Quantitative culture and gram stain of sputum in pneumonia. Am Rev Respir Dis 1978;
118:997&hyph;1005. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
33. Johanson WG, Jr, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with gram-negative bacilli.
Ann Intern Med 1972; 77:701&hyph;706. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
34. Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR. Risk factors for pneumonia and fatality
in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986; 133:792&hyph;796. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
35. Celis R, Torres A, Gatell JM, et al. Nosocomial pneumonia_a multivariate analysis of risk and prognosis. Chest
1988; 93:318&hyph;324. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
36. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect
Control 1988; 16:128&hyph;140. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
37. Fagon JY, Chastre J, Hance AJ, Domart Y, Trouillet JL, Gibert C. Evaluation of clinical judgment in the identification
and treatment of nosocomial pneumonia in ventilated patients. Chest 1993; 103:547&hyph;553. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
38. Baughman RP, Thorpe JE, Staneck J, et al. Use of the protected specimen brush in patients with endotracheal or tracheostomy
tubes. Chest 1987; 91:233&hyph;235. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
39. Meduri GU, Wunderink RG, Leeper KV, Beals DH. Management of bacterial pneumonia in ventilated patients. The role
of protected bronchoalveolar lavage. Chest 1992; 101:500&hyph;508. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
40. Bryant LR, Trinkle JK, Mobin-Uddin K, Baker J, Griffin WO. Bacterial colonization profile with tracheal intubation
and mechanical ventilation. Arch Surg 1972; 104:647&hyph;651. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
41. Torres A, De La Bellacasa JP, Xaubet A, et al. Diagnostic value of quantitative cultures of bronchoalveolar lavage
and telescoping plugged catheter in mechanically ventilated patients with bacterial pneumonia. Am Rev Respir Dis
1989; 140:306&hyph;310. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
42. Lambert RS, Vereen LE, George RB. Comparison of tracheal aspirates and protected brush catheter specimens for
identifying pathogenic bacteria in mechanically ventilated patients. Am J Med Sci 1989; 297:377&hyph;382. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
43. Seidenfeld JJ, Pohl DF, Bell RC, et al. Incidence, site and outcome of infections in patients with the adult respiratory
distress syndrome. Am Rev Respir Dis 1986; 134:12&hyph;16. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
44. Meduri GU, Chastre J. The standardization of bronchoscopic techniques for ventilator-associated pneumonia.
Chest 1992; 102(Suppl 1):557S&hyph;563S. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
45. Baselski V, El-Torky M, Coalson SS, Griffin J. The standardization of criteria for processing and interpreting
laboratory specimens. Chest 1992; 102:571S&hyph;579S. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
46. Wunderink RG, Mayhall G, Gibert C. Methodology for clinical investigation of ventilator-associated pneumonia:
Epidemiology and therapeutic intervention. Chest 1992; 102(Suppl 1):580S&hyph;588S. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
47. Martos JA, Ferrer M, Torres A, et al. Specificity of quantitative cultures of protected specimen brush and bronchoalveolar
lavage in mechanically ventilated patients. Am Rev Respir Dis 1990; 141:A276. (abstract) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
48. Marquette CH, Ramon P, Courcol R, et al. Bronchoscopic protected catheter brush for the diagnosis of pulmonary
infections. Chest 1988; 93:746&hyph;755. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
49. Kahn FW, Jones JM. Diagnosing bacterial respiratory infection by bronchoalveolar lavage. J Infect Dis 1987;
155:862&hyph;869. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
50. Thorpe JE, Baughman RP, Frame PT, Wesseler TA, Staneck JL. Bronchoalveolar lavage for diagnosing acute bacterial
pneumonia. J Infect Dis 1987; 155:855&hyph;861. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
51. Johanson WG, Jr., Seidenfeld JJ, Gomez P, De los Santos R, Coalson JJ. Bacteriologic diagnosis of nosocomial pneumonia
following prolonged mechanical ventilation. Am Rev Respir Dis 1988; 137:259&hyph;264. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
52. Guerra LF, Baughman PP. Use of bronchoalveolar lavage to diagnose bacterial pneumonia in mechanically ventilated
patients. Crit Care Med 1990; 18:169&hyph;173. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
53. Chastre J, Fagon JY, Soler P, et al. Quantification of BAL cells containing intracellular bacteria rapidly identifies
ventilated patients with nosocomial pneumonia. Chest 1989; 95:190S&hyph;192S. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
54. Rouby JJ, Rossignon MD, Nicolas MH, et al. A prospective study of protected bronchoalveolar lavage in the diagnosis
of nosocomial pneumonia. Anesthesiology 1989; 71:679&hyph;685. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
55. Trouillet JL, Guiget M, Gibert C, et al. Fiberoptic bronchoscopy in ventilated patients. Evaluation of cardiopulmonary
risk under midazolam sedation. Chest 1990; 97:927&hyph;933. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
56. Lindholm CE, Ollman B, Snyder JV, et al. Cardiorespiratory effects of flexible fiberoptic bronchoscopy in critically
ill patients. Chest 1978; 74:362&hyph;368. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
57. Rouby JJ, De Lasalle EM, Poete P, et al. Nosocomial bronchopneumonia in the critically ill. Am Rev Respir Dis 1992;
146:1059&hyph;1066. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
58. Piperno D, Gaussorgues P, Bachmann P, Jaboulay M, Robert D. Diagnostic value of nonbronchoscopic bronchoalveolar
lavage during mechanical ventilation. Chest 1988; 93:223. (letter) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00132 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
59. Garibaldi RA, Britt MR, Coleman ML, Reading JC, Pace NL. Risk factors for postoperative pneumonia. Am J Med 1981;
70:677&hyph;680. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
60. Haley RW, Hooton TM, Culver DH, et al. Nosocomial infections in U.S. hospitals, 1975&hyph;1976; estimated frequency
by selected characteristics of patients. Am J Med 1981; 70:947&hyph;959. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
61. Emori TG, Banerjee SN, Culver DH, et al. Nosocomial infections in elderly patients in the United States, 1986&hyph;1990.
Am J Med 1991; 91(Suppl 3B):289S&hyph;293S. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
62. Cross AS, Roup B. Role of respiratory assistance device in endemic nosocomial pneumonia. Am J Med 1981; 70:681&hyph;685.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
63. Jarvis WR, Edwards JR, Culver DH, et al. Nosocomial infection rates in adult and pediatric intensive care units
in the United States. Am J Med 1991; 91 (suppl 3B):185S&hyph;191S. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
64. Rello J, Quintana E, Ausina V, et al. Risk factors for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Staphylococcus aureus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 pneumonia in critically ill patients. Am Rev Respir Dis 1990; 142:1320&hyph;1324. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
65. Gaynes R, Bizek B, Mowry-Hanley J, et al. Risk factors for nosocomial pneumonia after coronary artery bypass graft
operations. Ann Thorac Surg 1991; 51:215&hyph;218. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
66. Joshi N, Localio AR, Hamory BH. A predictive risk index for nosocomial pneumonia in the intensive care unit. Am
J Med 1992; 93:135&hyph;142. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
67. Jacobs S, Chang RWS, Lee B, Bartlett FW. Continuous enteral feeding: a major cause of pneumonia among ventilated
intensive care unit patients. J Parent Enter Nutr 1990; 14:353&hyph;356. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
68. Ashbaugh DC, Petty TL. Sepsis complicating the acute respiratory distress syndrome. Surg Gynecol Obstet 1972;
135:865&hyph;868. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
69. Chevret S, Hemmer M, Carlet J, Langer M, et al. Incidence and risk factors of pneumonia acquired in intensive care
units. Intensive Care Med 1993; 19:256&hyph;264. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
70. Craven DE, Kunches LM, Lichtenberg DA, et al. Nosocomial infection and fatality in medical and surgical intensive
care unit patients. Arch Intern Med 1988; 148:1161&hyph;1168. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
71. Graybill JR, Marshall LW, Charache P, Wallace CK, Melvin VB. Nosocomial pneumonia_a continuing major problem.
Am Rev Respir Dis 1973; 108:1130&hyph;1140. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
72. Gross PA, Van Antwerpen C. Nosocomial infections and hospital deaths. Am J Med 1983; 75:658&hyph;662. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
73. Stevens RM, Teres D, Skillman JJ, Feingold DS. Pneumonia in an intensive care unit. A 30-month experience. Arch
Intern Med 1974; 134:106&hyph;111. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
74. Craig CP, Connelly S. Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. Am
J Infect Control 1984; 4:233&hyph;238. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
75. Leu HS, Kaiser DL, Mori M, Woolson RF, Wenzel RP. Hospital-acquired pneumonia: attributable mortality and morbidity.
Am J Epidemiol 1989; 129:1258&hyph;1267. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
76. Haley RW, Schaberg DR, Crowwley KH, Von Allmen SD, McGowan JE,Jr. Extra charges and prolongation of stay attributable
to nosocomial infections: a prospective interhospital comparison. Am J Med 1981; 70:51&hyph;58. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
77. Freeman J, Rosner BA, McGowan JE. Adverse effects of nosocomial infection. J Infect Dis 1979; 140:732&hyph;740.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
78. Wenzel RP. Hospital-acquired pneumonia: overview of the current state of the art of prevention and control. Eur
J Clin Microbiol Infect Dis 1989; 8:56&hyph;60. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
79. Huxley EJ, Viroslav J, Gray WR, Pierce AK. Pharyngeal aspiration in normal adults and patients with depressed
consciousness. Am J Med 1973; 64:564&hyph;568. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
80. Olivares L, Segovia A, Revuelta R. Tube feeding and lethal aspiration in neurologic patients: A review of 720 autopsy
cases. Stroke 1974; 5:654&hyph;657. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
81. Johanson WG,Jr, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients. N Engl
J Med 1969; 281:1137&hyph;1140. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
82. Niederman MS, Merrill WW, Ferranti RD. Nutritional status and bacterial binding in the lower respiratory tract
in patients with chronic tracheostomy. Ann Intern Med 1984; 100:795&hyph;800. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
83. Reynolds HY. Bacterial adherence to respiratory tract mucosa: A dynamic interaction leading to colonization.
Seminars Respir Infect 1987; 2:8&hyph;19. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
84. Louria DB, Kanimski T. The effects of four antimicrobial drug regimens on sputum superinfection in hospitalized
patients. Am Rev Respir Dis 1962; 85:649&hyph;665. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
85. Rosenthal S, Tager IB. Prevalence of gram-negative rods in the normal pharyngeal flora. Ann Intern Med 1975; 83:355&hyph;357.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
86. Mackowiak PA, Martin RM, Jones SR. Pharyngeal colonization by gram-negative bacilli in aspiration-prone persons.
Arch Intern Med 1978; 138:1224&hyph;1227. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
87. Valenti WM, Trudell RG, Bentley DW. Factors predisposing to oropharyngeal colonization with gram-negative
bacilli in the aged. N Engl J Med 1978; 298:1108&hyph;1111. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
88. Woods DE, Straus DC, Johanson WG, Berry VK, Bass JA. Role of pili in adherence of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Pseudomonas aeruginosa
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 to mammalian buccal epithelial cells. Infect Immun 1980; 29:1146&hyph;1151. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
89. Niederman MS. Bacterial adherence as a mechanism of airway colonization. Eur J Clin Microbiol Infect Dis 1989;
8:15&hyph;20. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
90. Johanson WG,Jr, Higuchi JH, Chaudhuri TR. Bacterial adherence to epithelial cells in bacillary colonization
of the respiratory tract. Am Rev Respir Dis 1980; 121:55&hyph;63. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
91. Abraham SN, Beachey EH, Simpson WA, et al. Adherence of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Streptococcus pyogenes, Escherichia coli,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Pseudomonas aeruginosa
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 to fibronectin-coated and uncoated epithelial cells. Infect Immun 1983; 41:1261&hyph;1268. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
92. Beachey EH. Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal
surfaces. J Infect Dis 1981; 143:325&hyph;345. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
93. Woods DE, Straus DC, Johanson WG, Bass JA. Role of fibronectin in the prevention of adherence of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Pseudomonas aeruginosa
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 to buccal cells. J Infect Dis 1981; 143:784&hyph;790. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
94. Woods DE, Straus DC, Johanson WG, Bass JA. Role of salivary protease activity in adherence of gram-negative bacilli
to mammalian buccal epithelial cells in vitro. J Clin Invest 1981; 68:1435&hyph;1440. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
95. Ramphal R, Small PM, Shands JW,Jr, et al. Adherence of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Pseudomonas aeruginosa
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 to tracheal cells injured by influenza infection or by endotracheal intubation. Infect Immun 1980; 27:614&hyph;619.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
96. Niederman MS, Merrill WW, Polomski LM, Reynolds HY, Gee JBL. Influence of sputum IgA and elastase on tracheal cell
bacterial adherence. Am Rev Respir Dis 1986; 133:255&hyph;260. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
97. Niederman MS, Raferty TD, Sasaki CT, et al. Comparison of bacterial adherence to ciliated and squamous epithelial
cells obtained from the human respiratory tract. Am Rev Respir Dis 1983; 127:85&hyph;90. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
98. Franklin AL, Todd T, Gurman G, et al. Adherence of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Pseudomonas aeruginosa
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 to cilia of human tracheal epithelial cells. Infect Immun 1987; 55:1523&hyph;1525. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
99. Palmer LB, Merrill WW, Niederman MS, et al. Bacterial adherence to respiratory tract cells: Relationships between
in vivo and in vitro pH and bacterial attachments. Am Rev Respir Dis 1986; 133:784&hyph;788. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
100. Dal Nogare AR, Toews GB, Pierce AK. Increased salivary elastase precedes gram-negative bacillary colonization
in postoperative patients. Am Rev Respir Dis 1987; 135:671&hyph;675. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
101. Proctor RA. Fibronectin: a brief overview of its structure, function, and physiology. Rev Infect Dis 1987; 9:S317&hyph;S321.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
102. Niederman MS, Mantovani R, Schoch P, et al. Patterns and routes of tracheobronchial colonization in mechanically
ventilated patients: The role of nutritional status in colonization of the lower airway by 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Pseudomonas
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 species. Chest 1989; 95:155&hyph;161. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103. Atherton ST, White DJ. Stomach as source of bacteria colonising respiratory tract during artificial ventilation.
Lancet 1978; 2:968&hyph;969. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
104. Du Moulin GC, Paterson DG, White JH, Lisbon A. Aspiration of gastric bacteria in antacid-treated patients: a
frequent cause of postoperative colonisation of the airway. Lancet 1982; 2:242&hyph;245. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00133 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
105. Kappstein I, Friedrich T, Hellinger P. Incidence of pneumonia in mechanically ventilated patients treated
with sucralfate or cimetidine as prophylaxis for stress bleeding: bacterial colonization of the stomach. Am J Med
1991; 91 (suppl 2A):125S&hyph;131S. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
106. Daschner F, Kappstein I, Reuschenbach K, Pfisterer J, Krieg N, Vogel W. Stress ulcer prophylaxis and ventilation
pneumonia: prevention by antibacterial cytoprotective agents? Infect Control 1988; 9:59&hyph;65. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
107. Torres A, El-ebiary M, Gonzalez J, et al. Gastric and pharyngeal flora in nosocomial pneumonia acquired during
mechanical ventilation. Am Rev Respir Dis 1993; 148:352&hyph;357. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
108. Martin LF, Booth FVM, Karlstadt RG, et al. Continuous intravenous cimetidine decreases stress-related upper
gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med 1993; 21:19&hyph;29. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
109. Inglis TJJ, Sherratt MJ, Sproat LJ, Gibson JS, Hawkey PM. Gastroduodenal dysfunction and bacterial colonisation
of the ventilated lung. Lancet 1993; 341:911&hyph;913. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
110. Pingleton SK, Hinthron DR, Liu C. Enteral nutrition in patients receiving mechanical ventilation: Multiple
sources of tracheal colonization include the stomach. Am J Med 1986; 80:827&hyph;832. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
111. Driks MR, Craven DE, Celli BR, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared
with antacids or histamine type 2 blockers. N Engl J Med 1987; 317:1376&hyph;1382. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
112. Drasar BS, Shiner M, McLeod GM. Studies of the intestinal flora. I. The bacterial flora of the gastrointestinal
tract in healthy and achlorhydric persons. Gastroenterology 1969; 56:71&hyph;79. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
113. Garrod LP. A study of the bactericidal power of hydrochloric acid and of gastric juice. St Barth Hosp Rep 1939;
72:145&hyph;167. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
114. Arnold I. The bacterial flora within the stomach and small intestine: The effect of experimental alterations
of acid-base balance and the age of the subject. Am J Med Sci 1933; 186:471&hyph;481. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
115. Ruddell WSJ, Axon ATR, Findlay JM. Effect of cimetidine on the gastric bacterial flora. Lancet 1980; 1:672&hyph;674.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
116. Donowitz LG, Page MC, Mileur BL, Guenthner SH. Alteration of normal gastric flora in critical patients receiving
antacid and cimetidine therapy. Infect Control 1986; 7:23&hyph;26. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
117. Priebe HJ, Skillman JJ, Bushnell LS, Long PC, Silen W. Antacid versus cimetidine in preventing acute gastrointestinal
bleeding. N Engl J Med 1992; 302:426&hyph;430. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
118. Zinner MJ, Zuidema GD, Smith PL, Mignosa M. The prevention of upper gastrointestinal tract bleeding in patients
in an intensive care unit. Surg Gynecol Obstet 1981; 153:214&hyph;220. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
119. Reinarz JA, Pierce AK, Mays BB, Sanford JP. The potential role of inhalation therapy equipment in nosocomial
pulmonary infection. J Clin Invest 1965; 44:831&hyph;839. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
120. Schulze T, Edmondson EB, Pierce AK, Sanford JP. Studies on a new humidifying device as a potential source of bacterial
aerosol. Am Rev Respir Dis 1967; 96:517&hyph;519. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
121. Pierce AK, Sanford JP, Thomas GD, Leonard JS. Long-term evaluation of decontamination of inhalation-therapy
equipment and the occurrence of necrotizing pneumonia. N Engl J Med 1970; 292:528&hyph;531. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
122. Edmondson EB, Reinarz JA, Pierce AK, Sanford JP. Nebulization equipment: a potential source of infection in
gram-negative pneumonias. Am J Dis Child 1966; 111:357&hyph;360. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
123. Pierce AK, Sanford JP. Bacterial contamination of aerosols. Arch Intern Med 1973; 131:156&hyph;159. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
124. Brain JD, Valberg PA. Deposition of aerosol in the respiratory tract. Am Rev Respir Dis 1979; 120:1325&hyph;1373.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
125. Rhame FS, Streifel A, McComb C, Boyle M. Bubbling humidifiers produce microaerosols which can carry bacteria.
Infect Control 1986; 7:403&hyph;407. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
126. Deitch EA, Berg R. Bacterial translocation from the gut: A mechanism of infection. J Burn Care Rehab 1987; 8:475&hyph;482.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
127. Fiddian-Green RG, Baaker S. Nosocomial pneumonia in the critically ill: Product of aspiration or translocation?
Crit Care Med 1991; 19:763&hyph;769. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
128. Harkness GA, Bentley DW, Roghmann KJ. Risk factors for nosocomial pneumonia in the elderly. Am J Med 1990; 89:457&hyph;463.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
129. Windsor JA, Hill GL. Risk factors for postoperative pneumonia. Ann Surg 1988; 208:209&hyph;214. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
130. Penn RG, Sanders WE, Sanders CC. Colonization of the oropharynx with gram-negative bacilli: a major antecedent
to nosocomial pneumonia. Am J Infect Control 1981; 9:25&hyph;34. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
131. Lepper MH, Kofman S, Blatt N, et al. Effect of eight antibiotics used singly and in combination on the tracheal
flora following tracheostomy in poliomyelitis. Antibiot Chemother 1954; 4:829&hyph;833. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
132. Klick JM, Du Moulin GC, Hedley-Whyte J, Teres D, Bushnell LS, Feingold DS. Prevention of gram-negative bacillary
pneumonia using polymyxin aerosol as prophylaxis. J Clin Invest 1975; 55:514&hyph;519. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
133. Feeley TW, Du Moulin GC, Hedley-Whyte J, Bushnell LS, Gilbert JP, Feingold DS. Aerosol polymyxin and pneumonia
in seriously ill patients. N Engl J Med 1975; 293:471&hyph;475. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
134. Sprunt K, Redman W. Evidence suggesting importance of role of interbacterial inhibition in maintaining balance
of normal flora. Ann Intern Med 1968; 68:579&hyph;590. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
135. Sprunt K, Leidy G, Redman W. Abnormal colonization of neonates in an ICU: conversion to normal colonization by
pharyngeal implantation of alpha hemolytic streptococcus strain 215. Petiatr Res 1980; 14:308&hyph;313. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
136. Klastersky J, Huysmans E, Werts D, Hensgens C, Daneau D. Endotracheally administered gentamicin for the prevention
of infections of the respiratory tract in patients with tracheostomy: a double-blind study. Chest 1974; 65:650&hyph;654.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
137. Greenfield S, Teres D, Bushnell LS, Hedley-Whyte J, Feingold DS. Prevention of gram-negative bacillary pneumonia
using aerosol polymyxin as prophylaxis. J Clin Invest 1973; 52:2935&hyph;2940. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
138. Daschner F. Stress ulcer prophylaxis and the risk of nosocomial pneumonia in artificially ventilated patients.
Eur J Clin Microbiol 1987; 6:129&hyph;131. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
139. Goularte TA, Lichtenberg DA, Craven DE. Gastric colonization in patients receiving antacids and mechanical
ventilation: a mechanism for pharyngeal colonization. Am J Infect Control 1986; 14:88. (abstract) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
140. Prod'hom G, Leuenberger PH, Koerfer J, et al. Effect of stress-ulcer prophylaxis on nosocomial pneumonia in
ventilated patients: a randomized comparative study. Abstracts of the 31st Interscience Conference on Antimicrobial
Agents and Chemotherapy 1991; 265.(abstract) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
141. Tryba M. Risk of acute stress bleeding and nosocomial pneumonia in ventilated intensive care unit patients:
sucralfate versus antacids. Am J Med 1987; 83 Suppl 3B:117&hyph;124. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
142. Tryba M, Mantey-Stiers F. Antibacterial activity of sucralfate in human gastric juice. Am J Med 1987; 83 (suppl
3B):125&hyph;127. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
143. Lacroix J, Infante-Rivard C, Jenicek M, Gauthier M. Prophylaxis of upper gastrointestinal bleeding in intensive
care units: A meta-analysis. Crit Care Med 1991; 19:942&hyph;949. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
144. Laggner AN, Lenz K, Base W, Druml WC, Schneweiss B, Grimm G. Prevention of upper gastrointestinal bleeding in
long-term ventilated patients. Sucralfate versus ranitidine. Am J Med 1989; 86(suppl 6A):81&hyph;84. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
145. Ryan P, Dawson J, Teres D, Navab F. Continuous infusion of cimetidine versus sucralfate: Incidence of pneumonia
and bleeding compared. Crit Care Med 1990; 18(suppl):253.(abstract) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
146. Cook DJ, Laine LA, Guyatt GH, Raffin TA. Nosocomial pneumonia and the role of gastric pH. A meta-analysis. Chest
1991; 100:7&hyph;13. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
147. Stoutenbeek CP, Van Saene HKF, Miranda DR, Zandstra DF. The effect of selective decontamination of the digestive
tract on colonisation and infection rate in multiple trauma patients. Intensive Care Med 1984; 10:185&hyph;192.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00134 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
148. Unertl K, Ruckdeschel G, Selbmann K, et al. Prevention of colonization and respiratory infections in long-term
ventilated patients by local antimicrobial prophylaxis. Intensive Care Med 1987; 13:106&hyph;113. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
149. Ledingham IM, Alcock SR, Eastaway AT, McDonald JG, Mckay I, Ramsay G. Triple regimen of selective decontamination
of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection
in intensive care. Lancet 1988; 785&hyph;790. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
150. Kerver JH, Rommes JH, Mevissen-Verhage EAE, et al. Prevention of colonization and infection in critically ill
patients: a prospective study. Crit Care Med 1988; 16:1087&hyph;1093. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
151. Ulrich C, Harinck-de Weerd JE, Bakker NC, Jacz K, Doornbos L, de Ridder VA. Selective decontamination of the digestive
tract with norfloxacin in the prevention of ICU-acquired infections: a prospective randomized study. Intensive
Care Med 1989; 15:424&hyph;431. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
152. Brun-Buisson C, Legrand P, Rauss A, et al. Intestinal decontamination for control of nosocomial multiresistant
gram-negative bacilli: Study of an outbreak in an intensive care unit. Ann Intern Med 1989; 110:873&hyph;881. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
153. Godard J, Guillaume C, Reverdy ME, et al. Intestinal decontamination in a polyvalent ICU. Intensive Care Med
1990; 16:307&hyph;311. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
154. Rodriguez-Roldan JM, Altuna-Cuesta A, Lopez A, et al. Prevention of nosocomial lung infection in ventilated
patients: Use of an antimicrobial pharyngeal nonabsorbable paste. Crit Care Med 1990; 180:1239&hyph;1242. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
155. Flaherty J, Nathan C, Kabins SA, Weinstein RA. Pilot trial of selective decontamination for prevention of bacterial
infection in an intensive care unit. J Infect Dis 1990; 162:1393&hyph;1397. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
156. McClelland P, Murray AE, Williams PS, et al. Reducing sepsis in severe combined acute renal and respiratory failure
by selective decontamination of the digestive tract. Crit Care Med 1990; 18:935&hyph;939. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
157. Tetteroo GWM, Wagenvoort JHT, Casterlein A, Tilanus HW, Ince C, Buining HA. Selective decontamination to reduce
gram-negative colonisation and infections after oesophageal resection. Lancet 1990; 335:704&hyph;707. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
158. Pugin J, Auckenthaler R, Lew DP, Suter PM. Oropharyngeal decontamination decreases incidence of ventilator-associated
pneumonia: A randomized, placebo-controlled, double-blind clinical trial. JAMA 1991; 265:2704&hyph;2710. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
159. Aerdts SJA, van Daelen R, Clasener HAL, Festen J, Van Lier HJJ, Vollaard EJ. Antibiotic prophylaxis of respiratory
tract infection in mechanically ventilated patients: A prospective, blinded, randomized trial of the effect of
a novel regimen. Chest 1991; 100:783&hyph;791. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
160. Hartenauer U, Thulig B, Diemer W, et al. Effect of selective flora suppression on colonization, infection, and
mortality in critically ill patients: A one-year, prospective consecutive study. Crit Care Med 1991; 19:463&hyph;473.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
161. Fox MA, Peterson S, Fabri BM, Van Saene HKF, Williets T. Selective decontamination of the digestive tract in cardiac
surgical patients. Crit Care Med 1991; 19:1486&hyph;1490. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
162. Blair P, Rowlands BJ, Lowry K, Webb H, Armstrong P, Smilie J. Selective decontamination of the digestive tract:
A stratified, randomized, prospective study in a mixed intensive care unit. Surgery 1991; 110:303&hyph;310. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
163. Vandenbroucke-Grauls CMJE, Vandenbroucke JP. Effect of selective decontamination of the digestive tract
on respiratory tract infections and mortality in the intensive care unit. Lancet 1991; 338:859&hyph;862. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
164. Winter R, Humphreys H, Pick A, MacGowan P, Wilatts SM, Speller DCE. A controlled trial of selective decontamination
of the digestive tract in intensive care and its effect on nosocomial infection. J Antimicrob Chemother 1992; 30:73&hyph;87.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
165. Ferrer M, Torres A, Gonzalez J, et al. Utility of selective decontamination in a general population of mechanically
ventilated patients. Am Rev Respir Dis 1992; 4:A112.(abstract) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
166. Hammond JMJ, Potgieter PD, Saunders GL, Forder AA. A double blind study of selective decontamination in Intensive
Care. Lancet 1992; 340:5&hyph;9. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
167. Gastinne H, Wolff M, Destour F, Faurisson F, Chevret S. A controlled trial in intensive care units of selective
decontamination of the digestive tract with nonabsorbable antibiotics. N Engl J Med 1992; 326:594&hyph;599. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
168. Cockerill FR, Muller SM, Anhalt JP, et al. Prevention of infection on critically ill patients by selective decontamination
of the digestive tract. Ann Intern Med 1992; 117:545&hyph;553. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
169. Korinek AM, Laisne MJ, Nicolas MH, Raskine S, Deroin V, Sanson-Lepors MJ. Selective decontamination of the digestive
tract in neurosurgical intensive care unit patients: A double-blind, randomized, placebo-controlled study. Crit
Care Med 1993; 21:1466&hyph;1473. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
170. Selective Decontamination of the Digestive Tract Trialists' Collaborative Group. Meta-analysis of randomised
controlled trials of selective decontamination of the digestive tract. Br Med J 1993; 307:525&hyph;532. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
171. Heyland D, Bradley C, Mandell LA. Effect of acidified enteral feedings on gastric colonization in the critically
ill patient. Crit Care Med 1992; 20:1388&hyph;1394. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
172. Bartlett JG, Gorbach SL. The triple threat of aspiration pneumonia. Chest 1975; 68:560&hyph;566. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
173. Winterbauer RH, Durning RB, Barron E, McFadden MC. Aspirated nasogastric feeding solution detected by glucose
strips. Ann Intern Med 1981; 95:67&hyph;68. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
174. Becker DM, Gonzalez M, Gentili A, Eismont F, Green BA. Prevention of deep venous thrombosis in patients with acute
spinal cord injuries: use of rotating treatment tables. Neurosurgery 1987; 20:675&hyph;677. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00135 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
175. Treolar DM, Stechmiller J. Pulmonary aspiration of tube-fed patients with artificial airways. Heart Lung 1984;
13:667&hyph;671. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
176. Metheny NA, Eisenberg P, Spies M. Aspiration pneumonia in patients fed through nasoenteral tubes. Heart Lung
1986; 15:256&hyph;261. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
177. Cheadle WG, Vitale GC, Mackie CR, Cuschiere A. Prophylactic postoperative nasogastric decompression. Ann
Surg 1985; 202:361&hyph;366. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
178. Ibanez J, Penafiel A, Raurich J. Gastroesophageal reflux and aspiration of gastric contents during nasogastric
feeding; the effect of posture. Intensive Care Med 1988; 14 Suppl 2:296.(abstract) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
179. Anderson KR, Norris DJ, Godfrey LB, et al. Bacterial contamination of the tube-feeding formulas. J Parent Enter
Nutr 1984; 8:673&hyph;678. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
180. Schroeder P, Fisher D, Volz M. Microbial contamination of enteral feeding solutions in a community hospital.
J Parent Enter Nutr 1983; 7:459&hyph;461. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
181. Thurn J, Crossley K, Gerdts A, et al. Enteral hyperalimentation as a source of nosocomial infection. J Hosp Infect
1990; 15:203&hyph;217. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
182. Civil ID, Schwab CW. The effect of enteral feeding on gastric pH. Am Surg 1987; 12:688&hyph;690. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
183. Lee B, Chang RWS, Jacobs S. Intermittent nasogastric feeding: A simple and effective method to reduce pneumonia
among ventilated ICU patients. Clin Intensive Care 1990; 1:100&hyph;102. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
184. Torres A, Serra-Battles J, Ros E, et al. Pulmonary aspiration of gastric contents in patients receiving mechanical
ventilation: the effect of body position. Ann Intern Med 1992; 116:540&hyph;542. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
185. Wynne JW, Modell JH. Respiratory aspiration of stomach contents. Ann Intern Med 1977; 87:466&hyph;474. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
186. Dohbie RP, Hoffmeister JA. Continuous pump-tube enteric hyperalimentation. Surg Gynecol Obstet 1976; 143:273&hyph;276.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
187. Betcher E, Seltzer M, Slocum M, et al. Complications occurring during enteral nutritional support: a prospective
study. J Parent Enter Nutr 1983; 7:546&hyph;552. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
188. Bernard M, Forlaw L. Complications and their prevention. In: Rombeau J, Caldwell M, eds. Clinical Nutrition.
Vol I: Enteral and Tube Feeding. Philadelphia: W.B. Saunders, Co., 1984:534. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
189. Strong RM, Condon SC, Solinger MR, et al. Equal aspiration rates from postpylorus and intragastric-placed feeding
tubes: a randomized, prospective study. J Parent Enter Nutr 1992; 16:59&hyph;63. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
190. Montecalvo M, Steger KA, Farber HW, et al. Nutritional outcome and pneumonia in critical care patients randomized
to gastric versus jejunal tube feedings. Crit Care Med 1992; 20:1377&hyph;1387. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
191. Sanderson PJ. Colonisation of the trachea in ventilated patients. What is the bacterial pathway? J Hosp Infect
1983; 4:15&hyph;18. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
192. Sottile FD, Marrie TJ, Prough DS, et al. Nosocomial pulmonary infection: possible etiologic significance of
bacterial adhesion to endotracheal tubes. Crit Care Med 1986; 14:265&hyph;270. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
193. Inglis TJJ, Jones JG, Newman SP. Gas-liquid interaction with tracheal tube biofilm: a means of bacterial colonisation
of the lung. Br J Hosp Med 1989; 42:141&hyph;142. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
194. Inglis TJJ, Millar MR, Jones JG, Robinson DA. Tracheal tube biofilm as a source of bacterial colonisation of the
lung. J Clin Microbiol 1989; 27:2014&hyph;2018. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
195. Spray SB, Zuidema GD, Cameron HL. Aspiration pneumonia: incidence of aspiration with endotracheal tubes. Am
J Surg 1976; 131:701&hyph;703. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
196. McCrae W, Wallace P. Aspiration around high volume, low pressure endotracheal cuff. Br Med J 1981; 2:1220&hyph;1221.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
197. Mahul Ph, Auboyer C, Jospe R, et al. Prevention of nosocomial pneumonia in intubated patients: respective role
of mechanical subglottic drainage and stress ulcer prophylaxis. Intensive Care Med 1992; 18:20&hyph;25. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
198. Weinstein RA, Nathan C, Gruensfelder R. Endemic aminoglycoside resistance in gram-negative bacilli: Epidemiology
and mechanisms. J Infect Dis 1980; 141:338&hyph;345. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
199. Maki DG. Control of colonization and transmission of pathogenic bacteria in the hospital. Ann Intern Med 1979;
89:777&hyph;780. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
200. Larson E. Persistent carriage of gram-negative bacteria on hands. Am J Infect Control 1981; 9:112&hyph;119.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
201. Adams BG, Marrie TJ. Hand carriage of gram-negative rods may not be transient. J Hyg 1982; 89:33&hyph;46. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
202. Daschner FD. The transmission of infections in hospitals by staff carriers, methods of prevention and control.
Infect Control 1985; 6:97&hyph;98. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
203. Adams BG, Marrie TJ. Hand carriage of aerobic gram-negative rods by health care personnel. J Hyg 1982; 89:23&hyph;31.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
204. Marples RR, Towers AG. A laboratory model for the investigation of contact transfer of micro-organisms. J Hyg
1979; 82:237&hyph;248. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
205. Casewell M, Phillips I. Hands as a route of transmission of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Klebsiella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
species. Br Med J 1977; 2:1315&hyph;1317. 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00136 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
206. Mortimer EA, Lipsitz PJ, Wolinsky E, et al. Transmission of staphylococci between newborns. Am J Dis Child 1962;
104:289&hyph;295. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
207. Lowbury EJL, Lilly HA, Bull JP. Disinfection of hands: removal of transient organisms. Br Med J 1964; 2:230&hyph;233.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
208. Sprunt K, Redman W, Leidy G. Antibacterial effectiveness of routine handwashing. Pediatrics 1973; 52:264&hyph;271.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
209. Steere AC, Mallison GF. Handwashing practices for the prevention of nosocomial infections. Ann Intern Med 1975;
83:683&hyph;690. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
210. Albert RK, Condie F. Hand-washing patterns in medical intensive care units. N Engl J Med 1981; 304:146&hyph;147.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
211. Doebbeling BN, Stanley GL, Sheetz CT, et al. Comparative efficacy of alternative hand-washing agents in reducing
nosocomial infections in intensive care units. N Engl J Med 1992; 327:88&hyph;93. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
212. Simmons B, Bryant J, Neiman K, Spencer L, Arheart K. The role of handwashing in prevention of endemic intensive
care unit infections. Infect Control Hosp Epidemiol 1990; 11:589&hyph;594. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
213. Garner JS, Simmons BP. Guideline for isolation precautions in hospitals. Infect Control 1983; 4 Suppl:245&hyph;325.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
214. Garner JS, Simmons BP. Guideline for handwashing and environmental control. Infect Control 1986; 7:231&hyph;242.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
215. LeClair JM, Freeman J, Sullivan BF, Crowley CM, Goldmann DA. Prevention of nosocomial respiratory syncytial
virus infections through compliance with glove and gown isolation precautions. N Engl J Med 1987; 317:329&hyph;333.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
216. Klein BS, Perloff WH, Maki DG, et al. Reduction of nosocomial infection during pediatric intensive care by protective
isolation. N Engl J Med 1989; 320:1714&hyph;1721. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
217. Doebbeling BN, Pfaller MA, Houston AK, Wenzel RP. Removal of nosocomial pathogens from the contaminated glove.
Ann Intern Med 1988; 109:394&hyph;398. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
218. Maki DG, McCormick RD, Zilz MA, et al. An MRSA outbreak in a SICU during universal precautions: new epidemiology
for nosocomial MRSA; downside for universal precautions (UPs). Abstracts of the 30th Interscience Conference on
Antimicrobial Agents and Chemotherapy 1990; 165.(abstract) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
219. Pandit SK, Mehta S, Agarwal SC. Risk of cross-infection from inhalation anesthetic equipment. Br J Anaesth 1967;
39:838&hyph;844. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
220. Cunha BA, Klimek JJ, Gracewski J, McLaughlin JC, Quintiliani R. A common source outbreak of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Acinetobacter 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
pulmonary infection traced to Wright respirometers. Postgrad Med J 1980; 56:169&hyph;172. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
221. Phillips J. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Pseudomonas aeruginosa 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
respiratory tract infections in patients receiving mechanical ventilation. J Hyg 1967; 65:229&hyph;235. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
222. Grieble HG, Colton FR, Thomas MS, et al. Fine particle humidifiers: Source of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Pseudomonas aeruginosa 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
infections in a respiratory-disease unit. N Engl J Med 1970; 282:531&hyph;533. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
223. Mertz JJ, Scharer L, McClement JH. A hospital outbreak of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Klebsiella 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
pneumonia from inhalation therapy with contaminated aerosols. Am Rev Respir Dis 1967; 95:454&hyph;460. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
224. Ringrose RE, McKown B, Felton FG, Barclay BO, Muchmore HG, Rhoades ER. A hospital outbreak of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Serratia marcescens 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
associated with ultrasonic nebulizers. Ann Intern Med 1968; 69:719&hyph;729. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
225. Rhoades ER, Ringrose R, Mohr JA, Brooks L, McKown BA, Felton F. Contamination of ultrasonic nebulization equipment
with gram negative bacteria. Arch Intern Med 1971; 127:228&hyph;232. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
226. Wheeler PW, Lancaster D, Kaiser AB. Bronchopulmonary cross-colonization and infection related to mycobacterial
contamination of suction valves of bronchoscopes. J Infect Dis 1989; 159:954&hyph;958. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
227. Arnow PM, Chou T, Weil D, et al. Nosocomial Legionnaires' disease caused by aerosolized tap water from respiratory
devices. J Infect Dis 1982; 146:460&hyph;467. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
228. Craven DE, Lichtenberg DA, Goularte TA, Make BJ, McCabe WR. Contaminated medication nebulizers in mechanical
ventilator circuits. Am J Med 1984; 77:834&hyph;838. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
229. Babington PCB, Baker AB, Johnson HH. Retrograde spread of organisms from ventilator to patient via the expiratory
limb. Lancet 1971; 1:61&hyph;63. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
230. Smith JR, Howland WS. Endotracheal tube as a source of infection. JAMA 1959; 169:343&hyph;345. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
231. Dyer ED, Peterson DE. How far do bacteria travel from the exhalation valve of IPPB equipment? Anesth Analg 1972;
51:516&hyph;519. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
232. Hovig B. Lower respiratory tract infections associated with respiratory therapy and anesthesia equipment.
J Hosp Infect 1981; 2:301&hyph;315. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
233. Carson LA, Favero MS, Bond WW, Petersen NJ. Morphological, biochemical, and growth characteristics of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Pseudomonas cepacia 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
from distilled water. Appl Microbiol 1973; 25:476&hyph;483. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
234. Favero MS, et al. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Pseudomonas aeruginosa: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Growth in distilled water from hospitals. Science 1971; 173:836&hyph;838. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
235. Carson LA, Petersen NJ, Favero MS, Aguero SM. Growth characteristics of atypical mycobacteria in water and their
comparative resistance to disinfectants. Appl Environ Microbiol 1978; 36:839&hyph;846. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
236. Zuravleff JJ, Yu VL, Shonnard JW, Best M. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
contamination of a hospital humidifier: demonstration of aerosol transmission and subsequent subclinical infection
in exposed guinea pigs. Am Rev Respir Dis 1983; 128:657&hyph;661. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
237. Gorman GW, Yu VL, Brown A. Isolation of Pittsburgh pneumonia agent from nebulizers used in respiratory therapy.
Ann Intern Med 1980; 93:572&hyph;573. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
238. Habeeb AFSA, Hiramoto R. Reaction of proteins with glutaraldehyde. Arch Biochem 1968; 126:16. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
239. Fierer J, Taylor PM, Gezon HM. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Pseudomonas aeruginosa 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
epidemic traced to delivery-room resuscitators. N Engl J Med 1967; 276:991&hyph;996. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
240. Spaulding EH. Chemical sterilization of surgical instruments. Surg Gynecol Obstet 1939; 69:738&hyph;744.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
241. Snow JC, Mangiaracine AB, Anderson ML. Sterilization of anesthesia equipment with ethylene oxide. N Engl J Med
1962; 266:443&hyph;445. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
242. Roberts FJ, Cockcroft WH, Johnson HE. A hot water disinfection method for inhalation therapy equipment. Can
Med Assoc J 1969; 101:30&hyph;32. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
243. Nelson EJ, Ryan KJ. A new use for pasteurization: disinfection of inhalation therapy equipment. Respir Care
1971; 16:97&hyph;103. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
244. Craig DB, Cowan SA, Forsyth W, Parker SE. Disinfection of anesthesia equipment by a mechanical pasteurization
method. Can Anaesth Soc J 1975; 22:219&hyph;223. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
245. Favero MS. Principles of sterilization and disinfection. Anesth Clin N Am 1989; 7:941&hyph;949. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
246. Favero MS, Bond WW. Clinical disinfection of medical and surgical materials. In: Block S, ed. Disinfection,
Sterilization, and Preservation. 4th ed. Philadelphia: Lea and Febiger, 1991:617&hyph;641. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
247. Haselhuhn DH, Brason FW, Borick PM. ``In-use study'' of buffered gluteraldehyde for cold sterilization of anesthesia
equipment. Anesth Analg 1967; 46:468&hyph;474. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
248. Moffet HL, Williams T. Bacteria recovered from distilled water and inhalation therapy equipment. Am J Dis Child
1967; 114:7&hyph;12. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
249. Highsmith AK, Emori TG, Aguero SM, Favero MS, Hughes JM. Heterotrophic bacteria isolated from hospital water
system. International Symposium on Water-Related Health Issues 1986; 181&hyph;187. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
250. Alary M, Joly JR. Factors contributing to the contamination of hospital water distribution systems by Legionellae.
J Infect Dis 1992; 165:565&hyph;569. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00137 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
251. Holdcroft A, Lumley J, Gaya H, et al. Why disinfect ventilators? Lancet 1973; 1:240&hyph;242. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
252. Bishop C, Roper WAG, Williams SR. The use of an absolute filter to sterilize the inspiratory air during intermittent
positive pressure respiration. Br J Anaesth 1963; 35:32&hyph;34. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
253. Hellewell J. The Williams bacterial filter, use in the intensive care unit. Anaesthesia 1967; 22:497&hyph;503.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
254. Garibaldi RA, Britt MR, Webster C, Pace NL. Failure of bacterial filters to reduce the incidence of pneumonia
after inhalation anesthesia. Anesthesiology 1981; 54:364&hyph;368. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
255. Feeley TW, Hamilton WK, Xavier B, Moyers J. Sterile anesthesia breathing circuits do not prevent postoperative
pulmonary infection. Anesthesiology 1981; 54:369&hyph;372. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
256. Christopher KL, Saravolatz LD, Bush TL. Cross-infection: a study using a canine model for pneumonia. Am Rev Respir
Dis 1983; 128:271&hyph;275. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
257. Goularte TA, Manning M, Craven DE. Bacterial colonization in humidifying cascade reservoirs after 24 and 48
hours of continuous mechanical ventilation. Infect Control 1987; 8:200&hyph;203. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
258. Vesley D, Anderson J, Halbert MM, Wyman L. Bacterial output from three respiratory therapy humidifying devices.
Respir Care 1979; 24:228&hyph;234. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
259. Boyce JM, White RL, Spruill EY, Wall M. Cost-effective application of the Centers for Disease Control guideline
for prevention of nosocomial pneumonia. Am J Infect Control 1985; 13:228&hyph;232. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
260. Craven DE, Goularte TA, Make BA. Contaminated condensate in mechanical ventilator circuits_risk factor for
nosocomial pneumonia? Am Rev Respir Dis 1984; 129:625&hyph;628. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
261. Lareau SC, Ryan KJ, Diener CF. The relationship between frequency of ventilator circuit changes and infectious
hazard. Am Rev Respir Dis 1978; 118:493&hyph;496. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
262. Craven DE, Connolly MG, Lichtenberg DA, Primeau PJ, McCabe WR. Contamination of mechanical ventilators with
tubing changes every 24 or 48 hours. N Engl J Med 1982; 306:1505&hyph;1509. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
263. Dreyfuss D, Djedaini K, Weber P, et al. Prospective study of nosocomial pneumonia and of patient and circuit colonization
during mechanical ventilation with circuit changes every 48 hours vs no change. Am Rev Respir Dis 1991; 143:738&hyph;743.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
264. Miyao H, Hirokawa T, Miyasaka K, Kawazoe T. Relative humidity, not absolute humidity, is of great importance
when using a humidifier with a heating wire. Crit Care Med 1992; 20:674&hyph;679. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
265. MacIntyre NR, Anderson HR, Silver RM. Pulmonary function in mechanically-ventilated patients using 24-hour
use of a hygroscopic condenser humidifier. Chest 1983; 84:560&hyph;564. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
266. Make BJ, Craven DE, O'Donnell C. Clinical and bacteriologic comparison of hygroscopic and cascade humidifiers
in ventilated patients [Abstract]. Am Rev Respir Dis 1987; 135:A212. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
267. Suzukawa M, Usuda Y, Numata K. The effects on sputum characteristics of combining an unheated humidifier with
a heat-moisture exchanging filter. Respir Care 1989; 34:976&hyph;984. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
268. Hay R, Millar WC. Efficacy of a new hygroscopic condenser humidifier. Crit Care Med 1982; 10:49&hyph;51. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
269. Mebius C. A comparative study of disposable humidifiers. Acta Anaesth Scand 1983; 27:403&hyph;409. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
270. Shelly MP, Bethune DW, Latimer RD. A comparison of five heat and moisture exchangers. Anaesthesia 1986; 41:527&hyph;532.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
271. Branson RD, Hurst JM. Laboratory evaluation of moisture output of seven airway heat and moisture exchangers.
Respir Care 1987; 32:741&hyph;747. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
272. Branson RD, Campbell RS, Davis KJ, Johnson DJ, Porombka D. Humidification in the intensive care unit. Prospective
study of a new protocol utilizing heated humidification and a hygroscopic condenser humidifier. Chest 1993; 104:1800&hyph;1805.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
273. Roustan JP, Kienlen J, Aubas P, Aubas S, du Cailar J. Comparison of hydrophobic heat and moisture exchanger with
heated humidifier during prolonged mechanical ventilation. Intensive Care Med 1992; 18:97&hyph;100. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
274. Misset B, Escudier B, Rivara D, Leclercq B, Nitenberg G. Heat and moisture exchanger vs heated humidifier during
long-term mechanical ventilation: a prospective randomized study. Chest 1991; 100:160&hyph;163. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
275. Gallagher J, Strangeways JE, Allt-Graham J. Contamination control in long term ventilation: A clinical study
using heat and moisture exchanging filter. Anaesthesia 1987; 42:476&hyph;481. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
276. Martin C, Perrin G, Gevaudan MJ, Saux P, Gouin F. Heat and moisture exchangers and vaporizing humidifiers in the
intensive care unit. Chest 1990; 97:144&hyph;149. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
277. Kaan JA, Simoons-Smit AM, MacLaren DM. Another source of aerosol causing nosocomial Legionnaire's disease.
J Infect 1985; 11:145&hyph;148. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
278. Sanders CV, Luby JP, Johanson WG, Barnett JA, Sanford JP. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Serratia marcescens 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
infections from inhalation therapy medications: nosocomial outbreak. Ann Intern Med 1970; 73:15&hyph;21. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
279. Decker MD, Lancaster AD, Latham RH, Bunce CP, Becker NR, Burns K. Influence of closed suctioning system on ventilator-associated
pneumonias. Third Annual Meeting of the Society for Hospital Epidemiology of America 1993; A6 (abstract).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
280. Mayhall CCG. The Trach Care closed tracheal suction system: a new medical device to permit tracheal suctioning
without interruption of ventilatory assistance. Infect Control Hosp Epidemiol 1988; 9:125&hyph;126. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
281. Ritz R, Scott LR, Coyle MB, Pierson DJ. Contamination of a multiple-use suction catheter in a closed-circuit
system compared to contamination of a disposable, single-use suction catheter. Respir Care 1986; 31:1087&hyph;1091.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
282. Deppe SA, Kelly JW, Thoi LL, et al. Incidence of colonization, nosocomial pneumonia, and mortality in critically
ill patients using Trach Care closed-suction system versus open-suction system: prospective, randomized study.
Crit Care Med 1990; 18:1389&hyph;1393. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
283. Stone JW, Das BC. Investigation of an outbreak of infection with 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Acinetobacter calcoaceticus 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
in a special care baby unit. J Hosp Infect 1986; 7:42&hyph;48. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
284. Thompson AC, Wilder BJ, Powner DJ. Bedside resuscitation bags: a source of bacterial contamination. Infect
Control 1985; 6:231&hyph;232. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
285. Weber DJ, Wilson MB, Rutala WA, Thomann CA. Manual ventilation bags as a source for bacterial colonization of
intubated patients. Am Rev Respir Dis 1990; 142:892&hyph;894. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
286. Irwin RS, Demers RR, Pratter MR. An outbreak of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Acinetobacter 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
infection associated with the use of a ventilator spirometer. Respir Care 1980; 25:232&hyph;237. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
287. Djokovic JL, Hedley-White J. Prediction of outcome of surgery and anesthesia in patients over 80. JAMA 1979;
242:2301&hyph;2306. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
288. Tisi GM. Preoperative evaluation of pulmonary function: validity, indications and benefits. Am Rev Respir
Dis 1979; 119:293&hyph;310. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
289. Gould AB. Effect of obesity in respiratory complications following general anesthesia. Anesth Analg 1962;
41:448&hyph;452. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
290. Cain HD, Stevens PM. Preoperative pulmonary function and complications after cardiovascular surgery. Chest
1979; 76:130&hyph;135. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
291. Wightman JAK. A prospective study of the incidence of postoperative pulmonary complications. Br J Surg 1968;
55:85&hyph;91. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
292. Culver GA, Makel HP, Beecher HK. Frequency of aspiration of gastric contents by lungs during anesthesia and surgery.
Ann Surg 1961; 133:289&hyph;292. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
293. Rigg JDA. Pulmonary atelectasis after anaesthesia: Pathophysiology and management. Can Anaesth Soc J 1981;
28:306&hyph;311. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
294. Simonneau G, Vivien A, Sartene R, et al. Diaphragm dysfunction induced by upper abdominal surgery. Am Rev Respir
Dis 1983; 128:899&hyph;903. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
295. Bartlett RH, Gazzaniga AB, Geraghty TR. Respiratory maneuvers to prevent postoperative pulmonary complications.
JAMA 1973; 234:1017&hyph;1021. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00138 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
296. Ali J, Serette C, Wood LDM, et al. Effect of postoperative intermittent positive pressure breathing on lung function.
Chest 1984; 85:192&hyph;196. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
297. Pontoppidan H. Mechanical aids to lung expansion in non-intubated surgical patients. Am Rev Respir Dis 1980;
122(suppl):109&hyph;119. 
<!-- PJG 0012 frnewline -->
298. Morran CG, Finlay IG, Mithieson M, McKay AJ, Wilson N, McArdle CS. Randomized controlled trial of physiotherapy
for postoperative pulmonary complications. Br J Anaesth 1983; 55:1113&hyph;1116. 
<!-- PJG 0012 frnewline -->
299. Castillo R, Haas A. Chest physical therapy: comparative efficacy of preoperative and postoperative in the elderly.
Arch Phys Med Rehabil 1985; 66:376&hyph;379. 
<!-- PJG 0012 frnewline -->
300. Cordier P, Squifflet JP, Carlier M, Alexandre GPJ. Postoperative continuous positive airway pressure helps
to prevent pulmonary infection after human renal transplantation. Transplant Proc 1984; 16:1337&hyph;1339. 
<!-- PJG 0012 frnewline -->
301. Vraciu JK. Effectiveness of breathing exercises in preventing pulmonary complications following open heart
surgery. Phys Ther 1977; 57:1367&hyph;1371. 
<!-- PJG 0012 frnewline -->
302. Celli BR, Rodriguea KS, Smider GL. A controlled trial of intermittent positive pressure breathing, incentive
spirometry, and deep breathing exercises in preventing pulmonary conmplications after abdominal surgery. Am Rev
Respir Dis 1984; 1304:12&hyph;15. 
<!-- PJG 0012 frnewline -->
303. Schwiger I, Gamulin ZB, Forster A, Meyer P, Gemperle MB, Suter PM. Absence of benefit of incentive spirometry
in low-risk patients undergoing elective cholocystectomy: a controlled randomized study. Chest 1986; 89:652&hyph;656.

<!-- PJG 0012 frnewline -->
304. Roukema JA, Carol EJ, Prins JG. The prevention of pulmonary complications after upper abdominal surgery in patients
with noncompromised pulmonary status. Arch Surg 1988; 123:30&hyph;34. 
<!-- PJG 0012 frnewline -->
305. Stock MC, Downs JB, Gauer PK, Alster JM, Imrey PB. Prevention of postoperative pulmonary complications with
CPAP, incentive spirometry, and conservative therapy. Chest 1985; 87:151&hyph;157. 
<!-- PJG 0012 frnewline -->
306. Stein M, Cassara EL. Preoperative pulmonary evaluation and therapy for surgery patients. JAMA 1970; 211:787&hyph;790.

<!-- PJG 0012 frnewline -->
307. Schwieger I, Gamulin A, Forster A, Meyer P, Gemperle M, Suter PM. Absence of benefit of incentive spirometry in
low-risk patients undergoing elective cholecystectomy. Chest 1986; 89:652&hyph;656. 
<!-- PJG 0012 frnewline -->
308. Avorn J, Soumerai SB, Everitt DE, Ross-Dengan D, Beers MH. A randomized trial of a program to reduce the use of psychoactive
drugs in nursing homes. N Engl J Med 1992; 327:168&hyph;173. 
<!-- PJG 0012 frnewline -->
309. Rutter PC, Murphy D, Dudley HAF. Morphine: controlled trial of different methods of administration for postoperative
pain. Br Med J 1980; 280:12&hyph;13. 
<!-- PJG 0012 frnewline -->
310. Wasylak TJC, Abbott FV, English MJM, Jeans ME. Reduction of postoperative morbidity following patient-controlled
morphine. Can J Anaesth 1990; 37:726&hyph;731. 
<!-- PJG 0012 frnewline -->
311. Egbert AM, Leland HP, Short LM, Burnett ML. Randomized trial of postoperative patient-controlled analgesia
vs. intramuscular narcotics in frail elderly men. Arch Intern Med 1990; 150:1897&hyph;1903. 
<!-- PJG 0012 frnewline -->
312. Lange MP, Dahn MS, Jacobs LA. Patient-controlled analgesia versus intermittent analgesia dosing. Heart Lung
1988; 17:495&hyph;498. 
<!-- PJG 0012 frnewline -->
313. Addison NV, Brear FA, Budd K, Whitaker M. Epidural analgesia following cholecystectomy. Br J Surg 1974; 61:850&hyph;852.

<!-- PJG 0012 frnewline -->
314. Rawal N, Shostrand U, Christofferson E, Dahlstrom B, Arvill A, Rydman H. Comparison of intramuscular and epidural
morphine for postoperative analgesia in the grossly obese: Influence on postoperative ambulation and pulmonary
function. Anesth Analg 1984; 63:583&hyph;592. 
<!-- PJG 0012 frnewline -->
315. Cushieri RJ, Morran CG, Howie JC, McArtle CS. Postoperative pain and pulmonary complications: comparison of
three analgesic regimens. Br J Surg 1985; 72:495&hyph;498. 
<!-- PJG 0012 frnewline -->
316. Gould FK, Magee JG, Ingham HR. A hospital outbreak of antibiotic-resistant 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Streptococcus pneumoniae.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 J Infect 1987; 15:77&hyph;79. 
<!-- PJG 0012 frnewline -->
317. Moore EP, Williams EW. Hospital transmission of multiply antibiotic resistant 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Streptococcus pneumoniae.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 J Infect 1988; 16:199&hyph;208. 
<!-- PJG 0012 frnewline -->
318. Alvarez S, Shell CG, Wooley TW, et al. Nosocomial infections in long-term care facilities. J Gerontol 1992; 43:M9&hyph;M12.

<!-- PJG 0012 frnewline -->
319. Advisory Committee on Immunization Practices. Pneumococcal polysaccharide vaccine. MMWR 1989; 38:64&hyph;76.

<!-- PJG 0012 frnewline -->
320. Shapiro ED, Clemens JD. A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients
at high risk of serious pneumococcal infections. Ann Intern Med 1984; 101:325&hyph;330. 
<!-- PJG 0012 frnewline -->
321. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR. Immunization policies and vaccine coverage
among adults: the risk for missed opportunities. Ann Intern Med 1988; 108:616&hyph;625. 
<!-- PJG 0012 frnewline -->
322. Petersdorf RG, Curtin JA, Hoeprich PD, Peeler RN, Bennet LL. A study of antibiotic prophylaxis in unconscious
patients. N Engl J Med 1957; 257:1001&hyph;1009. 
<!-- PJG 0012 frnewline -->
323. Tillotson JR, Finland M. Bacterial colonization and clinical superinfection of the respiratory tract complicating
antibiotic treatment of pneumonia. J Infect Dis 1969; 119:597&hyph;624. 
<!-- PJG 0012 frnewline -->
324. Sen P, Kapila P, Chmel H, Armstrong DA, Louria DB. Superinfection: another look. Am J Med 1982; 73:706&hyph;718.

<!-- PJG 0012 frnewline -->
325. Nord CE, Kager L, Hemdahl A. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of
infections. Am J Med 1984; 80:99&hyph;106. 
<!-- PJG 0012 frnewline -->
326. Goodpasture HC, Romig DA, Voth DW. A prospective study of tracheobronchial bacterial flora in aute brain-injured
patients with and without antibiotic prophylaxis. J Neurosurg 1977; 47:228&hyph;235. 
<!-- PJG 0012 frnewline -->
327. Kelley RE, Vibulsresth S, Bell L, Duncan RC. Evaluation of kinetic therapy in the prevention of complications
of prolonged bed rest secondary to stroke. Stroke 1987; 18:638&hyph;642. 
<!-- PJG 0012 frnewline -->
328. Gentilello L, Thompson DA, Tonnesen AS, et al. Effect of a rotating bed on the incidence of pulmonary complications
in critically ill patients. Crit Care Med 1988; 16:783&hyph;786. 
<!-- PJG 0012 frnewline -->
329. Summer WR, Curry P, Haponik EF, Nelson S, Elston R. Continuous mechanical turning of intensive care unit patients
shortens length of stay in some diagnostic-related groups. J Crit Care 1989; 4:45&hyph;53. 
<!-- PJG 0012 frnewline -->
330. Fink MP, Helsmoortel CM, Stein KL, Lee PC, Cohn SM. The efficacy of an oscillating bed in the prevention of lower
respiratory tract infection in critically ill victims of blunt trauma: a prospective study. Chest 1990; 97:132&hyph;137.

<!-- PJG 0012 frnewline -->
331. Nelson LD, Choi SC. Kinetic therapy in critically ill trauma patients. J Crit Care 1992; 7:57&hyph;62. 
<!-- PJG 0012 frnewline -->
332. deBoisblanc BP, Castro M, Everret B, Grender J, Walker CD, Summer WB. Effect of air-supported, continuous, postural
oscillation on the risk of early ICU pneumonia in nontraumatic critical illness. Chest 1993; 103:1543&hyph;1547.

<!-- PJG 0012 frnewline -->
333. Zack MB, Pontoppidan H, Kazemi H. The effect of lateral positions on gas exchange in pulmonary disease: a prospective
evaluation. Am Rev Respir Dis 1974; 110:49&hyph;54. 
<!-- PJG 0012 frnewline -->
334. Wong JW, Keens TG, Wannamaker EM, Crozier DN, Levison H, Aspin N. The effects of gravity on tracheal mucous transport
rates in normal subjects and patients with cystic fibrosis. Pediatrics 1977; 60:146&hyph;152. 
<!-- PJG 0012 frnewline -->
335. Blake JR. On the movement of mucous in the lung. J Biochem 1975; 8:175&hyph;190. 
<!-- PJG 0012 frnewline -->
336. Hoge CW, Breiman RF. Advances in the epidemiology and control of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 infections. Epidemiol Rev 1991; 13:329&hyph;340. 
<!-- PJG 0012 frnewline -->
337. Brennen C, Vickers JP, Yu VL, Puntereri A, Yee YC. Discovery of occult 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 pneumonia in a long-stay hospital: results of prospective serologic survey. Br Med J 1987; 295:306&hyph;307. 
<!-- PJG 0012 frnewline -->
338. Marrie TJ, MacDonald S, Clarke K, Haldane D. Nosocomial Legionnaires' disease: lessons from a four-year prospective
study. Am J Infect Control 1991; 19:79&hyph;85. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00139 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
339. Muder RR, Yu VL, McClure JK, Kroboth FJ, Kominos SD, Lumish RN. Nosocomial Legionnaires' disease uncovered in
a prospective pneumonia study: Implications for underdiagnosis. JAMA 1983; 249:3184&hyph;3188. 
<!-- PJG 0012 frnewline -->
340. Fliermans CD, Cherry WB, Orrison LH, Smith SJ, Tison DL, Pope DH. Ecologic distribution of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Appl Environ Microbiol 1981; 41:9&hyph;16. 
<!-- PJG 0012 frnewline -->
341. Morris GK, Patton CM, Feeley JC, et al. Isolation of the Legionnaires' disease bacterium from environmental
samples. Ann Intern Med 1979; 90:664&hyph;666. 
<!-- PJG 0012 frnewline -->
342. Hsu SC, Martin R, Wentworth BB. Isolation of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 species from drinking water. Appl Environ Microbiol 1984; 48:830&hyph;832. 
<!-- PJG 0012 frnewline -->
343. Tison DL, Seidler RJ. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 incidence and density in potable drinking water. Appl Environ Microbiol 1983; 45:337&hyph;339. 
<!-- PJG 0012 frnewline -->
344. Muraca P, Stout JE, Yu VL. Comparative assessment of chlorine, heat, ozone, and UV light for killing 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
within a model plumbing system. Appl Environ Microbiol 1987; 53:447&hyph;453. 
<!-- PJG 0012 frnewline -->
345. Farrell ID, Barker JE, Miles EP, Hutchinson JCP. A field study of the survival of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in a hospital hot-water system. Epidemiol Infect 1990; 104:381&hyph;387. 
<!-- PJG 0012 frnewline -->
346. Stout JE, Yu VL, Best MG. Ecology of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 within water distribution systems. Appl Environ Microbiol 1985; 49:221&hyph;228. 
<!-- PJG 0012 frnewline -->
347. Sanden GN, Fields BS, Barbaree JM, et al. Viability of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in chlorine-free water at elevated temperatures. Curr Microbiol 1989; 18:61&hyph;65. 
<!-- PJG 0012 frnewline -->
348. Schulze-Robbecke R, Rodder M, Exner M. Multiplication and killing temperatures of naturally occurring legionellae.
Zbl Bakt Hyg B 1987; 184:495&hyph;500. 
<!-- PJG 0012 frnewline -->
349. Habicht W, Muller HE. Occurrence and parameters of frequency of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in warm water systems of hospitals and hotels in Lower Saxony. Zbl Bakt Hyg B 1988; 186:79&hyph;88. 
<!-- PJG 0012 frnewline -->
350. Ciesielski CA, Blaser MJ, Wang WL. Role of stagnation and obstruction of water flow in isolation of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 from hospital plumbing. Appl Environ Microbiol 1984; 48:984&hyph;987. 
<!-- PJG 0012 frnewline -->
351. Rowbotham TJ. Preliminary report on the pathogenicity of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 for freshwater and soil amoebae. J Clin Path 1980; 33:1179&hyph;1183. 
<!-- PJG 0012 frnewline -->
352. Fields BS, Sanden GN, Barbaree JM, et al. Intracellular multiplication of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in amoebae isolated from hospital hot water tanks. Curr Microbiol 1989; 18:131&hyph;137. 
<!-- PJG 0012 frnewline -->
353. Le Saux NM, Sekla L, McLeod J, et al. Epidemic of nosocomial Legionnaires' disease in renal transplant recipients:
a case-control and environmental study. Can Med Assoc J 1989; 140:1047&hyph;1053. 
<!-- PJG 0012 frnewline -->
354. Berendt RF, Young HW, Allen RG, Knutsen GL. Dose-response of guinea pigs experimentally infected with aerosols
of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
. J Infect Dis 1980; 141:186&hyph;192. 
<!-- PJG 0012 frnewline -->
355. Marston BJ, Lipman HB, Breiman RF. Surveillance for Legionnaires' disease 1980&hyph;1989: Risk factors for
disease and disease-related mortality. Abstracts of the 33rd Interscience Conference on Antimicrobial Agents
and Chemotherapy 1993; 33:373.(abstract) 
<!-- PJG 0012 frnewline -->
356. Kirby BD, Snyder KM, Meyer RD, et al. Legionnaires' disease. Report of 65 nosocomially acquired cases and review
of the literature. Medicine 1980; 59:188&hyph;205. 
<!-- PJG 0012 frnewline -->
357. Haley CE, Cohen ML, Halter J, Meyer RD. Nosocomial Legionnaires' disease: A continuing common-source epidemic
at Wadsworth Medical Center. Medicine 1979; 90:583&hyph;586. 
<!-- PJG 0012 frnewline -->
358. Bock BV, Kirby BD, Edelstein PH, et al. Legionnaires' disease in renal transplant recipients. Lancet 1978; 1:410&hyph;413.

<!-- PJG 0012 frnewline -->
359. Brady MT. Nosocomial Legionnaires' disease in a children's hospital. J Pediatr 1989; 115:46&hyph;50. 
<!-- PJG 0012 frnewline -->
360. Horie H, Kawakami H, Minoshima K, et al. Neonatal Legionnaires' disease: histologic findings in an autopsied
neonate. Acta Pathol Jpn 1992; 42:427&hyph;431. 
<!-- PJG 0012 frnewline -->
361. Helms CM, Viner JP, Sturm RH, et al. Comparative features of pneumococcal, mycoplasma, and Legionnaires' disease
pneumonias. Ann Intern Med 1979; 90:543&hyph;547. 
<!-- PJG 0012 frnewline -->
362. Yu V, Kroboth FJ, Shonnard J, Brown A, McDearman S, Magnussen M. Legionnaires' disease: New clinical perspectives
from a prospective pneumonia study. Am J Med 1982; 73:357&hyph;361. 
<!-- PJG 0012 frnewline -->
363. Marston B, Plouffe J, File T, et al. Evidence of mixed infection in patients with antibody to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Chlamydia pneumoniae
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
. Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy 1992; 808.(abstract)

<!-- PJG 0012 frnewline -->
364. Ussery XT, Butler JC, Breiman R, et al. Outbreak of Legionnaires' disease associated with 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Mycoplasma
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 infection. Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy 1992; 815.(abstract)

<!-- PJG 0012 frnewline -->
365. Jimenez ML, Aspa J, Padilla B, et al. Fiberoptic bronchoscopic diagnosis of pulmonary disease in 151 HIV-infected
patients with pneumonitis. Eur J Clin Microbiol Infect Dis 1991; 10:491&hyph;497. 
<!-- PJG 0012 frnewline -->
366. Centers for Disease Control. Case definitions for public health surveillance. MMWR 1990; 39 RR13:18. 
<!-- PJG 0012 frnewline -->
367. Helms CM, Renner ED, Viner JP, Hierholzer WJ, Wintermeyer LA, Johnson W. Indirect immunofluorescence antibodies
to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
: frequency in a rural community. J Clin Microbiol 1980; 12:326&hyph;328. 
<!-- PJG 0012 frnewline -->
368. Wilkerson HW, Reingold AL, Brake BJ, McGiboney DL, Gorman GW, Broome CV. Reactivity of serum from patients with
suspected legionellosis against 29 antigens of Legionellaceae and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
-like organisms by indirect immunofluorescence assay. J Infect Dis 1983; 147:23&hyph;31. 
<!-- PJG 0012 frnewline -->
369. Nichol KL, Parenti CM, Johnson JE. High prevalence of positive antibodies to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 among outpatients. Chest 1991; 100:663&hyph;666. 
<!-- PJG 0012 frnewline -->
370. Storch G, Hayes PS, Hill DL, Baine W. Prevalence of antibody to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in middle-aged and elderly Americans. J Infect Dis 1979; 140:784&hyph;788. 
<!-- PJG 0012 frnewline -->
371. Plouffe J, Marston B, Straus W, Breiman R, Hackman B, Moyenuddin M. Utility of diagnostic studies in Legionnaires'
disease: Franklin County. Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy
1992; 817.(abstract) 
<!-- PJG 0012 frnewline -->
372. Edelstein PH. The laboratory diagnosis of Legionnaires' disease. Seminars Respir Infect 1987; 2:235&hyph;241.

<!-- PJG 0012 frnewline -->
373. Bridge JA, Edelstein PH. Oropharyngeal colonization with 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
. J Clin Microbiol 1983; 18:1108&hyph;1112. 
<!-- PJG 0012 frnewline -->
374. Fukunaga H, Akagi K, Yabuchi E. Asymptomatic infection of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in four cases with pulmonary disease in Japanese. Nippon Saikingaku Zasshi 1990; 45:833&hyph;840. 
<!-- PJG 0012 frnewline -->
375. Dondero TJ, Rendtorff RC, Mallison GF, et al. An outbreak of Legionnaires' disease associated with a contaminated
air-conditioning cooling tower. N Engl J Med 1980; 302:365&hyph;370. 
<!-- PJG 0012 frnewline -->
376. Garbe PL, Davis BJ, Weisfield JS, et al. Nosocomial Legionnaires' disease: epidemiologic demonstration of
cooling towers as a source. JAMA 1985; 254:521&hyph;524. 
<!-- PJG 0012 frnewline -->
377. O'Mahony MC, Stanwell-Smith RE, Tillett HE, et al. The Stafford outbreak of Legionnaires' disease. Epidemiol
Infect 1990; 104:361&hyph;380. 
<!-- PJG 0012 frnewline -->
378. Mastro TD, Fields BS, Breiman RF, Campbell J, Plikaytis BD, Spika JS. Nosocomial Legionnaires' disease and use
of medication nebulizers. J Infect Dis 1991; 163:667&hyph;670. 
<!-- PJG 0012 frnewline -->
379. Breiman RF, Fields BS, Sanden G, Volmer L, Meier A, Spika J. An outbreak of Legionnaires' disease associated with
shower use: possible role of amoebae. JAMA 1990; 263:2924&hyph;2926. 
<!-- PJG 0012 frnewline -->
380. Hanrahan JP, Morse DL, Scharf VB, et al. A community hospital outbreak of Legionellosis: Transmission by potable
hot water. Am J Epidemiol 1987; 125:639&hyph;649. 
<!-- PJG 0012 frnewline -->
381. Breiman RF, VanLoock FL, Sion JP, et al. Association of ``sink bathing'' and Legionnaires' disease. Abstracts
of the 91st Meeting of the American Society for Microbiology 1991; L18.(abstract) 
<!-- PJG 0012 frnewline -->
382. Struelens MJ, Maes N, Rost F, et al. Genotypic and phenotypic methods for the investigation of a nosocomial 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 outbreak and efficacy of control measures. J Infect Dis 1992; 166:22&hyph;30. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00140 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
383. Johnson JT, Yu VL, Best MG, et al. Nosocomial legionellosis in surgical patients with head and neck cancer: Implications
for epidemiological reservoir and mode of transmission. Lancet 1985; 2:298&hyph;300. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
384. Marrie TJ, Haldane D, MacDonald S, et al. Control of endemic nosocomial Legionnaires' disease by using sterile
potable water for high risk patients. Epidemiol Infect 1991; 107:591&hyph;605. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
385. Blatt SP, Parkinson MD, Pace E, et al. Nosocomial Legionnaires' disease: aspiration as a primary mode of disease
acquisition. Am J Med 1993; 95:16&hyph;22. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
386. Fraser DW, Tsai TR, Oremstein W, et al. Legionnaires' disease: description of an epidemic of pneumonia. N Engl
J Med 1977; 297:1189&hyph;1197. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
387. Yu VL. Routine culturing for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in the hospital environment may be a good idea: A three-hospital prospective study. Am J Med 1987; 294:97&hyph;99.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
388. Goetz A, Yu VL. Screening for nosocomial legionellosis by culture of the water supply and targeting of high-risk
patients for specialized laboratory testing. Am J Infect Control 1991; 19:63&hyph;66. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
389. Yu VL. Nosocomial legionellosis: current epidemiologic issues. In: Remington JS, Swartz MN, eds. Current Clinical
Topics in Infectious Diseases. New York: McGraw-Hill, 1986:239&hyph;253. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
390. Vickers RM, Yu VL, Hanna SS. Determinants of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 contamination of water distribution systems: 15-hospital prospective study. Infect Control 1987; 8:357&hyph;363.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
391. Tobin JO, Swann RA, Bartlett CLR. Isolation of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 from water systems: Methods and preliminary results. Br Med J 1981; 282:515&hyph;517. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
392. Dennis PJ, Fitzgeorge RB, Taylor JA, et al. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in water plumbing systems. Lancet 1982; 1:949&hyph;951. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
393. Marrie TJ, Haldane D, Bezanson G, Peppard R. Each water outlet is a unique ecologic niche for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
. Epidemiol Infect 1992; 108:261&hyph;270. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
394. Marrie TJ, Berzcason G, Fox J, Kuehn R, Haldane D, Birbridge S. Dynamics of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in the potable water of one floor of a hospital. In: Barbaree JM, Breiman RF, Dufow AP, eds. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
: Current status and emerging perspectives. Washington, D.C.: ASM, 1993:238&hyph;240. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
395. Plouffe JF, Para MF, Maher WE, Hackman B, Webster L. Subtypes of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 serogroup 1 associated with different attack rates. Lancet 1983; 2:649&hyph;650. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
396. Fraser DW. Sources of legionellosis. In: Thornsberry C, Balows A, Feeley JC, Jakubowski W, eds. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
: Proceedings of the 2nd International Symposium. Washington, D.C.: American Society for Microbiology, 1984:277&hyph;280.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
397. Dourmon E, Bibb WF, Rajagopalan P, Desplaces N, McKinney RM. Monoclonal antibody reactivity as a virulence marker
for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 serogroup 1 strain. J Infect Dis 1992; 165:569&hyph;573. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
398. Brundrett GW. Guides on avoiding Legionnaires' disease. In: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 and Building Services. Oxford: Butterworth Heineman, 1992:346&hyph;373. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
399. Kugler JW, Armitage JO, Helms CM, et al. Nosocomial Legionnaires' disease. Occurrence in recipients of bone
marrow transplants. Am J Med 1983; 74:281&hyph;288. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
400. Department of Health. The Control of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in Health Care Premises: A Code of Practice. London: HMSO, 1991. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
401. Helms CM, Massanari RM, Wenzel RP, et al. Legionnaires' disease associated with a hospital water system: A five-year
progress report on continuous hyperchlorination. JAMA 1988; 259:2423&hyph;2427. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
402. Snyder MB, Siwicki M, Wireman J, et al. Reduction of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 through heat flushing followed by continuous supplemental chlorination of hospital hot water. J Infect Dis 1990;
162:127&hyph;132. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
403. Ezzeddine H, Van Ossel C, Delmee M, Wauters G. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 spp. in a hospital hot water system: Effect of control measures. J Hosp Infect 1989; 13:121&hyph;131. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
404. Johnston JM, Latham RH, Meier FA, et al. Nosocomial outbreak of Legionnaires' disease: molecular epidemiology
and disease control measures. Infect Control 1987; 8:53&hyph;58. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
405. Joly JR, McKinney RM, Tobin JO, Bibb WF, Watkins ID, Ramsay D. Development of a standardized subgrouping scheme
for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 serogroup 1 using monoclonal antibodies. J Clin Microbiol 1986; 23:768&hyph;771. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
406. Schoonmaker D, Helmberger T, Birkhead G. Comparison of ribotyping and restriction enzyme analysis using pulsed-field
gel electrophoresis for distinguishing 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 isolates obtained during a nosocomial outbreak. J Clin Microbiol 1992; 30:1491&hyph;1498. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
407. Barbaree JM. Selecting a subtyping technique for use in investigations of legionellosis epidemics. In: Barbaree
JM, Breiman RF, Dufow AP, eds. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
: Current status and emerging perspectives. Washington, D.C.: ASM, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
408. Best M, Yu VL, Stout J, Goetz A, Muder RR, Taylor F. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
ceae in the hospital water supply: epidemiologic link with disease and evaluation of a method for control of nosocomial
Legionnaires' disease and Pittsburgh pneumonia. Lancet 1983; 2:307&hyph;310. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
409. Meenhorst PL, Reingold AL, Groothuis DG, et al. Water-related nosocomial pneumonia caused by 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 serogroups 1 and 10. J Infect Dis 1985; 152:356&hyph;364. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
410. Johnston JM, Latham RH, Meier FA, et al. Nosocomial outbreak of Legionnaires' disease: molecular epidemiology
and disease control measures. Infect Control 1987; 8:53&hyph;58. 
<!-- PJG 0012 frnewline -->
411. Domingue EL, Tyndall RL, Mayberry WR, Pancorbo OC. Effects of three oxidizing biocides of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 serogroup 1. Appl Environ Microbiol 1988; 54:741&hyph;747. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
412. Landeen LK, Yahya MT, Gerba CP. Efficacy of copper and silver ions and reduced levels of free chlorine in inactivation
of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
. Appl Environ Microbiol 1989; 55:3045&hyph;3050. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
413. Matulonis U, Rosenfeld CS, Shadduck RK. Prevention of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 infections in a bone marrow transplant unit: multifaceted approach to decontamination of a water system. Infect
Control Hosp Epidemiol 1993; 14:571&hyph;583. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
414. Edelstein PH, Whittaker RE, Kreiling RL, Howell CL. Efficacy of ozone in eradication of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 from hospital fixtures. Appl Environ Microbiol 1982; 44:1330&hyph;1334. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
415. Wisconsin Department of Health and Social Services. Control of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in Cooling Towers: Summary Guidelines. Madison, WI: Wisconsin Division of Health, 1987. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
416. Best MG, Goetz A, Yu VL. Heat eradication measures for control of nosocomial Legionnaire's disease: Implementation,
education, and cost analysis. Infect Control 1984; 12:26&hyph;30. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
417. Muraca PW, Yu VL, Goetz A. Disinfection of water distribution systems for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
: a review of application procedures and methodologies. Infect Control Hosp Epidemiol 1990; 11:79&hyph;88. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
418. Walsh TJ, Dixon DM. Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis
and treatment. Eur J Epidemiol 1989; 5:131&hyph;142. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
419. Bodey GP, Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis 1989; 8:413&hyph;437. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
420. Fraser DW, Ward JL, Ajello L, Plikaytis BD. Aspergillosis and other systemic mycoses: the growing problem. JAMA
1979; 242:1631&hyph;1635. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
421. Iwen PC, Reed EC, Armitage JO, et al. Nosocomial invasive aspergillosis in lymphoma patients treated with bone
marrow or peripheral stem cell transplants. Infect Control Hosp Epidemiol 1993; 14:131&hyph;139. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
422. Cordonnier C, Bernaudin JF, Bierling P, Huet Y, Vernant JP. Pulmonary complications occurring after allogeneic
bone marrow transplantation: a study of 130 consecutive transplanted patients. Cancer 1986; 58:1047&hyph;1054.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
423. Klimowski LL, Rotstein C, Cummings KM. Incidence of nosocomial aspergillosis in patients with leukemia over
a twenty-year period. Infect Control Hosp Epidemiol 1989; 10:299&hyph;305. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
424. Sherertz RJ, Belani A, Kramer BS, et al. Impact of air filtration on nosocomial aspergillus infections. Unique
risk of bone marrow transplant recipients. Am J Med 1987; 83:709&hyph;718. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
425. Rhame FS. Lessons from the Roswell Park bone marrow transplant aspergillosis outbreak. Infect Control 1985;
6:345&hyph;346. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00141 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
426. Rotstein C, Cummings KM, Tiddings J, et al. An outbreak of invasive aspergillosis among bone marrow transplants:
a case-control study. Infect Control 1985; 6:347&hyph;355. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
427. Aisner J, Schimpff SC, Bennett JE, et al. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Aspergillus 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
infections in cancer patients. Association with fireproofing materials in a new hospital. JAMA 1976; 235:411&hyph;412.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
428. Arnow PM, Anderson RI, Mainous PD, Smith EJ. Pulmonary aspergillosis during hospital renovation. Am Rev Respir
Dis 1978; 118:49&hyph;53. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
429. Streifel AJ, Laner JL, Vesley D, et al. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Aspergillus fumigatus 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
and other thermotolerant fungi generated by hospital building demolition. Appl Environ Microbiol 1983; 46:375&hyph;378.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
430. Hopkins CC, Weber DJ, Rubin RH. Invasive aspergillosis infection: possible non-ward common source within the
hospital environment. J Hosp Infect 1989; 13:19&hyph;25. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
431. Gurwith MJ, Stinson EB, Remington JS. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Aspergillus 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
infection complicating cardiac transplantation: report of five cases. Arch Intern Med 1971; 128:541&hyph;545.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
432. Weiland D, Ferguson RM, Peterson PK, Snover DC, Simmons RL, Najarian JS. Aspergillosis in 25 renal transplant
patients. Ann Surg 1983; 198:622&hyph;629. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
433. Hofflin JM, Potasman I, Baldwin JC, Oyster PE, Stinson EB, Remington JS. Infectious complications in heart transplant
recipients receiving cyclosporine and corticosteroids. Ann Intern Med 1987; 106:209&hyph;216. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
434. Schulman LL, Smith CR, Drusin R, Rose EA, Enson Y, Reemtsma K. Respiratory complications of cardiac transplantation.
Am J Med Sci 1988; 296:1&hyph;10. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
435. Gustafson TL, Schaffner W, Lavely GB, Stratton CW, Johnson HK, Hutcheson RH. Invasive aspergillosis in renal
transplant recipients: correlation with corticosteroid therapy. J Infect Dis 1983; 148:230&hyph;238. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
436. Ho M, Dummer JS. Risk factors and approaches to infections in transplant recipients. In: Mandell GL, Douglas
RG,Jr., Bennett JE, eds. Principles and Practice of Infectious Diseases. 3rd ed. New York: Churchill Livingstone,
Inc., 1990:2284&hyph;2291. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
437. Rhame FS, Streifel AJ, Kersey JHJ. Extrinsic risk factors for pneumonia in the patient at high risk for infection.
Am J Med 1984; 76:42&hyph;52. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
438. Aisner J, Murillo J, Schimpff SC, Steere AC. Invasive aspergillosis in acute leukemia: correlation with nose
cultures and antibiotic use. Ann Intern Med 1979; 90:4&hyph;9. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
439. Ho M, Dummer JS, Peterson PK, Simmons RL. Infections in solid organ transplant recipients. In: Mandell GL, Douglas
RG,Jr., Bennett JE, eds. Principles and Practice of Infectious Diseases. 3rd ed. New York: Churchill Livingstone,
1990:2294&hyph;2303. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
440. Walsh TR, Guttendorf J, Dummer S, et al. The value of protective isolation procedures in cardiac transplant recipients.
Ann Thorac Surg 1989; 47:539&hyph;545. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
441. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published
cases. Rev Infect Dis 1990; 12:1147&hyph;1201. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
442. Pannuti CS, Pfaller MA, Wenzel RP. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation:
a 9-year study. J Clin Oncol 1991; 9:77&hyph;84. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
443. Weinberger M, Elattaar I, Marshall D, et al. Patterns of infection in patients with aplastic anaemia and the emergence
of aspergillus as a major cause of death. Medicine 1992; 71:24&hyph;43. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
444. Orr DP, Myerowitz RL, Jemkins R, et al. Patho-radiologic correlation of invasive pulmonary aspergillosis in
the compromised host. Case report and review of literature. Cancer 1978; 41:2028&hyph;2039. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
445. Young RC, Bennett JE, Vogel CL, Carbone PP, DeVita VT. Aspergillosis: the spectrum of the disease in 98 patients.
Medicine 1970; 49:147&hyph;173. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
446. Meyer RD, Young LS, Armstrong D, et al. Aspergillosis complicating neoplastic disease. Am J Med 1973; 54:6&hyph;15.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
447. Yu VL, Muder RR, Poorsattar A. Significance of isolation of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Aspergillus 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results of a three-year prospective
study. Am J Med 1986; 81:249&hyph;254. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
448. Martino P, Raccah R, Gentile G, Venditti M, Girmenea C, Mandelli F. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Aspergillus 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
colonization of the nose and pulmonary aspergillosis in neutropenic patients: a retrospective study. Hematologica
1989; 74:263&hyph;265. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
449. Richet HM, McNeil MM, Davis BJ, et al. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Aspergillus fumigatus 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
sternal wound infections in patients undergoing open heart surgery. Am J Epidemiol 1992; 135:48&hyph;58. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
450. Albelda SM, Talbot GH, Gerson SL, Miller WT, Cassileth PA. Role of fiberoptic bronchoscopy in the diagnosis of
invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med 1984; 76:1027&hyph;1034. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
451. Kahn FW, Jones JM, England DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis.
Am J Clin Pathol 1986; 86:518&hyph;523. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
452. Saito H, Anaissie EJ, Morice RC, Dekmezian R, Bodey GP. Bronchoalveolar lavage in the diagnosis of pulmonary
infiltrates in patients with acute leukemia. Am J Med 1984; 76:1027&hyph;1034. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
453. Cohen J. Clinical manifestations and management of aspergillosis in the compromised patient. In: Warnock DW,
Richardson MD, eds. Fungal Infections in the Compromised Patient. London: John Wiley &amp; Sons Ltd., 1991:117&hyph;152.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
454. Pepys J, Riddell RW, Citron KM, Clayton YM, Short EI. Clinical and immunologic significance of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Aspergillus fumigatus 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
in the sputum. Am Rev Respir Dis 1959; 80:167&hyph;180. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
455. Karam GH, Griffin JR. Invasive pulmonary aspergillosis in nonimmunocompromised, non-neutropenic hosts.
Rev Infect Dis 1986; 8:357&hyph;363. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
456. Kammer RB, Utz JP. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Aspergillus 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
species endocarditis: the new face of a not so rare disease. Am J Med 1974; 56:506&hyph;521. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
457. Holmberg K, Berdischewsky M, Young LS. Serologic immunodiagnosis of invasive aspergillosis. J Infect Dis 1980;
141:656&hyph;664. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
458. Matthews R, Burnie JP, Fox A, Tabaqchali S. Immunoblot analysis of serological responses in invasive aspergillosis.
J Clin Path 1985; 38:1300&hyph;1303. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
459. Burnie JP, Matthews RC, Clark I, Milne LJ. Immunoblot fingerprinting of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Aspergillus fumigatus. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
J Immunol Methods 1989; 118:179&hyph;186. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
460. Talbot GH, Weiner MH, Person SL, Provencher M, Hurwitz S. Serodiagnosis of invasive aspergillosis in patients
with hematologic malignancy: validation of the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Aspergillus fumigatus 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
antigen radioimmunoassay. J Infect Dis 1987; 155:12&hyph;27. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
461. Dupont B, Huber M, Kim SJ, Bennett JE. Galactomannan antigenemia and antigenuria in aspergillosis: studies
in patients and experimentally infected rabbits. J Infect Dis 1987; 155:1&hyph;11. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
462. Gerson SL, Talbot GH, Hurwitz S, Strom B, Lusk EJ. Prolonged granulocytopenia: the major risk factor for invasive
pulmonary aspergillosis in patients with leukemia. Ann Intern Med 1984; 100:345&hyph;351. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
463. Wingard JR, Beals SU, Santos GW, Mertz WG, Saral R. Aspergillus infections in bone marrow transplant recipients.
Bone Marrow Transplant 1987; 2:175&hyph;181. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
464. Peters WP. Use of cytokines during prolonged neutropenia associated with autologous bone marrow transplantation.
Rev Infect Dis 1991; 13:993&hyph;996. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
465. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating
factor. N Engl J Med 1992; 327:28&hyph;35. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
466. Karp JE, Burch PA, Merz WG, et al. An approach to intensive antileukemia therapy in patients with previous invasive
aspergillosis. Am J Med 1988; 85:203&hyph;206. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
467. Meunier-Carpentier F, Snoeck R, Gerain J, et al. Chemoprophylaxis of fungal infections. Am J Med 1984; 76:652&hyph;656.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
468. Wajszczuk CP, Dummer JS, Ho M, et al. Fungal infections in liver transplant recipients. Transplantation 1985;
40:347&hyph;353. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
469. Rhame FS, Streifel A, Stevens P, et al. Endemic 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Aspergillus 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
airborne spore levels are a major risk factor for aspergillosis in bone marrow transplant patients. Abstracts of
the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy 1985; (abstract) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00142 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
470. Lentino JR, Rosenkranz MA, Michaels JA, et al. Nosocomial aspergillosis: a retrospective review of airborne
disease secondary to road construction and contaminated air conditiners. Am J Epidemiol 1982; 116:430&hyph;437.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
471. Sarubbi FA, Kopf HB, Brejetta Wilson M, et al. Increased recovery of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Aspergillus flavus 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
from respiratory specimens during hospital construction. Am Rev Respir Dis 1982; 125:33&hyph;38. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
472. Krasinski K, Holzman RS, Hanna B, et al. Nosocomial fungal infection during hospital renovation. Infect Control
1985; 6:278&hyph;282. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
473. Weems JJ, Davis BJ, Tablan OC, Kaufman L, Martone WJ. Construction activity: an independent risk factor for invasive
aspergillosis and zygomycosis in patients with hematologic malignancy. Infect Control 1987; 8:71&hyph;75. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
474. Cage AA, Dean DC, Schimert G, Minsley N. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Aspergillus 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
infection after cardiac surgery. Arch Surg 1970; 101:384&hyph;387. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
475. Streifel AJ, Stevens PP, Rhame FS. In-hospital source of airborne 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Penicillium 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
spores. J Clin Microbiol 1987; 25:1&hyph;4. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
476. Keller NP, Cleveland TE, Bhatnagar D. Variable electrophoretic karyotypes of members of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Aspergillus flavi. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Curr Genet 1992; 21:371&hyph;375. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
477. Denning DW, Clemons KV, Hanson LH, Stevens DA. Restriction endonuclease analysis of total cellular DNA of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Aspergillus fumigatus 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
isolates of geographically and epidemiologically diverse origin. J Infect Dis 1990; 162:1151&hyph;1158. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
478. Rhame FS. Prevention of nosocomial aspergillosis. J Hosp Infect 1991; 18:466&hyph;472. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
479. Buckner CD, Clift RA, Sanders AJ, et al. Protective environment for marrow transplant recipients. Ann Intern
Med 1978; 89:893&hyph;901. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
480. Murray WA, Streifel AJ, O'Dea TJ, Rhame FS. Ventilation for protection of immune compromised patients. ASHRAE
Transactions 1988; 94:1185&hyph;1191. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
481. Streifel AJ, Vesley D. Control of airborne fungal spores in a university hospital. Environment International
1989; 12:441&hyph;444. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
482. Streifel AJ, Rhame FS. Hospital air filamentous fungal spore and particle counts in a specially designed hospital.
Proc Indoor Air 1993; 4:161&hyph;163. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
483. Perry S, Penland WZ. The portable laminar flow isolator: new unit for patient protection in a germ-free environment.
In: Recent Results in Cancer Research. New York: Springer-Verlag, 1970. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
484. Barnes RA, Rogers TR. Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. J Hosp
Infect 1989; 14:89&hyph;94. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
485. Levine AS, Siegel SE, Schrelber AD, et al. Protected environments and prophylactic antibiotics. N Engl J Med
1973; 288:477&hyph;483. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
486. ASHRAE Handbook. Heating Ventilation Air Conditioning Applications. Atlanta: ASHRAE, 1991:7.1&hyph;7.12.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
487. Rhame FS. Nosocomial aspergillosis: how much protection for which patients? Infect Control Hosp Epidemiol
1989; 10:296&hyph;298. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
488. Opal SM, Asp AA, Cannady PB, Morse PL, Burton LJ, Hammer PG. Efficacy of infection control measures during a nosocomial
outbreak of disseminated aspergillosis associated with hospital construction. J Infect Dis 1986; 153:634&hyph;637.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
489. Welliver RC, McLaughlin S. Unique epidemiology of nosocomial infections in a children's hospital. Am J Dis Child
1984; 138:131&hyph;135. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
490. Valenti WM, Hall CB, Douglas RG,Jr., Menegus MA, Pincus PH. Nosocomial viral infections: I. Epidemiology and
significance. Infect Control 1980; 1:33&hyph;37. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
491. Mintz L, Ballard RA, Sniderman SH, et al. Nosocomial respiratory syncytial virus infections in an intensive
care nursery: Rapid diagnosis by direct immunofluorescence. Pediatrics 1979; 64:149&hyph;153. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
492. Hall CB, McBride JT, Walsh EE, et al. Aerosolized ribavirin treatment in infants with respiratory syncytial
virus infection. N Engl J Med 1983; 308:1443&hyph;1447. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
493. Betts RF. Amantadine and rimantadine for the prevention of influenza A. Seminars Respir Infect 1989; 4:304&hyph;310.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
494. Rodriguez WJ, Parrott RH. Ribavirin aerosol treatment of serious respiratory syncytial virus infection in
infants. Infect Dis Clin N Am 1987; 2:425. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
495. Krasinski K. Severe respiratory syncytial virus infection: clinical features, nosocomial acquisition and
outcome. Pediatr Infect Dis 1985; 4:250&hyph;256. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
496. Meissner HC, Murray SA, Kiernan MA, et al. A simultaneous outbreak of respiratory syncytial virus and parainfluenza
virus type 3 in a newborn nursery. J Pediatr 1984; 104:680&hyph;684. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
497. Hall CB, Powell KR, MacDonald NE, et al. Respiratory syncytial virus infection in children with compromised
immune function. N Engl J Med 1986; 315:77&hyph;81. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
498. Mathur U, Bentley DW, Hall CB. Concurrent respiratory syncytial virus and influenza A infections in the institutionalized
elderly and chronically ill. Ann Intern Med 1980; 93:49&hyph;52. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
499. MacDonald NE, Hall CB, Suffin SC, Alexon C, Harris PJ, Manning JA. Respiratory syncytial viral infection in infants
with congenital heart disease. N Engl J Med 1982; 307:397&hyph;400. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
500. Drescher J, Zink P, Verhagen W, et al. Recent influenza virus A infections in forensic cases of sudden unexplained
death. Virology 1987; 92:63&hyph;76. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
501. Hertz MI, Englund JA, Snover D, Bitterman PB, McGlave PB. Respiratory syncytial virus-induced acute lung injury
in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine 1989;
68:269&hyph;281. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
502. Baron RC, Dicker RC, Bussell KE, Herndon JL. Assessing trends in mortality in 121 U.S. cities, 1970&hyph;1979,
from all causes and from pneumonia and influenza. Public Health Rep 1988; 103:120&hyph;128. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
503. Hall CB. The nosocomial spread of respiratory syncytial viral infections. Ann Rev Med 1983; 34:311&hyph;319.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
504. Finger F, Anderson LJ, Dicker RC, et al. Epidemic infections caused by respiratory syncytial virus in institutionalized
young adults. J Infect Dis 1987; 155:1335&hyph;1339. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
505. Hall CB. Nosocomial viral infections: perennial weeds on pediatric wards. Am J Med 1981; 70:670&hyph;676. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
506. Hall CB, Douglas RG,Jr. Nosocomial influenza infection as a cause of intercurrent fevers in infants. Pediatrics
1975; 55:673&hyph;677. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
507. Glezen WP. Viral pneumonia as a cause and result of hospitalization. J Infect Dis 1983; 147:765&hyph;770. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
508. Wenzel RP, Deal EC, Hendley JO. Hospital-acquired viral respiratory illness on a pediatric ward. Pediatrics
1977; 60:367&hyph;371. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
509. Hall CB. Hospital-acquired pneumonia in children. Seminars Respir Infect 1987; 2:48&hyph;56. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
510. Glezen WP, Loda FA, Clyde WA,Jr., et al. Epidemiologic patterns of acute lower respiratory diseases in pediatric
group practice. J Pediatr 1971; 78:397&hyph;406. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
511. Henderson FW, Collier AM, Clyde WA,Jr., et al. Respiratory-syncytial-virus infections, reinfections and
immunity: a prospective, longitudinal study in young children. N Engl J Med 1979; 300:530&hyph;534. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
512. Hall WJ, Hall CB, Speers DM. Respiratory syncytial virus infection in adults: clinical, virologic, and serial
pulmonary function studies. Ann Intern Med 1978; 88:203&hyph;205. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
513. Englund JA, Anderson LJ, Rhame FS. Nosocomial transmission of respiratory syncytial virus in immunocompromised
adults. J Clin Microbiol 1991; 29:115&hyph;119. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
514. Falsey AR, Walsh EE, Betts RF. Serologic evidence of respiratory syncytial virus infection in nursing home patients.
J Infect Dis 1990; 162:568&hyph;569. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
515. Hall CB, Kopelman AE, Douglas G,Jr., Griman JM, Meagher MP. Neonatal respiratory syncytial virus infection.
N Engl J Med 1979; 300:393&hyph;396. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00143 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
516. Hall CB, Douglas RG,Jr., Geiman JM, et al. Nosocomial respiratory syncytial virus infections. N Engl J Med 1975;
203:1343&hyph;1346. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
517. Centers for Disease Control. Parainfluenza outbreaks in extended-care facilities. MMWR 1978; 27:475&hyph;476.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
518. De Fabritus AM, Riggio RR, David DS, et al. Parainfluenza type 3 in a transplant unit. JAMA 1979; 241:384&hyph;385.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
519. Mufson MA, Mocega HE, Krause HE. Acquisition of parainfluenza 3 virus infection by hospitalized children. I.
Frequencies, rates, and temporal data. J Infect Dis 1973; 128:141&hyph;147. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
520. McNamara MJ, Phillips IA, Williams OB. Viral and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Mycoplasma pneumoniae 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
infections in exacerbations of chronic lung disease. Am Rev Respir Dis 1969; 100:19&hyph;24. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
521. Meyers JD, MacQuarrie MB, Merigan TC, Jennison MH. Nosocomial varicella_Part I. Outbreak in oncology patients
at a children's hospital. West J Med 1979; 130:196&hyph;199. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
522. Graman PS, Hall CB. Epidemiology and control of nosocomial viral infections. Infect Dis Clin N Am 1989; 3:815&hyph;841.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
523. Atkinson WL, Markowitz LE, Adams NC, Seastrom GR. Transmission of measles in medical settings: United States,
1985&hyph;1989. Am J Med 1991; 91 (Suppl 3B):252S&hyph;255S. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
524. Hall CB, Douglas RG,Jr. Modes of transmission of respiratory syncytial virus. J Pediatr 1981; 99:100&hyph;103.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
525. Hall CB, Douglas RG,Jr., Geiman JM. Possible transmission by fomites of respiratory syncytial virus. J Infect
Dis 1980; 141:98&hyph;102. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
526. Hall CB, Douglas RG,Jr., Schnabel KC, Geiman JM. Infectivity of respiratory syncytial virus by various routes
of inoculation. Infect Immun 1981; 33:779&hyph;783. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
527. Hendley JO, Wenzel RP, Gwaltney JM. Transmission of rhinovirus colds by self-inoculation. N Engl J Med 1973;
288:1362&hyph;1364. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
528. Gwaltney JM, Mosalski PB, Hendley JO. Hand to hand transmission of rhinovirus. Ann Intern Med 1978; 88:453&hyph;467.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
529. Couch RB, Cate TR, Fleet WF, Gerone PJ, Knight V. Aerosol-induced adenovirus illness resembling the naturally
occurring illness in military recruits. Am Rev Respir Dis 1966; 93:529&hyph;535. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
530. Brandt CD, Kim HW, Arrobio JO, et al. Epidemiology of respiratory syncytial virus in Washington, D.C. III. Composite
analysis of 11 consecutive yearly epidemics. Am J Epidemiol 1973; 98:355&hyph;364. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
531. Glezen WP, Denny FW. Epidemiology of acute lower respiratory disease in children. N Engl J Med 1973; 288:498&hyph;505.

<!-- PJG 0012 frnewline -->
532. Englund JA, Sullivan CJ, Jordan C, Dehner LP, Vercellotti GM, Balfour HH. Respiratory syncytial virus infection
in immunocompromised adults. Ann Intern Med 1988; 109:203&hyph;208. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
533. Sorvillo FJ, Huie SF, Strassburg MA, Butsumyo A, Shandera WX, Fannin SL. An outbreak of respiratory syncytial
virus pneumonia in a nursing home for the elderly. J Infect 1984; 9:252&hyph;256. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
534. Anderson LJ, Parker RA, Strikas RL. Association between respiratory syncytial virus outbreaks and lower respiratory
tract deaths in infants and young children. J Infect Dis 1990; 161:640&hyph;646. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
535. Waner JL, Whitehurst NJ, Todd SJ, et al. Comparison of Directigen RSV with viral isolation and direct immunofluorescence
for identification of respiratory syncytial virus. J Clin Microbiol 1990; 28:480&hyph;483. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
536. Ray CG, Minnich LL. Efficacy of immunofluorescence for rapid diagnosis of common respiratory viruses. J Clin
Microbiol 1987; 25:355&hyph;357. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
537. Popow-Kraupp T, Kern G, Binder C, et al. Detection of RSV in nasopharyngeal secretions by enzyme-linked immunosorbent
assay, indirect immunofluorescence and virus isolation. J Med Virol 1986; 19:123&hyph;134. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
538. Kellogg JA. Culture vs direct antigen assays for detection of microbial pathogens from lower respiratory tract
specimens suspected of containing the respiratory syncytial virus. Arch Pathol Lab Med 1991; 115:451&hyph;458.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
539. Storch GA, Park CS, Dohner DE. RNA fingerprinting of respiratory syncytial virus using ribonuclease protection:
Application to molecular epidemiology. J Clin Invest 1989; 83:1894&hyph;1902. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
540. Hall CB, Douglas RG,Jr., Geiman J. Respiratory syncytial virus infections in infants: Quantitation and duration
of shedding. J Pediatr 1976; 89:11&hyph;15. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
541. Berglund M. Respiratory syncytial virus infections in families: a study of family members of children hospitalized
for acute respiratory disease. Acta Pediatr Scand 1967; 56:395&hyph;404. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
542. Hall CB, Douglas RG,Jr. Nosocomial respiratory syncytial viral infections. Should gowns and masks be used?
Am J Dis Child 1981; 135:512&hyph;515. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
543. Snydman DR, Greer C, Meissner HC, McIntosh K. Prevention of nosocomial transmission of respiratory syncytial
virus in a newborn nursery. Infect Control Hosp Epidemiol 1988; 9:105&hyph;108. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
544. Murphy D, Todd JK, Chao RK, et al. The use of gowns and masks to control respiratory illness in pediatric hospital
personnel. J Pediatr 1981; 99:746&hyph;750. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
545. Krasinski K, LaCouture R, Holzman RS, Waithe E, Bank S, Hanna B. Screening for respiratory syncytial virus and
assignment to a cohort at admission to reduce nosocomial transmission. J Pediatr 1990; 116:894&hyph;898. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
546. Agah R, Cherry JD, Garakian AJ, et al. Respiratory syncytial virus (RSV) infection rate in personnel caring for
children with RSV infections: Routine isolation procedure vs routine procedure supplemented by use of masks and
goggles. Am J Dis Child 1987; 141:695&hyph;697. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
547. Hall CB, Geiman JM, Douglas RG. Control of nosocomial respiratory syncytial viral infections. Pediatrics 1978;
62:728&hyph;732. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
548. Itano A, Sorvillo F. Infection control practices for respiratory syncytial virus (RSV) among acute care hospitals
in Los Angeles County. Am J Infect Control 1991; 19:107 (abstract). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
549. Madge P, Paton JY, McColl JH, Mackie PLK. Prospective controlled study of four infection control procedures
to prevent nosocomial infection with respiratory syncytial virus. Lancet 1992; 340:1079&hyph;1083. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
550. Gala CL, Hall CB, Schnabel MA, et al. The use of eye-nose goggles to control nosocomial respiratory syncytial
virus infection. JAMA 1986; 256:2706&hyph;2708. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
551. Louria DB, Blumenfeld HL, Ellis JT, Kilbourne ED, Rogers DE. Studies on influenza in the pandemic of 1957&hyph;58.
II. Pulmonary complications of influenza. J Clin Invest 1959; 38:213&hyph;265. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
552. Lindsay MI,Jr., Herrman EC,Jr., Morrow GW,Jr., et al. Hong Kong influenza: clinical, microbiologic, and pathologic
features of 127 cases. JAMA 1970; 214:1825&hyph;1832. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
553. Schwarzmann SW, Adler JL, Sullivan RJ, et al. Bacterial pneumonia during the Hong Kong influenza epidemic of
1968&hyph;1969. Arch Intern Med 1971; 127:1037&hyph;1041. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
554. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics. Arch Intern Med 1982; 142:85&hyph;89.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
555. Mullooly JP, Barker WH. Impact of type A influenza on children: A retrospective study. Am J Public Health 1982;
72:1008&hyph;1016. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
556. Eickhoff TC, Sherman IL, Serfling RE. Observations on excess mortality associated with epidemic influenza.
JAMA 1961; 176:104&hyph;110. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
557. Noble GR. Epidemiological and clinical aspects of influenza. In: Beare AS, ed. Basic and applied influenza research.
Boca Raton, FL: CRC Press, 1982:11&hyph;49. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
558. Monto AS, Kioumehr F. The Tecumseh study of respiratory illness. IX. Occurrence of influenza in the community,
1966&hyph;1971. Am J Epidemiol 1975; 102:553&hyph;563. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
559. Blumenfeld HL, Kilbourne ED, Louria DB, et al. Studies on influenza in the pandemic of 1957&hyph;1958 I. An epidemiologic,
clinical, and serologic investigation of an intra-hospital epidemic, with a note on vaccine efficacy. J Clin Invest
1959; 38:199&hyph;212. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
560. Bean B, Rhame FS, Hughes RS, et al. Influenza B: hospital activity during a community epidemic. Diag Microbiol
Infect Dis 1983; 1:177&hyph;183. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
561. Hoffman PC, Dixon RE. Control of influenza in the hospital. Ann Intern Med 1977; 87:725&hyph;728. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00144 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
562. Arden NH, Patriarca PA, Fasano MB, et al. The roles of vaccination and amantadine prophylaxis in controlling
an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med 1988; 148:865&hyph;868. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
563. Arroyo JC, Postic B, Brown A, et al. Influenza A/Philippines/2/82 outbreak in a nursing home: Limitations of
influenza vaccination in the elderly. Am J Infect Control 1984; 12:329&hyph;334. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
564. Patriarca PA, Weber JA, Parker RA, et al. Efficacy of influenza vaccine in nursing homes: Reduction in illness
and complications during influenza A (H3N2) epidemic. JAMA 1985; 253:1136&hyph;1139. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
565. Saah AJ, Neufeld R, Rodstein M, et al. Influenza vaccine and pneumonia mortality in a nursing home population.
Arch Intern Med 1986; 146:2353&hyph;2357. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
566. Alford RH, Kasel JA, Gerone PJ, Knight V. Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol
Med 1966; 122:800&hyph;804. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
567. Moser MR, Bender TR, Margolis HS, Noble GR, Kendal AP, Ritter DG. An outbreak of influenza aboard a commercial
airliner. Am J Epidemiol 1979; 110:1&hyph;6. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
568. Knight V. Airborne transmission and pulmonary deposition of respiratory viruses. In: Mulder J, Hers JFP, eds.
Influenza. Groningen, Netherlands: Wolters-Noordhoff, 1972:1&hyph;9. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
569. Loosli CG, Lemon HM, Robertson OH, et al. Experimental air-borne influenza infection. I. Influence of humidity
on survival of virus in air. Proc Soc Exp Biol Med 1943; 53:205&hyph;206. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
570. Bean B, Moore BM, Sterner B, et al. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982;
146:47&hyph;52. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
571. Kilbourne ED. Influenza. New York: Plenum Publishing, 1987. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
572. Glezen WP, Decker M, Joseph SW, Mercready RG, Jr. Acute respiratory disease associated with influenza epidemics
in Houston, 1981&hyph;1983. J Infect Dis 1987; 155:1119&hyph;1126. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
573. McQuillin J, Madeley CR, Kendal AP. Monoclonal antibodies for the rapid diagnosis of influenza A and B virus infections
by immunofluorescence. Lancet 1985; 2:911&hyph;914. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
574. Berg RA, Yolken RH, Rennard SI, et al. New enzyme immunoassay for measurement of influenza A/Victoria/3/75 virus
in nasal washes. Lancet 1980; 1:851&hyph;853. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
575. Espy MJ, Smith TF, Harmon MW, et al. Rapid detection of influenza virus by shell vial assay with monoclonal antibodies.
J Clin Microbiol 1986; 24:677&hyph;679. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
576. Chomel JJ, Pardon D, Thouvenot D, Allard JP, Aynard M. Comparison between three rapid methods for direct diagnosis
of influenza and the conventional isolation procedure. Biologicals 1991; 19:287&hyph;292. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
577. Bucher DJ, Mikhail A, Popple S, et al. Rapid detection of type A influenza viruses with monoclonal antibodies
to the M protein (M1) by enzyme-linked immunosorbent assay and time-resolved fluoroimmunoassay. J Clin Microbiol
1991; 29:2484&hyph;2488. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
578. Spada B, Biehler K, Chegas P, Kaye J, Riepenhoff-Talty M. Comparison of rapid immunofluorescence assay to cell
culture isolation for the detection of influenza A and B viruses in nasopharyngeal secretions from infants and children.
J Virol Methods 1991; 33:305&hyph;310. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
579. Barker WH, Mullooly JP. Influenza vaccination of elderly persons: Reduction in pneumonia and influenza hospitalizations
and deaths. JAMA 1980; 244:2547&hyph;2549. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
580. Foster DA, Tolsma AN, Newson AF, et al. Influenza vaccine effectiveness in preventing hospitalizations for
pneumonia in the elderly. Am J Epidemiol 1992; 136:286&hyph;307. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
581. Advisory Committee on Immunization Practices. Prevention and Control of Influenza: Part I, Vaccines. Recommendations
of the Advisory Committee on Immunization Practices (ACIP). MMWR 1993; 42 (RR&hyph;6):1&hyph;14. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
582. Patriarca PA, Weber JA, Parker RA, et al. Risk factors for outbreaks of influenza in nursing homes: A case control
study. Am J Epidemiol 1986; 124:114&hyph;119. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
583. Fox JP, Elveback L, Scott W, Gatewood L, Ackerman E. Herd immunity: basic concept and relevance to public health
immunization practices. Am J Epidemiol 1971; 94:171&hyph;189. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
584. Advisory Committee on Immunization Practices. Prevention and control of influenza. MMWR 1992; 41:1&hyph;17.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
585. Tominack RL, Hayden FG. Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections.
Infect Dis Clin N Am 1987; 1:459&hyph;478. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
586. Hall CB, Dolin R, Gala CL, et al. Children with influenza A infection: treatment with rimantadine. Pediatrics
1987; 80:275&hyph;282. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
587. Dolin R, Reichman RC, Madore HP, et al. A controlled trial of amantadine and rimantadine prophylaxis of influenza
infection. N Engl J Med 1982; 307:580&hyph;584. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
588. Douglas RG. Drug therapy: prophylaxis and treatment of influenza. N Engl J Med 1990; 322:443&hyph;450. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
589. Younkin SW, Betts RF, Roth FK, et al. Reduction in fever and symptoms in young adults with influenza A/Brazil/78
H1N1 infection after treatment. Antimicrob Agents Chemother 1983; 23:577&hyph;82. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
590. Van Voris LP, Betts RF, Hayden FG. Successful treatment of naturally occurring influenza A/USSR/77/H1N1. JAMA
1981; 245:1128&hyph;1131. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
591. Atkinson WL, Arden NH, Patriarca PA, et al. Amantadine prophylaxis during an institutional outbreak of type
A(H1N1) influenza. Arch Intern Med 1986; 146:1751&hyph;1756. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
592. O'Donoghue JM, Ray CG, Terry DW, Jr., Beaty HN. Prevention of nosocomial influenza infection with amantadine.
Am J Epidemiol 1973; 97:276&hyph;282. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
593. Leeming JK. Amantadine hydrochloride and the elderly. Lancet 1969; 1:313&hyph;314. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
594. Postma JU, Tilburg WV. Visual hallucinations and delirium during treatment with amantadine (Symmetrel). J
Am Geriatr Soc 1975; 23:212&hyph;215. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
595. Ing TS, Daugirdas JT, Soung LS, et al. Toxic effects of amantadine in patients with renal failure. Can Med Assoc
J 1979; 120:695&hyph;698. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
596. Horadom VW, Sharp JG, Smilack JD, et al. Pharmacokinetics of amantadine hydrochloride in subjects with normal
and impaired renal function. Ann Intern Med 1981; 94:454&hyph;458. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
597. Drusano GL, Muncie HL, Hoopes JM, et al. Commonly used methods of estimating creatinine clearance are inadequate
for elderly debilitated nursing home patients. J Am Geriatr Soc 1988; 36:437&hyph;441. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
598. Hayden FG, Sperber SJ, Belshe RB, Clover RD, Hay AJ, Pyke S. Recovery of drug-resistant influenza A virus during
therapeutic use of rimantadine. Antimicrob Agents Chemother 1991; 35:1741&hyph;1747. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
599. Mast EE, Harmon MW, Gravenstein S, et al. Emergence and possible transmission of amantadine-resistant viruses
during nursing home outbreaks of influenza A(H3N2). Am J Epidemiol 1991; 13:988&hyph;997. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
600. Hayden PG, Blake RB, Clover RD, Hey AJ, Oakes MG, Soo W. Emergence and apparent transmission of rimantadine-resistant
influenza A virus in families. N Engl J Med 1989; 321:1696&hyph;1702. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
601. Hayden FG, Couch RB. Clinical and epidemiological importance of influenza A viruses resistant to amantadine
and rimantadine. Rev Med Virol 1992; 2:89&hyph;96. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
602. Monto AS, Arden NH. Implications of viral resistance to amantadine in control of influenza A. Clin Infect Dis
1992; 15:362&hyph;367. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
603. Fedson DS. Immunizations for health care workers and patients in hospitals. In: Wenzel RP, ed. Prevention and
Control of Nosocomial Infection. Baltimore: Williams and Wilkins, 1987:116&hyph;174. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
604. Valenti WM, Betts RF, Hall CB, Hruska JF, Douglas RG, Jr. Nosocomial viral infections: II. Guidelines for prevention
and control of respiratory viruses, herpesviruses, and hepatitis viruses. Infect Control 1981; 1:165&hyph;178.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
605. Williams WW. Guideline for infection control in hospital personnel. Infect Control 1983; 4:326&hyph;349.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00145 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
606. Wong ES, Hooton TM. Guideline for prevention of catheter-associated urinary tract infections. Am J Infect Control
1983; 11:28&hyph;33. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
607. Simmons BP, Hooton TM, Wong ES, Allen JR. Guideline for prevention of intravascular infections. Infect Control
1982; 3:61&hyph;72. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
608. Simmons BP, Wong ES. Guideline for prevention of nosocomial pneumonia. Infect Control 1982; 3:327&hyph;333.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
609. Garner JS. Guideline for prevention of surgical wound infections. Infect Control 1986; 7:193&hyph;200. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
610. Britt MR, Schleupner CJ, Matsumiya S. Severity of underlying disease as a predictor of nosocomial infection.
JAMA 1978; 239:1047&hyph;1051. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
611. Johnson MW, Mitch WE, Heller AH, Spector R. The impact of an educational program on gentamicin use in a teaching
hospital. Am J Med 1982; 73:9&hyph;14. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
612. Soumerai SB, Salem-Schatz S, Avorn J, Casteris CS, Ross-Degnan D, Popovsky MA. A controlled trial of educational
outreach to improve blood transfusion practice. JAMA 1993; 270:961&hyph;966. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
613. Eisenberg JM. An education program to modify laboratory use by house staff. J Med Educ 1977; 52:578&hyph;581.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
614. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing
nosocomial infections in US hospitals. Am J Epidemiol 1985; 121:182&hyph;205. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
615. Gross AS, Roup B. Role of respiratory assistance devices in endemic nosocomial pneumonia. Am J Med 1981; 70:681&hyph;685.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
616. Hall JC, Tarala RA, Hall JL, Mander J. A multivariate analysis of the risk of pulmonary complications after laparotomy.
Chest 1991; 99:923&hyph;927. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
617. Josephson A, Karanfil L, Alonso H, Watson A, Blight J. Risk-specific nosocomial infection rates. Am J Med 1991;
91(suppl 3B):131S&hyph;137S. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
618. Freeman J, McGowan JE. Methodologic issues in hospital epidemiology. I. Rates, case finding and interpretation.
Rev Infect Dis 1981; 3:658&hyph;667. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
619. Madison R, Afifi AA. Definition and comparability of nosocomial infection rates. Am J Infect Control 1982; 10:49&hyph;52.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
620. American Hospital Association Committee on Infection within Hospitals. Statement on microbiologic sampling.
Hospitals 1974; 48:125&hyph;126. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
621. Eickhoff TC. Microbiologic sampling. Hospitals 1970; 44:86&hyph;87.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
622. Bond WW, Ott BJ, Franke KA, McCracken JE. Effective use of liquid chemical germicides on medical devices: instrument
design problems. In: Block SS, ed. Disinfection, Sterilization, and Preservation. 4th ed. Philadelphia: Lea and
Febiger, 1991:1097&hyph;1106. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
623. McDonald WL, Welch HJ, Keet JE. Antisepsis of endotracheal tubes and face masks. Anesthesiology 1955; 16:206.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
624. Institute for Health Policy Analysis. Proceedings of International Conference on the Reuse of Disposable Medical
Devices in the 1980's. Washington, D.C.: Georgetown University Medical Center, 1984. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
625. Bosomworth PP, Hamelberg W. Effect of sterilization on safety and durability of endotracheal tubes and cuffs.
Anesth Analg 1965; 44:576&hyph;586. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
626. Comhaire A, Lamy RM. Contamination rate of sterilized ventilators in an ICU. Crit Care Med 1981; 9:546&hyph;548.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
627. Du Moulin GC, Sauberman AJ. The anesthesia machine and circle system are not likely to be sources of bacterial
contamination. Anesthesiology 1977; 47:353&hyph;358. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
628. Rutala DR, Rutala WA, Weber DJ, Thomann CA. Infection risks associated with spirometry. Infect Control Hosp
Epidemiol 1991; 12:89&hyph;92. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
629. Hazaleus RE, Cole J, Berdischewsky M. Tuberculin skin test conversion from exposure to contaminated pulmonary
function testing apparatus. Respir Care 1980; 26:53&hyph;55. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
630. Ping FC, Oulton JL, Smith JA, Skidmore AG, Jenkins LC. Bacterial filters_are they necessary on anesthetic machines?
Can Anaesth Soc J 1979; 26:415&hyph;419. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
631. Seto WH, Ching TY, Yuen KY, Lam WK. Evaluating the sterility of disposable wall oxygen humidifiers, during and
between use on patients. Infect Control 1990; 11:604&hyph;605. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
632. Stoler BS. Sterility of a disposable oxygen humidification system. Respir Care 1972; 17:572&hyph;573. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
633. Meehan TP. Sterility in oxygen humidifiers. Respir Tech 1977; 14:15&hyph;22. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
634. Golar SD, Sutherland LLA, Ford GT. Multipatient use of prefilled disposable oxygen humidifiers for up to 30 days:
patient safety and cost analysis. Respir Care 1993; 38:343&hyph;347. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
635. Henderson E, Ledgerwood D, Hope KM, et al. Prolonged and multipatient use of prefilled disposable oxygen humidifier
bottles: safety and cost. Infect Control Hosp Epidemiol 1993; 14:463&hyph;468. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
636. Longfield R, Longfield J, Smith LP, Hyams K, Strohmer ME. Multidose medication vial sterility: an in-use study
and a review of the literature. Infect Control 1984; 5:165&hyph;169.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
637. Sheth NK, Post GT, Wisniewski TR, Uttech BV. Multi-dose vials versus single-dose vials: a study in sterility
and cost-effectiveness. J Clin Microbiol 1983; 17:377&hyph;379. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
638. Smith PW, Massanari RM. Room humidifiers as the source of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Acinetobacter
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 infections. JAMA 1977; 237:795&hyph;797. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
639. Moffet HL, Allan D. Survival and dissemination of bacteria in nebulizers and incubators. Am J Dis Child 1967;
114:13&hyph;20. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
640. Cross DF, Benichimol A, Dimond EG. Faucet aerators- source of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
P. aeruginosa
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
. N Engl J Med 1966; 274:1430&hyph;1431. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
641. Knittle MA, Eitzman DV, Baer H. Role of hand contamination of personnel in the epidemiology of gram-negative
nosocomial infections. J Pediatr 1975; 86:433&hyph;437. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
642. Reybrouck G. Role of the hands in the spread of nosocomial infections. J Hosp Infect 1983; 41:103&hyph;110. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
643. Bernard M, Braunstein N, Stevens R, et al. Incidence of aspiration pneumonia in enteral hyperalimentation.
J Parent Enter Nutr 1982; 6:588.(abstract) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
644. Harvey P, Bell P, Harris O. Accidental intrapulmonary clinifeed. Anesth Analg 1981; 36:518&hyph;522. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
645. Hand R, Kempster M, Levy J, Rogol R, Spirin P. Inadvertent transbronchial insertion of narrow-bore feeding tubes
into the pleural space. JAMA 1984; 251:2396&hyph;2397. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
646. Dorsey J, Cogordan J. Nasotracheal intubation and pulmonary parenchymal perforation: an unusual complication
of nasoenteral feeding with small-diameter feeding tubes. Chest 1985; 87:131&hyph;132. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
647. Heymsfield SB, Bethel RA, Ansley JD, Nixon DW, Rudman D. Enteral hyperalimentation: an alternative to central
venous hyperalimentation. Ann Intern Med 1979; 90:63&hyph;71. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
648. Bury KD, Jambanathan G. Effects of elemental diets on gastric emptying and gastric secretion in man. Am J Surg
1974; 127:59&hyph;64. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
649. Douglas RG. Influenza in man. In: Kilbourne ED, ed. The influenza viruses and influenza. New York: New York Academy
Press, 1975. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
650. Holzapfel L, Chevret S, Madinier G, et al. Influence of long-term oro- or nasotracheal intubation on nosocomial
maxillary sinusitis and pneumonia: Results of a prospective, randomized clinical trial. Crit Care Med 1993; 21:1132&hyph;1138.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
651. Cerra FB, Maddaus MA, Dunn DL, et al. Selective gut decontamination reduces nosocomial infections and length
of stay but not mortality or organ failure in surgical intensive care unit patients. Arch Surg 1992; 127:163&hyph;169.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00146 </DOCNO>
<PARENT> FR940202-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
652. Nayman J. Measurement and control of postoperative pain. Ann R Coll Surg Engl 1979; 61:419&hyph;426. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
653. Roberts NJ, Douglas RG. Gentamicin use and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Pseudomonas
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Serratia
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 resistance: effect of a surgical prophylaxis regimen. Antimicrob Agents Chemother 1978; 13:214&hyph;220. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
654. Ruf B, Schurmann D, Horbach I, et al. Prevalence and diagnosis of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 pneumonia: a 3-year prospective study with emphasis on application of urinary antigen detection. J Infect Dis 1990;
162:1341&hyph;1348. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
655. Redd SC, Cohen ML. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in water: What should be done? JAMA 1987; 257:1221&hyph;1222. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
656. Woo AH, Yu VL, Goetz A. Potential in-hospital modes of transmission of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
: demonstration experiments for dissemination by showers, humidifiers, and rinsing of ventilation bag apparatus.
Am J Med 1986; 80:567&hyph;573. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
657. World Health Organization. Environmental Aspects of the Control of Legionellosis. 14th ed. Copenhagen: World
Health Organization, 1986:118&hyph;120. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
658. Bhopal RS, Barr G. Maintenance of cooling towers following two outbreaks of Legionnaires' disease in a city.
Epidemiol Infect 1990; 104:29&hyph;38. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
659. Pannuti C, Gingrich R, Pfaller MA, Kao C, Wenzel RP. Nosocomial pneumonia in patients having bone marrow transplant:
attributable mortality and risk factors. Cancer 1992; 69:2653&hyph;2662. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
660. Rogers TR. Infections in hematologic malignancy. Infect Control 1986; 7S:124&hyph;125. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
661. McWhinney PHM, Kibbler CC, Hamon MD, et al. Progress in the diagnosis and management of aspergillosis in bone
marrow transplantation: 13 years. J Infect Dis 1993; 17:397&hyph;404. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
662. Staib F. Ecological and epidemiological aspects of aspergilli pathogenic for man and animal in Berlin (West).
Zbl Bakt Hyg A 1984; 257:240&hyph;245. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
663. Staib F, Folkens U, Tompak B, Abel T, Thiel D. A comparative study of antigens of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Aspergillus fumigatus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 isolates from patients and soil of ornamental plants in the immunodiffusion test. Zbl Bakt Hyg I Abt Orig A 1978; 242:93&hyph;99.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
664. Lie TS, Hofer M, Hohnke C, et al. Aspergillose nach lebertransplantation als hospitalismusinfekion. Dtsch
Med Wschr 1987; 112:297&hyph;301. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
665. Bodey GP. Current status of prophylaxis of infection with protected environments. Am J Med 1984; 76:678&hyph;684.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
666. Grossman ME, Fithian EC, Behrens C, Bissinger J, Fracaro M, Neu HC. Primary cutaneous aspergillosis in six leukemic
children. J Am Acad Dermatol 1985; 12:313&hyph;318. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
667. Walsh TJ, Van Cutsem J, Polak AM, Graybill JR. Immunomodulation and antifungal treatment of experimental invasive
candidosis, histoplasmosis and aspergillosis. Recent advances and concepts. 
<!-- PJG 0012 frnewline -->
J Med Vet Mycol 1992; 30(Suppl 1):225&hyph;240. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
668. Nichol KL. Preventing influenza: The physician's role. Seminars Respir Infect 1992; 7:71&hyph;77. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
669. Pachucki CT, Lentino JR, Jackson CG. Attitudes and behavior of health care personnel regarding the use and efficacy
of influenza vaccine. J Infect Dis 1985; 151:1170&hyph;1171. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
670. Fedson DS, Kessler HA. A hospital-based influenza immunization program, 1977&hyph;78. Am J Public Health 1983;
73:442&hyph;445. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
671. Williams WW, Hickson MA, Kane MA, et al. Immunization policies and vaccine coverage among adults. Ann Intern
Med 1988; 108:616&hyph;625. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
672. Arden N, Patriarca PA, Kendal AP. Experiences in the use and efficacy of inactivated vaccines in nursing homes.
In: Kendal AP, Patriarca PA, eds. Options for the Control of Influenza. New York: Alan Liss, 1985:155&hyph;168. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
673. Ksiazek TG, Olson JG, Irving GS, Settle CS, White R, Petrusso R. An influenza outbreak due to A/USSR/77-like (H1N1)
virus aboard a US navy ship. Am J Epidemiol 1980; 112:487&hyph;494. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
674. Berlinberg CD, Weingarten SR, Bolton LB, Waterman SH. Occupational exposure to influenza_introduction of
an index case to a hospital. Infect Control Hosp Epidemiol 1989; 10:70&hyph;73. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
675. Askonas BA, McMichael AJ, Webster RG. The immune response to influenza viruses and the problem of protection
against infection. In: Beare AS, ed. Basic and Applied Influenza Research. Boca Raton, FL: CRC Press, 1982:159&hyph;182.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
676. Schulze-Robbecke R, Jung KD, Pullman H, Hundgeburth J. Control of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in a hospital hot water system. Zbl Hyg 1990; 190:84&hyph;100. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
677. Groothis DG, Veenendaal HR, Dijkstra HL. Influence of temperature on the number of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in hot water systems. J Appl Bacteriol 1985; 59:529&hyph;536. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
678. Colbourne JS, Pratt DJ, Smith MG, Fisher-Hoch SP, Harper D. Water fittings as sources of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in a hospital plumbing system. Lancet 1984; 1:210&hyph;213. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
679. Environmental Protection Agency. National interim primary drinking water regulations: Control of trihalothanes
in drinking water: Final rules. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 1979; 44:68624&hyph;68705. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
680. Environmental Protection Agency. National interim primary drinking water regulations: Trihalothanes. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 1983; 48:8406&hyph;8414. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
681. Alary MA, Jean JR. Comparison of culture methods and an immunofluorescence assay for the detection of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in domestic hot water devices. Curr Microbiol 1992; 25:19&hyph;25. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
682. Vickers RM, Stout JE, Yu VL. Failure of a diagnostic monoclonal immunofluorescent reagent to detect 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in environmental samples. Appl Environ Microbiol 1990; 56:2912&hyph;2914. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
683. Flournoy DJ, Belobraydic KA, Silberg SL, Lawrence CH, Guthrie PJ. False positive 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 direct immunofluorescent monoclonal antibody test caused by 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Bacillus cereus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 spores. Diag Microbiol Infect Dis 1988; 9:123&hyph;125. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
684. Bej AK, Mahbubani MH, Atlas RM. Detection of viable 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Legionella pneumophila
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in water by polymerase chain reaction and gene probe methods. Appl Environ Microbiol 1991; 57:597&hyph;600.
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2178 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;18&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00147 </DOCNO>
<PARENT> FR940202-2-00072 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4717 -->

<!-- PJG STAG 4717 -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Wednesday
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
February 2, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=1 -->
Part III
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->
Corporation for National and Community Service
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Availability of Funds for Summer of Safety; Notice
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG FTAG 4701 -->

<!-- PJG STAG 4701 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 22&blank;/&blank;Wednesday, February 2, 1994&blank;/&blank;Notices
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<USDEPT>CORPORATION FOR NATIONAL AND COMMUNITY SERVICE</USDEPT>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Availability of Funds for Summer of Safety
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Corporation for National and Community Service.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of availability of funds.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Corporation for National and Community Service announces the availability of up to $3 million for grants to support
the Summer of Safety, an AmeriCorps project, that will focus on enhancing public safety. These funds must be matched
with non-Corporation funds, and will provide opportunities for more than 1000 Americans, especially young people,
to serve full time in community-based collaborative efforts to respond to the problems of crime, violence and fear.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The deadline for the submission of proposals is Monday, March 14, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Corporation for National and Community Service, (202) 606&hyph;4949.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Background
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On September 21, 1993, the President signed into law the National and Community Service Trust Act (the Act), which
created the Corporation for National and Community Service. The Corporation's mission is to engage Americans of
all ages and backgrounds in service that addresses the nation's educational, public safety, health, and environmental
needs to achieve direct and demonstrable results. In doing so, the Corporation will foster civic responsibility,
strengthen the ties that bind us together as a people, and provide educational opportunity for those who make a substantial
commitment to service.
<!-- PJG 0012 frnewline -->
The Corporation is a new federal agency that encompasses the work and staff of two existing independent agencies,
the Commission on National and Community Service and ACTION. The Corporation will fund a new national service initiative
called AmeriCorps, service-learning initiatives for elementary and secondary schools and institutions of higher
education called Learn and Serve America, and the new National Civilian Community Corps, and also engage in efforts
to improve the quality of service programs. In addition, the Corporation will continue to support the Volunteers
In Service To America (VISTA) program and the senior volunteer programs previously sponsored by ACTION.
<!-- PJG 0012 frnewline -->
The Act authorizes the Corporation to support summer service programs directly (such as the Summer of Safety) and
indirectly, in conjunction with the States. Programs that operate during the summer offer an excellent opportunity
to experiment with new approaches to solving community problems and to bring new resources and participants into
community service efforts.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Program Objectives
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
``Summer of Safety,'' the Corporation's 1994 summer service program, is being launched to respond to the growing
fear of and frustration over the levels of crime and violence in every part of the country. The 1994 Summer of Safety
will demonstrate the potential of national service to respond to these urgent needs by unleashing the talents and
energies of Americans of all ages and backgrounds, especially young adults. Summer of Safety will specifically address
the public safety needs of communities by achieving the following objectives:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_Make direct and demonstrable impacts on crime, violence and fear by identifying and meeting public safety needs;
<!-- PJG 0012 frnewline -->
_Build new partnerships and collaborations for safety that capitalize on all of the community's resources;
<!-- PJG 0012 frnewline -->
_Demonstrate that every citizen_especially young people_can help make communities safer;
<!-- PJG 0012 frnewline -->
_Provide seed support for innovative service programs that address public safety needs; and 
<!-- PJG 0012 frnewline -->
_Stimulate public interest in national service as a means to respond to America's problems.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Program Overview
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Corporation will directly fund Summer of Safety programs in up to 20 locations, both urban and rural, for the summer
months. Summer of Safety programs will be run by partnerships that may include law enforcement, other public agencies,
non-profit and community-based organizations, institutions of higher education, Indian tribes, and the business
community.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Participants will engage in service activities directly related to enhancing public safety. Permissible program
activities may range from assisting police officers in community policing initiatives, to escorting seniors in
high-crime neighborhoods, to working in victim assistance programs, to supervising recreation activities for
children and youth that incorporate safety and violence prevention education. A program may establish terms of participants
to carry out a range of different public safety-related activities during the summer, or place participants individually
or in small groups in core assignments for the whole summer.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Participants will be selected by local programs, and they must receive training appropriate to their service assignments.
Participants will receive living allowances of at least $147.00 per week during their service, and, upon successful
completion of the program (and a minimum of 381 hours of service), a postservice benefit of $1000 which may be used for
support of higher education programs, certain vocational training and school-to-work programs, or repayment of
student loans.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00148 </DOCNO>
<PARENT> FR940202-2-00072 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
In addition to the programs supported under this grant competition, the Corporation is sponsoring other Summer of
Safety initiatives. These are briefly described in Appendix 2.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Eligibility
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Public agencies (including law enforcement agencies, local units of government, health/social service agencies,
etc.), nonprofit organizations (including youth-servin groups, community based organizations, service organizations,
etc.), institutions of higher education, and Indian tribes are eligible to apply. State agencies that intend to operate
the program directly are also eligible.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
While a single entity may be the actual recipient of the grant thereby responsible for financial administration and
program management we expect that the Summer of safety programs will be conducted by working partnerships among any
or all of the above types of organizations.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Special Funding Requirements
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Summer of Safety grants may be made from one of three sources of funds: Subtitle H of the Act (Investment for Quality
and Innovation), Subtitle B&hyph;2 of the Act (Learn and Serve America: Higher Education) and Subtitle C of the Act
(AmeriCorps Grants). Applicants should specify which type of funding they are seeking. While Subtitle H carries
no restrictions, Subtitles B&hyph;2 and C contain the following:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Subtitle B&hyph;2 requires, among other things, that an applicant be an institution of higher education (or a consortium
of such institutions), or a partnership of public or private nonprofit organizations and one or more institutions
of higher education. Programs must involve, but are not limited to, current students. Pursuant to the Act, priority
will be given to applications that meet certain characteristics, as detailed in Appendix 3.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Corporation will ensure that at least 50% of the funds awarded under Subtitle C will support projects that will
be conducted in areas of need, as detailed in Appendix 4.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Beyond the requirements specific to the Subtitles from which the funding originates, applicants must meet all other
requirements in this notice, regardless of the type of funds being requested. Proposals that do not indicate a preferred
type of funding will be reviewed as the Corporation deems appropriate. Each of the two types of funds require a non-Corporation
match of at least 25% of program costs. The Corporation has the flexibility to ensure that the highest quality proposals
are funded, regardless of whether they are submitted under Subtitle B2 or Subtitle C.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Content of Proposal
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Summer of Safety applicants should submit program proposals that contain the sections noted below and meet the requirements
in this notice. Should you desire further guidance on the format of your proposal, you should contact the Corporation
at 202/606&hyph;4949.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
1. Title Page
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
List: (1) Name and address of legal applicant (and include the signature of the authorized executive); (2) names of
organizations participating in partnership; (3) amount of Federal funds requested, amount of non-federal match
(both cash and in-kind); (4) number of stipended participants and number of additional volunteers who will not receive
a stipend; and (5) one paragraph describing program activities and target community.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
2. Program Narrative
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
A narrative describing the proposed program should contain sections that respond to the following requirements:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
(a) Community Need/Anticipated Impact
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
The paramount goal of Summer of Safety is to address problems of crime, violence and fear in the communities where programs
are conducted. To have such an impact, problems must be identified and defined and strategies developed which have
specific objectives. Accordingly, successful proposals will:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) Discuss the specific needs or problems that exist in the target community/neighborhood(s) which the project
will address. Sources of official data (demographic data, crime offense data, etc.), public opinion surveys, expert
analysis, and other sources of local information are all useful.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) Describe specifically how the program will address the identified problem(s). Outcomes must be direct and demonstrable.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
While the goal of every project should be the reduction of crime, violence and fear, it may be very difficult to document
such accomplishments, given the limited time during which a summer program can operate. Accordingly, as well as quantifiable
measures of outcome, there may also be intermediate measures of effort and accomplishment which are appropriate
as specific objectives.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Examples of such objectives each of which should address only one activity and include one result may include reduction
in reported crime of XX% (generally, or in more limited focus, i.e., robberies of convenience stores, gang-related
assaults, attacks against senior citizens, etc.), XX% of neighborhood residents feel safer compared to before program,
XX victims of violent crime assisted at court or at home, XX Safe Houses established, XX playgrounds refurbished and
supervised, XX ``crack houses'' rehabilitated, XX youth provided crime prevention/violence reduction training,
etc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00149 </DOCNO>
<PARENT> FR940202-2-00072 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(iii) Discuss the appropriateness of a summer program to address the identified needs/problems and to achieve the
specified objectives. This should include discussion of long-term effects (i.e., safe houses established during
the summer will continue to operate during the school year; vacant lots or abandoned playgrounds will be restored
to community use; neighborhood volunteers will continue activities initiated during the summer; etc.)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
(b) Participants
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Programs must provide quality service opportunities and living allowances (stipends) for between 20 and 150 Summer
of Safety participants. The $1000 post-service benefit, which may be used only for higher educational purposes,
including loan repayment, or certain types of vocational training, will be administered by the Corporation through
the National Service Trust Fund.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Participants must be at least 17 years old, and demonstrate leadership potential. Programs should seek to enroll
participants from diverse racial, economic, and educational backgrounds (including entering and current college
students, recent graduates, and youth not attending college), and include residents from the community where the
program will be conducted. Participant selection decisions are made solely by the program.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Programs should be willing to enroll participants from other parts of the country not simply from the host community.
Grant funds may be used for transportation costs for eligible participants. The Corporation may provide names and
addresses of potential participants to programs. In addition, programs may be contacted by potential participants
who are recruited nationally.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The physical safety of participants must be of paramount concern, and programs that do not take appropriate measures
to protect the safety of participants will not be approved. (See Section 2c, Service Activities, for further information).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Accordingly, proposals must include:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) A description of plans to recruit, screen, select, and assign a qualified and diverse pool of participants, including
individuals from the community served, to carry out the agreed-upon service activities;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) A description of the training that will be provided to participants to ensure successful involvement in the summer
program;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iii) A discussion of how the entire summer experience for participants orientation, training, service activity,
etc._will develop useful skills, teach them about public safety, promote active citizenship, and strengthen their
commitment to service;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iv) A description of policies and practices designed to assure the safety of participants while carrying out service
activities;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(v) A description of plans to provide appropriate child care for certain program participants. Preliminary guidance
may be found in the Corporation's proposed regulations (See Appendix 5);
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
These plans may be revised prior to final grant approval, as a result of requirements in these areas that will be set
forth in the Corporation's final regulations;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(vi) A description of arrangements that will be made to provide appropriate program and participant liability coverage;
and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(vii) A description of arrangements that will be made to cover on-the-job injuries to participants, such as linkage
with the State Workers' Compensation Program or other appropriate accident and injury policies.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
(c) Service Activities
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Summer of Safety projects must have the clear purpose of strengthening the ability of the community to respond to problems
of crime, violence and fear through service. Projects must include at least 8 weeks and 381 hours of full-time service
activity for participants, including the period of orientation and training.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The ideal Summer of Safety service program will develop a range of service activities that depends on the community's
needs and the resources the various members of the partnership bring to the overall initiative. For example, some
activities may involve direct work with police officers or community groups to solve specific crime problems; others
may involve work with victim assistance programs, including efforts to help special groups such as victims of family
violence or seniors. Still others might involve providing training in crime prevention or conflict resolution to
parents and children. An approach to developing a program and examples of possible service activities may be found
in Appendix 1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Participants will be assigned to specific service activities determined by the program based on the needs identified
within the community and the skill level of participants. Teams of participants can readily be trained and assigned
to take on a number of distinct activities as part of a broad community effort. Individual assignments to appropriate
activities are also acceptable. Appropriate training and effective supervision of participant service activity
are important to project success.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Accordingly, successful proposals will:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) Describe the specific service activities that will be conducted by the program during the summer;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) Identify the number of stipended participants and unstipended volunteers who will serve in each of the identified
activities;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iii) Discuss the background, skills or other factors related to assigning participants to the various service activities;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iv) Describe the specific training which will be necessary to enable participants to carry out respective service
assignments;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00150 </DOCNO>
<PARENT> FR940202-2-00072 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(v) Describe procedures for the supervision of participants engaged in the service activities; and
<!-- PJG 0012 frnewline -->
(vi) Discuss the process by which the program will ensure that service participants will not displace paid workers,
including considerations with appropriate labor unions.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Limitations
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
There are activities that are not appropriate for Summer of Safety participants. Concern for the physical safety
of participants and the specialized training/skill requirements for certain law enforcement/corrections tasks
limit the types of service activities which are appropriate. Certain other activities are not appropriate absent
a clear link to a broad community public safety effort. Finally, some tasks are not suitable for national service programs
at all. Specifically:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_The Corporation will not support programs that place service participants in situations that: (1) Involve the arrest
process, (2) involve the chain of custody of evidence, (3) involve witnessing criminal incidents which may result
in participants being called as witnesses in adjudicatory proceedings, (4) result in intentional contact with suspected
criminal offenders, (5) involve contact with defendants or convicted offenders unless appropriate safeguards
are in place, or (6) otherwise pose significant risk to participant safety (e.g., working alone in a high-crime neighborhood,
etc.).
<!-- PJG 0012 frnewline -->
_Although the Corporation recognizes the importance of such activities and their indirect connection to public
safety in the long-term, Summer of Safety grant funds may not be used to support programs which provide positive activities
for youth (i.e., recreation, field trips, cultural opportunities, social/athletic events, vocational support,
academic assistance, mentoring, etc.) unless they are conducted as components of specific public safety initiatives.
The program, when taken as a whole, must have a clear, consistent, and visible public safety purpose and target specific
crime/violence/fear reduction outcomes.
<!-- PJG 0012 frnewline -->
_Activities that do not provide a direct benefit to the community, such as clerical work or research, may be performed
if they support direct service, but may not be the primary activity of a national service program.
<!-- PJG 0012 frnewline -->
_Certain activities are prohibited for participants in all national service programs. These activities include:
efforts to influence legislation; organizing protests; petitions; boycotts or strikes; assisting or deterring
union organizing; impairing contracts for services or collective bargaining agreements; partisan political activity;
religious instruction; or benefitting profit-making businesses, labor unions, partisan political organizations,
or non-profit organizations which fail to comply with section 501(c) of the Internal Revenue Code. Further information
about these prohibited activities may be found in the Corporation's Proposed Program Regulations, published in
the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
 on January 7, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
(d) Continuation
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
While demonstrable impact should be evidenced during the summer, it is not likely that problems will be solved during
an 8&hyph;10 week period. In addition, efforts with a longer-term horizon, such as the development of plans for action
beyond the scope of the summer effort, may also begin during the summer. It is important to ensure that promising community-based
activities are not lost at the end of the summer.
<!-- PJG 0012 frnewline -->
Unless a program will achieve its intended impact in the summer only or its impact will be long-term with no further
program effort, the continuation of priority program activity should be addressed in the proposal. Among the possibilities
for continuation which should be considered are:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_The SOS program is able to institutionalize the conduct of critical service activities with existing resources.
<!-- PJG 0012 frnewline -->
_A combination of local, state and private funds are found which permit the continuation of service and volunteer
activities.
<!-- PJG 0012 frnewline -->
_The SOS program partnership may establish (or expand) an effective volunteer cadre to continue its efforts.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Accordingly, proposals must include plans that:
<!-- PJG 0012 frnewline -->
(i) Identify priority activities or strategies which will be sustained following the summer. This may be the entire
program, select components, or efforts begun in the summer that will be brought to fruition.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00151 </DOCNO>
<PARENT> FR940202-2-00072 </PARENT>
<TEXT>
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(ii) Describe the resources and approaches that will assure continuation of the program activity. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Programs that will accomplish their objectives by the end of the summer or those that have no need to sustain activity
because impact will occur in the long-term as a result of the summer effort need not respond to this section of the Notice.

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
(e) Workplan/Timeline 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Successful applicants will receive notice of tentative selection by April 1 (see Section 6, Selection and Approval
Process). Accordingly, proposals must include a timeline that: 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(i) Identifies specific steps and milestones in a program development, implementation and management process that
begins April 1 and extends through the end of the summer program; 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(ii) Incorporates a required national-scope training and technical assistance workshop for Summer of Safety program
leadership (program director and two key supervisory staff) in later April; and 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(iii) Absent compelling reason to do otherwise, establishes the week of June 13 for participant orientation and training,
uses June 21 as the official date to ``launch'' their efforts, and sets the program's end at August 24. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
(f) Applicant Capacity 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The capacity of the applicant to implement and manage the program successfully and the quality of program leadership
are of critical importance in the selection process. Accordingly, proposals must: 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(i) Describe the applicant's institutional capacity to develop and administer the program, including payment of
living allowances of at least $147.00 per week of full-time (40 hours) service to participants and management of the
partnership (described below). 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(ii) Include brief resumes or other descriptions of experience and background of proposed program director and key
supervisory personnel. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(iii) Describe the working relationships that exist with appropriate community organizations and public agencies.

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(iv) Describe and document the nature and quality of the relationship with the local law enforcement agency(s) (if
the applicant is not a law enforcement agency). 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(v) Review the applicant's experience in conducting public safety and/or community service/volunteer programs.

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(vi) Certify the applicant's willingness to promote a national identity for the Summer of Safety program, as part
of AmeriCorps, through the use of logos and other materials, and participate in activities such as common opening
or closing ceremonies and other events. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
(g) Partnership 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Summer of Safety programs will build and strengthen new partnerships and collaborations for safety that capitalize
on all of the community's resources. Given the range of needs that must be met and the variety of possible service activities
that may help meet these needs, there are many organizations, institutions and individuals within the community
that can meaningfully contribute.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Such entities include law enforcement, schools and other public agencies, private non-profit organizations including
victim assistance and youth-serving organizations, community and neighborhood groups, health and welfare programs,
senior centers, civic organizations, youth groups, institutions of higher education, and the business sector.
Individuals who represent segments of the community not otherwise represented in the partnership should also be
included. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
To ensure that a program establishes service activities that strengthen the capacity of the community to respond
to problems of crime, violence and fear, Summer of Safety programs must be carried out by collaborative partnerships
of such organizations. Accordingly, proposals must: 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(i) Identify the organizations and agencies (and, as appropriate, individuals) who have committed to participating
in the Partnership effort, and identify the leader of the Partnership; 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(ii) Describe the commitment each partner has made to carry out specific roles and contribute specific resources
(training, expertise, space, supplies, funds, publicity, etc.) to support the Summer of Safety program. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(iii) Identify the number of service participants and type(s) of service activity individual partners propose to
carry out as components of the program. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00152 </DOCNO>
<PARENT> FR940202-2-00072 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
(h) Monitoring and Evaluation 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Programs must track progress toward achievement of their program objectives. Programs must also monitor the quality
of service activities, the satisfaction of both persons served and program participants, and management effectiveness.
Internal evaluation and monitoring should be a continuous process, allowing for frequent feedback and quick correction
of weaknesses. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Additionally, programs must cooperate with the Corporation and its evaluators in all Corporation monitoring and
evaluation efforts. As part of this effort, programs must collect and submit to the Corporation certain participant
data, including the total number of participants in the program, and the number of participants by race, ethnicity,
sex, age, economic background, education level, disability classification, and geographic region. The Corporation
will provide forms for collecting participant data. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Proposals must: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) Describe how progress toward program objectives will be monitored. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) Describe how the quality of service activity and the satisfaction of the participants and the individuals or
institutions served will be assessed on an on-going basis. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iii) Include sound plans for ensuring the required descriptive and demographic data is collected. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iv) Include the results from previous evaluations. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(v) Commit to cooperating with the Corporation's national evaluation effort. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
(3) Budget 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Budget Summary Form included here should be completed. On an attached sheet, please provide brief explanations
and/or justifications of each budget item. Please note the following: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) ``Other expenses'' may include other allowable costs (including such things as local training, equipment, transportation,
insurance, etc.), related to the operation of the program. Each component of ``other expenses'' must be explained.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Required Match. Match may include cash and in-kind services. Other federal funds may be used as match for the purposes
of this proposal, except as noted below. The amount and type of match provided will be considered in the selection process.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Summer of Safety programs must provide a match
<FOOTCITE>1</FOOTCITE>
 of at least: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Applicants submitting proposals under Subtitle B2 (Higher Education are normally required to provide 50% match.
Pursuant to the Act, the Corporation is reducing the requirement to 25% match for proposals submitted under this Notice.
Nevertheless, match beyond this minimum is strongly encourage. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(i) Twenty-five percent (25%) of the cost of operating the program. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) Fifteen percent (15%) of the cost of the living allowance for participants. This match may not include in-kind
services or other federal funds. However, applicants desiring to provide certain living expenses on an in-kind basis
(housing, meals or transportation), may apply to the Corporation for a reduction in the amount of the required living
allowance for program participants. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) Include in your budget an estimate of $700 for the cost of travel and per diem for the program director and two key
supervisory staff to attend a three day training program that will be held in late April in a location to be determined
by the Corporation. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) The Corporation is in the process of determining the advisability of requiring health care coverage for participants
(see Appendix 5). For purposes of this budget, please reflect a line item for health care equal to $300 per participant,
$255 of which is paid for by the Corporation and $45 of which is paid for by the program. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) The educational benefit of $1000 for participants will be administered directly by the Corporation (National
Service Trust Fund) and should not be included in the budget submitted for this proposal.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
(4) Additional Requirements 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Awards made by the Corporation are Federal grants and are subject to the Corporation's Regulations and applicable
OMB Circulars, including Audit Requirements and other appropriate Federal Statutory requirements. These various
requirements will be incorporated into the terms and conditions of the grant award. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Corporation's proposed program regulations were published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Volume 59, No. 5) on January 7, 1994. The Corporation intends to issue its regulations in final form prior to this application
submission deadline. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
(5) Selection Criteria 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Failure to follow the format identified in Sections 2 and 3 (above) or to respond to program requirements discussed
in this Notice may result in the removal of a proposal from further consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00153 </DOCNO>
<PARENT> FR940202-2-00072 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Program Narrative (Section 2) may not exceed 20 type-written double-spaced pages. The Budget and accompanying
explanation may not exceed 3 pages. Abbreviated resumes are requested. Please do not permanently bind your proposal,
in case additional copies must be made.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The criteria noted below, which are based on the guidelines and requirements contained in this Notice, will be used
to select applicants for awards. Each criteria will be considered up to the percentage of the total proposal as noted:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
(a) Quality (65%)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Plan
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (30%): The proposal narrative (Section 2, a&hyph;h) describes a high quality public safety-focussed service initiative
with:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_Direct and demonstrable outcomes;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Feasible project implementation plans and realistic timetables, which were developed with input from the community;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_A range of service activities appropriate to community needs and participant backgrounds and skills. Discussion
of proposed service activities should include description of specific assignments;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Recruitment and selection plans that will attract a qualified and diverse group of participants, including community
residents;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Plans to involve additional community volunteers of all ages who are not receiving stipends in project service activities;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Evaluation reports, if available, that support the proposed program; and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Self-assessment techniques to monitor performance against objectives.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sponsor and Partnership
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (35%): The applicant organization evidences:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_Selection of a well-qualified project director and supervisors for participants;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Experience in operating public safety and/or community service initiatives;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Track record demonstrating capacity to organize and facilitate partnership of participating agencies and organizations;
and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Ability to conduct fiscal affairs of program.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In addition, the proposal identifies a broad-based working partnership of agencies and organizations to carry out
public safety-related service activities that:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_Includes appropriate public and private agencies and organizations with track records of operating public safety
programs and youth and community service efforts. If local law enforcement agencies/organizations are not included,
proposal must explain why the participation of law enforcement is not necessary;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Includes residents of communities in which program will be based;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Evidences specific commitments from participating entities to contribute to and cooperate with activities initiated
by community partnership;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Identifies tasks and roles to be carried out by partnership members during project planning phase (prior to summer)
and during operating phase; and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Defines procedures for the effective operation of a practical working partnership.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
(b) Cost Effectiveness (15%)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposal evidences a cost effective approach to the use of Corporation and other Federal funds and non-Federal
resources (cash, in-kind and human). Specifically:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_The budget is reasonable for the proposed service activities and the identified community needs;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_The match requirement is achieved. Additional match that enhances the cost effectiveness of the proposal is strongly
encouraged;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_The extent and type of matching funds and other resources from other public (including Federal) agencies and private
sources will be considered; and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Linkages with other federally funded programs are encouraged.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
(c) Sustainability (10%)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The quality and feasibility of plans to sustain especially effective elements of program activity following the
completion of the summer program without additional Corporation funding will be considered.
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00154 </DOCNO>
<PARENT> FR940202-2-00072 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
(d) Innovation and replication (10%)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposal incorporates innovative approaches to partnerships, community involvement, and service, and evidences
strategies and activities potentially replicable in other locations.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
(6) Selection and Approval Process
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
An original and four copies of each proposal must be submitted together, and be received by the Corporation for National
and Community Service, 1100 Vermont Ave., NW., 20525, by 6 pm EST on Monday, March 14, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Proposals that meet the minimum requirements outlined above will be reviewed by panels that include experts from
the fields of public safety and service. Publication of this announcement does not obligate the Corporation to award
any specific number of grants or obligate the entire amount of funds available.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Additional factors that may be taken into account in the selection process include population density, geographic
distribution of programs, and diversity among participants and program strategies.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Notification of tentative selection will be made by April 1, 1994. Selections will be considered tentative until
execution of a final grant agreement, which may require discussions between Corporation and program staff to resolve
remaining financial or programmatic issues and to refine and/or further develop plans or specific strategies.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addition, the Corporation anticipates providing extensive technical assistance to successful applicants between
the time of selection through the launch of project service activity, and throughout the summer. This assistance
will include a mandatory 3 day training/technical assistance workshop to be conducted for all Summer of Safety program
directors and key staff in late April.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Appendix 1
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This Appendix provides suggestions for how you might approach the development of a Summer of Safety program. It is
meant to be thought-provoking and is not a required process.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Identify the Crime/Violence Problem To Be Addressed
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
By working directly with local law enforcement, canvassing door-to-door in neighborhoods, attending community
meetings, setting up meetings for law enforcement with community groups, contacting and surveying local businesses,
public agencies, service organizations, youth groups, senior groups, etc., your organization can identify specific
crime problems which confront the community and concern residents. The types of issues most readily identified through
this kind of analysis include:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_Specific population needs (e.g., seniors who are afraid to go to the market after dark, or children who can't use a
playground because of drug activity, debris or disrepair, or teenagers who get in trouble when a facility_theater,
club, etc._closes for the evening, or targets of hate crimes);
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Physical hazards (e.g., drug houses, vacant structures used for drug trade or other illegal or disorderly purpose,
abandoned vehicles, missing street lights, broken fences, dangerous vehicle traffic patterns, open-air drug markets);
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Resident safety concerns (e.g., fear of crime and victimization, need for crime prevention information_locks,
etc., lack of information about crime within neighborhood); and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Unreported or undetected criminal activity (e.g., drug use or sales in a neighborhood location, gang activity,
prostitution, victims of crime who have not reported the victimization or who continue to be victimized_especially
victims of domestic violence or fraudulent solicitors/practices).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Pick The Partners
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Think broadly about the range of organizations that are already involved in reducing crime and violence in your community,
or that may be interested in joining such an effort. Try to determine which ones have missions, resources or experience
comparable to yours. City agencies, especially local law enforcement agencies, should be considered. Other possible
partners include:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_Schools (including higher education institutions).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Private non-profit organizations (particularly those that work to prevent crime and violence or that work with
youth or victims of crime).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Community and neighborhood organizations.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Senior or neighborhood centers.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Private businesses.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Please read Program Narrative section 2(g) (``Partnership'') carefully regarding the delineation of roles and
other aspects of creating a useful partnership. Keep in mind that, while effective partnerships will involve many
elements in a community, eligibility to receive funds and parameters of allowable activities are limited. (See sections
entitled, ``Eligibility'' and ``Limitations''.)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Craft a Specific Problem Response
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
After analyzing the community's needs and picking your partners, you will plan and implement a specific program designed
to make a direct and demonstrable difference.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00155 </DOCNO>
<PARENT> FR940202-2-00072 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It may help to have various activities linked with a common theme. For example, in a victims' assistance program, participants
might be engaged in the following activities:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_Supporting victim services within the court, notify victims of court dates and procedures, meet and accompany victims
to courtrooms, staff child care centers, follow-up on restitution orders, etc.;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Accompanying law enforcement on calls to provide immediate crisis intervention support, accompany victims to
hospital or police department, make social services referrals (including to battered women's shelters), arrange
lock/home repairs, assist with emergency funds, lost documents, public assistance, etc.;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Maintaining follow-up contact with victims to help identify longer-term needs; and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Assisting in operation of a victim service program; i.e., work in a family violence shelter providing child care,
tutoring, transportation, vocational help; serve with a sexual assault crisis center/hotline or abused children's
center.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is also possible that, within a Summer of Safety Program, there may be a number of different service activities which
can positively impact the safety of the community. But make sure that the activities you are contemplating are realistic.
Will they make a real difference in your communities within the short time frame of the summer? Clearly, not every problem
can be solved in one summer, but appropriate responses can be developed that identify the parties responsible for
necessary actions, specify and take initial steps, and evidence impact.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
While the range of possible effective activities is potentially limitless, below are additional examples of activities
that can be started and have appreciable impact in a short time:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_Involving neighborhood youth in a senior escort service;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Conducting and disseminating crime prevention surveys and information/advice;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Undertaking community clean-up efforts, focusing on graffiti, vacant lots, alleys, and other sites where fear
of crime and disorder are evident;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Identifying and boarding-up abandoned properties in which drug use/trade may be occurring;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Organizing neighborhood watch-type programs;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Initiating or enhancing relationships between law enforcement and local youth organizations;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Developing a network of ``Safe Houses'' or ``Safe Corridors'' in neighborhood, and training parents and children
about the program;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Developing and conducting anti-violence presentations for youth groups;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Joining with senior volunteers in intergenerational efforts designed around youth safety themes;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Developing and supervising youth activities that incorporate age-appropriate personal safety/violence prevention
training; e.g., illicit drug use, impaired driving, etc.;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Establishing conflict resolution programs, including outreach, training, and ongoing activities for youth through
schools and community-based youth organizations; and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Leading public safety-related field trips for youth, with appropriate orientation; e.g., to jails/prisons, police
stations, courts, hospitals, family violence shelters, etc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Appendix 2
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The other components of 1994 Summer of Safety which are sponsored by the Corporation for National and Community Service
are briefly described below. For further information about any of these Summer of Safety initiatives, please contact
the Corporation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
VISTA Summer Associates 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The VISTA Summer of Safety Program will support 1,000 full-time VISTA Summer Associates beginning service between
June 1 and June 21, and serving from 8&hyph;10 weeks on projects which also have full-year VISTA Volunteers assigned.
Participants will receive a living allowance, and those who successfully complete the summer term of service are
eligible to receive a $1,000 educational award from the National Service Trust.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00156 </DOCNO>
<PARENT> FR940202-2-00072 </PARENT>
<TEXT>
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
VISTA Summer Associate activities will address the issues of crime, violence, and fear in low-income communities
by working on efforts such as community policing, crime prevention, and victim assistance. Both new and existing
VISTA-sponsoring organizations are eligible to apply for VISTA Summer Associates through ACTION State Offices
which will provide technical assistance in developing project applications. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Youth Corps_the Corporation will award grants to operate 10&hyph;12 week summer youth corps programs for 1000 youth,
ages 16 to 25. Participants will receive a living allowance, and those who successfully complete the program become
eligible to receive a $1,000 educational award from the National Service Trust. Service activities during the summer
will focus on the areas of public safety and the environment. At least one-half of the available funds will support
public safety-related service activities. In selecting programs, the Corporation will give preference to programs
that are creatively designed to address both public safety and environmental needs. The Corporation expects to award
between 10 and 20 grants ranging in size from $50,000 to $250,000. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Learn and Serve America 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Summer of Safety grants of up to $50,000 will be made through the Corporation's Learn &amp; Serve America Program to
engage 1500 youth between the ages of five and seventeen in innovative public safety-related community service.
Eligible applicants are public or private nonprofit organizations that have experience working with school-age
youths, and that have been in existence for at least one year. K&hyph;12 Summer of Safety programs must be innovative,
and may encompass multiple program sites. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
National Senior Volunteer Corps 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The National Senior Volunteer Corps will fund 20 grants to existing NSVC sponsors involving the full range of public
safety activities. An estimated 2,800 Senior Corp members will be recruited. The Corps will include professionally
trained and other seniors interested in serving public safety needs. There will be a targeted recruitment campaign
to attract highly skilled senior or retired police officers, sheriff's deputies, correctional officers, military
police, social workers, teachers, public defenders and community leaders. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Activities may include: Providing administrative support to police departments, conducting neighborhood crime
surveys, providing crime prevention education to seniors, assisting domestic violence victims navigate the court
system, coordinating neighborhood watch programs, and serving as mentors, tutors and counselors to juveniles under
court supervision. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Guidance to existing sponsors will be issued in late January with projects becoming operational in June. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
National Civilian Community Corps 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Approximately 200 Corps members, aged 14&hyph;17, will do public safety-related service projects with schools,
local law enforcement agencies, and community-based organizations. Corps members will receive leadership training
and a mix of the best military and civilian youth service programming during their eight weeks at the camp on an underutilized
military installation. The site for the NCCC Summer of Safety camp will be selected by March, 1994. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Appendix 3 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Act requires that, for funding under Subtitle B&hyph;2, priority will be given to applications that: 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(1) Demonstrate the commitment of the institution of higher education, other than by demonstrating the commitment
of its students, to supporting the community service projects carried out under the program. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(2) Specify how the institution will promote faculty, administration, and staff participation in the community
service projects. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(3) Specify the manner in which the institution will provide service to the community through organized programs,
including, where appropriate, clinical programs for students in professional schools. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(4) Describe any partnership that will participate in the community service projects, such as a partnership comprised
of the institution, a student organization, a community-based agency, a local government agency, or a nonprofit
entity that serves or involves school-age youth or older adults. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(5) Demonstrate community involvement in the development of the proposal. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00157 </DOCNO>
<PARENT> FR940202-2-00072 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(6) Specify that the institution will use funds under this part to strengthen the infrastructure in institutions
of higher education.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(7) With respect to projects involving delivery of service, specify projects that involve leadership development
of school-age youth.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Appendix 4
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Act requires that, in selecting projects for funding under Subtitle C, the Corporation consider whether the project
would be conducted in areas of need, which are:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) Communities designated by the Federal government or States as empowerment zones or redevelopment areas, targeted
for special economic incentives, or otherwise identifiable as having high concentrations of low-income people.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Areas that are environmentally distressed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Areas adversely affected by Federal actions related to the management of Federal lands that result in significant
regional job losses and economic dislocation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) Areas adversely affected by reductions in defense spending or the closure or realignment of military installations.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) Areas that have an unemployment rate greater than the national average unemployment rate for the most recent 12
months for which satisfactory data are available.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Appendix 5 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Corporation is in the process of determining the advisability of requiring health care policies for Summer of
Safety participants. That determination will be discussed with prospective grantees prior to entering into a final
grant agreement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Act requires that service programs make child care available or provide an allowance for child care for service
participants. The Act further requires the Corporation to issue guidelines for child care and the child care allowance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Below is the guidance contained in the Corporation's proposed regulations, &sect;2522.250, published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Volume 59, No. 5) on January 7, 1994. This guidance is subject to change upon issuance of the Corporation's final regulations.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Child care
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Grantees must provide child care through an eligible provider or a child care allowance in an amount determined by
the Corporation to those full-time participants who need child care in order to participate.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Need
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. A participant is considered to need child care in order to participate in the program if he or she:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) Is the parent or legal guardian of, or is acting in loco parentis for, a child under 13 who resides with the participant;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) Has a family income that does not exceed 75 percent of the State's median income for a family of the same size;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iii) At the time of acceptance into the program, is not currently receiving child care assistance from another source,
including a parent or guardian, which would continue to be provided while the participant serves in the program; and

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iv) Certifies that he or she needs child care in order to participate in the program.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Provider eligibility
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Eligible child care providers are those who are eligible child care providers as defined in the Child Care and Development
Block Grant Act of 1990 (42 U.S.C. 9858n(5).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Child care allowance
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. The amount of the child care allowance will be determined by the Corporation based on payment rates for the Child Care
and Development Block Grant Act of 1990 (42 U.S.C. 9858c(4)(A).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Federal share
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. The Corporation will pay 100% of the child care allowance, or if the program provides child care through an eligible
provider, the actual cost of the care or the amount of the allowance, whichever is less.
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6820&hyph;BA&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d645 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
E:GRAPHICSEN02FE94.003
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

</IMPORT>

<!-- PJG /STAG -->

<!-- PJG STAG 4703 -->

<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6820&hyph;BA&hyph;C
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Catherine Milton,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Vice President and Director of National and Community Service Programs.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2255 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6820&hyph;BA&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00158 </DOCNO>
<PARENT> FR940202-2-00073 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4717 -->

<!-- PJG STAG 4717 -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Wednesday
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
February 2, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=1 -->
Part IV
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->
Department of Housing and Urban Development
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Office of the Assistant Secretary for Housing_Federal Housing Commissioner
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Supportive Housing for the Elderly; Notice of Funding Availability
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG FTAG 4701 -->

<!-- PJG STAG 4701 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 22&blank;/&blank;Wednesday, February 2, 1994&blank;/&blank;Notices
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Office of Assistant Secretary for Housing_Federal Housing Commissioner 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. N&hyph;94&hyph;3688; FR&hyph;3589&hyph;N&hyph;01] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Notice of Fund Availability (NOFA) for Supportive Housing for the Elderly 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Office of Assistant Secretary for Housing_Federal Housing Commissioner, HUD.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of fund availability for FY 94. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This NOFA announces HUD's funding for supportive housing for the elderly. In the body of this document is information
concerning the following: (a) the purpose of the NOFA and information regarding eligibility, submission requirements,
available amounts, and selection criteria and (b) application processing, including how to apply and how selections
will be made.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
APPLICATION PACKAGE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The application package can be obtained from the Multifamily Housing Clearinghouse, P.O. Box 6424, Rockville, MD
20850; telephone 1&hyph;800&hyph;955&hyph;2232. A checklist of steps and exhibits involved in the application
process is included in the application package.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The deadline date for receipt of applications in response to this NOFA is 4 p.m. local time on May 3, 1994. The application
deadline is firm as to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
date
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
hour. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In the interest of fairness to all applicants, HUD will not consider any application that is received after the deadline.
Sponsors should take this into account and submit applications as early as possible to avoid risk brought about by
unanticipated delays or delivery-related problems. In particular, Sponsors intending to mail applications must
provide sufficient time to permit delivery on or before the deadline date and hour. Acceptance by a Post Office or private
mailer does not constitute delivery. Facsimile (FAX), COD, and postage due applications will not be accepted.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Applications must be delivered to the Director of the Housing Development Division in the HUD Field Office for your
jurisdiction. A listing of HUD Field Offices, their addresses and telephone numbers (including TDD telephone numbers)
is attached as appendix A to this NOFA. HUD will date and time stamp incoming applications to evidence timely receipt,
and upon request, provide the applicant with an acknowledgement of receipt.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The HUD Field Office for your jurisdiction. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00159 </DOCNO>
<PARENT> FR940202-2-00073 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Paperwork Reduction Act Statement 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
In accordance with the Paperwork Reduction Act of 1980 (44 U.S.C. 3501&hyph;220), the information collection requirements
have been assigned OMB Control Number 2502&hyph;0267. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
I. Purpose and Substantive Description 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=2 -->
A. Authority 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Section 801 of the Cranston-Gonzalez National Affordable Housing Act (NAHA) amended section 202 of the Housing Act
of 1959. Section 202 was also amended by the Housing and Community Development Act of 1992 (HCD Act of 1992). The Secretary
is authorized to provide assistance to private nonprofit organizations and nonprofit consumer cooperatives to
expand the supply of supportive housing for the elderly. The assistance is provided as capital advances and contracts
for project rental assistance in accordance with 24 CFR part 889. This assistance may be used to finance the construction
or rehabilitation of a structure, or acquisition of a structure from the Resolution Trust Corporation (RTC), to be
used as supportive housing for the elderly in accordance with part 889. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For supportive housing for the elderly, the Departments of Veterans Affairs and Housing and Urban Development, and
Independent Agencies Appropriations Act, 1994, (Pub. L. 103&hyph;124, enacted October 28, 1993, (Fiscal Year 1994
Appropriations Act) provides $1,158,000,000 for capital advances, including amendments to capital advance contracts
(not procurement contracts), for housing for the elderly as authorized by section 202 of the Housing Act of 1959, (as
amended by the NAHA and HCD Act of 1992), and for project rental assistance, and amendments to contracts for project
rental assistance, for supportive housing for the elderly under section 202(c)(2) of the Housing Act of 1959, as amended.
Any unreserved balances provided in prior years for such purposes are to be merged with amounts provided in the Fiscal
Year 1994 Appropriations Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In accordance with an agreement between HUD and the Farmers Home Administration (FmHA) which facilitates the coordination
between the two agencies in administering their respective rental assistance programs, HUD is required to notify
FmHA of applications for housing assistance it receives. The purpose of this notification is to give FmHA the opportunity
to comment if it has concern about the demand for additional assisted housing and possible harm to existing projects
in the same housing market area. HUD will consider the FmHA comments in its review and project selection process. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=2 -->
B. Allocation Amounts 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
In accordance with 24 CFR part 791, the Assistant Secretary will allocate the amounts available for capital advances
for supportive housing for the elderly. The Department reserves project rental assistance funds sufficient for
20-year project rental assistance contracts in support of the units selected for capital advances, consistent with
current operating cost standards. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The allocation formula for section 202 funds consists of a measure of the number of one- and two-person elderly renter
households with incomes at or below the very low-income limit (50 percent of area median family income, as determined
by HUD, with an adjustment for household size), which have housing deficiencies. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Applicants for capital advances in the area served by the Washington, DC, Field Office are hereby put on notice that
the capital advance amount available to the DC Office, as stated in this NOFA, may be reduced or eliminated due to ongoing
legal proceedings occurring between HUD and a prior-year applicant, and that the determination of whether to reduce
or eliminate those funds is entirely within the discretion of HUD. If such action or actions are taken, a notice to that
effect will be published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Based on this formula, the Department has allocated the available capital advance funds as shown on the following
chart: 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00160 </DOCNO>
<PARENT> FR940202-2-00073 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 7,L2,s25,15,8,15,8,15,8 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Fiscal Year 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
1994 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Allocations for Supportive Housing for the Elderly_Fiscal year 1994 section 202 allocations
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Field Offices
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Metropolitan capital advance authority
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Units
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Nonmetropolitan capital advance authority
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Units
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Totals capital advance authority
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Units
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Region I: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=4 -->
*Boston 
<!-- PJG 007 0104 intable -->
$18,517,727 
<!-- PJG 007 0104 intable -->
236 
<!-- PJG 007 0104 intable -->
$3,091,858 
<!-- PJG 007 0104 intable -->
40 
<!-- PJG 007 0104 intable -->
$21,609,585 
<!-- PJG 007 0104 intable -->
276 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hartford 
<!-- PJG 007 0104 intable -->
9,563,287 
<!-- PJG 007 0104 intable -->
121 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
9,563,287 
<!-- PJG 007 0104 intable -->
121 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Manchester 
<!-- PJG 007 0104 intable -->
2,811,600 
<!-- PJG 007 0104 intable -->
47 
<!-- PJG 007 0104 intable -->
2,955,417 
<!-- PJG 007 0104 intable -->
50 
<!-- PJG 007 0104 intable -->
5,767,017 
<!-- PJG 007 0104 intable -->
97 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Providence 
<!-- PJG 007 0104 intable -->
4,360,974 
<!-- PJG 007 0104 intable -->
57 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
4,360,974 
<!-- PJG 007 0104 intable -->
57 
<!-- PJG 007 0162 intable -->
n,s 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=4 -->
Total I 
<!-- PJG 007 0104 intable -->
35,253,588 
<!-- PJG 007 0104 intable -->
461 
<!-- PJG 007 0104 intable -->
6,047,275 
<!-- PJG 007 0104 intable -->
90 
<!-- PJG 007 0104 intable -->
41,300,863 
<!-- PJG 007 0104 intable -->
551 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Region II: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=4 -->
Buffalo 
<!-- PJG 007 0104 intable -->
13,228,711 
<!-- PJG 007 0104 intable -->
199 
<!-- PJG 007 0104 intable -->
2,620,372 
<!-- PJG 007 0104 intable -->
40 
<!-- PJG 007 0104 intable -->
15,849,083 
<!-- PJG 007 0104 intable -->
239 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
New York 
<!-- PJG 007 0104 intable -->
61,481,464 
<!-- PJG 007 0104 intable -->
757 
<!-- PJG 007 0104 intable -->
3,193,805 
<!-- PJG 007 0104 intable -->
40 
<!-- PJG 007 0104 intable -->
64,675,269 
<!-- PJG 007 0104 intable -->
797 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Newark 
<!-- PJG 007 0104 intable -->
24,568,887 
<!-- PJG 007 0104 intable -->
313 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
24,568,887 
<!-- PJG 007 0104 intable -->
313 
<!-- PJG 007 0162 intable -->
n,s 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=4 -->
Total II 
<!-- PJG 007 0104 intable -->
99,279,062 
<!-- PJG 007 0104 intable -->
1269 
<!-- PJG 007 0104 intable -->
5,814,177 
<!-- PJG 007 0104 intable -->
80 
<!-- PJG 007 0104 intable -->
105,093,239 
<!-- PJG 007 0104 intable -->
1349 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Region III: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=4 -->
Baltimore 
<!-- PJG 007 0104 intable -->
5,075,628 
<!-- PJG 007 0104 intable -->
82 
<!-- PJG 007 0104 intable -->
1,228,801 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 007 0104 intable -->
6,304,429 
<!-- PJG 007 0104 intable -->
102 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Charleston 
<!-- PJG 007 0104 intable -->
2,383,393 
<!-- PJG 007 0104 intable -->
43 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
2,383,393 
<!-- PJG 007 0104 intable -->
43 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Philadelphia 
<!-- PJG 007 0104 intable -->
12,412,192 
<!-- PJG 007 0104 intable -->
180 
<!-- PJG 007 0104 intable -->
2,036,856 
<!-- PJG 007 0104 intable -->
30 
<!-- PJG 007 0104 intable -->
14,449,048 
<!-- PJG 007 0104 intable -->
210 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pittsburgh 
<!-- PJG 007 0104 intable -->
7,037,242 
<!-- PJG 007 0104 intable -->
118 
<!-- PJG 007 0104 intable -->
1,170,676 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 007 0104 intable -->
8,207,918 
<!-- PJG 007 0104 intable -->
138 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Richmond 
<!-- PJG 007 0104 intable -->
4,519,456 
<!-- PJG 007 0104 intable -->
85 
<!-- PJG 007 0104 intable -->
1,838,717 
<!-- PJG 007 0104 intable -->
35 
<!-- PJG 007 0104 intable -->
6,358,173 
<!-- PJG 007 0104 intable -->
120 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D.C. 
<!-- PJG 007 0104 intable -->
6,249,461 
<!-- PJG 007 0104 intable -->
94 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
6,249,461 
<!-- PJG 007 0104 intable -->
94 
<!-- PJG 007 0162 intable -->
n,s 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=4 -->
Total III 
<!-- PJG 007 0104 intable -->
37,677,372 
<!-- PJG 007 0104 intable -->
602 
<!-- PJG 007 0104 intable -->
6,275,050 
<!-- PJG 007 0104 intable -->
105 
<!-- PJG 007 0104 intable -->
43,952,422 
<!-- PJG 007 0104 intable -->
707 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Region IV: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=4 -->
Atlanta 
<!-- PJG 007 0104 intable -->
5,387,363 
<!-- PJG 007 0104 intable -->
108 
<!-- PJG 007 0104 intable -->
2,854,420 
<!-- PJG 007 0104 intable -->
58 
<!-- PJG 007 0104 intable -->
8,241,783 
<!-- PJG 007 0104 intable -->
166 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Birmingham 
<!-- PJG 007 0104 intable -->
3,577,338 
<!-- PJG 007 0104 intable -->
71 
<!-- PJG 007 0104 intable -->
1,869,666 
<!-- PJG 007 0104 intable -->
38 
<!-- PJG 007 0104 intable -->
5,447,004 
<!-- PJG 007 0104 intable -->
109 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Caribbean 
<!-- PJG 007 0104 intable -->
2,287,981 
<!-- PJG 007 0104 intable -->
40 
<!-- PJG 007 0104 intable -->
1,126,588 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 007 0104 intable -->
3,414,569 
<!-- PJG 007 0104 intable -->
60 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Columbia 
<!-- PJG 007 0104 intable -->
2,643,025 
<!-- PJG 007 0104 intable -->
51 
<!-- PJG 007 0104 intable -->
1,228,771 
<!-- PJG 007 0104 intable -->
24 
<!-- PJG 007 0104 intable -->
3,871,796 
<!-- PJG 007 0104 intable -->
75 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Greensboro 
<!-- PJG 007 0104 intable -->
6,161,620 
<!-- PJG 007 0104 intable -->
106 
<!-- PJG 007 0104 intable -->
3,689,574 
<!-- PJG 007 0104 intable -->
65 
<!-- PJG 007 0104 intable -->
9,851,194 
<!-- PJG 007 0104 intable -->
171 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Jackson 
<!-- PJG 007 0104 intable -->
3,094,819 
<!-- PJG 007 0104 intable -->
64 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
3,094,819 
<!-- PJG 007 0104 intable -->
64 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Jacksonville 
<!-- PJG 007 0104 intable -->
19,372,418 
<!-- PJG 007 0104 intable -->
353 
<!-- PJG 007 0104 intable -->
2,158,938 
<!-- PJG 007 0104 intable -->
40 
<!-- PJG 007 0104 intable -->
21,531,356 
<!-- PJG 007 0104 intable -->
393 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Louisville 
<!-- PJG 007 0104 intable -->
2,887,617 
<!-- PJG 007 0104 intable -->
54 
<!-- PJG 007 0104 intable -->
2,276,143 
<!-- PJG 007 0104 intable -->
43 
<!-- PJG 007 0104 intable -->
5,163,760 
<!-- PJG 007 0104 intable -->
97 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Knoxville 
<!-- PJG 007 0104 intable -->
2,184,507 
<!-- PJG 007 0104 intable -->
44 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
2,184,507 
<!-- PJG 007 0104 intable -->
44 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Nashville 
<!-- PJG 007 0104 intable -->
3,015,435 
<!-- PJG 007 0104 intable -->
62 
<!-- PJG 007 0104 intable -->
1,303,035 
<!-- PJG 007 0104 intable -->
27 
<!-- PJG 007 0104 intable -->
4,318,470 
<!-- PJG 007 0104 intable -->
89 
<!-- PJG 007 0162 intable -->
n,s 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=4 -->
Total 
<!-- PJG 007 0104 intable -->
50,612,123 
<!-- PJG 007 0104 intable -->
953 
<!-- PJG 007 0104 intable -->
16,507,135 
<!-- PJG 007 0104 intable -->
315 
<!-- PJG 007 0104 intable -->
67,119,258 
<!-- PJG 007 0104 intable -->
1268 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Region V: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=4 -->
Chicago 
<!-- PJG 007 0104 intable -->
23,823,446 
<!-- PJG 007 0104 intable -->
347 
<!-- PJG 007 0104 intable -->
3,696,465 
<!-- PJG 007 0104 intable -->
55 
<!-- PJG 007 0104 intable -->
27,519,911 
<!-- PJG 007 0104 intable -->
402 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cincinnati 
<!-- PJG 007 0104 intable -->
4,780,204 
<!-- PJG 007 0104 intable -->
84 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
4,780,204 
<!-- PJG 007 0104 intable -->
84 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cleveland 
<!-- PJG 007 0104 intable -->
9,529,447 
<!-- PJG 007 0104 intable -->
152 
<!-- PJG 007 0104 intable -->
1,213,879 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 007 0104 intable -->
10,743,326 
<!-- PJG 007 0104 intable -->
172 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Columbus 
<!-- PJG 007 0104 intable -->
2,239,660 
<!-- PJG 007 0104 intable -->
40 
<!-- PJG 007 0104 intable -->
1,876,598 
<!-- PJG 007 0104 intable -->
34 
<!-- PJG 007 0104 intable -->
4,116,258 
<!-- PJG 007 0104 intable -->
74 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Detroit 
<!-- PJG 007 0104 intable -->
9,609,231 
<!-- PJG 007 0104 intable -->
152 
<!-- PJG 007 0104 intable -->
1,237,936 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 007 0104 intable -->
10,847,167 
<!-- PJG 007 0104 intable -->
172 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Grand Rapids 
<!-- PJG 007 0104 intable -->
2,466,015 
<!-- PJG 007 0104 intable -->
46 
<!-- PJG 007 0104 intable -->
1,310,147 
<!-- PJG 007 0104 intable -->
25 
<!-- PJG 007 0104 intable -->
3,776,162 
<!-- PJG 007 0104 intable -->
71 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Indianapolis 
<!-- PJG 007 0104 intable -->
6,113,591 
<!-- PJG 007 0104 intable -->
108 
<!-- PJG 007 0104 intable -->
1,959,977 
<!-- PJG 007 0104 intable -->
35 
<!-- PJG 007 0104 intable -->
8,073,568 
<!-- PJG 007 0104 intable -->
143 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Milwaukee 
<!-- PJG 007 0104 intable -->
7,061,812 
<!-- PJG 007 0104 intable -->
115 
<!-- PJG 007 0104 intable -->
2,965,893 
<!-- PJG 007 0104 intable -->
49 
<!-- PJG 007 0104 intable -->
10,027,705 
<!-- PJG 007 0104 intable -->
164 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Minn-St. Paul 
<!-- PJG 007 0104 intable -->
6,282,998 
<!-- PJG 007 0104 intable -->
98 
<!-- PJG 007 0104 intable -->
2,802,188 
<!-- PJG 007 0104 intable -->
44 
<!-- PJG 007 0104 intable -->
9,085,186 
<!-- PJG 007 0104 intable -->
142 
<!-- PJG 007 0162 intable -->
n,s 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=4 -->
Total V 
<!-- PJG 007 0104 intable -->
71,906,404 
<!-- PJG 007 0104 intable -->
1142 
<!-- PJG 007 0104 intable -->
17,063,083 
<!-- PJG 007 0104 intable -->
282 
<!-- PJG 007 0104 intable -->
88,969,487 
<!-- PJG 007 0104 intable -->
1424 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Region VI: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=4 -->
Fort Worth (NM) 
<!-- PJG 007 0104 intable -->
7,588,323 
<!-- PJG 007 0104 intable -->
148 
<!-- PJG 007 0104 intable -->
2,530,768 
<!-- PJG 007 0104 intable -->
50 
<!-- PJG 007 0104 intable -->
10,119,091 
<!-- PJG 007 0104 intable -->
198 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Houston 
<!-- PJG 007 0104 intable -->
4,884,422 
<!-- PJG 007 0104 intable -->
94 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
4,884,422 
<!-- PJG 007 0104 intable -->
94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Little Rock 
<!-- PJG 007 0104 intable -->
2,376,180 
<!-- PJG 007 0104 intable -->
52 
<!-- PJG 007 0104 intable -->
884,523 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 007 0104 intable -->
3,260,703 
<!-- PJG 007 0104 intable -->
72 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
New Orleans 
<!-- PJG 007 0104 intable -->
4,152,676 
<!-- PJG 007 0104 intable -->
83 
<!-- PJG 007 0104 intable -->
1,066,812 
<!-- PJG 007 0104 intable -->
22 
<!-- PJG 007 0104 intable -->
5,219,488 
<!-- PJG 007 0104 intable -->
105 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Oklahoma 
<!-- PJG 007 0104 intable -->
2,731,249 
<!-- PJG 007 0104 intable -->
56 
<!-- PJG 007 0104 intable -->
959,293 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 007 0104 intable -->
3,690,542 
<!-- PJG 007 0104 intable -->
76 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
San Antonio 
<!-- PJG 007 0104 intable -->
2,925,297 
<!-- PJG 007 0104 intable -->
59 
<!-- PJG 007 0104 intable -->
973,098 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 007 0104 intable -->
3,898,395 
<!-- PJG 007 0104 intable -->
79 
<!-- PJG 007 0162 intable -->
n,s 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=4 -->
Total VI 
<!-- PJG 007 0104 intable -->
24,658,147 
<!-- PJG 007 0104 intable -->
492 
<!-- PJG 007 0104 intable -->
6,414,494 
<!-- PJG 007 0104 intable -->
132 
<!-- PJG 007 0104 intable -->
31,072,641 
<!-- PJG 007 0104 intable -->
624 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Region VII: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=4 -->
Des Moines 
<!-- PJG 007 0104 intable -->
2,846,598 
<!-- PJG 007 0104 intable -->
55 
<!-- PJG 007 0104 intable -->
1,010,775 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 007 0104 intable -->
3,857,373 
<!-- PJG 007 0104 intable -->
75 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kansas City 
<!-- PJG 007 0104 intable -->
4,232,977 
<!-- PJG 007 0104 intable -->
80 
<!-- PJG 007 0104 intable -->
2,040,609 
<!-- PJG 007 0104 intable -->
40 
<!-- PJG 007 0104 intable -->
6,273,586 
<!-- PJG 007 0104 intable -->
120 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Omaha 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
2,000,654 
<!-- PJG 007 0104 intable -->
40 
<!-- PJG 007 0104 intable -->
2,000,654 
<!-- PJG 007 0104 intable -->
40 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
St. Louis 
<!-- PJG 007 0104 intable -->
2,556,300 
<!-- PJG 007 0104 intable -->
43 
<!-- PJG 007 0104 intable -->
1,184,487 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 007 0104 intable -->
3,740,787 
<!-- PJG 007 0104 intable -->
63 
<!-- PJG 007 0162 intable -->
n,s 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=4 -->
Total VII 
<!-- PJG 007 0104 intable -->
9,635,875 
<!-- PJG 007 0104 intable -->
178 
<!-- PJG 007 0104 intable -->
6,236,525 
<!-- PJG 007 0104 intable -->
120 
<!-- PJG 007 0104 intable -->
15,872,400 
<!-- PJG 007 0104 intable -->
298 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Region VIII: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=4 -->
Denver 
<!-- PJG 007 0104 intable -->
5,927,630 
<!-- PJG 007 0104 intable -->
114 
<!-- PJG 007 0104 intable -->
2,990,131 
<!-- PJG 007 0104 intable -->
60 
<!-- PJG 007 0104 intable -->
8,917,761 
<!-- PJG 007 0104 intable -->
174 
<!-- PJG 007 0162 intable -->
n,s 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=4 -->
Total VIII 
<!-- PJG 007 0104 intable -->
5,927,630 
<!-- PJG 007 0104 intable -->
114 
<!-- PJG 007 0104 intable -->
2,990,131 
<!-- PJG 007 0104 intable -->
60 
<!-- PJG 007 0104 intable -->
8,917,761 
<!-- PJG 007 0104 intable -->
174 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Region IX: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=4 -->
Honolulu (Guam) 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
2,258,519 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 007 0104 intable -->
2,258,519 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Los Angeles 
<!-- PJG 007 0104 intable -->
40,649,178 
<!-- PJG 007 0104 intable -->
549 
<!-- PJG 007 0104 intable -->
2,913,050 
<!-- PJG 007 0104 intable -->
40 
<!-- PJG 007 0104 intable -->
43,562,228 
<!-- PJG 007 0104 intable -->
589 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Phoenix 
<!-- PJG 007 0104 intable -->
3,263,678 
<!-- PJG 007 0104 intable -->
65 
<!-- PJG 007 0104 intable -->
984,583 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 007 0104 intable -->
4,248,261 
<!-- PJG 007 0104 intable -->
85 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sacramento 
<!-- PJG 007 0104 intable -->
4,078,500 
<!-- PJG 007 0104 intable -->
62 
<!-- PJG 007 0104 intable -->
1,289,025 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 007 0104 intable -->
5,367,525 
<!-- PJG 007 0104 intable -->
82 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
San Francisco 
<!-- PJG 007 0104 intable -->
22,033,435 
<!-- PJG 007 0104 intable -->
280 
<!-- PJG 007 0104 intable -->
3,030,757 
<!-- PJG 007 0104 intable -->
40 
<!-- PJG 007 0104 intable -->
25,064,192 
<!-- PJG 007 0104 intable -->
320 
<!-- PJG 007 0162 intable -->
n,s 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=4 -->
Total IX 
<!-- PJG 007 0104 intable -->
70,024,791 
<!-- PJG 007 0104 intable -->
956 
<!-- PJG 007 0104 intable -->
10,475,934 
<!-- PJG 007 0104 intable -->
140 
<!-- PJG 007 0104 intable -->
80,500,725 
<!-- PJG 007 0104 intable -->
1096 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Region X: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=4 -->
Anchorage 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
2,260,745 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 007 0104 intable -->
2,260,745 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Portland 
<!-- PJG 007 0104 intable -->
4,275,182 
<!-- PJG 007 0104 intable -->
76 
<!-- PJG 007 0104 intable -->
1,625,961 
<!-- PJG 007 0104 intable -->
30 
<!-- PJG 007 0104 intable -->
5,901,143 
<!-- PJG 007 0104 intable -->
106 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Seattle 
<!-- PJG 007 0104 intable -->
7,104,051 
<!-- PJG 007 0104 intable -->
108 
<!-- PJG 007 0104 intable -->
1,296,765 
<!-- PJG 007 0104 intable -->
20 
<!-- PJG 007 0104 intable -->
8,400,816 
<!-- PJG 007 0104 intable -->
128 
<!-- PJG 007 0162 intable -->
n,s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=4 -->
Total X 
<!-- PJG 007 0104 intable -->
11,379,233 
<!-- PJG 007 0104 intable -->
184 
<!-- PJG 007 0104 intable -->
5,183,471 
<!-- PJG 007 0104 intable -->
70 
<!-- PJG 007 0104 intable -->
16,562,704 
<!-- PJG 007 0104 intable -->
254 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
National total 
<!-- PJG 007 0104 intable -->
416,354,225 
<!-- PJG 007 0104 intable -->
6351 
<!-- PJG 007 0104 intable -->
83,007,275 
<!-- PJG 007 0104 intable -->
1394 
<!-- PJG 007 0104 intable -->
499,361,500 
<!-- PJG 007 0104 intable -->
7745 
<!-- PJG /ITAG -->

</TABLE>
 
<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00161 </DOCNO>
<PARENT> FR940202-2-00073 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=4 -->
C. Eligibility 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
The only eligible applicants under this program are private, nonprofit organizations and nonprofit consumer cooperatives.
Neither a public body nor an instrumentality of a public body is eligible to participate in the program. No organization
shall participate as Sponsor or Co-sponsor in the filing of application(s) for a capital advance in a single region
in this fiscal year in excess of that necessary to finance the construction, rehabilitation or acquisition (acquisition
permitted only with RTC properties) of 300 units of housing and related facilities for the elderly. This limit shall
apply to organizations that participate as Co-sponsors regardless of whether the Co-sponsors are affiliated or
non-affiliated entities. In addition, the national limit for any one applicant is 10 percent of the total units allocated
in all Regions. Affiliated entities which submit separate applications shall be deemed to be a single entity for the
purposes of these limits. No single application may propose more than the number of units allocated to a Field Office
or 125 units, whichever is less. Reservations for projects will not be approved for less than 40 units in metropolitan
areas or less than 5 units in nonmetropolitan areas. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=4 -->
D. Initial Screening, Technical Processing and Selection Criteria 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
1. Initial Screening 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Applications for section 202 capital advances that are received by HUD at the appropriate address by 4 p.m. local time
on May 3, 1994 will be reviewed to determine if all parts of the application are included. HUD will not review the content
of the application as part of initial screening. Deficiency letters will be sent informing Sponsors of any missing
parts of the application. Sponsors must correct such deficiencies within 14 calendar days from the date of the deficiency
letter. The deficiency letter is to be sent by certified mail. Any document requested as a result of the initial screening
may be executed or prepared within the deficiency period, except for Forms HUD&hyph;92015&hyph;CAs, Articles of
Incorporation, IRS exemption rulings, Forms SF&hyph;424, Board Resolution committing the minimum capital investment,
and site control documents (all of these excepted items must be dated no later than the application deadline date).

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
2. Technical Processing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
All applications will be placed in technical processing upon receipt of the response to the deficiency letter or at
the end of the 14-day period. All applications will undergo a complete analysis. If a reviewer finds that clarification
is needed to complete the review or an exhibit is missing that was not requested after initial screening, the reviewer
shall immediately advise the Multifamily Housing Representative who will: (a) Request, by telephone, that the Sponsor
submit the information within five (5) working days, and (b) follow up by certified letter. Communications must be
attached to the technical review and findings memorandum. As part of this analysis, HUD will conduct its environmental
review in accordance with 24 CFR part 50. Examples of reasons for technical processing rejection include an ineligible
Sponsor, ineligible population to be served, lack of legal capacity, lack of site control and unacceptable site based
upon a site visit. The Secretary will not reject an application based on technical processing without giving notice
of that rejection with all rejection reasons, and affording the applicant an opportunity to appeal. An applicant
will be afforded 14 calendar days from the date of HUD's written notice to appeal a technical rejection to the Field
Office. The Field Office must respond within 5 working days to the Sponsor. The Field Office shall make a determination
on an appeal prior to making its selection recommendations. All applications will be either rated or technically
rejected at the end of technical processing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Technical processing will also assure that if the Sponsor has been found by a court or by a Federal, State, or local agency,
in noncompliance with any of the statutes, regulations, or other requirements listed in the civil rights certification
(&sect;889.270(b)(8)(i)), HUD will obtain from the Sponsor a statement of the actions taken to correct that noncompliance.
There must be no pending civil rights suits against the Sponsor instituted by the Department of Justice and no pending
administrative actions for civil rights violations instituted by HUD. Moreover, there must not be a deferral of the
processing of applications from the Sponsor imposed by HUD under Title VI of the Civil Rights Act of 1964, the Department's
implementing regulations (24 CFR 1.8), procedures (HUD Handbook 8040.1), and the Attorney General's Guidelines
(28 CFR 50.3); or under section 504 of the Rehabilitation Act of 1973 and the Department's implementing regulations
(24 CFR 8.57), and the Americans with Disabilities Act of 1990. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Upon completion of technical processing, all acceptable applications will be rated according to the selection criteria
in &sect;889.300(d) (also below in I.D.3). Applications which have a total score of 50 points or more will be eligible
for selection and will be placed in rank order. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
3. Selection Criteria
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Applications for section 202 capital advances that successfully complete technical processing will be rated using
the following selection criteria: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) In determining the Sponsor's ability to develop and operate the proposed housing on a long-term basis, consider
the following (50 points maximum): 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The scope, extent and quality of the Sponsor's experience in providing housing or related services to those proposed
to be served by the project and the scope of the proposed project (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
i.e.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 number of units, services, relocation costs, development, and operation) in relationship to the Sponsor's demonstrated
development and management capacity. 
<!-- PJG 0012 frnewline -->
(32 points); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The scope, extent and quality of the Sponsor's experience in providing housing or related services to minority
persons or families (5 points); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) The scope, extent and quality of the Sponsor's experience in providing opportunities for minority and women-owned
business enterprises participation (3 points); and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) The extent of local community support for the Sponsor's activities, including previous experience in serving
the area where the project is to be located, and Sponsor's demonstrated ability to enlist volunteers and local funds
(10 points); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) In determining the need for supportive housing for the elderly in the area to be served and the suitability of the
site, consider (25 points maximum): 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00162 </DOCNO>
<PARENT> FR940202-2-00073 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(1) The extent of the need for the project in the area based on a determination by the Field Office. This determination
will be made taking into consideration the Sponsor's evidence of need in the area based on the guidelines in &sect;889.270(b)(17),
as well as other economic, demographic and housing market data available to the Field Office. The data could include
the availability of existing Federally assisted housing (HUD and FmHA) (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
e.g.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 considering availability and vacancy rates of public housing) for the elderly and current occupancy in such facilities,
Federally assisted housing for the elderly under construction or for which fund reservations have been issued, and
in accordance with an agreement between HUD and the FmHA, comments from the FmHA on the demand for additional assisted
housing and the possible harm to existing projects in the same housing market area (8 points). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The proximity or accessibility of the site to shopping, medical facilities, transportation, places of worship,
recreational facilities, places of employment, and other necessary services to the intended occupants, adequacy
of utilities and streets, freedom of the site from adverse environmental conditions, compliance with site and neighborhood
standards (10 points); and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Suitability of the site from the standpoint of promoting a greater choice of housing opportunities for minority
elderly persons/families (7 points); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) In determining adequacy of the provision of supportive services and of the proposed facility consider (25 points
maximum): 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The extent to which the proposed design will meet the special physical needs of elderly persons (4 points);
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The extent to which the proposed size and unit mix of the housing will enable the Sponsor to manage and operate the
housing efficiently and ensure that the provision of supportive services will be accomplished in an economical fashion
(4 points); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) The extent to which the proposed design of the housing will accommodate the provision of supportive services that
are expected to be needed, initially and over the useful life of the housing, by the category or categories of elderly
persons the housing is intended to serve (2 points); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) The extent to which the proposed supportive services meet the identified needs of the residents (8 points); and

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) The extent to which the Sponsor demonstrated that the identified supportive services will be provided on a consistent
long-term basis (7 points). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Application Process 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
All applications for Section 202 capital advances submitted by eligible Sponsors must be filed with the appropriate
HUD Field Office receiving an allocation and must meet the requirements of this Notice. No application will be accepted
after 4 p.m. local time on May 3, 1994, unless that date and time is extended by a Notice published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Applications received after that date and time will not be accepted, even if postmarked by the deadline date. Applications
submitted by facsimile are not acceptable. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Immediately upon publication of this NOFA, if names have not already been provided to the Multifamily Housing Clearinghouse,
Field Offices shall notify elderly and minority media, all persons and organizations on their mailing lists and minority
and other organizations within their jurisdiction involved in housing and community development and groups with
special interest in housing for elderly households. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Organizations interested in applying for a section 202 capital advance should contact the Multifamily Housing Clearinghouse
at 1&hyph;800&hyph;955&hyph;2232 for a copy of the application package, and advise the appropriate Field Office
whether they wish to attend the workshop described below. HUD encourages minority organizations to participate
in this program as Sponsors. Field Offices will advise all organizations on their mailing list of the date, time and
place of workshops at which the Section 202 Program will be explained. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
HUD strongly recommends that prospective applicants attend the local Field Office workshop. Interested persons
with disabilities should contact the Field Office to assure that any necessary arrangements can be made for them to
enable their attendance and participation in the workshop. While strongly urged to do so, if Sponsors cannot attend
a workshop, Application Packages can be obtained from the Multifamily Housing Clearinghouse (see address and telephone
number under 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
SUMMARY
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 above). However, Sponsors must contact the appropriate Field Office with any questions regarding the submission
of applications and for any additional application requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
At the workshops, application procedures and requirements will be explained. Also, concerns such as local market
conditions, building codes, historic preservation, floodplain management, displacement and relocation, zoning
and housing costs will be addressed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Application Submission Requirements 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00163 </DOCNO>
<PARENT> FR940202-2-00073 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Application
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Each application shall include all of the information, materials, forms, and exhibits listed in section III. B. below,
with the exception of applications submitted by Sponsors selected for a Section 202 fund reservation within the last
three funding cycles, and must be indexed and tabbed. Previously selected Section 202 Sponsors are not required to
submit the information described in B. 2. (a), (b) and (c) below (Exhibit 2, a., b., and 
<!-- PJG 0012 frnewline -->
c. of the application which are the articles of incorporation, (or other organizational documents), by-laws, and
the IRS tax exemption, respectively). The Field Office will base its determination of the eligibility of a new Sponsor
for a reservation of section 202 capital advance funds on the information provided in the application. Field Offices
will verify a Sponsor's indication of previous HUD approval by checking the project number and approval status with
the appropriate Field Office. If there has been a change in any of the eligibility documents since its previous HUD
approval, the Sponsor must submit the updated information in its application. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addition to this relief of paperwork burden in preparing applications, applicants will be able to utilize information
and exhibits previously prepared for prior applications under section 202, section 811 or other funding programs.
Examples of exhibits that may be readily adapted or amended to decrease the burden of application preparation include,
among others, those on previous participation in the section 202 or section 811 programs; applicant experience in
provision of housing and services; supportive services plan; community ties, and experience serving minorities.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. General Application Requirements
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Form HUD&hyph;92015&hyph;CA, Application for Section 202 Supportive Housing Capital Advance. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Evidence of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
each
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Sponsor's legal status as a private, nonprofit organization or nonprofit consumer cooperative, including the following:

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) Articles of Incorporation, constitution, or other organizational documents; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) By-laws; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) IRS tax exemption ruling (this must be submitted by all Sponsors, including churches). A nonprofit organization
organized in the Commonwealth of Puerto Rico and exempt from income taxation under Puerto Rico law, or a consumer cooperative
that is tax exempt under State law, has never been liable for payment of Federal income taxes, and does not pay patronage
dividends may be exempt from the requirement set out in the previous sentence if they are not eligible for tax exemption;
and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) Resolution of the board, duly certified by an officer, that no officer or director of the Sponsor or Owner has or
will have any financial interest in any contract with the Owner or in any firm or corporation which has or will have a
contract with the Owner and which includes a current listing of all duly qualified and sitting officers and directors
by title and the beginning and ending date of each person's term.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
[
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Note:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Sponsors who have received a section 202 fund reservation within the last three funding cycles are not required to
submit the documents described in (a), (b), and (c), above. Instead, sponsors must submit the project number of the
most recently selected application and the field office to which it was submitted. If there have been any modifications
or additions to the subject documents, indicate such, and submit the new material.]
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. CHAS certification. The Sponsor must submit a certification by the jurisdiction in which the proposed project
will be located that the Sponsor's application is consistent with the jurisdiction's HUD-approved CHAS for FY 1994.
The certification must be made by the unit of general local government if it is required to have, or has, a complete CHAS.
Otherwise the certification may be made by the State, or if the project will be located in a unit of general local government
authorized to use an abbreviated strategy, by the unit of general local government if it is willing to prepare such
a CHAS. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
All CHAS certifications must be made by the public official responsible for submitting the CHAS to HUD. All CHAS certifications
must be submitted as part of the application by the application submission deadline set forth in this NOFA, except
as provided in the next paragraph. The required CHAS must therefore have been submitted more than 60 days before the
application submission deadline, since HUD has 60 days to review and approve the CHAS. Where the certification of
consistency is permitted to be submitted after the application submission deadline, as described in the next paragraph,
the CHAS must be submitted for approval in time for the certification to be made by the later date. In no event will an
application be considered if the CHAS has not been submitted for approval by the application submission deadline.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
If the required certification will be made by a unit of general local government with respect to an abbreviated strategy,
and such CHAS has been submitted by the application submission deadline but has not yet been approved by HUD, the deadline
will not be applied to the certification for consistency. Instead, the application must include a written statement
from the public official responsible for submitting the CHAS that the jurisdiction has submitted an abbreviated
strategy for FY 1994 for HUD approval and that the application is consistent with the CHAS. If HUD approved the CHAS,
the required certification that the application is consistent with a HUD-approved CHAS for FY 1994 must be submitted
before June 2, 1994. An application will not be selected for funding unless the CHAS is approved and the required certification
is made by June 2, 1994. The CHAS regulations are published in 24 CFR part 91. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. E.O. 12372. A certification that the Sponsor has submitted a copy of its applications, if required, to the State
agency (single point of contact) for State review in accordance with Executive Order 12372. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. SF&hyph;424. A certification on SF&hyph;424, Application for Federal Assistance, that the Sponsor(s) is not
delinquent on the repayment of any Federal debt. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00164 </DOCNO>
<PARENT> FR940202-2-00073 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
6. Disclosure of Lobbying Activities. If the amount applied for is greater than $100,000, the certification with
regard to lobbying required by 24 CFR part 87 must be included. If the amount applied for is greater than $100,000 and
the applicant has made or has agreed to make any payment using nonappropriated funds for lobbying activity, as described
in 24 CFR part 87, the submission must also include SF&hyph;LLL, Disclosure of Lobbying Activities. The applicant
determines if the submission of the SF&hyph;LLL form is applicable.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. A statement that (a) identifies all persons (families, individuals, businesses and nonprofit organizations
identified by race/minority group, and status as owners or tenants) occupying the property on the date of submission
of the application for a capital advance; (b) indicates the estimated cost of relocation payments and other services,
and (c) identifies the staff organization that will carry out the relocation activities.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
[
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Note:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 If any of the relocation costs will be funded from sources other than the section 202 capital advance, the sponsor must
provide evidence of a firm commitment of these funds. When evaluating applications, HUD will consider the total cost
of proposals (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
i.e.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 cost of site acquisition, relocation, construction and other project costs).]
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
8. Additional Certifications. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) A certification of the Sponsor(s)' intent to comply with section 504 of the Rehabilitation Act of 1973 (29 U.S.C.
794) and the implementing regulations at 24 CFR part 8; the Fair Housing Act (42 U.S.C. 3600&hyph;3619) and the implementing
regulations at 24 CFR parts 100, 108, 109, and 110; Title VI of the Civil Rights Act of 1964 (42 U.S.C. 2000d) and the implementing
regulations at 24 CFR part 1; section 3 of the Housing and Urban Development Act of 1968 (12 U.S.C. 1701u) and the implementing
regulations at 24 CFR part 135; the Age Discrimination Act of 1975 (42 U.S.C. 6101&hyph;6107) and the implementing
regulations at 24 CFR part 146; Executive Order 11246 (as amended) and the implementing regulations at 41 CFR chapter
60; the regulations implementing Executive Order 11063 (Equal Opportunity in Housing) at 24 CFR part 107; the Americans
with Disabilities Act (42 U.S.C. 12101 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) to the extent applicable; the affirmative fair housing marketing requirements of 24 CFR part 200, subpart M and the
implementing regulations at 24 CFR part 108; and other applicable Federal, State and local laws prohibiting discrimination
and promoting equal opportunity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) A certification that the Sponsor(s) will comply with the requirements of the Drug-Free Workplace Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) A certification that the project will comply with HUD's design and cost standards, the Uniform Federal Accessibility
Standards and HUD's implementing regulations at 24 CFR part 40, Section 504 of the Rehabilitation Act of 1973 and HUD's
implementing regulations at 24 CFR part 8, and for covered multifamily dwellings designed and constructed for first
occupancy after March 13, 1991, the design and construction requirements of the Fair Housing Act and HUD's implementing
regulations at 24 CFR part 100, and the Americans with Disabilities Act of 1990. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) A certification by the Sponsor(s) that it will comply (or has complied) with the acquisition and relocation requirements
of the Uniform Relocation Assistance and Real Property Acquisition Policies Act of 1970, as amended (URA), implemented
by regulations at 49 CFR part 24, and 24 CFR 
<!-- PJG 0012 frnewline -->
889.265(e). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) A certification by the Sponsor(s) that it will form an Owner (as defined in &sect;889.105) after the issuance of
the capital advance, will cause the Owner to file a request for determination of eligibility and a request for capital
advance under &sect;889.300, and will provide sufficient resources to the Owner to insure the development and long-term
operation of the project, including capitalizing the Owner at conditional commitment processing in an amount sufficient
to meet its obligations in connection with the project. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00165 </DOCNO>
<PARENT> FR940202-2-00073 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
9. A description of Sponsor's purposes and activities, ties to the community and minority support and how long it has
been in existence (include any additional related information). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10. A description of any other rental housing projects and/or medical facilities, sponsored, owned and operated
by the Sponsor including a description of experience in providing housing and/or medical facilities to the elderly
and/or families and minorities. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11. A description of the Sponsor's past or current involvement in any programs other than housing (including its provision
of services) that demonstrates the Sponsor's management capabilities and experience, including a description
of the Sponsor's experience in serving the elderly and/or families and minorities. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12. A description of the Sponsor's experience in contracting with minority and women-owned businesses, including
a summary of the total amount awarded in each of the two categories for the preceding three years and the percentage
that amount represents of the total contracts awarded by the Sponsor in the relevant time period. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
13. A certified Board Resolution, acknowledging responsibilities of sponsorship, long-term support of the project(s),
willingness of Sponsor to assist the Owner to develop, own, manage and provide appropriate services in connection
with the proposed project, and that it reflects the will of its membership. Also, evidence, in the form of a certified
Board Resolution, of the Sponsor's willingness to fund the estimated start-up expenses, the Minimum Capital Investment
(one-half of one percent of the HUD-approved capital advance, not to exceed $10,000, if non-affiliated with National
Sponsor; one-half of one percent of the HUD-approved capital advance, not to exceed $25,000, for all other Sponsors;
see 889.250), and the estimated cost of any amenities or features (and operating costs related thereto) which would
not be covered by the approved capital advance. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
14. A list of the applications, if any, the Sponsor has submitted or is planning to submit to any other Field Office in
response to this NOFA or the NOFA for Supportive Housing for Persons with Disabilities (published elsewhere in today's

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
). Indicate by Field Office, the proposed location by city and State, and the number of units requested for each application.
A list of all FY 1993 and prior year projects to which the Sponsor(s) is a party, identified by project number and Field
Office, which have not been finally closed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
15. HUD&hyph;2880, Applicant/Recipient Disclosure/Update Report, including Social Security Numbers and Employee
Identification Numbers. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
16. Evidence of need for supportive housing. A description of the category or categories of elderly persons the housing
is intended to serve and evidence demonstrating sustained effective demand for supportive housing for that population
in the market area to be served, taking into consideration the occupancy and vacancy conditions in existing Federally
assisted housing for the elderly (HUD and FmHA) (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
e.g.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, public housing), state or local data on the limitations in activities of daily living among the elderly in the area,
aging in place in existing assisted rentals; trends in demographic changes in elderly population and households;
the numbers of income eligible elderly households by size, tenure and housing condition, and the types of supportive
services arrangements currently available in the area and the utilization of such services as evidenced by data from
local social service agencies or agencies on aging. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
17. Evidence of site control and permissive zoning. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) Evidence that the Sponsor has entered into a legally binding option agreement to buy or lease the proposed site;
or has a copy of the contract of sale for the site, a deed, long-term leasehold, a request with all supporting documentation,
submitted either prior to or with the Application for Capital Advance, for a partial release of a site covered by a mortgage
under a HUD program or other evidence of legal ownership of the site (including properties to be acquired from the Resolution
Trust Corporation). The option agreement period must extend through the end of the current fiscal year and contain
a renewal provision so that the option can be renewed for at least an additional six months. The Sponsor must also identify
any restrictive covenants, including reverter clauses. In the case of a site to be acquired from a public body, evidence
that the public body possesses clear title to the site, and has entered into a legally binding agreement to lease or
convey the site to the Sponsor after it receives and accepts a notice of Section 202 capital advance and identification
of any restrictive covenants, including reverter clauses. However, in localities where HUD determines the time
constraints of the funding round will not permit all of the required official actions (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
e.g.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, approval of Community Planning Boards) which are necessary to convey publicly-owned sites, a letter in the application
from the Mayor or Director of the appropriate local agency indicating approval of conveyance of the site contingent
upon the necessary approval action is acceptable and may be approved by the Field Office if it has satisfactory experience
with timely conveyance of sites from that public body. In such cases, documentation shall also include a copy of the
public body's evidence of ownership and identification of any restrictive covenants, including reverter clauses.
For properties to be acquired from the RTC, include a copy of the RTC prepared Transaction Screen Checklist or Phase
I Environmental Site Assessment, and applicable documentation, per the RTC Environmental Guidelines.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
[
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Note:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 A proposed project site may not be acquired or optioned from a general contractor (or its affiliate) which will construct
the section 202 project or from any other development team member.]
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) Evidence that the project as proposed is permissible under applicable zoning ordinances or regulations, or a
statement of the proposed action required to make the proposed project permissible and the basis for belief that the
proposed action will be completed successfully before the submission of the commitment application (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
e.g.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, a summary of the results of any recent requests for rezoning on land in similar zoning classifications and the time
required for such rezoning, preliminary indications of acceptability from zoning bodies, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
etc
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
18. Narrative description of site and area surrounding the site, characteristics of neighborhood, how the site will
promote greater housing opportunities for minorities, and any other information that impacts on the suitability
of the site for the elderly. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
19. A map showing the location of the site and the racial composition of the neighborhood, with the area of racial concentration
delineated. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
20. Provision of supportive services and proposed facility. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00166 </DOCNO>
<PARENT> FR940202-2-00073 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) A detailed description of the supportive services proposed to be provided to the anticipated occupancy. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Form HUD 92013E, Supplemental Application Processing Form_Housing for the Elderly. Identify all supportive
services, if any, to be provided to the persons occupying such housing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) A description of public or private sources of assistance that reasonably could be expected to fund the proposed
services. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) The manner in which such services will be provided to such persons (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
i.e.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, on or off-site), including, whether a service coordinator will facilitate the adequate provision of such services,
and how the services will meet the identified needs of the residents. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) Narrative description of the building design including a description of any special design features and community
space, and how this design will facilitate the delivery of services in an economical fashion and accommodate the changing
needs of the residents over the next 10&hyph;20 years. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(f) Describe if and how the project will promote energy efficiency and, if applicable, innovative construction or
rehabilitation methods or technologies to be used that will promote efficient construction. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Other Matters 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Environmental Impact 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A Finding of No Significant Impact with respect to the environment has been made in accordance with HUD regulations
that implement section 102(2)(C) of the National Environmental Policy Act of 1969, 42 U.S.C. 4332. The Finding of
No Significant Impact is available for public inspection during business hours in the Office of the Rules Docket Clerk,
Office of General Counsel, room 10276, Department of Housing and Urban Development, 451 Seventh Street SW., Washington,
DC 20410. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Federalism Executive Order 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The General Counsel, as the Designated Official under section 6(a) of Executive Order No. 12612, Federalism, has
determined that this NOFA does not have substantial direct effects on States or their political subdivisions, or
on the relationship between the Federal government and the States, or on the distribution of power and responsibilities
among the various levels of government. This NOFA merely notifies the public of the availability of capital advances
and project rental assistance for supportive housing for the elderly. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Family Executive Order 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The General Counsel, as the Designated Official under Executive Order No. 12606, The Family, has determined that
this NOFA does not significantly affect family formation, maintenance, or general well-being, and, thus, is not
subject to review under the order. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
D. Accountability in the Provision of HUD Assistance 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
HUD has promulgated a final rule to implement section 102 of the Department of Housing and Urban Development Reform
Act of 1989 (HUD Reform Act). The final rule is codified at 24 CFR part 12. Section 102 contains a number of provisions
that are designed to ensure greater accountability and integrity in the provision of certain types of assistance
administered by HUD. On January 14, 1992, HUD published at 57 FR 1942, additional information that gave the public
(including applicants for, and recipients of, HUD assistance) further information on the implementation, public
access, and disclosure requirements of section 102. The documentation, public access, and disclosure requirements
of section 102 are applicable to assistance awarded under this NOFA as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
1. Documentation and Public Access 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
HUD will ensure documentation and other information regarding each application submitted pursuant to this NOFA
are sufficient to indicate the basis upon which assistance was provided or denied. This material, including any letters
of support, will be made available for public inspection for a five-year period beginning not less than 30 days after
the award of the assistance. Material will be made available in accordance with the Freedom of Information Act (5 U.S.C.
552) and HUD's implementing regulations at 24 CFR part 15. In addition, HUD will include the recipients of assistance
pursuant to this NOFA in its quarterly 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice of all recipients of HUD assistance awarded on a competitive basis. (See 24 CFR 12.14(a) and 12.16(b), and the
notice published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on January 16, 1992 (57 FR 1942), for further information on these requirements.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2. Disclosures 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
HUD will make available to the public for five years all applicant disclosure reports (HUD Form 2880) submitted in
connection with this NOFA. Update reports (also Form 2880) will be made available along with the applicant disclosure
reports, but in no case for a period less than three years. All reports_both applicant disclosures and updates_will
be made available in accordance with the Freedom of Information Act (5 U.S.C. 552) and HUD's implementing regulations
at 24 CFR part 15. (See 24 CFR subpart C, and the notice published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on January 16, 1992 (57 FR 1942), for further information on these disclosure requirements.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
E. Documentation and Public Access Requirements: HUD Reform Act 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
HUD will ensure that documentation and other information regarding each application submitted pursuant to this
NOFA are sufficient to indicate the basis upon which assistance was provided or denied. This material, including
any letters of support, will be made available for public inspection for a five-year period beginning not less than
30 days after the award of the assistance. Material will be made available in accordance with the Freedom of Information
Act (5 U.S.C. 552) and HUD's implementing regulations at 24 CFR part 15. In addition, HUD will include the recipients
of assistance pursuant to this NOFA in its quarterly 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice of all recipients of HUD assistance awarded on a competitive basis. (See CFR 12.14(a) and 12.16(b), and the
notice published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on January 16, 1992 (57 FR 1942), for further information on these requirements.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00167 </DOCNO>
<PARENT> FR940202-2-00073 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
F. Section 103 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
HUD's regulation implementing section 103 of the Department of Housing and Urban Development Reform Act of 1989 was
published May 13, 1991 (56 FR 22088) and became effective on June 12, 1991. That regulation, codified as 24 CFR part
4, applies to the funding competition announced today. The requirements of the rule continue to apply until the announcement
of the selection of successful applicants. 
<!-- PJG 0012 frnewline -->
HUD employees involved in the review of applications and in the making of funding decisions are restrained by part
4 from providing advance information to any person (other than an authorized employee of HUD) concerning funding
decisions, or from otherwise giving any applicant an unfair competitive advantage. Persons who apply for assistance
in this competition should confine their inquiries to the subject areas permitted under 24 CFR part 4. 
<!-- PJG 0012 frnewline -->
Applicants who have questions should contact the HUD Office of Ethics (202) 708&hyph;3815 (TDD/Voice). (This is
not a toll-free number.) The Office of Ethics can provide information of a general nature to HUD employees, as well.
However, a HUD employee who has specific program questions, such as whether particular subject matter can be discussed
with persons outside the Department, should contact his or her Regional or Field Office Counsel, or Headquarters
counsel for the program to which the question pertains. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
G. Lobbying 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 13 of the Department of Housing and Urban Development Act (42 U.S.C. 3537b) contains two provisions dealing
with efforts to influence HUD's decisions with respect to financial assistance. The first imposes disclosure requirements
on those who are typically involved in these efforts_those who pay others to influence the award of assistance or the
taking of a management action by the Department and those who are paid to provide the influence. The second restricts
the payment of fees to those who are paid to influence the award of HUD assistance, if the fees are tied to the number of
housing units received or are based on the amount of assistance received, or if they are contingent upon the receipt
of assistance. 
<!-- PJG 0012 frnewline -->
Section 13 was implemented by final rule published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on May 17, 1991 (56 FR 22912). If readers are involved in any efforts to influence the Department in these ways, they
are urged to read the final rule, particularly the examples contained in Appendix A of the rule. 
<!-- PJG 0012 frnewline -->
Any questions regarding the rule should be directed to the Director, Office of Ethics, room 2158, Department of Housing
and Urban Development, 451 Seventh Street SW., Washington, DC 20410. Telephone: (202) 708&hyph;3815 (TDD/Voice).
(This is not a toll-free number.) Forms necessary for compliance with the rule may be obtained from the local HUD office.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
H. Prohibition Against Lobbying Activities 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The use of funds awarded under this NOFA is subject to the disclosure requirements and prohibitions of Section 319
of the Department of Interior and Related Agencies Appropriations Act for Fiscal Year 1990 (31 U.S.C. 1352) (the ``Byrd
Amendment'') and the implementing regulations at 24 CFR part 87. These authorities prohibit recipients of federal
contracts, grants or loans from using appropriated funds for lobbying the Executive or Legislative Branches of the
Federal Government in connection with a specific contract, grant or loan. The prohibition also covers the awarding
of contracts, grants, cooperative agreements or loans unless the recipient has made an acceptable certification
regarding lobbying. Under 24 CFR part 87, applicants, recipients and subrecipients of assistance exceeding $100,000
must certify that no federal funds have been or will be spent on lobbying activities in connection with the assistance.

<!-- PJG 0012 frnewline -->
I. Catalog of Federal Domestic Assistance Program 
<!-- PJG 0012 frnewline -->
The Catalog of Federal Domestic Assistance Program title and number is 14.181, Housing for the Elderly or Handicapped.

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Section 202, Housing Act of 1959, as amended (12 U.S.C. 1701q), Section 7(d), Department of Housing and Urban Development
Act (42 U.S.C. 3535(d)). 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 12, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Nicolas P. Retsinas,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Secretary for Housing, Federal Housing Commissioner.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00168 </DOCNO>
<PARENT> FR940202-2-00073 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Appendix A_HUD Field Offices 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Regional and Field Office Directory 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
HUD Field Offices 
<!-- PJG 0012 frnewline -->
Region I 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Boston, Massachusetts Regional Office 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Jeanne McHallam 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Boston Regional Office 
<!-- PJG 0012 frnewline -->
Room 375 
<!-- PJG 0012 frnewline -->
Thomas P. O'Neill, Jr. Federal Building 
<!-- PJG 0012 frnewline -->
10 Causeway Street, 
<!-- PJG 0012 frnewline -->
Boston, Massachusetts 02222&hyph;1092 
<!-- PJG 0012 frnewline -->
(617) 565&hyph;5234 FAX (617) 565&hyph;5257 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Hartford, Connecticut Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Ronald Black 
<!-- PJG 0012 frnewline -->
Director, Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Hartford Office 
<!-- PJG 0012 frnewline -->
330 Main Street 
<!-- PJG 0012 frnewline -->
Hartford, Connecticut 06106&hyph;1860 
<!-- PJG 0012 frnewline -->
(203) 240&hyph;4523 FAX (203) 240&hyph;4674 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Manchester, New Hampshire Office (B) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Loren W. Cole 
<!-- PJG 0012 frnewline -->
Director, Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Manchester Office 
<!-- PJG 0012 frnewline -->
Norris Cotton Federal Building 
<!-- PJG 0012 frnewline -->
275 Chestnut Street 
<!-- PJG 0012 frnewline -->
Manchester, New Hampshire 03103&hyph;2487 
<!-- PJG 0012 frnewline -->
(603) 666&hyph;7681 FAX (603) 666&hyph;7736 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Providence, Rhode Island Office (B) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Michael Dziok 
<!-- PJG 0012 frnewline -->
Director, Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Providence Office 
<!-- PJG 0012 frnewline -->
330 John O. Pastore Federal Building 
<!-- PJG 0012 frnewline -->
and U.S. Post Office_Kennedy Plaza 
<!-- PJG 0012 frnewline -->
Providence, Rhode Island 02902&hyph;1785 
<!-- PJG 0012 frnewline -->
(401) 528&hyph;5351 FAX (401) 528&hyph;5312 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
New York Regional Office 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Martin Sckalor 
<!-- PJG 0012 frnewline -->
Director, Housing Development 
<!-- PJG 0012 frnewline -->
Regional Housing Commissioner 
<!-- PJG 0012 frnewline -->
HUD-New York Regional Office 
<!-- PJG 0012 frnewline -->
26 Federal Plaza 
<!-- PJG 0012 frnewline -->
New York, New York 10278&hyph;0068 
<!-- PJG 0012 frnewline -->
(212) 264&hyph;6500 FAX (212) 264&hyph;0246 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Buffalo, New York Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Robert Rifenberick 
<!-- PJG 0012 frnewline -->
Director, Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Buffalo Office 
<!-- PJG 0012 frnewline -->
5th Floor 
<!-- PJG 0012 frnewline -->
Lafayette Court 
<!-- PJG 0012 frnewline -->
465 Main Street 
<!-- PJG 0012 frnewline -->
Buffalo, New York 14203&hyph;1780 
<!-- PJG 0012 frnewline -->
(716) 846&hyph;5755 FAX (716) 846&hyph;5752 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Newark, New Jersey Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Geraldine McGann 
<!-- PJG 0012 frnewline -->
Director, Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Newark Office 
<!-- PJG 0012 frnewline -->
1 Newark Center 
<!-- PJG 0012 frnewline -->
Newark, New Jersey 07102&hyph;5504 
<!-- PJG 0012 frnewline -->
(201) 622&hyph;7900 Ext. 3102 FAX (201) 645&hyph;2323 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region III 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Philadelphia Regional Office 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Michael J. Perretta 
<!-- PJG 0012 frnewline -->
Director, Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Philadelphia Regional Office 
<!-- PJG 0012 frnewline -->
Liberty Square Building 
<!-- PJG 0012 frnewline -->
105 South 7th Street 
<!-- PJG 0012 frnewline -->
Philadelphia, Pennsylvania 19106&hyph;3392 
<!-- PJG 0012 frnewline -->
(215) 597&hyph;2560 FAX (215) 597&hyph;9627 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Baltimore, Maryland Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Candace L. Simms 
<!-- PJG 0012 frnewline -->
Director, Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Baltimore Office 
<!-- PJG 0012 frnewline -->
5th Floor 
<!-- PJG 0012 frnewline -->
City Crescent Building 
<!-- PJG 0012 frnewline -->
10 South Howard Street 
<!-- PJG 0012 frnewline -->
Baltimore, Maryland 21201&hyph;2505 
<!-- PJG 0012 frnewline -->
(410) 962&hyph;2520 FAX (410) 962&hyph;4947 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Charleston, West Virginia Office (B) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Robert J. Gibson 
<!-- PJG 0012 frnewline -->
Chief, Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Charleston Office 
<!-- PJG 0012 frnewline -->
Suite 708 
<!-- PJG 0012 frnewline -->
405 Capitol Street 
<!-- PJG 0012 frnewline -->
Charleston, West Virginia 25301&hyph;1795 
<!-- PJG 0012 frnewline -->
(304) 347&hyph;7000 FAX (304) 347&hyph;7050 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Pittsburgh, Pennsylvania Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Edward Palombizio 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Pittsburgh Office 
<!-- PJG 0012 frnewline -->
412 Old Post Office Courthouse 
<!-- PJG 0012 frnewline -->
7th Avenue &amp; Grant Street 
<!-- PJG 0012 frnewline -->
Pittsburgh, Pennsylvania 15219 
<!-- PJG 0012 frnewline -->
(412) 644&hyph;6428 FAX (412) 644&hyph;6499 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00169 </DOCNO>
<PARENT> FR940202-2-00073 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Richmond, Virginia Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Charlie Famuliner 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Richmond Office 
<!-- PJG 0012 frnewline -->
The 3600 Centre 
<!-- PJG 0012 frnewline -->
3600 West Broad Street 
<!-- PJG 0012 frnewline -->
P. O. Box 90331 
<!-- PJG 0012 frnewline -->
Richmond, Virginia 23230&hyph;0331 
<!-- PJG 0012 frnewline -->
(804) 278&hyph;4507 FAX (804) 771&hyph;2314 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Washington, DC Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Felicia Williams 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Washington, DC Office 
<!-- PJG 0012 frnewline -->
Suite 300 
<!-- PJG 0012 frnewline -->
Union Center Plaza, Phase II 
<!-- PJG 0012 frnewline -->
820 First Street, NE 
<!-- PJG 0012 frnewline -->
Washington, DC 20002&hyph;4205 
<!-- PJG 0012 frnewline -->
(202) 275&hyph;9200 FAX (202) 275&hyph;0779 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region IV 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Atlanta, Georgia Regional Office 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Gayle F. Burbidge 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
Richard B. Russell Federal Building 
<!-- PJG 0012 frnewline -->
75 Spring Street, S.W. 
<!-- PJG 0012 frnewline -->
Atlanta, Georgia 30303&hyph;3388 
<!-- PJG 0012 frnewline -->
(404) 331&hyph;5136 FAX (404) 331&hyph;0845 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Birmingham, Alabama Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Martha K. Andus 
<!-- PJG 0012 frnewline -->
Acting Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Birmingham Office 
<!-- PJG 0012 frnewline -->
Suite 300 
<!-- PJG 0012 frnewline -->
Beacon Ridge Tower 
<!-- PJG 0012 frnewline -->
600 Beacon Parkway West 
<!-- PJG 0012 frnewline -->
Birmingham, Alabama 35209&hyph;3144 
<!-- PJG 0012 frnewline -->
(205) 290&hyph;7617 FAX (205) 290&hyph;7593 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Caribbean Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Alberto Rosado 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Caribbean Office 
<!-- PJG 0012 frnewline -->
New San Juan Office Building 
<!-- PJG 0012 frnewline -->
159 Carlos E. Chardon Avenue 
<!-- PJG 0012 frnewline -->
San Juan, Puerto Rico 00918&hyph;1804 
<!-- PJG 0012 frnewline -->
(809) 766&hyph;6121 FAX (809) 766&hyph;5995 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Columbia, South Carolina Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Keene R. LaFountain 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Columbia Office 
<!-- PJG 0012 frnewline -->
Strom Thurmond Federal Building 
<!-- PJG 0012 frnewline -->
1835 Assembly Street 
<!-- PJG 0012 frnewline -->
Columbia, South Carolina 29201&hyph;2480 
<!-- PJG 0012 frnewline -->
(803) 765&hyph;5592 FAX (803) 765&hyph;5515 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Greensboro, North Carolina (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Daniel A. McCanless 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Greensboro Office 
<!-- PJG 0012 frnewline -->
Koger Building 
<!-- PJG 0012 frnewline -->
2306 West Meadowview Road 
<!-- PJG 0012 frnewline -->
Greensboro, North Carolina 27407&hyph;3707 
<!-- PJG 0012 frnewline -->
(919) 547&hyph;4001 FAX (919) 547&hyph;4015 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Jackson, Mississippi Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Reba G. Cook 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Jackson Office 
<!-- PJG 0012 frnewline -->
Dr. A.H. McCoy Federal Building 
<!-- PJG 0012 frnewline -->
100 West Capitol Street, Room 910 
<!-- PJG 0012 frnewline -->
Jackson, Mississippi 39269&hyph;1096 
<!-- PJG 0012 frnewline -->
(601) 965&hyph;5308 FAX (601) 965&hyph;4773 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Jacksonville, Florida Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Donald E. Odenthal 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Jacksonville Office 
<!-- PJG 0012 frnewline -->
Suite 2200 
<!-- PJG 0012 frnewline -->
Southern Bell Tower 
<!-- PJG 0012 frnewline -->
301 West Bay Street 
<!-- PJG 0012 frnewline -->
Jacksonville, Florida 32202&hyph;5121 
<!-- PJG 0012 frnewline -->
(904) 232&hyph;2626 FAX (904) 232&hyph;3759 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Knoxville, Tennessee Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
John E. Robbins 
<!-- PJG 0012 frnewline -->
Director_Housing Management 
<!-- PJG 0012 frnewline -->
HUD-Knoxville Office 
<!-- PJG 0012 frnewline -->
Third Floor 
<!-- PJG 0012 frnewline -->
John J. Duncan Federal Building 
<!-- PJG 0012 frnewline -->
710 Locust Street, S.W. 
<!-- PJG 0012 frnewline -->
Knoxville, Tennessee 37902&hyph;2526 
<!-- PJG 0012 frnewline -->
(615) 545&hyph;4384 FAX (615) 545&hyph;4569 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Louisville, Kentucky Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
David A. Powell 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Louisville Office 
<!-- PJG 0012 frnewline -->
601 West Broadway 
<!-- PJG 0012 frnewline -->
P.O. Box 1044 
<!-- PJG 0012 frnewline -->
Louisville, Kentucky 40201&hyph;1044 
<!-- PJG 0012 frnewline -->
(502) 582&hyph;5251 FAX (502) 582&hyph;6074 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Nashville, Tennessee Office (B) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Ed M. Phillips 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Nashville Office 
<!-- PJG 0012 frnewline -->
Suite 200 
<!-- PJG 0012 frnewline -->
251 Cumberland Bend Drive 
<!-- PJG 0012 frnewline -->
Nashville, Tennessee 37228&hyph;1803 
<!-- PJG 0012 frnewline -->
(615) 736&hyph;5213 FAX (615) 736&hyph;2018
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region V 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Chicago, Illinois Regional Office 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Louis Berra 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Chicago Regional Office 
<!-- PJG 0012 frnewline -->
Ralph Metcalfe Federal Building 
<!-- PJG 0012 frnewline -->
77 West Jackson Boulevard 
<!-- PJG 0012 frnewline -->
Chicago, Illinois 60604&hyph;3507 
<!-- PJG 0012 frnewline -->
(312) 353&hyph;5680 FAX (312) 353&hyph;0121 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Cincinnati, Ohio Office (B) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Loustine Tuck 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Cincinnati Office 
<!-- PJG 0012 frnewline -->
Room 9002 
<!-- PJG 0012 frnewline -->
Federal Office Building 
<!-- PJG 0012 frnewline -->
550 Main Street 
<!-- PJG 0012 frnewline -->
Cincinnati, Ohio 45202&hyph;3253 
<!-- PJG 0012 frnewline -->
(513) 684&hyph;2884 FAX (513) 684&hyph;6224 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Cleveland, Ohio Office (B) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Phillip J. Giaconia 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Cleveland Office 
<!-- PJG 0012 frnewline -->
Room 420 
<!-- PJG 0012 frnewline -->
One Playhouse Square 
<!-- PJG 0012 frnewline -->
1375 Euclid Avenue 
<!-- PJG 0012 frnewline -->
Cleveland, Ohio 44114&hyph;1670 
<!-- PJG 0012 frnewline -->
(216) 522&hyph;4065 FAX (216) 522&hyph;2975 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Columbus, Ohio Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Don Jakob 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Columbus Office 
<!-- PJG 0012 frnewline -->
200 North High Street 
<!-- PJG 0012 frnewline -->
Columbus, Ohio 43215&hyph;2499 
<!-- PJG 0012 frnewline -->
(614) 469&hyph;5737 FAX (614) 469&hyph;2432 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00170 </DOCNO>
<PARENT> FR940202-2-00073 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Detroit, Michigan Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Robert Brown 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Detroit Office 
<!-- PJG 0012 frnewline -->
Patrick V. McNamara Federal Building 
<!-- PJG 0012 frnewline -->
477 Michigan Avenue 
<!-- PJG 0012 frnewline -->
Detroit, Michigan 48226&hyph;2592 
<!-- PJG 0012 frnewline -->
(313) 226&hyph;7900 FAX (313) 226&hyph;4394 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Grand Rapids, Michigan Office (B) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
John Milchick 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Grand Rapids Office 
<!-- PJG 0012 frnewline -->
2922 Fuller Avenue, N.E. 
<!-- PJG 0012 frnewline -->
Grand Rapids, Michigan 49505&hyph;3499 
<!-- PJG 0012 frnewline -->
(616) 456&hyph;2100 FAX (616) 456&hyph;2191 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Indianapolis, Indiana Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Erica Dobreff 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Indianapolis Office 
<!-- PJG 0012 frnewline -->
151 North Delaware Street 
<!-- PJG 0012 frnewline -->
Indianapolis, Indiana 46204&hyph;2526 
<!-- PJG 0012 frnewline -->
(317) 226&hyph;6303 FAX (317) 226&hyph;6317 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Milwaukee, Wisconsin Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Lester Marriner 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Milwaukee Office 
<!-- PJG 0012 frnewline -->
Suite 1380 
<!-- PJG 0012 frnewline -->
Henry S. Reuss Federal Plaza 
<!-- PJG 0012 frnewline -->
310 West Wisconsin Avenue 
<!-- PJG 0012 frnewline -->
Milwaukee, Wisconsin 53203&hyph;2289 
<!-- PJG 0012 frnewline -->
(414) 297&hyph;3214 FAX (414) 297&hyph;3947 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Minneapolis-St. Paul, Minnesota (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
John Buenger 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Minneapolis-St. Paul Office 
<!-- PJG 0012 frnewline -->
220 Second Street, South 
<!-- PJG 0012 frnewline -->
Minneapolis, Minnesota 55401&hyph;2195 
<!-- PJG 0012 frnewline -->
(612) 370&hyph;3000 FAX (612) 370&hyph;3220 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region VI 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Fort Worth, Texas Regional Office 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Larry Mumford 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Fort Worth Regional Office 
<!-- PJG 0012 frnewline -->
1600 Throckmorton 
<!-- PJG 0012 frnewline -->
P.O. Box 2905 
<!-- PJG 0012 frnewline -->
Fort Worth, Texas 76113&hyph;2905 
<!-- PJG 0012 frnewline -->
(817) 885&hyph;5401 FAX (817) 885&hyph;5629 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Houston, Texas Office (B) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Allen J. Novosad 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Houston Office 
<!-- PJG 0012 frnewline -->
Suite 200 
<!-- PJG 0012 frnewline -->
Norfolk Tower 
<!-- PJG 0012 frnewline -->
2211 Norfolk 
<!-- PJG 0012 frnewline -->
Houston, Texas 77098&hyph;4096 
<!-- PJG 0012 frnewline -->
(713) 653&hyph;3274 FAX (713) 653&hyph;3319 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Little Rock, Arkansas Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Nathan Abernathy 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Little Rock Office 
<!-- PJG 0012 frnewline -->
Suite 900 
<!-- PJG 0012 frnewline -->
TCBY Tower 
<!-- PJG 0012 frnewline -->
425 West Capitol Avenue 
<!-- PJG 0012 frnewline -->
Little Rock, Arkansas 72201&hyph;3488 
<!-- PJG 0012 frnewline -->
(501) 324&hyph;5931 FAX (501) 324&hyph;5900 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
New Orleans, Louisiana Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Jose A. Pagan 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-New Orleans Office 
<!-- PJG 0012 frnewline -->
Fisk Federal Building 
<!-- PJG 0012 frnewline -->
1661 Canal Street 
<!-- PJG 0012 frnewline -->
New Orleans, Louisiana 70112&hyph;1887 
<!-- PJG 0012 frnewline -->
(504) 589&hyph;7200 FAX (504) 589&hyph;2917 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Oklahoma City, Oklahoma Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Sherry Hunt 
<!-- PJG 0012 frnewline -->
Acting Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD_Oklahoma City Office 
<!-- PJG 0012 frnewline -->
Murrah Federal Building 
<!-- PJG 0012 frnewline -->
200 N.W. 5th Street 
<!-- PJG 0012 frnewline -->
Oklahoma 73102&hyph;3202 
<!-- PJG 0012 frnewline -->
(405) 231&hyph;4181 FAX (405) 231&hyph;4648 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
San Antonio, Texas Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Robert W. Hicks 
<!-- PJG 0012 frnewline -->
Acting Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD_San Antonio Office 
<!-- PJG 0012 frnewline -->
Washington Square Building 
<!-- PJG 0012 frnewline -->
800 Dolorosa Street 
<!-- PJG 0012 frnewline -->
San Antonio, Texas 78207&hyph;4563 
<!-- PJG 0012 frnewline -->
(210) 229&hyph;6800 FAX (210) 229&hyph;6753 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region VII 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Kansas City, Kansas Regional Office 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Richard Kluge 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD_Kansas City Regional Office 
<!-- PJG 0012 frnewline -->
Room 200 
<!-- PJG 0012 frnewline -->
Gateway Tower II 
<!-- PJG 0012 frnewline -->
400 State Avenue 
<!-- PJG 0012 frnewline -->
Kansas City, Kansas 66101&hyph;2406 
<!-- PJG 0012 frnewline -->
(913) 236&hyph;2162 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Des Moines, Iowa Office (B) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Donna Davis 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD_Des Moines Office 
<!-- PJG 0012 frnewline -->
Room 239 
<!-- PJG 0012 frnewline -->
Federal Building 
<!-- PJG 0012 frnewline -->
210 Walnut Street 
<!-- PJG 0012 frnewline -->
Des Moines, Iowa 50309&hyph;2155 
<!-- PJG 0012 frnewline -->
(515) 284&hyph;4512 FAX (515) 284&hyph;4743 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Omaha, Nebraska Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Robert E. Peterson 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD_Omaha Office 
<!-- PJG 0012 frnewline -->
Executive Tower Centre 
<!-- PJG 0012 frnewline -->
10909 Mill Valley Road 
<!-- PJG 0012 frnewline -->
Omaha, Nebraska 68154&hyph;3955 
<!-- PJG 0012 frnewline -->
(402) 492&hyph;3101 FAX (402) 492&hyph;3150 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
St. Louis, Missouri Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Joy Miller 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD_St. Louis Office 
<!-- PJG 0012 frnewline -->
Third Floor 
<!-- PJG 0012 frnewline -->
Robert A. Young Federal Building 
<!-- PJG 0012 frnewline -->
1222 Spruce Street 
<!-- PJG 0012 frnewline -->
St. Louis, Missouri 63103&hyph;2836 
<!-- PJG 0012 frnewline -->
(314) 539&hyph;6560 FAX (314) 539&hyph;6575 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00171 </DOCNO>
<PARENT> FR940202-2-00073 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region VIII 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Denver, Colorado Regional Office 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Arthur Tonilli 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD_Denver Regional Office 
<!-- PJG 0012 frnewline -->
Executive Tower Building 
<!-- PJG 0012 frnewline -->
1405 Curtis Street 
<!-- PJG 0012 frnewline -->
Denver, Colorado 80202&hyph;2349 
<!-- PJG 0012 frnewline -->
(303) 844&hyph;4513 FAX (303) 844&hyph;2475 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region IX 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
San Francisco, California Regional Office 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Jayne Hulbert Humphrey 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD_San Francisco Regional Office 
<!-- PJG 0012 frnewline -->
Philip Burton Federal Building &amp; U.S. Courthouse 
<!-- PJG 0012 frnewline -->
450 Golden Gate Avenue 
<!-- PJG 0012 frnewline -->
P.O. Box 36003 
<!-- PJG 0012 frnewline -->
San Francisco, California 94102&hyph;3448 
<!-- PJG 0012 frnewline -->
(415) 556&hyph;4752 FAX (415) 556&hyph;4176 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Honolulu, Hawaii Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Jill Hurt 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD_Honolulu Office 
<!-- PJG 0012 frnewline -->
Suite 500 
<!-- PJG 0012 frnewline -->
Seven Waterfront Plaza 
<!-- PJG 0012 frnewline -->
500 Ala Moana Blvd. 
<!-- PJG 0012 frnewline -->
Honolulu, Hawaii 96813&hyph;4918 
<!-- PJG 0012 frnewline -->
(808) 541&hyph;1323 FAX (808) 541&hyph;3146 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Los Angeles, California Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Joe L. Hirsch 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD_Los Angeles Office 
<!-- PJG 0012 frnewline -->
1615 West Olympic Boulevard 
<!-- PJG 0012 frnewline -->
Los Angeles, California 90015&hyph;3801 
<!-- PJG 0012 frnewline -->
(213) 251&hyph;7122 FAX (213) 251&hyph;7096 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Phoenix, Arizona Office (B) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Laura Massie 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Phoenix Office 
<!-- PJG 0012 frnewline -->
Suite 600 
<!-- PJG 0012 frnewline -->
Two Arizona Center 
<!-- PJG 0012 frnewline -->
400 North 5th Street 
<!-- PJG 0012 frnewline -->
Phoenix, Arizona 85004&hyph;2361 
<!-- PJG 0012 frnewline -->
(602) 379&hyph;4434 FAX (602) 379&hyph;3985 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Sacramento, California Office (B) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Williams F. Bolton 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Sacramento Office 
<!-- PJG 0012 frnewline -->
Suite 200 
<!-- PJG 0012 frnewline -->
777 12th Street 
<!-- PJG 0012 frnewline -->
Sacramento, California 95814&hyph;1977 
<!-- PJG 0012 frnewline -->
(916) 551&hyph;1351 FAX (916) 551&hyph;2899 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region X 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Seattle, Washington Regional Office 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
John H. Taylor 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Seattle Regional Office 
<!-- PJG 0012 frnewline -->
Suite 200 
<!-- PJG 0012 frnewline -->
Seattle Federal Office Building 
<!-- PJG 0012 frnewline -->
909 First Avenue 
<!-- PJG 0012 frnewline -->
Seattle, Washington 98104&hyph;1000 
<!-- PJG 0012 frnewline -->
(206) 220&hyph;5101 FAX (206) 553&hyph;4405 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Anchorage, Alaska Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Gene Dobrzynski 
<!-- PJG 0012 frnewline -->
Chief_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Anchorage Office 
<!-- PJG 0012 frnewline -->
Suite 401 
<!-- PJG 0012 frnewline -->
University Plaza Building 
<!-- PJG 0012 frnewline -->
949 East 36th Avenue 
<!-- PJG 0012 frnewline -->
Anchorage, Alaska 99508&hyph;4135 
<!-- PJG 0012 frnewline -->
(907) 271&hyph;4170 FAX (907) 271&hyph;3667 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Portland, Oregon Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Thomas C. Cusack 
<!-- PJG 0012 frnewline -->
Director_Housing Development 
<!-- PJG 0012 frnewline -->
HUD-Portland Office 
<!-- PJG 0012 frnewline -->
520 S.W. 6th Avenue 
<!-- PJG 0012 frnewline -->
Portland, Oregon 97204&hyph;1596 
<!-- PJG 0012 frnewline -->
(503) 326&hyph;2561 FAX (503) 326&hyph;3097 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2296 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4210&hyph;27&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00172 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4717 -->

<!-- PJG STAG 4717 -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Wednesday
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
February 2, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=1 -->
Part V
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->
Department of Housing and Urban Development
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Office of the Assistant Secretary for Housing_Federal Housing Commissioner
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Supportive Housing for Persons With Disabilities; Notice of Funding Availability
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG FTAG 4701 -->

<!-- PJG STAG 4701 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 22&blank;/&blank;Wednesday, February 2, 1994&blank;/&blank;Notices 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<USDEPT>DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT </USDEPT>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of Assistant Secretary for Housing_Federal Housing Commissioner</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. N&hyph;94&hyph;3689; FR&hyph;3590&hyph;N&hyph;01] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Notice of Fund Availability (NOFA) for Supportive Housing for Persons with Disabilities 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Office of Assistant Secretary for Housing_Federal Housing Commissioner, HUD.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of fund availability for FY 94. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This NOFA announces HUD's funding for supportive housing for persons with disabilities. In the body of this document
is information concerning the following: (a) the purpose of the NOFA and information regarding eligibility, submission
requirements, available amounts, and selection criteria and (b) application processing, including how to apply
and how selections will be made. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
APPLICATION PACKAGE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The application package can be obtained from the Multifamily Housing Clearinghouse, P.O. Box 6424, Rockville, MD
20850; telephone 1&hyph;800&hyph;955&hyph;2232. A checklist of steps and exhibits involved in the application
process is included in the application package. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The deadline date for receipt of applications in response to this NOFA is 4 p.m. local time on May 3, 1994. The application
deadline is firm as to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
date
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
hour
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
. In the interest of fairness to all applicants, HUD will not consider any application that is received after the deadline.
Sponsors should take this into account and submit applications as early as possible to avoid risk brought about by
unanticipated delays or delivery-related problems. In particular, Sponsors intending to mail applications must
provide sufficient time to permit delivery on or before the deadline date and hour. Acceptance by a Post Office or private
mailer does not constitute delivery. Facsimile (FAX), COD, and postage due applications will not be accepted. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Applications must be delivered to the Director of the Housing Development Division in the HUD Field Office for your
jurisdiction. A listing of HUD Field Offices, their addresses and telephone numbers (including TDD telephone numbers)
is attached as appendix A to this NOFA. HUD will date and time stamp incoming applications to evidence timely receipt,
and upon request, provide the applicant with an acknowledgement of receipt. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The HUD Field Office for your jurisdiction.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00173 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Paperwork Reduction Act Statement 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with the Paperwork Reduction Act of 1980 (44 U.S.C. 3501&hyph;220), the information collection requirements
have been assigned OMB Control Number 2502&hyph;0462. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Purpose and Substantive Description 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Authority 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 811 of the Cranston-Gonzalez National Affordable Housing Act (the NAHA) (and as amended by the Housing and
Community Development Act of 1992) (HCD Act of 1992), authorized a new supportive housing program for persons with
disabilities and replaced assistance for persons with disabilities previously covered by section 202 of the Housing
Act of 1959 (section 202 continues, as amended by section 801 of the NAHA, and HCD Act of 1992, to authorize supportive
housing for the elderly). The assistance is provided as capital advances and contracts for project rental assistance
in accordance with 24 CFR part 890. Capital advances may be used to finance the construction, rehabilitation, or acquisition
with or without rehabilitation, including acquisition from the Resolution Trust Corporation (RTC), of structures
to be developed into a variety of housing options ranging from group homes and independent living facilities, to dwelling
units in multifamily housing developments, condominium housing and cooperative housing. Acquisition without
rehabilitation is permitted only for group homes or properties acquired from the RTC. This assistance may also cover
the cost of real property acquisition, site improvement, conversion, demolition, relocation, and other expenses
that the Secretary determines are necessary to expand the supply of supportive housing for persons with disabilities.

<!-- PJG 0012 frnewline -->
For supportive housing for persons with disabilities, the Departments of Veterans Affairs and Housing and Urban
Development, and Independent Agencies Appropriations Act, 1994 (Pub. L. 103&hyph;124, enacted October 28, 1993,
(Fiscal Year 1994 Appropriations Act) provides $387,000,000 for capital advances, for supportive housing for persons
with disabilities, as authorized by section 811 of the NAHA, and for project rental assistance, and amendments to
contracts for project rental assistance, for supportive housing for persons with disabilities as authorized by
section 811 of the NAHA. Any unreserved balances provided in prior years for such purposes are to be merged with amounts
provided in the Fiscal Year 1994 Appropriations Act. It should be noted that although section 623 of the HCD Act of 1992
authorizes tenant-based assistance for persons with disabilities, appropriations have not been provided. 
<!-- PJG 0012 frnewline -->
In accordance with an agreement between HUD and the Farmers Home Administration (FmHA) which facilitates the coordination
between the two agencies in administering their respective rental assistance programs, HUD is required to notify
FmHA of applications for housing assistance it receives. The purpose of this notification is to give FmHA the opportunity
to comment if it has concern about the demand for additional assisted housing and possible harm to existing projects
in the same housing market area. HUD will consider the FmHA comments in its review and project selection process. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Allocation Amounts 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with 24 CFR part 791, the Assistant Secretary will allocate the amounts available for capital advances
for supportive housing for persons with disabilities. The Department reserves project rental assistance funds
sufficient for 20-year project rental assistance contracts in support of the units selected for capital advances,
consistent with current operating cost standards. 
<!-- PJG 0012 frnewline -->
The allocation formula for section 811 funds consists of the following two data elements: 
<!-- PJG 0012 frnewline -->
1. A measure of the number of non-institutionalized persons age 16 or older with a work disability and a mobility or
self-care limitation; and 
<!-- PJG 0012 frnewline -->
2. A measure of the number of non-institutionalized persons age 16 or older having a mobility or self-care limitation
but having no work disability. 
<!-- PJG 0012 frnewline -->
Based on this formula, the Department has allocated the available capital advance funds as shown on the following
chart: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00174 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 3,L2,i1,s100,13,5 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
Fiscal Year 1993 Allocation for Supportive Housing for Persons With Disabilities 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Region
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Capital advance
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Units
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
I
<!-- PJG 007 0104 intable -->
$8,714,817
<!-- PJG 007 0104 intable -->
121
<!-- PJG 0012 frnewline -->
II
<!-- PJG 007 0104 intable -->
22,768,105
<!-- PJG 007 0104 intable -->
305
<!-- PJG 0012 frnewline -->
III
<!-- PJG 007 0104 intable -->
16,738,362
<!-- PJG 007 0104 intable -->
280
<!-- PJG 0012 frnewline -->
IV
<!-- PJG 007 0104 intable -->
31,171,649
<!-- PJG 007 0104 intable -->
615
<!-- PJG 0012 frnewline -->
V
<!-- PJG 007 0104 intable -->
26,794,525
<!-- PJG 007 0104 intable -->
449
<!-- PJG 0012 frnewline -->
VI
<!-- PJG 007 0104 intable -->
14,990,460
<!-- PJG 007 0104 intable -->
314
<!-- PJG 0012 frnewline -->
VII
<!-- PJG 007 0104 intable -->
5,869,593
<!-- PJG 007 0104 intable -->
113 
<!-- PJG 0012 frnewline -->
VIII
<!-- PJG 007 0104 intable -->
2,583,448
<!-- PJG 007 0104 intable -->
52 
<!-- PJG 0012 frnewline -->
IX
<!-- PJG 007 0104 intable -->
24,127,484
<!-- PJG 007 0104 intable -->
345 
<!-- PJG 0012 frnewline -->
X
<!-- PJG 007 0104 intable -->
4,110,557
<!-- PJG 007 0104 intable -->
69
<!-- PJG 007 0162 intable -->
n,s
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
National total
<!-- PJG 007 0104 intable -->
$157,869,000
<!-- PJG 007 0104 intable -->
2663
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Eligibility 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The only eligible applicants under this program are nonprofit organizations with section 501(c)(3) tax exemptions
from the Internal Revenue Service. A single Sponsor shall not request more units in a given Region than permitted for
that Region in the Invitation. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
D. Initial Screening, Technical Processing and Selection Criteria 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
1. Initial Screening 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applications for section 811 capital advances that are received by HUD at the appropriate address by 4 p.m. local time
on May 3, 1994, will be reviewed to determine if all parts of the application are included. HUD will not review the content
of the application as part of initial screening. Deficiency letters will be sent informing Sponsors of any missing
parts of the application. Sponsors must correct such deficiencies within 14 calendar days from the date of the deficiency
letter. The deficiency letter is to be sent by certified mail. Any document requested as a result of the initial screening
may be executed or prepared within the deficiency period, except for Forms HUD&hyph;92016&hyph;CAs, Articles of
Incorporation, IRS exemption rulings, Forms SF&hyph;424, Board Resolution committing the minimum capital investment,
and site control documents (all of these excepted items must be dated no later than the application deadline date).

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00175 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2. Technical Processing
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
All applications will be placed in technical processing upon receipt of the response to the deficiency letter or at
the end of the 14-day period. All applications will undergo a complete analysis. If a reviewer finds that clarification
is needed to complete the review or an exhibit is missing that was not requested after initial screening, the reviewer
shall immediately advise the Multifamily Housing Representative who will: (a) Request, by telephone, that the Sponsor
submit the information within five (5) working days, and (b) follow up by certified letter. Communications must be
attached to the technical review and findings memorandum. As part of this analysis, HUD will conduct its environmental
review in accordance with 24 CFR part 50 on only those applications containing evidence of site control. Examples
of reasons for technical processing rejection include an ineligible Sponsor, ineligible population to be served,
lack of legal capacity and insufficient commitments or indications that supportive services will be available.
The Secretary will not reject an application based on technical processing without giving notice of that rejection
with all rejection reasons, and affording the applicant an opportunity to appeal. An applicant will be afforded 14
calendar days from the date of HUD's written notice to appeal a technical rejection to the Field Office. The Field Office
must respond within 5 working days to the Sponsor. The Field Office shall make a determination on an appeal prior to
making its selection recommendations. All applications will be either rated or 
<!-- PJG 0012 frnewline -->
Technically rejected at the end of technical processing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Technical processing will also assure that if the Sponsor has been found by a court or by a Federal, State, or local agency,
in noncompliance with any of the statutes, regulations, or other requirements listed in the civil rights certification
(&sect;890.265(b)(9)(i)), HUD will obtain from the Sponsor a statement of the actions taken to correct that noncompliance.
There must be no pending civil rights suits against the Sponsor instituted by the Department of Justice and no pending
administrative actions for civil rights violations instituted by HUD. Moreover, there must not be a deferral of the
processing of applications from the Sponsor imposed by HUD under Title VI of the Civil Rights Act of 1964, the Department's
implementing regulations (24 CFR 1.8), procedures (HUD Handbook 8040.1), and the Attorney General's Guidelines
(28 CFR 50.3); or under section 504 of the Rehabilitation Act of 1973 and the Department's implementing regulations
(24 CFR 8.57), and the Americans with Disabilities Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Upon completion of technical processing, all acceptable applications will be rated according to the selection criteria
in &sect;890.300(d) (also below in I.D.3). Applications which have a total score of 50 points or more will be eligible
for selection and will be placed in rank order. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3. Selection Criteria
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applications for section 811 capital advances that successfully complete technical processing will be rated using
the following selection criteria: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) The Sponsor's ability to develop and operate the proposed housing on a long-term basis, considering the following
(50 points maximum): 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The scope, extent and quality of the Sponsor's experience in providing housing or related services to those proposed
to be served by the project and the scope of the proposed project (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
i.e.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, number of units, services, relocation costs, development, and operation) in relationship to the Sponsor's demonstrated
development and management capacity. (32 points); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The scope, extent and quality of the Sponsor's experience in providing housing or related services to minority
persons or families (5 points); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) The scope, extent and quality of the Sponsor's experience in providing opportunities for minority and women-owned
business enterprises participation (3 points); and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) The extent of local community support for the Sponsor's activities, including previous experience in serving
the area where the project is to be located, and Sponsor's demonstrated ability to enlist volunteers and local funds
(10 points); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00176 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) The need for supportive housing for persons with disabilities in the area to be served, the extent to which the Sponsor
has site control, and the suitability of the site, considering (25 points): 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The extent of the need for the project in the area based on a determination by the Field Office. This determination
will be made by taking into consideration the Sponsor's evidence of need in the area based on the guidelines in &sect;890.265(b)(18),
as well as other economic, demographic and housing market data available to the Field Office. The data could include
the availability of existing Federally assisted housing (HUD and FmHA) for persons with disabilities and current
occupancy in such facilities, Federally assisted housing for persons with disabilities under construction or for
which fund reservations have been issued and, in accordance with an agreement between HUD and FmHA, comments from
the FmHA on the demand for additional assisted housing and the possible harm to existing projects in the same housing
market area (8 points); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The proximity or accessibility of the site to shopping, medical facilities, transportation, places of worship,
recreational facilities, places of employment, and other necessary services to the intended occupants, adequacy
of utilities and streets, freedom of the site from adverse environmental conditions, and compliance with the site
and neighborhood standards (10 points);
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Suitability of the site from the standpoint of promoting a greater choice of housing opportunities for minority
persons with disabilities (7 points); and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) Likelihood that Sponsor will have site control (if not already in control of an approvable site) within six months
of fund reservation (yes or no); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) The adequacy of the provision of supportive services and of the proposed facility considering (25 points maximum):

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The extent to which the Sponsor demonstrated that the identified supportive services will be provided on a consistent
long-term basis (considering any limitations imposed by State or local governments) - strength of commitments to
fund or provide the supportive services, or indications of the availability of supportive services to project residents
(10 points); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The quality of the services implementation plan (10 points); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) The extent to which the proposed design will meet any special needs of persons with disabilities the housing is
intended to serve and will accommodate the provision of any necessary on-site supportive services for the proposed
residents (5 points). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Application Process 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
All applications for Section 811 capital advances submitted by eligible Sponsors must be filed with the appropriate
HUD Field Office receiving an allocation and must meet the requirements of this Notice. No application will be accepted
after 4 p.m. local time on May 3, 1994, unless that date and time is extended by a Notice published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Applications received after that date and time will not be accepted, even if postmarked by the deadline date. Applications
submitted by facsimile are not acceptable. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Immediately upon publication of this NOFA, if names have not already been provided to the Multifamily Housing Clearinghouse,
Field Offices shall notify minority media and media for persons with disabilities, all persons and organizations
on their mailing lists and minority and other organizations within their jurisdiction involved in housing and community
development and groups with special interest in housing for disabled households. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Organizations interested in applying for a section 811 capital advance should contact the Multifamily Housing Clearinghouse
at 1&hyph;800&hyph;955&hyph;2232 for a copy of the application package and advise the appropriate Field Office
whether they wish to attend the workshop described below. HUD encourages minority organizations to participate
in this program as Sponsors. Field Offices will advise all organizations on their mailing list of the date, time and
place of workshops at which the Section 811 Program will be explained. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
HUD strongly recommends that prospective applicants attend the local Field Office workshop. Interested persons
with disabilities should contact the Field Office to assure that any necessary arrangements can be made for them to
enable their attendance and participation in the workshop. While strongly urged to do so, if Sponsors cannot attend
a workshop, Application Packages can be obtained from the Multifamily Housing Clearinghouse (see address and telephone
number under SUMMARY above). However, Sponsors must contact the appropriate Field Office with any questions regarding
the submission of applications and for any additional application requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
At the workshops, application procedures and requirements will be explained. Also, concerns such as local market
conditions, building codes, historic preservation, floodplain management, displacement and relocation, zoning,
housing costs and service plan requirements will be addressed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Application Submission Requirements 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Application 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Each application shall include all of the information, materials, forms, and exhibits listed in section III. B. below,
with the exception of applications submitted by Sponsors selected for a Section 811 fund reservation within the last
three funding cycles, and must be indexed and tabbed. Previously selected Section 811 Sponsors are not required to
submit the information described in B. 2. (a), (b) and (c) below (Exhibit 2, a. b., and c. of the application which are
the articles of incorporation (or other organizational documents), by-laws, and the IRS tax exemption, respectively).
The Field Office will base its determination of the eligibility of a new Sponsor for a reservation of section 811 capital
advance funds on the information provided in the application. Field Offices will verify a Sponsor's indication of
previous HUD approval by checking the project number and approval status with the appropriate Field Office. If there
has been a change in any of the eligibility documents since its previous HUD approval, the Sponsor must submit the updated
information in its application. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addition to this relief of paperwork burden in preparing applications, applicants will be able to utilize information
and exhibits previously prepared for prior applications under section 811, section 202 or other funding programs.
Examples of exhibits that may be readily adapted or amended to decrease the burden of application preparation include,
among others, those on previous participation in the section 202 or section 811 programs; applicant experience in
the provision of housing and services; supportive services plan; community ties, and experience serving minorities.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. General Application Requirements 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Form HUD&hyph;92016&hyph;CA, Application for Section 811 Supportive Housing Capital Advance. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
[
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Note:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 A sponsor may apply for a scattered site project provided each site contains the same facility type (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
e.g.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
, group home, independent living facility, condominium unit). If the sponsor proposes a mix of facility types, it
must submit one application per facility type].
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00177 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
2. Evidence of each Sponsor's legal status as a nonprofit organization, including the following:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) Articles of Incorporation, constitution, or other organizational documents; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) By-laws; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) IRS section 501(c)(3) tax exemption ruling (this must be submitted by all Sponsors, including churches). A nonprofit
organization organized in the Commonwealth of Puerto Rico and exempt from income taxation under Puerto Rico law,
has never been liable for payment of Federal income taxes, and does not pay patronage dividends may be exempt from the
requirement set out in the previous sentence if they are not eligible for tax exemption; and 
<!-- PJG 0012 frnewline -->
(d) Resolution of the board, duly certified by an officer, that no officer or director of the Sponsor or Owner has or
will have any financial interest in any contract with the Owner or in any firm or corporation which has or will have a
contract with the Owner and which includes a current listing of all duly qualified and sitting officers and directors
by title and the ending date of each person's term. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
[
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Note:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Sponsors who have received a section 811 fund reservation within the last three funding cycles are not required to
submit the documents described in (a), (b), and (c), above. Instead, sponsors must submit the project number of the
most recently selected application and the field office to which it was submitted. If there have been any modifications
or additions to the subject documents, indicate such, and submit the new material.]
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
3. CHAS certification. The Sponsor must submit a certification by the jurisdiction in which the proposed project
will be located that the Sponsor's application is consistent with the jurisdiction's HUD-approved CHAS for FY 1994.
The certification must be made by the unit of general local government if it is required to have, or has, a complete CHAS.
Otherwise the certification may be made by the State, or if the project will be located in a unit of general local government
authorized to use an abbreviated strategy, by the unit of general local government if it is willing to prepare such
a CHAS. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
All CHAS certifications must be made by the public official responsible for submitting the CHAS to HUD. All CHAS certifications
must be submitted as part of the application by the application submission deadline set forth in this NOFA, except
as provided in the next paragraph. The required CHAS must therefore have been submitted more than 60 days before the
application submission deadline, since HUD has 60 days to review and approve the CHAS. Where the certification of
consistency is permitted to be submitted after the application submission deadline, as described in the next paragraph,
the CHAS must be submitted for approval in time for the certification to be made by the later date. In no event will an
application be considered if the CHAS has not been submitted for approval by the application submission deadline.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
If the required certification will be made by a unit of general local government with respect to an abbreviated strategy,
and such CHAS has been submitted by the application submission deadline but has not yet been approved by HUD, the deadline
will not be applied to the certification for consistency. Instead, the application must include a written statement
from the public official responsible for submitting the CHAS that the jurisdiction has submitted an abbreviated
strategy for FY 1994 for HUD approval and that the application is consistent with the CHAS. If HUD approved the CHAS,
the required certification that the application is consistent with a HUD-approved CHAS for FY 1994 must be submitted
before June 2, 1994. An application will not be selected for funding unless the CHAS is approved and the required certification
is made by June 2, 1994. The CHAS regulations are published in 24 CFR part 91. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. E.O. 12372. A certification that the Sponsor has submitted a copy of its application, if required, to the State agency
(single point of contact) for State review in accordance with Executive Order 12372. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. Supportive Services Certification. A certification from the appropriate State or local agency that the provision
of supportive services is well designed to serve the special needs of persons with disabilities (the name, address,
and telephone number of the appropriate agency can be obtained from the Field Office). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00178 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
6. SF&hyph;424. A certification on SF&hyph;424, Application for Federal Assistance, that the Sponsor(s) is not
delinquent on the repayment of any Federal debt. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. Disclosure of Lobbying Activities. If the amount applied for is greater than $100,000, the certification with
regard to lobbying required by 24 CFR part 87 must be included. If the amount applied for is greater than $100,000 and
the applicant has made or has agreed to make any payment using nonappropriated funds for lobbying activity, as described
in 24 CFR part 87, the submission must also include SF-LLL, Disclosure of Lobbying Activities. The applicant determines
if the submission of the SF-LLL form is applicable. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8. A statement that (a) identifies all persons (families, individuals, businesses and nonprofit organizations
(identified by race/minority group, and status as owners or tenants) occupying the property on the date of submission
of the application for a capital advance (or date of initial site control, if later); (b) indicates the estimated cost
of relocation payments and other services, and (c) identifies the staff organization that will carry out the relocation
activities.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
[
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Note:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 If any of the relocation costs will be funded from sources other than the section 811 capital advance, the sponsor must
provide evidence of a firm commitment of these funds. When evaluating applications, HUD will consider the total cost
of proposals (i.e., cost of site acquisition, relocation, construction and other project costs).]
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
9. Additional Certifications. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) A certification of the Sponsor(s)' intent to comply with section 504 of the Rehabilitation Act of 1973 (29 U.S.C.
794) and the implementing regulations at 24 CFR part 8; the Fair Housing Act (42 U.S.C. 3600&hyph;3619) and the implementing
regulations at 24 CFR part 100, 108, 109, and 110; Title VI of the Civil Rights Act of 1964 (42 U.S.C. 2000d) and the implementing
regulations at 24 CFR part 1; section 3 of the Housing and Urban Development Act of 1968 (12 U.S.C. 1701u) and the implementing
regulations at 24 CFR part 135; the Age Discrimination Act of 1975 (42 U.S.C. 6101&hyph;6107) and the implementing
regulations at 24 CFR part 146; Executive Order 11246 (as amended) and the implementing regulations at 41 CFR Chapter
60; the regulations implementing Executive Order 11063 (Equal Opportunity in Housing) at 24 CFR part 107; the Americans
with Disabilities Act (42 U.S.C. 12101 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) to the extent applicable; the affirmative fair housing marketing requirements of 24 CFR part 200, subpart M and the
implementing regulations at 24 CFR part 108; and other applicable Federal, State and local laws prohibiting discrimination
and promoting equal opportunity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) A certification that the Sponsor(s) will comply with the requirements of the Drug-Free Workplace Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) A certification that the project will comply with HUD's design and cost standards, the Uniform Federal Accessibility
Standards and HUD's implementing regulations at 24 CFR part 40, Section 504 of the Rehabilitation Act of 1973 and HUD's
implementing regulations at 24 CFR part 8, and for covered multifamily dwellings designed and constructed for first
occupancy after March 13, 1991, the design and construction requirements of the Fair Housing Act and HUD's implementing
regulations at 24 CFR part 100, and the Americans with Disabilities Act of 1990. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) A certification by the Sponsor(s) that it will comply (or has complied) with the acquisition and relocation requirements
of the Uniform Relocation Assistance and Real Property Acquisition Policies Act of 1970, as amended (URA), implemented
by regulations at 49 CFR part 24, and 24 CFR 890.260(e). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) A certification by the Sponsor(s) that it will form an Owner (as defined in &sect;890.105) after the issuance of
the capital advance, will cause the Owner to file a request for determination of eligibility and a request for capital
advance under &sect;890.300, and will provide sufficient resources to the Owner to insure the development and long-term
operation of the project, including capitalizing the Owner at conditional commitment processing in an amount sufficient
to meet its obligations in connection with the project. 
<!-- PJG 0012 frnewline -->
(f) A certification that the Sponsor will comply with the requirements of the Lead-Based Point Poisoning Prevention
Act (42 U.S.C. 4821&hyph;4846) and implementing regulations at 24 CFR part 35 (except as superseded in &sect;890.260(f)(2)).

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00179 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
10. A description of Sponsor's purposes and activities, ties to the community (including local disability community),
any statements of support for the proposed project from non-governmental organizations familiar with the needs
of the population it would serve, any sources of local funds to serve the project, minority support and how long it has
been in existence (include any additional related information). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11. A description of any other rental housing projects and/or medical facilities, sponsored, owned and operated
by the Sponsor including a description of experience in providing housing and/or medical facilities to persons with
disabilities and minorities. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12. A description of the Sponsor's past or current involvement in any programs other than housing (including its provision
of services) that demonstrates the Sponsor's management capabilities and experience, including a description
of the Sponsor's experience in serving persons with disabilities and minorities. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
13. A description of the Sponsor's experience in contracting with minority and women-owned businesses, including
a summary of the total amount awarded in each of the two categories for the preceding three years and the percentage
that amount represents of the total contracts awarded by the Sponsor in the relevant time period. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
14. A certified Board Resolution, acknowledging responsibilities of sponsorship, long-term support of the project(s),
willingness of Sponsor to assist the Owner to develop, own, manage and provide appropriate services in connection
with the proposed project, and that it reflects the will of its membership. Also, evidence, in the form of a certified
Board Resolution, of the Sponsor's willingness to fund the estimated start-up expenses, the Minimum Capital Investment
(one-half of one-percent of the HUD-approved capital advance, not to exceed $10,000) (see 890.250), and the estimated
cost of any amenities or features (and operating costs related thereto) which would not be coverd by the approved capital
advance. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
15. A list of the applications, if any, the Sponsor has submitted or is planning to submit to any other Field Office in
response to this NOFA or the NOFA for Supportive Housing for the Elderly (published elsewhere in today's 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
). Indicate by Field Office, the number of units requested, and the proposed location by city and State for each application.
A list of all FY 1993 and prior year projects to which the Sponsor(s) is a party, identified by project number and Field
Office, which have not been finally closed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
16. HUD&hyph;2880, Applicant/Recipient Disclosure/Update Report including Social Security Numbers and Employee
Identification Numbers. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
17. Evidence of need for supportive housing. An identification of the proposed population and evidence demonstrating
sustained effective demand for the housing for the proposed population in the area to be served, such as a description
of market conditions in existing Federally assisted housing for persons with disabilities (occupancy, waiting
lists, etc.), state or local needs assessments of persons with disabilities in the area, the types of supportive services
arrangements currently available in the area, and the utilization of such services as evidenced by data from local
social service agencies. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
18. Evidence of control of an approvable site, or identification of a site for which the Sponsor provides reasonable
assurances that it will obtain control within 6 months from the date of fund reservation (if Sponsor is approved for
funding); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) If the Sponsor has control of the site, it must submit the following information: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) Evidence that the Sponsor has entered into a legally binding option agreement to purchase or lease the proposed
site; or has a copy of the contract of sale for the site, a deed, long-term leasehold, a request with all supporting documentation,
submitted either prior to or with the Application for Capital Advance, for a partial release of a site covered by a mortgage
under a HUD program or other evidence of legal ownership of the site (including properties to be acquired from the RTC).
The option agreement period must extend through the end of the current fiscal year and contain a renewal provision
so that the option can be renewed for at least an additional six months. The Sponsor must also identify any restrictive
covenants, including reverter clauses. In the case of a site to be acquired from a public body, evidence that the public
body possesses clear title to the site, and has entered into a legally binding agreement to lease or convey the site
to the Sponsor after it receives and accepts a notice of section 811 capital advance and identification of any restrictive
covenants, including reverter clauses. However, in localities where HUD determines that the time constraints of
the funding round will not permit all of the required official actions (e.g., approval of Community Planning Boards)
which are necessary to convey publicly-owned sites, a letter in the application from the Mayor or Director of the appropriate
local agency indicating their approval of conveyance of the site contingent upon the necessary approval action is
acceptable and may be approved by the Field Office if it has satisfactory experience with timely conveyance of sites
from that public body. In such cases, documentation shall also include a copy of the public body's evidence of ownership
and identification of any restrictive covenants, including reverter clauses. For properties to be acquired from
the RTC, include a copy of the RTC prepared Transaction Screen Checklist or Phase I Environmental Site Assessment,
and applicable documentation, per the RTC Environmental Guidelines. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
[
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Note:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 A proposed project site may not be acquired or optioned from a general contractor (or its affiliate) which will construct
the section 811 project or from any other development team member.] 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00180 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) Evidence that the project as proposed is permissible under applicable zoning ordinances or regulations, or a
statement of the proposed action required to make the proposed project permissible and the basis for the belief that
the proposed action will be completed successfully before the submission of the commitment application (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
e.g.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 a summary of the results of any recent requests for rezoning on land in similar zoning classifications and the time
required for such rezoning, preliminary indications of acceptability from zoning bodies, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
etc.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Narrative description of site and area surrounding the site, characteristics of neighborhood, how the site will
promote greater housing opportunities for minorities, and any other information that impacts on the suitability
of the site for persons with disabilities and including: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) Photographs of the site (four directional views); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) If acquisition, evidence that the structure has been constructed or occupied for at least three years (other
than RTC properties); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iii) A statement that the Sponsor is willing to seek a different site if the preferred site is unapprovable and site
control will be obtained within six months of notification of fund reservation; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iv) A map showing the location of the site and the racial composition of the neighborhood, with the area of racial concentration
delineated. 
<!-- PJG 0012 frnewline -->
(v) If the project is to be rehabilitated and an exception of the project size limits is necessary, describe why the
site was selected and demonstrate the following: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(A) The increased number of people is necessary for the economic feasibility of the project; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(B) The project is compatible with other residential development and the population density of the area in which the
project is to be located; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(C) The increased number of people will not prohibit their successful integration into the community; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(D) The project is marketable in the community; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(E) The size of the project is consistent with State and/or local policies governing similar facilities for the proposed
population; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(F) A statement that the Sponsor is willing to have its application processed at the project size limit should HUD not
approve the exception. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) If the Sponsor has identified a site, but does not have it under control, it must submit the following information:

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) A description of the location of the site, including its street address and unit number (if condominium), neighborhood/community
characteristics (to include racial and ethnic data), amenities, adjacent housing and/or facilities, how the site
will promote greater housing opportunities for minorities, and any other information that impacts on the suitability
of the site for persons with disabilities;
<!-- PJG 0012 frnewline -->
(2) A description of the activities undertaken to identify the site as well as what actions must be taken and the estimated
time necessary to obtain control of the site, if approved for funding; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) An indication as to whether the site is properly zoned. If it is not, an indication of the actions/time necessary
for proper zoning; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) A status of the sale of the site; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) An indication as to whether the site would involve relocation. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
19. Supportive Service plan that includes: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) A detailed description of whether the housing is intended to serve persons with physical, mental or emotional
impairments, developmental disabilities, or chronic mental illness. Include how and from where persons will be
referred and admitted to the project. The Sponsor may, with the approval of the Secretary, limit occupancy within
housing developed under this part to persons with disabilities who have similar disabilities and require a similar
set of supportive services in a supportive housing environment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) A detailed description of the service needs of the proposed population. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) A 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
detailed description of the supportive services
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 proposed to be provided to the anticipated occupancy, including: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The name(s) of the agency(s) which will be responsible for providing supportive services and evidence of the service
provider's capability and experience in providing such supportive services; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The manner in which such services will be provided (i.e., how, when and how often, where (on/off-site), including
assurances that the proposed residents will receive supportive services based on their individual needs. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) The staffing plan, including a description of the qualifications of residential staff, if any, and other staff
necessary to provide the proposed services. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) Identification of the extent of state and local funds available to assist in the provision of supportive services.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) Letters of intent from service providers or funding sources, indicating commitments to fund or provide the supportive
services or that a particular service will be available to project residents. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(f) If the Sponsor will be the sole service provider using its own funds, a letter indicating its capability and commitment
to either provide the supportive services or ensure their provision for the life of the project. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(g) If any state or local government funds will be provided, a description of the state/local agency's philosophy/policy
concerning residential facilities for the population to be served as well as a demonstration by the Sponsor that the
application is consistent with state or local plans and policies governing the development and operation of facilities
for the same disabled population. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00181 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(h) Form HUD 92013E, Supplemental Application Processing Form_Housing for Persons with Disabilities. Identify
all supportive services, if any, to be provided to the persons occupying such housing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
20. A written description of the design of the proposed housing, including: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) The development method; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Identification of the number and type of structure(s), and for an independent living facility, the number of units
by bedroom type and the number of residents with disabilities, and for a group home, the number of bedrooms and number
of residents with disabilities; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) An identification of all community spaces, amenities or features planned for the housing. A description of how
the spaces, amenities or features will be utilized and of the extent to which they are necessary to accommodate any
special needs of the proposed residents and the provision of any on-site supportive services also must be included.
If these community spaces, amenities, or features would not comply with the design and cost standards of &sect;890.220,
the Sponsor must demonstrate its ability and willingness to contribute both the incremental development cost and
continuing operating cost associated with the community spaces, amenities or features; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) Describe if and how the project will promote energy efficiency and, if applicable, innovative construction or
rehabilitation methods or technologies to be used that will promote efficient construction. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
21. For group homes to be licensed as intermediate care facilities (in which funding for the intermediate care is provided
under Title XIX of the Social Security Act) that serve persons with developmental disabilities, the following must
be submitted: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) Evidence demonstrating that the proposed project will primarily provide housing rather than medical facilities,
and is or will be licensed by appropriate State agencies; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Description of the medical training of the staff of the proposed facility and any nursing services that will be
required by the residents on-site; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) Description of the services that will be funded by Medicaid for residents of the proposed project, including their
nature, frequency and where the services are to be provided; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) Description of any special design features proposed for the group home that are not common to other section 811
group homes for the proposed population and the Sponsor's rationale for including them; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) Written evidence that the State Medicaid Office recognizes the need for a tenant contribution to rent and has agreed
to pay the cost of the tenant contribution in the Medicaid payment to the Owner; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00182 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(f) statement certifying that the Individual Program Plan for each resident will include participation in an out-of-the-home
activity program for at least six hours each work day. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Additional Information 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Sites 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The National Affordable Housing Act requires Sponsors submitting applications for section 811 fund reservations
to provide either (a) evidence of site control, or (b) reasonable assurances that it will have control of a site within
6 months of notification of fund reservation. Accordingly, if a Sponsor has control of a site at the time it submits
its application, it must include evidence of such as described in &sect;890.265. If it does not have site control,
it must provide the information required in &sect;890.265 as a reasonable assurance that site control will be obtained
within 6 months of fund reservation notification.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sponsors may select a site different from the one(s) submitted in their original applications if the original site
is not approvable. Selection of a different site will require HUD performance of an environmental review on the new
site, which could result in rejection of that site. However, if a Sponsor does not have site control for any reason 12
months after notification of fund reservation, the assistance will be recaptured and reallocated. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sponsors submitting satisfactory evidence of an approvable site (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
i.e.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, site control) will compete against each other in Category A. Sponsors submitting proper identification of a site
will compete against each other in Category B. HUD first shall select applications in the descending order of funding
priority from Category A that most closely approximates the capital advance authority provided to the allocation
area. If capital advance authority remains after selecting all approvable applications from Category A, HUD shall
then select applications in the descending order of funding priority from Category B that most closely approximates
the capital advance authority remaining in the allocation area. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Applications containing evidence of site control where either the evidence or the site is not approvable will 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
not
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 be rejected provided the application indicates the Sponsor's willingness to select another site and an assurance
that site control will be obtained within six months of fund reservation notification. Such applications will compete
for selection in Category B. However, only those applications where the evidence of site control was not approvable
will be eligible to receive any of the possible 17 points under selection criteria (b) (2) and (3) (see I.D.3.(b) (2)
and (3) above). Applications where the site was rejected will receive 0 points under selection criteria (b) (2) and
(3). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In the case of a scattered site application submitted with evidence of site control for all of the sites, the evidence
must be satisfactory for each site and all the sites must be approvable for the application to compete in Category A.
If such an application does not fulfill this requirement, it will be placed in Category B and will be eligible to receive
a prorated share of the 17 points possible under selection criteria (b) (2) and (3) based on the number of sites that
are approvable. The same applies to a scattered site application in which the Sponsor has control of some of the sites
and has identified others. It would also be considered in Category B and would be eligible for a prorated share of the
17 points as stated above. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00183 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
V. Other Matters 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Environmental Impact 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A Finding of No Significant Impact with respect to the environment has been made in accordance with HUD regulations
that implement section 102(2)(C) of the National Environmental Policy Act of 1969, 42 U.S.C. 4332. The Finding of
No Significant Impact is available for public inspection during business hours in the Office of the Rules Docket Clerk,
Office of General Counsel, room 10276, Department of Housing and Urban Development, 451 Seventh Street, Southwest,
Washington, DC 20410. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Federalism Executive Order 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The General Counsel, as the Designated Official under section 6(a) of Executive Order No. 12612, Federalism, has
determined that this NOFA does not have substantial direct effects on States or their political subdivisions, or
on the relationship between the Federal government and the States, or on the distribution of power and responsibilities
among the various levels of government. This NOFA merely notifies the public of the availability of capital advances
for supportive housing for persons with disabilities. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Family Executive Order 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The General Counsel, as the Designated Official under Executive Order No. 12606, The Family, has determined that
this NOFA does not significantly affect family formation, maintenance, or general well-being, and, thus, is not
subject to review under the order. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
D. Accountability in the Provision of HUD Assistance 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
HUD has promulgated a final rule to implement section 102 of the Department of Housing and Urban Development Reform
Act of 1989 (HUD Reform Act). The final rule is codified at 24 CFR part 12. Section 102 contains a number of provisions
that are designed to ensure greater accountability and integrity in the provision of certain types of assistance
administered by HUD. On January 14, 1992, HUD published at 57 FR 1942, additional information that gave the public
(including applicants for, and recipients of, HUD assistance) further information on the implementation, public
access, and disclosure requirements of section 102. The documentation, public access, and disclosure requirements
of section 102 are applicable to assistance awarded under this NOFA as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
1. Documentation and Public Access
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
HUD will ensure documentation and other information regarding each application submitted pursuant to this NOFA
are sufficient to indicate the basis upon which assistance was provided or denied. This material, including any letters
of support, will be made available for public inspection for a five-year period beginning not less than 30 days after
the award of the assistance. Material will be made available in accordance with the Freedom of Information Act (5 U.S.C.
552) and HUD's implementing regulations at 24 CFR part 15. In addition, HUD will include the recipients of assistance
pursuant to this NOFA in its quarterly 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice of all recipients of HUD assistance awarded on a competitive basis. (See 24 CFR 12.14(a) and 12.16(b), and the
notice published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on January 16, 1992 (57 FR 1942), for further information on these requirements.) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2. Disclosures
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
HUD will make available to the public for five years all applicant disclosure reports (HUD Form 2880) submitted in
connection with this NOFA. Update reports (also Form 2880) will be made available along with the applicant disclosure
reports, but in no case for a period less than three years. All reports_both applicant disclosures and updates_will
be made available in accordance with the Freedom of Information Act (5 U.S.C. 552) and HUD's implementing regulations
at 24 CFR part 15. (See 24 CFR subpart C, and the notice published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on January 16, 1992 (57 FR 1942), for further information on these disclosure requirements.) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
E. Documentation and Public Access Requirements: HUD Reform Act 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
HUD will ensure that documentation and other information regarding each application submitted pursuant to this
NOFA are sufficient to indicate the basis upon which assistance was provided or denied. This material, including
any letters of support, will be made available for public inspection for a five-year period beginning not less than
30 days after the award of the assistance. Material will be made available in accordance with the Freedom of Information
Act (5 U.S.C. 552) and HUD's implementing regulations at 24 CFR part 15. In addition, HUD will include the recipients
of assistance pursuant to this NOFA in its quarterly 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice of all recipients of HUD assistance awarded on a competitive basis. (See CFR 12.14(a) and 12.16(b), and the
notice published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on January 16, 1992 (57 FR 1942), for further information on these requirements.) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
F. Section 103 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
HUD's regulation implementing section 103 of the Department of Housing and Urban Development Reform Act of 1989 was
published May 13, 1991 (56 FR 22088) and became effective on June 12, 1991. That regulation, codified as 24 CFR part
4, applies to the funding competition announced today. The requirements of the rule continue to apply until the announcement
of the selection of successful applicants. 
<!-- PJG 0012 frnewline -->
HUD employees involved in the review of applications and in the making of funding decisions are restrained by Part
4 from providing advance information to any person (other than an authorized employee of HUD) concerning funding
decisions, or from otherwise giving any applicant an unfair competitive advantage. Persons who apply for assistance
in this competition should confine their inquiries to the subject areas permitted under 24 CFR part 4. 
<!-- PJG 0012 frnewline -->
Applicants who have questions should contact the HUD Office of Ethics (202) 708&hyph;3815 (TDD/Voice). (This is
not a toll-free number.) The Office of Ethics can provide information of a general nature to HUD employees, as well.
However, a HUD employee who has specific program questions, such as whether particular subject matter can be discussed
with persons outside the Department, should contact his or her Regional or Field Office Counsel, or Headquarters
counsel for the program to which the question pertains. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
G. Lobbying 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 13 of the Department of Housing and Urban Development Act (42 U.S.C. 3537b) contains two provisions dealing
with efforts to influence HUD's decisions with respect to financial assistance. The first imposes disclosure requirements
on those who are typically involved in these efforts_those who pay others to influence the award of assistance or the
taking of a management action by the Department and those who are paid to provide the influence. The second restricts
the payment of fees to those who are paid to influence the award of HUD assistance, if the fees are tied to the number of
housing units received or are based on the amount of assistance received, or if they are contingent upon the receipt
of assistance. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00184 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 13 was implemented by final rule published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on May 17, 1991 (56 FR 22912). If readers are involved in any efforts to influence the Department in these ways, they
are urged to read the final rule, particularly the examples contained in Appendix A of the rule. 
<!-- PJG 0012 frnewline -->
Any questions regarding the rule should be directed to the Director, Office of Ethics, Room 2158, Department of Housing
and Urban Development, 451 Seventh Street, SW., Washington, DC 20410. Telephone: (202) 708&hyph;3815 TDD/Voice).
(This is not a toll-free number.) Forms necessary for compliance with the rule may be obtained from the local HUD office.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
H. Prohibition Against Lobbying Activities 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The use of funds awarded under this NOFA is subject to the disclosure requirements and prohibitions of Section 319
of the Department of Interior and Related Agencies Appropriations Act for Fiscal Year 1990 (31 U.S.C. 1352) (the ``Byrd
Amendment'') and the implementing regulations at 24 CFR part 87. These authorities prohibit recipients of federal
contracts, grants or loans from using appropriated funds for lobbying the Executive or Legislative Branches of the
Federal Government in connection with a specific contract, grant or loan. The prohibition also covers the awarding
of contracts, grants, cooperative agreements or loans unless the recipient has made an acceptable certification
regarding lobbying. Under 24 CFR part 87, applicants, recipients and subrecipients of assistance exceeding $100,000
must certify that no federal funds have been or will be spent on lobbying activities in connection with the assistance.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
I. Catalog of Federal Domestic Assistance Program 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Catalog of Federal Domestic Assistance Program title and number is 14.181, Supportive Housing for Persons with
Disabilities. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Section 811, National Affordable Housing Act, as amended (42 U.S.C. 8013), Section 7(d), Department of Housing and
Urban Development Act (42 U.S.C. 3535(d)). 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 12, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Nicolas P. Retsinas,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Secretary for Housing, Federal Housing Commissioner.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00185 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Appendix A_HUD Field Offices
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Regional and Field Office Directory
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
HUD Field Offices_Region I
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Boston, Massachusetts Regional Office
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Jeanne McHallam, Director_Housing Development, HUD-Boston Regional Office, Room 375, Thomas P. O'Neill, Jr. Federal
Building, 10 Causeway Street, Boston, Massachusetts 02222&hyph;1092, (617) 565&hyph;5234, FAX (617) 565&hyph;525
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Hartford, Connecticut Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Ronald Black, Director, Housing Development, HUD-Hartford Office, 330 Main Street, Hartford, Connecticut 06106&hyph;1860,
(203) 240&hyph;4523, FAX (203) 240&hyph;467
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Manchester, New Hampshire Office (B)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Loren W. Cole, Director, Housing Development, HUD-Manchester Office, Norris Cotton Federal Building, 275 Chestnut
Street, Manchester, New Hampshire 03103&hyph;2487, (603) 666&hyph;7681, FAX (603) 666&hyph;7736
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Providence, Rhode Island Office (B)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Michael Dziok, Director, Housing Development, HUD-Providence Office, 330 John O. Pastore Federal Building and
U.S. Post Office_Kennedy Plaza, Providence, Rhode Island 02902&hyph;1785, (401) 528&hyph;5351, FAX (401) 528&hyph;5312
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region II
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
New York Regional Office
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Martin Sckalor, Director, Housing Development, Regional Housing Commissioner, HUD-New York Regional Office,
26 Federal Plaza, New York, New York 10278&hyph;0068, (212) 264&hyph;6500, FAX (212) 264&hyph;0246
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Buffalo, New York Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Robert Rifenberick, Director, Housing Development, HUD-Buffalo Office, 5th Floor, Lafayette Court, 465 Main Street,
Buffalo, New York 14203&hyph;1780, (716) 846&hyph;5755, FAX (716) 846&hyph;5752
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Newark, New Jersey Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Geraldine McGann, Director, Housing Development, HUD-Newark Office, 1 Newark Center, Newark, New Jersey 07102&hyph;5504,
(201) 622&hyph;7900 Ext. 3102, FAX (201) 645&hyph;2323
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region III
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Philadelphia Regional Office
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Michael J. Perretta, Director, Housing Development, HUD-Philadelphia Regional Office, Liberty Square Building,
105 South 7th Street, Philadelphia, Pennsylvania 19106&hyph;3392, (215) 597&hyph;2560, FAX (215) 597&hyph;9627
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Baltimore, Maryland Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Candace L. Simms, Director, Housing Development, HUD-Baltimore Office, 5th Floor, City Crescent Building, 10 South
Howard Street, Baltimore, Maryland 21201&hyph;2505, (410) 962&hyph;2520, FAX (410) 962&hyph;4947
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Charleston, West Virginia Office (B)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Robert J. Gibson, Chief, Housing Development, HUD-Charleston Office, Suite 708, 405 Capitol Street, Charleston,
West Virginia 25301&hyph;1795, (304) 347&hyph;7000, FAX (304) 347&hyph;7050
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Pittsburgh, Pennsylvania Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Edward Palombizio, Director_Housing Development, HUD-Pittsburgh Office, 412 Old Post Office Courthouse, 7th
Avenue &amp; Grant Street, Pittsburgh, Pennsylvania 15219, (412) 644&hyph;6428, FAX (412) 644&hyph;6499
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Richmond, Virginia Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Charlie Famuliner, Director_Housing Development, HUD-Richmond Office, The 3600 Centre, 3600 West Broad Street,
P. O. Box 90331, Richmond, Virginia 23230&hyph;0331, (804) 278&hyph;4507, FAX (804) 771&hyph;2314
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Washington, DC Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Felicia Williams, Director_Housing Development, HUD-Washington, DC Office, Suite 300, Union Center Plaza, Phase
II, 820 First Street, NE, Washington, DC 20002&hyph;4205, (202) 275&hyph;9200, FAX (202) 275&hyph;0779
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00186 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region IV
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Atlanta, Georgia Regional Office
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Gayle F. Burbidge, Director_Housing Development, Richard B. Russell Federal Building, 75 Spring Street, SW., Atlanta,
Georgia 30303&hyph;3388, (404) 331&hyph;5136, FAX (404) 331&hyph;0845
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Birmingham, Alabama Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Martha K. Andus, Acting Director_Housing Development, HUD-Birmingham Office, Suite 300, Beacon Ridge Tower, 600
Beacon Parkway West, Birmingham, Alabama 35209&hyph;3144, (205) 290&hyph;7617, FAX (205) 290&hyph;7593
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Caribbean Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Alberto Rosado, Director_Housing Development, HUD-Caribbean Office, New San Juan Office Building, 159 Carlos
E. Chardon Avenue, San Juan, Puerto Rico 00918&hyph;1804, (809) 766&hyph;6121, FAX (809) 766&hyph;5995
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Columbia, South Carolina Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Keene R. LaFountain, Director_Housing Development, HUD-Columbia Office, Strom Thurmond Federal Building, 1835
Assembly Street, Columbia, South Carolina 29201&hyph;2480, (803) 765&hyph;5592, FAX (803) 765&hyph;5515
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Greensboro, North Carolina (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Daniel A. McCanless, Director_Housing Development, HUD-Greensboro Office, Koger Building, 2306 West Meadowview
Road, Greensboro, North Carolina 27407&hyph;3707, (919) 547&hyph;4001, FAX (919) 547&hyph;4015
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Jackson, Mississippi Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Reba G. Cook, Director_Housing Development, HUD-Jackson Office, Dr. A.H. McCoy Federal Building, 100 West Capitol
Street, Room 910, Jackson, Mississippi 39269&hyph;1096, (601) 965&hyph;5308, FAX (601) 965&hyph;4773
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Jacksonville, Florida Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Donald E. Odenthal, Director_Housing Development, HUD-Jacksonville Office, Suite 2200, Southern Bell Tower,
301 West Bay Street, Jacksonville, Florida 32202&hyph;5121, (904) 232&hyph;2626, FAX (904) 232&hyph;3759
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Knoxville, Tennessee Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
John E. Robbins, Director_Housing Management, HUD-Knoxville Office, Third Floor, John J. Duncan Federal Building,
710 Locust Street, SW., Knoxville, Tennessee 37902&hyph;2526, (615) 545&hyph;4384, FAX (615) 545&hyph;4569
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Louisville, Kentucky Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
David A. Powell, Director_Housing Development, HUD-Louisville Office, 601 West Broadway, P.O. Box 1044, Louisville,
Kentucky 40201&hyph;1044, (502) 582&hyph;5251, FAX (502) 582&hyph;6074
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Nashville, Tennessee Office (B)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Ed M. Phillips, Director_Housing Development, HUD-Nashville Office, Suite 200, 251 Cumberland Bend Drive, Nashville,
Tennessee 37228&hyph;1803, (615) 736&hyph;5213, FAX (615) 736&hyph;2018
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region V
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Chicago, Illinois Regional Office
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Louis Berra, Director_Housing Development, HUD-Chicago Regional Office, Ralph Metcalfe Federal Building, 77
West Jackson Boulevard, Chicago, Illinois 60604&hyph;3507, (312) 353&hyph;5680, FAX (312) 353&hyph;0121
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Cincinnati, Ohio Office (B)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Loustine Tuck, Director_Housing Development, HUD-Cincinnati Office, Room 9002, Federal Office Building, 550
Main Street, Cincinnati, Ohio 45202&hyph;3253, (513) 684&hyph;2884, FAX (513) 684&hyph;6224
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Cleveland, Ohio Office (B)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Phillip J. Giaconia, Director_Housing Development, HUD-Cleveland Office, Room 420, One Playhouse Square, 1375
Euclid Avenue, Cleveland, Ohio 44114&hyph;1670, (216) 522&hyph;4065, FAX (216) 522&hyph;2975
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Columbus, Ohio Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Don Jakob, Director_Housing Development, HUD-Columbus Office, 200 North High Street, Columbus, Ohio 43215&hyph;2499,
(614) 469&hyph;5737, FAX (614) 469&hyph;2432
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Detroit, Michigan Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Robert Brown, Director_Housing Development, HUD-Detroit Office, Patrick V. McNamara Federal Building, 477 Michigan
Avenue, Detroit, Michigan 48226&hyph;2592, (313) 226&hyph;7900, FAX (313) 226&hyph;4394
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Grand Rapids, Michigan Office (B)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
John Milchick, Director_Housing Development, HUD-Grand Rapids Office, 2922 Fuller Avenue, N.E., Grand Rapids,
Michigan 49505&hyph;3499, (616) 456&hyph;2100, FAX (616) 456&hyph;2191
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Indianapolis, Indiana Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Erica Dobreff, Director_Housing Development, HUD-Indianapolis Office, 151 North Delaware Street, Indianapolis,
Indiana 46204&hyph;2526, (317) 226&hyph;6303, FAX (317) 226&hyph;6317
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Milwaukee, Wisconsin Office (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Lester Marriner, Director_Housing Development, HUD-Milwaukee Office, Suite 1380, Henry S. Reuss Federal Plaza,
310 West Wisconsin Avenue, Milwaukee, Wisconsin 53203&hyph;2289, (414) 297&hyph;3214, FAX (414) 297&hyph;3947
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Minneapolis-St. Paul, Minnesota (A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
John Buenger, Director_Housing Development, HUD-Minneapolis-St. Paul Office, 220 Second Street, South, Minneapolis,
Minnesota 55401&hyph;2195, (612) 370&hyph;3000, FAX (612) 370&hyph;3220 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00187 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region VI 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Fort Worth, Texas Regional Office 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Larry Mumford, 
<!-- PJG 0012 frnewline -->
Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-Fort Worth Regional Office, 
<!-- PJG 0012 frnewline -->
1600 Throckmorton, 
<!-- PJG 0012 frnewline -->
P.O. Box 2905, 
<!-- PJG 0012 frnewline -->
Fort Worth, Texas 76113&hyph;2905, 
<!-- PJG 0012 frnewline -->
(817) 885&hyph;5401, FAX (817) 885&hyph;5629
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Houston, Texas Office (B) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Allen J. Novosad, 
<!-- PJG 0012 frnewline -->
Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-Houston Office, 
<!-- PJG 0012 frnewline -->
Suite 200, 
<!-- PJG 0012 frnewline -->
Norfolk Tower, 
<!-- PJG 0012 frnewline -->
2211 Norfolk, 
<!-- PJG 0012 frnewline -->
Houston, Texas 77098&hyph;4096, 
<!-- PJG 0012 frnewline -->
(713) 653&hyph;3274, FAX (713) 653&hyph;3319 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Little Rock, Arkansas Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Nathan Abernathy, 
<!-- PJG 0012 frnewline -->
Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-Little Rock Office, 
<!-- PJG 0012 frnewline -->
Suite 900, 
<!-- PJG 0012 frnewline -->
TCBY Tower, 
<!-- PJG 0012 frnewline -->
425 West Capitol Avenue, 
<!-- PJG 0012 frnewline -->
Little Rock, Arkansas 72201&hyph;3488, 
<!-- PJG 0012 frnewline -->
(501) 324&hyph;5931, FAX (501) 324&hyph;5900 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
New Orleans, Louisiana Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Jose A. Pagan, 
<!-- PJG 0012 frnewline -->
Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-New Orleans Office, 
<!-- PJG 0012 frnewline -->
Fisk Federal Building, 
<!-- PJG 0012 frnewline -->
1661 Canal Street, 
<!-- PJG 0012 frnewline -->
New Orleans, Louisiana 70112&hyph;1887, 
<!-- PJG 0012 frnewline -->
(504) 589&hyph;7200, FAX (504) 589&hyph;2917 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Oklahoma City, Oklahoma Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Sherry Hunt, 
<!-- PJG 0012 frnewline -->
Acting Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-Oklahoma City Office, 
<!-- PJG 0012 frnewline -->
Murrah Federal Building, 
<!-- PJG 0012 frnewline -->
200 N.W. 5th Street, 
<!-- PJG 0012 frnewline -->
Oklahoma 73102&hyph;3202, 
<!-- PJG 0012 frnewline -->
(405) 231&hyph;4181, FAX (405) 231&hyph;4648 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
San Antonio, Texas Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Robert W. Hicks, 
<!-- PJG 0012 frnewline -->
Acting Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-San Antonio Office, 
<!-- PJG 0012 frnewline -->
Washington Square Building, 
<!-- PJG 0012 frnewline -->
800 Dolorosa Street, 
<!-- PJG 0012 frnewline -->
San Antonio, Texas 78207&hyph;4563, 
<!-- PJG 0012 frnewline -->
(210) 229&hyph;6800, FAX (210) 229&hyph;6753
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region VII 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Kansas City, Kansas Regional Office 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Richard Kluge, 
<!-- PJG 0012 frnewline -->
Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-Kansas City Regional Office, 
<!-- PJG 0012 frnewline -->
Room 200, 
<!-- PJG 0012 frnewline -->
Gateway Tower II, 
<!-- PJG 0012 frnewline -->
400 State Avenue, 
<!-- PJG 0012 frnewline -->
Kansas City, Kansas 66101&hyph;2406, 
<!-- PJG 0012 frnewline -->
(913) 236&hyph;2162 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Des Moines, Iowa Office (B) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Donna Davis, 
<!-- PJG 0012 frnewline -->
Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-Des Moines Office, 
<!-- PJG 0012 frnewline -->
Room 239, 
<!-- PJG 0012 frnewline -->
Federal Building, 
<!-- PJG 0012 frnewline -->
210 Walnut Street, 
<!-- PJG 0012 frnewline -->
Des Moines, Iowa 50309&hyph;2155, 
<!-- PJG 0012 frnewline -->
(515) 284&hyph;4512, FAX (515) 284&hyph;4743 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Omaha, Nebraska Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Robert E. Peterson, 
<!-- PJG 0012 frnewline -->
Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-Omaha Office, 
<!-- PJG 0012 frnewline -->
Executive Tower Centre, 
<!-- PJG 0012 frnewline -->
10909 Mill Valley Road, 
<!-- PJG 0012 frnewline -->
Omaha, Nebraska 68154&hyph;3955, 
<!-- PJG 0012 frnewline -->
(402) 492&hyph;3101, FAX (402) 492&hyph;3150 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
St. Louis, Missouri Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Joy Miller, 
<!-- PJG 0012 frnewline -->
Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-St. Louis Office, 
<!-- PJG 0012 frnewline -->
Third Floor, 
<!-- PJG 0012 frnewline -->
Robert A. Young Federal Building, 
<!-- PJG 0012 frnewline -->
1222 Spruce Street, 
<!-- PJG 0012 frnewline -->
St. Louis, Missouri 63103&hyph;2836, 
<!-- PJG 0012 frnewline -->
(314) 539&hyph;6560, FAX (314) 539&hyph;6575 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region VIII 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Denver, Colorado Regional Office 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Arthur Tonilli, 
<!-- PJG 0012 frnewline -->
Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-Denver Regional Office, 
<!-- PJG 0012 frnewline -->
Executive Tower Building, 
<!-- PJG 0012 frnewline -->
1405 Curtis Street, 
<!-- PJG 0012 frnewline -->
Denver, Colorado 80202&hyph;2349, 
<!-- PJG 0012 frnewline -->
(303) 844&hyph;4513, FAX (303) 844&hyph;2475 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00188 </DOCNO>
<PARENT> FR940202-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region IX 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
San Francisco, California Regional Office 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Jayne Hulbert Humphrey, 
<!-- PJG 0012 frnewline -->
Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-San Francisco Regional Office, 
<!-- PJG 0012 frnewline -->
Philip Burton Federal Building &amp; U.S. Courthouse, 
<!-- PJG 0012 frnewline -->
450 Golden Gate Avenue, 
<!-- PJG 0012 frnewline -->
P.O. Box 36003, 
<!-- PJG 0012 frnewline -->
San Francisco, California 94102&hyph;3448, 
<!-- PJG 0012 frnewline -->
(415) 556&hyph;4752, FAX (415) 556&hyph;4176 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Honolulu, Hawaii Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Jill Hurt, 
<!-- PJG 0012 frnewline -->
Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-Honolulu Office, 
<!-- PJG 0012 frnewline -->
Suite 500, 
<!-- PJG 0012 frnewline -->
Seven Waterfront Plaza, 
<!-- PJG 0012 frnewline -->
500 Ala Moana Blvd., 
<!-- PJG 0012 frnewline -->
Honolulu, Hawaii 96813&hyph;4918, 
<!-- PJG 0012 frnewline -->
(808) 541&hyph;1323, FAX (808) 541&hyph;3146 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Los Angeles, California Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Joe L. Hirsch, 
<!-- PJG 0012 frnewline -->
Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-Los Angeles Office, 
<!-- PJG 0012 frnewline -->
1615 West Olympic Boulevard, 
<!-- PJG 0012 frnewline -->
Los Angeles, California 90015&hyph;3801, 
<!-- PJG 0012 frnewline -->
(213) 251&hyph;7122, FAX (213) 251&hyph;7096 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Phoenix, Arizona Office (B) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Laura Massie, 
<!-- PJG 0012 frnewline -->
Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-Phoenix Office, 
<!-- PJG 0012 frnewline -->
Suite 600, 
<!-- PJG 0012 frnewline -->
Two Arizona Center, 
<!-- PJG 0012 frnewline -->
400 North 5th Street, 
<!-- PJG 0012 frnewline -->
Phoenix, Arizona 85004&hyph;2361, 
<!-- PJG 0012 frnewline -->
(602) 379&hyph;4434, FAX (602) 379&hyph;3985 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Sacramento, California Office (B) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Williams F. Bolton, 
<!-- PJG 0012 frnewline -->
Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-Sacramento Office, 
<!-- PJG 0012 frnewline -->
Suite 200, 
<!-- PJG 0012 frnewline -->
777 12th Street, 
<!-- PJG 0012 frnewline -->
Sacramento, California 95814&hyph;1977, 
<!-- PJG 0012 frnewline -->
(916) 551&hyph;1351, FAX (916) 551&hyph;2899 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region X 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Seattle, Washington Regional Office
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
John H. Taylor, 
<!-- PJG 0012 frnewline -->
Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-Seattle Regional Office, 
<!-- PJG 0012 frnewline -->
Suite 200, 
<!-- PJG 0012 frnewline -->
Seattle Federal Office Building, 
<!-- PJG 0012 frnewline -->
909 First Avenue, 
<!-- PJG 0012 frnewline -->
Seattle, Washington 98104&hyph;1000, 
<!-- PJG 0012 frnewline -->
(206) 220&hyph;5101, FAX (206) 553&hyph;4405 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Anchorage, Alaska Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Gene Dobrzynski, 
<!-- PJG 0012 frnewline -->
Chief_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-Anchorage Office, 
<!-- PJG 0012 frnewline -->
Suite 401, 
<!-- PJG 0012 frnewline -->
University Plaza Building, 
<!-- PJG 0012 frnewline -->
949 East 36th Avenue, 
<!-- PJG 0012 frnewline -->
Anchorage, Alaska 99508&hyph;4135, 
<!-- PJG 0012 frnewline -->
(907) 271&hyph;4170, FAX (907) 271&hyph;3667 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Portland, Oregon Office (A) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Thomas C. Cusack, 
<!-- PJG 0012 frnewline -->
Director_Housing Development, 
<!-- PJG 0012 frnewline -->
HUD-Portland Office, 
<!-- PJG 0012 frnewline -->
520 S.W. 6th Avenue, 
<!-- PJG 0012 frnewline -->
Portland, Oregon 97204&hyph;1596, 
<!-- PJG 0012 frnewline -->
(503) 326&hyph;2561, FAX (503) 326&hyph;3097 
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;2295 Filed 2&hyph;1&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4210&hyph;27&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940202-2-00189 </DOCNO>
<PARENT> FR940202-2-00075 </PARENT>
<TEXT>
</TEXT>
</DOC>



